primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Vomiting,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Fall,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Malaise,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Contusion,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Incorrect dose administered,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Ear infection,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Asthenopia,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Balance disorder,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Cataract,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Injection site pain,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Fatigue,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Dyspepsia,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Blood pressure systolic increased,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Insomnia,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Injection site haemorrhage,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Facial paralysis,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Weight decreased,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Obesity,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Ear pain,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Product dispensing error,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Blood pressure increased,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
1088525223,10885252,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Injection site mass,,2022,Q1,23,F,20140520.0,20220303.0,20150304,20220309,EXP,,PHHY2014CA065210,NOVARTIS,,62.0,YR,,F,Y,,,20220309,,CN,CA,CA,2022,Q1,Adult
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hypophagia,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Off label use,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Fall,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
121889382,12188938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,2,F,20160303.0,20160309.0,20160317,20220120,EXP,,CA-AstraZeneca-2016SE27977,ASTRAZENECA,,24206.0,DY,,M,Y,,,20220120,,HP,CA,,2022,Q1,Elderly
1368182612,13681826,43,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Hypothyroidism,,2022,Q1,12,F,20170119.0,20220316.0,20170623,20220321,EXP,,CN-ROCHE-1954213,ROCHE,,68.0,YR,,M,Y,76.0,KG,20220321,,MD,CN,,2022,Q1,Elderly
1368182612,13681826,43,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Blood creatine phosphokinase increased,,2022,Q1,12,F,20170119.0,20220316.0,20170623,20220321,EXP,,CN-ROCHE-1954213,ROCHE,,68.0,YR,,M,Y,76.0,KG,20220321,,MD,CN,,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day(BLINDED)",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
1415655010,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,10,F,20171010.0,20220316.0,20171103,20220329,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220329,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Malaise,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Hypotension,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Feeling hot,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Epididymitis,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
141686066,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q1,Groin pain,,2022,Q1,6,F,20171010.0,20220317.0,20171108,20220328,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220328,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Feeling hot,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Groin pain,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
142831995,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20171010.0,20220304.0,20171213,20220314,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,78.0,YR,,M,Y,,,20220314,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Blood urine present,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Blood urine present,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Blood urine present,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Blood urine present,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Polyuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Haematuria,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Weight decreased,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148220377,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,7,F,20180201.0,20220302.0,20180427,20220315,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220315,,MD,GB,GB,2022,Q1,Elderly
148502703,14850270,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12160.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20171012.0,20220127.0,20180505,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20220210,,MD,GB,GB,2022,Q1,Elderly
148502703,14850270,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12160.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,3,F,20171012.0,20220127.0,20180505,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20220210,,MD,GB,GB,2022,Q1,Elderly
148502703,14850270,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12160.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,3,F,20171012.0,20220127.0,20180505,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-023700,AUROBINDO,,78.0,YR,,M,Y,,,20220210,,MD,GB,GB,2022,Q1,Elderly
149074817,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,7,F,20171010.0,20220318.0,20180517,20220331,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220331,,MD,GB,GB,2022,Q1,Elderly
149074817,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,7,F,20171010.0,20220318.0,20180517,20220331,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220331,,MD,GB,GB,2022,Q1,Elderly
149074817,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,7,F,20171010.0,20220318.0,20180517,20220331,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220331,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Blood urine present,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Blood urine present,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
149166442,14916644,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,2,F,20180201.0,20220127.0,20180519,20220209,EXP,,GB-AUROBINDO-AUR-APL-2018-021014,AUROBINDO,,72.0,YR,,M,Y,107.0,KG,20220209,,MD,GB,GB,2022,Q1,Elderly
150823354,15082335,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unknown/Also received from 01-Jan-2015, 10 mg",,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Weight decreased,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unknown/Also received from 01-Jan-2015, 10 mg",,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Polyuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unknown/Also received from 01-Jan-2015, 10 mg",,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Haematuria,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
150823354,15082335,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unknown/Also received from 01-Jan-2015, 10 mg",,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Prostatic haemorrhage,,2022,Q1,4,F,20180201.0,20220308.0,20180628,20220318,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-TEVA-2018-GB-914153,TEVA,,72.0,YR,E,M,Y,93.2,KG,20220318,,CN,GB,GB,2022,Q1,Elderly
1565076312,15650763,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q1,Ischaemic stroke,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
1565076312,15650763,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q1,Headache,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
1565076312,15650763,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q1,Chest pain,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Ischaemic stroke,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Chest pain,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
159355644,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,4,F,20180201.0,20220215.0,20190208,20220225,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220225,,MD,GB,GB,2022,Q1,Elderly
159355644,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,4,F,20180201.0,20220215.0,20190208,20220225,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220225,,MD,GB,GB,2022,Q1,Elderly
159355644,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,4,F,20180201.0,20220215.0,20190208,20220225,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220225,,MD,GB,GB,2022,Q1,Elderly
159355644,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,4,F,20180201.0,20220215.0,20190208,20220225,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220225,,MD,GB,GB,2022,Q1,Elderly
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Fatigue,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Heart rate increased,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Gastritis,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Herpes zoster,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Heart rate increased,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Fatigue,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Restlessness,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Lymphadenopathy,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Hyperglycaemia,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Headache,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
1594711010,15947110,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Post herpetic neuralgia,,2022,Q1,10,F,20190807.0,20220125.0,20190212,20220203,EXP,,DE-ROCHE-2259750,ROCHE,,46.0,YR,,M,Y,105.0,KG,20220203,,CN,DE,,2022,Q1,Adult
161433637,16143363,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q1,Clear cell renal cell carcinoma,,2022,Q1,7,F,20190325.0,20220316.0,20190401,20220324,EXP,,BR-JNJFOC-20190342024,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,98.4,KG,20220324,,MD,BR,BR,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Body mass index increased,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Hypoglycaemia,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Latent autoimmune diabetes in adults,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Postprandial hypoglycaemia,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Blood glucose increased,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
162066044,16206604,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,U,,,,5.0,MG,,QD,2022,Q1,Drug ineffective,,2022,Q1,4,F,,20220311.0,20190417,20220324,EXP,,PT-AUROBINDO-AUR-APL-2019-020144,AUROBINDO,"Guiomar J. R., Moreno C., PaivaI., Cardoso L.M., Cunha N., Catarino D., et al.,.. Metabolic Surgery As An Option In The Treatment Of The Diabetes Mellitus In Selected Cases.. Revista Portuguesa de Diabetes.. 2019;14(1):47-122",52.0,YR,,F,Y,,,20220324,,HP,PT,PT,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Neutrophil percentage increased,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Malaise,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Off label use,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Weight increased,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Illness,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Pneumonia,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Eosinophil count increased,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Thinking abnormal,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Drug hypersensitivity,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Nasopharyngitis,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Drug effective for unapproved indication,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Eye disorder,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Ear discomfort,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Depression,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
1648059328,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q1,Crying,,2022,Q1,28,F,20150101.0,20220328.0,20190626,20220330,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220330,,CN,US,US,2022,Q1,Adult
170998849,17099884,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Chorioretinopathy,,2022,Q1,9,F,20180301.0,20220323.0,20191202,20220328,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20220329,,MD,ES,,2022,Q1,Adult
170998849,17099884,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Nephritis,,2022,Q1,9,F,20180301.0,20220323.0,20191202,20220328,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20220329,,MD,ES,,2022,Q1,Adult
170998849,17099884,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Nephritis,,2022,Q1,9,F,20180301.0,20220323.0,20191202,20220328,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20220329,,MD,ES,,2022,Q1,Adult
170998849,17099884,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Nephritis,,2022,Q1,9,F,20180301.0,20220323.0,20191202,20220328,EXP,,ES-ROCHE-2321521,ROCHE,,57.0,YR,,M,Y,83.0,KG,20220329,,MD,ES,,2022,Q1,Adult
173607197,17360719,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4250.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Influenza,,2022,Q1,7,F,20200113.0,20220127.0,20200203,20220210,EXP,,JP-AstraZeneca-2020SE13889,ASTRAZENECA,"Hashi R, Fujiki N, Yagi T. Tubular Injury Causing Protracted Glycosuria Following Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in the Development of Protracted Hypoglycemia and Ketoacidosis. Tohoku J. Exp. Med. 2021;255(S):291-296.",16464.0,DY,,F,Y,42.0,KG,20220210,,MD,JP,,2022,Q1,Elderly
173607197,17360719,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4250.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,7,F,20200113.0,20220127.0,20200203,20220210,EXP,,JP-AstraZeneca-2020SE13889,ASTRAZENECA,"Hashi R, Fujiki N, Yagi T. Tubular Injury Causing Protracted Glycosuria Following Withdrawal of a Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor: A Possible Role in the Development of Protracted Hypoglycemia and Ketoacidosis. Tohoku J. Exp. Med. 2021;255(S):291-296.",16464.0,DY,,F,Y,42.0,KG,20220210,,MD,JP,,2022,Q1,Elderly
174776063,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Prostatic haemorrhage,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
174776063,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q1,Polyuria,,2022,Q1,3,F,20180201.0,20220321.0,20200228,20220323,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220323,,MD,GB,GB,2022,Q1,Elderly
178216154,17821615,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram,,,,,,,,10.0,MG,Tablets,QD,2022,Q1,Colitis ulcerative,,2022,Q1,4,F,20191222.0,20220214.0,20200525,20220218,EXP,,IT-CELGENEUS-ITA-20200506828,CELGENE,,63.0,YR,,M,Y,81.0,KG,20220218,,MD,IT,IT,2022,Q1,Adult
180204022,18020402,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, QD",,,Y,,,,,5.0,MG,,QD,2022,Q1,Confusional state,,2022,Q1,2,F,20200611.0,20220309.0,20200714,20220316,EXP,,NVSC2020CH193125,NOVARTIS,,61.0,YR,,M,Y,,,20220316,,MD,CH,CH,2022,Q1,Adult
180204022,18020402,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, QD",,,Y,,,,,5.0,MG,,QD,2022,Q1,Klebsiella sepsis,,2022,Q1,2,F,20200611.0,20220309.0,20200714,20220316,EXP,,NVSC2020CH193125,NOVARTIS,,61.0,YR,,M,Y,,,20220316,,MD,CH,CH,2022,Q1,Adult
180204022,18020402,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, QD",,,Y,,,,,5.0,MG,,QD,2022,Q1,Klebsiella sepsis,,2022,Q1,2,F,20200611.0,20220309.0,20200714,20220316,EXP,,NVSC2020CH193125,NOVARTIS,,61.0,YR,,M,Y,,,20220316,,MD,CH,CH,2022,Q1,Adult
180237502,18023750,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Formulation unknown,QD,2022,Q1,Confusional state,,2022,Q1,2,F,20200611.0,20220309.0,20200715,20220314,EXP,,CH-ASTELLAS-2020US023248,ASTELLAS,,61.0,YR,,M,Y,,,20220314,,HP,CH,CH,2022,Q1,Adult
180237502,18023750,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Formulation unknown,QD,2022,Q1,Klebsiella sepsis,,2022,Q1,2,F,20200611.0,20220309.0,20200715,20220314,EXP,,CH-ASTELLAS-2020US023248,ASTELLAS,,61.0,YR,,M,Y,,,20220314,,HP,CH,CH,2022,Q1,Adult
180237502,18023750,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,Formulation unknown,QD,2022,Q1,Klebsiella sepsis,,2022,Q1,2,F,20200611.0,20220309.0,20200715,20220314,EXP,,CH-ASTELLAS-2020US023248,ASTELLAS,,61.0,YR,,M,Y,,,20220314,,HP,CH,CH,2022,Q1,Adult
180324153,18032415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg:0-0-1,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Klebsiella sepsis,,2022,Q1,3,F,20200611.0,20220309.0,20200716,20220317,EXP,,CH-AstraZeneca-2020SE86818,ASTRAZENECA,,61.0,YR,,M,Y,,,20220317,,MD,CH,,2022,Q1,Adult
180324153,18032415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg:0-0-1,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Confusional state,,2022,Q1,3,F,20200611.0,20220309.0,20200716,20220317,EXP,,CH-AstraZeneca-2020SE86818,ASTRAZENECA,,61.0,YR,,M,Y,,,20220317,,MD,CH,,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Dermatitis,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Urinary tract infection,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Pain,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Blood cholesterol increased,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Insomnia,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Blood pressure abnormal,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Bladder pain,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Sinusitis,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Hypersensitivity,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Therapy interrupted,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Feeling hot,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Memory impairment,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Weight increased,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Diabetes mellitus,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Jaundice,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Tinnitus,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Eye discharge,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Ear disorder,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Pyrexia,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Epistaxis,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Erythema,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Joint lock,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,COVID-19 immunisation,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Joint swelling,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Urinary tract pain,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,COVID-19,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Product availability issue,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Pneumonia,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Trismus,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
183227745,18322774,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once Daily (qd)",,,,,,,,,,,QD,2022,Q1,Dry skin,,2022,Q1,5,F,20180101.0,20211229.0,20200928,20220106,EXP,,BR-UCBSA-2020038058,UCB,,46.0,YR,,F,Y,65.0,KG,20220106,,CN,BR,BR,2022,Q1,Adult
184292529,18429252,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Ventricular arrhythmia,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac ventricular thrombosis,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Leukocytosis,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hypokalaemia,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Abdominal pain upper,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hypophosphataemia,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
186149974,18614997,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,4,F,20171101.0,20220317.0,20201214,20220324,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,44.0,KG,20220324,,HP,US,US,2022,Q1,Adult
187836566,18783656,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Surgery,,2022,Q1,6,F,,20220214.0,20210125,20220228,EXP,,CA-PFIZER INC-2020520051,PFIZER,,70.0,YR,,M,Y,,,20220228,,MD,CA,CA,2022,Q1,Elderly
187836566,18783656,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,6,F,,20220214.0,20210125,20220228,EXP,,CA-PFIZER INC-2020520051,PFIZER,,70.0,YR,,M,Y,,,20220228,,MD,CA,CA,2022,Q1,Elderly
187836566,18783656,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Infection,,2022,Q1,6,F,,20220214.0,20210125,20220228,EXP,,CA-PFIZER INC-2020520051,PFIZER,,70.0,YR,,M,Y,,,20220228,,MD,CA,CA,2022,Q1,Elderly
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Gait disturbance,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Respiratory symptom,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Dizziness,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Rash macular,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Pruritus,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Skin fissures,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Pain in extremity,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Fatigue,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Dehydration,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Dry skin,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Cough,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Viral infection,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Asthenia,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Blood potassium abnormal,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Productive cough,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Constipation,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Hyperhidrosis,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Muscle spasms,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Peripheral swelling,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Arthralgia,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Nausea,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Palpitations,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Syncope,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Gait disturbance,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Respiratory symptom,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Dizziness,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Rash macular,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Pruritus,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Skin fissures,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Pain in extremity,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Fatigue,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Dehydration,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Dry skin,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Cough,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Viral infection,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Asthenia,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Blood potassium abnormal,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Productive cough,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Constipation,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Hyperhidrosis,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Muscle spasms,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Peripheral swelling,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Arthralgia,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Nausea,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Palpitations,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188742527,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q1,Syncope,,2022,Q1,7,F,20210801.0,20220315.0,20210210,20220321,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220321,,CN,CA,CA,2022,Q1,Adult
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Hypoaesthesia,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Hypertension,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Localised oedema,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Respiratory rate increased,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Feeling hot,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Hypokinesia,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Fatigue,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Blood pressure decreased,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Pain in extremity,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Pyrexia,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Oedema peripheral,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Gait disturbance,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Asthenia,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Underdose,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Arthralgia,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Hypotension,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
188800569,18880056,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,9,F,20210101.0,20220219.0,20210211,20220225,EXP,,NVSC2021NG019057,NOVARTIS,,72.0,YR,,M,Y,,,20220225,,HP,NG,NG,2022,Q1,Elderly
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Pneumonia,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Pulmonary hypertension,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Emphysema,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hyperthyroidism,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiomegaly,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hyperkalaemia,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190076653,19007665,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Pulmonary oedema,,2022,Q1,3,F,,20220112.0,20210315,20220112,EXP,,PL-PFIZER INC-2021249711,PFIZER,,64.0,YR,,M,Y,,,20220112,,MD,PL,PL,2022,Q1,Adult
190125078,19012507,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MEQ,Tablets,,2022,Q1,Hypertensive crisis,,2022,Q1,8,F,20210311.0,20220128.0,20210315,20220131,EXP,,AU-Eisai Medical Research-EC-2021-089609,EISAI,,63.0,YR,A,F,Y,77.1,KG,20220131,,MD,AU,,2022,Q1,Adult
190125078,19012507,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MEQ,Tablets,,2022,Q1,Status epilepticus,,2022,Q1,8,F,20210311.0,20220128.0,20210315,20220131,EXP,,AU-Eisai Medical Research-EC-2021-089609,EISAI,,63.0,YR,A,F,Y,77.1,KG,20220131,,MD,AU,,2022,Q1,Adult
1909398621,19093986,80,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Myelosuppression,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1909398621,19093986,80,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1909398621,19093986,80,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Urinary retention,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1909398621,19093986,101,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Myelosuppression,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1909398621,19093986,101,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1909398621,19093986,101,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Urinary retention,,2022,Q1,21,F,20210316.0,20220211.0,20210405,20220218,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cough,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Product use issue,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Malaise,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Somnolence,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Discouragement,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Motion sickness,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dysentery,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Appetite disorder,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Speech disorder,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Aphthous ulcer,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Abdominal pain upper,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Swelling,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dysphonia,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Influenza,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Off label use,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Chills,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dysgeusia,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Product administration error,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Feeling of despair,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Contusion,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nausea,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Fall,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Product after taste,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Feeding disorder,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Malaise,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Gastrointestinal pain,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dry skin,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
1912961210,19129612,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,10,F,20210301.0,20220318.0,20210413,20220325,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220325,,CN,BR,BR,2022,Q1,Adult
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,COVID-19 pneumonia,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide abnormal,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Renal atrophy,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Prostatomegaly,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Urosepsis,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
191699593,19169959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, qd",,,,,,,,,,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,3,F,,20220112.0,20210422,20220118,EXP,,PL-PFIZER INC-2021432796,PFIZER,,70.0,YR,,M,Y,,,20220118,,MD,PL,PL,2022,Q1,Elderly
192238272,19223827,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days 3 days,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,2,F,20200930.0,20220114.0,20210506,20220124,EXP,,CA-AstraZeneca-2021A382735,ASTRAZENECA,,57.0,YR,,F,Y,66.7,KG,20220124,,MD,CA,,2022,Q1,Adult
192315942,19231594,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1 every 1 Days",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Necrotising fasciitis,,2022,Q1,2,F,20200510.0,20220114.0,20210507,20220121,EXP,,CA-AstraZeneca-2021A382742,ASTRAZENECA,,71.0,YR,,M,Y,,,20220121,,MD,CA,,2022,Q1,Elderly
192315942,19231594,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1 every 1 Days",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,2,F,20200510.0,20220114.0,20210507,20220121,EXP,,CA-AstraZeneca-2021A382742,ASTRAZENECA,,71.0,YR,,M,Y,,,20220121,,MD,CA,,2022,Q1,Elderly
1927499910,19274999,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 mg, Everyday, Oral Drug Unspecified Form",,,U,,,,,,,,,2022,Q1,Atrial thrombosis,,2022,Q1,10,F,20210317.0,20220120.0,20210519,20220124,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048529,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,68.0,KG,20220124,,MD,JP,JP,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Mitral valve thickening,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Ejection fraction decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Concomitant disease aggravated,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Haemoglobin decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Mitral valve calcification,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Platelet count decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Mitral valve incompetence,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Heart rate decreased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Pulmonary oedema,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193840627,19384062,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,7,F,20191101.0,20220128.0,20210608,20220201,EXP,,PL-AUROBINDO-AUR-APL-2021-023005,AUROBINDO,,65.0,YR,,M,Y,,,20220201,,MD,PL,PL,2022,Q1,Elderly
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Colitis,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Gastrooesophageal reflux disease,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
193948262,19394826,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,2,F,20210603.0,20220112.0,20210609,20220119,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,61.0,YR,,M,Y,,,20220119,,CN,CA,CA,2022,Q1,Adult
1942203712,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,12,F,20200715.0,20220204.0,20210616,20220211,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220211,,MD,ES,,2022,Q1,Elderly
1942203712,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypertension,,2022,Q1,12,F,20200715.0,20220204.0,20210616,20220211,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220211,,MD,ES,,2022,Q1,Elderly
1942203712,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Thrombotic microangiopathy,,2022,Q1,12,F,20200715.0,20220204.0,20210616,20220211,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220211,,MD,ES,,2022,Q1,Elderly
1942203712,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Liver function test increased,,2022,Q1,12,F,20200715.0,20220204.0,20210616,20220211,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220211,,MD,ES,,2022,Q1,Elderly
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Appendix disorder,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Palpitations,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Gastrointestinal wall thickening,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Appendicitis,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Nausea,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Vomiting,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Hepatic steatosis,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194606163,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q1,Procedural pain,,2022,Q1,3,F,20210331.0,20220104.0,20210625,20220109,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20220109,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q1,Adult
194779792,19477979,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Sepsis,,2022,Q1,2,F,20200909.0,20220218.0,20210630,20220223,EXP,,JP-AstraZeneca-2021A570516,ASTRAZENECA,,73.0,YR,,M,Y,,,20220223,,MD,JP,,2022,Q1,Elderly
194779792,19477979,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Vomiting,,2022,Q1,2,F,20200909.0,20220218.0,20210630,20220223,EXP,,JP-AstraZeneca-2021A570516,ASTRAZENECA,,73.0,YR,,M,Y,,,20220223,,MD,JP,,2022,Q1,Elderly
194779792,19477979,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Acute respiratory distress syndrome,,2022,Q1,2,F,20200909.0,20220218.0,20210630,20220223,EXP,,JP-AstraZeneca-2021A570516,ASTRAZENECA,,73.0,YR,,M,Y,,,20220223,,MD,JP,,2022,Q1,Elderly
194779792,19477979,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pneumonia aspiration,,2022,Q1,2,F,20200909.0,20220218.0,20210630,20220223,EXP,,JP-AstraZeneca-2021A570516,ASTRAZENECA,,73.0,YR,,M,Y,,,20220223,,MD,JP,,2022,Q1,Elderly
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cough,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Tachycardia,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Memory impairment,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Feeling abnormal,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood iron decreased,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194870426,19487042,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,6,F,20211214.0,20220203.0,20210702,20220206,PER,,NVSC2021US142350,NOVARTIS,,60.0,YR,,F,Y,,,20220205,,CN,US,US,2022,Q1,Adult
194880675,19488067,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2022,Q1,Hypokalaemia,,2022,Q1,5,F,,20220316.0,20210702,20220322,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20220322,,MD,JP,JP,2022,Q1,Child
194880675,19488067,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,,20220316.0,20210702,20220322,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20220322,,MD,JP,JP,2022,Q1,Child
194880675,19488067,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2022,Q1,Hypokalaemia,,2022,Q1,5,F,,20220316.0,20210702,20220322,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20220322,,MD,JP,JP,2022,Q1,Child
194880675,19488067,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,Tablet,,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,,20220316.0,20210702,20220322,EXP,,JP-009507513-2107JPN000278,MERCK,,8.0,DEC,,M,Y,,,20220322,,MD,JP,JP,2022,Q1,Child
195178924,19517892,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,4,F,20210319.0,20220322.0,20210712,20220330,EXP,,NVSJ2021JP010410,NOVARTIS,,79.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
195178924,19517892,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Dizziness,,2022,Q1,4,F,20210319.0,20220322.0,20210712,20220330,EXP,,NVSJ2021JP010410,NOVARTIS,,79.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
195178924,19517892,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Decreased appetite,,2022,Q1,4,F,20210319.0,20220322.0,20210712,20220330,EXP,,NVSJ2021JP010410,NOVARTIS,,79.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Diastolic dysfunction,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Cardiac steatosis,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Vomiting,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Pericardial effusion,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197080622,19708062,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, each morning",,,Y,,,,,10.0,MG,,QD,2022,Q1,Abdominal pain upper,,2022,Q1,2,F,20201001.0,20220314.0,20210817,20220328,EXP,LU-ALMPS-202102904,LU-ELI_LILLY_AND_COMPANY-LU202108001845,ELI LILLY AND CO,,48.0,YR,,F,Y,95.0,KG,20220328,,CN,LU,LU,2022,Q1,Adult
197260864,19726086,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,U,,,,,5.0,MG,,,2022,Q1,Pneumonia,,2022,Q1,4,F,20210812.0,20220316.0,20210819,20220325,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-080717,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,70.0,KG,20220325,,HP,JP,JP,2022,Q1,Elderly
197336536,19733653,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Septic shock,,2022,Q1,6,F,20210801.0,20220202.0,20210823,20220209,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083440,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,63.0,KG,20220209,,PH,JP,JP,2022,Q1,Elderly
197336536,19733653,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,6,F,20210801.0,20220202.0,20210823,20220209,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083440,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,63.0,KG,20220209,,PH,JP,JP,2022,Q1,Elderly
197336536,19733653,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Fulminant type 1 diabetes mellitus,,2022,Q1,6,F,20210801.0,20220202.0,20210823,20220209,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083440,BRISTOL MYERS SQUIBB,,82.0,YR,,M,Y,63.0,KG,20220209,,PH,JP,JP,2022,Q1,Elderly
197455833,19745583,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20210301.0,20210824.0,20210825,20220225,EXP,,NVSC2021EG187927,NOVARTIS,,56.0,YR,,M,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
197455833,19745583,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,3,F,20210301.0,20210824.0,20210825,20220225,EXP,,NVSC2021EG187927,NOVARTIS,,56.0,YR,,M,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
197455833,19745583,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2022,Q1,Diabetes mellitus,,2022,Q1,3,F,20210301.0,20210824.0,20210825,20220225,EXP,,NVSC2021EG187927,NOVARTIS,,56.0,YR,,M,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
197455833,19745583,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, QD",,,,,,,,,,Tablet,QD,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,20210301.0,20210824.0,20210825,20220225,EXP,,NVSC2021EG187927,NOVARTIS,,56.0,YR,,M,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Urticaria,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Fatigue,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Dizziness,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Pruritus,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Oxygen saturation decreased,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Anaphylactic reaction,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197567623,19756762,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1000 mg, UNK",,,U,,,,,1000.0,MG,,,2022,Q1,Hypotension,,2022,Q1,3,F,20210818.0,20210930.0,20210828,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-78544",REGENERON,,54.0,YR,,F,Y,,,20220114,,PH,US,US,2022,Q1,Adult
197859992,19785999,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,2,F,20210801.0,20211216.0,20210903,20220202,EXP,,JP-AstraZeneca-2021A699399,ASTRAZENECA,,80.0,YR,,F,Y,,,20220202,,MD,JP,,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Colitis ulcerative,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Off label use,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Frequent bowel movements,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Faeces soft,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Haematochezia,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Anal incontinence,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198294264,19829426,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Defaecation urgency,,2022,Q1,4,F,20210906.0,20220310.0,20210914,20220317,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220317,,MD,CA,CA,2022,Q1,Elderly
198742723,19874272,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,,20220131.0,20210923,20220209,EXP,,US-AstraZeneca-2021A733797,ASTRAZENECA,"Matli VVK, Fariduddin MM, Asafo-Agyei KO, Bansal N. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report. Clin. Case Rep. 2021;9(12):e05144.",48.0,YR,,M,Y,,,20220209,,MD,US,,2022,Q1,Adult
198945223,19894522,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",4250.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Chest pain,,2022,Q1,3,F,20210918.0,20220207.0,20210929,20220214,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-096387,BRISTOL MYERS SQUIBB,,58.0,YR,,M,Y,90.1,KG,20220214,,HP,GB,GB,2022,Q1,Adult
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Nephrogenic anaemia,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,End stage renal disease,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Cardiac arrest,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Hyperparathyroidism secondary,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199124822,19912482,32,C,SAXAGLIPTIN HYDROCHLORIDE/DAPAGLIFLOZIN,,2,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20170101.0,20220321.0,20211004,20220324,EXP,,US-AstraZeneca-2021A753791,ASTRAZENECA,,75.0,YR,,F,Y,77.0,KG,20220324,,LW,US,,2022,Q1,Elderly
199188267,19918826,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD(10 mg,1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,7,F,20210101.0,20220114.0,20211004,20220119,EXP,,NVSC2021DE222441,NOVARTIS,,52.0,YR,,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
199188267,19918826,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD(10 mg,1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,7,F,20210101.0,20220114.0,20211004,20220119,EXP,,NVSC2021DE222441,NOVARTIS,,52.0,YR,,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
199188267,19918826,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD(10 mg,1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,7,F,20210101.0,20220114.0,20211004,20220119,EXP,,NVSC2021DE222441,NOVARTIS,,52.0,YR,,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
199188267,19918826,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD(10 mg,1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,7,F,20210101.0,20220114.0,20211004,20220119,EXP,,NVSC2021DE222441,NOVARTIS,,52.0,YR,,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
199188267,19918826,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD(10 mg,1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,7,F,20210101.0,20220114.0,20211004,20220119,EXP,,NVSC2021DE222441,NOVARTIS,,52.0,YR,,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Secondary adrenocortical insufficiency,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Obesity,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Organising pneumonia,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Hypothyroidism,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Thyroiditis,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Lymphocytic hypophysitis,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Colitis ulcerative,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199201477,19920147,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Rash maculo-papular,,2022,Q1,7,F,20210216.0,20211202.0,20211006,20220127,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-046956,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,73.3,KG,20220127,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac hypertrophy,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Ventricular hyperkinesia,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac amyloidosis,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Oedema,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Cardiac hypertrophy,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Ventricular hyperkinesia,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Cardiac amyloidosis,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
199271783,19927178,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Oedema,,2022,Q1,3,F,20210524.0,20220228.0,20211006,20220303,EXP,,NVSJ2021JP016199,NOVARTIS,,76.0,YR,,M,Y,41.2,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,COVID-19,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
1993161311,19931613,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,11,F,20210101.0,20220302.0,20211007,20220311,EXP,,DE-PFIZER INC-202101273507,PFIZER,,52.0,YR,,M,Y,,,20220311,,MD,DE,DE,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Obesity,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Fatigue,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Type V hyperlipidaemia,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Nonalcoholic fatty liver disease,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Abdominal distension,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199359299,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,9,F,,20211229.0,20211008,20220111,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220111,,MD,PL,PL,2022,Q1,Adult
199370562,19937056,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2022,Q1,Respiratory failure,,2022,Q1,2,F,20210801.0,20211110.0,20211010,20220307,EXP,,JP-JNJFOC-20211015115,JOHNSON AND JOHNSON,,50.0,YR,A,F,Y,,,20220307,,MD,JP,JP,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Type V hyperlipidaemia,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Nonalcoholic fatty liver disease,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Abdominal distension,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Fatigue,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Obesity,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
199396376,19939637,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,6,F,,20220112.0,20211011,20220117,EXP,,PL-PFIZER INC-202101313815,PFIZER,,64.0,YR,,M,Y,,,20220117,,MD,PL,PL,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Fatigue,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Type V hyperlipidaemia,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Obesity,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Abdominal distension,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
1994035010,19940350,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Nonalcoholic fatty liver disease,,2022,Q1,10,F,,20211229.0,20211011,20220105,EXP,,PL-AstraZeneca-2021A756714,ASTRAZENECA,,64.0,YR,,M,Y,95.0,KG,20220105,,MD,PL,,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Fatigue,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Nonalcoholic fatty liver disease,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Type V hyperlipidaemia,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Abdominal distension,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Obesity,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199485559,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,9,F,,20211229.0,20211012,20220318,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220318,,MD,PL,PL,2022,Q1,Adult
199715664,19971566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pancreatic cyst,,2022,Q1,4,F,20210911.0,20220124.0,20211019,20220201,EXP,,JP-AstraZeneca-2021A773448,ASTRAZENECA,,30136.0,DY,,F,Y,56.0,KG,20220201,,MD,JP,,2022,Q1,Elderly
199715664,19971566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pancreatic mass,,2022,Q1,4,F,20210911.0,20220124.0,20211019,20220201,EXP,,JP-AstraZeneca-2021A773448,ASTRAZENECA,,30136.0,DY,,F,Y,56.0,KG,20220201,,MD,JP,,2022,Q1,Elderly
199715664,19971566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hepatic function abnormal,,2022,Q1,4,F,20210911.0,20220124.0,20211019,20220201,EXP,,JP-AstraZeneca-2021A773448,ASTRAZENECA,,30136.0,DY,,F,Y,56.0,KG,20220201,,MD,JP,,2022,Q1,Elderly
199715664,19971566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pancreatic duct dilatation,,2022,Q1,4,F,20210911.0,20220124.0,20211019,20220201,EXP,,JP-AstraZeneca-2021A773448,ASTRAZENECA,,30136.0,DY,,F,Y,56.0,KG,20220201,,MD,JP,,2022,Q1,Elderly
199715664,19971566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Gallbladder enlargement,,2022,Q1,4,F,20210911.0,20220124.0,20211019,20220201,EXP,,JP-AstraZeneca-2021A773448,ASTRAZENECA,,30136.0,DY,,F,Y,56.0,KG,20220201,,MD,JP,,2022,Q1,Elderly
199772632,19977263,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Shock haemorrhagic,,2022,Q1,2,F,20210901.0,20220222.0,20211021,20220225,EXP,,NVSJ2021JP017136,NOVARTIS,,68.0,YR,,M,Y,72.3,KG,20220225,,MD,JP,JP,2022,Q1,Elderly
199772632,19977263,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Haematemesis,,2022,Q1,2,F,20210901.0,20220222.0,20211021,20220225,EXP,,NVSJ2021JP017136,NOVARTIS,,68.0,YR,,M,Y,72.3,KG,20220225,,MD,JP,JP,2022,Q1,Elderly
199960385,19996038,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q1,Drug-induced liver injury,,2022,Q1,5,F,20211015.0,20220301.0,20211025,20220307,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-110810,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,133.0,KG,20220307,,HP,JP,JP,2022,Q1,Adult
200000704,20000070,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,UNKNOWN,,,,,Tablet,QD,2022,Q1,Colitis,,2022,Q1,4,F,20210823.0,20220112.0,20211027,20220124,EXP,,JP-ROCHE-2940068,ROCHE,,60.0,YR,,F,Y,58.1,KG,20220124,,MD,JP,JP,2022,Q1,Adult
200095203,20009520,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Respiratory syncytial virus infection,,2022,Q1,3,F,20211014.0,20220110.0,20211028,20220111,EXP,,CH-GILEAD-2021-0554319,GILEAD,,60.0,YR,A,M,Y,107.0,KG,20220111,,HP,CH,CH,2022,Q1,Adult
200095203,20009520,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Diffuse large B-cell lymphoma,,2022,Q1,3,F,20211014.0,20220110.0,20211028,20220111,EXP,,CH-GILEAD-2021-0554319,GILEAD,,60.0,YR,A,M,Y,107.0,KG,20220111,,HP,CH,CH,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood lactate dehydrogenase increased,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Neutrophil count decreased,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cerebral haemorrhage,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hiccups,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Neutropenia,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200274492,20027449,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Oesophagitis,,2022,Q1,2,F,20210209.0,20220119.0,20211103,20220131,EXP,,JP-ROCHE-2801227,ROCHE,,63.0,YR,,M,Y,55.0,KG,20220131,,MD,JP,JP,2022,Q1,Adult
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Klebsiella infection,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Blood thyroid stimulating hormone increased,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Otitis externa,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Dermatitis psoriasiform,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Malignant neoplasm progression,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200309602,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q1,Dermatitis allergic,,2022,Q1,2,F,20200816.0,20220315.0,20211103,20220323,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
200324763,20032476,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Myalgia,,2022,Q1,3,F,20211020.0,20220206.0,20211103,20220208,EXP,GB-MHRA-EYC 00264856,GB-009507513-2111GBR000596,MERCK,,91.0,YR,,F,Y,84.0,KG,20220208,,MD,GB,GB,2022,Q1,Elderly
200324763,20032476,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,3,F,20211020.0,20220206.0,20211103,20220208,EXP,GB-MHRA-EYC 00264856,GB-009507513-2111GBR000596,MERCK,,91.0,YR,,F,Y,84.0,KG,20220208,,MD,GB,GB,2022,Q1,Elderly
200324763,20032476,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,3,F,20211020.0,20220206.0,20211103,20220208,EXP,GB-MHRA-EYC 00264856,GB-009507513-2111GBR000596,MERCK,,91.0,YR,,F,Y,84.0,KG,20220208,,MD,GB,GB,2022,Q1,Elderly
200324763,20032476,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Immune-mediated myocarditis,,2022,Q1,3,F,20211020.0,20220206.0,20211103,20220208,EXP,GB-MHRA-EYC 00264856,GB-009507513-2111GBR000596,MERCK,,91.0,YR,,F,Y,84.0,KG,20220208,,MD,GB,GB,2022,Q1,Elderly
200425106,20042510,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet,,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,6,F,20210101.0,20220118.0,20211108,20220124,EXP,,DE-drreddys-SPO/GER/21/0143382,DR REDDYS,,52.0,YR,A,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
200425106,20042510,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet,,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,6,F,20210101.0,20220118.0,20211108,20220124,EXP,,DE-drreddys-SPO/GER/21/0143382,DR REDDYS,,52.0,YR,A,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
200425106,20042510,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet,,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,6,F,20210101.0,20220118.0,20211108,20220124,EXP,,DE-drreddys-SPO/GER/21/0143382,DR REDDYS,,52.0,YR,A,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
200425106,20042510,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet,,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,6,F,20210101.0,20220118.0,20211108,20220124,EXP,,DE-drreddys-SPO/GER/21/0143382,DR REDDYS,,52.0,YR,A,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
200425106,20042510,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet,,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,6,F,20210101.0,20220118.0,20211108,20220124,EXP,,DE-drreddys-SPO/GER/21/0143382,DR REDDYS,,52.0,YR,A,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Blood pressure increased,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Product availability issue,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200428745,20042874,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Fluid retention,,2022,Q1,5,F,20210804.0,20220206.0,20211108,20220208,EXP,,NVSC2021EG227296,NOVARTIS,,62.0,YR,,M,Y,,,20220208,,CN,EG,EG,2022,Q1,Adult
200454444,20045444,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q1,Acute myocardial infarction,,2022,Q1,4,F,20211004.0,20220104.0,20211108,20220107,EXP,,JP-CELGENEUS-JPN-20211003712,CELGENE,,62.0,YR,,M,Y,,,20220107,,MD,JP,JP,2022,Q1,Adult
200454444,20045444,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q1,Pulmonary nocardiosis,,2022,Q1,4,F,20211004.0,20220104.0,20211108,20220107,EXP,,JP-CELGENEUS-JPN-20211003712,CELGENE,,62.0,YR,,M,Y,,,20220107,,MD,JP,JP,2022,Q1,Adult
200529694,20052969,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Spinal compression fracture,,2022,Q1,4,F,20210911.0,20211221.0,20211110,20220111,EXP,,JP-AstraZeneca-2021A789488,ASTRAZENECA,,80.0,YR,,M,Y,,,20220111,,PH,JP,,2022,Q1,Elderly
200529694,20052969,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Decreased appetite,,2022,Q1,4,F,20210911.0,20211221.0,20211110,20220111,EXP,,JP-AstraZeneca-2021A789488,ASTRAZENECA,,80.0,YR,,M,Y,,,20220111,,PH,JP,,2022,Q1,Elderly
200563132,20056313,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Adrenal insufficiency,,2022,Q1,2,F,20210714.0,20220218.0,20211111,20220224,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-118835,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,49.2,KG,20220224,,MD,JP,JP,2022,Q1,Elderly
200563132,20056313,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210714.0,20220218.0,20211111,20220224,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-118835,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,49.2,KG,20220224,,MD,JP,JP,2022,Q1,Elderly
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Obesity,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Nonalcoholic fatty liver disease,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Type V hyperlipidaemia,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Fatigue,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Abdominal distension,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200582792,20058279,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,2,F,,20211230.0,20211111,20220107,EXP,,PL-PFIZER INC-202101489801,PFIZER,,64.0,YR,,M,Y,95.0,KG,20220107,,MD,PL,PL,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Neck pain,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Malaise,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Rash,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Illness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Muscle tightness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Pericarditis,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Neuropathy peripheral,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Eye haemorrhage,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Muscle tightness,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Inflammation,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cerebrovascular accident,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Back disorder,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Back pain,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Spinal pain,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hypoaesthesia,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Memory impairment,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Mouth ulceration,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Herpes zoster,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Rash,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Ear infection,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Swollen tongue,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Influenza,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cataract,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Excessive cerumen production,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Inflammation,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200591204,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cardiovascular disorder,,2022,Q1,4,F,20210914.0,20220228.0,20211111,20220309,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20220309,,CN,CA,,2022,Q1,Adult
200622643,20062264,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,U,,,,,,,Tablet,,2022,Q1,Disease recurrence,,2022,Q1,3,F,20210101.0,20220112.0,20211112,20220119,EXP,DE-GLAXOSMITHKLINE-DE2021EME182583,DE-TORRENT-00021445,TORRENT,,52.0,YR,A,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
200622643,20062264,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,U,,,,,,,Tablet,,2022,Q1,Herpes zoster,,2022,Q1,3,F,20210101.0,20220112.0,20211112,20220119,EXP,DE-GLAXOSMITHKLINE-DE2021EME182583,DE-TORRENT-00021445,TORRENT,,52.0,YR,A,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
200622643,20062264,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,U,,,,,,,Tablet,,2022,Q1,Rash,,2022,Q1,3,F,20210101.0,20220112.0,20211112,20220119,EXP,DE-GLAXOSMITHKLINE-DE2021EME182583,DE-TORRENT-00021445,TORRENT,,52.0,YR,A,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
200622643,20062264,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,U,,,,,,,Tablet,,2022,Q1,Pain,,2022,Q1,3,F,20210101.0,20220112.0,20211112,20220119,EXP,DE-GLAXOSMITHKLINE-DE2021EME182583,DE-TORRENT-00021445,TORRENT,,52.0,YR,A,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
200622643,20062264,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tablet in a day,,,U,,,,,,,Tablet,,2022,Q1,Vaccination failure,,2022,Q1,3,F,20210101.0,20220112.0,20211112,20220119,EXP,DE-GLAXOSMITHKLINE-DE2021EME182583,DE-TORRENT-00021445,TORRENT,,52.0,YR,A,M,Y,,,20220119,,MD,DE,DE,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Syncope,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Loss of consciousness,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Sleep deficit,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Blood pressure increased,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Chest pain,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Malaise,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Weight abnormal,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Chest discomfort,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Oedema,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Stress,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Dysstasia,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Feeling abnormal,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Abdominal pain upper,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Discomfort,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,Tablet,QD,2022,Q1,Feeling cold,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Syncope,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Loss of consciousness,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Sleep deficit,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Blood pressure increased,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Chest pain,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Malaise,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Dizziness,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Weight abnormal,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Chest discomfort,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Oedema,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Hypotension,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Stress,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Dysstasia,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Feeling abnormal,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Abdominal pain upper,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Decreased appetite,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Discomfort,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Fatigue,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200699935,20069993,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q1,Feeling cold,,2022,Q1,5,F,20210801.0,20220201.0,20211115,20220206,EXP,,NVSC2021MX229214,NOVARTIS,,37.0,YR,,M,Y,153.0,KG,20220204,,CN,MX,MX,2022,Q1,Adult
200744372,20074437,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Renal impairment,,2022,Q1,2,F,20210819.0,20220106.0,20211116,20220117,EXP,,BR-SA-2021SA378397,SANOFI AVENTIS,,80.0,YR,E,M,Y,75.0,KG,20220117,,CN,BR,BR,2022,Q1,Elderly
200744372,20074437,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,2,F,20210819.0,20220106.0,20211116,20220117,EXP,,BR-SA-2021SA378397,SANOFI AVENTIS,,80.0,YR,E,M,Y,75.0,KG,20220117,,CN,BR,BR,2022,Q1,Elderly
200744372,20074437,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Ulcer haemorrhage,,2022,Q1,2,F,20210819.0,20220106.0,20211116,20220117,EXP,,BR-SA-2021SA378397,SANOFI AVENTIS,,80.0,YR,E,M,Y,75.0,KG,20220117,,CN,BR,BR,2022,Q1,Elderly
200744372,20074437,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,2,F,20210819.0,20220106.0,20211116,20220117,EXP,,BR-SA-2021SA378397,SANOFI AVENTIS,,80.0,YR,E,M,Y,75.0,KG,20220117,,CN,BR,BR,2022,Q1,Elderly
200821083,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,3,F,,20220125.0,20211117,20220201,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220201,,MD,JP,JP,2022,Q1,Child
200821083,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q1,Disseminated intravascular coagulation,,2022,Q1,3,F,,20220125.0,20211117,20220201,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220201,,MD,JP,JP,2022,Q1,Child
200821083,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q1,Vascular stent thrombosis,,2022,Q1,3,F,,20220125.0,20211117,20220201,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220201,,MD,JP,JP,2022,Q1,Child
200836477,20083647,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Blood creatinine increased,,2022,Q1,7,F,20211011.0,20220214.0,20211118,20220220,EXP,,NVSJ2021JP018754,NOVARTIS,,85.0,YR,,M,Y,67.0,KG,20220221,,MD,JP,JP,2022,Q1,Elderly
200836477,20083647,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,7,F,20211011.0,20220214.0,20211118,20220220,EXP,,NVSJ2021JP018754,NOVARTIS,,85.0,YR,,M,Y,67.0,KG,20220221,,MD,JP,JP,2022,Q1,Elderly
200839983,20083998,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1640.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Escherichia urinary tract infection,,2022,Q1,3,F,20210829.0,20220201.0,20211118,20220228,EXP,,JP-AstraZeneca-2021A791771,ASTRAZENECA,,69.0,YR,,M,Y,44.0,KG,20220228,,MD,JP,,2022,Q1,Elderly
200839983,20083998,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1640.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210829.0,20220201.0,20211118,20220228,EXP,,JP-AstraZeneca-2021A791771,ASTRAZENECA,,69.0,YR,,M,Y,44.0,KG,20220228,,MD,JP,,2022,Q1,Elderly
200844285,20084428,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q1,Rash,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q1,Disease recurrence,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q1,Herpes zoster,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q1,Vaccination failure,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q1,Pain,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Rash,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Disease recurrence,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Herpes zoster,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Vaccination failure,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200844285,20084428,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Pain,,2022,Q1,5,F,20210101.0,20220118.0,20211118,20220201,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-317948,RANBAXY,,52.0,YR,,M,Y,,,20220201,,MD,DE,DE,2022,Q1,Adult
200904353,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2022,Q1,Lactic acidosis,,2022,Q1,3,F,,20220301.0,20211119,20220308,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20220308,,HP,GR,GR,2022,Q1,Elderly
200904353,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,3,F,,20220301.0,20211119,20220308,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20220308,,HP,GR,GR,2022,Q1,Elderly
200904353,20090435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,3,F,,20220301.0,20211119,20220308,EXP,,GR-BAUSCH-BL-2021-037962,BAUSCH AND LOMB,"Prokopiou D, Kiatou V, Girousis N, Papadopoulos R, Xanthopoulou K. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation. Hellenic Diabetological Chronicles. 2020;33(2):135.",74.0,YR,,F,Y,,,20220308,,HP,GR,GR,2022,Q1,Elderly
200932344,20093234,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,4,F,20210101.0,20220222.0,20211120,20220225,PER,,US-JNJFOC-20211127849,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,141.19,KG,20220225,,HP,US,US,2022,Q1,Elderly
200932344,20093234,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,4,F,20210101.0,20220222.0,20211120,20220225,PER,,US-JNJFOC-20211127849,JOHNSON AND JOHNSON,,68.0,YR,E,M,Y,141.19,KG,20220225,,HP,US,US,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood pressure decreased,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Syncope,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bradycardia,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal incontinence,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
200980425,20098042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,5,F,20210701.0,20220307.0,20211122,20220311,EXP,,JP-AstraZeneca-2021A817310,ASTRAZENECA,,82.0,YR,,F,Y,55.0,KG,20220311,,PH,JP,,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Sepsis,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Urinary tract infection,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Chills,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Hypothermia,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Chills,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Hypotension,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Hypotension,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Hypothermia,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201063032,20106303,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"0.5 mg, (In the afternoon) started 8 years ago",,,,,,,,0.5,MG,Tablet,,2022,Q1,Kidney infection,,2022,Q1,2,F,20211001.0,20211230.0,20211124,20220104,EXP,,NVSC2021MX266712,NOVARTIS,,70.0,YR,,M,Y,70.0,KG,20220104,,CN,MX,MX,2022,Q1,Elderly
201102586,20110258,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (1 Tablet in a day)",,,U,U,,,,,,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (1 Tablet in a day)",,,U,U,,,,,,Tablet,QD,2022,Q1,Pain,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (1 Tablet in a day)",,,U,U,,,,,,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (1 Tablet in a day)",,,U,U,,,,,,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (1 Tablet in a day)",,,U,U,,,,,,Tablet,QD,2022,Q1,Rash,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201102586,20110258,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,6,F,20210101.0,20220114.0,20211124,20220118,EXP,,DE-MYLANLABS-2021M1086136,MYLAN,,52.0,YR,,M,Y,,,20220118,,MD,DE,DE,2022,Q1,Adult
201127813,20112781,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Number of separate dosages unknown5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,20211007.0,20220203.0,20211125,20220222,EXP,,JP-AstraZeneca-2021A816854,ASTRAZENECA,,62.0,YR,,M,Y,,,20220222,,MD,JP,,2022,Q1,Adult
201162653,20116265,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg/day, unknown freq.",,,,,,,,10.0,MG,Per oral NOS,,2022,Q1,Duodenal ulcer,,2022,Q1,3,F,20210928.0,20220124.0,20211126,20220126,EXP,,JP-ASTELLAS-2021JP022592,ASTELLAS,,91.0,YR,,M,Y,,,20220126,,CN,JP,JP,2022,Q1,Elderly
201162653,20116265,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg/day, unknown freq.",,,,,,,,10.0,MG,Per oral NOS,,2022,Q1,Prescribed underdose,,2022,Q1,3,F,20210928.0,20220124.0,20211126,20220126,EXP,,JP-ASTELLAS-2021JP022592,ASTELLAS,,91.0,YR,,M,Y,,,20220126,,CN,JP,JP,2022,Q1,Elderly
201196722,20119672,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Myelodysplastic syndrome,,2022,Q1,2,F,20201125.0,20220110.0,20211126,20220110,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-127525,BRISTOL MYERS SQUIBB,,77.0,YR,,M,Y,66.2,KG,20220110,,HP,ES,ES,2022,Q1,Elderly
201200744,20120074,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,4,F,20210825.0,20211223.0,20211126,20220111,EXP,,JP-AstraZeneca-2021A821149,ASTRAZENECA,,76.0,YR,,M,Y,,,20220111,,MD,JP,,2022,Q1,Elderly
201200744,20120074,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Pneumonia aspiration,,2022,Q1,4,F,20210825.0,20211223.0,20211126,20220111,EXP,,JP-AstraZeneca-2021A821149,ASTRAZENECA,,76.0,YR,,M,Y,,,20220111,,MD,JP,,2022,Q1,Elderly
201200744,20120074,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,4,F,20210825.0,20211223.0,20211126,20220111,EXP,,JP-AstraZeneca-2021A821149,ASTRAZENECA,,76.0,YR,,M,Y,,,20220111,,MD,JP,,2022,Q1,Elderly
201200744,20120074,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Pneumonia aspiration,,2022,Q1,4,F,20210825.0,20211223.0,20211126,20220111,EXP,,JP-AstraZeneca-2021A821149,ASTRAZENECA,,76.0,YR,,M,Y,,,20220111,,MD,JP,,2022,Q1,Elderly
201422724,20142272,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Angina pectoris,,2022,Q1,4,F,20211123.0,20220201.0,20211202,20220202,EXP,,NVSC2021US269325,NOVARTIS,,38.0,YR,,M,Y,104.9,KG,20220202,,MD,US,US,2022,Q1,Adult
201422724,20142272,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Coronary artery disease,,2022,Q1,4,F,20211123.0,20220201.0,20211202,20220202,EXP,,NVSC2021US269325,NOVARTIS,,38.0,YR,,M,Y,104.9,KG,20220202,,MD,US,US,2022,Q1,Adult
201445623,20144562,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,20210527.0,20220111.0,20211203,20220120,EXP,,JP-AstraZeneca-2021A837282,ASTRAZENECA,"Narishima Y, et al.. 34 A case of euglycaemic ketosis considered to be caused by the use of SGLT2 inhibitors.. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine 2021;",75.0,YR,,F,Y,,,20220120,,MD,JP,,2022,Q1,Elderly
201445623,20144562,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,,,,Tablet,,2022,Q1,Product dose omission issue,,2022,Q1,3,F,20210527.0,20220111.0,20211203,20220120,EXP,,JP-AstraZeneca-2021A837282,ASTRAZENECA,"Narishima Y, et al.. 34 A case of euglycaemic ketosis considered to be caused by the use of SGLT2 inhibitors.. The 245th Tokai Regional Meeting of the Japanese Society of Internal Medicine 2021;",75.0,YR,,F,Y,,,20220120,,MD,JP,,2022,Q1,Elderly
201447243,20144724,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,20210316.0,20220120.0,20211203,20220126,EXP,,JP-AstraZeneca-2021A836491,ASTRAZENECA,"Nishio S, et al.. 1-C-05 A case of type 1 diabetes mellitus who developed euglycaemic ketoacidosis with concomitant SAP therapy and administration of SGLT2 inhibitor.. The 59th General Congress of Chugoku and Shikoku Regional Meeting of the Japan Diabetes Society 2021;50.",17.0,YR,,F,Y,59.0,KG,20220126,,MD,JP,,2022,Q1,Youth
201513663,20151366,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201513663,20151366,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210101.0,20220301.0,20211206,20220304,EXP,,JP-AstraZeneca-2021A851588,ASTRAZENECA,,86.0,YR,,M,Y,45.0,KG,20220304,,MD,JP,,2022,Q1,Elderly
201539522,20153952,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20211206.0,20211207,20220210,EXP,,BR-NOVOPROD-872913,NOVO NORDISK,,58.0,YR,,M,Y,59.8,KG,20220210,,MD,BR,BR,2022,Q1,Adult
201610573,20161057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,3,F,20211011.0,20211227.0,20211208,20220104,EXP,,JP-AstraZeneca-2021A853154,ASTRAZENECA,,65.0,YR,,M,Y,,,20220104,,MD,JP,,2022,Q1,Elderly
201610573,20161057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,3,F,20211011.0,20211227.0,20211208,20220104,EXP,,JP-AstraZeneca-2021A853154,ASTRAZENECA,,65.0,YR,,M,Y,,,20220104,,MD,JP,,2022,Q1,Elderly
201610573,20161057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Off label use,,2022,Q1,3,F,20211011.0,20211227.0,20211208,20220104,EXP,,JP-AstraZeneca-2021A853154,ASTRAZENECA,,65.0,YR,,M,Y,,,20220104,,MD,JP,,2022,Q1,Elderly
201655352,20165535,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,700.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20210101.0,20220128.0,20211209,20220204,EXP,,JP-AstraZeneca-2021A853379,ASTRAZENECA,,76.0,YR,,M,Y,47.0,KG,20220204,,MD,JP,,2022,Q1,Elderly
201655352,20165535,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,700.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,2,F,20210101.0,20220128.0,20211209,20220204,EXP,,JP-AstraZeneca-2021A853379,ASTRAZENECA,,76.0,YR,,M,Y,47.0,KG,20220204,,MD,JP,,2022,Q1,Elderly
201667442,20166744,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,/1000 2cp/day,,,,,unknown,,,,,,,2022,Q1,Drug titration error,,2022,Q1,2,F,20210923.0,20220119.0,20211209,20220204,EXP,,BR-NOVOPROD-873174,NOVO NORDISK,,58.0,YR,,F,Y,58.0,KG,20220204,,MD,BR,BR,2022,Q1,Adult
201667442,20166744,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,/1000 2cp/day,,,,,unknown,,,,,,,2022,Q1,Diabetic retinopathy,,2022,Q1,2,F,20210923.0,20220119.0,20211209,20220204,EXP,,BR-NOVOPROD-873174,NOVO NORDISK,,58.0,YR,,F,Y,58.0,KG,20220204,,MD,BR,BR,2022,Q1,Adult
201667442,20166744,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,/1000 2cp/day,,,,,unknown,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20210923.0,20220119.0,20211209,20220204,EXP,,BR-NOVOPROD-873174,NOVO NORDISK,,58.0,YR,,F,Y,58.0,KG,20220204,,MD,BR,BR,2022,Q1,Adult
201667442,20166744,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,/1000 2cp/day,,,,,unknown,,,,,,,2022,Q1,Cataract operation,,2022,Q1,2,F,20210923.0,20220119.0,20211209,20220204,EXP,,BR-NOVOPROD-873174,NOVO NORDISK,,58.0,YR,,F,Y,58.0,KG,20220204,,MD,BR,BR,2022,Q1,Adult
201685982,20168598,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Tumour lysis syndrome,,2022,Q1,2,F,20210528.0,20220106.0,20211210,20220114,EXP,,JP-ROCHE-2975984,ROCHE,,61.0,YR,,M,Y,74.3,KG,20220114,,MD,JP,JP,2022,Q1,Adult
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Renal impairment,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Renal vessel disorder,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Pulmonary congestion,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Volume blood decreased,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Malaise,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Depressed level of consciousness,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Dyspnoea at rest,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Low cardiac output syndrome,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201705052,20170505,10,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,U,,,,,,,,,2022,Q1,Hepatic enzyme increased,,2022,Q1,2,F,,20220218.0,20211210,20220224,EXP,,JP-OTSUKA-2021_042285,OTSUKA,,8.0,DEC,,M,Y,47.5,KG,20220224,,MD,JP,JP,2022,Q1,Child
201811374,20181137,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Hypothyroidism,,2022,Q1,4,F,20211128.0,20220121.0,20211214,20220128,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220128,,MD,JP,JP,2022,Q1,Child
201811374,20181137,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,4,F,20211128.0,20220121.0,20211214,20220128,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220128,,MD,JP,JP,2022,Q1,Child
201811374,20181137,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypothyroidism,,2022,Q1,4,F,20211128.0,20220121.0,20211214,20220128,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220128,,MD,JP,JP,2022,Q1,Child
201811374,20181137,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,4,F,20211128.0,20220121.0,20211214,20220128,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220128,,MD,JP,JP,2022,Q1,Child
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201817853,20181785,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,3,F,20210301.0,20220206.0,20211214,20220215,EXP,,PL-TEVA-2021-PL-1988144,TEVA,,71.0,YR,E,M,Y,,,20220215,,MD,PL,PL,2022,Q1,Elderly
201858804,20185880,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cardiac failure acute,,2022,Q1,4,F,20211128.0,20220121.0,20211215,20220131,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-136079,BRISTOL MYERS SQUIBB,,7.0,DEC,,F,Y,,,20220131,,MD,JP,JP,2022,Q1,Child
201858804,20185880,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypothyroidism,,2022,Q1,4,F,20211128.0,20220121.0,20211215,20220131,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-136079,BRISTOL MYERS SQUIBB,,7.0,DEC,,F,Y,,,20220131,,MD,JP,JP,2022,Q1,Child
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bradyphrenia,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Mucosal dryness,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Kussmaul respiration,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Heart rate increased,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Flatulence,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Skin turgor decreased,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Ketonuria,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Renal impairment,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Glycosuria,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acidosis,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Anuria,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201890962,20189096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Lactic acidosis,,2022,Q1,2,F,20190101.0,20220221.0,20211215,20220303,EXP,,GR-SA-2021SA416236,SANOFI AVENTIS,,74.0,YR,E,F,Y,,,20220303,,HP,GR,GR,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201922352,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220125.0,20211216,20220208,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220208,,MD,PL,PL,2022,Q1,Elderly
201942543,20194254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,5430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Endocarditis,,2022,Q1,3,F,20211205.0,20220224.0,20211216,20220301,EXP,,JP-AstraZeneca-2021A866968,ASTRAZENECA,,73.0,YR,,F,Y,75.0,KG,20220301,,MD,JP,,2022,Q1,Elderly
201942543,20194254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,5430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,3,F,20211205.0,20220224.0,20211216,20220301,EXP,,JP-AstraZeneca-2021A866968,ASTRAZENECA,,73.0,YR,,F,Y,75.0,KG,20220301,,MD,JP,,2022,Q1,Elderly
201942543,20194254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,5430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bacteraemia,,2022,Q1,3,F,20211205.0,20220224.0,20211216,20220301,EXP,,JP-AstraZeneca-2021A866968,ASTRAZENECA,,73.0,YR,,F,Y,75.0,KG,20220301,,MD,JP,,2022,Q1,Elderly
201942543,20194254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,5430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Sepsis,,2022,Q1,3,F,20211205.0,20220224.0,20211216,20220301,EXP,,JP-AstraZeneca-2021A866968,ASTRAZENECA,,73.0,YR,,F,Y,75.0,KG,20220301,,MD,JP,,2022,Q1,Elderly
202006802,20200680,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,Unknown,,,10.0,MG,,QD,2022,Q1,No adverse event,,2022,Q1,2,F,,20220103.0,20211217,20220112,EXP,,IT-PFIZER INC-202101753573,PFIZER,"Acanfora, C.. Fibrillazione Atriale, Diabete Mellito e Cardiopatia Ischemica. Un caso clinico complesso.. Cardiolink Scientific News. 2021",64.0,YR,,M,Y,97.0,KG,20220112,,MD,IT,IT,2022,Q1,Adult
202013335,20201333,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown freq.",,,U,,,,202293.0,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,5,F,20210128.0,20220222.0,20211217,20220302,EXP,,JP-AstraZeneca-2021A878609,ASTRAZENECA,,28178.0,DY,,M,Y,50.0,KG,20220302,,MD,JP,,2022,Q1,Elderly
202013335,20201333,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown freq.",,,U,,,,202293.0,,,,,2022,Q1,Cardiac failure,,2022,Q1,5,F,20210128.0,20220222.0,20211217,20220302,EXP,,JP-AstraZeneca-2021A878609,ASTRAZENECA,,28178.0,DY,,M,Y,50.0,KG,20220302,,MD,JP,,2022,Q1,Elderly
202013335,20201333,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown freq.",,,U,,,,202293.0,,,,,2022,Q1,Hypokalaemia,,2022,Q1,5,F,20210128.0,20220222.0,20211217,20220302,EXP,,JP-AstraZeneca-2021A878609,ASTRAZENECA,,28178.0,DY,,M,Y,50.0,KG,20220302,,MD,JP,,2022,Q1,Elderly
202013335,20201333,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown freq.",,,U,,,,202293.0,,,,,2022,Q1,Ventricular tachycardia,,2022,Q1,5,F,20210128.0,20220222.0,20211217,20220302,EXP,,JP-AstraZeneca-2021A878609,ASTRAZENECA,,28178.0,DY,,M,Y,50.0,KG,20220302,,MD,JP,,2022,Q1,Elderly
202025012,20202501,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, UNK(1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Disease recurrence,,2022,Q1,2,F,20210101.0,20220111.0,20211217,20220124,EXP,,DE-AUROBINDO-AUR-APL-2021-041515,AUROBINDO,,52.0,YR,,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
202025012,20202501,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, UNK(1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Herpes zoster,,2022,Q1,2,F,20210101.0,20220111.0,20211217,20220124,EXP,,DE-AUROBINDO-AUR-APL-2021-041515,AUROBINDO,,52.0,YR,,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
202025012,20202501,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, UNK(1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,2,F,20210101.0,20220111.0,20211217,20220124,EXP,,DE-AUROBINDO-AUR-APL-2021-041515,AUROBINDO,,52.0,YR,,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
202025012,20202501,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, UNK(1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Vaccination failure,,2022,Q1,2,F,20210101.0,20220111.0,20211217,20220124,EXP,,DE-AUROBINDO-AUR-APL-2021-041515,AUROBINDO,,52.0,YR,,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
202025012,20202501,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day, UNK(1 Tablet in a day)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,2,F,20210101.0,20220111.0,20211217,20220124,EXP,,DE-AUROBINDO-AUR-APL-2021-041515,AUROBINDO,,52.0,YR,,M,Y,,,20220124,,MD,DE,DE,2022,Q1,Adult
202075083,20207508,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Lactic acidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Renal impairment,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,Tablet,,2022,Q1,Acidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2022,Q1,Lactic acidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2022,Q1,Renal impairment,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202075083,20207508,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,U,,,,,,,,2022,Q1,Acidosis,,2022,Q1,3,F,20190101.0,20211224.0,20211220,20220103,EXP,,GR-MYLANLABS-2021M1093768,MYLAN,"Prokopiou D, Kiatou B, Girousis N., Papadopoulos R., Xanthopoulou K.. Euglycemic diabetic ketoacidosis, lactic acidosis and acute renal injury in the context of antidiabetic treatment with Dapagliflozin and Metformin. Case presentation.. Hellenic Diabetological Chronicles. 2020;33(2)",74.0,YR,,F,Y,,,20220103,,MD,GR,GR,2022,Q1,Elderly
202148292,20214829,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220224.0,20211222,20220228,EXP,,NVSJ2021JP020867,NOVARTIS,,59.0,YR,,M,Y,,,20220301,,MD,JP,JP,2022,Q1,Adult
202148292,20214829,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q1,Atrioventricular block complete,,2022,Q1,2,F,,20220224.0,20211222,20220228,EXP,,NVSJ2021JP020867,NOVARTIS,,59.0,YR,,M,Y,,,20220301,,MD,JP,JP,2022,Q1,Adult
202231023,20223102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q1,Renal impairment,,2022,Q1,3,F,,20211221.0,20211223,20220112,EXP,,JP-AstraZeneca-2021A888408,ASTRAZENECA,,81.0,YR,,F,Y,,,20220112,,PH,JP,,2022,Q1,Elderly
202231023,20223102,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q1,Renal impairment,,2022,Q1,3,F,,20211221.0,20211223,20220112,EXP,,JP-AstraZeneca-2021A888408,ASTRAZENECA,,81.0,YR,,F,Y,,,20220112,,PH,JP,,2022,Q1,Elderly
202270212,20227021,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Daily dose 10mg,,,,,,,,10.0,MG,,QD,2022,Q1,Malaise,,2022,Q1,2,F,20211001.0,20220127.0,20211224,20220202,EXP,,JP-009507513-2111JPN006290,MERCK,,66.0,YR,,M,Y,66.5,KG,20220202,,MD,JP,JP,2022,Q1,Elderly
202270212,20227021,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Daily dose 10mg,,,,,,,,10.0,MG,,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20211001.0,20220127.0,20211224,20220202,EXP,,JP-009507513-2111JPN006290,MERCK,,66.0,YR,,M,Y,66.5,KG,20220202,,MD,JP,JP,2022,Q1,Elderly
202270212,20227021,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Daily dose 10mg,,,,,,,,10.0,MG,,QD,2022,Q1,Brain natriuretic peptide increased,,2022,Q1,2,F,20211001.0,20220127.0,20211224,20220202,EXP,,JP-009507513-2111JPN006290,MERCK,,66.0,YR,,M,Y,66.5,KG,20220202,,MD,JP,JP,2022,Q1,Elderly
202270212,20227021,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Daily dose 10mg,,,,,,,,10.0,MG,,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20211001.0,20220127.0,20211224,20220202,EXP,,JP-009507513-2111JPN006290,MERCK,,66.0,YR,,M,Y,66.5,KG,20220202,,MD,JP,JP,2022,Q1,Elderly
202270212,20227021,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Daily dose 10mg,,,,,,,,10.0,MG,,QD,2022,Q1,Micturition disorder,,2022,Q1,2,F,20211001.0,20220127.0,20211224,20220202,EXP,,JP-009507513-2111JPN006290,MERCK,,66.0,YR,,M,Y,66.5,KG,20220202,,MD,JP,JP,2022,Q1,Elderly
202274143,20227414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",130.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,3,F,20211116.0,20220118.0,20211224,20220126,EXP,,ES-AstraZeneca-2021A882250,ASTRAZENECA,,66.0,YR,,F,Y,117.5,KG,20220126,,MD,ES,,2022,Q1,Elderly
202274143,20227414,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",130.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q1,Renal failure,,2022,Q1,3,F,20211116.0,20220118.0,20211224,20220126,EXP,,ES-AstraZeneca-2021A882250,ASTRAZENECA,,66.0,YR,,F,Y,117.5,KG,20220126,,MD,ES,,2022,Q1,Elderly
202277953,20227795,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure acute,,2022,Q1,3,F,20210101.0,20220322.0,20211224,20220331,EXP,,JP-AstraZeneca-2021A889850,ASTRAZENECA,,76.0,YR,,F,Y,51.0,KG,20220331,,MD,JP,,2022,Q1,Elderly
202277953,20227795,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood potassium decreased,,2022,Q1,3,F,20210101.0,20220322.0,20211224,20220331,EXP,,JP-AstraZeneca-2021A889850,ASTRAZENECA,,76.0,YR,,F,Y,51.0,KG,20220331,,MD,JP,,2022,Q1,Elderly
202277953,20227795,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pleural effusion,,2022,Q1,3,F,20210101.0,20220322.0,20211224,20220331,EXP,,JP-AstraZeneca-2021A889850,ASTRAZENECA,,76.0,YR,,F,Y,51.0,KG,20220331,,MD,JP,,2022,Q1,Elderly
202280662,20228066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Tubulointerstitial nephritis,,2022,Q1,2,F,,20220316.0,20211224,20220324,EXP,,US-AstraZeneca-2021A886821,ASTRAZENECA,,64.0,YR,,M,Y,,,20220324,,MD,US,,2022,Q1,Adult
202280662,20228066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal tubular disorder,,2022,Q1,2,F,,20220316.0,20211224,20220324,EXP,,US-AstraZeneca-2021A886821,ASTRAZENECA,,64.0,YR,,M,Y,,,20220324,,MD,US,,2022,Q1,Adult
202280662,20228066,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,,20220316.0,20211224,20220324,EXP,,US-AstraZeneca-2021A886821,ASTRAZENECA,,64.0,YR,,M,Y,,,20220324,,MD,US,,2022,Q1,Adult
202314043,20231404,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,3,F,20211116.0,20220214.0,20211227,20220220,EXP,,NVSC2021ES291086,NOVARTIS,,66.0,YR,,F,Y,117.5,KG,20220220,,MD,ES,ES,2022,Q1,Elderly
202314043,20231404,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q1,Renal failure,,2022,Q1,3,F,20211116.0,20220214.0,20211227,20220220,EXP,,NVSC2021ES291086,NOVARTIS,,66.0,YR,,F,Y,117.5,KG,20220220,,MD,ES,ES,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Device related infection,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Fall,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Muscular weakness,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202320004,20232000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Nausea,,2022,Q1,4,F,20211101.0,20220221.0,20211227,20220225,EXP,,JP-AstraZeneca-2021A895806,ASTRAZENECA,,73.0,YR,,F,Y,40.0,KG,20220225,,MD,JP,,2022,Q1,Elderly
202352923,20235292,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (qd)",,,,,,,,10.0,MG,,QD,2022,Q1,Renal failure,,2022,Q1,3,F,20211116.0,20220114.0,20211228,20220127,EXP,,ES-AUROBINDO-AUR-APL-2021-052830,AUROBINDO,,66.0,YR,,F,Y,117.5,KG,20220127,,MD,ES,ES,2022,Q1,Elderly
202352923,20235292,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (qd)",,,,,,,,10.0,MG,,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,3,F,20211116.0,20220114.0,20211228,20220127,EXP,,ES-AUROBINDO-AUR-APL-2021-052830,AUROBINDO,,66.0,YR,,F,Y,117.5,KG,20220127,,MD,ES,ES,2022,Q1,Elderly
202366943,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,3,F,20211101.0,20220209.0,20211228,20220215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220215,,CN,JP,JP,2022,Q1,Elderly
202366943,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20211101.0,20220209.0,20211228,20220215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220215,,CN,JP,JP,2022,Q1,Elderly
202366943,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q1,3,F,20211101.0,20220209.0,20211228,20220215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220215,,CN,JP,JP,2022,Q1,Elderly
202366943,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,3,F,20211101.0,20220209.0,20211228,20220215,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220215,,CN,JP,JP,2022,Q1,Elderly
202386292,20238629,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,2,F,20211129.0,20220111.0,20211228,20220113,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-139403,BRISTOL MYERS SQUIBB,,56.0,YR,,M,Y,,,20220113,,HP,FR,FR,2022,Q1,Adult
202386292,20238629,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q1,Cholecystitis,,2022,Q1,2,F,20211129.0,20220111.0,20211228,20220113,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-139403,BRISTOL MYERS SQUIBB,,56.0,YR,,M,Y,,,20220113,,HP,FR,FR,2022,Q1,Adult
202450973,20245097,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q1,Weight decreased,,2022,Q1,3,F,20210101.0,20220203.0,20211229,20220211,EXP,,JP-AstraZeneca-2021A899688,ASTRAZENECA,"Adachi R, et al.. 1-8-16 A case of elderly type 2 diabetes mellitus that was difficult to distinguish from diabetic neuropathy.. The 59th Kyushu Regional Meeting of the Japan Diabetes Society 2021;154.",76.0,YR,,M,Y,,,20220211,,MD,JP,,2022,Q1,Elderly
202450973,20245097,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q1,Muscle atrophy,,2022,Q1,3,F,20210101.0,20220203.0,20211229,20220211,EXP,,JP-AstraZeneca-2021A899688,ASTRAZENECA,"Adachi R, et al.. 1-8-16 A case of elderly type 2 diabetes mellitus that was difficult to distinguish from diabetic neuropathy.. The 59th Kyushu Regional Meeting of the Japan Diabetes Society 2021;154.",76.0,YR,,M,Y,,,20220211,,MD,JP,,2022,Q1,Elderly
202450973,20245097,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q1,Off label use,,2022,Q1,3,F,20210101.0,20220203.0,20211229,20220211,EXP,,JP-AstraZeneca-2021A899688,ASTRAZENECA,"Adachi R, et al.. 1-8-16 A case of elderly type 2 diabetes mellitus that was difficult to distinguish from diabetic neuropathy.. The 59th Kyushu Regional Meeting of the Japan Diabetes Society 2021;154.",76.0,YR,,M,Y,,,20220211,,MD,JP,,2022,Q1,Elderly
202461282,20246128,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,U,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketosis,,2022,Q1,2,F,,20211221.0,20211229,20220111,EXP,,JP-AstraZeneca-2021A899679,ASTRAZENECA,"Murata Y, et al.. 2-5-13 Diabetic cases with ketosis/ketoacidosis while taking an SGLT2 inhibitor at our hospital.. The 59th Kyushu Regional Meeting of the Japan Diabetes Society; 2021 Nov 19 2021;170.",50.0,YR,,F,Y,,,20220111,,MD,JP,,2022,Q1,Adult
202461802,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,20211010.0,20211226.0,20211229,20220329,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20220329,,CN,EG,EG,2022,Q1,Adult
202461802,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,2,F,20211010.0,20211226.0,20211229,20220329,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20220329,,CN,EG,EG,2022,Q1,Adult
202461802,20246180,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,2,F,20211010.0,20211226.0,20211229,20220329,EXP,,NVSC2021EG297410,NOVARTIS,,53.0,YR,,M,Y,,,20220329,,CN,EG,EG,2022,Q1,Adult
202470242,20247024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Subdural haematoma,,2022,Q1,2,F,,20211221.0,20211229,20220112,EXP,,GB-AstraZeneca-2021A892154,ASTRAZENECA,,58.0,YR,,M,Y,,,20220112,,PH,GB,,2022,Q1,Adult
202470252,20247025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,MT3074,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pruritus,,2022,Q1,2,F,20211111.0,20211221.0,20211229,20220112,EXP,,CN-AstraZeneca-2021A899751,ASTRAZENECA,,18628.0,DY,,M,Y,62.0,KG,20220112,,MD,CN,,2022,Q1,Elderly
202470252,20247025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,MT3074,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,2,F,20211111.0,20211221.0,20211229,20220112,EXP,,CN-AstraZeneca-2021A899751,ASTRAZENECA,,18628.0,DY,,M,Y,62.0,KG,20220112,,MD,CN,,2022,Q1,Elderly
202470252,20247025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,MT3074,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,2,F,20211111.0,20211221.0,20211229,20220112,EXP,,CN-AstraZeneca-2021A899751,ASTRAZENECA,,18628.0,DY,,M,Y,62.0,KG,20220112,,MD,CN,,2022,Q1,Elderly
202492433,20249243,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Neoplasm malignant,,2022,Q1,3,F,20211123.0,20211224.0,20211229,20220112,EXP,,JP-AstraZeneca-2021A904335,ASTRAZENECA,,90.0,YR,,M,Y,,,20220112,,PH,JP,,2022,Q1,Elderly
202492433,20249243,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urine analysis abnormal,,2022,Q1,3,F,20211123.0,20211224.0,20211229,20220112,EXP,,JP-AstraZeneca-2021A904335,ASTRAZENECA,,90.0,YR,,M,Y,,,20220112,,PH,JP,,2022,Q1,Elderly
202523665,20252366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Rhabdomyolysis,,2022,Q1,5,F,20211219.0,20220222.0,20211229,20220302,EXP,,JP-JNJFOC-20211250730,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,53.4,KG,20220302,,MD,JP,JP,2022,Q1,Elderly
202523665,20252366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypothermia,,2022,Q1,5,F,20211219.0,20220222.0,20211229,20220302,EXP,,JP-JNJFOC-20211250730,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,53.4,KG,20220302,,MD,JP,JP,2022,Q1,Elderly
202523665,20252366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Altered state of consciousness,,2022,Q1,5,F,20211219.0,20220222.0,20211229,20220302,EXP,,JP-JNJFOC-20211250730,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,53.4,KG,20220302,,MD,JP,JP,2022,Q1,Elderly
202523665,20252366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Seizure,,2022,Q1,5,F,20211219.0,20220222.0,20211229,20220302,EXP,,JP-JNJFOC-20211250730,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,53.4,KG,20220302,,MD,JP,JP,2022,Q1,Elderly
202523665,20252366,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Infection,,2022,Q1,5,F,20211219.0,20220222.0,20211229,20220302,EXP,,JP-JNJFOC-20211250730,JOHNSON AND JOHNSON,,83.0,YR,E,M,Y,53.4,KG,20220302,,MD,JP,JP,2022,Q1,Elderly
202644712,20264471,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pemphigoid,,2022,Q1,2,F,20200226.0,20211223.0,20211231,20220114,EXP,,JP-AstraZeneca-2021A901863,ASTRAZENECA,,49.0,YR,,F,Y,,,20220115,,MD,JP,,2022,Q1,Adult
202644712,20264471,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pemphigoid,,2022,Q1,2,F,20200226.0,20211223.0,20211231,20220114,EXP,,JP-AstraZeneca-2021A901863,ASTRAZENECA,,49.0,YR,,F,Y,,,20220115,,MD,JP,,2022,Q1,Adult
202644712,20264471,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pemphigoid,,2022,Q1,2,F,20200226.0,20211223.0,20211231,20220114,EXP,,JP-AstraZeneca-2021A901863,ASTRAZENECA,,49.0,YR,,F,Y,,,20220115,,MD,JP,,2022,Q1,Adult
202735001,20273500,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2022,Q1,Guillain-Barre syndrome,,2022,Q1,1,I,20211108.0,20211229.0,20220102,20220102,EXP,FR-AFSSAPS-NY20215559,FR-EMD Serono-E2B_90086257,EMD SERONO INC,,55.0,YR,A,M,Y,114.0,KG,20220102,,HP,FR,,2022,Q1,Adult
202782281,20278228,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd (daily)",,,,,,,,10.0,MG,,QD,2022,Q1,Immune-mediated myositis,,2022,Q1,1,I,20200101.0,20211223.0,20220103,20220103,EXP,,HK-ORGANON-O2112HKG002551,ORGANON,"Leung CCD, Chu WY, Ko CF. Statin-induced immune-mediated necrotising myopathy: a case report.. Asian J Gerontol Geriatr. 2021;16(2):90-1",79.0,YR,,M,Y,,,20220103,,MD,HK,HK,2022,Q1,Elderly
202784361,20278436,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day (10 mg, Daily each morning, continued)",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypocalcaemia,,2022,Q1,1,I,20210101.0,20211222.0,20220103,20220103,EXP,,GB-AUROBINDO-AUR-APL-2021-053909,AUROBINDO,,78.0,YR,,F,Y,,,20220103,,PH,GB,GB,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Lung disorder,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202795002,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,20210301.0,20220228.0,20220103,20220307,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220307,,MD,PL,PL,2022,Q1,Elderly
202798411,20279841,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,LC3182,,,10.0,MG,Tablet,QD,2022,Q1,Protein urine present,,2022,Q1,1,I,20211109.0,20211215.0,20220103,20220103,EXP,,CN-AstraZeneca-2021A885203,ASTRAZENECA,,16303.0,DY,,F,Y,,,20220103,,MD,CN,,2022,Q1,Elderly
202798411,20279841,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,LC3182,,,10.0,MG,Tablet,QD,2022,Q1,Ketosis,,2022,Q1,1,I,20211109.0,20211215.0,20220103,20220103,EXP,,CN-AstraZeneca-2021A885203,ASTRAZENECA,,16303.0,DY,,F,Y,,,20220103,,MD,CN,,2022,Q1,Elderly
202798461,20279846,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1675.0,MG,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20210303.0,20211224.0,20220103,20220103,EXP,,SE-AstraZeneca-2021A898463,ASTRAZENECA,,56.0,YR,,F,Y,,,20220103,,MD,SE,,2022,Q1,Adult
202800851,20280085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20211230.0,20220103,20220103,EXP,,GB-AstraZeneca-2021A908829,ASTRAZENECA,,56.0,YR,,F,Y,70.0,KG,20220103,,MD,GB,,2022,Q1,Adult
202800851,20280085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q1,Medication error,,2022,Q1,1,I,,20211230.0,20220103,20220103,EXP,,GB-AstraZeneca-2021A908829,ASTRAZENECA,,56.0,YR,,F,Y,70.0,KG,20220103,,MD,GB,,2022,Q1,Adult
202801451,20280145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Injury,,2022,Q1,1,I,20140501.0,20211229.0,20220103,20220103,EXP,,NO-AstraZeneca-2021A906890,ASTRAZENECA,,52.0,YR,,M,Y,105.0,KG,20220103,,MD,NO,,2022,Q1,Adult
202801451,20280145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Pollakiuria,,2022,Q1,1,I,20140501.0,20211229.0,20220103,20220103,EXP,,NO-AstraZeneca-2021A906890,ASTRAZENECA,,52.0,YR,,M,Y,105.0,KG,20220103,,MD,NO,,2022,Q1,Adult
202801451,20280145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20140501.0,20211229.0,20220103,20220103,EXP,,NO-AstraZeneca-2021A906890,ASTRAZENECA,,52.0,YR,,M,Y,105.0,KG,20220103,,MD,NO,,2022,Q1,Adult
202801451,20280145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Myalgia,,2022,Q1,1,I,20140501.0,20211229.0,20220103,20220103,EXP,,NO-AstraZeneca-2021A906890,ASTRAZENECA,,52.0,YR,,M,Y,105.0,KG,20220103,,MD,NO,,2022,Q1,Adult
202801451,20280145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20140501.0,20211229.0,20220103,20220103,EXP,,NO-AstraZeneca-2021A906890,ASTRAZENECA,,52.0,YR,,M,Y,105.0,KG,20220103,,MD,NO,,2022,Q1,Adult
202812111,20281211,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0, Tabletten",,,U,U,,,,,,Tablet,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096666,MYLAN,,69.0,YR,,M,Y,86.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202812111,20281211,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0, Tabletten",,,U,U,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096666,MYLAN,,69.0,YR,,M,Y,86.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202812111,20281211,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0, Tabletten",,,U,U,,,,,,Tablet,,2022,Q1,Nausea,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096666,MYLAN,,69.0,YR,,M,Y,86.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202812111,20281211,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0, Tabletten",,,U,U,,,,,,Tablet,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096666,MYLAN,,69.0,YR,,M,Y,86.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202812111,20281211,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5|850 mg, 1-1-0.5-0, Tabletten",,,U,U,,,,,,Tablet,,2022,Q1,Pain,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096666,MYLAN,,69.0,YR,,M,Y,86.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Blindness,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Blindness,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202890002,20289000,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Blood glucose abnormal,,2022,Q1,2,F,20211229.0,20220124.0,20220104,20220124,EXP,,BR-009507513-2112BRA010174,MERCK,,52.0,YR,,F,Y,99.0,KG,20220124,,CN,BR,BR,2022,Q1,Adult
202892381,20289238,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Film-coated tablet,,2022,Q1,Type I hypersensitivity,,2022,Q1,1,I,20210323.0,20211230.0,20220104,20220104,PER,FR-AFSSAPS-PV20213923,FR-AMGEN-FRASP2021207787,AMGEN,,71.0,YR,E,M,Y,,,20220104,,MD,FR,FR,2022,Q1,Elderly
202913041,20291304,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097796,MYLAN,,45.0,YR,,M,Y,82.0,KG,20220104,,PH,DE,DE,2022,Q1,Adult
202913041,20291304,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,International normalised ratio abnormal,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097796,MYLAN,,45.0,YR,,M,Y,82.0,KG,20220104,,PH,DE,DE,2022,Q1,Adult
202913341,20291334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg OD,,,Y,,,,202293.0,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20211226.0,20220104,20220104,EXP,,GB-AstraZeneca-2021A900935,ASTRAZENECA,,75.0,YR,,F,Y,76.0,KG,20220104,,MD,GB,,2022,Q1,Elderly
202963361,20296336,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once a Day",,,U,,,,,,,Film Coated Tablet,QD,2022,Q1,Guillain-Barre syndrome,,2022,Q1,1,I,20211108.0,20211224.0,20220105,20220105,EXP,,FR-AUROBINDO-AUR-APL-2021-054153,AUROBINDO,,55.0,YR,,M,Y,113.6,KG,20220105,,HP,FR,FR,2022,Q1,Adult
202973301,20297330,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0 ()",,,U,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322852,RANBAXY,,68.0,YR,,M,Y,,,20220105,,PH,DE,DE,2022,Q1,Elderly
202973301,20297330,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0 ()",,,U,,,,,,,,,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322852,RANBAXY,,68.0,YR,,M,Y,,,20220105,,PH,DE,DE,2022,Q1,Elderly
202973301,20297330,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0 ()",,,U,,,,,,,,,2022,Q1,Balance disorder,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322852,RANBAXY,,68.0,YR,,M,Y,,,20220105,,PH,DE,DE,2022,Q1,Elderly
202973301,20297330,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0 ()",,,U,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322852,RANBAXY,,68.0,YR,,M,Y,,,20220105,,PH,DE,DE,2022,Q1,Elderly
202973301,20297330,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0 ()",,,U,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322852,RANBAXY,,68.0,YR,,M,Y,,,20220105,,PH,DE,DE,2022,Q1,Elderly
202978922,20297892,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, QD (concentration: 10 mg, comprim? pellicul? )",530.182,MG,Y,,,,,10.0,MG,,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20211206.0,20220214.0,20220105,20220220,EXP,FR-AFSSAPS-MP20219225,NVSC2022FR000603,NOVARTIS,,56.0,YR,,M,Y,129.0,KG,20220220,,PH,FR,FR,2022,Q1,Adult
202988751,20298875,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4570.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,20211221.0,20211231.0,20220105,20220105,EXP,,FR-AstraZeneca-2021A909004,ASTRAZENECA,,64.0,YR,,F,Y,,,20220105,,MD,FR,,2022,Q1,Adult
202998942,20299894,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,20211231.0,20220107.0,20220105,20220112,EXP,,TW-JNJFOC-20220105588,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20220112,,MD,TW,TW,2022,Q1,Elderly
203054931,20305493,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebrovascular accident,,2022,Q1,1,I,20211201.0,20211229.0,20220106,20220106,EXP,,FR-AstraZeneca-2021A908492,ASTRAZENECA,,76.0,YR,,M,Y,,,20220106,,PH,FR,,2022,Q1,Elderly
203069492,20306949,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",530.182,MG,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20211206.0,20220210.0,20220107,20220223,EXP,,FR-AUROBINDO-AUR-APL-2022-000234,AUROBINDO,,56.0,YR,,M,Y,129.0,KG,20220223,,PH,FR,FR,2022,Q1,Adult
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Abdominal distension,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Chest discomfort,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Tachypnoea,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092891,20309289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,U,,2106018,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20211215.0,20211230.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002163,ASTRAZENECA,,27457.0,DY,,M,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092921,20309292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,U,,"MT3060,2106097",,202293.0,10.0,MG,Tablet,TID,2022,Q1,Dry mouth,,2022,Q1,1,I,20211129.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909727,ASTRAZENECA,,21185.0,DY,,F,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092921,20309292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,U,,"MT3060,2106097",,202293.0,10.0,MG,Tablet,TID,2022,Q1,Abdominal discomfort,,2022,Q1,1,I,20211129.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909727,ASTRAZENECA,,21185.0,DY,,F,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092921,20309292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,U,,"MT3060,2106097",,202293.0,10.0,MG,Tablet,TID,2022,Q1,Weight decreased,,2022,Q1,1,I,20211129.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909727,ASTRAZENECA,,21185.0,DY,,F,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092921,20309292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,U,,"MT3060,2106097",,202293.0,10.0,MG,Tablet,TID,2022,Q1,Asthenia,,2022,Q1,1,I,20211129.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909727,ASTRAZENECA,,21185.0,DY,,F,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092921,20309292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2700.0,MG,U,,"MT3060,2106097",,202293.0,10.0,MG,Tablet,TID,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211129.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909727,ASTRAZENECA,,21185.0,DY,,F,Y,,,20220107,,MD,CN,,2022,Q1,Elderly
203092931,20309293,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,ML3038,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20211213.0,20211229.0,20220107,20220107,EXP,,CN-AstraZeneca-2021A909885,ASTRAZENECA,,25049.0,DY,,M,Y,64.0,KG,20220107,,MD,CN,,2022,Q1,Elderly
203100061,20310006,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",360.0,MG,,,2104254,,,10.0,MG,,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20211224.0,20220105.0,20220107,20220107,EXP,,CN-BAYER-2022A002013,BAYER,,72.0,YR,E,M,Y,53.0,KG,20220107,,HP,CN,CN,2022,Q1,Elderly
203100061,20310006,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",360.0,MG,,,2104254,,,10.0,MG,,QD,2022,Q1,Cold sweat,,2022,Q1,1,I,20211224.0,20220105.0,20220107,20220107,EXP,,CN-BAYER-2022A002013,BAYER,,72.0,YR,E,M,Y,53.0,KG,20220107,,HP,CN,CN,2022,Q1,Elderly
203100061,20310006,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",360.0,MG,,,2104254,,,10.0,MG,,QD,2022,Q1,Unresponsive to stimuli,,2022,Q1,1,I,20211224.0,20220105.0,20220107,20220107,EXP,,CN-BAYER-2022A002013,BAYER,,72.0,YR,E,M,Y,53.0,KG,20220107,,HP,CN,CN,2022,Q1,Elderly
203101601,20310160,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,2104090,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vision blurred,,2022,Q1,1,I,20211222.0,20220101.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002463,ASTRAZENECA,,15790.0,DY,,F,Y,58.0,KG,20220107,,MD,CN,,2022,Q1,Elderly
203101601,20310160,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,2104090,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20211222.0,20220101.0,20220107,20220107,EXP,,CN-AstraZeneca-2022A002463,ASTRAZENECA,,15790.0,DY,,F,Y,58.0,KG,20220107,,MD,CN,,2022,Q1,Elderly
203134601,20313460,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,,,,,,,,Film-coated tablet,QD,2022,Q1,Guillain-Barre syndrome,,2022,Q1,1,I,20211108.0,20220103.0,20220110,20220110,EXP,FR-AFSSAPS-NY20215559,FR-MYLANLABS-2022M1000515,MYLAN,,55.0,YR,,M,Y,113.6,KG,20220110,,HP,FR,FR,2022,Q1,Adult
203187241,20318724,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,1,I,,20220105.0,20220110,20220110,EXP,,ZA-AstraZeneca-2022A010292,ASTRAZENECA,,58.0,YR,,F,Y,,,20220110,,CN,ZA,,2022,Q1,Adult
203210371,20321037,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20211101.0,20220103.0,20220111,20220111,EXP,,FR-AstraZeneca-2021A858637,ASTRAZENECA,,838.0,MON,,M,Y,117.0,KG,20220111,,MD,FR,,2022,Q1,Elderly
203210371,20321037,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20211101.0,20220103.0,20220111,20220111,EXP,,FR-AstraZeneca-2021A858637,ASTRAZENECA,,838.0,MON,,M,Y,117.0,KG,20220111,,MD,FR,,2022,Q1,Elderly
203210371,20321037,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20211101.0,20220103.0,20220111,20220111,EXP,,FR-AstraZeneca-2021A858637,ASTRAZENECA,,838.0,MON,,M,Y,117.0,KG,20220111,,MD,FR,,2022,Q1,Elderly
203210371,20321037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20211101.0,20220103.0,20220111,20220111,EXP,,FR-AstraZeneca-2021A858637,ASTRAZENECA,,838.0,MON,,M,Y,117.0,KG,20220111,,MD,FR,,2022,Q1,Elderly
203210961,20321096,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"FORXIGA 10 mg film-coated tablets, 1DF",,,,,"UNKNOWN,Unknown",,,,,Film-coated tablet,,2022,Q1,Guillain-Barre syndrome,,2022,Q1,1,I,20211108.0,20220102.0,20220111,20220111,EXP,FR-AFSSAPS-NY20215559,FR-TEVA-2022-FR-1996685,TEVA,,55.0,YR,A,M,Y,113.6,KG,20220111,,HP,FR,FR,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Heart rate irregular,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Tachycardia,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Mobility decreased,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Syncope,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203227482,20322748,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Abdominal pain upper,,2022,Q1,2,F,20210201.0,20220111.0,20220111,20220122,EXP,,NVSC2022EG003104,NOVARTIS,,46.0,YR,,M,Y,,,20220122,,CN,EG,EG,2022,Q1,Adult
203228762,20322876,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,UNK,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210701.0,20220120.0,20220111,20220127,EXP,,NVSC2022AR004498,NOVARTIS,,56.0,YR,,M,Y,,,20220127,,CN,AR,AR,2022,Q1,Adult
203228762,20322876,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,UNK,,,,,,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20210701.0,20220120.0,20220111,20220127,EXP,,NVSC2022AR004498,NOVARTIS,,56.0,YR,,M,Y,,,20220127,,CN,AR,AR,2022,Q1,Adult
203229711,20322971,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,,QD,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,20211218.0,20220110.0,20220111,20220111,EXP,NO-NOMAADVRE-RELISSO-2022-Vp7dr3,NVSC2022NO004780,NOVARTIS,,75.0,YR,,M,Y,,,20220111,,MD,NO,NO,2022,Q1,Elderly
203229711,20322971,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,,QD,2022,Q1,Vascular stent thrombosis,,2022,Q1,1,I,20211218.0,20220110.0,20220111,20220111,EXP,NO-NOMAADVRE-RELISSO-2022-Vp7dr3,NVSC2022NO004780,NOVARTIS,,75.0,YR,,M,Y,,,20220111,,MD,NO,NO,2022,Q1,Elderly
203230242,20323024,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",530.182,MG,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20211206.0,20220314.0,20220111,20220318,EXP,FR-AFSSAPS-MP20219225,FR-MYLANLABS-2022M1001603,MYLAN,,56.0,YR,,M,Y,129.0,KG,20220318,,PH,FR,FR,2022,Q1,Adult
203230951,20323095,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,0-1-0,,,Y,U,,,,,,Film-coated tablet,,2022,Q1,Hepatic cytolysis,,2022,Q1,1,I,20210725.0,20220106.0,20220111,20220111,EXP,FR-AFSSAPS-TO20216078,FR-MYLANLABS-2022M1001519,MYLAN,,80.0,YR,,M,Y,62.0,KG,20220111,,HP,FR,FR,2022,Q1,Elderly
203230951,20323095,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,0-1-0,,,Y,U,,,,,,Film-coated tablet,,2022,Q1,Rhabdomyolysis,,2022,Q1,1,I,20210725.0,20220106.0,20220111,20220111,EXP,FR-AFSSAPS-TO20216078,FR-MYLANLABS-2022M1001519,MYLAN,,80.0,YR,,M,Y,62.0,KG,20220111,,HP,FR,FR,2022,Q1,Elderly
203267241,20326724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 days,,,,,,,,10.0,MG,,,2022,Q1,Polyarthritis,,2022,Q1,1,I,,20220104.0,20220112,20220112,EXP,CA-MHPD-E2B_03554690,CA-Accord-250133,ACCORD,,55.0,YR,,M,Y,,,20220112,,HP,CA,CA,2022,Q1,Adult
203267241,20326724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 days,,,,,,,,10.0,MG,,,2022,Q1,Enthesopathy,,2022,Q1,1,I,,20220104.0,20220112,20220112,EXP,CA-MHPD-E2B_03554690,CA-Accord-250133,ACCORD,,55.0,YR,,M,Y,,,20220112,,HP,CA,CA,2022,Q1,Adult
203272951,20327295,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,360.0,MG,U,,2104254,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20211224.0,20220105.0,20220112,20220112,EXP,,CN-AstraZeneca-2022A011386,ASTRAZENECA,,26640.0,DY,,M,Y,,,20220112,,MD,CN,,2022,Q1,Elderly
203276752,20327675,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20211227.0,20220105.0,20220112,20220128,EXP,,CO-SA-2022SA008100,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20220128,,MD,CO,CO,2022,Q1,Adult
203276752,20327675,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Hyperglycaemic unconsciousness,,2022,Q1,2,F,20211227.0,20220105.0,20220112,20220128,EXP,,CO-SA-2022SA008100,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20220128,,MD,CO,CO,2022,Q1,Adult
203276752,20327675,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,2,F,20211227.0,20220105.0,20220112,20220128,EXP,,CO-SA-2022SA008100,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20220128,,MD,CO,CO,2022,Q1,Adult
203276752,20327675,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,20211227.0,20220105.0,20220112,20220128,EXP,,CO-SA-2022SA008100,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20220128,,MD,CO,CO,2022,Q1,Adult
203276752,20327675,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,2,F,20211227.0,20220105.0,20220112,20220128,EXP,,CO-SA-2022SA008100,SANOFI AVENTIS,,42.0,YR,A,F,Y,,,20220128,,MD,CO,CO,2022,Q1,Adult
203308101,20330810,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,MT30602105098,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Polyuria,,2022,Q1,1,I,20211219.0,20220106.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A014834,ASTRAZENECA,,18371.0,DY,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203308101,20330810,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,MT30602105098,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20211219.0,20220106.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A014834,ASTRAZENECA,,18371.0,DY,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203308101,20330810,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,MT30602105098,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20211219.0,20220106.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A014834,ASTRAZENECA,,18371.0,DY,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203308101,20330810,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,MT30602105098,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20211219.0,20220106.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A014834,ASTRAZENECA,,18371.0,DY,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203308891,20330889,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220105.0,20220113,20220113,EXP,CA-MHPD-E2B_03531529,CA-Accord-250248,ACCORD,,49.0,YR,,M,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
203308891,20330889,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q1,Loss of consciousness,,2022,Q1,1,I,,20220105.0,20220113,20220113,EXP,CA-MHPD-E2B_03531529,CA-Accord-250248,ACCORD,,49.0,YR,,M,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
203308891,20330889,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,,20220105.0,20220113,20220113,EXP,CA-MHPD-E2B_03531529,CA-Accord-250248,ACCORD,,49.0,YR,,M,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
203308891,20330889,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,,20220105.0,20220113,20220113,EXP,CA-MHPD-E2B_03531529,CA-Accord-250248,ACCORD,,49.0,YR,,M,Y,,,20220113,,HP,CA,CA,2022,Q1,Adult
203315901,20331590,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,Film-coated tablet,,2022,Q1,Type I hypersensitivity,,2022,Q1,1,I,20210323.0,20220103.0,20220113,20220113,EXP,FR-AFSSAPS-PV20213923,FR-TEVA-2022-FR-1997054,TEVA,,71.0,YR,E,M,Y,,,20220113,,MD,FR,FR,2022,Q1,Elderly
203317701,20331770,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cystatin C increased,,2022,Q1,1,I,,20220110.0,20220113,20220113,EXP,,DE-AstraZeneca-2022A015506,ASTRAZENECA,,90.0,YR,,M,Y,,,20220113,,MD,DE,,2022,Q1,Elderly
203317701,20331770,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220110.0,20220113,20220113,EXP,,DE-AstraZeneca-2022A015506,ASTRAZENECA,,90.0,YR,,M,Y,,,20220113,,MD,DE,,2022,Q1,Elderly
203317701,20331770,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cystatin C increased,,2022,Q1,1,I,,20220110.0,20220113,20220113,EXP,,DE-AstraZeneca-2022A015506,ASTRAZENECA,,90.0,YR,,M,Y,,,20220113,,MD,DE,,2022,Q1,Elderly
203317701,20331770,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220110.0,20220113,20220113,EXP,,DE-AstraZeneca-2022A015506,ASTRAZENECA,,90.0,YR,,M,Y,,,20220113,,MD,DE,,2022,Q1,Elderly
203317711,20331771,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,,MP2454,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Syncope,,2022,Q1,1,I,20220106.0,20220109.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A015000,ASTRAZENECA,,74.0,YR,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203317711,20331771,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5.0,MG,Y,,MP2454,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Drug hypersensitivity,,2022,Q1,1,I,20220106.0,20220109.0,20220113,20220113,EXP,,CN-AstraZeneca-2022A015000,ASTRAZENECA,,74.0,YR,,F,Y,,,20220113,,MD,CN,,2022,Q1,Elderly
203318442,20331844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,2,F,20211109.0,20220124.0,20220113,20220201,EXP,,FR-AstraZeneca-2022A014854,ASTRAZENECA,,74.0,YR,,M,Y,51.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203318442,20331844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Blood glucose abnormal,,2022,Q1,2,F,20211109.0,20220124.0,20220113,20220201,EXP,,FR-AstraZeneca-2022A014854,ASTRAZENECA,,74.0,YR,,M,Y,51.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203318442,20331844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Tachypnoea,,2022,Q1,2,F,20211109.0,20220124.0,20220113,20220201,EXP,,FR-AstraZeneca-2022A014854,ASTRAZENECA,,74.0,YR,,M,Y,51.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203318442,20331844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Off label use,,2022,Q1,2,F,20211109.0,20220124.0,20220113,20220201,EXP,,FR-AstraZeneca-2022A014854,ASTRAZENECA,,74.0,YR,,M,Y,51.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203318442,20331844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Ketonuria,,2022,Q1,2,F,20211109.0,20220124.0,20220113,20220201,EXP,,FR-AstraZeneca-2022A014854,ASTRAZENECA,,74.0,YR,,M,Y,51.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203318451,20331845,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220104.0,20220107.0,20220113,20220113,EXP,,GB-AstraZeneca-2022A012778,ASTRAZENECA,,52.0,YR,,M,Y,,,20220113,,MD,GB,,2022,Q1,Adult
203321152,20332115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood uric acid increased,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Muscle spasms,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal pain,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood uric acid increased,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Muscle spasms,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal pain,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203321152,20332115,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,640.0,MG,N,,Z609A,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,2,F,20211009.0,20220126.0,20220113,20220203,EXP,,FR-AstraZeneca-2022A014977,ASTRAZENECA,,23681.0,DY,,M,Y,135.0,KG,20220203,,CN,FR,,2022,Q1,Elderly
203333681,20333368,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,Film-coated tablet,,2022,Q1,Malaise,,2022,Q1,1,I,20211113.0,20211209.0,20220113,20220113,EXP,FR-AFSSAPS-NY20215297,FR-US-Provell Pharmaceuticals LLC-E2B_90086043,PROVELL PHARMACEUTICALS,,84.0,YR,E,M,Y,,,20220112,,CN,FR,FR,2022,Q1,Elderly
203333681,20333368,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,Film-coated tablet,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211113.0,20211209.0,20220113,20220113,EXP,FR-AFSSAPS-NY20215297,FR-US-Provell Pharmaceuticals LLC-E2B_90086043,PROVELL PHARMACEUTICALS,,84.0,YR,E,M,Y,,,20220112,,CN,FR,FR,2022,Q1,Elderly
203354191,20335419,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,MT3072//2105093,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211211.0,20220107.0,20220114,20220114,EXP,,CN-AstraZeneca-2022A018627,ASTRAZENECA,,22357.0,DY,,M,Y,52.0,KG,20220114,,MD,CN,,2022,Q1,Elderly
203356261,20335626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,2106100,,202293.0,,,Tablet,QD,2022,Q1,Urine ketone body present,,2022,Q1,1,I,20211208.0,20220107.0,20220114,20220114,EXP,,CN-AstraZeneca-2022A018604,ASTRAZENECA,,18954.0,DY,,M,Y,70.0,KG,20220114,,MD,CN,,2022,Q1,Elderly
203357462,20335746,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Form strength: 10 mg, unit dose: 10 mg",,,Y,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20211206.0,20220217.0,20220114,20220225,EXP,FR-AFSSAPS-MP20219225,FR-TEVA-2022-FR-1998106,TEVA,,56.0,YR,A,M,Y,129.0,KG,20220225,,PH,FR,FR,2022,Q1,Adult
203358761,20335876,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3540.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketosis,,2022,Q1,1,I,20211227.0,20220105.0,20220114,20220114,EXP,,CN-AstraZeneca-2022A013824,ASTRAZENECA,,16071.0,DY,,M,Y,,,20220114,,MD,CN,,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Lung disorder,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Lung disorder,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Lung disorder,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203433362,20343336,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Lung disorder,,2022,Q1,2,F,,20220208.0,20220117,20220222,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-323727,RANBAXY,,71.0,YR,,M,Y,,,20220222,,MD,PL,PL,2022,Q1,Elderly
203462241,20346224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,LC0148,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vulvovaginal dryness,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,LC0148,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,LC0148,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vulvovaginal burning sensation,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,LC0148,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vulvovaginal pruritus,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,LC0148,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urine output increased,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Vulvovaginal dryness,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Vulvovaginal burning sensation,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Vulvovaginal pruritus,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203462241,20346224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Urine output increased,,2022,Q1,1,I,20211101.0,20220112.0,20220118,20220118,EXP,,CR-AstraZeneca-2022A023161,ASTRAZENECA,,69.0,YR,,F,Y,,,20220118,,CN,CR,,2022,Q1,Elderly
203469771,20346977,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q1,Myocarditis,,2022,Q1,1,I,,20220111.0,20220118,20220118,EXP,,BR-AstraZeneca-2022A018795,ASTRAZENECA,,60.0,YR,,F,Y,,,20220118,,CN,BR,,2022,Q1,Adult
203495503,20349550,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Platelet count decreased,,2022,Q1,3,F,20211209.0,20220225.0,20220119,20220302,EXP,,NVSJ2022JP000955,NOVARTIS,,67.0,YR,,M,Y,,,20220303,,MD,JP,JP,2022,Q1,Elderly
203501331,20350133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20210101.0,20220110.0,20220119,20220119,EXP,,AT-AstraZeneca-2022A018126,ASTRAZENECA,,32.0,YR,,M,Y,,,20220119,,MD,AT,,2022,Q1,Young Adult
203501341,20350134,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q1,Heavy menstrual bleeding,,2022,Q1,1,I,20210922.0,20220114.0,20220119,20220119,EXP,,GB-AstraZeneca-2022A024164,ASTRAZENECA,,50.0,YR,,F,Y,110.0,KG,20220119,,MD,GB,,2022,Q1,Adult
203502352,20350235,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,2,F,,20220118.0,20220119,20220126,EXP,,TR-AstraZeneca-2022A024075,ASTRAZENECA,,57.0,YR,,M,Y,,,20220126,,MD,TR,,2022,Q1,Adult
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Creatinine renal clearance decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Haematocrit decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hyperkalaemia,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Lymphocyte count increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Mean cell haemoglobin increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Haemoglobin decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hypernatraemia,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Mean cell volume increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Red blood cell count decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Creatinine renal clearance decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Haematocrit decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hyperkalaemia,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Lymphocyte count increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Mean cell haemoglobin increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Haemoglobin decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hypernatraemia,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Mean cell volume increased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203502382,20350238,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily IN THE MORNING,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Red blood cell count decreased,,2022,Q1,2,F,20211201.0,20220124.0,20220119,20220201,EXP,,FR-AstraZeneca-2022A025690,ASTRAZENECA,,74.0,YR,,M,Y,84.0,KG,20220201,,MD,FR,,2022,Q1,Elderly
203503631,20350363,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Death,,2022,Q1,1,I,20211209.0,20220114.0,20220119,20220119,EXP,,NL-AstraZeneca-2022A025338,ASTRAZENECA,,77.0,YR,,M,Y,,,20220119,,HP,NL,,2022,Q1,Elderly
203505261,20350526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (0-1-0),,,Y,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q1,Rhabdomyolysis,,2022,Q1,1,I,20210725.0,20220107.0,20220119,20220119,EXP,FR-AFSSAPS-TO20216078,FR-PFIZER INC-202200024330,PFIZER,,80.0,YR,,M,Y,62.0,KG,20220119,,HP,FR,FR,2022,Q1,Elderly
203505261,20350526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (0-1-0),,,Y,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q1,Hepatic cytolysis,,2022,Q1,1,I,20210725.0,20220107.0,20220119,20220119,EXP,FR-AFSSAPS-TO20216078,FR-PFIZER INC-202200024330,PFIZER,,80.0,YR,,M,Y,62.0,KG,20220119,,HP,FR,FR,2022,Q1,Elderly
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Femoral neck fracture,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Anxiety,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203535112,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Underdose,,2022,Q1,2,F,20190729.0,20220120.0,20220119,20220125,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,105.0,KG,20220125,,HP,COUNTRY NOT SPECIFIED,US,2022,Q1,Adult
203558431,20355843,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,240.0,MG,Y,,2105243,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Nocturia,,2022,Q1,1,I,20220102.0,20220112.0,20220120,20220120,EXP,,CN-AstraZeneca-2022A024260,ASTRAZENECA,,19939.0,DY,,M,Y,70.0,KG,20220120,,MD,CN,,2022,Q1,Elderly
203558551,20355855,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220113.0,20220120,20220120,EXP,,JP-AstraZeneca-2022A025440,ASTRAZENECA,,80.0,YR,,M,Y,,,20220120,,MD,JP,,2022,Q1,Elderly
203565272,20356527,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",65.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Altered state of consciousness,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203565272,20356527,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",65.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203565272,20356527,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2.5 mg, Everyday",65.0,MG,Y,,,,,2.5,MG,Tablet,QD,2022,Q1,Altered state of consciousness,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203565272,20356527,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2.5 mg, Everyday",65.0,MG,Y,,,,,2.5,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203565272,20356527,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2.5 mg, Everyday",65.0,MG,Y,,,,,2.5,MG,Tablet,QD,2022,Q1,Altered state of consciousness,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203565272,20356527,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2.5 mg, Everyday",65.0,MG,Y,,,,,2.5,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20220101.0,20220131.0,20220120,20220204,EXP,,JP-009507513-2201JPN004072,MERCK,,62.0,YR,,M,Y,71.2,KG,20220204,,MD,JP,JP,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Glomerulonephritis membranoproliferative,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Tremor,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood albumin decreased,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Nephrotic syndrome,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203567053,20356705,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,3,F,,20220124.0,20220120,20220206,EXP,,NVSC2022SE008006,NOVARTIS,,42.0,YR,,F,Y,,,20220203,,PH,SE,SE,2022,Q1,Adult
203575651,20357565,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Pancreatitis,,2022,Q1,1,I,20210610.0,20210825.0,20220120,20220120,PER,,US-NOVOPROD-835945,NOVO NORDISK,,51.0,YR,,F,Y,71.7,KG,20220120,,HP,US,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Food aversion,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Muscle spasms,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Expired product administered,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203581291,20358129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20210501.0,20211012.0,20220120,20220120,PER,,MX-NOVOPROD-860413,NOVO NORDISK,,49.0,YR,,F,Y,60.0,KG,20220120,,CN,MX,US,2022,Q1,Adult
203590441,20359044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 tablet at a time, orally, once a day",,,Y,,2105203,,202293.0,,,Tablet,QD,2022,Q1,Blood ketone body increased,,2022,Q1,1,I,20211231.0,20220113.0,20220120,20220120,EXP,,CN-AstraZeneca-2022A025501,ASTRAZENECA,,27029.0,DY,,F,Y,54.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood pressure systolic increased,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Sleep disorder,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Eczema,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cough,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Gout,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood pressure systolic abnormal,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Heart rate increased,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood pressure diastolic abnormal,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Chronic obstructive pulmonary disease,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Oxygen saturation decreased,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood pressure diastolic decreased,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Gastritis,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203597101,20359710,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Oropharyngeal pain,,2022,Q1,1,I,,20220108.0,20220121,20220121,EXP,CA-MHPD-E2B_03581388,CA-Accord-250895,ACCORD,,69.0,YR,,F,Y,,,20220121,,HP,CA,CA,2022,Q1,Elderly
203602462,20360246,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Fungal infection,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Palpitations,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Fungal infection,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Palpitations,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Fungal infection,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Palpitations,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Fungal infection,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Pyrexia,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602462,20360246,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Okand,,202293.0,10.0,MG,Tablet,,2022,Q1,Palpitations,,2022,Q1,2,F,20220111.0,20220203.0,20220121,20220211,EXP,,SE-AstraZeneca-2022A025893,ASTRAZENECA,,29995.0,DY,,M,Y,,,20220211,,CN,SE,,2022,Q1,Elderly
203602511,20360251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,2104097,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urine ketone body present,,2022,Q1,1,I,20211220.0,20220114.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A028335,ASTRAZENECA,,2719.0,WK,,M,Y,86.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203602511,20360251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,2104097,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acidosis,,2022,Q1,1,I,20211220.0,20220114.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A028335,ASTRAZENECA,,2719.0,WK,,M,Y,86.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203602511,20360251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,2104097,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Nausea,,2022,Q1,1,I,20211220.0,20220114.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A028335,ASTRAZENECA,,2719.0,WK,,M,Y,86.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203602511,20360251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,2104097,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20211220.0,20220114.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A028335,ASTRAZENECA,,2719.0,WK,,M,Y,86.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203602511,20360251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,2104097,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vomiting,,2022,Q1,1,I,20211220.0,20220114.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A028335,ASTRAZENECA,,2719.0,WK,,M,Y,86.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203607751,20360775,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, od",,,U,,,,211564.0,10.0,MG,,QD,2022,Q1,Weight decreased,,2022,Q1,1,I,,20220112.0,20220121,20220121,EXP,,US-GLENMARK PHARMACEUTICALS-2022GMK069847,GLENMARK,"Matli VV, Fariduddin MM, Asafo-Agyei KO, Bansal N.. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report.. Clinical Case Reports. 2021;9:e05144",48.0,YR,,M,Y,,,20220121,,HP,US,US,2022,Q1,Adult
203607751,20360775,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, od",,,U,,,,211564.0,10.0,MG,,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220112.0,20220121,20220121,EXP,,US-GLENMARK PHARMACEUTICALS-2022GMK069847,GLENMARK,"Matli VV, Fariduddin MM, Asafo-Agyei KO, Bansal N.. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report.. Clinical Case Reports. 2021;9:e05144",48.0,YR,,M,Y,,,20220121,,HP,US,US,2022,Q1,Adult
203607751,20360775,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, od",,,U,,,,211564.0,10.0,MG,,QD,2022,Q1,Asthenia,,2022,Q1,1,I,,20220112.0,20220121,20220121,EXP,,US-GLENMARK PHARMACEUTICALS-2022GMK069847,GLENMARK,"Matli VV, Fariduddin MM, Asafo-Agyei KO, Bansal N.. Normoglycemic diabetic ketoacidosis in a type 2 diabetes patient on dapagliflozin: A case report.. Clinical Case Reports. 2021;9:e05144",48.0,YR,,M,Y,,,20220121,,HP,US,US,2022,Q1,Adult
203617181,20361718,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20220112.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A023072,ASTRAZENECA,"Suetsuna S, et al.. 36 A case of type 1 diabetes mellitus during SAP therapy who developed DKA after starting an SGLT2 inhibitor.. The 674th Kanto Regional Meeting of Japanese Society of Internal Medicine; 2021 Dec 11- 2021;",45.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Adult
203618701,20361870,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Liver injury,,2022,Q1,1,I,20211230.0,20220113.0,20220121,20220121,EXP,,DE-AstraZeneca-2022A020929,ASTRAZENECA,,55.0,YR,,F,Y,97.0,KG,20220121,,MD,DE,,2022,Q1,Adult
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Movement disorder,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Muscular weakness,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Dysstasia,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Fall,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203625121,20362512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q1,Feeding disorder,,2022,Q1,1,I,20211229.0,20220113.0,20220121,20220121,EXP,,JP-AstraZeneca-2022A025431,ASTRAZENECA,,75.0,YR,,M,Y,,,20220121,,MD,JP,,2022,Q1,Elderly
203626481,20362648,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203626481,20362648,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Sepsis,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203626481,20362648,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pulmonary embolism,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203626481,20362648,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203626481,20362648,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Sepsis,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203626481,20362648,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pulmonary embolism,,2022,Q1,1,I,20211110.0,20220114.0,20220121,20220121,EXP,,EE-AstraZeneca-2022A027993,ASTRAZENECA,,62.0,YR,,M,Y,,,20220121,,HP,EE,,2022,Q1,Adult
203633041,20363304,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,910.0,MG,N,,2104203,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Testicular pain,,2022,Q1,1,I,20220103.0,20220113.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A025587,ASTRAZENECA,,27914.0,DY,,M,Y,74.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203633041,20363304,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,910.0,MG,N,,2104203,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Orchitis,,2022,Q1,1,I,20220103.0,20220113.0,20220121,20220121,EXP,,CN-AstraZeneca-2022A025587,ASTRAZENECA,,27914.0,DY,,M,Y,74.0,KG,20220121,,MD,CN,,2022,Q1,Elderly
203638011,20363801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Hypertension,,2022,Q1,1,I,,20211222.0,20220121,20220121,EXP,,AU-AstraZeneca-2022A035324,ASTRAZENECA,,78.0,YR,,M,Y,,,20220121,,MD,AU,,2022,Q1,Elderly
203638011,20363801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Body mass index abnormal,,2022,Q1,1,I,,20211222.0,20220121,20220121,EXP,,AU-AstraZeneca-2022A035324,ASTRAZENECA,,78.0,YR,,M,Y,,,20220121,,MD,AU,,2022,Q1,Elderly
203638011,20363801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20211222.0,20220121,20220121,EXP,,AU-AstraZeneca-2022A035324,ASTRAZENECA,,78.0,YR,,M,Y,,,20220121,,MD,AU,,2022,Q1,Elderly
203638011,20363801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Dyslipidaemia,,2022,Q1,1,I,,20211222.0,20220121,20220121,EXP,,AU-AstraZeneca-2022A035324,ASTRAZENECA,,78.0,YR,,M,Y,,,20220121,,MD,AU,,2022,Q1,Elderly
203638011,20363801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Microalbuminuria,,2022,Q1,1,I,,20211222.0,20220121,20220121,EXP,,AU-AstraZeneca-2022A035324,ASTRAZENECA,,78.0,YR,,M,Y,,,20220121,,MD,AU,,2022,Q1,Elderly
203651011,20365101,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0, Tablet",,,U,,,,,,,Tablet,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20220111.0,20220122,20220122,EXP,DE-BFARM-21011586,DE-Accord-251151,ACCORD,,69.0,YR,E,M,Y,86.0,KG,20220122,,PH,DE,DE,2022,Q1,Elderly
203651011,20365101,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0, Tablet",,,U,,,,,,,Tablet,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20220111.0,20220122,20220122,EXP,DE-BFARM-21011586,DE-Accord-251151,ACCORD,,69.0,YR,E,M,Y,86.0,KG,20220122,,PH,DE,DE,2022,Q1,Elderly
203651011,20365101,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0, Tablet",,,U,,,,,,,Tablet,,2022,Q1,Nausea,,2022,Q1,1,I,,20220111.0,20220122,20220122,EXP,DE-BFARM-21011586,DE-Accord-251151,ACCORD,,69.0,YR,E,M,Y,86.0,KG,20220122,,PH,DE,DE,2022,Q1,Elderly
203651011,20365101,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0, Tablet",,,U,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220111.0,20220122,20220122,EXP,DE-BFARM-21011586,DE-Accord-251151,ACCORD,,69.0,YR,E,M,Y,86.0,KG,20220122,,PH,DE,DE,2022,Q1,Elderly
203651011,20365101,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/850 mg, 1-1-0.5-0, Tablet",,,U,,,,,,,Tablet,,2022,Q1,Pain,,2022,Q1,1,I,,20220111.0,20220122,20220122,EXP,DE-BFARM-21011586,DE-Accord-251151,ACCORD,,69.0,YR,E,M,Y,86.0,KG,20220122,,PH,DE,DE,2022,Q1,Elderly
203651611,20365161,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Strength: 10 mg,,,Y,,,,,,,Film-coated tablet,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211113.0,20220110.0,20220122,20220122,EXP,FR-AFSSAPS-NY20215297,FR-Accord-250664,ACCORD,,84.0,YR,E,M,Y,,,20220122,,CN,FR,FR,2022,Q1,Elderly
203651611,20365161,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Strength: 10 mg,,,Y,,,,,,,Film-coated tablet,,2022,Q1,Malaise,,2022,Q1,1,I,20211113.0,20220110.0,20220122,20220122,EXP,FR-AFSSAPS-NY20215297,FR-Accord-250664,ACCORD,,84.0,YR,E,M,Y,,,20220122,,CN,FR,FR,2022,Q1,Elderly
203672881,20367288,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,20210101.0,20220118.0,20220123,20220123,EXP,,NVSJ2022JP001463,NOVARTIS,,51.0,YR,,M,Y,,,20220124,,MD,JP,JP,2022,Q1,Adult
203672881,20367288,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiomyopathy alcoholic,,2022,Q1,1,I,20210101.0,20220118.0,20220123,20220123,EXP,,NVSJ2022JP001463,NOVARTIS,,51.0,YR,,M,Y,,,20220124,,MD,JP,JP,2022,Q1,Adult
203672881,20367288,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210101.0,20220118.0,20220123,20220123,EXP,,NVSJ2022JP001463,NOVARTIS,,51.0,YR,,M,Y,,,20220124,,MD,JP,JP,2022,Q1,Adult
203672881,20367288,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20210101.0,20220118.0,20220123,20220123,EXP,,NVSJ2022JP001463,NOVARTIS,,51.0,YR,,M,Y,,,20220124,,MD,JP,JP,2022,Q1,Adult
203690271,20369027,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,DE-BFARM-21011561,DE-Accord-251333,ACCORD,,68.0,YR,E,M,Y,,,20220124,,PH,DE,DE,2022,Q1,Elderly
203690271,20369027,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,DE-BFARM-21011561,DE-Accord-251333,ACCORD,,68.0,YR,E,M,Y,,,20220124,,PH,DE,DE,2022,Q1,Elderly
203690271,20369027,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,,,,,2022,Q1,Balance disorder,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,DE-BFARM-21011561,DE-Accord-251333,ACCORD,,68.0,YR,E,M,Y,,,20220124,,PH,DE,DE,2022,Q1,Elderly
203690271,20369027,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,DE-BFARM-21011561,DE-Accord-251333,ACCORD,,68.0,YR,E,M,Y,,,20220124,,PH,DE,DE,2022,Q1,Elderly
203690271,20369027,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,,,,,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,DE-BFARM-21011561,DE-Accord-251333,ACCORD,,68.0,YR,E,M,Y,,,20220124,,PH,DE,DE,2022,Q1,Elderly
203694041,20369404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20220113.0,20220124,20220124,EXP,,JP-AstraZeneca-2022A025380,ASTRAZENECA,,72.0,YR,,M,Y,,,20220124,,MD,JP,,2022,Q1,Elderly
203694051,20369405,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,20220112.0,20220114.0,20220124,20220124,EXP,,GB-AstraZeneca-2022A024195,ASTRAZENECA,,49.0,YR,,M,Y,75.0,KG,20220124,,MD,GB,,2022,Q1,Adult
203695341,20369534,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220113.0,20220118.0,20220124,20220124,EXP,,GB-AstraZeneca-2022A028968,ASTRAZENECA,,65.0,YR,,F,Y,80.0,KG,20220124,,MD,GB,,2022,Q1,Elderly
203697272,20369727,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,2,F,,20220128.0,20220124,20220207,EXP,,JP-AstraZeneca-2022A028285,ASTRAZENECA,"Kamoshima H, Nomoto N, Yamashita K et al. Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes. Endocrine Journal Advance Publication 2021;",46.0,YR,,F,Y,,,20220207,,MD,JP,,2022,Q1,Adult
203699321,20369932,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg daily, 1-0-0",,,U,,,,202293.0,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,20220102.0,20220117.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A024599,ASTRAZENECA,,54.0,YR,,M,Y,85.0,KG,20220124,,MD,DE,,2022,Q1,Adult
203699321,20369932,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg daily, 1-0-0",,,U,,,,202293.0,,,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20220102.0,20220117.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A024599,ASTRAZENECA,,54.0,YR,,M,Y,85.0,KG,20220124,,MD,DE,,2022,Q1,Adult
203699361,20369936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203699361,20369936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203699361,20369936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dyspnoea at rest,,2022,Q1,1,I,,20220116.0,20220124,20220124,EXP,,DE-AstraZeneca-2022A028055,ASTRAZENECA,,67.0,YR,,M,Y,112.0,KG,20220124,,MD,DE,,2022,Q1,Elderly
203715691,20371569,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Malaise,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,AU-009507513-2201AUS004223,MERCK,,66.0,YR,,M,Y,,,20220124,,MD,AU,AU,2022,Q1,Elderly
203715691,20371569,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,U,,,,,10.0,MG,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,AU-009507513-2201AUS004223,MERCK,,66.0,YR,,M,Y,,,20220124,,MD,AU,AU,2022,Q1,Elderly
203719581,20371958,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, unknown",,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20200101.0,20220118.0,20220124,20220124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201007002,ELI LILLY AND CO,,50.0,YR,,F,Y,65.0,KG,20220124,,CN,CN,CN,2022,Q1,Adult
203719581,20371958,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, unknown",,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20200101.0,20220118.0,20220124,20220124,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201007002,ELI LILLY AND CO,,50.0,YR,,F,Y,65.0,KG,20220124,,CN,CN,CN,2022,Q1,Adult
203738481,20373848,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,1,I,,20220120.0,20220125,20220125,EXP,,ZA-AstraZeneca-2022A036997,ASTRAZENECA,,82.0,YR,,F,Y,,,20220125,,CN,ZA,,2022,Q1,Elderly
203744881,20374488,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Candida infection,,2022,Q1,1,I,20211111.0,20220118.0,20220125,20220125,EXP,,GB-AstraZeneca-2022A028958,ASTRAZENECA,,35.0,YR,,F,Y,,,20220125,,MD,GB,,2022,Q1,Adult
203744881,20374488,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Gastroenteritis viral,,2022,Q1,1,I,20211111.0,20220118.0,20220125,20220125,EXP,,GB-AstraZeneca-2022A028958,ASTRAZENECA,,35.0,YR,,F,Y,,,20220125,,MD,GB,,2022,Q1,Adult
203745953,20374595,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Tablet,,2022,Q1,Accidental overdose,,2022,Q1,3,F,20220101.0,20220225.0,20220125,20220302,EXP,,JP-009507513-2201JPN001977J,MERCK,,79.0,YR,,M,Y,,,20220302,,PH,JP,JP,2022,Q1,Elderly
203745953,20374595,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Tablet,,2022,Q1,Oxygen saturation decreased,,2022,Q1,3,F,20220101.0,20220225.0,20220125,20220302,EXP,,JP-009507513-2201JPN001977J,MERCK,,79.0,YR,,M,Y,,,20220302,,PH,JP,JP,2022,Q1,Elderly
203766382,20376638,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Altered state of consciousness,,2022,Q1,2,F,20220102.0,20220126.0,20220125,20220207,EXP,,JP-PFIZER INC-202200081885,PFIZER,,89.0,YR,,M,Y,,,20220207,,MD,JP,JP,2022,Q1,Elderly
203777552,20377755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Microalbuminuria,,2022,Q1,2,F,20211201.0,20220126.0,20220126,20220203,EXP,,FR-AstraZeneca-2022A036010,ASTRAZENECA,,85.0,YR,,M,Y,,,20220203,,MD,FR,,2022,Q1,Elderly
203777552,20377755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Prostatitis,,2022,Q1,2,F,20211201.0,20220126.0,20220126,20220203,EXP,,FR-AstraZeneca-2022A036010,ASTRAZENECA,,85.0,YR,,M,Y,,,20220203,,MD,FR,,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Movement disorder,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Haemorrhoids,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Yellow skin,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Benign prostatic hyperplasia,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Urinary incontinence,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777611,20377761,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Haematochezia,,2022,Q1,1,I,20220101.0,20220115.0,20220126,20220126,EXP,,NVSC2022EG010225,NOVARTIS,,74.0,YR,,M,Y,,,20220126,,CN,EG,EG,2022,Q1,Elderly
203777861,20377786,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,Y,2105244,,,10.0,MG,Tablet,QD,2022,Q1,Pruritus,,2022,Q1,1,I,20220104.0,20220118.0,20220126,20220126,EXP,,CN-AstraZeneca-2022A034698,ASTRAZENECA,,20089.0,DY,,F,Y,55.0,KG,20220126,,MD,CN,,2022,Q1,Elderly
203784421,20378442,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,1,I,20211201.0,20220121.0,20220126,20220126,EXP,,ZA-AstraZeneca-2022A037387,ASTRAZENECA,,84.0,YR,,M,Y,,,20220126,,CN,ZA,,2022,Q1,Elderly
203786741,20378674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Ketoacidosis,,2022,Q1,1,I,,20220119.0,20220126,20220126,EXP,,GB-AstraZeneca-2022A032107,ASTRAZENECA,,82.0,YR,,F,Y,,,20220126,,MD,GB,,2022,Q1,Elderly
203786741,20378674,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,,20220119.0,20220126,20220126,EXP,,GB-AstraZeneca-2022A032107,ASTRAZENECA,,82.0,YR,,F,Y,,,20220126,,MD,GB,,2022,Q1,Elderly
203789181,20378918,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Disease progression,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Metastases to lung,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Metastases to bone,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203796572,20379657,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood creatinine increased,,2022,Q1,2,F,,20220121.0,20220126,20220128,EXP,,DE-AstraZeneca-2022A031495,ASTRAZENECA,,69.0,YR,,F,Y,,,20220128,,MD,DE,,2022,Q1,Elderly
203796572,20379657,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,2,F,,20220121.0,20220126,20220128,EXP,,DE-AstraZeneca-2022A031495,ASTRAZENECA,,69.0,YR,,F,Y,,,20220128,,MD,DE,,2022,Q1,Elderly
203796572,20379657,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bundle branch block left,,2022,Q1,2,F,,20220121.0,20220126,20220128,EXP,,DE-AstraZeneca-2022A031495,ASTRAZENECA,,69.0,YR,,F,Y,,,20220128,,MD,DE,,2022,Q1,Elderly
203796572,20379657,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Iron deficiency,,2022,Q1,2,F,,20220121.0,20220126,20220128,EXP,,DE-AstraZeneca-2022A031495,ASTRAZENECA,,69.0,YR,,F,Y,,,20220128,,MD,DE,,2022,Q1,Elderly
203808111,20380811,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2022,Q1,Incorrect route of product administration,,2022,Q1,1,I,20211111.0,20220118.0,20220127,20220127,EXP,GB-MHRA-EYC 00271501,GB-NOVOPROD-884541,NOVO NORDISK,,35.0,YR,,F,Y,,,20220127,,HP,GB,GB,2022,Q1,Adult
203808111,20380811,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2022,Q1,Candida infection,,2022,Q1,1,I,20211111.0,20220118.0,20220127,20220127,EXP,GB-MHRA-EYC 00271501,GB-NOVOPROD-884541,NOVO NORDISK,,35.0,YR,,F,Y,,,20220127,,HP,GB,GB,2022,Q1,Adult
203808111,20380811,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,Y,U,,,,10.0,MG,,QD,2022,Q1,Gastroenteritis viral,,2022,Q1,1,I,20211111.0,20220118.0,20220127,20220127,EXP,GB-MHRA-EYC 00271501,GB-NOVOPROD-884541,NOVO NORDISK,,35.0,YR,,F,Y,,,20220127,,HP,GB,GB,2022,Q1,Adult
203809801,20380980,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Lip swelling,,2022,Q1,1,I,20210706.0,20220118.0,20220127,20220127,EXP,,GB-AUROBINDO-AUR-APL-2022-002188,AUROBINDO,,43.0,YR,,M,Y,100.0,KG,20220127,,PH,GB,GB,2022,Q1,Adult
203812271,20381227,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Coated tablet,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220122.0,20220127,20220127,EXP,FR-AFSSAPS-GR20220201,FR-BAUSCH-BL-2022-002382,BAUSCH AND LOMB,,60.0,YR,,F,Y,,,20220127,,PH,FR,FR,2022,Q1,Adult
203812271,20381227,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Coated tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220122.0,20220127,20220127,EXP,FR-AFSSAPS-GR20220201,FR-BAUSCH-BL-2022-002382,BAUSCH AND LOMB,,60.0,YR,,F,Y,,,20220127,,PH,FR,FR,2022,Q1,Adult
203825291,20382529,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,Y,U,,,,,,,,2022,Q1,Urosepsis,,2022,Q1,1,I,,20220117.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201006080,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220127,,MD,US,US,2022,Q1,Adult
203825291,20382529,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,Y,U,,,,,,,,2022,Q1,Pyelonephritis,,2022,Q1,1,I,,20220117.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201006080,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220127,,MD,US,US,2022,Q1,Adult
203841391,20384139,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Vulvovaginal pain,,2022,Q1,1,I,20211010.0,20220119.0,20220127,20220127,EXP,,GB-AstraZeneca-2022A032040,ASTRAZENECA,,74.0,YR,,F,Y,66.0,KG,20220127,,MD,GB,,2022,Q1,Elderly
203848042,20384804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Off label use,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urine output increased,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Off label use,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urine output increased,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203848042,20384804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,2,F,20220105.0,20220128.0,20220127,20220202,EXP,,JP-AstraZeneca-2022A020537,ASTRAZENECA,,67.0,YR,,M,Y,105.0,KG,20220202,,MD,JP,,2022,Q1,Elderly
203851751,20385175,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG/J10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Orchitis,,2022,Q1,1,I,20211218.0,20220121.0,20220127,20220127,EXP,,FR-AstraZeneca-2022A034546,ASTRAZENECA,,64.0,YR,,M,Y,42.0,KG,20220127,,MD,FR,,2022,Q1,Adult
203891011,20389101,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q1,Lip swelling,,2022,Q1,1,I,20210706.0,20220118.0,20220128,20220128,EXP,GB-MHRA-EYC 00271502,GB-TEVA-2022-GB-2000874,TEVA,,43.0,YR,A,M,Y,100.0,KG,20220128,,PH,GB,GB,2022,Q1,Adult
203891971,20389197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,,20220125.0,20220128,20220128,EXP,,CA-AstraZeneca-2022A043463,ASTRAZENECA,,72.0,YR,,M,Y,80.0,KG,20220128,,MD,CA,,2022,Q1,Elderly
203891971,20389197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220125.0,20220128,20220128,EXP,,CA-AstraZeneca-2022A043463,ASTRAZENECA,,72.0,YR,,M,Y,80.0,KG,20220128,,MD,CA,,2022,Q1,Elderly
203891971,20389197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hepatic function abnormal,,2022,Q1,1,I,,20220125.0,20220128,20220128,EXP,,CA-AstraZeneca-2022A043463,ASTRAZENECA,,72.0,YR,,M,Y,80.0,KG,20220128,,MD,CA,,2022,Q1,Elderly
203896302,20389630,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,Y,,,,,5.0,MG,Tablet,,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211125.0,20220310.0,20220128,20220315,EXP,,NVSJ2022JP001909,NOVARTIS,,65.0,YR,,F,Y,88.5,KG,20220315,,PH,JP,JP,2022,Q1,Elderly
203896302,20389630,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,Y,,,,,5.0,MG,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,2,F,20211125.0,20220310.0,20220128,20220315,EXP,,NVSJ2022JP001909,NOVARTIS,,65.0,YR,,F,Y,88.5,KG,20220315,,PH,JP,JP,2022,Q1,Elderly
203897901,20389790,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Cholelithiasis,,2022,Q1,1,I,20201201.0,20220117.0,20220128,20220128,EXP,,JP-NOVOPROD-885345,NOVO NORDISK,,82.0,YR,,M,Y,,,20220128,,PH,JP,JP,2022,Q1,Elderly
203897901,20389790,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q1,Cholangitis,,2022,Q1,1,I,20201201.0,20220117.0,20220128,20220128,EXP,,JP-NOVOPROD-885345,NOVO NORDISK,,82.0,YR,,M,Y,,,20220128,,PH,JP,JP,2022,Q1,Elderly
203908953,20390895,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,3,F,,20220209.0,20220128,20220214,EXP,,JP-AstraZeneca-2022A035854,ASTRAZENECA,,60.0,YR,,M,Y,,,20220214,,PH,JP,,2022,Q1,Adult
203908953,20390895,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Drug interaction,,2022,Q1,3,F,,20220209.0,20220128,20220214,EXP,,JP-AstraZeneca-2022A035854,ASTRAZENECA,,60.0,YR,,M,Y,,,20220214,,PH,JP,,2022,Q1,Adult
203911312,20391131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q1,Gastric disorder,,2022,Q1,2,F,,20220129.0,20220128,20220208,EXP,,CN-SA-2022SA021486,SANOFI AVENTIS,,68.0,YR,E,F,Y,60.0,KG,20220208,,CN,CN,CN,2022,Q1,Elderly
203911312,20391131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,,20220129.0,20220128,20220208,EXP,,CN-SA-2022SA021486,SANOFI AVENTIS,,68.0,YR,E,F,Y,60.0,KG,20220208,,CN,CN,CN,2022,Q1,Elderly
203911312,20391131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,,20220129.0,20220128,20220208,EXP,,CN-SA-2022SA021486,SANOFI AVENTIS,,68.0,YR,E,F,Y,60.0,KG,20220208,,CN,CN,CN,2022,Q1,Elderly
203911312,20391131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q1,Product storage error,,2022,Q1,2,F,,20220129.0,20220128,20220208,EXP,,CN-SA-2022SA021486,SANOFI AVENTIS,,68.0,YR,E,F,Y,60.0,KG,20220208,,CN,CN,CN,2022,Q1,Elderly
203932521,20393252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220121.0,20220128,20220128,EXP,,RU-AstraZeneca-2022A043533,ASTRAZENECA,,40.0,YR,,F,Y,70.0,KG,20220128,,HP,RU,,2022,Q1,Adult
203932521,20393252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Hydrothorax,,2022,Q1,1,I,,20220121.0,20220128,20220128,EXP,,RU-AstraZeneca-2022A043533,ASTRAZENECA,,40.0,YR,,F,Y,70.0,KG,20220128,,HP,RU,,2022,Q1,Adult
203932521,20393252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Off label use,,2022,Q1,1,I,,20220121.0,20220128,20220128,EXP,,RU-AstraZeneca-2022A043533,ASTRAZENECA,,40.0,YR,,F,Y,70.0,KG,20220128,,HP,RU,,2022,Q1,Adult
203938531,20393853,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,,BID,2022,Q1,Renal impairment,,2022,Q1,1,I,,20220117.0,20220129,20220129,EXP,,PT-AUROBINDO-AUR-APL-2022-001979,AUROBINDO,"Barros, C Malheiro A, Martins M, Correia JP, Santos MP, Balza P.. Cetoacidose Diab?tica Precipitada pela COVID-19. GAZETA M?DICA. 2021;4",72.0,YR,,F,Y,,,20220129,,HP,PT,PT,2022,Q1,Elderly
203945321,20394532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220124.0,20220129,20220129,EXP,FR-AFSSAPS-GR20220201,NVSC2022FR015015,NOVARTIS,,60.0,YR,,F,Y,,,20220129,,PH,FR,FR,2022,Q1,Adult
203945321,20394532,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220124.0,20220129,20220129,EXP,FR-AFSSAPS-GR20220201,NVSC2022FR015015,NOVARTIS,,60.0,YR,,F,Y,,,20220129,,PH,FR,FR,2022,Q1,Adult
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Fatigue,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Weight decreased,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Dizziness,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Blood glucose abnormal,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Arthralgia,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Peripheral swelling,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Faeces hard,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Arthritis,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Pruritus,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Insomnia,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Renal cyst,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Neuritis,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Decreased appetite,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
203945783,20394578,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,2 DF (in the morning and in the evening),,,,,,,,,,Tablet,,2022,Q1,Calcinosis,,2022,Q1,3,F,20210101.0,20220203.0,20220129,20220209,EXP,,NVSC2021HU269910,NOVARTIS,,71.0,YR,,M,Y,,,20220209,,CN,HU,HU,2022,Q1,Elderly
204050911,20405091,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, QD",,,U,,,,,5.0,MG,Tablet,QD,2022,Q1,Hyperthyroidism,,2022,Q1,1,I,20220109.0,20220125.0,20220131,20220131,EXP,,NVSC2022CN018709,NOVARTIS,,74.0,YR,,M,Y,64.0,KG,20220131,,HP,CN,CN,2022,Q1,Elderly
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Blood albumin decreased,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Nephrotic syndrome,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Tremor,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Product use in unapproved indication,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204053402,20405340,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q1,Glomerulonephritis membranoproliferative,,2022,Q1,2,F,,20220202.0,20220131,20220209,EXP,SE-002147023-NVSC2022SE008006,SE-LEO Pharma-340728,LEO PHARM,,42.0,YR,A,F,Y,,,20220208,,CN,SE,SE,2022,Q1,Adult
204066383,20406638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hypoglycaemia,,2022,Q1,3,F,20200208.0,20220214.0,20220131,20220221,EXP,,JP-AstraZeneca-2022A019959,ASTRAZENECA,Saito F. O-162 A case of DKA that developed after starting an SGLT2 inhibitor in a type 1 diabetic patient using CSII.. The 59th Kanto and Koshinetsu Regional Meeting of the Japan Diabetes Society; 2022;,34.0,YR,,F,Y,70.0,KG,20220221,,MD,JP,,2022,Q1,Young Adult
204066383,20406638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Therapeutic response prolonged,,2022,Q1,3,F,20200208.0,20220214.0,20220131,20220221,EXP,,JP-AstraZeneca-2022A019959,ASTRAZENECA,Saito F. O-162 A case of DKA that developed after starting an SGLT2 inhibitor in a type 1 diabetic patient using CSII.. The 59th Kanto and Koshinetsu Regional Meeting of the Japan Diabetes Society; 2022;,34.0,YR,,F,Y,70.0,KG,20220221,,MD,JP,,2022,Q1,Young Adult
204066383,20406638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Product dose omission issue,,2022,Q1,3,F,20200208.0,20220214.0,20220131,20220221,EXP,,JP-AstraZeneca-2022A019959,ASTRAZENECA,Saito F. O-162 A case of DKA that developed after starting an SGLT2 inhibitor in a type 1 diabetic patient using CSII.. The 59th Kanto and Koshinetsu Regional Meeting of the Japan Diabetes Society; 2022;,34.0,YR,,F,Y,70.0,KG,20220221,,MD,JP,,2022,Q1,Young Adult
204066383,20406638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,3,F,20200208.0,20220214.0,20220131,20220221,EXP,,JP-AstraZeneca-2022A019959,ASTRAZENECA,Saito F. O-162 A case of DKA that developed after starting an SGLT2 inhibitor in a type 1 diabetic patient using CSII.. The 59th Kanto and Koshinetsu Regional Meeting of the Japan Diabetes Society; 2022;,34.0,YR,,F,Y,70.0,KG,20220221,,MD,JP,,2022,Q1,Young Adult
204081841,20408184,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,,,,,2022,Q1,Body mass index abnormal,,2022,Q1,1,I,,20220120.0,20220201,20220201,EXP,AU-TGA-0000663835,AU-NOVOPROD-886805,NOVO NORDISK,,78.0,YR,,M,Y,,,20220201,,MD,AU,AU,2022,Q1,Elderly
204081841,20408184,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,,,,,2022,Q1,Dyslipidaemia,,2022,Q1,1,I,,20220120.0,20220201,20220201,EXP,AU-TGA-0000663835,AU-NOVOPROD-886805,NOVO NORDISK,,78.0,YR,,M,Y,,,20220201,,MD,AU,AU,2022,Q1,Elderly
204081841,20408184,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220120.0,20220201,20220201,EXP,AU-TGA-0000663835,AU-NOVOPROD-886805,NOVO NORDISK,,78.0,YR,,M,Y,,,20220201,,MD,AU,AU,2022,Q1,Elderly
204081841,20408184,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,,,,,2022,Q1,Hypertension,,2022,Q1,1,I,,20220120.0,20220201,20220201,EXP,AU-TGA-0000663835,AU-NOVOPROD-886805,NOVO NORDISK,,78.0,YR,,M,Y,,,20220201,,MD,AU,AU,2022,Q1,Elderly
204081841,20408184,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,,,,,2022,Q1,Microalbuminuria,,2022,Q1,1,I,,20220120.0,20220201,20220201,EXP,AU-TGA-0000663835,AU-NOVOPROD-886805,NOVO NORDISK,,78.0,YR,,M,Y,,,20220201,,MD,AU,AU,2022,Q1,Elderly
204088421,20408842,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Film Coated Tablet,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220120.0,20220201,20220201,EXP,,FR-AUROBINDO-AUR-APL-2022-002425,AUROBINDO,,60.0,YR,,F,Y,,,20220201,,PH,FR,FR,2022,Q1,Adult
204088421,20408842,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Film Coated Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220120.0,20220201,20220201,EXP,,FR-AUROBINDO-AUR-APL-2022-002425,AUROBINDO,,60.0,YR,,F,Y,,,20220201,,PH,FR,FR,2022,Q1,Adult
204089441,20408944,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Not provided,,,U,U,,,,,,Not provided,,2022,Q1,Blood albumin decreased,,2022,Q1,1,I,,20220121.0,20220201,20220201,EXP,,SE-Noden Pharma DAC-NOD202201-000001,NODEN PHARMA,,42.0,YR,A,F,Y,,,20220201,,PH,SE,,2022,Q1,Adult
204089441,20408944,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Not provided,,,U,U,,,,,,Not provided,,2022,Q1,Nephrotic syndrome,,2022,Q1,1,I,,20220121.0,20220201,20220201,EXP,,SE-Noden Pharma DAC-NOD202201-000001,NODEN PHARMA,,42.0,YR,A,F,Y,,,20220201,,PH,SE,,2022,Q1,Adult
204089441,20408944,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Not provided,,,U,U,,,,,,Not provided,,2022,Q1,Ill-defined disorder,,2022,Q1,1,I,,20220121.0,20220201,20220201,EXP,,SE-Noden Pharma DAC-NOD202201-000001,NODEN PHARMA,,42.0,YR,A,F,Y,,,20220201,,PH,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Nephrotic syndrome,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Blood albumin decreased,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Tremor,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Abdominal discomfort,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,COVID-19,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Glomerulonephritis membranoproliferative,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204104012,20410401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q1,Ill-defined disorder,,2022,Q1,2,F,,20220202.0,20220201,20220208,EXP,,SE-AstraZeneca-2022A040322,ASTRAZENECA,,42.0,YR,,F,Y,,,20220208,,MD,SE,,2022,Q1,Adult
204108841,20410884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pancreatitis acute,,2022,Q1,1,I,,20220125.0,20220201,20220201,EXP,,CA-AstraZeneca-2022A043467,ASTRAZENECA,,55.0,YR,,M,Y,167.0,KG,20220201,,MD,CA,,2022,Q1,Adult
204155131,20415513,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q1,Bladder transitional cell carcinoma,,2022,Q1,1,I,,20220126.0,20220202,20220202,EXP,,ES-AstraZeneca-2022A048913,ASTRAZENECA,,64.0,YR,,F,Y,,,20220202,,MD,ES,,2022,Q1,Adult
204162621,20416262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220124.0,20220202,20220202,EXP,,FR-AstraZeneca-2022A037731,ASTRAZENECA,,60.0,YR,,F,Y,,,20220202,,MD,FR,,2022,Q1,Adult
204162621,20416262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220124.0,20220202,20220202,EXP,,FR-AstraZeneca-2022A037731,ASTRAZENECA,,60.0,YR,,F,Y,,,20220202,,MD,FR,,2022,Q1,Adult
204167882,20416788,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood creatine increased,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Oedema peripheral,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash pruritic,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood creatine increased,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Oedema peripheral,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash pruritic,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204167882,20416788,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20211212.0,20220204.0,20220202,20220211,EXP,,AR-AstraZeneca-2022A046860,ASTRAZENECA,,73.0,YR,,F,Y,90.0,KG,20220211,,HP,AR,,2022,Q1,Elderly
204168921,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q1,Shock,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220202,,MD,CA,,2022,Q1,Elderly
204168921,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220202,,MD,CA,,2022,Q1,Elderly
204179561,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Nausea,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220202,,MD,CA,,2022,Q1,Adult
204179561,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220202,,MD,CA,,2022,Q1,Adult
204179561,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Haematemesis,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220202,,MD,CA,,2022,Q1,Adult
204179561,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220202,,MD,CA,,2022,Q1,Adult
204179561,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 Days,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220202,,MD,CA,,2022,Q1,Adult
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Lung disorder,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Lung disorder,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Lung disorder,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204181121,20418112,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram per day,,,U,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220125.0,20220202,20220202,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-011999,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20220202,,MD,PL,PL,2022,Q1,Elderly
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Blood albumin decreased,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Glomerulonephritis membranoproliferative,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,COVID-19,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Off label use,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Tremor,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204190282,20419028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q1,Nephrotic syndrome,,2022,Q1,2,F,,20220203.0,20220203,20220211,EXP,,SE-VELOXIS PHARMACEUTICALS-2022VELSE-000030,VELOXIS PHARMACEUTICALS,,42.0,YR,,F,Y,,,20220211,,CN,SE,SE,2022,Q1,Adult
204211601,20421160,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,Y,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,20220113.0,20220126.0,20220203,20220203,EXP,,NO-AstraZeneca-2022A044014,ASTRAZENECA,,72.0,YR,,F,Y,,,20220203,,MD,NO,,2022,Q1,Elderly
204212332,20421233,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q1,Diverticulitis,,2022,Q1,2,F,,20220208.0,20220203,20220215,EXP,,JP-AstraZeneca-2022A048760,ASTRAZENECA,,72.0,YR,,M,Y,,,20220215,,PH,JP,,2022,Q1,Elderly
204212641,20421264,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,1,I,,20220126.0,20220203,20220203,EXP,,CA-JNJFOC-20220156678,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20220203,,HP,CA,CA,2022,Q1,Adult
204212641,20421264,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,1,I,,20220126.0,20220203,20220203,EXP,,CA-JNJFOC-20220156678,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20220203,,HP,CA,CA,2022,Q1,Adult
204212641,20421264,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,,20220126.0,20220203,20220203,EXP,,CA-JNJFOC-20220156678,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20220203,,HP,CA,CA,2022,Q1,Adult
204212641,20421264,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q1,Crohn's disease,,2022,Q1,1,I,,20220126.0,20220203,20220203,EXP,,CA-JNJFOC-20220156678,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,,,20220203,,HP,CA,CA,2022,Q1,Adult
204233632,20423363,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Drug eruption,,2022,Q1,2,F,20211024.0,20220221.0,20220203,20220303,EXP,,JP-PFIZER INC-202200144548,PFIZER,,75.0,YR,,F,Y,40.5,KG,20220303,,MD,JP,JP,2022,Q1,Elderly
204233632,20423363,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Urticaria,,2022,Q1,2,F,20211024.0,20220221.0,20220203,20220303,EXP,,JP-PFIZER INC-202200144548,PFIZER,,75.0,YR,,F,Y,40.5,KG,20220303,,MD,JP,JP,2022,Q1,Elderly
204233632,20423363,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypersensitivity,,2022,Q1,2,F,20211024.0,20220221.0,20220203,20220303,EXP,,JP-PFIZER INC-202200144548,PFIZER,,75.0,YR,,F,Y,40.5,KG,20220303,,MD,JP,JP,2022,Q1,Elderly
204233632,20423363,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20211024.0,20220221.0,20220203,20220303,EXP,,JP-PFIZER INC-202200144548,PFIZER,,75.0,YR,,F,Y,40.5,KG,20220303,,MD,JP,JP,2022,Q1,Elderly
204234541,20423454,13,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5/1000 MG/12H,,,,,,,,,,,Q12H,2022,Q1,Erythema,,2022,Q1,1,I,20220119.0,20220131.0,20220203,20220203,EXP,ES-AEMPS-1090628,ES-GILEAD-2022-0568029,GILEAD,,74.0,YR,E,M,Y,,,20220203,,PH,ES,ES,2022,Q1,Elderly
204234541,20423454,13,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5/1000 MG/12H,,,,,,,,,,,Q12H,2022,Q1,Anaphylactic reaction,,2022,Q1,1,I,20220119.0,20220131.0,20220203,20220203,EXP,ES-AEMPS-1090628,ES-GILEAD-2022-0568029,GILEAD,,74.0,YR,E,M,Y,,,20220203,,PH,ES,ES,2022,Q1,Elderly
204234541,20423454,13,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5/1000 MG/12H,,,,,,,,,,,Q12H,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220119.0,20220131.0,20220203,20220203,EXP,ES-AEMPS-1090628,ES-GILEAD-2022-0568029,GILEAD,,74.0,YR,E,M,Y,,,20220203,,PH,ES,ES,2022,Q1,Elderly
204290231,20429023,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1440.0,MG,,U,UNKNOWN,,,10.0,MG,Tablet,,2022,Q1,Rash,,2022,Q1,1,I,20220103.0,20220202.0,20220204,20220204,EXP,,GB-ABBVIE-22K-167-4265391-00,ABBVIE,,85.0,YR,,M,Y,,,20220204,,MD,GB,GB,2022,Q1,Elderly
204290561,20429056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg Once a day,,,N,,,,202293.0,,,,,2022,Q1,Peripheral ischaemia,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A051206,ASTRAZENECA,,72.0,YR,,M,Y,100.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204290561,20429056,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg Once a day,,,N,,,,202293.0,,,,,2022,Q1,Peripheral ischaemia,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A051206,ASTRAZENECA,,72.0,YR,,M,Y,100.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204290561,20429056,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dapagliflozin 10mg Once a day,,,N,,,,202293.0,,,,,2022,Q1,Peripheral ischaemia,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A051206,ASTRAZENECA,,72.0,YR,,M,Y,100.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204290561,20429056,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dapagliflozin 10mg Once a day,,,N,,,,202293.0,,,,,2022,Q1,Peripheral ischaemia,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A051206,ASTRAZENECA,,72.0,YR,,M,Y,100.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204293821,20429382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.0,MG,Y,,MT3062,,202293.0,50.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20220106.0,20220126.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A049913,ASTRAZENECA,,15960.0,DY,,F,Y,55.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204293821,20429382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.0,MG,Y,,MT3062,,202293.0,50.0,MG,Tablet,QD,2022,Q1,Abdominal distension,,2022,Q1,1,I,20220106.0,20220126.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A049913,ASTRAZENECA,,15960.0,DY,,F,Y,55.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204293821,20429382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.0,MG,Y,,MT3062,,202293.0,50.0,MG,Tablet,QD,2022,Q1,Urinary incontinence,,2022,Q1,1,I,20220106.0,20220126.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A049913,ASTRAZENECA,,15960.0,DY,,F,Y,55.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204293821,20429382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.0,MG,Y,,MT3062,,202293.0,50.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220106.0,20220126.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A049913,ASTRAZENECA,,15960.0,DY,,F,Y,55.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204293821,20429382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4200.0,MG,Y,,MT3062,,202293.0,50.0,MG,Tablet,QD,2022,Q1,Anal incontinence,,2022,Q1,1,I,20220106.0,20220126.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A049913,ASTRAZENECA,,15960.0,DY,,F,Y,55.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Mobility decreased,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Oedema,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Insomnia,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Rash,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Pruritus,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Erythema,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204297681,20429768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10, unknown",,,U,,,,202293.0,,,Tablet,,2022,Q1,Alopecia,,2022,Q1,1,I,20210730.0,20220201.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A054376,ASTRAZENECA,,66.0,YR,,M,Y,82.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204298861,20429886,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220124.0,20220126.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A046402,ASTRAZENECA,,51.0,YR,,F,Y,,,20220204,,MD,GB,,2022,Q1,Adult
204298871,20429887,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220125.0,20220126.0,20220204,20220204,EXP,,GB-AstraZeneca-2022A046434,ASTRAZENECA,,81.0,YR,,F,Y,40.0,KG,20220204,,MD,GB,,2022,Q1,Elderly
204306402,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204306402,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204306402,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204306402,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204306402,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204306402,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,2,F,20210116.0,20220301.0,20220204,20220309,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220309,,MD,JP,,2022,Q1,Elderly
204308441,20430844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,U,,,,202293.0,,,,,2022,Q1,Hallucination,,2022,Q1,1,I,20211215.0,20220127.0,20220204,20220204,EXP,,FR-AstraZeneca-2022A046661,ASTRAZENECA,,83.0,YR,,F,Y,,,20220204,,MD,FR,,2022,Q1,Elderly
204308441,20430844,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNKNOWN,,,U,,,,202293.0,,,,,2022,Q1,Confusional state,,2022,Q1,1,I,20211215.0,20220127.0,20220204,20220204,EXP,,FR-AstraZeneca-2022A046661,ASTRAZENECA,,83.0,YR,,F,Y,,,20220204,,MD,FR,,2022,Q1,Elderly
204311021,20431102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2260.0,MG,Y,,2106096,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20220113.0,20220127.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A050008,ASTRAZENECA,,18628.0,DY,,F,Y,69.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204311021,20431102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2260.0,MG,Y,,2106096,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,1,I,20220113.0,20220127.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A050008,ASTRAZENECA,,18628.0,DY,,F,Y,69.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Endocrine pancreatic disorder,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cataract,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cardiac disorder,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Retinopathy,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Visual impairment,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Retinal haemorrhage,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Rectal cancer,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204311882,20431188,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20140101.0,20220211.0,20220204,20220223,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009782,ELI LILLY AND CO,,70.0,YR,,F,Y,65.0,KG,20220223,,CN,CN,CN,2022,Q1,Elderly
204314101,20431410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",15640.0,MG,U,,UNKNOWN,,202293.0,10.0,MG,,QD,2022,Q1,Hypernatraemia,,2022,Q1,1,I,20211121.0,20220128.0,20220204,20220204,EXP,,FI-AstraZeneca-2022A049271,ASTRAZENECA,,68.0,YR,,F,Y,,,20220204,,MD,FI,,2022,Q1,Elderly
204314101,20431410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",15640.0,MG,U,,UNKNOWN,,202293.0,10.0,MG,,QD,2022,Q1,Dehydration,,2022,Q1,1,I,20211121.0,20220128.0,20220204,20220204,EXP,,FI-AstraZeneca-2022A049271,ASTRAZENECA,,68.0,YR,,F,Y,,,20220204,,MD,FI,,2022,Q1,Elderly
204314101,20431410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",15640.0,MG,U,,UNKNOWN,,202293.0,10.0,MG,,QD,2022,Q1,Genital infection fungal,,2022,Q1,1,I,20211121.0,20220128.0,20220204,20220204,EXP,,FI-AstraZeneca-2022A049271,ASTRAZENECA,,68.0,YR,,F,Y,,,20220204,,MD,FI,,2022,Q1,Elderly
204314101,20431410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",15640.0,MG,U,,UNKNOWN,,202293.0,10.0,MG,,QD,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20211121.0,20220128.0,20220204,20220204,EXP,,FI-AstraZeneca-2022A049271,ASTRAZENECA,,68.0,YR,,F,Y,,,20220204,,MD,FI,,2022,Q1,Elderly
204314101,20431410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",15640.0,MG,U,,UNKNOWN,,202293.0,10.0,MG,,QD,2022,Q1,Fall,,2022,Q1,1,I,20211121.0,20220128.0,20220204,20220204,EXP,,FI-AstraZeneca-2022A049271,ASTRAZENECA,,68.0,YR,,F,Y,,,20220204,,MD,FI,,2022,Q1,Elderly
204315261,20431526,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MT3075,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebral infarction,,2022,Q1,1,I,20220113.0,20220129.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A054252,ASTRAZENECA,,19595.0,DY,,M,Y,51.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204315261,20431526,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MT3075,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Condition aggravated,,2022,Q1,1,I,20220113.0,20220129.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A054252,ASTRAZENECA,,19595.0,DY,,M,Y,51.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204315261,20431526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,continued to orally take Dapagliflozin 10 mg daily after discharge,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Cerebral infarction,,2022,Q1,1,I,20220113.0,20220129.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A054252,ASTRAZENECA,,19595.0,DY,,M,Y,51.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204315261,20431526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,continued to orally take Dapagliflozin 10 mg daily after discharge,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Condition aggravated,,2022,Q1,1,I,20220113.0,20220129.0,20220204,20220204,EXP,,CN-AstraZeneca-2022A054252,ASTRAZENECA,,19595.0,DY,,M,Y,51.0,KG,20220204,,MD,CN,,2022,Q1,Elderly
204316011,20431601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Urinary retention,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,PL-AstraZeneca-2022A049823,ASTRAZENECA,,71.0,YR,,F,Y,,,20220204,,MD,PL,,2022,Q1,Elderly
204316011,20431601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,,20220127.0,20220204,20220204,EXP,,PL-AstraZeneca-2022A049823,ASTRAZENECA,,71.0,YR,,F,Y,,,20220204,,MD,PL,,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Haemoglobin increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood potassium increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Arthralgia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Joint dislocation,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood triglycerides increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Feeling abnormal,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood cholesterol increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Renal disorder,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Ischaemic stroke,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood pressure abnormal,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood pressure fluctuation,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Hypertension,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Renal cyst,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Blood creatinine increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Anaemia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Diabetes mellitus,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Asthenia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Fall,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Vomiting,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Limb deformity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Hypersensitivity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Malaise,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,Tablet,,2022,Q1,Movement disorder,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Haemoglobin increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood potassium increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Arthralgia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Joint dislocation,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood triglycerides increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Feeling abnormal,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood cholesterol increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Renal disorder,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Ischaemic stroke,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood pressure abnormal,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood pressure fluctuation,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Hypertension,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Renal cyst,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Blood creatinine increased,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Diabetes mellitus,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Fall,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Vomiting,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Limb deformity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Hypersensitivity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Malaise,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Pain in extremity,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204343683,20434368,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 dosage form, QD (started: About 7 or 8 years ago)",,,,,,,,,,Tablet,QD,2022,Q1,Movement disorder,,2022,Q1,3,F,20210804.0,20220210.0,20220206,20220310,EXP,,NVSC2022BR021251,NOVARTIS,,78.0,YR,,F,Y,73.8,KG,20220310,,CN,BR,BR,2022,Q1,Elderly
204363391,20436339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,,2107166,,202293.0,20.0,MG,Tablet,QD,2022,Q1,Micturition disorder,,2022,Q1,1,I,20220116.0,20220129.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A055498,ASTRAZENECA,,15809.0,DY,,M,Y,62.0,KG,20220207,,MD,CN,,2022,Q1,Elderly
204374531,20437453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,2105235,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220120.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A056684,ASTRAZENECA,,72.0,YR,,M,Y,72.0,KG,20220207,,MD,CN,,2022,Q1,Elderly
204393241,20439324,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd (in the morning for one month)",,,,,,,,10.0,MG,,QD,2022,Q1,Hepatic cytolysis,,2022,Q1,1,I,20220104.0,20220128.0,20220207,20220207,PER,,FR-AMGEN-FRANI2022016356,AMGEN,,62.0,YR,A,F,Y,,,20220207,,MD,FR,FR,2022,Q1,Adult
204393241,20439324,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd (in the morning for one month)",,,,,,,,10.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220104.0,20220128.0,20220207,20220207,PER,,FR-AMGEN-FRANI2022016356,AMGEN,,62.0,YR,A,F,Y,,,20220207,,MD,FR,FR,2022,Q1,Adult
204393241,20439324,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd (in the morning for one month)",,,,,,,,10.0,MG,,QD,2022,Q1,Generalised oedema,,2022,Q1,1,I,20220104.0,20220128.0,20220207,20220207,PER,,FR-AMGEN-FRANI2022016356,AMGEN,,62.0,YR,A,F,Y,,,20220207,,MD,FR,FR,2022,Q1,Adult
204393951,20439395,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,,NA2974,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220120.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057168,ASTRAZENECA,,24472.0,DY,,F,Y,52.0,KG,20220207,,MD,CN,,2022,Q1,Elderly
204393951,20439395,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,,NA2974,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypertension,,2022,Q1,1,I,20220120.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057168,ASTRAZENECA,,24472.0,DY,,F,Y,52.0,KG,20220207,,MD,CN,,2022,Q1,Elderly
204405671,20440567,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MP2451,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220125.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057158,ASTRAZENECA,,56.0,YR,,M,Y,80.0,KG,20220208,,MD,CN,,2022,Q1,Adult
204405671,20440567,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MP2451,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Drug hypersensitivity,,2022,Q1,1,I,20220125.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057158,ASTRAZENECA,,56.0,YR,,M,Y,80.0,KG,20220208,,MD,CN,,2022,Q1,Adult
204405671,20440567,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MP2451,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pruritus,,2022,Q1,1,I,20220125.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057158,ASTRAZENECA,,56.0,YR,,M,Y,80.0,KG,20220208,,MD,CN,,2022,Q1,Adult
204405671,20440567,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,MP2451,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urticaria,,2022,Q1,1,I,20220125.0,20220130.0,20220207,20220207,EXP,,CN-AstraZeneca-2022A057158,ASTRAZENECA,,56.0,YR,,M,Y,80.0,KG,20220208,,MD,CN,,2022,Q1,Adult
204430421,20443042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,1320421,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vasculitis,,2022,Q1,1,I,20220128.0,20220131.0,20220208,20220208,EXP,,RU-AstraZeneca-2022A055182,ASTRAZENECA,,19422.0,DY,,F,Y,80.0,KG,20220208,,MD,RU,,2022,Q1,Elderly
204430421,20443042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,1320421,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cough,,2022,Q1,1,I,20220128.0,20220131.0,20220208,20220208,EXP,,RU-AstraZeneca-2022A055182,ASTRAZENECA,,19422.0,DY,,F,Y,80.0,KG,20220208,,MD,RU,,2022,Q1,Elderly
204430421,20443042,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,1320421,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vasculitis,,2022,Q1,1,I,20220128.0,20220131.0,20220208,20220208,EXP,,RU-AstraZeneca-2022A055182,ASTRAZENECA,,19422.0,DY,,F,Y,80.0,KG,20220208,,MD,RU,,2022,Q1,Elderly
204430421,20443042,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,1320421,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cough,,2022,Q1,1,I,20220128.0,20220131.0,20220208,20220208,EXP,,RU-AstraZeneca-2022A055182,ASTRAZENECA,,19422.0,DY,,F,Y,80.0,KG,20220208,,MD,RU,,2022,Q1,Elderly
204432492,20443249,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,Y,,2106096,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketosis,,2022,Q1,2,F,20220107.0,20220127.0,20220208,20220218,EXP,,CN-AstraZeneca-2022A050006,ASTRAZENECA,,21575.0,DY,,F,Y,67.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung cancer metastatic,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Fall,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204463851,20446385,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,1,I,,20220201.0,20220208,20220208,EXP,,CA-PFIZER INC-202200148643,PFIZER,,89.0,YR,,M,Y,,,20220208,,HP,CA,CA,2022,Q1,Elderly
204481981,20448198,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, UNK",,,,,,,,10.0,MG,,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220126.0,20220209,20220209,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-326011,RANBAXY,,60.0,YR,,F,Y,,,20220209,,PH,FR,FR,2022,Q1,Adult
204481981,20448198,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, UNK",,,,,,,,10.0,MG,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220126.0,20220209,20220209,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-326011,RANBAXY,,60.0,YR,,F,Y,,,20220209,,PH,FR,FR,2022,Q1,Adult
204488281,20448828,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7830.0,MG,Y,,215090,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220126.0,20220131.0,20220209,20220209,EXP,,CN-AstraZeneca-2022A057164,ASTRAZENECA,,20850.0,DY,,M,Y,68.0,KG,20220209,,MD,CN,,2022,Q1,Elderly
204488301,20448830,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20220101.0,20220131.0,20220209,20220209,EXP,,FR-AstraZeneca-2022A057299,ASTRAZENECA,,57.0,YR,,F,Y,,,20220209,,MD,FR,,2022,Q1,Adult
204489972,20448997,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,2,F,20220126.0,20220302.0,20220209,20220307,EXP,,JP-009507513-2202JPN000722J,MERCK,,45.0,YR,,M,Y,,,20220307,,HP,JP,JP,2022,Q1,Adult
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Product use in unapproved indication,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Pain,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Gastritis,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204490405,20449040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,5,F,20220131.0,20220308.0,20220209,20220311,EXP,,CO-GLAXOSMITHKLINE-CO2022AMR018712,GLAXOSMITHKLINE,,76.0,YR,,F,Y,71.0,KG,20220311,,PH,CO,CO,2022,Q1,Elderly
204496241,20449624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,10.0,MG,,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210601.0,20220201.0,20220209,20220209,EXP,,DE-AstraZeneca-2022A058952,ASTRAZENECA,,77.0,YR,,M,Y,76.0,KG,20220209,,MD,DE,,2022,Q1,Elderly
204496241,20449624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,10.0,MG,,QD,2022,Q1,Presyncope,,2022,Q1,1,I,20210601.0,20220201.0,20220209,20220209,EXP,,DE-AstraZeneca-2022A058952,ASTRAZENECA,,77.0,YR,,M,Y,76.0,KG,20220209,,MD,DE,,2022,Q1,Elderly
204496241,20449624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,10.0,MG,,QD,2022,Q1,Ventricular tachycardia,,2022,Q1,1,I,20210601.0,20220201.0,20220209,20220209,EXP,,DE-AstraZeneca-2022A058952,ASTRAZENECA,,77.0,YR,,M,Y,76.0,KG,20220209,,MD,DE,,2022,Q1,Elderly
204499491,20449949,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,1.0,PCT,,QD,2022,Q1,Oral discomfort,,2022,Q1,1,I,20220127.0,20220201.0,20220209,20220209,EXP,,GB-AstraZeneca-2022A054359,ASTRAZENECA,,67.0,YR,,F,Y,71.0,KG,20220209,,MD,GB,,2022,Q1,Elderly
204499491,20449949,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,1.0,PCT,,QD,2022,Q1,Lip swelling,,2022,Q1,1,I,20220127.0,20220201.0,20220209,20220209,EXP,,GB-AstraZeneca-2022A054359,ASTRAZENECA,,67.0,YR,,F,Y,71.0,KG,20220209,,MD,GB,,2022,Q1,Elderly
204502881,20450288,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gastroenteritis,,2022,Q1,1,I,20220115.0,20220201.0,20220209,20220209,EXP,,ZA-AstraZeneca-2022A060919,ASTRAZENECA,,16529.0,DY,,F,Y,72.0,KG,20220209,,MD,ZA,,2022,Q1,Elderly
204504762,20450476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Renal impairment,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204504762,20450476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204504762,20450476,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Off label use,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204504762,20450476,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q1,Renal impairment,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204504762,20450476,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204504762,20450476,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q1,Off label use,,2022,Q1,2,F,,20220215.0,20220209,20220223,EXP,,JP-AstraZeneca-2022A058697,ASTRAZENECA,,89.0,YR,,F,Y,55.3,KG,20220223,,MD,JP,,2022,Q1,Elderly
204507391,20450739,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, UNK",,,,,,,,,,,,2022,Q1,Renal impairment,,2022,Q1,1,I,,20220201.0,20220209,20220209,EXP,,JP-OTSUKA-2022_004261,OTSUKA,,71.0,YR,,M,Y,71.4,KG,20220209,,MD,JP,JP,2022,Q1,Elderly
204508281,20450828,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,1,I,,20220201.0,20220209,20220209,EXP,,JP-AstraZeneca-2022A018678,ASTRAZENECA,,79.0,YR,,M,Y,,,20220209,,PH,JP,,2022,Q1,Elderly
204509061,20450906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Abdominal pain,,2022,Q1,1,I,20210101.0,20220201.0,20220209,20220209,EXP,,DK-AstraZeneca-2022A053212,ASTRAZENECA,,77.0,YR,,M,Y,80.0,KG,20220209,,MD,DK,,2022,Q1,Elderly
204509061,20450906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Constipation,,2022,Q1,1,I,20210101.0,20220201.0,20220209,20220209,EXP,,DK-AstraZeneca-2022A053212,ASTRAZENECA,,77.0,YR,,M,Y,80.0,KG,20220209,,MD,DK,,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Insomnia,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Rash,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Mobility decreased,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Pruritus,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Erythema,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Alopecia,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204538711,20453871,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q1,Oedema,,2022,Q1,1,I,20210730.0,20220201.0,20220210,20220210,EXP,GB-MHRA-ADR 26532562,GB-Accord-252692,ACCORD,,66.0,YR,,M,Y,82.0,KG,20220210,,HP,GB,GB,2022,Q1,Elderly
204542222,20454222,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Strength: 10mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20211206.0,20220303.0,20220210,20220314,EXP,FR-AFSSAPS-MP20219225,FR-Accord-252698,ACCORD,,56.0,YR,A,M,Y,129.0,KG,20220314,,PH,FR,FR,2022,Q1,Adult
204547631,20454763,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204547631,20454763,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204547631,20454763,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204547631,20454763,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204547631,20454763,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204547631,20454763,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,202293.0,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055793,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220210,,MD,GB,,2022,Q1,Elderly
204551492,20455149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Fracture,,2022,Q1,2,F,20220118.0,20220209.0,20220210,20220216,EXP,,JP-AstraZeneca-2022A058496,ASTRAZENECA,,56.0,YR,,M,Y,,,20220216,,PH,JP,,2022,Q1,Adult
204551492,20455149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Liver function test increased,,2022,Q1,2,F,20220118.0,20220209.0,20220210,20220216,EXP,,JP-AstraZeneca-2022A058496,ASTRAZENECA,,56.0,YR,,M,Y,,,20220216,,PH,JP,,2022,Q1,Adult
204557471,20455747,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,1,I,20220206.0,20220207.0,20220210,20220210,EXP,,JP-009507513-2202JPN001089J,MERCK,,64.0,YR,,M,Y,,,20220210,,PH,JP,JP,2022,Q1,Adult
204557471,20455747,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220206.0,20220207.0,20220210,20220210,EXP,,JP-009507513-2202JPN001089J,MERCK,,64.0,YR,,M,Y,,,20220210,,PH,JP,JP,2022,Q1,Adult
204558521,20455852,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,17590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Necrotising fasciitis,,2022,Q1,1,I,20211228.0,20220202.0,20220210,20220210,EXP,,GB-AstraZeneca-2022A055935,ASTRAZENECA,,59.0,YR,,M,Y,,,20220210,,MD,GB,,2022,Q1,Adult
204572812,20457281,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,N,,,,,10.0,MG,,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20220204.0,20220227.0,20220210,20220303,EXP,,AU-SEATTLE GENETICS-2022SGN00811,SEATTLE GENETICS,,65.0,YR,,F,Y,75.7,KG,20220303,,MD,AU,AU,2022,Q1,Elderly
204572812,20457281,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,N,,,,,10.0,MG,,QD,2022,Q1,Electrocardiogram QT prolonged,,2022,Q1,2,F,20220204.0,20220227.0,20220210,20220303,EXP,,AU-SEATTLE GENETICS-2022SGN00811,SEATTLE GENETICS,,65.0,YR,,F,Y,75.7,KG,20220303,,MD,AU,AU,2022,Q1,Elderly
204614042,20461404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Alanine aminotransferase increased,,2022,Q1,2,F,20220101.0,20220223.0,20220211,20220303,EXP,,RO-AstraZeneca-2022A063233,ASTRAZENECA,,808.0,MON,,M,Y,,,20220303,,MD,RO,,2022,Q1,Elderly
204614042,20461404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Aspartate aminotransferase increased,,2022,Q1,2,F,20220101.0,20220223.0,20220211,20220303,EXP,,RO-AstraZeneca-2022A063233,ASTRAZENECA,,808.0,MON,,M,Y,,,20220303,,MD,RO,,2022,Q1,Elderly
204614042,20461404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hepatic cytolysis,,2022,Q1,2,F,20220101.0,20220223.0,20220211,20220303,EXP,,RO-AstraZeneca-2022A063233,ASTRAZENECA,,808.0,MON,,M,Y,,,20220303,,MD,RO,,2022,Q1,Elderly
204615601,20461560,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,1,I,20220121.0,20220207.0,20220211,20220211,EXP,,ZA-AstraZeneca-2022A064523,ASTRAZENECA,,79.0,YR,,M,Y,,,20220211,,CN,ZA,,2022,Q1,Elderly
204626254,20462625,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Haemarthrosis,,2022,Q1,4,F,20210425.0,20220315.0,20220211,20220328,EXP,,ES-PFIZER INC-202101726463,PFIZER,,78.0,YR,,M,Y,66.2,KG,20220328,,HP,ES,ES,2022,Q1,Elderly
204627542,20462754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,2,F,,20220208.0,20220211,20220307,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220308,,MD,JP,,2022,Q1,Elderly
204627542,20462754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Shock,,2022,Q1,2,F,,20220208.0,20220211,20220307,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220308,,MD,JP,,2022,Q1,Elderly
204628101,20462810,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,130.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220108.0,20220128.0,20220211,20220211,EXP,,LU-AstraZeneca-2022A049311,ASTRAZENECA,,51.0,YR,,M,Y,102.0,KG,20220211,,MD,LU,,2022,Q1,Adult
204672972,20467297,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,Unknown,,,,,,,2022,Q1,Enzyme induction,,2022,Q1,2,F,20211221.0,20220321.0,20220214,20220329,EXP,,CH-NOVOPROD-889434,NOVO NORDISK,,74.0,YR,,M,Y,112.0,KG,20220329,,MD,CH,CH,2022,Q1,Elderly
204672972,20467297,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,Unknown,,,,,,,2022,Q1,International normalised ratio decreased,,2022,Q1,2,F,20211221.0,20220321.0,20220214,20220329,EXP,,CH-NOVOPROD-889434,NOVO NORDISK,,74.0,YR,,M,Y,112.0,KG,20220329,,MD,CH,CH,2022,Q1,Elderly
204675491,20467549,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 {DF}, qd",,,D,,,,,,,,QD,2022,Q1,Ventricular tachycardia,,2022,Q1,1,I,20220122.0,20220210.0,20220214,20220214,EXP,FR-AFSSAPS-MP20220790,FR-EXELIXIS-CABO-22048958,EXELIXIS,,68.0,YR,,M,Y,84.5,KG,20220214,,PH,FR,FR,2022,Q1,Elderly
204675491,20467549,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,,,2022,Q1,Ventricular tachycardia,,2022,Q1,1,I,20220122.0,20220210.0,20220214,20220214,EXP,FR-AFSSAPS-MP20220790,FR-EXELIXIS-CABO-22048958,EXELIXIS,,68.0,YR,,M,Y,84.5,KG,20220214,,PH,FR,FR,2022,Q1,Elderly
204683811,20468381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"0-1-0, 10 mg",,,Y,,,,,,,Film-coated tablet,,2022,Q1,Hepatic cytolysis,,2022,Q1,1,I,,20220201.0,20220214,20220214,EXP,FR-AFSSAPS-TO20216078,FR-Accord-253191,ACCORD,,80.0,YR,E,M,Y,62.0,KG,20220214,,HP,FR,FR,2022,Q1,Elderly
204683811,20468381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"0-1-0, 10 mg",,,Y,,,,,,,Film-coated tablet,,2022,Q1,Rhabdomyolysis,,2022,Q1,1,I,,20220201.0,20220214,20220214,EXP,FR-AFSSAPS-TO20216078,FR-Accord-253191,ACCORD,,80.0,YR,E,M,Y,62.0,KG,20220214,,HP,FR,FR,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hyperuricaemia,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Tricuspid valve incompetence,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Gout,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Mitral valve incompetence,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Dyslipidaemia,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Aortic aneurysm,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204684631,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Concomitant disease aggravated,,2022,Q1,1,I,20210419.0,20220207.0,20220214,20220214,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220214,,MD,JP,JP,2022,Q1,Elderly
204692891,20469289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061629,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",47.0,YR,,F,Y,,,20220214,,HP,BE,AU,2022,Q1,Adult
204692901,20469290,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A056750,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",72.0,YR,,M,Y,,,20220214,,HP,BE,,2022,Q1,Elderly
204692911,20469291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061606,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",63.0,YR,,F,Y,,,20220214,,HP,BE,AU,2022,Q1,Adult
204692921,20469292,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061614,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",60.0,YR,,M,Y,,,20220214,,HP,BE,AU,2022,Q1,Adult
204692931,20469293,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061593,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",55.0,YR,,M,Y,,,20220214,,HP,BE,AU,2022,Q1,Adult
204692951,20469295,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061636,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",40.0,YR,,F,Y,,,20220214,,HP,BE,AU,2022,Q1,Adult
204692971,20469297,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061639,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",78.0,YR,,F,Y,,,20220214,,HP,BE,AU,2022,Q1,Elderly
204692981,20469298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A061851,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",52.0,YR,,M,Y,,,20220214,,HP,BE,,2022,Q1,Adult
204693711,20469371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063236,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",33.0,YR,,F,Y,,,20220214,,HP,BE,KR,2022,Q1,Young Adult
204693721,20469372,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063243,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",23.0,YR,,F,Y,,,20220214,,HP,BE,KR,2022,Q1,Youth
204693741,20469374,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063327,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",63.0,YR,,M,Y,,,20220214,,HP,BE,KR,2022,Q1,Adult
204693751,20469375,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063350,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",70.0,YR,,M,Y,,,20220214,,HP,BE,KR,2022,Q1,Elderly
204693761,20469376,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063364,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",77.0,YR,,M,Y,,,20220214,,HP,BE,KR,2022,Q1,Elderly
204693771,20469377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063395,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",37.0,YR,,F,Y,,,20220214,,HP,BE,KR,2022,Q1,Adult
204693791,20469379,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063316,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",59.0,YR,,F,Y,,,20220214,,HP,BE,KR,2022,Q1,Adult
204693811,20469381,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063428,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",55.0,YR,,F,Y,,,20220214,,HP,BE,KR,2022,Q1,Adult
204693821,20469382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220203.0,20220214,20220214,EXP,,BE-AstraZeneca-2022A063464,ASTRAZENECA,"Menghoum N., Oriot P., Hermans M.P.. Clinical and biochemical characteristics and analysis of risk factors for euglycaemic diabetic ketoacidosis in type 2 diabetic individuals treated withSGLT2 inhibitors: A review of 72 cases over a 4.5-year period. Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2021) 2021;15(6):102275.",39.0,YR,,M,Y,,,20220214,,HP,BE,KR,2022,Q1,Adult
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Underdose,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Renal ischaemia,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Hyperkalaemia,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204706143,20470614,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,,,2022,Q1,Metabolic acidosis,,2022,Q1,3,F,20211101.0,20220325.0,20220214,20220330,EXP,,NVSJ2022JP001906,NOVARTIS,,86.0,YR,,F,Y,,,20220330,,MD,JP,JP,2022,Q1,Elderly
204761421,20476142,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,BID,2022,Q1,Renal impairment,,2022,Q1,1,I,,20220207.0,20220215,20220215,EXP,,PT-AstraZeneca-2022A060295,ASTRAZENECA,"Barros, C Malheiro A, Martins M, Correia JP, Santos MP, Balza P. Cetoacidose Diabetica Precipitada pela COVID-19. GAZETA MEDICA 2021;4:",72.0,YR,,F,Y,,,20220215,,MD,PT,,2022,Q1,Elderly
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Limb discomfort,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Echocardiogram abnormal,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Histamine level increased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Polyuria,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Dyspnoea paroxysmal nocturnal,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Bundle branch block left,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Weight decreased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Blood pressure decreased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Cardiomyopathy,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Blood creatinine increased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Ejection fraction decreased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Hypervolaemia,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Orthopnoea,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Body mass index increased,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Palpitations,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204774381,20477438,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Mitral valve incompetence,,2022,Q1,1,I,20210101.0,20220204.0,20220215,20220215,PER,AU-TGA-685941,AU-AMGEN-AUSSP2022023647,AMGEN,,50.0,YR,A,M,Y,,,20220215,,HP,AU,AU,2022,Q1,Adult
204788683,20478868,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,3,F,20220101.0,20220301.0,20220216,20220307,EXP,,NVSC2022AE034348,NOVARTIS,,60.0,YR,,M,Y,,,20220305,,CN,AE,AE,2022,Q1,Adult
204788683,20478868,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q1,Pulmonary oedema,,2022,Q1,3,F,20220101.0,20220301.0,20220216,20220307,EXP,,NVSC2022AE034348,NOVARTIS,,60.0,YR,,M,Y,,,20220305,,CN,AE,AE,2022,Q1,Adult
204789491,20478949,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,36530.0,MG,Y,,,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20210901.0,20220209.0,20220216,20220216,EXP,,GB-AstraZeneca-2022A065415,ASTRAZENECA,,58.0,YR,,F,Y,,,20220216,,MD,GB,,2022,Q1,Adult
204797871,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pollakiuria,,2022,Q1,1,I,,20220214.0,20220216,20220216,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220216,,MD,CA,,2022,Q1,Adult
204797871,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bladder spasm,,2022,Q1,1,I,,20220214.0,20220216,20220216,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220216,,MD,CA,,2022,Q1,Adult
204797871,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract procedural complication,,2022,Q1,1,I,,20220214.0,20220216,20220216,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220216,,MD,CA,,2022,Q1,Adult
204797871,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bladder cancer recurrent,,2022,Q1,1,I,,20220214.0,20220216,20220216,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220216,,MD,CA,,2022,Q1,Adult
204800711,20480071,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Osteomyelitis,,2022,Q1,1,I,20220112.0,20220208.0,20220216,20220216,EXP,,IE-AstraZeneca-2022A061988,ASTRAZENECA,,70.0,YR,,M,Y,76.0,KG,20220216,,MD,IE,,2022,Q1,Elderly
204802621,20480262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Gastroenteritis,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Gastroenteritis,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gastroenteritis,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gastroenteritis,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204802621,20480262,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210201.0,20220208.0,20220216,20220216,EXP,,JP-AstraZeneca-2021A789965,ASTRAZENECA,,53.0,YR,,M,Y,77.0,KG,20220216,,MD,JP,,2022,Q1,Adult
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Upper limb fracture,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Accident,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Fall,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Drug intolerance,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204807054,20480705,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q1,Humerus fracture,,2022,Q1,4,F,20211224.0,20220222.0,20220216,20220303,EXP,,NVSC2022MX010895,NOVARTIS,,69.0,YR,,F,Y,64.0,KG,20220303,,HP,MX,MX,2022,Q1,Elderly
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Hepatic cirrhosis,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Endometriosis,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Haemorrhage,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Vaginal infection,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Vaginal lesion,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204822421,20482242,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Vulvovaginal injury,,2022,Q1,1,I,,20220209.0,20220216,20220216,EXP,,CA-APOTEX-2022AP003346,APOTEX,,57.0,YR,,F,Y,,,20220216,,MD,CA,CA,2022,Q1,Adult
204836141,20483614,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Weight decreased,,2022,Q1,1,I,,20220208.0,20220217,20220217,EXP,,BR-NOVOPROD-890319,NOVO NORDISK,,71.0,YR,,F,Y,65.0,KG,20220217,,MD,BR,BR,2022,Q1,Elderly
204836141,20483614,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Rectal haemorrhage,,2022,Q1,1,I,,20220208.0,20220217,20220217,EXP,,BR-NOVOPROD-890319,NOVO NORDISK,,71.0,YR,,F,Y,65.0,KG,20220217,,MD,BR,BR,2022,Q1,Elderly
204839671,20483967,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220204.0,20220208.0,20220217,20220217,EXP,,GB-AstraZeneca-2022A066366,ASTRAZENECA,,56.0,YR,,F,Y,65.0,KG,20220217,,MD,GB,,2022,Q1,Adult
204840211,20484021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220214.0,20220217,20220217,EXP,,CA-AstraZeneca-2022A071605,ASTRAZENECA,,77.0,YR,,F,Y,54.0,KG,20220217,,MD,CA,,2022,Q1,Elderly
204853191,20485319,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220208.0,20220209.0,20220217,20220217,EXP,,GB-AstraZeneca-2022A073213,ASTRAZENECA,,54.0,YR,,M,Y,110.0,KG,20220217,,MD,GB,,2022,Q1,Adult
204853191,20485319,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220208.0,20220209.0,20220217,20220217,EXP,,GB-AstraZeneca-2022A073213,ASTRAZENECA,,54.0,YR,,M,Y,110.0,KG,20220217,,MD,GB,,2022,Q1,Adult
204853191,20485319,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Abdominal pain,,2022,Q1,1,I,20220208.0,20220209.0,20220217,20220217,EXP,,GB-AstraZeneca-2022A073213,ASTRAZENECA,,54.0,YR,,M,Y,110.0,KG,20220217,,MD,GB,,2022,Q1,Adult
204853251,20485325,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20211208.0,20220209.0,20220217,20220217,EXP,,CN-AstraZeneca-2022A069570,ASTRAZENECA,,28308.0,DY,,,Y,50.0,KG,20220217,,MD,CN,,2022,Q1,Elderly
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Cough,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204854631,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,SARS-CoV-2 test positive,,2022,Q1,1,I,20211001.0,20220208.0,20220217,20220217,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220217,,HP,GB,GB,2022,Q1,Adult
204866881,20486688,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220214.0,20220217,20220217,EXP,FR-AFSSAPS-AM20220348,NVSC2022FR034665,NOVARTIS,,55.0,YR,,M,Y,70.0,KG,20220217,,PH,FR,FR,2022,Q1,Adult
204866881,20486688,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220214.0,20220217,20220217,EXP,FR-AFSSAPS-AM20220348,NVSC2022FR034665,NOVARTIS,,55.0,YR,,M,Y,70.0,KG,20220217,,PH,FR,FR,2022,Q1,Adult
204879561,20487956,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220214.0,20220218,20220218,EXP,FR-AFSSAPS-AM20220348,FR-BAUSCH-BL-2022-004553,BAUSCH AND LOMB,,55.0,YR,,M,Y,70.0,KG,20220218,,PH,FR,FR,2022,Q1,Adult
204879561,20487956,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220214.0,20220218,20220218,EXP,FR-AFSSAPS-AM20220348,FR-BAUSCH-BL-2022-004553,BAUSCH AND LOMB,,55.0,YR,,M,Y,70.0,KG,20220218,,PH,FR,FR,2022,Q1,Adult
204887151,20488715,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (in morning)",,,U,,,,,10.0,MG,,QD,2022,Q1,Uveitis,,2022,Q1,1,I,20220129.0,20220215.0,20220218,20220218,EXP,,NVSC2022RU025795,NOVARTIS,,65.0,YR,,F,Y,,,20220218,,MD,RU,RU,2022,Q1,Elderly
204887151,20488715,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (in morning)",,,U,,,,,10.0,MG,,QD,2022,Q1,Eye disorder,,2022,Q1,1,I,20220129.0,20220215.0,20220218,20220218,EXP,,NVSC2022RU025795,NOVARTIS,,65.0,YR,,F,Y,,,20220218,,MD,RU,RU,2022,Q1,Elderly
204891191,20489119,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220214.0,20220218,20220218,EXP,,CA-AstraZeneca-2022A071617,ASTRAZENECA,,72.0,YR,,M,Y,88.9,KG,20220218,,MD,CA,,2022,Q1,Elderly
204901452,20490145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Proteinuria,,2022,Q1,2,F,,20220215.0,20220218,20220223,EXP,,CN-AstraZeneca-2022A070848,ASTRAZENECA,,52.0,YR,,F,Y,,,20220223,,MD,CN,,2022,Q1,Adult
204901452,20490145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Urine ketone body present,,2022,Q1,2,F,,20220215.0,20220218,20220223,EXP,,CN-AstraZeneca-2022A070848,ASTRAZENECA,,52.0,YR,,F,Y,,,20220223,,MD,CN,,2022,Q1,Adult
204901452,20490145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pyelonephritis,,2022,Q1,2,F,,20220215.0,20220218,20220223,EXP,,CN-AstraZeneca-2022A070848,ASTRAZENECA,,52.0,YR,,F,Y,,,20220223,,MD,CN,,2022,Q1,Adult
204901452,20490145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Back pain,,2022,Q1,2,F,,20220215.0,20220218,20220223,EXP,,CN-AstraZeneca-2022A070848,ASTRAZENECA,,52.0,YR,,F,Y,,,20220223,,MD,CN,,2022,Q1,Adult
204901452,20490145,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hyperpyrexia,,2022,Q1,2,F,,20220215.0,20220218,20220223,EXP,,CN-AstraZeneca-2022A070848,ASTRAZENECA,,52.0,YR,,F,Y,,,20220223,,MD,CN,,2022,Q1,Adult
204901501,20490150,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal fissure,,2022,Q1,1,I,20210901.0,20220211.0,20220218,20220218,EXP,,ES-AstraZeneca-2022A067880,ASTRAZENECA,,70.0,YR,,M,Y,,,20220218,,MD,ES,,2022,Q1,Elderly
204901501,20490150,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Genital herpes,,2022,Q1,1,I,20210901.0,20220211.0,20220218,20220218,EXP,,ES-AstraZeneca-2022A067880,ASTRAZENECA,,70.0,YR,,M,Y,,,20220218,,MD,ES,,2022,Q1,Elderly
204903961,20490396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NB2271,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fall,,2022,Q1,1,I,20220104.0,20220211.0,20220218,20220218,EXP,,CN-AstraZeneca-2022A071868,ASTRAZENECA,,27546.0,DY,,M,Y,60.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204903961,20490396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NB2271,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Electrocardiogram ST-T change,,2022,Q1,1,I,20220104.0,20220211.0,20220218,20220218,EXP,,CN-AstraZeneca-2022A071868,ASTRAZENECA,,27546.0,DY,,M,Y,60.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204903961,20490396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NB2271,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220104.0,20220211.0,20220218,20220218,EXP,,CN-AstraZeneca-2022A071868,ASTRAZENECA,,27546.0,DY,,M,Y,60.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204903961,20490396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NB2271,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Altered state of consciousness,,2022,Q1,1,I,20220104.0,20220211.0,20220218,20220218,EXP,,CN-AstraZeneca-2022A071868,ASTRAZENECA,,27546.0,DY,,M,Y,60.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204903961,20490396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NB2271,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood pressure decreased,,2022,Q1,1,I,20220104.0,20220211.0,20220218,20220218,EXP,,CN-AstraZeneca-2022A071868,ASTRAZENECA,,27546.0,DY,,M,Y,60.0,KG,20220218,,MD,CN,,2022,Q1,Elderly
204929051,20492905,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q1,Death,,2022,Q1,1,I,,20220217.0,20220219,20220219,EXP,,NVSC2022FR038416,NOVARTIS,,85.0,YR,,M,Y,,,20220219,,MD,FR,FR,2022,Q1,Elderly
204929051,20492905,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220217.0,20220219,20220219,EXP,,NVSC2022FR038416,NOVARTIS,,85.0,YR,,M,Y,,,20220219,,MD,FR,FR,2022,Q1,Elderly
204949851,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,20210821.0,20220213.0,20220221,20220221,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220221,,MD,GB,GB,2022,Q1,Adult
204949851,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiomegaly,,2022,Q1,1,I,20210821.0,20220213.0,20220221,20220221,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220221,,MD,GB,GB,2022,Q1,Adult
204949851,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,20210821.0,20220213.0,20220221,20220221,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220221,,MD,GB,GB,2022,Q1,Adult
204964161,20496416,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,190.0,MG,Y,,2104233,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketosis,,2022,Q1,1,I,20220119.0,20220210.0,20220221,20220221,EXP,,CN-AstraZeneca-2022A072007,ASTRAZENECA,,15654.0,DY,,F,Y,,,20220221,,MD,CN,,2022,Q1,Elderly
204964171,20496417,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,MT3040,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20220127.0,20220210.0,20220221,20220221,EXP,,CN-AstraZeneca-2022A071627,ASTRAZENECA,,20982.0,DY,,F,Y,,,20220221,,MD,CN,,2022,Q1,Elderly
204964171,20496417,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,MT3040,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Abdominal distension,,2022,Q1,1,I,20220127.0,20220210.0,20220221,20220221,EXP,,CN-AstraZeneca-2022A071627,ASTRAZENECA,,20982.0,DY,,F,Y,,,20220221,,MD,CN,,2022,Q1,Elderly
204964171,20496417,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,MT3040,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketosis,,2022,Q1,1,I,20220127.0,20220210.0,20220221,20220221,EXP,,CN-AstraZeneca-2022A071627,ASTRAZENECA,,20982.0,DY,,F,Y,,,20220221,,MD,CN,,2022,Q1,Elderly
204964631,20496463,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,100.0,MG,,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220208.0,20220215.0,20220221,20220221,EXP,,GB-AstraZeneca-2022A073194,ASTRAZENECA,,59.0,YR,,M,Y,65.0,KG,20220221,,MD,GB,,2022,Q1,Adult
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Jul-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"-Sep-2021, 10 UNK",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204970251,20497025,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Lung disorder,,2022,Q1,1,I,20210301.0,20220209.0,20220221,20220221,EXP,,PL-US-Provell Pharmaceuticals LLC-E2B_90086866,PROVELL PHARMACEUTICALS,,71.0,YR,E,M,Y,,,20220219,,MD,PL,PL,2022,Q1,Elderly
204973682,20497368,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",981.818,MG,U,U,,,,10.0,MG,,QD,2022,Q1,Lymphoma,,2022,Q1,2,F,20211228.0,20220302.0,20220221,20220307,EXP,FR-AFSSAPS-CN20220186,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-024562,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,88.0,KG,20220307,,MD,FR,FR,2022,Q1,Elderly
204973682,20497368,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",981.818,MG,U,U,,,,10.0,MG,,QD,2022,Q1,Perineal abscess,,2022,Q1,2,F,20211228.0,20220302.0,20220221,20220307,EXP,FR-AFSSAPS-CN20220186,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-024562,BRISTOL MYERS SQUIBB,,70.0,YR,,M,Y,88.0,KG,20220307,,MD,FR,FR,2022,Q1,Elderly
204976144,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Hypotension,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Groin pain,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Epididymitis,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Malaise,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Hypotension,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Groin pain,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Epididymitis,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204976144,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q1,Malaise,,2022,Q1,4,F,,20220321.0,20220221,20220325,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220325,,MD,GB,GB,2022,Q1,Elderly
204994161,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,20210821.0,20220213.0,20220222,20220222,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220222,,MD,GB,GB,2022,Q1,Adult
204994161,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,20210821.0,20220213.0,20220222,20220222,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220222,,MD,GB,GB,2022,Q1,Adult
205004101,20500410,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1 Day)",,,,,,,,10.0,MG,,QD,2022,Q1,Upper gastrointestinal haemorrhage,,2022,Q1,1,I,20210821.0,20220213.0,20220222,20220222,EXP,,GB-BAYER-2022A022342,BAYER,,61.0,YR,A,M,Y,,,20220222,,MD,GB,GB,2022,Q1,Adult
205004101,20500410,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1 Day)",,,,,,,,10.0,MG,,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,20210821.0,20220213.0,20220222,20220222,EXP,,GB-BAYER-2022A022342,BAYER,,61.0,YR,A,M,Y,,,20220222,,MD,GB,GB,2022,Q1,Adult
205004991,20500499,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Asked But Unknown,,,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220127.0,20220214.0,20220222,20220222,EXP,NO-NOMAADVRE-RELISV-2022-Vz3jzj,"NO-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-153661",BOEHRINGER INGELHEIM,,67.0,YR,E,F,Y,,,20220222,,MD,NO,NO,2022,Q1,Elderly
205004991,20500499,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,U,,,,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220127.0,20220214.0,20220222,20220222,EXP,NO-NOMAADVRE-RELISV-2022-Vz3jzj,"NO-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-153661",BOEHRINGER INGELHEIM,,67.0,YR,E,F,Y,,,20220222,,MD,NO,NO,2022,Q1,Elderly
205013861,20501386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cystitis,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,JP-AstraZeneca-2022A077882,ASTRAZENECA,,79.0,YR,,F,Y,,,20220222,,MD,JP,,2022,Q1,Elderly
205013861,20501386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gastric ulcer,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,JP-AstraZeneca-2022A077882,ASTRAZENECA,,79.0,YR,,F,Y,,,20220222,,MD,JP,,2022,Q1,Elderly
205013911,20501391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,CA-AstraZeneca-2022A071620,ASTRAZENECA,,80.0,YR,,F,Y,63.0,KG,20220222,,MD,CA,,2022,Q1,Elderly
205013911,20501391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Weight decreased,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,CA-AstraZeneca-2022A071620,ASTRAZENECA,,80.0,YR,,F,Y,63.0,KG,20220222,,MD,CA,,2022,Q1,Elderly
205015841,20501584,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10.000000 mg, once every day",,,Y,,2105080,,202293.0,,,Tablet,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220204.0,20220216.0,20220222,20220222,EXP,,CN-AstraZeneca-2022A076732,ASTRAZENECA,,32.0,YR,,M,Y,90.0,KG,20220222,,MD,CN,,2022,Q1,Young Adult
205018881,20501888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Proctitis,,2022,Q1,1,I,20210527.0,20220214.0,20220222,20220222,EXP,,DE-AstraZeneca-2022A070154,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20220222,,MD,DE,,2022,Q1,Adult
205018881,20501888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20210527.0,20220214.0,20220222,20220222,EXP,,DE-AstraZeneca-2022A070154,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20220222,,MD,DE,,2022,Q1,Adult
205018881,20501888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Perineal abscess,,2022,Q1,1,I,20210527.0,20220214.0,20220222,20220222,EXP,,DE-AstraZeneca-2022A070154,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20220222,,MD,DE,,2022,Q1,Adult
205018881,20501888,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q1,Prostatitis,,2022,Q1,1,I,20210527.0,20220214.0,20220222,20220222,EXP,,DE-AstraZeneca-2022A070154,ASTRAZENECA,,63.0,YR,,M,Y,86.0,KG,20220222,,MD,DE,,2022,Q1,Adult
205028661,20502866,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Death,,2022,Q1,1,I,,20220217.0,20220222,20220222,EXP,,AU-AstraZeneca-2022A080029,ASTRAZENECA,,80.0,YR,,F,Y,,,20220222,,MD,AU,,2022,Q1,Elderly
205061991,20506199,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,U,,NA3028,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220212.0,20220214.0,20220223,20220223,EXP,,CN-AstraZeneca-2022A076085,ASTRAZENECA,,14756.0,DY,,F,Y,60.0,KG,20220223,,MD,CN,,2022,Q1,Elderly
205064311,20506431,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,2103155,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood pressure decreased,,2022,Q1,1,I,20211106.0,20220215.0,20220223,20220223,EXP,,CN-AstraZeneca-2022A078609,ASTRAZENECA,,25245.0,DY,,M,Y,70.0,KG,20220223,,MD,CN,,2022,Q1,Elderly
205068361,20506836,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,,,,,2022,Q1,Transient ischaemic attack,,2022,Q1,1,I,,20220220.0,20220223,20220223,EXP,,GB-AstraZeneca-2022A078849,ASTRAZENECA,,62.0,YR,,M,Y,91.0,KG,20220223,,MD,GB,,2022,Q1,Adult
205068371,20506837,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220216.0,20220223,20220223,EXP,,FR-AstraZeneca-2022A073583,ASTRAZENECA,,55.0,YR,,M,Y,70.0,KG,20220223,,MD,FR,,2022,Q1,Adult
205068371,20506837,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220216.0,20220223,20220223,EXP,,FR-AstraZeneca-2022A073583,ASTRAZENECA,,55.0,YR,,M,Y,70.0,KG,20220223,,MD,FR,,2022,Q1,Adult
205070311,20507031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,,D,,,,10.0,MG,,QD,2022,Q1,Immunosuppression,,2022,Q1,1,I,20220220.0,,20220222,20220222,DIR,604690,,FDA-CTU,,67.0,YR,,F,N,74.1,KG,20220222,N,PH,US,,2022,Q1,Elderly
205070311,20507031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,,D,,,,10.0,MG,,QD,2022,Q1,Emphysematous cystitis,,2022,Q1,1,I,20220220.0,,20220222,20220222,DIR,604690,,FDA-CTU,,67.0,YR,,F,N,74.1,KG,20220222,N,PH,US,,2022,Q1,Elderly
205071941,20507194,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q1,Eye swelling,,2022,Q1,1,I,20220128.0,20220216.0,20220223,20220223,EXP,,NVSC2022RU037461,NOVARTIS,,65.0,YR,,F,Y,78.0,KG,20220223,,MD,RU,RU,2022,Q1,Elderly
205073711,20507371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2984,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20220210.0,20220215.0,20220223,20220223,EXP,,CN-AstraZeneca-2022A076419,ASTRAZENECA,,22646.0,DY,,F,Y,63.0,KG,20220223,,MD,CN,,2022,Q1,Elderly
205075501,20507550,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20220216.0,20220223,20220223,EXP,,JP-DSJP-DSJ-2022-105814,DAIICHI,,72.0,YR,,F,Y,60.0,KG,20220223,,MD,JP,JP,2022,Q1,Elderly
205077241,20507724,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,20210821.0,20220213.0,20220223,20220223,EXP,,GB-DSJP-DSE-2022-105383,DAIICHI,,61.0,YR,,M,Y,,,20220223,,MD,GB,GB,2022,Q1,Adult
205077241,20507724,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,20210821.0,20220213.0,20220223,20220223,EXP,,GB-DSJP-DSE-2022-105383,DAIICHI,,61.0,YR,,M,Y,,,20220223,,MD,GB,GB,2022,Q1,Adult
205111981,20511198,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220127.0,20220215.0,20220224,20220224,EXP,,NO-AstraZeneca-2022A072268,ASTRAZENECA,,67.0,YR,,F,Y,,,20220224,,MD,NO,,2022,Q1,Elderly
205111981,20511198,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220127.0,20220215.0,20220224,20220224,EXP,,NO-AstraZeneca-2022A072268,ASTRAZENECA,,67.0,YR,,F,Y,,,20220224,,MD,NO,,2022,Q1,Elderly
205114951,20511495,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Headache,,2022,Q1,1,I,20210831.0,20210831.0,20220224,20220224,PER,,US-LANTHEUS-LMI-2021-01089,LANTHEUS MEDICAL IMAGING,,73.0,YR,,F,Y,113.0,KG,20220211,,CN,US,US,2022,Q1,Elderly
205114951,20511495,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Hypertension,,2022,Q1,1,I,20210831.0,20210831.0,20220224,20220224,PER,,US-LANTHEUS-LMI-2021-01089,LANTHEUS MEDICAL IMAGING,,73.0,YR,,F,Y,113.0,KG,20220211,,CN,US,US,2022,Q1,Elderly
205128151,20512815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,225.0,MG,Y,,SADU2,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Oedema genital,,2022,Q1,1,I,20220114.0,20220216.0,20220224,20220224,EXP,,CN-AstraZeneca-2022A078765,ASTRAZENECA,,20.0,YR,,M,Y,,,20220224,,MD,CN,,2022,Q1,Youth
205128151,20512815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,225.0,MG,Y,,SADU2,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Dry mouth,,2022,Q1,1,I,20220114.0,20220216.0,20220224,20220224,EXP,,CN-AstraZeneca-2022A078765,ASTRAZENECA,,20.0,YR,,M,Y,,,20220224,,MD,CN,,2022,Q1,Youth
205128151,20512815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,225.0,MG,Y,,SADU2,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Chest pain,,2022,Q1,1,I,20220114.0,20220216.0,20220224,20220224,EXP,,CN-AstraZeneca-2022A078765,ASTRAZENECA,,20.0,YR,,M,Y,,,20220224,,MD,CN,,2022,Q1,Youth
205150811,20515081,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,NA3013,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20220211.0,20220215.0,20220224,20220224,EXP,,CN-AstraZeneca-2022A076043,ASTRAZENECA,,25414.0,DY,,M,Y,57.0,KG,20220224,,MD,CN,,2022,Q1,Elderly
205159391,20515939,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220214.0,20220225,20220225,EXP,,FR-AUROBINDO-AUR-APL-2022-005379,AUROBINDO,,55.0,YR,,M,Y,70.0,KG,20220225,,PH,FR,FR,2022,Q1,Adult
205159391,20515939,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220214.0,20220225,20220225,EXP,,FR-AUROBINDO-AUR-APL-2022-005379,AUROBINDO,,55.0,YR,,M,Y,70.0,KG,20220225,,PH,FR,FR,2022,Q1,Adult
205161871,20516187,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Death,,2022,Q1,1,I,20220220.0,20220222.0,20220225,20220225,EXP,,MX-AstraZeneca-2022A085709,ASTRAZENECA,,3784.0,WK,,M,Y,,,20220225,,CN,MX,,2022,Q1,Elderly
205162221,20516222,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, BID",,,U,,,,,,,,BID,2022,Q1,Rash,,2022,Q1,1,I,20211201.0,20220219.0,20220225,20220225,EXP,,NVSC2022EG040959,NOVARTIS,,58.0,YR,,F,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
205162221,20516222,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, BID",,,U,,,,,,,,BID,2022,Q1,COVID-19,,2022,Q1,1,I,20211201.0,20220219.0,20220225,20220225,EXP,,NVSC2022EG040959,NOVARTIS,,58.0,YR,,F,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
205162221,20516222,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, BID",,,U,,,,,,,,BID,2022,Q1,Blood cholesterol increased,,2022,Q1,1,I,20211201.0,20220219.0,20220225,20220225,EXP,,NVSC2022EG040959,NOVARTIS,,58.0,YR,,F,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
205162221,20516222,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, BID",,,U,,,,,,,,BID,2022,Q1,Myocardial infarction,,2022,Q1,1,I,20211201.0,20220219.0,20220225,20220225,EXP,,NVSC2022EG040959,NOVARTIS,,58.0,YR,,F,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
205162221,20516222,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, BID",,,U,,,,,,,,BID,2022,Q1,Haemoglobin decreased,,2022,Q1,1,I,20211201.0,20220219.0,20220225,20220225,EXP,,NVSC2022EG040959,NOVARTIS,,58.0,YR,,F,Y,,,20220225,,CN,EG,EG,2022,Q1,Adult
205162341,20516234,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220215.0,20220225,20220225,EXP,,CA-TEVA-2022-CA-2009535,TEVA,,60.0,YR,A,M,Y,97.0,KG,20220225,,HP,CA,CA,2022,Q1,Adult
205162341,20516234,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Febrile neutropenia,,2022,Q1,1,I,,20220215.0,20220225,20220225,EXP,,CA-TEVA-2022-CA-2009535,TEVA,,60.0,YR,A,M,Y,97.0,KG,20220225,,HP,CA,CA,2022,Q1,Adult
205163291,20516329,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Ejection fraction decreased,,2022,Q1,1,I,,20220217.0,20220225,20220225,EXP,,NVSC2022CN039715,NOVARTIS,,47.0,YR,,M,Y,,,20220225,,MD,CN,CN,2022,Q1,Adult
205163291,20516329,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Blood pressure increased,,2022,Q1,1,I,,20220217.0,20220225,20220225,EXP,,NVSC2022CN039715,NOVARTIS,,47.0,YR,,M,Y,,,20220225,,MD,CN,CN,2022,Q1,Adult
205163291,20516329,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,,20220217.0,20220225,20220225,EXP,,NVSC2022CN039715,NOVARTIS,,47.0,YR,,M,Y,,,20220225,,MD,CN,CN,2022,Q1,Adult
205173721,20517372,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,280214,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211217.0,20220216.0,20220225,20220225,EXP,,RU-AstraZeneca-2022A078969,ASTRAZENECA,,62.0,YR,,F,Y,82.0,KG,20220225,,MD,RU,,2022,Q1,Adult
205173751,20517375,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2080.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220206.0,20220218.0,20220225,20220225,EXP,,ES-AstraZeneca-2022A077022,ASTRAZENECA,,65.0,YR,,F,Y,,,20220225,,MD,ES,,2022,Q1,Elderly
205175411,20517541,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pulmonary hypertension,,2022,Q1,1,I,20180104.0,20220218.0,20220225,20220225,EXP,,FR-AstraZeneca-2022A077001,ASTRAZENECA,,72.0,YR,,M,Y,76.0,KG,20220225,,MD,FR,,2022,Q1,Elderly
205180851,20518085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,680.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Bacterial infection,,2022,Q1,1,I,20220118.0,20220218.0,20220225,20220225,EXP,,CN-AstraZeneca-2022A084047,ASTRAZENECA,,22646.0,DY,,F,Y,61.0,KG,20220225,,MD,CN,,2022,Q1,Elderly
205180851,20518085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,680.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220118.0,20220218.0,20220225,20220225,EXP,,CN-AstraZeneca-2022A084047,ASTRAZENECA,,22646.0,DY,,F,Y,61.0,KG,20220225,,MD,CN,,2022,Q1,Elderly
205180851,20518085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,680.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urosepsis,,2022,Q1,1,I,20220118.0,20220218.0,20220225,20220225,EXP,,CN-AstraZeneca-2022A084047,ASTRAZENECA,,22646.0,DY,,F,Y,61.0,KG,20220225,,MD,CN,,2022,Q1,Elderly
205180851,20518085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,680.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20220118.0,20220218.0,20220225,20220225,EXP,,CN-AstraZeneca-2022A084047,ASTRAZENECA,,22646.0,DY,,F,Y,61.0,KG,20220225,,MD,CN,,2022,Q1,Elderly
205193271,20519327,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,NA3048,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketosis,,2022,Q1,1,I,20220209.0,20220218.0,20220225,20220225,EXP,,CN-AstraZeneca-2022A082007,ASTRAZENECA,,28506.0,DY,,M,Y,,,20220225,,MD,CN,,2022,Q1,Elderly
205195671,20519567,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220210.0,20220223.0,20220225,20220225,EXP,DK-DKMA-WBS-0098272,DK-GLAXOSMITHKLINE-DK2022033274,GLAXOSMITHKLINE,,59.0,YR,,F,Y,,,20220225,,MD,DK,DK,2022,Q1,Adult
205195671,20519567,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,20220210.0,20220223.0,20220225,20220225,EXP,DK-DKMA-WBS-0098272,DK-GLAXOSMITHKLINE-DK2022033274,GLAXOSMITHKLINE,,59.0,YR,,F,Y,,,20220225,,MD,DK,DK,2022,Q1,Adult
205195671,20519567,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,20220210.0,20220223.0,20220225,20220225,EXP,DK-DKMA-WBS-0098272,DK-GLAXOSMITHKLINE-DK2022033274,GLAXOSMITHKLINE,,59.0,YR,,F,Y,,,20220225,,MD,DK,DK,2022,Q1,Adult
205195671,20519567,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,1,I,20220210.0,20220223.0,20220225,20220225,EXP,DK-DKMA-WBS-0098272,DK-GLAXOSMITHKLINE-DK2022033274,GLAXOSMITHKLINE,,59.0,YR,,F,Y,,,20220225,,MD,DK,DK,2022,Q1,Adult
205203142,20520314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,990.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Perineal abscess,,2022,Q1,2,F,20211228.0,20220304.0,20220225,20220311,EXP,,FR-AstraZeneca-2022A076970,ASTRAZENECA,,70.0,YR,,M,Y,88.0,KG,20220311,,MD,FR,,2022,Q1,Elderly
205203142,20520314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,990.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Lymphoma,,2022,Q1,2,F,20211228.0,20220304.0,20220225,20220311,EXP,,FR-AstraZeneca-2022A076970,ASTRAZENECA,,70.0,YR,,M,Y,88.0,KG,20220311,,MD,FR,,2022,Q1,Elderly
205203211,20520321,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10MG X 1 ADAY,,,,,PLGB 18799/3830,,202293.0,,,,,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20220101.0,20220224.0,20220225,20220225,EXP,,GB-AstraZeneca-2022A086514,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220225,,MD,GB,,2022,Q1,Elderly
205203211,20520321,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10MG X 1 ADAY,,,,,PLGB 18799/3830,,202293.0,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220224.0,20220225,20220225,EXP,,GB-AstraZeneca-2022A086514,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220225,,MD,GB,,2022,Q1,Elderly
205203211,20520321,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10MG X 1 ADAY,,,,,PLGB 18799/3830,,202293.0,,,,,2022,Q1,Adverse drug reaction,,2022,Q1,1,I,20220101.0,20220224.0,20220225,20220225,EXP,,GB-AstraZeneca-2022A086514,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220225,,MD,GB,,2022,Q1,Elderly
205203211,20520321,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10MG X 1 ADAY,,,,,PLGB 18799/3830,,202293.0,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220224.0,20220225,20220225,EXP,,GB-AstraZeneca-2022A086514,ASTRAZENECA,,71.0,YR,,F,Y,88.9,KG,20220225,,MD,GB,,2022,Q1,Elderly
205203401,20520340,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20211108.0,20220222.0,20220225,20220225,EXP,,GB-MYLANLABS-2022M1014864,MYLAN,,56.0,YR,,F,Y,107.0,KG,20220225,,HP,GB,GB,2022,Q1,Adult
205203401,20520340,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211108.0,20220222.0,20220225,20220225,EXP,,GB-MYLANLABS-2022M1014864,MYLAN,,56.0,YR,,F,Y,107.0,KG,20220225,,HP,GB,GB,2022,Q1,Adult
205203401,20520340,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Chest discomfort,,2022,Q1,1,I,20211108.0,20220222.0,20220225,20220225,EXP,,GB-MYLANLABS-2022M1014864,MYLAN,,56.0,YR,,F,Y,107.0,KG,20220225,,HP,GB,GB,2022,Q1,Adult
205203401,20520340,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20211108.0,20220222.0,20220225,20220225,EXP,,GB-MYLANLABS-2022M1014864,MYLAN,,56.0,YR,,F,Y,107.0,KG,20220225,,HP,GB,GB,2022,Q1,Adult
205212491,20521249,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Malaise,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Gait disturbance,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Malaise,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205212491,20521249,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220129.0,20220220.0,20220226,20220226,EXP,,NVSC2022EG034896,NOVARTIS,,38.0,YR,,M,Y,,,20220226,,CN,EG,EG,2022,Q1,Adult
205251074,20525107,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q1,Fournier's gangrene,,2022,Q1,4,F,20220211.0,20220324.0,20220228,20220328,EXP,,IT-Eisai Medical Research-EC-2022-109549,EISAI,,67.0,YR,E,M,Y,80.0,KG,20220328,,MD,IT,,2022,Q1,Elderly
205260491,20526049,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,FR-AstraZeneca-2022A083324,ASTRAZENECA,,85.0,YR,,M,Y,,,20220228,,MD,FR,,2022,Q1,Elderly
205260491,20526049,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg10.0mg UNKNOWN,,,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Death,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,FR-AstraZeneca-2022A083324,ASTRAZENECA,,85.0,YR,,M,Y,,,20220228,,MD,FR,,2022,Q1,Elderly
205260531,20526053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,4750.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20220118.0,20220222.0,20220228,20220228,EXP,,DK-AstraZeneca-2022A080992,ASTRAZENECA,,75.0,YR,,F,Y,,,20220228,,MD,DK,,2022,Q1,Elderly
205260561,20526056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,stop during ep of sickness/diarrhoea or severe infections and contact surg for advice on restart,,,U,,,,202293.0,,,Tablet,,2022,Q1,Abscess,,2022,Q1,1,I,20220114.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084939,ASTRAZENECA,,54.0,YR,,F,Y,113.2,KG,20220228,,MD,GB,,2022,Q1,Adult
205260561,20526056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,stop during ep of sickness/diarrhoea or severe infections and contact surg for advice on restart,,,U,,,,202293.0,,,Tablet,,2022,Q1,Vulval abscess,,2022,Q1,1,I,20220114.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084939,ASTRAZENECA,,54.0,YR,,F,Y,113.2,KG,20220228,,MD,GB,,2022,Q1,Adult
205260561,20526056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,stop during ep of sickness/diarrhoea or severe infections and contact surg for advice on restart,,,U,,,,202293.0,,,Tablet,,2022,Q1,Groin abscess,,2022,Q1,1,I,20220114.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084939,ASTRAZENECA,,54.0,YR,,F,Y,113.2,KG,20220228,,MD,GB,,2022,Q1,Adult
205260561,20526056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,stop during ep of sickness/diarrhoea or severe infections and contact surg for advice on restart,,,U,,,,202293.0,,,Tablet,,2022,Q1,Necrotising fasciitis,,2022,Q1,1,I,20220114.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084939,ASTRAZENECA,,54.0,YR,,F,Y,113.2,KG,20220228,,MD,GB,,2022,Q1,Adult
205270362,20527036,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,2,F,20211103.0,20220315.0,20220228,20220323,EXP,,NVSC2021CN244070,NOVARTIS,,65.0,YR,,M,Y,82.0,KG,20220323,,MD,CN,CN,2022,Q1,Elderly
205274421,20527442,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Septic shock,,2022,Q1,1,I,20211117.0,20220222.0,20220228,20220228,EXP,,FR-AstraZeneca-2022A058378,ASTRAZENECA,,20005.0,DY,,M,Y,103.0,KG,20220228,,MD,FR,,2022,Q1,Elderly
205274421,20527442,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20211117.0,20220222.0,20220228,20220228,EXP,,FR-AstraZeneca-2022A058378,ASTRAZENECA,,20005.0,DY,,M,Y,103.0,KG,20220228,,MD,FR,,2022,Q1,Elderly
205274421,20527442,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Pelvic abscess,,2022,Q1,1,I,20211117.0,20220222.0,20220228,20220228,EXP,,FR-AstraZeneca-2022A058378,ASTRAZENECA,,20005.0,DY,,M,Y,103.0,KG,20220228,,MD,FR,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Groin pain,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Heart rate decreased,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205275861,20527586,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1530.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,20211125.0,20220223.0,20220228,20220228,EXP,,GB-AstraZeneca-2022A084966,ASTRAZENECA,,71.0,YR,,M,Y,,,20220228,,MD,GB,,2022,Q1,Elderly
205302852,20530285,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,20220104.0,20220311.0,20220301,20220314,EXP,,NVSJ2022JP003514,NOVARTIS,,86.0,YR,,F,Y,,,20220315,,MD,JP,JP,2022,Q1,Elderly
205302852,20530285,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20220104.0,20220311.0,20220301,20220314,EXP,,NVSJ2022JP003514,NOVARTIS,,86.0,YR,,F,Y,,,20220315,,MD,JP,JP,2022,Q1,Elderly
205302852,20530285,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Weight increased,,2022,Q1,2,F,20220104.0,20220311.0,20220301,20220314,EXP,,NVSJ2022JP003514,NOVARTIS,,86.0,YR,,F,Y,,,20220315,,MD,JP,JP,2022,Q1,Elderly
205302852,20530285,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,2,F,20220104.0,20220311.0,20220301,20220314,EXP,,NVSJ2022JP003514,NOVARTIS,,86.0,YR,,F,Y,,,20220315,,MD,JP,JP,2022,Q1,Elderly
205302852,20530285,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea exertional,,2022,Q1,2,F,20220104.0,20220311.0,20220301,20220314,EXP,,NVSJ2022JP003514,NOVARTIS,,86.0,YR,,F,Y,,,20220315,,MD,JP,JP,2022,Q1,Elderly
205304461,20530446,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,1,I,,20220225.0,20220301,20220301,EXP,,NVSC2022US046220,NOVARTIS,"A Kankam, B Daines, SA Tanami, KG Holder, V Vemulapalli, R Nambiar. Chronic diarrhea with significant weight loss due to olmesartan induced enteropathy. JOURNAL OF INVESTIGATIVE MEDICINE. 2022;70(2)",54.0,YR,,M,Y,,,20220301,,HP,US,US,2022,Q1,Adult
205311761,20531176,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220222.0,20220301,20220301,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-029994,BRISTOL MYERS SQUIBB,,86.0,YR,,M,Y,65.0,KG,20220301,,MD,JP,JP,2022,Q1,Elderly
205318641,20531864,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2180.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20211221.0,20220210.0,20220301,20220301,EXP,,CN-AstraZeneca-2022A087958,ASTRAZENECA,,27394.0,DY,,F,Y,63.5,KG,20220301,,MD,CN,,2022,Q1,Elderly
205318641,20531864,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2180.0,MG,U,,2105243 MP2442,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection bacterial,,2022,Q1,1,I,20211221.0,20220210.0,20220301,20220301,EXP,,CN-AstraZeneca-2022A087958,ASTRAZENECA,,27394.0,DY,,F,Y,63.5,KG,20220301,,MD,CN,,2022,Q1,Elderly
205318701,20531870,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,13630.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220103.0,20220223.0,20220301,20220301,EXP,,SE-AstraZeneca-2022A083625,ASTRAZENECA,,60.0,YR,,M,Y,,,20220301,,MD,SE,,2022,Q1,Adult
205320091,20532009,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2107112,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Erythema multiforme,,2022,Q1,1,I,20220114.0,20220221.0,20220301,20220301,EXP,,CN-AstraZeneca-2022A082740,ASTRAZENECA,,30.0,YR,,M,Y,,,20220301,,MD,CN,,2022,Q1,Young Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Coronary artery stenosis,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Palpitations,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Oedema peripheral,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea exertional,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Micturition frequency decreased,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Arteriosclerosis coronary artery,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Syncope,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Wrong technique in product usage process,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205321723,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q1,Arrhythmia,,2022,Q1,3,F,20220101.0,20220321.0,20220301,20220325,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220325,,MD,PL,PL,2022,Q1,Adult
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperthermia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Skin plaque,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal abscess,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Perineal abscess,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dermo-hypodermitis,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal injury,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Inflammation,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Tissue infiltration,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyponatraemia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dermatitis diaper,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperthermia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Skin plaque,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal abscess,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pneumonia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Perineal abscess,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dermo-hypodermitis,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anal injury,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Inflammation,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Tissue infiltration,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyponatraemia,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205324391,20532439,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dermatitis diaper,,2022,Q1,1,I,,20220221.0,20220301,20220301,EXP,,FR-AstraZeneca-2022A061723,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220301,,PH,FR,,2022,Q1,Elderly
205335891,20533589,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once a day,,,Y,,,,202293.0,,,,,2022,Q1,Confusional state,,2022,Q1,1,I,20220207.0,20220220.0,20220301,20220301,EXP,,GB-AstraZeneca-2022A078799,ASTRAZENECA,,52.0,YR,,F,Y,,,20220301,,MD,GB,,2022,Q1,Adult
205335891,20533589,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once a day,,,Y,,,,202293.0,,,,,2022,Q1,Dehydration,,2022,Q1,1,I,20220207.0,20220220.0,20220301,20220301,EXP,,GB-AstraZeneca-2022A078799,ASTRAZENECA,,52.0,YR,,F,Y,,,20220301,,MD,GB,,2022,Q1,Adult
205335891,20533589,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once a day,,,Y,,,,202293.0,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220207.0,20220220.0,20220301,20220301,EXP,,GB-AstraZeneca-2022A078799,ASTRAZENECA,,52.0,YR,,F,Y,,,20220301,,MD,GB,,2022,Q1,Adult
205341501,20534150,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,U,,,,10.0,MG,,,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220215.0,20220301,20220301,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328419,RANBAXY,,55.0,YR,,M,Y,70.0,KG,20220302,,PH,FR,FR,2022,Q1,Adult
205341501,20534150,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,U,,,,10.0,MG,,,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220215.0,20220301,20220301,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-328419,RANBAXY,,55.0,YR,,M,Y,70.0,KG,20220302,,PH,FR,FR,2022,Q1,Adult
205362761,20536276,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q1,Dyslipidaemia,,2022,Q1,1,I,,20220216.0,20220302,20220302,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-01301,ALKEM,,78.0,YR,,M,Y,,,20220302,,HP,AU,AU,2022,Q1,Elderly
205362761,20536276,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q1,Hypertension,,2022,Q1,1,I,,20220216.0,20220302,20220302,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-01301,ALKEM,,78.0,YR,,M,Y,,,20220302,,HP,AU,AU,2022,Q1,Elderly
205362761,20536276,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q1,Body mass index abnormal,,2022,Q1,1,I,,20220216.0,20220302,20220302,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-01301,ALKEM,,78.0,YR,,M,Y,,,20220302,,HP,AU,AU,2022,Q1,Elderly
205362761,20536276,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220216.0,20220302,20220302,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-01301,ALKEM,,78.0,YR,,M,Y,,,20220302,,HP,AU,AU,2022,Q1,Elderly
205362761,20536276,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q1,Microalbuminuria,,2022,Q1,1,I,,20220216.0,20220302,20220302,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-01301,ALKEM,,78.0,YR,,M,Y,,,20220302,,HP,AU,AU,2022,Q1,Elderly
205382181,20538218,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,Rp280,,202293.0,,,Tablet,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,1,I,20220101.0,20220223.0,20220302,20220302,EXP,,GB-AstraZeneca-2022A084948,ASTRAZENECA,,69.0,YR,,F,Y,87.0,KG,20220302,,MD,GB,,2022,Q1,Elderly
205389741,20538974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,every morning,,,Y,,NA3010,,202293.0,,,Tablet,QD,2022,Q1,Dysuria,,2022,Q1,1,I,20220217.0,20220222.0,20220302,20220302,EXP,,CN-AstraZeneca-2022A087728,ASTRAZENECA,,21185.0,DY,,F,Y,55.0,KG,20220302,,MD,CN,,2022,Q1,Elderly
205389741,20538974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,every morning,,,Y,,NA3010,,202293.0,,,Tablet,QD,2022,Q1,Abdominal pain lower,,2022,Q1,1,I,20220217.0,20220222.0,20220302,20220302,EXP,,CN-AstraZeneca-2022A087728,ASTRAZENECA,,21185.0,DY,,F,Y,55.0,KG,20220302,,MD,CN,,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Neoplasm progression,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Vomiting,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Dysphagia,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Cardiopulmonary failure,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205395481,20539548,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,1,I,20211011.0,20211028.0,20220302,20220302,EXP,,CN-JNJFOC-20211056657,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205401801,20540180,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,N,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q1,Pulmonary hypertension,,2022,Q1,1,I,20180104.0,20220218.0,20220302,20220302,EXP,FR-AFSSAPS-PV20220175,FR-PFIZER INC-202200293979,PFIZER,,72.0,YR,,M,Y,76.0,KG,20220302,,CN,FR,FR,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Left ventricular dysfunction,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Nephritis,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Product prescribing issue,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Ventricular hypertrophy,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Hepatic cyst,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Haematuria,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Mitral valve incompetence,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Incorrect dose administered,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205407241,20540724,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1000.0,MG,,,,,,10.0,MG,,QD,2022,Q1,Cystitis haemorrhagic,,2022,Q1,1,I,20210519.0,20210925.0,20220302,20220302,EXP,,CN-JNJFOC-20210956617,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,63.3,KG,20220302,,HP,CN,CN,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vision blurred,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pain in extremity,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205408731,20540873,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20220124.0,20220222.0,20220302,20220302,EXP,,FR-AstraZeneca-2022A089951,ASTRAZENECA,,75.0,YR,,M,Y,126.0,KG,20220302,,CN,FR,,2022,Q1,Elderly
205409191,20540919,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"1 DF, BID",,,,,,,,,,,BID,2022,Q1,Hypertransaminasaemia,,2022,Q1,1,I,20201223.0,20211005.0,20220302,20220302,EXP,ES-AEMPS-1013815,ES-JNJFOC-20211009417,JOHNSON AND JOHNSON,,60.0,YR,A,M,Y,,,20220302,,PH,ES,ES,2022,Q1,Adult
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Neoplasm progression,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Drug ineffective,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Coronavirus infection,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Coronavirus infection,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205409871,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20210401.0,20220223.0,20220302,20220302,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220302,,CN,EG,EG,2022,Q1,Elderly
205412701,20541270,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210801.0,20211022.0,20220302,20220302,EXP,,JP-JNJFOC-20211022186,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20220302,,PH,JP,JP,2022,Q1,Elderly
205412701,20541270,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Cerebellar haemorrhage,,2022,Q1,1,I,20210801.0,20211022.0,20220302,20220302,EXP,,JP-JNJFOC-20211022186,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20220302,,PH,JP,JP,2022,Q1,Elderly
205412701,20541270,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,1,I,20210801.0,20211022.0,20220302,20220302,EXP,,JP-JNJFOC-20211022186,JOHNSON AND JOHNSON,,85.0,YR,E,M,Y,,,20220302,,PH,JP,JP,2022,Q1,Elderly
205413791,20541379,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,5.0,MG,Tablet,QID,2022,Q1,Death,,2022,Q1,1,I,,20211021.0,20220302,20220302,EXP,,CN-JNJFOC-20211040491,JOHNSON AND JOHNSON,,75.0,YR,E,M,Y,54.0,KG,20220302,,CN,CN,CN,2022,Q1,Elderly
205416161,20541616,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q1,Nephrogenic anaemia,,2022,Q1,1,I,,20220218.0,20220302,20220302,EXP,,JP-DSJP-DSJ-2022-106150AA,DAIICHI,,40.0,YR,,F,Y,35.9,KG,20220302,,MD,JP,JP,2022,Q1,Adult
205422241,20542224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,,,2022,Q1,Constipation,,2022,Q1,1,I,,20220222.0,20220302,20220302,EXP,,GB-AstraZeneca-2022A082922,ASTRAZENECA,,73.0,YR,,F,Y,80.0,KG,20220302,,MD,GB,,2022,Q1,Elderly
205422241,20542224,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,,,2022,Q1,Thirst,,2022,Q1,1,I,,20220222.0,20220302,20220302,EXP,,GB-AstraZeneca-2022A082922,ASTRAZENECA,,73.0,YR,,F,Y,80.0,KG,20220302,,MD,GB,,2022,Q1,Elderly
205423911,20542391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1x per day 1 tablet8718438001712,",,,,,8718438001712,,202293.0,,,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20220214.0,20220222.0,20220302,20220302,EXP,,NL-AstraZeneca-2022A081360,ASTRAZENECA,,64.0,YR,,M,Y,92.0,KG,20220302,,MD,NL,,2022,Q1,Adult
205423911,20542391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1x per day 1 tablet8718438001712,",,,,,8718438001712,,202293.0,,,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,1,I,20220214.0,20220222.0,20220302,20220302,EXP,,NL-AstraZeneca-2022A081360,ASTRAZENECA,,64.0,YR,,M,Y,92.0,KG,20220302,,MD,NL,,2022,Q1,Adult
205423911,20542391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1x per day 1 tablet8718438001712,",,,,,8718438001712,,202293.0,,,Tablet,QD,2022,Q1,Pollakiuria,,2022,Q1,1,I,20220214.0,20220222.0,20220302,20220302,EXP,,NL-AstraZeneca-2022A081360,ASTRAZENECA,,64.0,YR,,M,Y,92.0,KG,20220302,,MD,NL,,2022,Q1,Adult
205431201,20543120,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20211223.0,20220225.0,20220302,20220302,EXP,FR-AFSSAPS-GR20220201,FR-MYLANLABS-2022M1016226,MYLAN,,60.0,YR,,F,Y,,,20220302,,PH,FR,FR,2022,Q1,Adult
205431201,20543120,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20211223.0,20220225.0,20220302,20220302,EXP,FR-AFSSAPS-GR20220201,FR-MYLANLABS-2022M1016226,MYLAN,,60.0,YR,,F,Y,,,20220302,,PH,FR,FR,2022,Q1,Adult
205433401,20543340,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,MT3050/2104238,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20220209.0,20220223.0,20220302,20220302,EXP,,CN-AstraZeneca-2022A088902,ASTRAZENECA,,32599.0,DY,,F,Y,80.0,KG,20220302,,MD,CN,,2022,Q1,Elderly
205437601,20543760,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,D,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220221.0,20220303,20220303,EXP,,FR-AUROBINDO-AUR-APL-2022-006380,AUROBINDO,,85.0,YR,,M,Y,,,20220303,,MD,FR,FR,2022,Q1,Elderly
205437601,20543760,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,D,,,,,10.0,MG,,,2022,Q1,Death,,2022,Q1,1,I,,20220221.0,20220303,20220303,EXP,,FR-AUROBINDO-AUR-APL-2022-006380,AUROBINDO,,85.0,YR,,M,Y,,,20220303,,MD,FR,FR,2022,Q1,Elderly
205444681,20544468,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Chest discomfort,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,,GB-AUROBINDO-AUR-APL-2022-006587,AUROBINDO,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205444681,20544468,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,,GB-AUROBINDO-AUR-APL-2022-006587,AUROBINDO,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205444681,20544468,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,,GB-AUROBINDO-AUR-APL-2022-006587,AUROBINDO,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205455811,20545581,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,GB-MHRA-ADR 26610170,GB-Accord-255841,ACCORD,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205455811,20545581,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,GB-MHRA-ADR 26610170,GB-Accord-255841,ACCORD,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205455811,20545581,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,GB-MHRA-ADR 26610170,GB-Accord-255841,ACCORD,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205455811,20545581,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,Chest discomfort,,2022,Q1,1,I,20211108.0,20220222.0,20220303,20220303,EXP,GB-MHRA-ADR 26610170,GB-Accord-255841,ACCORD,,56.0,YR,,F,Y,107.0,KG,20220303,,HP,GB,GB,2022,Q1,Adult
205463631,20546363,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg daily,,,Y,,,,202293.0,10.0,MG,,QD,2022,Q1,Necrotising fasciitis,,2022,Q1,1,I,20220204.0,20220224.0,20220303,20220303,EXP,,GB-AstraZeneca-2022A090879,ASTRAZENECA,,58.0,YR,,M,Y,,,20220303,,MD,GB,,2022,Q1,Adult
205470111,20547011,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q1,Malaise,,2022,Q1,1,I,20220224.0,20220227.0,20220303,20220303,EXP,GB-MHRA-TPP20835801C6527397YC1645694525586,GB-MYLANLABS-2022M1016109,MYLAN,,42.0,YR,,F,Y,66.0,KG,20220303,,MD,GB,GB,2022,Q1,Adult
205470111,20547011,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20220224.0,20220227.0,20220303,20220303,EXP,GB-MHRA-TPP20835801C6527397YC1645694525586,GB-MYLANLABS-2022M1016109,MYLAN,,42.0,YR,,F,Y,66.0,KG,20220303,,MD,GB,GB,2022,Q1,Adult
205475301,20547530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,20220101.0,20220224.0,20220303,20220303,EXP,SE-MPA-2022-010479,NVSC2022SE043562,NOVARTIS,,69.0,YR,,M,Y,,,20220303,,MD,SE,SE,2022,Q1,Elderly
205475301,20547530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Vision blurred,,2022,Q1,1,I,20220101.0,20220224.0,20220303,20220303,EXP,SE-MPA-2022-010479,NVSC2022SE043562,NOVARTIS,,69.0,YR,,M,Y,,,20220303,,MD,SE,SE,2022,Q1,Elderly
205475301,20547530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,20220101.0,20220224.0,20220303,20220303,EXP,SE-MPA-2022-010479,NVSC2022SE043562,NOVARTIS,,69.0,YR,,M,Y,,,20220303,,MD,SE,SE,2022,Q1,Elderly
205478141,20547814,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hallucination,,2022,Q1,1,I,20220205.0,20220223.0,20220303,20220303,EXP,,ES-AstraZeneca-2022A083107,ASTRAZENECA,,72.0,YR,,F,Y,75.0,KG,20220303,,MD,ES,,2022,Q1,Elderly
205478141,20547814,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Pollakiuria,,2022,Q1,1,I,20220205.0,20220223.0,20220303,20220303,EXP,,ES-AstraZeneca-2022A083107,ASTRAZENECA,,72.0,YR,,F,Y,75.0,KG,20220303,,MD,ES,,2022,Q1,Elderly
205478141,20547814,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Disorientation,,2022,Q1,1,I,20220205.0,20220223.0,20220303,20220303,EXP,,ES-AstraZeneca-2022A083107,ASTRAZENECA,,72.0,YR,,F,Y,75.0,KG,20220303,,MD,ES,,2022,Q1,Elderly
205478141,20547814,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 MG,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Urinary incontinence,,2022,Q1,1,I,20220205.0,20220223.0,20220303,20220303,EXP,,ES-AstraZeneca-2022A083107,ASTRAZENECA,,72.0,YR,,F,Y,75.0,KG,20220303,,MD,ES,,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Ejection fraction decreased,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Haemoglobin decreased,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Ventricular internal diameter abnormal,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205515701,20551570,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (1 tab 10 mg, pc)",,,U,,,,,,,Tablet,QD,2022,Q1,Prescribed underdose,,2022,Q1,1,I,,20220226.0,20220304,20220304,EXP,,NVSC2022TH046558,NOVARTIS,,74.0,YR,,M,Y,,,20220304,,MD,TH,TH,2022,Q1,Elderly
205522751,20552275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Vomiting,,2022,Q1,1,I,20220120.0,20220224.0,20220304,20220304,EXP,,FR-AstraZeneca-2022A085378,ASTRAZENECA,,56.0,YR,,M,Y,,,20220304,,MD,FR,,2022,Q1,Adult
205522751,20552275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20220120.0,20220224.0,20220304,20220304,EXP,,FR-AstraZeneca-2022A085378,ASTRAZENECA,,56.0,YR,,M,Y,,,20220304,,MD,FR,,2022,Q1,Adult
205522751,20552275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hypokalaemia,,2022,Q1,1,I,20220120.0,20220224.0,20220304,20220304,EXP,,FR-AstraZeneca-2022A085378,ASTRAZENECA,,56.0,YR,,M,Y,,,20220304,,MD,FR,,2022,Q1,Adult
205522751,20552275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Hyponatraemia,,2022,Q1,1,I,20220120.0,20220224.0,20220304,20220304,EXP,,FR-AstraZeneca-2022A085378,ASTRAZENECA,,56.0,YR,,M,Y,,,20220304,,MD,FR,,2022,Q1,Adult
205522751,20552275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Dizziness,,2022,Q1,1,I,20220120.0,20220224.0,20220304,20220304,EXP,,FR-AstraZeneca-2022A085378,ASTRAZENECA,,56.0,YR,,M,Y,,,20220304,,MD,FR,,2022,Q1,Adult
205524721,20552472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2022,Q1,Chest pain,,2022,Q1,1,I,,20220223.0,20220304,20220304,EXP,,US-TORRENT-00011769,TORRENT,,54.0,YR,A,M,Y,,,20220304,,HP,US,US,2022,Q1,Adult
205524721,20552472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2022,Q1,Condition aggravated,,2022,Q1,1,I,,20220223.0,20220304,20220304,EXP,,US-TORRENT-00011769,TORRENT,,54.0,YR,A,M,Y,,,20220304,,HP,US,US,2022,Q1,Adult
205524721,20552472,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Unknown,,,U,,,,,,,,,2022,Q1,Sprue-like enteropathy,,2022,Q1,1,I,,20220223.0,20220304,20220304,EXP,,US-TORRENT-00011769,TORRENT,,54.0,YR,A,M,Y,,,20220304,,HP,US,US,2022,Q1,Adult
205525642,20552564,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,unknown,,202293.0,10.0,MG,,,2022,Q1,Acute myocardial infarction,,2022,Q1,2,F,,20220316.0,20220304,20220318,EXP,,DE-AstraZeneca-2022A095638,ASTRAZENECA,,66.0,YR,,,Y,,,20220318,,MD,DE,,2022,Q1,Elderly
205525642,20552564,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,unknown,,202293.0,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,2,F,,20220316.0,20220304,20220318,EXP,,DE-AstraZeneca-2022A095638,ASTRAZENECA,,66.0,YR,,,Y,,,20220318,,MD,DE,,2022,Q1,Elderly
205526862,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gastrointestinal polyp haemorrhage,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205526862,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205526862,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebral infarction,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205526862,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Gastrointestinal polyp haemorrhage,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205526862,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Anaemia,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205526862,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Cerebral infarction,,2022,Q1,2,F,20211211.0,20220316.0,20220304,20220323,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220323,,MD,JP,,2022,Q1,Elderly
205532392,20553239,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,570.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebral infarction,,2022,Q1,2,F,20220112.0,20220310.0,20220304,20220317,EXP,,JP-AstraZeneca-2022A089957,ASTRAZENECA,,89.0,YR,,F,Y,,,20220318,,MD,JP,,2022,Q1,Elderly
205536501,20553650,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,,,,,,10.0,MG,,QD,2022,Q1,Polycythaemia,,2022,Q1,1,I,20220302.0,,20220304,20220304,DIR,605820,,FDA-CTU,,65.0,YR,,M,N,105.0,KG,20220304,N,MD,US,,2022,Q1,Elderly
205544531,20554453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q1,Dizziness,,2022,Q1,1,I,20220101.0,20220224.0,20220304,20220304,EXP,,SE-AstraZeneca-2022A085356,ASTRAZENECA,,69.0,YR,,M,Y,,,20220304,,MD,SE,,2022,Q1,Elderly
205544531,20554453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q1,Vision blurred,,2022,Q1,1,I,20220101.0,20220224.0,20220304,20220304,EXP,,SE-AstraZeneca-2022A085356,ASTRAZENECA,,69.0,YR,,M,Y,,,20220304,,MD,SE,,2022,Q1,Elderly
205544531,20554453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q1,Headache,,2022,Q1,1,I,20220101.0,20220224.0,20220304,20220304,EXP,,SE-AstraZeneca-2022A085356,ASTRAZENECA,,69.0,YR,,M,Y,,,20220304,,MD,SE,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Anxiety,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Vomiting,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Enterobacter test positive,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pollakiuria,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hyperpyrexia,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Nausea,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Tremor,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544541,20554454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,2106095,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220221.0,20220225.0,20220304,20220304,EXP,,CN-AstraZeneca-2022A093114,ASTRAZENECA,,27746.0,DY,,M,Y,75.0,KG,20220304,,MD,CN,,2022,Q1,Elderly
205544761,20554476,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg/day,,,,,,,,,,Tablet,,2022,Q1,Rectal cancer,,2022,Q1,1,I,,20220301.0,20220304,20220304,EXP,,JP-DSJP-DSJ-2022-107639,DAIICHI,,80.0,YR,,M,Y,44.0,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
205544761,20554476,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg/day,,,,,,,,,,Tablet,,2022,Q1,Coronary artery stenosis,,2022,Q1,1,I,,20220301.0,20220304,20220304,EXP,,JP-DSJP-DSJ-2022-107639,DAIICHI,,80.0,YR,,M,Y,44.0,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
205544761,20554476,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg/day,,,,,,,,,,Tablet,,2022,Q1,Small cell lung cancer,,2022,Q1,1,I,,20220301.0,20220304,20220304,EXP,,JP-DSJP-DSJ-2022-107639,DAIICHI,,80.0,YR,,M,Y,44.0,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
205544761,20554476,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5mg/day,,,,,,,,,,Tablet,,2022,Q1,Coronary artery disease,,2022,Q1,1,I,,20220301.0,20220304,20220304,EXP,,JP-DSJP-DSJ-2022-107639,DAIICHI,,80.0,YR,,M,Y,44.0,KG,20220304,,MD,JP,JP,2022,Q1,Elderly
205545461,20554546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Plasma cell myeloma,,2022,Q1,1,I,,20220210.0,20220304,20220304,EXP,,JP-AstraZeneca-2022A070863,ASTRAZENECA,,90.0,YR,,M,Y,,,20220304,,MD,JP,,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Eating disorder,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Product use in unapproved indication,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Arrhythmia,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pallor,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Cardiomegaly,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Blood pressure fluctuation,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Blood cholesterol increased,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Left ventricle outflow tract obstruction,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205547133,20554713,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Therapeutic response unexpected,,2022,Q1,3,F,20210801.0,20220309.0,20220304,20220324,EXP,,NVSC2022BR049280,NOVARTIS,,68.0,YR,,M,Y,113.0,KG,20220324,,CN,BR,BR,2022,Q1,Elderly
205548732,20554873,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 milligram,,,,,,,,5.0,MG,Tablet,,2022,Q1,Renal impairment,,2022,Q1,2,F,20210301.0,20220323.0,20220304,20220329,PER,,JP-AMGEN-JPNSP2022037763,AMGEN,,82.0,YR,E,M,Y,,,20220329,,MD,JP,JP,2022,Q1,Elderly
205588121,20558812,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20220224.0,20220227.0,20220307,20220307,EXP,GB-MHRA-ADR 26645544,GB-Accord-256440,ACCORD,,42.0,YR,,F,Y,66.0,KG,20220307,,MD,GB,GB,2022,Q1,Adult
205588121,20558812,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Malaise,,2022,Q1,1,I,20220224.0,20220227.0,20220307,20220307,EXP,GB-MHRA-ADR 26645544,GB-Accord-256440,ACCORD,,42.0,YR,,F,Y,66.0,KG,20220307,,MD,GB,GB,2022,Q1,Adult
205601623,20560162,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cardiac failure acute,,2022,Q1,3,F,20210220.0,20220317.0,20220307,20220322,EXP,,JP-AstraZeneca-2022A098719,ASTRAZENECA,,98.0,YR,,F,Y,55.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
205601623,20560162,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Renal impairment,,2022,Q1,3,F,20210220.0,20220317.0,20220307,20220322,EXP,,JP-AstraZeneca-2022A098719,ASTRAZENECA,,98.0,YR,,F,Y,55.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
205614721,20561472,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,N,,,,,,,,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,,20220228.0,20220307,20220307,EXP,,DE-ANIPHARMA-2022-DE-000026,ANI,,66.0,YR,,UNK,Y,,,20220307,,MD,DE,DE,2022,Q1,Elderly
205614721,20561472,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,N,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220228.0,20220307,20220307,EXP,,DE-ANIPHARMA-2022-DE-000026,ANI,,66.0,YR,,UNK,Y,,,20220307,,MD,DE,DE,2022,Q1,Elderly
205617641,20561764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,211564.0,,,,,2022,Q1,Euglycaemic diabetic ketoacidosis,,2022,Q1,1,I,,20220223.0,20220307,20220307,EXP,,IN-GLENMARK PHARMACEUTICALS-2022GMK071021,GLENMARK,"Muthukumaran A, Thoppalan B, Seshadri J.. POS-092 SGLT2 Inhibitor - Induced euglycemic diabetic ketoacidosis in guillain-barre syndrome: A case report.. Conference: ISN World Congress of Nephrology (WCN).. 2022;7(2 Supplement):(pp S39)",42.0,YR,,M,Y,,,20220307,,HP,IN,IN,2022,Q1,Adult
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Pulmonary congestion,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiothoracic ratio increased,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Pleural effusion,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205636662,20563666,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,2,F,,20220310.0,20220308,20220314,EXP,,NVSJ2022JP004082,NOVARTIS,,96.0,YR,,F,Y,,,20220314,,MD,JP,JP,2022,Q1,Elderly
205652331,20565233,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (daily dose: 10 Mg millgram(s) every Days)",,,U,,,,,10.0,MG,,QD,2022,Q1,Coma,,2022,Q1,1,I,20220131.0,20220307.0,20220308,20220308,EXP,DE-DCGMA-22196824,NVSC2022DE053561,NOVARTIS,,79.0,YR,,M,Y,65.0,KG,20220308,,MD,DE,DE,2022,Q1,Elderly
205652331,20565233,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (daily dose: 10 Mg millgram(s) every Days)",,,U,,,,,10.0,MG,,QD,2022,Q1,Lactic acidosis,,2022,Q1,1,I,20220131.0,20220307.0,20220308,20220308,EXP,DE-DCGMA-22196824,NVSC2022DE053561,NOVARTIS,,79.0,YR,,M,Y,65.0,KG,20220308,,MD,DE,DE,2022,Q1,Elderly
205667812,20566781,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,2,F,20210801.0,20220228.0,20220308,20220309,EXP,,DE-AstraZeneca-2022A095567,ASTRAZENECA,,70.0,YR,,M,Y,,,20220309,,MD,DE,,2022,Q1,Elderly
205667812,20566781,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ocular discomfort,,2022,Q1,2,F,20210801.0,20220228.0,20220308,20220309,EXP,,DE-AstraZeneca-2022A095567,ASTRAZENECA,,70.0,YR,,M,Y,,,20220309,,MD,DE,,2022,Q1,Elderly
205667812,20566781,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood pressure systolic increased,,2022,Q1,2,F,20210801.0,20220228.0,20220308,20220309,EXP,,DE-AstraZeneca-2022A095567,ASTRAZENECA,,70.0,YR,,M,Y,,,20220309,,MD,DE,,2022,Q1,Elderly
205673661,20567366,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Pruritus,,2022,Q1,1,I,20220222.0,20220228.0,20220308,20220308,EXP,,GB-AstraZeneca-2022A093198,ASTRAZENECA,,78.0,YR,,F,Y,86.0,KG,20220308,,MD,GB,,2022,Q1,Elderly
205676991,20567699,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Death,,2022,Q1,1,I,20220303.0,20220303.0,20220308,20220308,EXP,,ZA-AstraZeneca-2022A100189,ASTRAZENECA,,25607.0,DY,,M,Y,,,20220308,,CN,ZA,,2022,Q1,Elderly
205705482,20570548,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (tabletten),,,U,,,,,,,Tablet,,2022,Q1,Loss of consciousness,,2022,Q1,2,F,20220220.0,20220316.0,20220309,20220319,EXP,NL-LRB-00794384,NVSC2022NL053876,NOVARTIS,,69.0,YR,,M,Y,67.0,KG,20220319,,CN,NL,NL,2022,Q1,Elderly
205705482,20570548,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (tabletten),,,U,,,,,,,Tablet,,2022,Q1,Hypotension,,2022,Q1,2,F,20220220.0,20220316.0,20220309,20220319,EXP,NL-LRB-00794384,NVSC2022NL053876,NOVARTIS,,69.0,YR,,M,Y,67.0,KG,20220319,,CN,NL,NL,2022,Q1,Elderly
205709831,20570983,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,20220103.0,20220304.0,20220309,20220309,EXP,,NVSJ2022JP002635,NOVARTIS,,82.0,YR,,M,Y,,,20220309,,MD,JP,JP,2022,Q1,Elderly
205709831,20570983,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Brain natriuretic peptide increased,,2022,Q1,1,I,20220103.0,20220304.0,20220309,20220309,EXP,,NVSJ2022JP002635,NOVARTIS,,82.0,YR,,M,Y,,,20220309,,MD,JP,JP,2022,Q1,Elderly
205727251,20572725,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10mg, 1 in the morning",,,,,,,,,,,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20220129.0,20220228.0,20220309,20220309,EXP,,FR-AstraZeneca-2022A100179,ASTRAZENECA,,68.0,YR,,M,Y,95.0,KG,20220309,,MD,FR,,2022,Q1,Elderly
205727251,20572725,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10mg, 1 in the morning",,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20220129.0,20220228.0,20220309,20220309,EXP,,FR-AstraZeneca-2022A100179,ASTRAZENECA,,68.0,YR,,M,Y,95.0,KG,20220309,,MD,FR,,2022,Q1,Elderly
205736001,20573600,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Drug eruption,,2022,Q1,1,I,20211101.0,20220301.0,20220309,20220309,EXP,,JP-AstraZeneca-2022A099544,ASTRAZENECA,,100.0,YR,,F,Y,,,20220309,,MD,JP,,2022,Q1,Elderly
205740171,20574017,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220101.0,20220222.0,20220309,20220309,EXP,,HR-TEVA-2022-HR-2015539,TEVA,,49.0,YR,A,M,Y,93.0,KG,20220309,,MD,HR,HR,2022,Q1,Adult
205740171,20574017,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220101.0,20220222.0,20220309,20220309,EXP,,HR-TEVA-2022-HR-2015539,TEVA,,49.0,YR,A,M,Y,93.0,KG,20220309,,MD,HR,HR,2022,Q1,Adult
205740171,20574017,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2022,Q1,Colitis ulcerative,,2022,Q1,1,I,20220101.0,20220222.0,20220309,20220309,EXP,,HR-TEVA-2022-HR-2015539,TEVA,,49.0,YR,A,M,Y,93.0,KG,20220309,,MD,HR,HR,2022,Q1,Adult
205740171,20574017,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,,2022,Q1,Cough,,2022,Q1,1,I,20220101.0,20220222.0,20220309,20220309,EXP,,HR-TEVA-2022-HR-2015539,TEVA,,49.0,YR,A,M,Y,93.0,KG,20220309,,MD,HR,HR,2022,Q1,Adult
205746961,20574696,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Epididymitis,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205746961,20574696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,,10.0,MG,Tablet,QD,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20171010.0,20220302.0,20220309,20220309,EXP,,GB-AstraZeneca-2017SF05024,ASTRAZENECA,,28563.0,DY,,M,Y,,,20220310,,MD,GB,,2022,Q1,Elderly
205747781,20574778,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,***,,2022,Q1,Tendon rupture,,2022,Q1,1,I,20220221.0,20220228.0,20220310,20220310,EXP,,CO-ABBVIE-22K-036-4309551-00,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20220309,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q1,Elderly
205761832,20576183,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Intentional dose omission,,2022,Q1,2,F,20220207.0,20220314.0,20220310,20220322,EXP,,BR-SA-2022SA051594,SANOFI AVENTIS,,45.0,YR,A,F,Y,78.0,KG,20220322,,MD,BR,BR,2022,Q1,Adult
205761832,20576183,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q1,Neck pain,,2022,Q1,2,F,20220207.0,20220314.0,20220310,20220322,EXP,,BR-SA-2022SA051594,SANOFI AVENTIS,,45.0,YR,A,F,Y,78.0,KG,20220322,,MD,BR,BR,2022,Q1,Adult
205777291,20577729,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q1,Rhinocerebral mucormycosis,,2022,Q1,1,I,20210101.0,20220226.0,20220310,20220310,EXP,,IN-PFIZER INC-202200365132,PFIZER,"Aggarwal, S.. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.. American Journal of Tropical Medicine and Hygiene. 2022;106(2):566-570",33.0,YR,,M,Y,,,20220310,,MD,IN,IN,2022,Q1,Young Adult
205782571,20578257,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1310.0,MG,,,2107111,,,10.0,MG,,QD,2022,Q1,Depressed level of consciousness,,2022,Q1,1,I,20220307.0,20220309.0,20220310,20220310,EXP,,CN-BAYER-2022A035764,BAYER,,80.0,YR,E,F,Y,,,20220310,,HP,CN,CN,2022,Q1,Elderly
205782571,20578257,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1310.0,MG,,,2107111,,,10.0,MG,,QD,2022,Q1,Unresponsive to stimuli,,2022,Q1,1,I,20220307.0,20220309.0,20220310,20220310,EXP,,CN-BAYER-2022A035764,BAYER,,80.0,YR,E,F,Y,,,20220310,,HP,CN,CN,2022,Q1,Elderly
205782571,20578257,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1310.0,MG,,,2107111,,,10.0,MG,,QD,2022,Q1,Speech disorder,,2022,Q1,1,I,20220307.0,20220309.0,20220310,20220310,EXP,,CN-BAYER-2022A035764,BAYER,,80.0,YR,E,F,Y,,,20220310,,HP,CN,CN,2022,Q1,Elderly
205782571,20578257,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1310.0,MG,,,2107111,,,10.0,MG,,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20220307.0,20220309.0,20220310,20220310,EXP,,CN-BAYER-2022A035764,BAYER,,80.0,YR,E,F,Y,,,20220310,,HP,CN,CN,2022,Q1,Elderly
205789891,20578989,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Oesophageal carcinoma,,2022,Q1,1,I,,20220302.0,20220310,20220310,EXP,,JP-AstraZeneca-2022A099234,ASTRAZENECA,,70.0,YR,,F,Y,,,20220310,,MD,JP,,2022,Q1,Elderly
205789891,20578989,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Weight decreased,,2022,Q1,1,I,,20220302.0,20220310,20220310,EXP,,JP-AstraZeneca-2022A099234,ASTRAZENECA,,70.0,YR,,F,Y,,,20220310,,MD,JP,,2022,Q1,Elderly
205789891,20578989,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20220302.0,20220310,20220310,EXP,,JP-AstraZeneca-2022A099234,ASTRAZENECA,,70.0,YR,,F,Y,,,20220310,,MD,JP,,2022,Q1,Elderly
205797551,20579755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q1,Drug reaction with eosinophilia and systemic symptoms,,2022,Q1,1,I,20211227.0,20220302.0,20220310,20220310,EXP,,FR-AstraZeneca-2022A094431,ASTRAZENECA,,46.0,YR,,F,Y,70.2,KG,20220310,,MD,FR,,2022,Q1,Adult
205799551,20579955,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q1,Coma,,2022,Q1,1,I,20220131.0,20220307.0,20220310,20220310,EXP,,DE-BAUSCH-BL-2022-006169,BAUSCH AND LOMB,,79.0,YR,,M,Y,65.0,KG,20220311,,MD,DE,DE,2022,Q1,Elderly
205799551,20579955,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q1,Lactic acidosis,,2022,Q1,1,I,20220131.0,20220307.0,20220310,20220310,EXP,,DE-BAUSCH-BL-2022-006169,BAUSCH AND LOMB,,79.0,YR,,M,Y,65.0,KG,20220311,,MD,DE,DE,2022,Q1,Elderly
205800471,20580047,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,U,,,,202293.0,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220122.0,20220306.0,20220310,20220310,EXP,,GB-AstraZeneca-2022A100473,ASTRAZENECA,,72.0,YR,,F,Y,,,20220311,,MD,GB,,2022,Q1,Elderly
205802771,20580277,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Malaise,,2022,Q1,1,I,20220224.0,20220228.0,20220310,20220310,EXP,GB-MHRA-TPP20835801C6527397YC1645694525586,GB-MICRO LABS LIMITED-ML2022-00804,MICRO LABS,,42.0,YR,A,F,Y,66.0,KG,20220311,,MD,GB,GB,2022,Q1,Adult
205802771,20580277,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q1,Hypotension,,2022,Q1,1,I,20220224.0,20220228.0,20220310,20220310,EXP,GB-MHRA-TPP20835801C6527397YC1645694525586,GB-MICRO LABS LIMITED-ML2022-00804,MICRO LABS,,42.0,YR,A,F,Y,66.0,KG,20220311,,MD,GB,GB,2022,Q1,Adult
205819941,20581994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,MT3044,,202293.0,10.0,MG,Tablet,QOD,2022,Q1,Intentional dose omission,,2022,Q1,1,I,20220205.0,20220308.0,20220311,20220311,EXP,,CN-AstraZeneca-2022A107035,ASTRAZENECA,,7850.0,DY,,F,Y,57.0,KG,20220311,,MD,CN,,2022,Q1,Elderly
205819941,20581994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,MT3044,,202293.0,10.0,MG,Tablet,QOD,2022,Q1,Diabetic ketoacidotic hyperglycaemic coma,,2022,Q1,1,I,20220205.0,20220308.0,20220311,20220311,EXP,,CN-AstraZeneca-2022A107035,ASTRAZENECA,,7850.0,DY,,F,Y,57.0,KG,20220311,,MD,CN,,2022,Q1,Elderly
205819941,20581994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,MT3044,,202293.0,10.0,MG,Tablet,QOD,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20220205.0,20220308.0,20220311,20220311,EXP,,CN-AstraZeneca-2022A107035,ASTRAZENECA,,7850.0,DY,,F,Y,57.0,KG,20220311,,MD,CN,,2022,Q1,Elderly
205819941,20581994,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,U,,MT3044,,202293.0,10.0,MG,Tablet,QOD,2022,Q1,Condition aggravated,,2022,Q1,1,I,20220205.0,20220308.0,20220311,20220311,EXP,,CN-AstraZeneca-2022A107035,ASTRAZENECA,,7850.0,DY,,F,Y,57.0,KG,20220311,,MD,CN,,2022,Q1,Elderly
205828481,20582848,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,Asked but unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20210203.0,20220304.0,20220311,20220311,EXP,,DK-AstraZeneca-2022A098138,ASTRAZENECA,,67.0,YR,,M,Y,,,20220311,,MD,DK,,2022,Q1,Elderly
205830901,20583090,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd (10mg once a day)",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q1,Balanitis candida,,2022,Q1,1,I,20220115.0,20220306.0,20220311,20220311,EXP,,GB-MYLANLABS-2022M1018307,MYLAN,,60.0,YR,,M,Y,102.0,KG,20220311,,CN,GB,GB,2022,Q1,Adult
205835581,20583558,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day; ;,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gangrene,,2022,Q1,1,I,,20220305.0,20220311,20220311,EXP,,GB-AstraZeneca-2022A100271,ASTRAZENECA,,78.0,YR,,M,Y,87.0,KG,20220311,,MD,GB,,2022,Q1,Elderly
205835631,20583563,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,QD,2022,Q1,Superinfection bacterial,,2022,Q1,1,I,20220114.0,20220303.0,20220311,20220311,EXP,,FR-AstraZeneca-2022A096741,ASTRAZENECA,,77.0,YR,,M,Y,96.0,KG,20220311,,MD,FR,,2022,Q1,Elderly
205835631,20583563,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,QD,2022,Q1,Necrosis,,2022,Q1,1,I,20220114.0,20220303.0,20220311,20220311,EXP,,FR-AstraZeneca-2022A096741,ASTRAZENECA,,77.0,YR,,M,Y,96.0,KG,20220311,,MD,FR,,2022,Q1,Elderly
205845332,20584533,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q1,Hypertension,,2022,Q1,2,F,20220305.0,20220320.0,20220311,20220325,EXP,,NVSC2022EG054035,NOVARTIS,,74.0,YR,,F,Y,,,20220325,,CN,EG,EG,2022,Q1,Elderly
205874854,20587485,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Acute myocardial infarction,,2022,Q1,4,F,,20220323.0,20220314,20220328,EXP,,NVSC2022DE057669,NOVARTIS,,66.0,YR,,,Y,,,20220328,,MD,DE,DE,2022,Q1,Elderly
205874854,20587485,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,4,F,,20220323.0,20220314,20220328,EXP,,NVSC2022DE057669,NOVARTIS,,66.0,YR,,,Y,,,20220328,,MD,DE,DE,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Glomerular filtration rate abnormal,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Congestive cardiomyopathy,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,N-terminal prohormone brain natriuretic peptide increased,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Lung disorder,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899261,20589926,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 UNK,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220302.0,20220314,20220314,EXP,PL-EMA-DD-20220203-pawar_p-144421,PL-Accord-256837,ACCORD,,71.0,YR,,M,Y,,,20220314,,MD,PL,PL,2022,Q1,Elderly
205899552,20589955,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q1,Volvulus,,2022,Q1,2,F,20211230.0,20220314.0,20220314,20220316,EXP,,CA-GLAXOSMITHKLINE-CA2022044735,GLAXOSMITHKLINE,,63.0,YR,,F,Y,,,20220316,,CN,CA,CA,2022,Q1,Adult
205900231,20590023,3,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,1,I,20210101.0,20220310.0,20220314,20220314,EXP,,RU-AstraZeneca-2022A111675,ASTRAZENECA,,71.0,YR,,F,Y,165.0,KG,20220314,,HP,RU,,2022,Q1,Elderly
205900231,20590023,3,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210101.0,20220310.0,20220314,20220314,EXP,,RU-AstraZeneca-2022A111675,ASTRAZENECA,,71.0,YR,,F,Y,165.0,KG,20220314,,HP,RU,,2022,Q1,Elderly
205900241,20590024,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1310.0,MG,Y,U,2107111,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypoglycaemic coma,,2022,Q1,1,I,20220307.0,20220309.0,20220314,20220314,EXP,,CN-AstraZeneca-2022A108684,ASTRAZENECA,,29220.0,DY,,F,Y,,,20220314,,MD,CN,,2022,Q1,Elderly
205904341,20590434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,40.03,MG,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Constipation,,2022,Q1,1,I,20220225.0,20220306.0,20220314,20220314,EXP,,GB-AstraZeneca-2022A105104,ASTRAZENECA,,73.0,YR,,F,Y,,,20220314,,MD,GB,,2022,Q1,Elderly
205904341,20590434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,40.03,MG,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Back pain,,2022,Q1,1,I,20220225.0,20220306.0,20220314,20220314,EXP,,GB-AstraZeneca-2022A105104,ASTRAZENECA,,73.0,YR,,F,Y,,,20220314,,MD,GB,,2022,Q1,Elderly
205904341,20590434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,40.03,MG,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,20220225.0,20220306.0,20220314,20220314,EXP,,GB-AstraZeneca-2022A105104,ASTRAZENECA,,73.0,YR,,F,Y,,,20220314,,MD,GB,,2022,Q1,Elderly
205904341,20590434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,40.03,MG,D,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Nausea,,2022,Q1,1,I,20220225.0,20220306.0,20220314,20220314,EXP,,GB-AstraZeneca-2022A105104,ASTRAZENECA,,73.0,YR,,F,Y,,,20220314,,MD,GB,,2022,Q1,Elderly
205906811,20590681,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220110.0,20220307.0,20220314,20220314,EXP,,NVSC2022EG055792,NOVARTIS,,62.0,YR,,M,Y,,,20220314,,CN,EG,EG,2022,Q1,Adult
205906811,20590681,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q1,Tachypnoea,,2022,Q1,1,I,20220110.0,20220307.0,20220314,20220314,EXP,,NVSC2022EG055792,NOVARTIS,,62.0,YR,,M,Y,,,20220314,,CN,EG,EG,2022,Q1,Adult
205906811,20590681,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20220110.0,20220307.0,20220314,20220314,EXP,,NVSC2022EG055792,NOVARTIS,,62.0,YR,,M,Y,,,20220314,,CN,EG,EG,2022,Q1,Adult
205906811,20590681,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q1,Chest pain,,2022,Q1,1,I,20220110.0,20220307.0,20220314,20220314,EXP,,NVSC2022EG055792,NOVARTIS,,62.0,YR,,M,Y,,,20220314,,CN,EG,EG,2022,Q1,Adult
205906811,20590681,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q1,Chest discomfort,,2022,Q1,1,I,20220110.0,20220307.0,20220314,20220314,EXP,,NVSC2022EG055792,NOVARTIS,,62.0,YR,,M,Y,,,20220314,,CN,EG,EG,2022,Q1,Adult
205907141,20590714,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardioactive drug level increased,,2022,Q1,1,I,,20220312.0,20220314,20220314,EXP,GB-MHRA-MIDB-1e50bc4b-14c4-40c6-9850-fd52a9193105,NVSC2022GB058717,NOVARTIS,,79.0,YR,,M,Y,,,20220314,,PH,GB,GB,2022,Q1,Elderly
205915182,20591518,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q1,COVID-19,,2022,Q1,2,F,20220225.0,20220316.0,20220314,20220323,EXP,,CH-ROCHE-3042825,ROCHE,,69.0,YR,,M,Y,102.4,KG,20220323,,MD,CH,,2022,Q1,Elderly
205919362,20591936,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,QD,2022,Q1,Coma,,2022,Q1,2,F,20220131.0,20220315.0,20220314,20220317,EXP,,DE-EMD Serono-E2B_90087192,EMD SERONO INC,,79.0,YR,E,M,Y,65.0,KG,20220317,,MD,DE,DE,2022,Q1,Elderly
205919362,20591936,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,QD,2022,Q1,Lactic acidosis,,2022,Q1,2,F,20220131.0,20220315.0,20220314,20220317,EXP,,DE-EMD Serono-E2B_90087192,EMD SERONO INC,,79.0,YR,E,M,Y,65.0,KG,20220317,,MD,DE,DE,2022,Q1,Elderly
205925162,20592516,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,2,F,20211004.0,20220315.0,20220314,20220323,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220324,,MD,JP,JP,2022,Q1,Adult
205925162,20592516,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,2,F,20211004.0,20220315.0,20220314,20220323,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220324,,MD,JP,JP,2022,Q1,Adult
205925162,20592516,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Blood creatinine increased,,2022,Q1,2,F,20211004.0,20220315.0,20220314,20220323,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220324,,MD,JP,JP,2022,Q1,Adult
205949701,20594970,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Rhinocerebral mucormycosis,,2022,Q1,1,I,20210101.0,20220303.0,20220315,20220315,EXP,,IN-GLENMARK PHARMACEUTICALS-2022GMK071050,GLENMARK,"Aggarwal SK, Kaur U, Talda D, Pandey A, Jaiswal S, Kanakan A, et al.. Case Report: Rhino-orbital Mucormycosis Related to COVID-19: A Case Series Exploring Risk Factors.. American Journal of Tropical Medicine and Hygiene.. 2022;106 (2):566-70",33.0,YR,,M,Y,,,20220315,,MD,IN,IN,2022,Q1,Young Adult
205957201,20595720,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,Unknown,,,10.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220103.0,20220315.0,20220315,20220315,EXP,ES-AEMPS-1127043,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-159347",BOEHRINGER INGELHEIM,,80.0,YR,E,M,Y,86.0,KG,20220315,,CN,ES,ES,2022,Q1,Elderly
205957201,20595720,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,Unknown,,,10.0,MG,,QD,2022,Q1,Dermatitis bullous,,2022,Q1,1,I,20220103.0,20220315.0,20220315,20220315,EXP,ES-AEMPS-1127043,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-159347",BOEHRINGER INGELHEIM,,80.0,YR,E,M,Y,86.0,KG,20220315,,CN,ES,ES,2022,Q1,Elderly
205962031,20596203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205962031,20596203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic vascular disorder,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205962031,20596203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205962031,20596203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205962031,20596203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetic vascular disorder,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205962031,20596203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,,,2106157,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20220216.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107060,ASTRAZENECA,,88.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Elderly
205966622,20596662,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Colitis ulcerative,,2022,Q1,2,F,20220101.0,20220314.0,20220315,20220329,EXP,,NVSC2022HR058955,NOVARTIS,,49.0,YR,,M,Y,93.0,KG,20220329,,MD,HR,HR,2022,Q1,Adult
205966622,20596662,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,2,F,20220101.0,20220314.0,20220315,20220329,EXP,,NVSC2022HR058955,NOVARTIS,,49.0,YR,,M,Y,93.0,KG,20220329,,MD,HR,HR,2022,Q1,Adult
205966622,20596662,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,2,F,20220101.0,20220314.0,20220315,20220329,EXP,,NVSC2022HR058955,NOVARTIS,,49.0,YR,,M,Y,93.0,KG,20220329,,MD,HR,HR,2022,Q1,Adult
205966622,20596662,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cough,,2022,Q1,2,F,20220101.0,20220314.0,20220315,20220329,EXP,,NVSC2022HR058955,NOVARTIS,,49.0,YR,,M,Y,93.0,KG,20220329,,MD,HR,HR,2022,Q1,Adult
205977561,20597756,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,,20220310.0,20220315,20220315,EXP,,DE-AstraZeneca-2022A110329,ASTRAZENECA,,87.0,YR,,F,Y,,,20220315,,MD,DE,,2022,Q1,Elderly
205989451,20598945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,,2106017,,202293.0,20.0,MG,Tablet,BID,2022,Q1,Overdose,,2022,Q1,1,I,20220120.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107048,ASTRAZENECA,,32.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Young Adult
205989451,20598945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,,2106017,,202293.0,20.0,MG,Tablet,BID,2022,Q1,Ketosis,,2022,Q1,1,I,20220120.0,20220308.0,20220315,20220315,EXP,,CN-AstraZeneca-2022A107048,ASTRAZENECA,,32.0,YR,,F,Y,,,20220315,,MD,CN,,2022,Q1,Young Adult
206017972,20601797,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q1,Osteitis,,2022,Q1,2,F,20220207.0,20220316.0,20220316,20220324,EXP,,FR-AstraZeneca-2022A107502,ASTRAZENECA,,71.0,YR,,M,Y,84.7,KG,20220324,,MD,FR,,2022,Q1,Elderly
206017972,20601797,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q1,Toe amputation,,2022,Q1,2,F,20220207.0,20220316.0,20220316,20220324,EXP,,FR-AstraZeneca-2022A107502,ASTRAZENECA,,71.0,YR,,M,Y,84.7,KG,20220324,,MD,FR,,2022,Q1,Elderly
206028861,20602886,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,RR982,,202293.0,5.0,MG,,QD,2022,Q1,Palpitations,,2022,Q1,1,I,,20220308.0,20220316,20220316,EXP,,GB-AstraZeneca-2022A110249,ASTRAZENECA,,56.0,YR,,M,Y,,,20220316,,MD,GB,,2022,Q1,Adult
206028861,20602886,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,RR982,,202293.0,5.0,MG,,QD,2022,Q1,Tachycardia,,2022,Q1,1,I,,20220308.0,20220316,20220316,EXP,,GB-AstraZeneca-2022A110249,ASTRAZENECA,,56.0,YR,,M,Y,,,20220316,,MD,GB,,2022,Q1,Adult
206028861,20602886,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,RR982,,202293.0,5.0,MG,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220308.0,20220316,20220316,EXP,,GB-AstraZeneca-2022A110249,ASTRAZENECA,,56.0,YR,,M,Y,,,20220316,,MD,GB,,2022,Q1,Adult
206041651,20604165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cutaneous vasculitis,,2022,Q1,1,I,20220225.0,20220308.0,20220316,20220316,EXP,,ES-AstraZeneca-2022A104002,ASTRAZENECA,,83.0,YR,,F,Y,,,20220316,,MD,ES,,2022,Q1,Elderly
206047231,20604723,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20220105.0,20220315.0,20220317,20220317,EXP,,FR-AstraZeneca-2022A112904,ASTRAZENECA,,80.0,YR,,M,Y,,,20220317,,MD,FR,,2022,Q1,Elderly
206048721,20604872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q1,Dizziness,,2022,Q1,1,I,,20220308.0,20220317,20220317,EXP,,CA-AstraZeneca-2022A108709,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,CA,,2022,Q1,Elderly
206048721,20604872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,,20220308.0,20220317,20220317,EXP,,CA-AstraZeneca-2022A108709,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,CA,,2022,Q1,Elderly
206068911,20606891,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg once a day.; ;,,,Y,,,,,,,Tablet,,2022,Q1,Balanitis candida,,2022,Q1,1,I,20220115.0,20220306.0,20220317,20220317,EXP,GB-MHRA-ADR 26687116,GB-Accord-257315,ACCORD,,60.0,YR,,M,Y,102.0,KG,20220317,,CN,GB,GB,2022,Q1,Adult
206072041,20607204,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg once a day,,,Y,,,,,,,Tablet,,2022,Q1,Balanitis candida,,2022,Q1,1,I,20220115.0,20220307.0,20220317,20220317,EXP,GB-MHRA-MED-202203042140570370-UUENV,GB-MICRO LABS LIMITED-ML2022-00869,MICRO LABS,,60.0,YR,A,M,Y,102.0,KG,20220317,,CN,GB,,2022,Q1,Adult
206085641,20608564,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,KL2824B,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Anxiety,,2022,Q1,1,I,20220306.0,20220311.0,20220317,20220317,EXP,,CN-AstraZeneca-2022A113680,ASTRAZENECA,,80.0,YR,,F,Y,,,20220317,,MD,CN,,2022,Q1,Elderly
206085641,20608564,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,KL2824B,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Restlessness,,2022,Q1,1,I,20220306.0,20220311.0,20220317,20220317,EXP,,CN-AstraZeneca-2022A113680,ASTRAZENECA,,80.0,YR,,F,Y,,,20220317,,MD,CN,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Dizziness,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Fall,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Dehydration,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Weight decreased,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Decreased appetite,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206088471,20608847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Malaise,,2022,Q1,1,I,20211023.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A793261,ASTRAZENECA,,77.0,YR,,F,Y,,,20220317,,MD,JP,,2022,Q1,Elderly
206091401,20609140,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Systemic candida,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Systemic candida,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Dehydration,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Systemic candida,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Dehydration,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Systemic candida,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091401,20609140,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20210101.0,20220309.0,20220317,20220317,EXP,,JP-AstraZeneca-2021A825583,ASTRAZENECA,,93.0,YR,,F,Y,41.0,KG,20220317,,PH,JP,,2022,Q1,Elderly
206091941,20609194,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2022,Q1,Coronary artery stenosis,,2022,Q1,1,I,,20220310.0,20220317,20220317,EXP,,JP-DSJP-DSJ-2022-108844,DAIICHI,,80.0,YR,,M,Y,67.0,KG,20220317,,MD,JP,JP,2022,Q1,Elderly
206091941,20609194,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2022,Q1,Chest pain,,2022,Q1,1,I,,20220310.0,20220317,20220317,EXP,,JP-DSJP-DSJ-2022-108844,DAIICHI,,80.0,YR,,M,Y,67.0,KG,20220317,,MD,JP,JP,2022,Q1,Elderly
206092121,20609212,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q1,Arteriosclerosis coronary artery,,2022,Q1,1,I,20211001.0,20220311.0,20220317,20220317,EXP,,NVSC2022ME059602,NOVARTIS,,66.0,YR,,M,Y,,,20220317,,MD,ME,ME,2022,Q1,Elderly
206093131,20609313,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220310.0,20220317,20220317,EXP,,JP-AstraZeneca-2022A112170,ASTRAZENECA,,55.0,YR,,F,Y,,,20220318,,MD,JP,,2022,Q1,Adult
206096291,20609629,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2022A112338,ASTRAZENECA,,37.0,YR,,M,Y,,,20220318,,MD,JP,,2022,Q1,Adult
206096291,20609629,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Adrenal insufficiency,,2022,Q1,1,I,,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2022A112338,ASTRAZENECA,,37.0,YR,,M,Y,,,20220318,,MD,JP,,2022,Q1,Adult
206100261,20610026,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,,QD,2022,Q1,Coma,,2022,Q1,1,I,20220131.0,20220305.0,20220318,20220318,EXP,,DE-AUROBINDO-AUR-APL-2022-008027,AUROBINDO,,79.0,YR,,M,Y,65.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
206100261,20610026,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,,QD,2022,Q1,Lactic acidosis,,2022,Q1,1,I,20220131.0,20220305.0,20220318,20220318,EXP,,DE-AUROBINDO-AUR-APL-2022-008027,AUROBINDO,,79.0,YR,,M,Y,65.0,KG,20220318,,MD,DE,DE,2022,Q1,Elderly
206105101,20610510,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Torsade de pointes,,2022,Q1,1,I,,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2022A112137,ASTRAZENECA,,52.0,YR,,F,Y,,,20220318,,MD,JP,,2022,Q1,Adult
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Tubulointerstitial nephritis,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Proteinuria,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Pain,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Weight decreased,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Body temperature increased,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206117261,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,20210610.0,20220310.0,20220318,20220318,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220318,,MD,JP,,2022,Q1,Elderly
206119281,20611928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebrovascular accident,,2022,Q1,1,I,,20220315.0,20220318,20220318,EXP,,RU-AstraZeneca-2022A116222,ASTRAZENECA,,60.0,YR,,M,Y,60.0,KG,20220318,,HP,RU,,2022,Q1,Adult
206119281,20611928,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Infarction,,2022,Q1,1,I,,20220315.0,20220318,20220318,EXP,,RU-AstraZeneca-2022A116222,ASTRAZENECA,,60.0,YR,,M,Y,60.0,KG,20220318,,HP,RU,,2022,Q1,Adult
206120091,20612009,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220311.0,20220318,20220318,EXP,,DE-PFIZER INC-202200400635,PFIZER,,66.0,YR,,,Y,,,20220318,,MD,DE,DE,2022,Q1,Elderly
206120091,20612009,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,,20220311.0,20220318,20220318,EXP,,DE-PFIZER INC-202200400635,PFIZER,,66.0,YR,,,Y,,,20220318,,MD,DE,DE,2022,Q1,Elderly
206125662,20612566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Death,,2022,Q1,2,F,,20220321.0,20220318,20220325,EXP,,FR-AstraZeneca-2022A117402,ASTRAZENECA,,74.0,YR,,M,Y,,,20220325,,PH,FR,,2022,Q1,Elderly
206125662,20612566,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Malaise,,2022,Q1,2,F,,20220321.0,20220318,20220325,EXP,,FR-AstraZeneca-2022A117402,ASTRAZENECA,,74.0,YR,,M,Y,,,20220325,,PH,FR,,2022,Q1,Elderly
206129213,20612921,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,3,F,,20220325.0,20220318,20220330,EXP,,DE-009507513-2203DEU004420,MERCK,,66.0,YR,,,Y,,,20220330,,MD,DE,DE,2022,Q1,Elderly
206129213,20612921,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q1,Acute myocardial infarction,,2022,Q1,3,F,,20220325.0,20220318,20220330,EXP,,DE-009507513-2203DEU004420,MERCK,,66.0,YR,,,Y,,,20220330,,MD,DE,DE,2022,Q1,Elderly
206145221,20614522,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10mg once a day, UNK",,,Y,U,,,,,,Tablet,,2022,Q1,Balanitis candida,,2022,Q1,1,I,20220115.0,20220306.0,20220321,20220321,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-330189,RANBAXY,,60.0,YR,,M,Y,102.0,KG,20220321,,CN,GB,GB,2022,Q1,Adult
206146821,20614682,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,Unknown,,,,,,,2022,Q1,Gastrointestinal disorder,,2022,Q1,1,I,,20220308.0,20220321,20220321,EXP,,US-RISINGPHARMA-US-2022RISLIT00266,RISING PHARMACEUTICALS,A Kankam.Chronic diarrhea with significant weight loss due to olmesartan induced enteropathy.Journal of Investigative Medicine.FEB-2022;70(No.2):502,54.0,YR,A,M,Y,,,20220321,,HP,US,US,2022,Q1,Adult
206176791,20617679,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; strength : 10 mg , 28 tablet Acute Medication Prescribed.",,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Cardioactive drug level increased,,2022,Q1,1,I,,20220312.0,20220321,20220321,EXP,GB-MHRA-MIDB-1e50bc4b-14c4-40c6-9850-fd52a9193105,GB-TEVA-2022-GB-2018001,TEVA,,79.0,YR,E,M,Y,,,20220321,,PH,GB,GB,2022,Q1,Elderly
206187651,20618765,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Medication error,,2022,Q1,1,I,20220305.0,20220309.0,20220322,20220322,EXP,,GB-AUROBINDO-AUR-APL-2022-008831,AUROBINDO,,71.0,YR,,M,Y,,,20220322,,HP,GB,GB,2022,Q1,Elderly
206187651,20618765,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hepatic ischaemia,,2022,Q1,1,I,20220305.0,20220309.0,20220322,20220322,EXP,,GB-AUROBINDO-AUR-APL-2022-008831,AUROBINDO,,71.0,YR,,M,Y,,,20220322,,HP,GB,GB,2022,Q1,Elderly
206188641,20618864,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20210705.0,20220309.0,20220322,20220322,EXP,,DE-AUROBINDO-AUR-APL-2022-008694,AUROBINDO,,66.0,YR,,,Y,,,20220322,,MD,DE,DE,2022,Q1,Elderly
206188641,20618864,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,20210705.0,20220309.0,20220322,20220322,EXP,,DE-AUROBINDO-AUR-APL-2022-008694,AUROBINDO,,66.0,YR,,,Y,,,20220322,,MD,DE,DE,2022,Q1,Elderly
206216501,20621650,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNK,,2022,Q1,Acute myocardial infarction,,2022,Q1,1,I,,20220315.0,20220322,20220322,EXP,DE-AstraZeneca-2022A095638,DE-TORRENT-00022198,TORRENT,,66.0,YR,E,,Y,,,20220322,,MD,DE,DE,2022,Q1,Elderly
206216501,20621650,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,UNK,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,,20220315.0,20220322,20220322,EXP,DE-AstraZeneca-2022A095638,DE-TORRENT-00022198,TORRENT,,66.0,YR,E,,Y,,,20220322,,MD,DE,DE,2022,Q1,Elderly
206217031,20621703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,380.0,MG,Y,,2105214,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Pancreatitis acute,,2022,Q1,1,I,20220311.0,20220315.0,20220322,20220322,EXP,,CN-AstraZeneca-2022A116611,ASTRAZENECA,,20236.0,DY,,F,Y,65.0,KG,20220322,,MD,CN,,2022,Q1,Elderly
206217031,20621703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,380.0,MG,Y,,2105214,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Condition aggravated,,2022,Q1,1,I,20220311.0,20220315.0,20220322,20220322,EXP,,CN-AstraZeneca-2022A116611,ASTRAZENECA,,20236.0,DY,,F,Y,65.0,KG,20220322,,MD,CN,,2022,Q1,Elderly
206217031,20621703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,380.0,MG,Y,,2105214,,202293.0,10.0,MG,Tablet,BID,2022,Q1,Pulmonary embolism,,2022,Q1,1,I,20220311.0,20220315.0,20220322,20220322,EXP,,CN-AstraZeneca-2022A116611,ASTRAZENECA,,20236.0,DY,,F,Y,65.0,KG,20220322,,MD,CN,,2022,Q1,Elderly
206219491,20621949,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,N,D,,,,,,,,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20220228.0,,20220321,20220321,DIR,607686,,FDA-CTU,,60.0,YR,,M,N,92.0,KG,20220321,N,MD,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Dysuria,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Abdominal discomfort,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Haematochezia,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Misleading laboratory test result,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Anal pruritus,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Penile pain,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Anorectal discomfort,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206220701,20622070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,N80139,20240101.0,99.0,,,Tablets,,2022,Q1,Frustration tolerance decreased,,2022,Q1,1,I,,,20220321,20220321,DIR,607722,,FDA-CTU,,42.0,YR,,M,N,91.35,KG,20220321,Y,CN,US,,2022,Q1,Adult
206231961,20623196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20211101.0,20220314.0,20220322,20220322,EXP,,JP-AstraZeneca-2022A077465,ASTRAZENECA,,72.0,YR,,M,Y,63.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
206231961,20623196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dehydration,,2022,Q1,1,I,20211101.0,20220314.0,20220322,20220322,EXP,,JP-AstraZeneca-2022A077465,ASTRAZENECA,,72.0,YR,,M,Y,63.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
206231961,20623196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal failure,,2022,Q1,1,I,20211101.0,20220314.0,20220322,20220322,EXP,,JP-AstraZeneca-2022A077465,ASTRAZENECA,,72.0,YR,,M,Y,63.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
206231961,20623196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1070.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Diabetes mellitus,,2022,Q1,1,I,20211101.0,20220314.0,20220322,20220322,EXP,,JP-AstraZeneca-2022A077465,ASTRAZENECA,,72.0,YR,,M,Y,63.0,KG,20220322,,MD,JP,,2022,Q1,Elderly
206260421,20626042,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220321.0,20220323,20220323,EXP,,JP-009507513-2203JPN007256,MERCK,,82.0,YR,,M,Y,,,20220323,,MD,JP,JP,2022,Q1,Elderly
206264471,20626447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebrovascular accident,,2022,Q1,1,I,20220101.0,20220315.0,20220323,20220323,EXP,,FR-AstraZeneca-2022A119242,ASTRAZENECA,,781.0,MON,,F,Y,,,20220323,,CN,FR,,2022,Q1,Elderly
206264471,20626447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Off label use,,2022,Q1,1,I,20220101.0,20220315.0,20220323,20220323,EXP,,FR-AstraZeneca-2022A119242,ASTRAZENECA,,781.0,MON,,F,Y,,,20220323,,CN,FR,,2022,Q1,Elderly
206264471,20626447,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dizziness,,2022,Q1,1,I,20220101.0,20220315.0,20220323,20220323,EXP,,FR-AstraZeneca-2022A119242,ASTRAZENECA,,781.0,MON,,F,Y,,,20220323,,CN,FR,,2022,Q1,Elderly
206282272,20628227,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,2,F,20220101.0,20220318.0,20220323,20220325,EXP,,CA-ROCHE-3055597,ROCHE,,43.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Adult
206286271,20628627,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Tablet,,,10.0,MG,,QD,2022,Q1,Cardiac failure chronic,,2022,Q1,1,I,20210101.0,20220310.0,20220323,20220323,EXP,,RU-TOPROL-2022000092,TOPROL ACQUISITION,,71.0,YR,E,F,Y,165.0,KG,20220323,,HP,RU,RU,2022,Q1,Elderly
206286271,20628627,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Tablet,,,10.0,MG,,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,20210101.0,20220310.0,20220323,20220323,EXP,,RU-TOPROL-2022000092,TOPROL ACQUISITION,,71.0,YR,E,F,Y,165.0,KG,20220323,,HP,RU,RU,2022,Q1,Elderly
206286271,20628627,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Tablet,,,10.0,MG,,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,1,I,20210101.0,20220310.0,20220323,20220323,EXP,,RU-TOPROL-2022000092,TOPROL ACQUISITION,,71.0,YR,E,F,Y,165.0,KG,20220323,,HP,RU,RU,2022,Q1,Elderly
206292031,20629203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 TABLET every day,,,,,,,202293.0,,,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20200728.0,20220318.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A118004,ASTRAZENECA,,76.0,YR,,F,Y,74.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206292031,20629203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 TABLET every day,,,,,,,202293.0,,,Tablet,QD,2022,Q1,Creatinine renal clearance decreased,,2022,Q1,1,I,20200728.0,20220318.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A118004,ASTRAZENECA,,76.0,YR,,F,Y,74.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206292031,20629203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 TABLET every day,,,,,,,202293.0,,,Tablet,QD,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20200728.0,20220318.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A118004,ASTRAZENECA,,76.0,YR,,F,Y,74.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206292031,20629203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 TABLET every day,,,,,,,202293.0,,,Tablet,QD,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20200728.0,20220318.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A118004,ASTRAZENECA,,76.0,YR,,F,Y,74.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206296241,20629624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,0-1-0,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Diarrhoea,,2022,Q1,1,I,20220103.0,20220316.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A114546,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206296241,20629624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,0-1-0,10.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q1,Dermatitis bullous,,2022,Q1,1,I,20220103.0,20220316.0,20220323,20220323,EXP,,ES-AstraZeneca-2022A114546,ASTRAZENECA,,80.0,YR,,M,Y,86.0,KG,20220323,,MD,ES,,2022,Q1,Elderly
206303491,20630349,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q1,Coma,,2022,Q1,1,I,20220131.0,20220314.0,20220324,20220324,EXP,,DE-TEVA-2022-DE-2018352,TEVA,,79.0,YR,E,M,Y,65.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206303491,20630349,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q1,Lactic acidosis,,2022,Q1,1,I,20220131.0,20220314.0,20220324,20220324,EXP,,DE-TEVA-2022-DE-2018352,TEVA,,79.0,YR,E,M,Y,65.0,KG,20220324,,MD,DE,DE,2022,Q1,Elderly
206303511,20630351,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q1,Myalgia,,2022,Q1,1,I,20211201.0,20220314.0,20220324,20220324,EXP,DK-DKMA-WBS-0097039,DK-TEVA-2022-DK-2018530,TEVA,,76.0,YR,E,F,Y,,,20220324,,MD,DK,DK,2022,Q1,Elderly
206303511,20630351,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,1,I,20211201.0,20220314.0,20220324,20220324,EXP,DK-DKMA-WBS-0097039,DK-TEVA-2022-DK-2018530,TEVA,,76.0,YR,E,F,Y,,,20220324,,MD,DK,DK,2022,Q1,Elderly
206303511,20630351,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q1,Blood creatine phosphokinase increased,,2022,Q1,1,I,20211201.0,20220314.0,20220324,20220324,EXP,DK-DKMA-WBS-0097039,DK-TEVA-2022-DK-2018530,TEVA,,76.0,YR,E,F,Y,,,20220324,,MD,DK,DK,2022,Q1,Elderly
206303511,20630351,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q1,Hepatitis toxic,,2022,Q1,1,I,20211201.0,20220314.0,20220324,20220324,EXP,DK-DKMA-WBS-0097039,DK-TEVA-2022-DK-2018530,TEVA,,76.0,YR,E,F,Y,,,20220324,,MD,DK,DK,2022,Q1,Elderly
206306961,20630696,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20190101.0,20220320.0,20220324,20220324,EXP,,FI-BAUSCH-BL-2022-007267,BAUSCH AND LOMB,,49.0,YR,,F,Y,,,20220324,,CN,FI,FI,2022,Q1,Adult
206322751,20632275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Cough,,2022,Q1,1,I,20220101.0,20220316.0,20220324,20220324,EXP,,HR-AstraZeneca-2022A114528,ASTRAZENECA,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,,2022,Q1,Adult
206322751,20632275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220101.0,20220316.0,20220324,20220324,EXP,,HR-AstraZeneca-2022A114528,ASTRAZENECA,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,,2022,Q1,Adult
206322751,20632275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220101.0,20220316.0,20220324,20220324,EXP,,HR-AstraZeneca-2022A114528,ASTRAZENECA,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,,2022,Q1,Adult
206322751,20632275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,10.0,MG,,,2022,Q1,Colitis ulcerative,,2022,Q1,1,I,20220101.0,20220316.0,20220324,20220324,EXP,,HR-AstraZeneca-2022A114528,ASTRAZENECA,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,,2022,Q1,Adult
206323241,20632324,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada d?a,,,D,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,20200728.0,20220321.0,20220324,20220324,EXP,ES-AEMPS-793628,NVSC2022ES065006,NOVARTIS,,76.0,YR,,F,Y,74.0,KG,20220324,,PH,ES,ES,2022,Q1,Elderly
206323241,20632324,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada d?a,,,D,,,,,,,,,2022,Q1,Creatinine renal clearance decreased,,2022,Q1,1,I,20200728.0,20220321.0,20220324,20220324,EXP,ES-AEMPS-793628,NVSC2022ES065006,NOVARTIS,,76.0,YR,,F,Y,74.0,KG,20220324,,PH,ES,ES,2022,Q1,Elderly
206323241,20632324,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada d?a,,,D,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20200728.0,20220321.0,20220324,20220324,EXP,ES-AEMPS-793628,NVSC2022ES065006,NOVARTIS,,76.0,YR,,F,Y,74.0,KG,20220324,,PH,ES,ES,2022,Q1,Elderly
206323241,20632324,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada d?a,,,D,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,1,I,20200728.0,20220321.0,20220324,20220324,EXP,ES-AEMPS-793628,NVSC2022ES065006,NOVARTIS,,76.0,YR,,F,Y,74.0,KG,20220324,,PH,ES,ES,2022,Q1,Elderly
206323771,20632377,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,Unknown,,,10.0,MG,,,2022,Q1,Colitis ulcerative,,2022,Q1,1,I,20220101.0,20220314.0,20220324,20220324,EXP,,HR-PFIZER INC-202200404465,PFIZER,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,HR,2022,Q1,Adult
206323771,20632377,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,Unknown,,,10.0,MG,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220101.0,20220314.0,20220324,20220324,EXP,,HR-PFIZER INC-202200404465,PFIZER,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,HR,2022,Q1,Adult
206323771,20632377,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,Unknown,,,10.0,MG,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,20220101.0,20220314.0,20220324,20220324,EXP,,HR-PFIZER INC-202200404465,PFIZER,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,HR,2022,Q1,Adult
206323771,20632377,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,Unknown,,,10.0,MG,,,2022,Q1,Cough,,2022,Q1,1,I,20220101.0,20220314.0,20220324,20220324,EXP,,HR-PFIZER INC-202200404465,PFIZER,,49.0,YR,,M,Y,93.0,KG,20220324,,MD,HR,HR,2022,Q1,Adult
206330091,20633009,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,Film-coated tablet,QD,2022,Q1,Potentiating drug interaction,,2022,Q1,1,I,20211117.0,20220314.0,20220324,20220324,EXP,FR-AFSSAPS-MP20221326,FR-PFIZER INC-202200404697,PFIZER,,69.0,YR,,M,Y,73.5,KG,20220324,,PH,FR,FR,2022,Q1,Elderly
206330091,20633009,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,Film-coated tablet,QD,2022,Q1,Pleural effusion,,2022,Q1,1,I,20211117.0,20220314.0,20220324,20220324,EXP,FR-AFSSAPS-MP20221326,FR-PFIZER INC-202200404697,PFIZER,,69.0,YR,,M,Y,73.5,KG,20220324,,PH,FR,FR,2022,Q1,Elderly
206330091,20633009,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Film-coated tablet,,2022,Q1,Potentiating drug interaction,,2022,Q1,1,I,20211117.0,20220314.0,20220324,20220324,EXP,FR-AFSSAPS-MP20221326,FR-PFIZER INC-202200404697,PFIZER,,69.0,YR,,M,Y,73.5,KG,20220324,,PH,FR,FR,2022,Q1,Elderly
206330091,20633009,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Film-coated tablet,,2022,Q1,Pleural effusion,,2022,Q1,1,I,20211117.0,20220314.0,20220324,20220324,EXP,FR-AFSSAPS-MP20221326,FR-PFIZER INC-202200404697,PFIZER,,69.0,YR,,M,Y,73.5,KG,20220324,,PH,FR,FR,2022,Q1,Elderly
206332121,20633212,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q1,Anaemia,,2022,Q1,1,I,20210925.0,20220321.0,20220324,20220324,EXP,,GB-AstraZeneca-2021A750354,ASTRAZENECA,,20571.0,DY,,F,Y,,,20220324,,MD,GB,,2022,Q1,Elderly
206335041,20633504,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20190101.0,20220321.0,20220324,20220324,EXP,,NVSC2022FI064853,NOVARTIS,,49.0,YR,,F,Y,,,20220324,,CN,FI,FI,2022,Q1,Adult
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Thirst,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Back pain,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Myalgia,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Mobility decreased,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dysuria,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gait disturbance,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Systemic lupus erythematosus,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206340531,20634053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,started around 2 months ago,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Emotional disorder,,2022,Q1,1,I,20220313.0,20220318.0,20220324,20220324,EXP,,CA-AstraZeneca-2022A122937,ASTRAZENECA,,73.0,YR,,F,Y,,,20220325,,CN,CA,,2022,Q1,Elderly
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Body mass index increased,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Postprandial hypoglycaemia,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Latent autoimmune diabetes in adults,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206342981,20634298,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,Y,,,,,5.0,MG,,QD,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220311.0,20220325,20220325,EXP,,PT-AUROBINDO-AUR-APL-2019-017859,AUROBINDO,"Guiomar JR, Moreno C, Paiva I, Cardoso LM, Cunha N, Catarino D et al. Metabolic surgery as an option in the treatment of diabetes mellitus in selected cases. Revista Portuguesa de Diabetes. 2019;14 (1):47-122",52.0,YR,,F,Y,,,20220325,,HP,PT,PT,2022,Q1,Adult
206349211,20634921,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q1,Left ventricular dysfunction,,2022,Q1,1,I,20211101.0,20220318.0,20220325,20220325,PER,FR-AFSSAPS-CN20220481,FR-AMGEN-FRASP2022049209,AMGEN,,65.0,YR,E,M,Y,102.0,KG,20220325,,MD,FR,FR,2022,Q1,Elderly
206353151,20635315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,460.0,MG,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q1,Budd-Chiari syndrome,,2022,Q1,1,I,20220303.0,20220317.0,20220325,20220325,EXP,,ZA-AstraZeneca-2022A120566,ASTRAZENECA,,53.0,YR,,F,Y,,,20220325,,HP,ZA,,2022,Q1,Adult
206353181,20635318,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Toxic skin eruption,,2022,Q1,1,I,20220203.0,20220318.0,20220325,20220325,EXP,,JP-AstraZeneca-2022A122269,ASTRAZENECA,,90.0,YR,,M,Y,35.0,KG,20220325,,MD,JP,,2022,Q1,Elderly
206356251,20635625,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q1,Chest pain,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,CA-MHPD-E2B_03717833,CA-Accord-258010,ACCORD,,71.0,YR,,M,Y,,,20220325,,CN,CA,CA,2022,Q1,Elderly
206356251,20635625,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q1,Arteriosclerosis coronary artery,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,CA-MHPD-E2B_03717833,CA-Accord-258010,ACCORD,,71.0,YR,,M,Y,,,20220325,,CN,CA,CA,2022,Q1,Elderly
206356251,20635625,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q1,Pneumonia,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,CA-MHPD-E2B_03717833,CA-Accord-258010,ACCORD,,71.0,YR,,M,Y,,,20220325,,CN,CA,CA,2022,Q1,Elderly
206356251,20635625,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,CA-MHPD-E2B_03717833,CA-Accord-258010,ACCORD,,71.0,YR,,M,Y,,,20220325,,CN,CA,CA,2022,Q1,Elderly
206360401,20636040,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Coated tablet,QD,2022,Q1,Metabolic acidosis,,2022,Q1,1,I,20220121.0,20220318.0,20220325,20220325,EXP,FR-AFSSAPS-AM20220348,FR-MYLANLABS-2022M1021139,MYLAN,,55.0,YR,,M,Y,70.0,KG,20220325,,PH,FR,FR,2022,Q1,Adult
206360401,20636040,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Coated tablet,QD,2022,Q1,Rash,,2022,Q1,1,I,20220121.0,20220318.0,20220325,20220325,EXP,FR-AFSSAPS-AM20220348,FR-MYLANLABS-2022M1021139,MYLAN,,55.0,YR,,M,Y,70.0,KG,20220325,,PH,FR,FR,2022,Q1,Adult
206361711,20636171,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,Tablet,,2022,Q1,Cardioactive drug level increased,,2022,Q1,1,I,,20220312.0,20220325,20220325,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-330343,RANBAXY,,79.0,YR,,M,Y,,,20220325,,PH,GB,GB,2022,Q1,Elderly
206370541,20637054,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ketosis,,2022,Q1,1,I,20220302.0,20220317.0,20220325,20220325,EXP,,CN-AstraZeneca-2022A120142,ASTRAZENECA,,50.0,YR,,M,Y,70.0,KG,20220325,,MD,CN,,2022,Q1,Adult
206378201,20637820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hypermetropia,,2022,Q1,1,I,20220226.0,20220317.0,20220325,20220325,EXP,,TR-AstraZeneca-2022A121912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220325,,CN,TR,,2022,Q1,Elderly
206378201,20637820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Vision blurred,,2022,Q1,1,I,20220226.0,20220317.0,20220325,20220325,EXP,,TR-AstraZeneca-2022A121912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220325,,CN,TR,,2022,Q1,Elderly
206378201,20637820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Ocular hyperaemia,,2022,Q1,1,I,20220226.0,20220317.0,20220325,20220325,EXP,,TR-AstraZeneca-2022A121912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220325,,CN,TR,,2022,Q1,Elderly
206378221,20637822,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Take one daily,,,U,,,,202293.0,,,,,2022,Q1,Haematuria,,2022,Q1,1,I,20220316.0,20220318.0,20220325,20220325,EXP,,GB-AstraZeneca-2022A119482,ASTRAZENECA,,77.0,YR,,M,Y,91.0,KG,20220325,,MD,GB,,2022,Q1,Elderly
206378221,20637822,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5mg tablets5.0mg UNKNOWN,,,U,,,,,5.0,MG,Tablet,,2022,Q1,Haematuria,,2022,Q1,1,I,20220316.0,20220318.0,20220325,20220325,EXP,,GB-AstraZeneca-2022A119482,ASTRAZENECA,,77.0,YR,,M,Y,91.0,KG,20220325,,MD,GB,,2022,Q1,Elderly
206378511,20637851,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20220322.0,20220325,20220325,EXP,,CA-TAKEDA-2021TUS036001,TAKEDA,,62.0,YR,,F,Y,,,20220325,,CN,CA,CA,2022,Q1,Adult
206378511,20637851,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Frequent bowel movements,,2022,Q1,1,I,,20220322.0,20220325,20220325,EXP,,CA-TAKEDA-2021TUS036001,TAKEDA,,62.0,YR,,F,Y,,,20220325,,CN,CA,CA,2022,Q1,Adult
206378511,20637851,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Colitis ulcerative,,2022,Q1,1,I,,20220322.0,20220325,20220325,EXP,,CA-TAKEDA-2021TUS036001,TAKEDA,,62.0,YR,,F,Y,,,20220325,,CN,CA,CA,2022,Q1,Adult
206378641,20637864,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gout,,2022,Q1,1,I,20211001.0,20220318.0,20220325,20220325,EXP,,DK-AstraZeneca-2022A117951,ASTRAZENECA,,66.0,YR,,F,Y,70.0,KG,20220325,,MD,DK,,2022,Q1,Elderly
206379041,20637904,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,D,U,,,,10.0,MG,Film-coated tablet,QD,2022,Q1,Pulmonary hypertension,,2022,Q1,1,I,20180104.0,20220321.0,20220325,20220325,EXP,FR-AFSSAPS-PV20220175,FR-MYLANLABS-2022M1021917,MYLAN,,72.0,YR,,M,Y,76.0,KG,20220325,,CN,FR,FR,2022,Q1,Elderly
206379581,20637958,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Left ventricular hypertrophy,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,DE-AstraZeneca-2022A122422,ASTRAZENECA,,76.0,YR,,M,Y,,,20220325,,MD,DE,,2022,Q1,Elderly
206379581,20637958,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Amyloidosis,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,DE-AstraZeneca-2022A122422,ASTRAZENECA,,76.0,YR,,M,Y,,,20220325,,MD,DE,,2022,Q1,Elderly
206380121,20638012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (10 mg),,,D,,,,,10.0,MG,,,2022,Q1,Death,,2022,Q1,1,I,,20220323.0,20220325,20220325,EXP,,FR-MYLANLABS-2022M1022245,MYLAN,,85.0,YR,,M,Y,,,20220325,,MD,FR,FR,2022,Q1,Elderly
206380121,20638012,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (10 mg),,,D,,,,,10.0,MG,,,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220323.0,20220325,20220325,EXP,,FR-MYLANLABS-2022M1022245,MYLAN,,85.0,YR,,M,Y,,,20220325,,MD,FR,FR,2022,Q1,Elderly
206380911,20638091,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,330.0,MG,Y,,NA3042,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Blood ketone body increased,,2022,Q1,1,I,20220307.0,20220317.0,20220325,20220325,EXP,,CN-AstraZeneca-2022A120185,ASTRAZENECA,,48.0,YR,,M,Y,,,20220325,,MD,CN,,2022,Q1,Adult
206384451,20638445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,COVID-19,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,,RU-AstraZeneca-2022A122244,ASTRAZENECA,,60.0,YR,,M,Y,125.0,KG,20220325,,HP,RU,,2022,Q1,Adult
206384451,20638445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,COVID-19 pneumonia,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,,RU-AstraZeneca-2022A122244,ASTRAZENECA,,60.0,YR,,M,Y,125.0,KG,20220325,,HP,RU,,2022,Q1,Adult
206384451,20638445,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,Y,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Scrotal oedema,,2022,Q1,1,I,,20220317.0,20220325,20220325,EXP,,RU-AstraZeneca-2022A122244,ASTRAZENECA,,60.0,YR,,M,Y,125.0,KG,20220325,,HP,RU,,2022,Q1,Adult
206384681,20638468,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q1,Ejection fraction decreased,,2022,Q1,1,I,20220104.0,20220314.0,20220325,20220325,EXP,,FR-PFIZER INC-202200076260,PFIZER,,54.0,YR,,M,Y,76.0,KG,20220325,,MD,FR,FR,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Cardiovascular disorder,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Back pain,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Neuropathy peripheral,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Swollen tongue,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Excessive cerumen production,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Rash,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Hypoaesthesia,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Pericarditis,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Herpes zoster,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Cerebrovascular accident,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Inflammation,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206385611,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,,20220318.0,20220325,20220325,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220325,,HP,CA,CA,2022,Q1,Adult
206391121,20639112,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Ventricular tachycardia,,2022,Q1,1,I,,20220320.0,20220326,20220326,EXP,,NVSC2022RS065989,NOVARTIS,,59.0,YR,,M,Y,,,20220326,,MD,RS,RS,2022,Q1,Adult
206391121,20639112,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Cardiac tamponade,,2022,Q1,1,I,,20220320.0,20220326,20220326,EXP,,NVSC2022RS065989,NOVARTIS,,59.0,YR,,M,Y,,,20220326,,MD,RS,RS,2022,Q1,Adult
206391121,20639112,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q1,Blood pressure systolic decreased,,2022,Q1,1,I,,20220320.0,20220326,20220326,EXP,,NVSC2022RS065989,NOVARTIS,,59.0,YR,,M,Y,,,20220326,,MD,RS,RS,2022,Q1,Adult
206392691,20639269,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",192.308,MG,U,,,,,10.0,MG,,QD,2022,Q1,Dermatitis exfoliative generalised,,2022,Q1,1,I,20220301.0,20220321.0,20220326,20220326,EXP,FR-AFSSAPS-CN20220499,NVSC2022FR066257,NOVARTIS,,76.0,YR,,M,Y,90.0,KG,20220326,,MD,FR,FR,2022,Q1,Elderly
206482911,20648291,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,UNK,,2022,Q1,Microalbuminuria,,2022,Q1,1,I,,20220322.0,20220329,20220329,EXP,,AU-TAKEDA-2022TJP033129,TAKEDA,,62.0,YR,,M,Y,,,20220329,,HP,AU,AU,2022,Q1,Adult
206482911,20648291,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,UNK,,2022,Q1,Glomerular filtration rate decreased,,2022,Q1,1,I,,20220322.0,20220329,20220329,EXP,,AU-TAKEDA-2022TJP033129,TAKEDA,,62.0,YR,,M,Y,,,20220329,,HP,AU,AU,2022,Q1,Adult
206496701,20649670,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Somatic symptom disorder,,2022,Q1,1,I,,20220321.0,20220329,20220329,EXP,,DE-AstraZeneca-2022A127406,ASTRAZENECA,,43.0,YR,,F,Y,,,20220329,,MD,DE,,2022,Q1,Adult
206496701,20649670,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Dressler's syndrome,,2022,Q1,1,I,,20220321.0,20220329,20220329,EXP,,DE-AstraZeneca-2022A127406,ASTRAZENECA,,43.0,YR,,F,Y,,,20220329,,MD,DE,,2022,Q1,Adult
206496701,20649670,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Orthostatic hypotension,,2022,Q1,1,I,,20220321.0,20220329,20220329,EXP,,DE-AstraZeneca-2022A127406,ASTRAZENECA,,43.0,YR,,F,Y,,,20220329,,MD,DE,,2022,Q1,Adult
206499021,20649902,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Left ventricular failure,,2022,Q1,1,I,20220201.0,20220321.0,20220329,20220329,EXP,,RU-AstraZeneca-2022A122252,ASTRAZENECA,,70.0,YR,,F,Y,85.0,KG,20220329,,HP,RU,,2022,Q1,Elderly
206499021,20649902,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Left ventricular failure,,2022,Q1,1,I,20220201.0,20220321.0,20220329,20220329,EXP,,RU-AstraZeneca-2022A122252,ASTRAZENECA,,70.0,YR,,F,Y,85.0,KG,20220329,,HP,RU,,2022,Q1,Elderly
206500431,20650043,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Balanoposthitis,,2022,Q1,1,I,20220220.0,20220321.0,20220329,20220329,EXP,,FR-AstraZeneca-2022A121009,ASTRAZENECA,,72.0,YR,,M,Y,77.0,KG,20220329,,MD,FR,,2022,Q1,Elderly
206500431,20650043,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q1,Oedema,,2022,Q1,1,I,20220220.0,20220321.0,20220329,20220329,EXP,,FR-AstraZeneca-2022A121009,ASTRAZENECA,,72.0,YR,,M,Y,77.0,KG,20220329,,MD,FR,,2022,Q1,Elderly
206511101,20651110,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1220.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Gout,,2022,Q1,1,I,,20220322.0,20220329,20220329,EXP,,GB-AstraZeneca-2022A127426,ASTRAZENECA,,70.0,YR,,,Y,112.0,KG,20220330,,MD,GB,,2022,Q1,Elderly
206511101,20651110,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1220.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pain in extremity,,2022,Q1,1,I,,20220322.0,20220329,20220329,EXP,,GB-AstraZeneca-2022A127426,ASTRAZENECA,,70.0,YR,,,Y,112.0,KG,20220330,,MD,GB,,2022,Q1,Elderly
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Herpes zoster,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Inflammation,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Malaise,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Hypoaesthesia,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Cerebrovascular accident,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Back pain,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Neuropathy peripheral,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Cardiovascular disorder,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Rash,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Ill-defined disorder,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Excessive cerumen production,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Pericarditis,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206514851,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q1,Swollen tongue,,2022,Q1,1,I,,20220318.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220330,,HP,CA,,2022,Q1,Adult
206531621,20653162,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q1,Anaphylactic reaction,,2022,Q1,1,I,20210317.0,20220323.0,20220330,20220330,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203011875,ELI LILLY AND CO,,67.0,YR,,M,Y,116.0,KG,20220330,,CN,GB,GB,2022,Q1,Elderly
206531621,20653162,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q1,Cardiac arrest,,2022,Q1,1,I,20210317.0,20220323.0,20220330,20220330,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203011875,ELI LILLY AND CO,,67.0,YR,,M,Y,116.0,KG,20220330,,CN,GB,GB,2022,Q1,Elderly
206531621,20653162,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q1,Hypertension,,2022,Q1,1,I,20210317.0,20220323.0,20220330,20220330,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203011875,ELI LILLY AND CO,,67.0,YR,,M,Y,116.0,KG,20220330,,CN,GB,GB,2022,Q1,Elderly
206531621,20653162,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q1,Type 2 diabetes mellitus,,2022,Q1,1,I,20210317.0,20220323.0,20220330,20220330,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203011875,ELI LILLY AND CO,,67.0,YR,,M,Y,116.0,KG,20220330,,CN,GB,GB,2022,Q1,Elderly
206531621,20653162,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q1,Mesothelioma malignant,,2022,Q1,1,I,20210317.0,20220323.0,20220330,20220330,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202203011875,ELI LILLY AND CO,,67.0,YR,,M,Y,116.0,KG,20220330,,CN,GB,GB,2022,Q1,Elderly
206533861,20653386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,DE-AstraZeneca-2022A122844,ASTRAZENECA,,72.0,YR,,M,Y,,,20220330,,MD,DE,,2022,Q1,Elderly
206533861,20653386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cerebellar infarction,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,DE-AstraZeneca-2022A122844,ASTRAZENECA,,72.0,YR,,M,Y,,,20220330,,MD,DE,,2022,Q1,Elderly
206533861,20653386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Thrombosis,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,DE-AstraZeneca-2022A122844,ASTRAZENECA,,72.0,YR,,M,Y,,,20220330,,MD,DE,,2022,Q1,Elderly
206533861,20653386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,DE-AstraZeneca-2022A122844,ASTRAZENECA,,72.0,YR,,M,Y,,,20220330,,MD,DE,,2022,Q1,Elderly
206533861,20653386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Chest discomfort,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,DE-AstraZeneca-2022A122844,ASTRAZENECA,,72.0,YR,,M,Y,,,20220330,,MD,DE,,2022,Q1,Elderly
206538531,20653853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,200.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Dermatitis exfoliative generalised,,2022,Q1,1,I,20220301.0,20220322.0,20220330,20220330,EXP,,FR-AstraZeneca-2022A122195,ASTRAZENECA,,76.0,YR,,M,Y,90.0,KG,20220330,,MD,FR,,2022,Q1,Elderly
206541091,20654109,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Asthenia,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206541091,20654109,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Fatigue,,2022,Q1,1,I,20220216.0,20220322.0,20220330,20220330,EXP,,AU-AstraZeneca-2022A127189,ASTRAZENECA,,23928.0,DY,,M,Y,,,20220330,,MD,AU,,2022,Q1,Elderly
206542211,20654221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Peripheral swelling,,2022,Q1,1,I,20210530.0,20220323.0,20220330,20220330,EXP,,GB-AstraZeneca-2021A640609,ASTRAZENECA,,60.0,YR,,M,Y,150.0,KG,20220330,,MD,GB,,2022,Q1,Adult
206542211,20654221,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Dermatitis allergic,,2022,Q1,1,I,20210530.0,20220323.0,20220330,20220330,EXP,,GB-AstraZeneca-2021A640609,ASTRAZENECA,,60.0,YR,,M,Y,150.0,KG,20220330,,MD,GB,,2022,Q1,Adult
206553011,20655301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Pulmonary congestion,,2022,Q1,1,I,,20220323.0,20220330,20220330,EXP,,BG-AstraZeneca-2022A124593,ASTRAZENECA,,69.0,YR,,F,Y,,,20220330,,MD,BG,,2022,Q1,Elderly
206553011,20655301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Renal impairment,,2022,Q1,1,I,,20220323.0,20220330,20220330,EXP,,BG-AstraZeneca-2022A124593,ASTRAZENECA,,69.0,YR,,F,Y,,,20220330,,MD,BG,,2022,Q1,Elderly
206553011,20655301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Oedema peripheral,,2022,Q1,1,I,,20220323.0,20220330,20220330,EXP,,BG-AstraZeneca-2022A124593,ASTRAZENECA,,69.0,YR,,F,Y,,,20220330,,MD,BG,,2022,Q1,Elderly
206557511,20655751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Cerebral infarction,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,JP-AstraZeneca-2022A126480,ASTRAZENECA,,80.0,YR,,,Y,,,20220330,,PH,JP,,2022,Q1,Elderly
206557511,20655751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Myocardial infarction,,2022,Q1,1,I,,20220322.0,20220330,20220330,EXP,,JP-AstraZeneca-2022A126480,ASTRAZENECA,,80.0,YR,,,Y,,,20220330,,PH,JP,,2022,Q1,Elderly
206561531,20656153,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20220301.0,20220328.0,20220330,20220330,EXP,,KW-ABBVIE-22K-091-4337894-00,ABBVIE,,55.0,YR,,F,Y,,,20220330,,CN,COUNTRY NOT SPECIFIED,KW,2022,Q1,Adult
206561531,20656153,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q1,Productive cough,,2022,Q1,1,I,20220301.0,20220328.0,20220330,20220330,EXP,,KW-ABBVIE-22K-091-4337894-00,ABBVIE,,55.0,YR,,F,Y,,,20220330,,CN,COUNTRY NOT SPECIFIED,KW,2022,Q1,Adult
206564791,20656479,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac valve disease,,2022,Q1,1,I,,20220323.0,20220331,20220331,EXP,,JP-AstraZeneca-2022A127102,ASTRAZENECA,,83.0,YR,,M,Y,,,20220331,,MD,JP,,2022,Q1,Elderly
206564791,20656479,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Cardiac failure,,2022,Q1,1,I,,20220323.0,20220331,20220331,EXP,,JP-AstraZeneca-2022A127102,ASTRAZENECA,,83.0,YR,,M,Y,,,20220331,,MD,JP,,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Multiple fractures,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Contusion,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Thirst,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Haemorrhage,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Drug interaction,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Myocardial infarction,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Rhinorrhoea,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Cardiac disorder,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Mood swings,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Back disorder,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Pain,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571071,20657107,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Nasopharyngitis,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02561,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Drug interaction,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Nasopharyngitis,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Mood swings,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Back disorder,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Pain,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Haemorrhage,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Myocardial infarction,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Gait disturbance,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Loss of personal independence in daily activities,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Rhinorrhoea,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Thirst,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Cardiac disorder,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Contusion,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Dyspnoea exertional,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206571081,20657108,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q1,Multiple fractures,,2022,Q1,1,I,,20220316.0,20220331,20220331,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-02564,ALKEM,,69.0,YR,,M,Y,,,20220331,,HP,AU,AU,2022,Q1,Elderly
206585141,20658514,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Phimosis,,2022,Q1,1,I,20220101.0,20220325.0,20220331,20220331,EXP,,FR-AstraZeneca-2022A131312,ASTRAZENECA,,72.0,YR,,M,Y,,,20220331,,MD,FR,,2022,Q1,Elderly
206585141,20658514,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Balanoposthitis,,2022,Q1,1,I,20220101.0,20220325.0,20220331,20220331,EXP,,FR-AstraZeneca-2022A131312,ASTRAZENECA,,72.0,YR,,M,Y,,,20220331,,MD,FR,,2022,Q1,Elderly
206585141,20658514,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Phimosis,,2022,Q1,1,I,20220101.0,20220325.0,20220331,20220331,EXP,,FR-AstraZeneca-2022A131312,ASTRAZENECA,,72.0,YR,,M,Y,,,20220331,,MD,FR,,2022,Q1,Elderly
206585141,20658514,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q1,Balanoposthitis,,2022,Q1,1,I,20220101.0,20220325.0,20220331,20220331,EXP,,FR-AstraZeneca-2022A131312,ASTRAZENECA,,72.0,YR,,M,Y,,,20220331,,MD,FR,,2022,Q1,Elderly
206599381,20659938,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,25mg,,,,,unknown,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20200101.0,20201026.0,20220331,20220331,EXP,,BR-NOVOPROD-813931,NOVO NORDISK,,69.0,YR,,M,Y,62.0,KG,20220331,,MD,BR,BR,2022,Q1,Elderly
206599381,20659938,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,25mg,,,,,unknown,,,,,,,2022,Q1,Adenocarcinoma of colon,,2022,Q1,1,I,20200101.0,20201026.0,20220331,20220331,EXP,,BR-NOVOPROD-813931,NOVO NORDISK,,69.0,YR,,M,Y,62.0,KG,20220331,,MD,BR,BR,2022,Q1,Elderly
206599381,20659938,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,25mg,,,,,unknown,,,,,,,2022,Q1,Head injury,,2022,Q1,1,I,20200101.0,20201026.0,20220331,20220331,EXP,,BR-NOVOPROD-813931,NOVO NORDISK,,69.0,YR,,M,Y,62.0,KG,20220331,,MD,BR,BR,2022,Q1,Elderly
206600971,20660097,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1540.0,MG,,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q1,Acute respiratory failure,,2022,Q1,1,I,20220201.0,20220323.0,20220331,20220331,EXP,,RO-AstraZeneca-2022A127883,ASTRAZENECA,,71.0,YR,,M,Y,,,20220331,,MD,RO,,2022,Q1,Elderly
1368182613,13681826,46,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Blood creatine phosphokinase increased,,2022,Q2,13,F,20170119.0,20220421.0,20170623,20220425,EXP,,CN-ROCHE-1954213,ROCHE,,68.0,YR,,M,Y,82.0,KG,20220425,,MD,CN,,2022,Q2,Elderly
1368182613,13681826,46,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Hypothyroidism,,2022,Q2,13,F,20170119.0,20220421.0,20170623,20220425,EXP,,CN-ROCHE-1954213,ROCHE,,68.0,YR,,M,Y,82.0,KG,20220425,,MD,CN,,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
1415655012,14156550,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",12820.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,12,F,20171010.0,20220517.0,20171103,20220601,EXP,,GB-AUROBINDO-AUR-APL-2017-42783,AUROBINDO,,78.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Epididymitis,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Groin pain,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Feeling hot,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Hypotension,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
141686067,14168606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,also received 10 mg on 15-Nov-2017,12820.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Malaise,,2022,Q2,7,F,20171010.0,20220517.0,20171108,20220525,EXP,GB-MHRA-ADR 24225544,GB-Accord-060710,ACCORD,,78.0,YR,E,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,BLINDED,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
142831997,14283199,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20171010.0,20220614.0,20171213,20220621,EXP,GB-MHRA-ADR 24225544,GB-BAUSCH-BL-2017-033239,BAUSCH AND LOMB,,28563.0,DY,,M,Y,,,20220621,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood urine present,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood urine present,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood urine present,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood urine present,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148220378,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220615.0,20180427,20220623,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20220623,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
148600728,14860072,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,8,F,20180201.0,20220624.0,20180508,20220629,EXP,,GB-PFIZER INC-2018145757,PFIZER,,72.0,YR,,M,Y,93.2,KG,20220629,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
149074819,14907481,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12170.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,9,F,20171010.0,20220524.0,20180517,20220606,EXP,GB-MHRA-24225544,GB-ALVOGEN-2018-ALVOGEN-096160,ALVOGEN,,78.0,YR,,M,Y,,,20220606,,MD,GB,GB,2022,Q2,Elderly
161433639,16143363,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Clear cell renal cell carcinoma,,2022,Q2,9,F,20190325.0,20220614.0,20190401,20220621,EXP,,BR-JNJFOC-20190342024,JOHNSON AND JOHNSON,,61.0,YR,A,F,Y,98.4,KG,20220621,,MD,BR,BR,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Illness,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Crying,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Neutrophil percentage increased,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Thinking abnormal,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Ear discomfort,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Depression,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Weight increased,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Off label use,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Drug hypersensitivity,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Nasopharyngitis,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Drug effective for unapproved indication,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Pneumonia,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Eye disorder,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
1648059329,16480593,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Eosinophil count increased,,2022,Q2,29,F,20150101.0,20220524.0,20190626,20220527,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20220527,,CN,US,US,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Nausea,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Injection site pain,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Crohn's disease,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Paralysis,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Blister,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Intestinal obstruction,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Medical induction of coma,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Incisional hernia,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Hernia,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Scar,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Walking aid user,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Swelling,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Amnesia,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Diarrhoea,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Post procedural swelling,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Oxygen saturation decreased,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Stoma creation,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
167930615,16793061,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Fall,,2022,Q2,5,F,20181201.0,20220613.0,20190911,20220616,EXP,,CA-ABBVIE-19K-028-2690135-00,ABBVIE,,50.0,YR,,F,Y,,,20220616,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q2,Adult
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Fatigue,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Hyperglycaemia,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Hypertension,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Blood cholesterol increased,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Blood triglycerides increased,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174178903,17417890,36,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"1 dosage form, 2x/Day (bid)",,,U,U,,,,,,,BID,2022,Q2,Off label use,,2022,Q2,3,F,,20220516.0,20200213,20220525,EXP,,ES-UCBSA-2018008861,UCB,,72.0,YR,,M,Y,,,20220525,,PH,ES,ES,2022,Q2,Elderly
174776065,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Prostatic haemorrhage,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Polyuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
174776065,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Haematuria,,2022,Q2,5,F,20180201.0,20220623.0,20200228,20220627,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20220627,,MD,GB,GB,2022,Q2,Elderly
175469634,17546963,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,more than one year OD,,,,,unknown,,,,,,,2022,Q2,Myocardial infarction,,2022,Q2,4,F,20200126.0,20220531.0,20200316,20220610,EXP,,PK-NOVOPROD-718224,NOVO NORDISK,,60.0,YR,,F,Y,80.0,KG,20220610,,CN,PK,PK,2022,Q2,Adult
181981212,18198121,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,,20220422.0,20200826,20220429,EXP,,CA-APOTEX-2020AP016521,APOTEX,,36.0,YR,,F,Y,,,20220429,,PH,CA,CA,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Nausea,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Chills,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Chest discomfort,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Nasopharyngitis,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Hypokalaemia,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
184609225,18460922,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Pyrexia,,2022,Q2,5,F,20191129.0,20220606.0,20201104,20220614,EXP,,JP-ALXN-A202015832AA,ALEXION,,45.0,YR,,M,Y,113.0,KG,20220614,,MD,JP,JP,2022,Q2,Adult
186064595,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q2,Malaise,,2022,Q2,5,F,20201124.0,20220516.0,20201211,20220522,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20220522,,MD,JP,JP,2022,Q2,Elderly
186064595,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q2,Rash,,2022,Q2,5,F,20201124.0,20220516.0,20201211,20220522,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20220522,,MD,JP,JP,2022,Q2,Elderly
186064595,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q2,Neutropenia,,2022,Q2,5,F,20201124.0,20220516.0,20201211,20220522,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20220522,,MD,JP,JP,2022,Q2,Elderly
186064595,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q2,White blood cell count decreased,,2022,Q2,5,F,20201124.0,20220516.0,20201211,20220522,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20220522,,MD,JP,JP,2022,Q2,Elderly
186064595,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q2,Treatment noncompliance,,2022,Q2,5,F,20201124.0,20220516.0,20201211,20220522,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20220522,,MD,JP,JP,2022,Q2,Elderly
187193102,18719310,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Electrocardiogram QT prolonged,,2022,Q2,2,F,20201023.0,20220401.0,20210108,20220414,EXP,CH-SM-2020-19405,CH-SUNOVION-2020SUN003934,SUNOVION,,46.0,YR,,F,Y,,,20220414,,MD,CH,CH,2022,Q2,Adult
187193102,18719310,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Cardiopulmonary failure,,2022,Q2,2,F,20201023.0,20220401.0,20210108,20220414,EXP,CH-SM-2020-19405,CH-SUNOVION-2020SUN003934,SUNOVION,,46.0,YR,,F,Y,,,20220414,,MD,CH,CH,2022,Q2,Adult
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Lipids abnormal,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Blood alkaline phosphatase increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Drug-induced liver injury,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Serum ferritin increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Blood bilirubin increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Blood iron increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Gamma-glutamyltransferase increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Alanine aminotransferase increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Blood lactate dehydrogenase increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,C-reactive protein increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188178765,18817876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",1515.0,MG,Y,,,,,5.0,MG,Tablet,QD,2022,Q2,Bilirubin conjugated increased,,2022,Q2,5,F,20190524.0,20220527.0,20210201,20220601,EXP,,JP-009507513-2101JPN012630,MERCK,,65.0,YR,,M,Y,72.5,KG,20220601,,MD,JP,JP,2022,Q2,Elderly
188971472,18897147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,2,F,,20220328.0,20210215,20220405,EXP,,CA-AstraZeneca-2021A049012,ASTRAZENECA,,20.0,YR,,F,Y,,,20220405,,MD,CA,,2022,Q2,Youth
188971472,18897147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220328.0,20210215,20220405,EXP,,CA-AstraZeneca-2021A049012,ASTRAZENECA,,20.0,YR,,F,Y,,,20220405,,MD,CA,,2022,Q2,Youth
188971472,18897147,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Nausea,,2022,Q2,2,F,,20220328.0,20210215,20220405,EXP,,CA-AstraZeneca-2021A049012,ASTRAZENECA,,20.0,YR,,F,Y,,,20220405,,MD,CA,,2022,Q2,Youth
189397182,18939718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Alanine aminotransferase increased,,2022,Q2,2,F,20210214.0,20220113.0,20210224,20220602,EXP,GB-MHRA-WEBCOVID-202102161503292160,GB-ROCHE-2773795,ROCHE,,46.0,YR,,M,Y,114.0,KG,20220602,,PH,GB,GB,2022,Q2,Adult
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling hot,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Groin pain,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Epididymitis,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189553349,18955334,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (BLINDED)",10950.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,9,F,20171010.0,20220520.0,20210301,20220525,EXP,,GB-MYLANLABS-2021M1011654,MYLAN,,78.0,YR,,M,Y,,,20220525,,MD,GB,GB,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Groin pain,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Feeling hot,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Epididymitis,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Hypotension,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Groin pain,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Feeling hot,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Epididymitis,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Hypotension,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
189629946,18962994,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Blinded,12820.0,MG,D,,,,,10.0,MG,,QD,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20171010.0,20220517.0,20210303,20220527,EXP,,GB-EMD Serono-8198829,EMD SERONO INC,,78.0,YR,E,M,Y,,,20220527,,MD,GB,,2022,Q2,Elderly
1909398623,19093986,79,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Urinary retention,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
1909398623,19093986,79,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myelosuppression,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
1909398623,19093986,79,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Cardiac failure,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
1909398623,19093986,100,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Urinary retention,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
1909398623,19093986,100,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myelosuppression,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
1909398623,19093986,100,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Cardiac failure,,2022,Q2,23,F,20210316.0,20220518.0,20210405,20220601,EXP,,CN-ROCHE-2796984,ROCHE,,68.0,YR,,M,Y,70.0,KG,20220601,,MD,CN,,2022,Q2,Elderly
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Malaise,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Throat clearing,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Nausea,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Rhinorrhoea,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Dysstasia,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Eructation,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Visual impairment,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Back pain,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Product dose omission issue,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Flatulence,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
192612695,19261269,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,Unknown,,,,,,,2022,Q2,Hypotension,,2022,Q2,5,F,20210401.0,20220412.0,20210515,20220413,PER,,NVSC2021US104649,NOVARTIS,,64.0,YR,,F,Y,,,20220413,,CN,US,US,2022,Q2,Adult
1927499911,19274999,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 mg, Everyday, Oral Drug Unspecified Form",,,U,,,,,,,,,2022,Q2,Malignant neoplasm progression,,2022,Q2,11,F,20210317.0,20220507.0,20210519,20220518,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048529,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,68.0,KG,20220518,,MD,JP,JP,2022,Q2,Elderly
1927499911,19274999,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 mg, Everyday, Oral Drug Unspecified Form",,,U,,,,,,,,,2022,Q2,Atrial thrombosis,,2022,Q2,11,F,20210317.0,20220507.0,20210519,20220518,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048529,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,68.0,KG,20220518,,MD,JP,JP,2022,Q2,Elderly
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,White blood cell count decreased,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood urea increased,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood creatinine increased,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Metastases to lung,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193613609,19361360,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,9,F,20220601.0,20220610.0,20210601,20220614,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220614,,HP,TH,TH,2022,Q2,Adult
193697285,19369728,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2022,Q2,Hyperthyroidism,,2022,Q2,5,F,20210503.0,20220427.0,20210603,20220505,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220505,,MD,ES,ES,2022,Q2,Adult
193697285,19369728,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,5,F,20210503.0,20220427.0,20210603,20220505,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220505,,MD,ES,ES,2022,Q2,Adult
193697285,19369728,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Hyperthyroidism,,2022,Q2,5,F,20210503.0,20220427.0,20210603,20220505,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220505,,MD,ES,ES,2022,Q2,Adult
193697285,19369728,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,5,F,20210503.0,20220427.0,20210603,20220505,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220505,,MD,ES,ES,2022,Q2,Adult
194090162,19409016,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Spinal compression fracture,,2022,Q2,2,F,,20220610.0,20210613,20220616,EXP,,NVSJ2021JP008703,NOVARTIS,,95.0,YR,,F,Y,38.0,KG,20220617,,MD,JP,JP,2022,Q2,Elderly
194436342,19443634,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac arrest,,2022,Q2,2,F,20210317.0,20220324.0,20210621,20220406,EXP,GB-MHRA-EYC 00252646,GB-PFIZER INC-2021671466,PFIZER,,67.0,YR,,M,Y,116.0,KG,20220406,,PH,GB,GB,2022,Q2,Elderly
194436342,19443634,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,2,F,20210317.0,20220324.0,20210621,20220406,EXP,GB-MHRA-EYC 00252646,GB-PFIZER INC-2021671466,PFIZER,,67.0,YR,,M,Y,116.0,KG,20220406,,PH,GB,GB,2022,Q2,Elderly
194436342,19443634,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Myocardial infarction,,2022,Q2,2,F,20210317.0,20220324.0,20210621,20220406,EXP,GB-MHRA-EYC 00252646,GB-PFIZER INC-2021671466,PFIZER,,67.0,YR,,M,Y,116.0,KG,20220406,,PH,GB,GB,2022,Q2,Elderly
194436342,19443634,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Anaphylactic reaction,,2022,Q2,2,F,20210317.0,20220324.0,20210621,20220406,EXP,GB-MHRA-EYC 00252646,GB-PFIZER INC-2021671466,PFIZER,,67.0,YR,,M,Y,116.0,KG,20220406,,PH,GB,GB,2022,Q2,Elderly
194812342,19481234,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"20 milligram, Daily",,,Y,U,,,,20.0,MG,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20210505.0,20220509.0,20210701,20220524,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-302689,RANBAXY,,39.0,YR,,M,Y,70.0,KG,20220524,,MD,FR,FR,2022,Q2,Adult
195861242,19586124,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9515.0,MG,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Urosepsis,,2022,Q2,2,F,20210216.0,20220328.0,20210721,20220405,EXP,,CA-AstraZeneca-2021A624812,ASTRAZENECA,,73.0,YR,,M,Y,175.0,KG,20220405,,MD,CA,,2022,Q2,Elderly
195861242,19586124,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9515.0,MG,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Glycosuria,,2022,Q2,2,F,20210216.0,20220328.0,20210721,20220405,EXP,,CA-AstraZeneca-2021A624812,ASTRAZENECA,,73.0,YR,,M,Y,175.0,KG,20220405,,MD,CA,,2022,Q2,Elderly
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Abdominal pain,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal failure,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Lactic acidosis,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
195892262,19589226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Metabolic alkalosis,,2022,Q2,2,F,,20220328.0,20210721,20220401,EXP,,CA-AstraZeneca-2021A624910,ASTRAZENECA,,52.0,YR,,F,Y,,,20220401,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Appendicitis,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pain,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
196022022,19602202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Abdominal pain,,2022,Q2,2,F,,20220328.0,20210723,20220405,EXP,,CA-AstraZeneca-2021A624839,ASTRAZENECA,,48.0,YR,,M,Y,100.0,KG,20220405,,MD,CA,,2022,Q2,Adult
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Frequent bowel movements,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Anal incontinence,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Faeces soft,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Defaecation urgency,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Haematochezia,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Off label use,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198294265,19829426,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Colitis ulcerative,,2022,Q2,5,F,20210906.0,20220602.0,20210914,20220607,EXP,,CA-TAKEDA-2021TUS056178,TAKEDA,,67.0,YR,,F,Y,,,20220607,,MD,CA,CA,2022,Q2,Elderly
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
198948047,19894804,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,7,F,,20220530.0,20210928,20220604,EXP,NVSC2021PL217368,NVSC2021PL217368,NOVARTIS,,64.0,YR,,M,Y,,,20220604,,MD,PL,PL,2022,Q2,Adult
199266705,19926670,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form=1 unit NOS,,,U,,,,,,,,,2022,Q2,Urinary tract obstruction,,2022,Q2,5,F,20210925.0,20220408.0,20211006,20220418,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-099741,BRISTOL MYERS SQUIBB,,53.0,YR,A,M,Y,86.0,KG,20220418,,HP,AR,AR,2022,Q2,Adult
199266705,19926670,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form=1 unit NOS,,,U,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,5,F,20210925.0,20220408.0,20211006,20220418,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-099741,BRISTOL MYERS SQUIBB,,53.0,YR,A,M,Y,86.0,KG,20220418,,HP,AR,AR,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Obesity,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Hypertension,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Blood pressure decreased,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Diabetes mellitus,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1993592910,19935929,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Hyperuricaemia,,2022,Q2,10,F,,20211229.0,20211008,20220518,EXP,,PL-BAUSCH-BL-2021-033656,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220518,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Diabetes mellitus,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Hyperuricaemia,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Blood pressure decreased,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Obesity,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
1994855511,19948555,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,10.0,MG,,,2022,Q2,Hypertension,,2022,Q2,11,F,,20220110.0,20211012,20220601,EXP,,PL-TEVA-2021-PL-1965195,TEVA,,64.0,YR,A,M,Y,,,20220601,,MD,PL,PL,2022,Q2,Adult
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Drug interaction,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Myocardial infarction,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Heart rate irregular,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Mood swings,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Haemorrhage,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Hypervolaemia,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Thirst,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Contusion,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Mental disorder,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
199506373,19950637,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Rhinorrhoea,,2022,Q2,3,F,,20220616.0,20211013,20220624,EXP,,AU-GENERIC HEALTH PTY. LTD.-2021-19200,LUPIN,,69.0,YR,,M,Y,93.0,KG,20220624,,CN,AU,AU,2022,Q2,Elderly
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
1995165310,19951653,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram(10 mg),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,10,F,,20220527.0,20211014,20220610,EXP,,PL-AUROBINDO-AUR-APL-2021-041994,AUROBINDO,,64.0,YR,,M,Y,95.0,KG,20220610,,MD,PL,PL,2022,Q2,Adult
199683352,19968335,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",1745.0,MG,,,,,,5.0,MG,,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,2,F,20190709.0,20220620.0,20211019,20220624,PER,,JP-AMGEN-JPNNI2021158449,AMGEN,,70.0,YR,E,F,Y,75.0,KG,20220624,,MD,JP,JP,2022,Q2,Elderly
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
1996931210,19969312,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,10,F,,20220601.0,20211019,20220608,EXP,,PL-ORGANON-O2110POL001257,ORGANON,,64.0,YR,,M,Y,,,20220608,,MD,PL,PL,2022,Q2,Adult
199768123,19976812,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Inflammation,,2022,Q2,3,F,,20220404.0,20211020,20220604,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-106548,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,90.0,KG,20220604,,CN,CA,CA,2022,Q2,Elderly
199768123,19976812,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,3,F,,20220404.0,20211020,20220604,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-106548,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,90.0,KG,20220604,,CN,CA,CA,2022,Q2,Elderly
199768123,19976812,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,COVID-19,,2022,Q2,3,F,,20220404.0,20211020,20220604,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-106548,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,90.0,KG,20220604,,CN,CA,CA,2022,Q2,Elderly
199768123,19976812,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Eye disorder,,2022,Q2,3,F,,20220404.0,20211020,20220604,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-106548,BRISTOL MYERS SQUIBB,,71.0,YR,E,F,Y,90.0,KG,20220604,,CN,CA,CA,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Dental caries,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Lung disorder,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Haemoglobin decreased,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Hypersomnia,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
1998429910,19984299,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Peripheral swelling,,2022,Q2,10,F,20210901.0,20220506.0,20211021,20220512,EXP,,CO-ABBVIE-21K-036-4130259-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220512,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
200285632,20028563,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2022,Q2,Diarrhoea,,2022,Q2,2,F,20211001.0,20220615.0,20211103,20220622,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20220622,,MD,IT,IT,2022,Q2,Elderly
200285632,20028563,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2022,Q2,Transaminases increased,,2022,Q2,2,F,20211001.0,20220615.0,20211103,20220622,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20220622,,MD,IT,IT,2022,Q2,Elderly
200285632,20028563,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2022,Q2,Cholelithiasis,,2022,Q2,2,F,20211001.0,20220615.0,20211103,20220622,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20220622,,MD,IT,IT,2022,Q2,Elderly
200285632,20028563,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2022,Q2,Cholangitis,,2022,Q2,2,F,20211001.0,20220615.0,20211103,20220622,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20220622,,MD,IT,IT,2022,Q2,Elderly
200285632,20028563,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,9400.0,MG,,,UNKNOWN,,,10.0,MG,"Tablet, Film Coated",QD,2022,Q2,Asthenia,,2022,Q2,2,F,20211001.0,20220615.0,20211103,20220622,EXP,IT-MINISAL02-798905,IT-ROCHE-2941016,ROCHE,,75.0,YR,,M,Y,,,20220622,,MD,IT,IT,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Blood thyroid stimulating hormone increased,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Dermatitis psoriasiform,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Otitis externa,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Malignant neoplasm progression,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Dermatitis allergic,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200309603,20030960,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Klebsiella infection,,2022,Q2,3,F,20200816.0,20220419.0,20211103,20220427,EXP,,JP-009507513-2101JPN002078J,MERCK,,65.0,YR,,M,Y,,,20220427,,MD,JP,JP,2022,Q2,Elderly
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Fatigue,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Mitral valve incompetence,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Acute myocardial infarction,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Cough,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Bradycardia,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Coronary artery disease,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Chest pain,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Pericardial effusion,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Intra-abdominal haematoma,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Aortic valve incompetence,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Asymptomatic COVID-19,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Acute myocardial infarction,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Acute myocardial infarction,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200497633,20049763,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (at breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20211005.0,20220405.0,20211109,20220413,EXP,,NVSC2021PT250689,NOVARTIS,,49.0,YR,,M,Y,45.0,KG,20220413,,PH,PT,PT,2022,Q2,Adult
200737625,20073762,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Pneumonia fungal,,2022,Q2,5,F,20211109.0,20220419.0,20211116,20220426,EXP,,JP-ASTELLAS-2021JP021921,ASTELLAS,,68.0,YR,,F,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Carotid artery stenosis,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Aortic perforation,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Dysarthria,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Cerebrovascular accident,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac aneurysm,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Ventricular tachycardia,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Prostate cancer,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Carotid artery aneurysm,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Speech disorder,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200762579,20076257,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 lunch)",,,,,,,,10.0,MG,,QD,2022,Q2,Dilatation atrial,,2022,Q2,9,F,20210901.0,20220510.0,20211116,20220514,EXP,,NVSC2021PT260642,NOVARTIS,,66.0,YR,,M,Y,83.5,KG,20220514,,CN,PT,PT,2022,Q2,Elderly
200971233,20097123,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Interstitial lung disease,,2022,Q2,3,F,,20220411.0,20211122,20220415,EXP,,JP-009507513-2111JPN007179,MERCK,"Ichimura T, et al.. Effectiveness of corticosteroids on immune checkpoint inhibitor-induced interstitial pneumonia among patients with a history of interstitial pneumonia: A case series.. SAGE Open Medical Case Reports. 2021;9:1-5",68.0,YR,,M,Y,67.9,KG,20220415,,PH,JP,JP,2022,Q2,Elderly
201133152,20113315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Renal pain,,2022,Q2,2,F,,20220526.0,20211125,20220602,EXP,,CA-AstraZeneca-2021A810073,ASTRAZENECA,,69.0,YR,,M,Y,,,20220602,,MD,CA,,2022,Q2,Elderly
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201248356,20124835,20,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (10 mg),,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,6,F,,20220602.0,20211129,20220607,EXP,,PL-MYLANLABS-2021M1086777,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220607,,MD,PL,PL,2022,Q2,Adult
201351296,20135129,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,6,F,20211127.0,20220330.0,20211201,20220404,EXP,,NVSC2021KR272983,NOVARTIS,,61.0,YR,,F,Y,59.3,KG,20220404,,MD,KR,KR,2022,Q2,Adult
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,46,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,47,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,48,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,49,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201418382,20141838,50,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20210301.0,20220413.0,20211202,20220418,EXP,,NVSC2021PL267813,NOVARTIS,,71.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Elderly
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Hypertension,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Diabetes mellitus,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Obesity,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Blood pressure decreased,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Hyperuricaemia,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201666393,20166639,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,3,F,,20220425.0,20211209,20220510,EXP,,PL-MYLANLABS-2021M1090727,MYLAN,,64.0,YR,,M,Y,,,20220510,,MD,PL,PL,2022,Q2,Adult
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,23,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,24,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,25,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,26,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,27,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,28,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201741047,20174104,29,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,7,F,20210301.0,20220513.0,20211213,20220520,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-132439,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220520,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,43,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201812323,20181232,44,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20210301.0,20220413.0,20211214,20220420,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-142296",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,,,20220420,,CN,PL,PL,2022,Q2,Elderly
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Blood pressure decreased,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Hyperuricaemia,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Hypertension,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Obesity,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201837492,20183749,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Diabetes mellitus,,2022,Q2,2,F,,20220425.0,20211214,20220510,EXP,,PL-MYLANLABS-2021M1091735,MYLAN,,64.0,YR,,M,Y,95.0,KG,20220510,,MD,PL,PL,2022,Q2,Adult
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
201922355,20192235,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,5,F,20210301.0,20220513.0,20211216,20220527,EXP,,PL-AUROBINDO-AUR-APL-2021-051139,AUROBINDO,,71.0,YR,,M,Y,,,20220527,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
2019610413,20196104,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,13,F,20210301.0,20220627.0,20211216,20220630,EXP,,PL-PFIZER INC-202101733614,PFIZER,,71.0,YR,,M,Y,,,20220630,,MD,PL,PL,2022,Q2,Elderly
202239382,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Rash,,2022,Q2,2,F,20210601.0,20220521.0,20211223,20220527,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,67.0,YR,,M,Y,73.0,KG,20220527,,MD,JP,,2022,Q2,Elderly
202239382,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Obesity,,2022,Q2,2,F,20210601.0,20220521.0,20211223,20220527,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,67.0,YR,,M,Y,73.0,KG,20220527,,MD,JP,,2022,Q2,Elderly
202239382,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Adrenal insufficiency,,2022,Q2,2,F,20210601.0,20220521.0,20211223,20220527,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,67.0,YR,,M,Y,73.0,KG,20220527,,MD,JP,,2022,Q2,Elderly
202239382,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Thyroiditis,,2022,Q2,2,F,20210601.0,20220521.0,20211223,20220527,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,67.0,YR,,M,Y,73.0,KG,20220527,,MD,JP,,2022,Q2,Elderly
202239382,20223938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Hypopituitarism,,2022,Q2,2,F,20210601.0,20220521.0,20211223,20220527,EXP,,JP-AstraZeneca-2021A882864,ASTRAZENECA,,67.0,YR,,M,Y,73.0,KG,20220527,,MD,JP,,2022,Q2,Elderly
202303422,20230342,29,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q2,Cardiac failure congestive,,2022,Q2,2,F,20190402.0,20220428.0,20211226,20220510,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20220510,,MD,JP,JP,2022,Q2,Elderly
202303422,20230342,29,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q2,Cardiac failure congestive,,2022,Q2,2,F,20190402.0,20220428.0,20211226,20220510,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20220510,,MD,JP,JP,2022,Q2,Elderly
202303422,20230342,29,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,2,F,20190402.0,20220428.0,20211226,20220510,PER,,JP-AMGEN-JPNCT2020046688,AMGEN,,83.0,YR,E,M,Y,,,20220510,,MD,JP,JP,2022,Q2,Elderly
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Creatinine renal clearance decreased,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Nephropathy toxic,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Rash papular,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Pruritus,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Pericarditis,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Skin lesion,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Toxic skin eruption,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Rash,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Hydrothorax,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202363227,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q2,Hyperthermia,,2022,Q2,7,F,20210927.0,20220531.0,20211228,20220602,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20220602,,MD,RU,RU,2022,Q2,Adult
202366944,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,4,F,20211101.0,20220517.0,20211228,20220524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220524,,CN,JP,JP,2022,Q2,Elderly
202366944,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,4,F,20211101.0,20220517.0,20211228,20220524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220524,,CN,JP,JP,2022,Q2,Elderly
202366944,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20211101.0,20220517.0,20211228,20220524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220524,,CN,JP,JP,2022,Q2,Elderly
202366944,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,4,F,20211101.0,20220517.0,20211228,20220524,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220524,,CN,JP,JP,2022,Q2,Elderly
202386293,20238629,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,3,F,20211129.0,20220420.0,20211228,20220502,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-139403,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20220502,,HP,FR,FR,2022,Q2,Adult
202386293,20238629,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q2,Cholecystitis,,2022,Q2,3,F,20211129.0,20220420.0,20211228,20220502,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-139403,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20220502,,HP,FR,FR,2022,Q2,Adult
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,35,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,36,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,37,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Lung disorder,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Lung disorder,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,Congestive cardiomyopathy,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
202795004,20279500,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,Tablet,,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,4,F,20210301.0,20220505.0,20220103,20220509,EXP,,PL-MYLANLABS-2021M1096293,MYLAN,,71.0,YR,,M,Y,,,20220509,,MD,PL,PL,2022,Q2,Elderly
204031812,20403181,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Renal pain,,2022,Q2,2,F,,20220325.0,20220131,20220404,EXP,CA-HEALTHCANVIG-E2B_04516041,CA-NOVOPROD-884962,NOVO NORDISK,,69.0,YR,,M,Y,,,20220404,,CN,CA,CA,2022,Q2,Elderly
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,White blood cell count increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Basophil count increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,General physical health deterioration,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Arthralgia,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Photosensitivity reaction,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Hepatitis B surface antibody positive,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Haemoglobin increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Lymphocyte percentage increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Blood triglycerides increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Creatinine urine increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Ill-defined disorder,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,COVID-19,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Pain,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Blood creatinine increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Osteoarthritis,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,COVID-19 pneumonia,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Haematocrit decreased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Back pain,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Basophil percentage increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Influenza,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Hypertension,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Product supply issue,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Acute respiratory distress syndrome,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Red blood cell sedimentation rate increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Deformity thorax,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Low density lipoprotein increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Adjusted calcium increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,High density lipoprotein decreased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,C-reactive protein increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Lymphadenopathy,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Plantar fasciitis,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Red blood cell count increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Alanine aminotransferase increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Very low density lipoprotein increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Lymphocyte count increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Oxygen saturation decreased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Red cell distribution width increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Platelet count decreased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Hypersensitivity,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Dyslipidaemia,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Neutrophil count increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Eosinophil percentage increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Illness,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Ocular hyperaemia,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Protein urine present,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Musculoskeletal stiffness,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204092397,20409239,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Blood cholesterol increased,,2022,Q2,7,F,20190917.0,20220609.0,20220201,20220611,EXP,,NVSC2021CO168708,NOVARTIS,,53.0,YR,,M,Y,79.0,KG,20220612,,CN,CO,CO,2022,Q2,Adult
204108842,20410884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pancreatitis acute,,2022,Q2,2,F,20210303.0,20220426.0,20220201,20220504,EXP,,CA-AstraZeneca-2022A043467,ASTRAZENECA,,55.0,YR,,M,Y,167.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204168922,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20210901.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220504,,MD,CA,,2022,Q2,Elderly
204168922,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q2,Shock,,2022,Q2,2,F,20210901.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220504,,MD,CA,,2022,Q2,Elderly
204168922,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q2,Intensive care,,2022,Q2,2,F,20210901.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220504,,MD,CA,,2022,Q2,Elderly
204168922,20416892,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,QD,2022,Q2,Endotracheal intubation,,2022,Q2,2,F,20210901.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043468,ASTRAZENECA,,75.0,YR,,M,Y,140.0,KG,20220504,,MD,CA,,2022,Q2,Elderly
204179562,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20210914.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204179562,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,2,F,20210914.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204179562,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Haematemesis,,2022,Q2,2,F,20210914.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204179562,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210914.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204179562,20417956,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12590.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,General physical health deterioration,,2022,Q2,2,F,20210914.0,20220426.0,20220202,20220504,EXP,,CA-AstraZeneca-2022A043472,ASTRAZENECA,,59.0,YR,,F,Y,71.0,KG,20220504,,MD,CA,,2022,Q2,Adult
204306403,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204306403,20430640,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2005.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,3,F,20210116.0,20220511.0,20220204,20220519,EXP,,JP-AstraZeneca-2021A854697,ASTRAZENECA,,82.0,YR,,M,Y,59.0,KG,20220519,,MD,JP,,2022,Q2,Elderly
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Weight fluctuation,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Drug resistance,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Cough,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Back pain,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Suicidal ideation,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Bone pain,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Drug ineffective,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Oropharyngeal pain,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Anxiety,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Laboratory test abnormal,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Gastritis,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Blood glucose increased,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Abdominal discomfort,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Blood glucose decreased,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypoaesthesia,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Choking,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Headache,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Feeling abnormal,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Throat irritation,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Constipation,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Fear,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Initial insomnia,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Chest pain,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Emotional disorder,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Sensation of foreign body,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Chromaturia,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Pain in extremity,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Influenza,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204345713,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,3,F,20210501.0,20220411.0,20220206,20220414,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220414,,CN,MX,MX,2022,Q2,Adult
204508955,20450895,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Fluid retention,,2022,Q2,5,F,20211116.0,20220511.0,20220209,20220519,EXP,,JP-PFIZER INC-202200175937,PFIZER,,75.0,YR,,M,Y,58.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
204508955,20450895,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,5,F,20211116.0,20220511.0,20220209,20220519,EXP,,JP-PFIZER INC-202200175937,PFIZER,,75.0,YR,,M,Y,58.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
204508955,20450895,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,5,F,20211116.0,20220511.0,20220209,20220519,EXP,,JP-PFIZER INC-202200175937,PFIZER,,75.0,YR,,M,Y,58.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
204508955,20450895,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,5,F,20211116.0,20220511.0,20220209,20220519,EXP,,JP-PFIZER INC-202200175937,PFIZER,,75.0,YR,,M,Y,58.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
204508955,20450895,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,5,F,20211116.0,20220511.0,20220209,20220519,EXP,,JP-PFIZER INC-202200175937,PFIZER,,75.0,YR,,M,Y,58.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Insomnia,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Disseminated intravascular coagulation,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Sepsis,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204509054,20450905,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2370.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Gastric ulcer haemorrhage,,2022,Q2,4,F,20220119.0,20220414.0,20220209,20220419,EXP,,JP-AstraZeneca-2022A058800,ASTRAZENECA,,89.0,YR,,M,Y,45.0,KG,20220419,,MD,JP,,2022,Q2,Elderly
204572813,20457281,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220204.0,20220504.0,20220210,20220512,EXP,,AU-SEATTLE GENETICS-2022SGN00811,SEATTLE GENETICS,,65.0,YR,,F,Y,75.7,KG,20220512,,MD,AU,AU,2022,Q2,Elderly
204580354,20458035,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",2370.0,MG,,,,,,10.0,MG,,QD,2022,Q2,Pneumonia,,2022,Q2,4,F,20220123.0,20220414.0,20220211,20220423,PER,JP-ONO-2022JP003190,JP-AMGEN-JPNSP2022021707,AMGEN,,89.0,YR,E,M,Y,45.2,KG,20220422,,MD,JP,JP,2022,Q2,Elderly
204580354,20458035,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",2370.0,MG,,,,,,10.0,MG,,QD,2022,Q2,Disseminated intravascular coagulation,,2022,Q2,4,F,20220123.0,20220414.0,20220211,20220423,PER,JP-ONO-2022JP003190,JP-AMGEN-JPNSP2022021707,AMGEN,,89.0,YR,E,M,Y,45.2,KG,20220422,,MD,JP,JP,2022,Q2,Elderly
204580354,20458035,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",2370.0,MG,,,,,,10.0,MG,,QD,2022,Q2,Sepsis,,2022,Q2,4,F,20220123.0,20220414.0,20220211,20220423,PER,JP-ONO-2022JP003190,JP-AMGEN-JPNSP2022021707,AMGEN,,89.0,YR,E,M,Y,45.2,KG,20220422,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Concomitant disease aggravated,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Tricuspid valve incompetence,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Mitral valve incompetence,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204684632,20468463,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Gout,,2022,Q2,2,F,20210419.0,20220421.0,20220214,20220426,EXP,,NVSJ2022JP002727,NOVARTIS,,78.0,YR,,M,Y,78.8,KG,20220426,,MD,JP,JP,2022,Q2,Elderly
204797872,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,7610.0,MG,Y,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Bladder spasm,,2022,Q2,2,F,20191101.0,20220503.0,20220216,20220511,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220511,,MD,CA,,2022,Q2,Adult
204797872,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,7610.0,MG,Y,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Bladder cancer recurrent,,2022,Q2,2,F,20191101.0,20220503.0,20220216,20220511,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220511,,MD,CA,,2022,Q2,Adult
204797872,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,7610.0,MG,Y,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pollakiuria,,2022,Q2,2,F,20191101.0,20220503.0,20220216,20220511,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220511,,MD,CA,,2022,Q2,Adult
204797872,20479787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,7610.0,MG,Y,,UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract procedural complication,,2022,Q2,2,F,20191101.0,20220503.0,20220216,20220511,EXP,,CA-AstraZeneca-2022A071616,ASTRAZENECA,,55.0,YR,,M,Y,,,20220511,,MD,CA,,2022,Q2,Adult
204805876,20480587,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Formulation unknown,QD,2022,Q2,Lung opacity,,2022,Q2,6,F,20220209.0,20220429.0,20220216,20220505,EXP,,KR-ASTELLAS-2022US006042,ASTELLAS,,58.0,YR,,M,Y,,,20220505,,CN,KR,KR,2022,Q2,Adult
204809522,20480952,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220129.0,20220404.0,20220216,20220408,EXP,,JP-PFIZER INC-202200223091,PFIZER,,78.0,YR,,M,Y,55.9,KG,20220408,,MD,JP,JP,2022,Q2,Elderly
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,SARS-CoV-2 test positive,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204854632,20485463,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Cough,,2022,Q2,2,F,20211001.0,20220518.0,20220217,20220613,PER,,GB-AMGEN-GBRSP2022023055,AMGEN,,57.0,YR,A,M,Y,118.0,KG,20220613,,HP,GB,GB,2022,Q2,Adult
204949852,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,2,F,20210821.0,20220619.0,20220221,20220622,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220622,,MD,GB,GB,2022,Q2,Adult
204949852,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,2,F,20210821.0,20220619.0,20220221,20220622,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220622,,MD,GB,GB,2022,Q2,Adult
204949852,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiomegaly,,2022,Q2,2,F,20210821.0,20220619.0,20220221,20220622,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220622,,MD,GB,GB,2022,Q2,Adult
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Groin pain,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Malaise,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Epididymitis,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Feeling hot,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Hypotension,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, per day (Blinded)",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Groin pain,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Malaise,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Epididymitis,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Feeling hot,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Hypotension,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204976145,20497614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",12820.0,MG,D,,,,,10.0,MG,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,5,F,,20220509.0,20220221,20220512,EXP,GB-AstraZeneca-2017SF05024,GB-STRIDES ARCOLAB LIMITED-2020SP009791,STRIDES,,78.0,YR,,M,Y,,,20220512,,MD,GB,GB,2022,Q2,Elderly
204994162,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,2,F,20210821.0,20220619.0,20220222,20220630,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220630,,MD,GB,GB,2022,Q2,Adult
204994162,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,2,F,20210821.0,20220619.0,20220222,20220630,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220630,,MD,GB,GB,2022,Q2,Adult
205013912,20501391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1180.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,2,F,20211004.0,20220503.0,20220222,20220511,EXP,,CA-AstraZeneca-2022A071620,ASTRAZENECA,,80.0,YR,,F,Y,63.6,KG,20220511,,MD,CA,,2022,Q2,Elderly
205013912,20501391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1180.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,2,F,20211004.0,20220503.0,20220222,20220511,EXP,,CA-AstraZeneca-2022A071620,ASTRAZENECA,,80.0,YR,,F,Y,63.6,KG,20220511,,MD,CA,,2022,Q2,Elderly
205077242,20507724,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Pneumonia,,2022,Q2,2,F,20210821.0,20220619.0,20220223,20220623,EXP,,GB-DSJP-DSE-2022-105383,DAIICHI,,61.0,YR,,M,Y,,,20220623,,MD,GB,GB,2022,Q2,Adult
205077242,20507724,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,2,F,20210821.0,20220619.0,20220223,20220623,EXP,,GB-DSJP-DSE-2022-105383,DAIICHI,,61.0,YR,,M,Y,,,20220623,,MD,GB,GB,2022,Q2,Adult
205181333,20518133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,3,F,20220201.0,20220428.0,20220225,20220506,EXP,,JP-AstraZeneca-2022A079933,ASTRAZENECA,,80.0,YR,,M,Y,,,20220506,,MD,JP,,2022,Q2,Elderly
205181333,20518133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,3,F,20220201.0,20220428.0,20220225,20220506,EXP,,JP-AstraZeneca-2022A079933,ASTRAZENECA,,80.0,YR,,M,Y,,,20220506,,MD,JP,,2022,Q2,Elderly
205181333,20518133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Coma,,2022,Q2,3,F,20220201.0,20220428.0,20220225,20220506,EXP,,JP-AstraZeneca-2022A079933,ASTRAZENECA,,80.0,YR,,M,Y,,,20220506,,MD,JP,,2022,Q2,Elderly
205261582,20526158,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,2,F,20210801.0,20220401.0,20220228,20220408,EXP,,NVSC2021PT302471,NOVARTIS,,48.0,YR,,M,Y,44.0,KG,20220408,,PH,PT,PT,2022,Q2,Adult
205261582,20526158,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (breakfast)",,,U,,,,,10.0,MG,,QD,2022,Q2,Blood pressure increased,,2022,Q2,2,F,20210801.0,20220401.0,20220228,20220408,EXP,,NVSC2021PT302471,NOVARTIS,,48.0,YR,,M,Y,44.0,KG,20220408,,PH,PT,PT,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Syncope,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Arrhythmia,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Coronary artery stenosis,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Dyspnoea exertional,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Palpitations,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Wrong technique in product usage process,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205321724,20532172,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Micturition frequency decreased,,2022,Q2,4,F,20220101.0,20220321.0,20220301,20220506,EXP,,NVSC2022PL043542,NOVARTIS,,59.0,YR,,M,Y,,,20220506,,MD,PL,PL,2022,Q2,Adult
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Coronavirus infection,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Malignant neoplasm progression,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Breast cancer metastatic,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Drug ineffective,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Coronavirus infection,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205409872,20540987,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,2,F,20210401.0,20220223.0,20220302,20220603,EXP,,NVSC2022EG046096,NOVARTIS,,77.0,YR,,F,Y,,,20220603,,CN,EG,EG,2022,Q2,Elderly
205526863,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Anaemia,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205526863,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Gastrointestinal polyp haemorrhage,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205526863,20552686,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cerebral infarction,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205526863,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Anaemia,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205526863,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Gastrointestinal polyp haemorrhage,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205526863,20552686,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cerebral infarction,,2022,Q2,3,F,20211211.0,20220425.0,20220304,20220503,EXP,,JP-AstraZeneca-2022A089710,ASTRAZENECA,,83.0,YR,,F,Y,50.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
205635242,20563524,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, qd, after breakfast",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Infusion related reaction,,2022,Q2,2,F,20220228.0,20220325.0,20220308,20220401,EXP,,JP-GLAXOSMITHKLINE-JP2022037469,GLAXOSMITHKLINE,,80.0,YR,,M,Y,,,20220401,,PH,JP,JP,2022,Q2,Elderly
205635242,20563524,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, qd, after breakfast",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,2,F,20220228.0,20220325.0,20220308,20220401,EXP,,JP-GLAXOSMITHKLINE-JP2022037469,GLAXOSMITHKLINE,,80.0,YR,,M,Y,,,20220401,,PH,JP,JP,2022,Q2,Elderly
205635242,20563524,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, qd, after breakfast",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,2,F,20220228.0,20220325.0,20220308,20220401,EXP,,JP-GLAXOSMITHKLINE-JP2022037469,GLAXOSMITHKLINE,,80.0,YR,,M,Y,,,20220401,,PH,JP,JP,2022,Q2,Elderly
205685192,20568519,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,2,F,20220104.0,20220329.0,20220308,20220406,EXP,,JP-DSJP-DSJ-2022-104188AA,DAIICHI,,85.0,YR,,F,Y,42.0,KG,20220406,,MD,JP,JP,2022,Q2,Elderly
205685192,20568519,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Bleeding time prolonged,,2022,Q2,2,F,20220104.0,20220329.0,20220308,20220406,EXP,,JP-DSJP-DSJ-2022-104188AA,DAIICHI,,85.0,YR,,F,Y,42.0,KG,20220406,,MD,JP,JP,2022,Q2,Elderly
205685192,20568519,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qid",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,2,F,20220104.0,20220329.0,20220308,20220406,EXP,,JP-DSJP-DSJ-2022-104188AA,DAIICHI,,85.0,YR,,F,Y,42.0,KG,20220406,,MD,JP,JP,2022,Q2,Elderly
205685192,20568519,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qid",,,,,,,,5.0,MG,Tablet,QD,2022,Q2,Bleeding time prolonged,,2022,Q2,2,F,20220104.0,20220329.0,20220308,20220406,EXP,,JP-DSJP-DSJ-2022-104188AA,DAIICHI,,85.0,YR,,F,Y,42.0,KG,20220406,,MD,JP,JP,2022,Q2,Elderly
205688342,20568834,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q2,Ketoacidosis,,2022,Q2,2,F,20220218.0,20220516.0,20220308,20220527,EXP,,IE-ELI_LILLY_AND_COMPANY-IE202202010825,ELI LILLY AND CO,,80.0,YR,,M,Y,130.0,KG,20220527,,MD,IE,IE,2022,Q2,Elderly
205688342,20568834,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,2,F,20220218.0,20220516.0,20220308,20220527,EXP,,IE-ELI_LILLY_AND_COMPANY-IE202202010825,ELI LILLY AND CO,,80.0,YR,,M,Y,130.0,KG,20220527,,MD,IE,IE,2022,Q2,Elderly
205688342,20568834,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q2,Abdominal distension,,2022,Q2,2,F,20220218.0,20220516.0,20220308,20220527,EXP,,IE-ELI_LILLY_AND_COMPANY-IE202202010825,ELI LILLY AND CO,,80.0,YR,,M,Y,130.0,KG,20220527,,MD,IE,IE,2022,Q2,Elderly
205688342,20568834,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220218.0,20220516.0,20220308,20220527,EXP,,IE-ELI_LILLY_AND_COMPANY-IE202202010825,ELI LILLY AND CO,,80.0,YR,,M,Y,130.0,KG,20220527,,MD,IE,IE,2022,Q2,Elderly
205688342,20568834,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,2,F,20220218.0,20220516.0,20220308,20220527,EXP,,IE-ELI_LILLY_AND_COMPANY-IE202202010825,ELI LILLY AND CO,,80.0,YR,,M,Y,130.0,KG,20220527,,MD,IE,IE,2022,Q2,Elderly
205695722,20569572,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10.0,mg,",,,,,,,,,,,,2022,Q2,Cholelithiasis,,2022,Q2,2,F,20220225.0,20220321.0,20220309,20220401,EXP,,GB-NOVOPROD-895521,NOVO NORDISK,,63.0,YR,,F,Y,95.0,KG,20220401,,MD,GB,GB,2022,Q2,Adult
205730572,20573057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Intentional overdose,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Intentional product misuse,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Intentional overdose,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Intentional product misuse,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,"2107093,J20170040",,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Intentional overdose,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Intentional product misuse,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Intentional overdose,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Intentional product misuse,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205730572,20573057,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,J20170040,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,20220206.0,20220405.0,20220309,20220413,EXP,,CN-AstraZeneca-2022A099918,ASTRAZENECA,,16802.0,DY,,M,Y,72.0,KG,20220413,,MD,CN,,2022,Q2,Elderly
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Coronary artery stenosis,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Micturition frequency decreased,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Palpitations,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Syncope,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Arrhythmia,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram (1 tab in the morning),,,U,,,,,10.0,MG,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Coronary artery stenosis,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Micturition frequency decreased,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Palpitations,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Syncope,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Arrhythmia,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205869193,20586919,17,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 milligram(1 tab in the morning),,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220101.0,20220328.0,20220314,20220406,EXP,,PL-AUROBINDO-AUR-APL-2022-007899,AUROBINDO,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Palpitations,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Micturition frequency decreased,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Coronary artery stenosis,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Syncope,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205917503,20591750,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,10 mg (1 tab in the morning),,,,,Unknown,,,10.0,MG,Tablet,,2022,Q2,Arrhythmia,,2022,Q2,3,F,20220101.0,20220329.0,20220314,20220406,EXP,,PL-PFIZER INC-202200363176,PFIZER,,59.0,YR,,M,Y,,,20220406,,MD,PL,PL,2022,Q2,Adult
205958222,20595822,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q2,Knee arthroplasty,,2022,Q2,2,F,20210706.0,20220404.0,20220315,20220418,EXP,,US-PFIZER INC-202100963505,PFIZER,,57.0,YR,,F,Y,,,20220418,,HP,US,US,2022,Q2,Adult
205958222,20595822,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q2,Diarrhoea,,2022,Q2,2,F,20210706.0,20220404.0,20220315,20220418,EXP,,US-PFIZER INC-202100963505,PFIZER,,57.0,YR,,F,Y,,,20220418,,HP,US,US,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Coronary artery stenosis,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Palpitations,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Dyspnoea exertional,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Micturition frequency decreased,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Oedema peripheral,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206016035,20601603,14,C,DAPAGLIFLOZIN; METFORMIN,,2,Unknown,10 Milligram Daily; 1 tab in the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Arrhythmia,,2022,Q2,5,F,20220101.0,20220330.0,20220316,20220623,EXP,,PL-TEVA-2022-PL-2017223,TEVA,,59.0,YR,A,M,Y,,,20220623,,MD,PL,PL,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Atrial fibrillation,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Atrial fibrillation,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Throat clearing,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Device malfunction,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Loss of consciousness,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Cough,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,COVID-19,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206021416,20602141,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (every morning),,,U,,Unk,,,10.0,MG,,,2022,Q2,Blindness,,2022,Q2,6,F,20220312.0,20220520.0,20220316,20220527,EXP,,NVSC2022US059956,NOVARTIS,,64.0,YR,,M,Y,90.6,KG,20220527,,CN,US,US,2022,Q2,Adult
206041662,20604166,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg, Po, QD. After taking it for about 2 weeks,",,,Y,,unknown,,202293.0,,,Tablet,,2022,Q2,Retinal haemorrhage,,2022,Q2,2,F,,20220408.0,20220316,20220414,EXP,,CN-AstraZeneca-2022A110623,ASTRAZENECA,"Zeng Yan, Ma Chunling.. A case of retinal hemorrhage caused by Dapagliflozin. Chin J Pharmacoepidemiol 2022;31(2):143-144.",43.0,YR,,M,Y,80.0,KG,20220414,,HP,CN,,2022,Q2,Adult
206041662,20604166,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg, Po, QD. After taking it for about 2 weeks,",,,Y,,unknown,,202293.0,,,Tablet,,2022,Q2,Diabetic retinopathy,,2022,Q2,2,F,,20220408.0,20220316,20220414,EXP,,CN-AstraZeneca-2022A110623,ASTRAZENECA,"Zeng Yan, Ma Chunling.. A case of retinal hemorrhage caused by Dapagliflozin. Chin J Pharmacoepidemiol 2022;31(2):143-144.",43.0,YR,,M,Y,80.0,KG,20220414,,HP,CN,,2022,Q2,Adult
206041662,20604166,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Retinal haemorrhage,,2022,Q2,2,F,,20220408.0,20220316,20220414,EXP,,CN-AstraZeneca-2022A110623,ASTRAZENECA,"Zeng Yan, Ma Chunling.. A case of retinal hemorrhage caused by Dapagliflozin. Chin J Pharmacoepidemiol 2022;31(2):143-144.",43.0,YR,,M,Y,80.0,KG,20220414,,HP,CN,,2022,Q2,Adult
206041662,20604166,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic retinopathy,,2022,Q2,2,F,,20220408.0,20220316,20220414,EXP,,CN-AstraZeneca-2022A110623,ASTRAZENECA,"Zeng Yan, Ma Chunling.. A case of retinal hemorrhage caused by Dapagliflozin. Chin J Pharmacoepidemiol 2022;31(2):143-144.",43.0,YR,,M,Y,80.0,KG,20220414,,HP,CN,,2022,Q2,Adult
206048722,20604872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220419.0,20220317,20220427,EXP,,CA-AstraZeneca-2022A108709,ASTRAZENECA,,77.0,YR,,F,Y,,,20220427,,MD,CA,,2022,Q2,Elderly
206048722,20604872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220419.0,20220317,20220427,EXP,,CA-AstraZeneca-2022A108709,ASTRAZENECA,,77.0,YR,,F,Y,,,20220427,,MD,CA,,2022,Q2,Elderly
206048722,20604872,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q2,Abdominal pain upper,,2022,Q2,2,F,,20220419.0,20220317,20220427,EXP,,CA-AstraZeneca-2022A108709,ASTRAZENECA,,77.0,YR,,F,Y,,,20220427,,MD,CA,,2022,Q2,Elderly
206091152,20609115,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220323.0,20220317,20220401,EXP,,US-TEVA-2022-US-2016768,TEVA,"Kankam A, Daines B, Tanami SA, Holder KG, Vemulapalli V, Nambiar R. Chronic diarrhea with significant weight loss due to olmesartan induced enteropathy. J-Invest-Med 2022;70(2):502.",54.0,YR,A,M,Y,,,20220401,,HP,US,US,2022,Q2,Adult
206091152,20609115,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q2,Gastrointestinal disorder,,2022,Q2,2,F,,20220323.0,20220317,20220401,EXP,,US-TEVA-2022-US-2016768,TEVA,"Kankam A, Daines B, Tanami SA, Holder KG, Vemulapalli V, Nambiar R. Chronic diarrhea with significant weight loss due to olmesartan induced enteropathy. J-Invest-Med 2022;70(2):502.",54.0,YR,A,M,Y,,,20220401,,HP,US,US,2022,Q2,Adult
206115894,20611589,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,4,F,,20220314.0,20220318,20220406,EXP,,JP-009507513-2203JPN005996,MERCK,"Mitsui Y, et al.. A case of acromegaly diagnosed after diabetic ketoacidosis during administration of SGLT2 inhibitors. The 32nd Annual Meeting of the Japanese Society for Hypothalamic and Pituitary T. 2022;77",55.0,YR,,M,Y,,,20220406,,MD,JP,JP,2022,Q2,Adult
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Product dose omission issue,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Proteinuria,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Pain,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Peripheral vascular disorder,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Tubulointerstitial nephritis,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Anaemia,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Body temperature increased,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206117262,20611726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Arthralgia,,2022,Q2,2,F,20210510.0,20220608.0,20220318,20220616,EXP,,JP-AstraZeneca-2021A774741,ASTRAZENECA,,72.0,YR,,M,Y,69.0,KG,20220616,,MD,JP,,2022,Q2,Elderly
206125933,20612593,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Gastroenteritis,,2022,Q2,3,F,,20220325.0,20220318,20220401,EXP,,JP-AstraZeneca-2022A114056,ASTRAZENECA,,80.0,YR,,M,Y,,,20220401,,MD,JP,,2022,Q2,Elderly
206125933,20612593,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Decreased appetite,,2022,Q2,3,F,,20220325.0,20220318,20220401,EXP,,JP-AstraZeneca-2022A114056,ASTRAZENECA,,80.0,YR,,M,Y,,,20220401,,MD,JP,,2022,Q2,Elderly
206125933,20612593,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Gastroenteritis,,2022,Q2,3,F,,20220325.0,20220318,20220401,EXP,,JP-AstraZeneca-2022A114056,ASTRAZENECA,,80.0,YR,,M,Y,,,20220401,,MD,JP,,2022,Q2,Elderly
206125933,20612593,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Decreased appetite,,2022,Q2,3,F,,20220325.0,20220318,20220401,EXP,,JP-AstraZeneca-2022A114056,ASTRAZENECA,,80.0,YR,,M,Y,,,20220401,,MD,JP,,2022,Q2,Elderly
206166363,20616636,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, daily",,,,,,,,10.0,MG,,,2022,Q2,Drug interaction,,2022,Q2,3,F,20211001.0,20220325.0,20220321,20220405,EXP,,PT-PFIZER INC-202200395166,PFIZER,,81.0,YR,,F,Y,50.0,KG,20220405,,MD,PT,PT,2022,Q2,Elderly
206166363,20616636,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, daily",,,,,,,,10.0,MG,,,2022,Q2,Presyncope,Presyncope,2022,Q2,3,F,20211001.0,20220325.0,20220321,20220405,EXP,,PT-PFIZER INC-202200395166,PFIZER,,81.0,YR,,F,Y,50.0,KG,20220405,,MD,PT,PT,2022,Q2,Elderly
206166363,20616636,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, daily",,,,,,,,10.0,MG,,,2022,Q2,Syncope,Syncope,2022,Q2,3,F,20211001.0,20220325.0,20220321,20220405,EXP,,PT-PFIZER INC-202200395166,PFIZER,,81.0,YR,,F,Y,50.0,KG,20220405,,MD,PT,PT,2022,Q2,Elderly
206218132,20621813,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD (1+0+0)",,,,,,,,,,,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20211224.0,20220329.0,20220322,20220404,EXP,,NVSC2022PT062432,NOVARTIS,,72.0,YR,,M,Y,,,20220404,,CN,PT,PT,2022,Q2,Elderly
206218132,20621813,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD (1+0+0)",,,,,,,,,,,QD,2022,Q2,Dyspnoea,,2022,Q2,2,F,20211224.0,20220329.0,20220322,20220404,EXP,,NVSC2022PT062432,NOVARTIS,,72.0,YR,,M,Y,,,20220404,,CN,PT,PT,2022,Q2,Elderly
206218132,20621813,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD (1+0+0)",,,,,,,,,,,QD,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,2,F,20211224.0,20220329.0,20220322,20220404,EXP,,NVSC2022PT062432,NOVARTIS,,72.0,YR,,M,Y,,,20220404,,CN,PT,PT,2022,Q2,Elderly
206218132,20621813,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD (1+0+0)",,,,,,,,,,,QD,2022,Q2,Cardiac disorder,,2022,Q2,2,F,20211224.0,20220329.0,20220322,20220404,EXP,,NVSC2022PT062432,NOVARTIS,,72.0,YR,,M,Y,,,20220404,,CN,PT,PT,2022,Q2,Elderly
206237022,20623702,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Multiple organ dysfunction syndrome,,2022,Q2,2,F,20211201.0,20220415.0,20220322,20220425,EXP,,JP-PFIZER INC-202200403880,PFIZER,,86.0,YR,,M,Y,45.6,KG,20220425,,MD,JP,JP,2022,Q2,Elderly
206237022,20623702,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Disease progression,,2022,Q2,2,F,20211201.0,20220415.0,20220322,20220425,EXP,,JP-PFIZER INC-202200403880,PFIZER,,86.0,YR,,M,Y,45.6,KG,20220425,,MD,JP,JP,2022,Q2,Elderly
206237022,20623702,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20211201.0,20220415.0,20220322,20220425,EXP,,JP-PFIZER INC-202200403880,PFIZER,,86.0,YR,,M,Y,45.6,KG,20220425,,MD,JP,JP,2022,Q2,Elderly
206237022,20623702,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,2,F,20211201.0,20220415.0,20220322,20220425,EXP,,JP-PFIZER INC-202200403880,PFIZER,,86.0,YR,,M,Y,45.6,KG,20220425,,MD,JP,JP,2022,Q2,Elderly
206237022,20623702,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac amyloidosis,,2022,Q2,2,F,20211201.0,20220415.0,20220322,20220425,EXP,,JP-PFIZER INC-202200403880,PFIZER,,86.0,YR,,M,Y,45.6,KG,20220425,,MD,JP,JP,2022,Q2,Elderly
206245783,20624578,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cerebral infarction,,2022,Q2,3,F,,20220324.0,20220322,20220405,EXP,,JP-AstraZeneca-2022A119192,ASTRAZENECA,,76.0,YR,,M,Y,,,20220405,,MD,JP,,2022,Q2,Elderly
206245783,20624578,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220324.0,20220322,20220405,EXP,,JP-AstraZeneca-2022A119192,ASTRAZENECA,,76.0,YR,,M,Y,,,20220405,,MD,JP,,2022,Q2,Elderly
206245783,20624578,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNK,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fibrin D dimer increased,,2022,Q2,3,F,,20220324.0,20220322,20220405,EXP,,JP-AstraZeneca-2022A119192,ASTRAZENECA,,76.0,YR,,M,Y,,,20220405,,MD,JP,,2022,Q2,Elderly
206333643,20633364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dry gangrene,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Limb injury,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Osteitis,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dry gangrene,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Limb injury,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206333643,20633364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Osteitis,,2022,Q2,3,F,20200901.0,20220413.0,20220324,20220420,EXP,,FR-AstraZeneca-2022A121262,ASTRAZENECA,,813.0,MON,,M,Y,78.6,KG,20220420,,MD,FR,,2022,Q2,Elderly
206341823,20634182,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,3,F,20210706.0,20220426.0,20220324,20220503,EXP,,CO-ABBVIE-22K-036-4318129-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220503,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
206341823,20634182,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Acne,,2022,Q2,3,F,20210706.0,20220426.0,20220324,20220503,EXP,,CO-ABBVIE-22K-036-4318129-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220503,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
206341823,20634182,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Haemoglobin decreased,,2022,Q2,3,F,20210706.0,20220426.0,20220324,20220503,EXP,,CO-ABBVIE-22K-036-4318129-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220503,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
206341823,20634182,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Aspiration bone marrow,,2022,Q2,3,F,20210706.0,20220426.0,20220324,20220503,EXP,,CO-ABBVIE-22K-036-4318129-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220503,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
206341823,20634182,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Product use issue,,2022,Q2,3,F,20210706.0,20220426.0,20220324,20220503,EXP,,CO-ABBVIE-22K-036-4318129-00,ABBVIE,,74.0,YR,,F,Y,79.0,KG,20220503,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
206344082,20634408,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,2,F,20220101.0,20220331.0,20220325,20220408,EXP,,JP-AstraZeneca-2022A119249,ASTRAZENECA,,80.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206344082,20634408,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Movement disorder,,2022,Q2,2,F,20220101.0,20220331.0,20220325,20220408,EXP,,JP-AstraZeneca-2022A119249,ASTRAZENECA,,80.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206344082,20634408,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Off label use,,2022,Q2,2,F,20220101.0,20220331.0,20220325,20220408,EXP,,JP-AstraZeneca-2022A119249,ASTRAZENECA,,80.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206344082,20634408,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Physical deconditioning,,2022,Q2,2,F,20220101.0,20220331.0,20220325,20220408,EXP,,JP-AstraZeneca-2022A119249,ASTRAZENECA,,80.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Muscular weakness,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Excessive cerumen production,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Muscle tightness,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Cerebrovascular accident,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Illness,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Cardiovascular disorder,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Swollen tongue,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Hypoaesthesia,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Back disorder,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Pericarditis,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Influenza,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Inflammation,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Ill-defined disorder,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Ear infection,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Rash,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206385612,20638561,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q2,Herpes zoster,,2022,Q2,2,F,,20220530.0,20220325,20220606,EXP,,CA-PFIZER INC-202200447368,PFIZER,,58.0,YR,,F,Y,,,20220606,,HP,CA,CA,2022,Q2,Adult
206436852,20643685,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Toe amputation,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206436852,20643685,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Limb injury,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206436852,20643685,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Extremity necrosis,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206436852,20643685,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Toe amputation,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206436852,20643685,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Limb injury,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206436852,20643685,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Extremity necrosis,,2022,Q2,2,F,20220205.0,20220331.0,20220328,20220408,EXP,,FR-AstraZeneca-2022A125612,ASTRAZENECA,,21586.0,DY,,M,Y,70.6,KG,20220408,,MD,FR,,2022,Q2,Elderly
206445022,20644502,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Unknown,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,,20220318.0,20220328,20220403,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-JPN-20220207099,BRISTOL MYERS SQUIBB,,98.0,YR,E,F,Y,,,20220404,,PH,JP,JP,2022,Q2,Elderly
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Back disorder,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Herpes zoster,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Ill-defined disorder,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Rash,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Influenza,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Pericarditis,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Cerebrovascular accident,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Excessive cerumen production,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Muscular weakness,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Illness,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Inflammation,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Ear infection,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypoaesthesia,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Swollen tongue,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Cardiovascular disorder,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Muscle tightness,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206514852,20651485,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,2,F,,20220530.0,20220330,20220607,EXP,,CA-Orion Corporation ORION PHARMA-22_00018066,ORION,,58.0,YR,A,F,Y,,,20220608,,HP,CA,,2022,Q2,Adult
206520752,20652075,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Blood pressure decreased,,2022,Q2,2,F,20211001.0,20220322.0,20220330,20220404,EXP,,NVSC2022RS067108,NOVARTIS,,63.0,YR,,M,Y,,,20220404,,MD,RS,RS,2022,Q2,Adult
206520752,20652075,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Hyperkalaemia,,2022,Q2,2,F,20211001.0,20220322.0,20220330,20220404,EXP,,NVSC2022RS067108,NOVARTIS,,63.0,YR,,M,Y,,,20220404,,MD,RS,RS,2022,Q2,Adult
206520752,20652075,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,2,F,20211001.0,20220322.0,20220330,20220404,EXP,,NVSC2022RS067108,NOVARTIS,,63.0,YR,,M,Y,,,20220404,,MD,RS,RS,2022,Q2,Adult
206520752,20652075,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Hypertensive crisis,,2022,Q2,2,F,20211001.0,20220322.0,20220330,20220404,EXP,,NVSC2022RS067108,NOVARTIS,,63.0,YR,,M,Y,,,20220404,,MD,RS,RS,2022,Q2,Adult
206521943,20652194,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,U,,UNK,,,10.0,MG,,QD,2022,Q2,Neuritis cranial,,2022,Q2,3,F,20191218.0,20220525.0,20220330,20220602,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-044661",REGENERON,Huang Y;Gericke C. Aflibercept-induced recurrent cranial nerve neuritis affecting varying cranial nerves. 74th Annual Meeting of the American Academy of Neurology. 2022;XXX:XXX,67.0,YR,,M,Y,,,20220602,,HP,AU,AU,2022,Q2,Elderly
206562882,20656288,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Ongoing,,,U,,,,,5.0,MG,"Nasal drops, solution",Q12H,2022,Q2,Pericardial effusion,,2022,Q2,2,F,20220302.0,20220330.0,20220331,20220412,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-012366,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,70.0,KG,20220412,,HP,ES,ES,2022,Q2,Adult
206562882,20656288,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Ongoing,,,U,,,,,5.0,MG,"Nasal drops, solution",Q12H,2022,Q2,Asthenia,,2022,Q2,2,F,20220302.0,20220330.0,20220331,20220412,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-012366,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,70.0,KG,20220412,,HP,ES,ES,2022,Q2,Adult
206566673,20656667,11,C,"XIGDUO, DAPAGLIFLOZIN/METFORMINHYDROCHLORID",,2,Oral,,,,U,,,,,1000.0,MG,,QOD,2022,Q2,Hepatitis,,2022,Q2,3,F,20220316.0,20220506.0,20220331,20220512,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-012844,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,69.0,KG,20220512,,HP,DE,DE,2022,Q2,Adult
206606752,20660675,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2022,Q2,Extradural abscess,,2022,Q2,2,F,,20220414.0,20220331,20220419,EXP,,JP-DSJP-DSJ-2022-110929,DAIICHI,,69.0,YR,,M,Y,68.9,KG,20220419,,MD,JP,JP,2022,Q2,Elderly
206606752,20660675,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2022,Q2,Intervertebral discitis,,2022,Q2,2,F,,20220414.0,20220331,20220419,EXP,,JP-DSJP-DSJ-2022-110929,DAIICHI,,69.0,YR,,M,Y,68.9,KG,20220419,,MD,JP,JP,2022,Q2,Elderly
206606752,20660675,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg/day,,,,,,,,,,,,2022,Q2,Infective spondylitis,,2022,Q2,2,F,,20220414.0,20220331,20220419,EXP,,JP-DSJP-DSJ-2022-110929,DAIICHI,,69.0,YR,,M,Y,68.9,KG,20220419,,MD,JP,JP,2022,Q2,Elderly
206614461,20661446,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,20211014.0,20220321.0,20220401,20220401,EXP,AU-TGA-0000678971,AU-NOVOPROD-905094,NOVO NORDISK,,61.0,YR,,M,Y,,,20220401,,HP,AU,AU,2022,Q2,Adult
206614461,20661446,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Abdominal pain,,2022,Q2,1,I,20211014.0,20220321.0,20220401,20220401,EXP,AU-TGA-0000678971,AU-NOVOPROD-905094,NOVO NORDISK,,61.0,YR,,M,Y,,,20220401,,HP,AU,AU,2022,Q2,Adult
206614461,20661446,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,20211014.0,20220321.0,20220401,20220401,EXP,AU-TGA-0000678971,AU-NOVOPROD-905094,NOVO NORDISK,,61.0,YR,,M,Y,,,20220401,,HP,AU,AU,2022,Q2,Adult
206614503,20661450,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Syncope,,2022,Q2,3,F,20211001.0,20220407.0,20220401,20220421,EXP,,PT-AUROBINDO-AUR-APL-2022-010735,AUROBINDO,,81.0,YR,,F,Y,50.0,KG,20220421,,MD,PT,PT,2022,Q2,Elderly
206614503,20661450,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Drug interaction,,2022,Q2,3,F,20211001.0,20220407.0,20220401,20220421,EXP,,PT-AUROBINDO-AUR-APL-2022-010735,AUROBINDO,,81.0,YR,,F,Y,50.0,KG,20220421,,MD,PT,PT,2022,Q2,Elderly
206614503,20661450,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Presyncope,,2022,Q2,3,F,20211001.0,20220407.0,20220401,20220421,EXP,,PT-AUROBINDO-AUR-APL-2022-010735,AUROBINDO,,81.0,YR,,F,Y,50.0,KG,20220421,,MD,PT,PT,2022,Q2,Elderly
206614561,20661456,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram,,,,,,,,,,,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20210702.0,20220321.0,20220401,20220401,EXP,AU-TGA-0000668626,AU-NOVOPROD-904879,NOVO NORDISK,,74.0,YR,,M,Y,,,20220401,,MD,AU,AU,2022,Q2,Elderly
206614561,20661456,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram,,,,,,,,,,,,2022,Q2,Renal impairment,,2022,Q2,1,I,20210702.0,20220321.0,20220401,20220401,EXP,AU-TGA-0000668626,AU-NOVOPROD-904879,NOVO NORDISK,,74.0,YR,,M,Y,,,20220401,,MD,AU,AU,2022,Q2,Elderly
206618692,20661869,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unknown,,,10.0,MG,,,2022,Q2,Chronic kidney disease,,2022,Q2,2,F,,20220329.0,20220401,20220408,EXP,,DE-TEVA-2022-DE-2021786,TEVA,,66.0,YR,E,,Y,,,20220408,,MD,DE,DE,2022,Q2,Elderly
206618692,20661869,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg,,,,,unknown,,,10.0,MG,,,2022,Q2,Acute myocardial infarction,,2022,Q2,2,F,,20220329.0,20220401,20220408,EXP,,DE-TEVA-2022-DE-2021786,TEVA,,66.0,YR,E,,Y,,,20220408,,MD,DE,DE,2022,Q2,Elderly
206629301,20662930,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (take one daily)",,,,,,,,,,,QD,2022,Q2,Angioedema,,2022,Q2,1,I,20220328.0,20220329.0,20220401,20220401,EXP,GB-MHRA-TPP23067701C4890028YC1648478180362,GB-MYLANLABS-2022M1023938,MYLAN,,76.0,YR,,M,Y,95.0,KG,20220401,,MD,GB,GB,2022,Q2,Elderly
206629301,20662930,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd (take one daily)",,,,,,,,,,,QD,2022,Q2,Lip swelling,,2022,Q2,1,I,20220328.0,20220329.0,20220401,20220401,EXP,GB-MHRA-TPP23067701C4890028YC1648478180362,GB-MYLANLABS-2022M1023938,MYLAN,,76.0,YR,,M,Y,95.0,KG,20220401,,MD,GB,GB,2022,Q2,Elderly
206635172,20663517,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1010.0,MG,Y,,MT3063,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ketosis,,2022,Q2,2,F,20220309.0,20220324.0,20220401,20220405,EXP,,CN-AstraZeneca-2022A128834,ASTRAZENECA,,56.0,YR,,F,Y,65.0,KG,20220405,,MD,CN,,2022,Q2,Adult
206642281,20664228,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac arrest,,2022,Q2,1,I,20210317.0,20220323.0,20220401,20220401,PER,GB-MHRA-EYC 00252646,GB-AMGEN-GBRSP2022052308,AMGEN,,67.0,YR,E,M,Y,116.0,KG,20220401,,PH,GB,GB,2022,Q2,Elderly
206642281,20664228,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Anaphylactic reaction,,2022,Q2,1,I,20210317.0,20220323.0,20220401,20220401,PER,GB-MHRA-EYC 00252646,GB-AMGEN-GBRSP2022052308,AMGEN,,67.0,YR,E,M,Y,116.0,KG,20220401,,PH,GB,GB,2022,Q2,Elderly
206643581,20664358,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,1,I,20220201.0,20220322.0,20220401,20220401,EXP,,FR-AstraZeneca-2022A127950,ASTRAZENECA,,948.0,MON,,M,Y,,,20220401,,MD,FR,,2022,Q2,Elderly
206643581,20664358,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20220201.0,20220322.0,20220401,20220401,EXP,,FR-AstraZeneca-2022A127950,ASTRAZENECA,,948.0,MON,,M,Y,,,20220401,,MD,FR,,2022,Q2,Elderly
206643611,20664361,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,1150.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Sepsis,,2022,Q2,1,I,20220126.0,20220325.0,20220401,20220401,EXP,,RO-AstraZeneca-2022A126702,ASTRAZENECA,,63.0,YR,,M,Y,94.0,KG,20220401,,MD,RO,,2022,Q2,Adult
206643611,20664361,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,1150.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection bacterial,,2022,Q2,1,I,20220126.0,20220325.0,20220401,20220401,EXP,,RO-AstraZeneca-2022A126702,ASTRAZENECA,,63.0,YR,,M,Y,94.0,KG,20220401,,MD,RO,,2022,Q2,Adult
206643851,20664385,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,U,,,,202293.0,,,Tablet,,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20211210.0,20220324.0,20220401,20220401,EXP,,DE-AstraZeneca-2022A125551,ASTRAZENECA,,55.0,YR,,M,Y,116.0,KG,20220401,,MD,DE,,2022,Q2,Adult
206643851,20664385,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,U,,,,202293.0,,,Tablet,,2022,Q2,Fournier's gangrene,,2022,Q2,1,I,20211210.0,20220324.0,20220401,20220401,EXP,,DE-AstraZeneca-2022A125551,ASTRAZENECA,,55.0,YR,,M,Y,116.0,KG,20220401,,MD,DE,,2022,Q2,Adult
206647172,20664717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,COVID-19,,2022,Q2,2,F,,20220328.0,20220401,20220405,EXP,,BG-AstraZeneca-2022A133039,ASTRAZENECA,,67.0,YR,,M,Y,,,20220405,,MD,BG,,2022,Q2,Elderly
206657511,20665751,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,U,,,,,10.0,MG,,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20211001.0,20220331.0,20220402,20220402,EXP,,NVSC2022PT067955,NOVARTIS,,81.0,YR,,F,Y,50.0,KG,20220402,,MD,PT,PT,2022,Q2,Elderly
206657511,20665751,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,U,,,,,10.0,MG,,QD,2022,Q2,Syncope,,2022,Q2,1,I,20211001.0,20220331.0,20220402,20220402,EXP,,NVSC2022PT067955,NOVARTIS,,81.0,YR,,F,Y,50.0,KG,20220402,,MD,PT,PT,2022,Q2,Elderly
206657511,20665751,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,U,,,,,10.0,MG,,QD,2022,Q2,Presyncope,,2022,Q2,1,I,20211001.0,20220331.0,20220402,20220402,EXP,,NVSC2022PT067955,NOVARTIS,,81.0,YR,,F,Y,50.0,KG,20220402,,MD,PT,PT,2022,Q2,Elderly
206692751,20669275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,unknown,,202293.0,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,1,I,20210506.0,20220327.0,20220404,20220404,EXP,,GB-AstraZeneca-2021A672325,ASTRAZENECA,,57.0,YR,,F,Y,92.1,KG,20220404,,MD,GB,,2022,Q2,Adult
206692751,20669275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,unknown,,202293.0,10.0,MG,,,2022,Q2,Asthma,,2022,Q2,1,I,20210506.0,20220327.0,20220404,20220404,EXP,,GB-AstraZeneca-2021A672325,ASTRAZENECA,,57.0,YR,,F,Y,92.1,KG,20220404,,MD,GB,,2022,Q2,Adult
206692751,20669275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,unknown,,202293.0,10.0,MG,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20210506.0,20220327.0,20220404,20220404,EXP,,GB-AstraZeneca-2021A672325,ASTRAZENECA,,57.0,YR,,F,Y,92.1,KG,20220404,,MD,GB,,2022,Q2,Adult
206692751,20669275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,unknown,,202293.0,10.0,MG,,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20210506.0,20220327.0,20220404,20220404,EXP,,GB-AstraZeneca-2021A672325,ASTRAZENECA,,57.0,YR,,F,Y,92.1,KG,20220404,,MD,GB,,2022,Q2,Adult
206692751,20669275,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,unknown,,202293.0,10.0,MG,,,2022,Q2,Cough,,2022,Q2,1,I,20210506.0,20220327.0,20220404,20220404,EXP,,GB-AstraZeneca-2021A672325,ASTRAZENECA,,57.0,YR,,F,Y,92.1,KG,20220404,,MD,GB,,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Palpitations,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Oedema peripheral,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Wrong technique in product usage process,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Micturition frequency decreased,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Arrhythmia,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206699722,20669972,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"10 milligram, AM (10 mg (1 tab in the morning))",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Coronary artery stenosis,,2022,Q2,2,F,20220101.0,20220413.0,20220404,20220418,EXP,,PL-MYLANLABS-2022M1024439,MYLAN,,59.0,YR,,M,Y,,,20220418,,MD,PL,PL,2022,Q2,Adult
206702911,20670291,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,Tablet,,2022,Q2,Dizziness,,2022,Q2,1,I,20211008.0,20220330.0,20220404,20220404,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20220404,,CN,GB,GB,2022,Q2,Adult
206702911,20670291,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,U,,,,,,Tablet,,2022,Q2,Pneumonia,,2022,Q2,1,I,20211008.0,20220330.0,20220404,20220404,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20220404,,CN,GB,GB,2022,Q2,Adult
206705511,20670551,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (strength: 10 mg)",,,Y,,2009156,,,10.0,MG,Tablet,QD,2022,Q2,Renal ischaemia,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206705511,20670551,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (strength: 10 mg)",,,Y,,2009156,,,10.0,MG,Tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206705511,20670551,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (strength: 10 mg)",,,Y,,2009156,,,10.0,MG,Tablet,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206714643,20671464,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,,,UNKNOWN,,,10.0,MG,Unknown,QD,2022,Q2,Syncope,,2022,Q2,3,F,20211001.0,20220411.0,20220404,20220415,EXP,,PT-Fresenius Kabi-FK202203791,FRESENIUS KABI,,81.0,YR,,F,Y,50.0,KG,20220415,,HP,NL,,2022,Q2,Elderly
206714643,20671464,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,,,UNKNOWN,,,10.0,MG,Unknown,QD,2022,Q2,Presyncope,,2022,Q2,3,F,20211001.0,20220411.0,20220404,20220415,EXP,,PT-Fresenius Kabi-FK202203791,FRESENIUS KABI,,81.0,YR,,F,Y,50.0,KG,20220415,,HP,NL,,2022,Q2,Elderly
206714643,20671464,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, daily",,,,,UNKNOWN,,,10.0,MG,Unknown,QD,2022,Q2,Drug interaction,,2022,Q2,3,F,20211001.0,20220411.0,20220404,20220415,EXP,,PT-Fresenius Kabi-FK202203791,FRESENIUS KABI,,81.0,YR,,F,Y,50.0,KG,20220415,,HP,NL,,2022,Q2,Elderly
206720112,20672011,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Hyperthyroidism,,2022,Q2,2,F,,20220404.0,20220405,20220418,EXP,,PT-AUROBINDO-AUR-APL-2022-010615,AUROBINDO,"Mendon?a F, Amador F, Costa CM, Borges-Canha M, Neves JS, Pinto R, et al.. DRAMATIC CLINICAL IMPROVEMENT after TOTAL THYROIDECTOMY in A PATIENT AWAITING HEART TRANSPLANT with AMIODARONE-INDUCED THYROTOXICOSIS: A CASE REPORT.. European Thyroid Journal.. 2021;10(1):17",53.0,YR,,M,Y,,,20220418,,MD,PT,PT,2022,Q2,Adult
206720112,20672011,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,2,F,,20220404.0,20220405,20220418,EXP,,PT-AUROBINDO-AUR-APL-2022-010615,AUROBINDO,"Mendon?a F, Amador F, Costa CM, Borges-Canha M, Neves JS, Pinto R, et al.. DRAMATIC CLINICAL IMPROVEMENT after TOTAL THYROIDECTOMY in A PATIENT AWAITING HEART TRANSPLANT with AMIODARONE-INDUCED THYROTOXICOSIS: A CASE REPORT.. European Thyroid Journal.. 2021;10(1):17",53.0,YR,,M,Y,,,20220418,,MD,PT,PT,2022,Q2,Adult
206720112,20672011,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Cachexia,,2022,Q2,2,F,,20220404.0,20220405,20220418,EXP,,PT-AUROBINDO-AUR-APL-2022-010615,AUROBINDO,"Mendon?a F, Amador F, Costa CM, Borges-Canha M, Neves JS, Pinto R, et al.. DRAMATIC CLINICAL IMPROVEMENT after TOTAL THYROIDECTOMY in A PATIENT AWAITING HEART TRANSPLANT with AMIODARONE-INDUCED THYROTOXICOSIS: A CASE REPORT.. European Thyroid Journal.. 2021;10(1):17",53.0,YR,,M,Y,,,20220418,,MD,PT,PT,2022,Q2,Adult
206720112,20672011,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Congestive cardiomyopathy,,2022,Q2,2,F,,20220404.0,20220405,20220418,EXP,,PT-AUROBINDO-AUR-APL-2022-010615,AUROBINDO,"Mendon?a F, Amador F, Costa CM, Borges-Canha M, Neves JS, Pinto R, et al.. DRAMATIC CLINICAL IMPROVEMENT after TOTAL THYROIDECTOMY in A PATIENT AWAITING HEART TRANSPLANT with AMIODARONE-INDUCED THYROTOXICOSIS: A CASE REPORT.. European Thyroid Journal.. 2021;10(1):17",53.0,YR,,M,Y,,,20220418,,MD,PT,PT,2022,Q2,Adult
206720112,20672011,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,,20220404.0,20220405,20220418,EXP,,PT-AUROBINDO-AUR-APL-2022-010615,AUROBINDO,"Mendon?a F, Amador F, Costa CM, Borges-Canha M, Neves JS, Pinto R, et al.. DRAMATIC CLINICAL IMPROVEMENT after TOTAL THYROIDECTOMY in A PATIENT AWAITING HEART TRANSPLANT with AMIODARONE-INDUCED THYROTOXICOSIS: A CASE REPORT.. European Thyroid Journal.. 2021;10(1):17",53.0,YR,,M,Y,,,20220418,,MD,PT,PT,2022,Q2,Adult
206721791,20672179,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Hypertension,,2022,Q2,1,I,,20220325.0,20220405,20220405,EXP,,AU-009507513-2203AUS009756,MERCK,,81.0,YR,,M,Y,,,20220405,,MD,AU,AU,2022,Q2,Elderly
206721791,20672179,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Microalbuminuria,,2022,Q2,1,I,,20220325.0,20220405,20220405,EXP,,AU-009507513-2203AUS009756,MERCK,,81.0,YR,,M,Y,,,20220405,,MD,AU,AU,2022,Q2,Elderly
206721791,20672179,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,,20220325.0,20220405,20220405,EXP,,AU-009507513-2203AUS009756,MERCK,,81.0,YR,,M,Y,,,20220405,,MD,AU,AU,2022,Q2,Elderly
206730701,20673070,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,600.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,1,I,20220208.0,20220331.0,20220405,20220405,EXP,,CO-AstraZeneca-2022A137145,ASTRAZENECA,,31780.0,DY,,F,Y,,,20220405,,CN,CO,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Limb discomfort,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Headache,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chest discomfort,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Peripheral coldness,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206736752,20673675,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Throat tightness,,2022,Q2,2,F,20220326.0,20220419.0,20220405,20220427,EXP,,CA-AstraZeneca-2022A133111,ASTRAZENECA,,72.0,YR,,F,Y,,,20220427,,HP,CA,,2022,Q2,Elderly
206770462,20677046,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220415.0,20220406,20220425,EXP,,GR-NOVOPROD-904969,NOVO NORDISK,,65.0,YR,,M,Y,,,20220425,,MD,GR,GR,2022,Q2,Elderly
206770462,20677046,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q2,Pancreatic carcinoma,,2022,Q2,2,F,,20220415.0,20220406,20220425,EXP,,GR-NOVOPROD-904969,NOVO NORDISK,,65.0,YR,,M,Y,,,20220425,,MD,GR,GR,2022,Q2,Elderly
206784051,20678405,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,20220314.0,20220402.0,20220406,20220406,EXP,FR-AFSSAPS-AM20220841,FR-BAUSCH-BL-2022-008341,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20220406,,MD,FR,FR,2022,Q2,Elderly
206789541,20678954,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,,,,,,5.0,MG,Tablet,,2022,Q2,Vomiting,,2022,Q2,1,I,20220301.0,20220331.0,20220406,20220406,EXP,,JP-009507513-2203JPN004447J,MERCK,,68.0,YR,,F,Y,,,20220406,,PH,JP,JP,2022,Q2,Elderly
206789541,20678954,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram,,,,,,,,5.0,MG,Tablet,,2022,Q2,Adverse event,,2022,Q2,1,I,20220301.0,20220331.0,20220406,20220406,EXP,,JP-009507513-2203JPN004447J,MERCK,,68.0,YR,,F,Y,,,20220406,,PH,JP,JP,2022,Q2,Elderly
206791602,20679160,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Lung opacity,,2022,Q2,2,F,20220318.0,20220401.0,20220406,20220408,EXP,,JP-AstraZeneca-2022A123098,ASTRAZENECA,,81.0,YR,,M,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206791602,20679160,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pulmonary fibrosis,,2022,Q2,2,F,20220318.0,20220401.0,20220406,20220408,EXP,,JP-AstraZeneca-2022A123098,ASTRAZENECA,,81.0,YR,,M,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206792475,20679247,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Febrile bone marrow aplasia,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Sepsis,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206792475,20679247,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Septic shock,,2022,Q2,5,F,20220323.0,20220525.0,20220406,20220526,EXP,,FR-GILEAD-2022-0575736,GILEAD,,67.0,YR,E,F,Y,75.0,KG,20220526,,MD,FR,FR,2022,Q2,Elderly
206800271,20680027,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,20220314.0,20220404.0,20220406,20220406,EXP,FR-AFSSAPS-AM20220841,NVSC2022FR076007,NOVARTIS,,74.0,YR,,M,Y,,,20220406,,MD,FR,FR,2022,Q2,Elderly
206807981,20680798,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal disorder,,2022,Q2,1,I,20180604.0,20220327.0,20220406,20220406,EXP,,IL-AstraZeneca-2022A132012,ASTRAZENECA,,70.0,YR,,F,Y,,,20220406,,MD,IL,,2022,Q2,Elderly
206807981,20680798,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20180604.0,20220327.0,20220406,20220406,EXP,,IL-AstraZeneca-2022A132012,ASTRAZENECA,,70.0,YR,,F,Y,,,20220406,,MD,IL,,2022,Q2,Elderly
206809921,20680992,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,20180101.0,20220331.0,20220406,20220406,EXP,,DE-AstraZeneca-2022A137634,ASTRAZENECA,,74.0,YR,,M,Y,,,20220406,,MD,DE,,2022,Q2,Elderly
206809921,20680992,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20180101.0,20220331.0,20220406,20220406,EXP,,DE-AstraZeneca-2022A137634,ASTRAZENECA,,74.0,YR,,M,Y,,,20220406,,MD,DE,,2022,Q2,Elderly
206824771,20682477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20220306.0,20220330.0,20220407,20220407,EXP,,ES-AstraZeneca-2022A109401,ASTRAZENECA,,37.0,YR,,F,Y,62.0,KG,20220407,,MD,ES,,2022,Q2,Adult
206824771,20682477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220306.0,20220330.0,20220407,20220407,EXP,,ES-AstraZeneca-2022A109401,ASTRAZENECA,,37.0,YR,,F,Y,62.0,KG,20220407,,MD,ES,,2022,Q2,Adult
206828901,20682890,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet,,,,,Unknown,,,,,,,2022,Q2,Rash macular,,2022,Q2,1,I,20220203.0,20220207.0,20220407,20220407,EXP,GB-MHRA-ADR 26555998,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-01100,ALKEM,,35.0,YR,,M,Y,65.0,KG,20220407,,HP,GB,GB,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Immunosuppressant drug level increased,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Dialysis,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Sepsis,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Liver injury,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206834591,20683459,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Device related infection,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,CA-MYLANLABS-2022M1024455,MYLAN,,57.0,YR,,F,Y,,,20220407,,HP,CA,CA,2022,Q2,Adult
206837201,20683720,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,US-MYLANLABS-2022M1025271,MYLAN,"Kumar GS, Chaudhary C, Cheng R, Klein L. A SURPRISING CASE OF MELAS IN A PATIENT PRESENTING WITH DECOMPENSATED HEART FAILURE. J-Am-Coll-Cardiol 2022;79 (Suppl.)(9):3382.",31.0,YR,,F,Y,,,20220407,,HP,US,US,2022,Q2,Young Adult
206841271,20684127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220226.0,20220330.0,20220407,20220407,EXP,,RO-AstraZeneca-2022A131918,ASTRAZENECA,,64.0,YR,,,Y,72.0,KG,20220407,,MD,RO,,2022,Q2,Adult
206841271,20684127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Candida infection,,2022,Q2,1,I,20220226.0,20220330.0,20220407,20220407,EXP,,RO-AstraZeneca-2022A131918,ASTRAZENECA,,64.0,YR,,,Y,72.0,KG,20220407,,MD,RO,,2022,Q2,Adult
206850111,20685011,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q2,Melaena,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,IT-AstraZeneca-2022A131990,ASTRAZENECA,,72.0,YR,,F,Y,,,20220407,,MD,IT,,2022,Q2,Elderly
206850111,20685011,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q2,Anaemia,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,IT-AstraZeneca-2022A131990,ASTRAZENECA,,72.0,YR,,F,Y,,,20220407,,MD,IT,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Insomnia,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cataract,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic neuropathy,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Off label use,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Myalgia,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Eye oedema,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Keratitis,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Visual impairment,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Back pain,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206852663,20685266,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,18270.0,MG,U,,apd184,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pain in extremity,,2022,Q2,3,F,20180101.0,20220406.0,20220407,20220421,EXP,,DO-AstraZeneca-2021A634698,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,CN,DO,,2022,Q2,Elderly
206859321,20685932,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pruritus,,2022,Q2,1,I,20220228.0,20220330.0,20220407,20220407,EXP,,FR-AstraZeneca-2022A132048,ASTRAZENECA,,89.0,YR,,F,Y,63.6,KG,20220407,,MD,FR,,2022,Q2,Elderly
206870901,20687090,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Interstitial lung disease,,2022,Q2,1,I,,20220404.0,20220407,20220407,EXP,,NVSJ2022JP005648,NOVARTIS,,70.0,YR,,M,Y,,,20220408,,MD,JP,JP,2022,Q2,Elderly
206873281,20687328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Abdominal pain,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Pulmonary embolism,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Blood viscosity increased,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Hypercoagulation,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Hypovolaemia,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206881921,20688192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Right ventricular dysfunction,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,GB-AstraZeneca-2022A137141,ASTRAZENECA,"Brinksman P, Kejem H, Srinivas-Shankar U. Do sodium-glucose link transporter 2 inhibitors (SGLT2i) predispose to venous thromboembolism?. 2022 UK PROFESSIONAL CONFERENCE ON DIABETES - DIABETES UK 2022;32582444.",59.0,YR,,M,Y,,,20220408,,HP,GB,,2022,Q2,Adult
206882671,20688267,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Toxic skin eruption,,2022,Q2,1,I,20220225.0,20220404.0,20220408,20220408,EXP,FR-AFSSAPS-LL20221266,NVSC2022FR077013,NOVARTIS,,79.0,YR,,M,Y,92.0,KG,20220408,,PH,FR,FR,2022,Q2,Elderly
206882671,20688267,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Rash maculo-papular,,2022,Q2,1,I,20220225.0,20220404.0,20220408,20220408,EXP,FR-AFSSAPS-LL20221266,NVSC2022FR077013,NOVARTIS,,79.0,YR,,M,Y,92.0,KG,20220408,,PH,FR,FR,2022,Q2,Elderly
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Micturition frequency decreased,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Arrhythmia,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Coronary artery stenosis,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Palpitations,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Arteriosclerosis coronary artery,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Syncope,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Wrong technique in product usage process,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206885311,20688531,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 tab in the morning,,,U,,,,,10.0,MG,,,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,20220101.0,20220325.0,20220408,20220408,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-332434,RANBAXY,,59.0,YR,,M,Y,,,20220408,,MD,PL,PL,2022,Q2,Adult
206901331,20690133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg increased to 25 mg,,,U,,,,202293.0,,,Tablet,,2022,Q2,Off label use,,2022,Q2,1,I,20220202.0,20220401.0,20220408,20220408,EXP,,CA-AstraZeneca-2022A107235,ASTRAZENECA,,76.0,YR,,M,Y,,,20220408,,HP,CA,,2022,Q2,Elderly
206901331,20690133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg increased to 25 mg,,,U,,,,202293.0,,,Tablet,,2022,Q2,Prostatic disorder,,2022,Q2,1,I,20220202.0,20220401.0,20220408,20220408,EXP,,CA-AstraZeneca-2022A107235,ASTRAZENECA,,76.0,YR,,M,Y,,,20220408,,HP,CA,,2022,Q2,Elderly
206901331,20690133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg increased to 25 mg,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary incontinence,,2022,Q2,1,I,20220202.0,20220401.0,20220408,20220408,EXP,,CA-AstraZeneca-2022A107235,ASTRAZENECA,,76.0,YR,,M,Y,,,20220408,,HP,CA,,2022,Q2,Elderly
206902181,20690218,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Agranulocytosis,,2022,Q2,1,I,20220308.0,20220405.0,20220408,20220408,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20220408,,MD,CH,CH,2022,Q2,Elderly
206902181,20690218,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Pancytopenia,,2022,Q2,1,I,20220308.0,20220405.0,20220408,20220408,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20220408,,MD,CH,CH,2022,Q2,Elderly
206902181,20690218,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,1,I,20220308.0,20220405.0,20220408,20220408,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20220408,,MD,CH,CH,2022,Q2,Elderly
206909951,20690995,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ischaemia,,2022,Q2,1,I,20220108.0,20220331.0,20220408,20220408,EXP,,FR-AstraZeneca-2022A137769,ASTRAZENECA,,32581.0,DY,,F,Y,,,20220408,,MD,FR,,2022,Q2,Elderly
206909981,20690998,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Eructation,,2022,Q2,1,I,20210314.0,20220330.0,20220408,20220408,EXP,,CN-Eisai Medical Research-EC-2022-112228,EISAI,,68.0,YR,E,F,Y,85.0,KG,20220408,,MD,CN,,2022,Q2,Elderly
206909981,20690998,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Platelet count decreased,,2022,Q2,1,I,20210314.0,20220330.0,20220408,20220408,EXP,,CN-Eisai Medical Research-EC-2022-112228,EISAI,,68.0,YR,E,F,Y,85.0,KG,20220408,,MD,CN,,2022,Q2,Elderly
206909981,20690998,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Blood albumin decreased,,2022,Q2,1,I,20210314.0,20220330.0,20220408,20220408,EXP,,CN-Eisai Medical Research-EC-2022-112228,EISAI,,68.0,YR,E,F,Y,85.0,KG,20220408,,MD,CN,,2022,Q2,Elderly
206909981,20690998,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Epistaxis,,2022,Q2,1,I,20210314.0,20220330.0,20220408,20220408,EXP,,CN-Eisai Medical Research-EC-2022-112228,EISAI,,68.0,YR,E,F,Y,85.0,KG,20220408,,MD,CN,,2022,Q2,Elderly
206909981,20690998,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20210314.0,20220330.0,20220408,20220408,EXP,,CN-Eisai Medical Research-EC-2022-112228,EISAI,,68.0,YR,E,F,Y,85.0,KG,20220408,,MD,CN,,2022,Q2,Elderly
206910131,20691013,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,,10.0,MG,Tablet,,2022,Q2,Hepatic function abnormal,,2022,Q2,1,I,20220121.0,20220404.0,20220408,20220408,EXP,,JP-009507513-2204JPN002592,MERCK,,6.0,DEC,,F,Y,,,20220408,,MD,JP,JP,2022,Q2,Child
206914441,20691444,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,,QD,2022,Q2,Syncope,,2022,Q2,1,I,20211228.0,20220331.0,20220408,20220408,EXP,,US-AstraZeneca-2022A035598,ASTRAZENECA,,30605.0,DY,,M,Y,,,20220408,,MD,GB,,2022,Q2,Elderly
206914441,20691444,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,1,I,20211228.0,20220331.0,20220408,20220408,EXP,,US-AstraZeneca-2022A035598,ASTRAZENECA,,30605.0,DY,,M,Y,,,20220408,,MD,GB,,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Thermal burn,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac arrest,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Productive cough,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Chest discomfort,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Thyroid disorder,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Fall,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206916152,20691615,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (one tablet after breakfast)",,,,,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Drug ineffective,,2022,Q2,2,F,20210101.0,20220402.0,20220408,20220412,EXP,,NVSC2022EG076752,NOVARTIS,,70.0,YR,,F,Y,,,20220412,,CN,EG,EG,2022,Q2,Elderly
206926971,20692697,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,,20220331.0,20220409,20220409,EXP,,JP-AstraZeneca-2022A137865,ASTRAZENECA,,45.0,YR,,F,Y,,,20220409,,MD,JP,,2022,Q2,Adult
206926971,20692697,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,,20220331.0,20220409,20220409,EXP,,JP-AstraZeneca-2022A137865,ASTRAZENECA,,45.0,YR,,F,Y,,,20220409,,MD,JP,,2022,Q2,Adult
206927172,20692717,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",110.769,MG,Y,,,,,10.0,MG,,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,2,F,20220316.0,20220509.0,20220409,20220510,EXP,FR-AFSSAPS-MP20221516,NVSC2022FR076254,NOVARTIS,,46.0,YR,,F,Y,,,20220510,,MD,FR,FR,2022,Q2,Adult
206935291,20693529,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q2,Dizziness,,2022,Q2,1,I,20211008.0,20220330.0,20220411,20220411,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20220411,,MD,GB,GB,2022,Q2,Adult
206935291,20693529,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q2,Pneumonia,,2022,Q2,1,I,20211008.0,20220330.0,20220411,20220411,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20220411,,MD,GB,GB,2022,Q2,Adult
206935291,20693529,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q2,Dizziness,,2022,Q2,1,I,20211008.0,20220330.0,20220411,20220411,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20220411,,MD,GB,GB,2022,Q2,Adult
206935291,20693529,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q2,Pneumonia,,2022,Q2,1,I,20211008.0,20220330.0,20220411,20220411,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20220411,,MD,GB,GB,2022,Q2,Adult
206943271,20694327,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220330.0,20220411,20220411,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-05255,LUPIN,"Kumar GS, Chaudhary C, Cheng R, Klein L. A surprising case of melas in a patient presenting with decompensated heart failure. Journal of the American College of Cardiology. 2022;79(9):3382",31.0,YR,,F,Y,,,20220411,,HP,US,US,2022,Q2,Young Adult
206943271,20694327,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220330.0,20220411,20220411,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-05255,LUPIN,"Kumar GS, Chaudhary C, Cheng R, Klein L. A surprising case of melas in a patient presenting with decompensated heart failure. Journal of the American College of Cardiology. 2022;79(9):3382",31.0,YR,,F,Y,,,20220411,,HP,US,US,2022,Q2,Young Adult
206943271,20694327,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220330.0,20220411,20220411,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-05255,LUPIN,"Kumar GS, Chaudhary C, Cheng R, Klein L. A surprising case of melas in a patient presenting with decompensated heart failure. Journal of the American College of Cardiology. 2022;79(9):3382",31.0,YR,,F,Y,,,20220411,,HP,US,US,2022,Q2,Young Adult
206947171,20694717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,In the morning,,,Y,,,,202293.0,,,,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,20220213.0,20220401.0,20220411,20220411,EXP,,GB-AstraZeneca-2022A136251,ASTRAZENECA,,73.0,YR,,M,Y,,,20220411,,MD,GB,,2022,Q2,Elderly
206947171,20694717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,In the morning,,,Y,,,,202293.0,,,,,2022,Q2,Gangrene,,2022,Q2,1,I,20220213.0,20220401.0,20220411,20220411,EXP,,GB-AstraZeneca-2022A136251,ASTRAZENECA,,73.0,YR,,M,Y,,,20220411,,MD,GB,,2022,Q2,Elderly
206959581,20695958,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,"Hallucination, visual",,2022,Q2,1,I,20220309.0,20220407.0,20220411,20220411,EXP,,DE-009507513-2204DEU002567,MERCK,,91.0,YR,,F,Y,,,20220411,,MD,DE,DE,2022,Q2,Elderly
206959581,20695958,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Delirium,,2022,Q2,1,I,20220309.0,20220407.0,20220411,20220411,EXP,,DE-009507513-2204DEU002567,MERCK,,91.0,YR,,F,Y,,,20220411,,MD,DE,DE,2022,Q2,Elderly
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Haemorrhage,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Pleural effusion,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Pruritus,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Blood pressure increased,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Pericardial effusion,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206963863,20696386,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (one tablet per day in the morning),,,,,,,,,,,,2022,Q2,Scratch,,2022,Q2,3,F,20211025.0,20220411.0,20220411,20220419,EXP,,NVSC2022EG080110,NOVARTIS,,62.0,YR,,M,Y,,,20220419,,CN,EG,EG,2022,Q2,Adult
206965071,20696507,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, 1x/day",,,,,,,,,,,QD,2022,Q2,Angioedema,,2022,Q2,1,I,20220328.0,20220329.0,20220411,20220411,EXP,GB-MHRA-TPP23067701C4890028YC1648478180362,GB-PFIZER INC-202200488998,PFIZER,,76.0,YR,,M,Y,95.0,KG,20220411,,MD,GB,GB,2022,Q2,Elderly
206965071,20696507,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, 1x/day",,,,,,,,,,,QD,2022,Q2,Lip swelling,,2022,Q2,1,I,20220328.0,20220329.0,20220411,20220411,EXP,GB-MHRA-TPP23067701C4890028YC1648478180362,GB-PFIZER INC-202200488998,PFIZER,,76.0,YR,,M,Y,95.0,KG,20220411,,MD,GB,GB,2022,Q2,Elderly
206971013,20697101,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,560.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Skin exfoliation,,2022,Q2,3,F,20211207.0,20220518.0,20220411,20220523,EXP,,JP-AstraZeneca-2022A144117,ASTRAZENECA,,89.0,YR,,M,Y,,,20220523,,MD,JP,,2022,Q2,Elderly
206971013,20697101,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,560.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rash,,2022,Q2,3,F,20211207.0,20220518.0,20220411,20220523,EXP,,JP-AstraZeneca-2022A144117,ASTRAZENECA,,89.0,YR,,M,Y,,,20220523,,MD,JP,,2022,Q2,Elderly
206971013,20697101,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,560.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Circulatory collapse,,2022,Q2,3,F,20211207.0,20220518.0,20220411,20220523,EXP,,JP-AstraZeneca-2022A144117,ASTRAZENECA,,89.0,YR,,M,Y,,,20220523,,MD,JP,,2022,Q2,Elderly
206971013,20697101,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,560.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Oedema,,2022,Q2,3,F,20211207.0,20220518.0,20220411,20220523,EXP,,JP-AstraZeneca-2022A144117,ASTRAZENECA,,89.0,YR,,M,Y,,,20220523,,MD,JP,,2022,Q2,Elderly
206980421,20698042,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Surgery,,2022,Q2,1,I,20220401.0,20220408.0,20220412,20220412,EXP,,LB-ABBVIE-22K-093-4352585-00,ABBVIE,,80.0,YR,,F,Y,,,20220412,,CN,COUNTRY NOT SPECIFIED,LB,2022,Q2,Elderly
206992401,20699240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,500.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hepatic function abnormal,,2022,Q2,1,I,20220121.0,20220404.0,20220412,20220412,EXP,,JP-AstraZeneca-2022A098272,ASTRAZENECA,,60.0,YR,,F,Y,,,20220412,,MD,JP,,2022,Q2,Adult
206999591,20699959,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Pulmonary embolism,,2022,Q2,1,I,,20220404.0,20220412,20220412,EXP,,JP-AstraZeneca-2022A143565,ASTRAZENECA,,80.0,YR,,M,Y,,,20220412,,PH,JP,,2022,Q2,Elderly
206999591,20699959,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Varicose vein,,2022,Q2,1,I,,20220404.0,20220412,20220412,EXP,,JP-AstraZeneca-2022A143565,ASTRAZENECA,,80.0,YR,,M,Y,,,20220412,,PH,JP,,2022,Q2,Elderly
206999591,20699959,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Pulmonary embolism,,2022,Q2,1,I,,20220404.0,20220412,20220412,EXP,,JP-AstraZeneca-2022A143565,ASTRAZENECA,,80.0,YR,,M,Y,,,20220412,,PH,JP,,2022,Q2,Elderly
206999591,20699959,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Varicose vein,,2022,Q2,1,I,,20220404.0,20220412,20220412,EXP,,JP-AstraZeneca-2022A143565,ASTRAZENECA,,80.0,YR,,M,Y,,,20220412,,PH,JP,,2022,Q2,Elderly
207001961,20700196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,U,,2105209,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Ketoacidosis,,2022,Q2,1,I,20220322.0,20220404.0,20220412,20220412,EXP,,CN-AstraZeneca-2022A141735,ASTRAZENECA,,13540.0,DY,,M,Y,,,20220412,,MD,CN,,2022,Q2,Elderly
207001961,20700196,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,U,,2105209,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Ulnar nerve injury,,2022,Q2,1,I,20220322.0,20220404.0,20220412,20220412,EXP,,CN-AstraZeneca-2022A141735,ASTRAZENECA,,13540.0,DY,,M,Y,,,20220412,,MD,CN,,2022,Q2,Elderly
207003713,20700371,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Sudden cardiac death,,2022,Q2,3,F,20220322.0,20220509.0,20220412,20220519,EXP,,DE-009507513-2204DEU003361,MERCK,,82.0,YR,,F,Y,89.3,KG,20220519,,MD,DE,DE,2022,Q2,Elderly
207005463,20700546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Bacteraemia,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cardiac failure congestive,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Bacteraemia,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2485.0,MG,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cardiac failure congestive,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Bacteraemia,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207005463,20700546,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure congestive,,2022,Q2,3,F,20211118.0,20220620.0,20220412,20220624,EXP,,JP-AstraZeneca-2021A882184,ASTRAZENECA,,83.0,YR,,M,Y,84.0,KG,20220624,,MD,JP,,2022,Q2,Elderly
207008201,20700820,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Hypotension,,2022,Q2,1,I,20220101.0,20220407.0,20220412,20220412,EXP,,HR-MYLANLABS-2022M1026452,MYLAN,,49.0,YR,,M,Y,93.0,KG,20220412,,MD,HR,HR,2022,Q2,Adult
207008201,20700820,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Cough,,2022,Q2,1,I,20220101.0,20220407.0,20220412,20220412,EXP,,HR-MYLANLABS-2022M1026452,MYLAN,,49.0,YR,,M,Y,93.0,KG,20220412,,MD,HR,HR,2022,Q2,Adult
207008201,20700820,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Colitis ulcerative,,2022,Q2,1,I,20220101.0,20220407.0,20220412,20220412,EXP,,HR-MYLANLABS-2022M1026452,MYLAN,,49.0,YR,,M,Y,93.0,KG,20220412,,MD,HR,HR,2022,Q2,Adult
207008201,20700820,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220101.0,20220407.0,20220412,20220412,EXP,,HR-MYLANLABS-2022M1026452,MYLAN,,49.0,YR,,M,Y,93.0,KG,20220412,,MD,HR,HR,2022,Q2,Adult
207016262,20701626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac disorder,,2022,Q2,2,F,,20220405.0,20220412,20220413,EXP,,RU-AstraZeneca-2022A140912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220413,,HP,RU,,2022,Q2,Elderly
207016262,20701626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood pressure increased,,2022,Q2,2,F,,20220405.0,20220412,20220413,EXP,,RU-AstraZeneca-2022A140912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220413,,HP,RU,,2022,Q2,Elderly
207016262,20701626,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Abdominal discomfort,,2022,Q2,2,F,,20220405.0,20220412,20220413,EXP,,RU-AstraZeneca-2022A140912,ASTRAZENECA,,70.0,YR,,F,Y,,,20220413,,HP,RU,,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Haematemesis,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Syncope,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Shock haemorrhagic,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207027061,20702706,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,tablets,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220407.0,20220412,20220412,EXP,,CA-DSJP-DSU-2022-112489,DAIICHI,,72.0,YR,,M,Y,,,20220412,,PH,CA,CA,2022,Q2,Elderly
207028642,20702864,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Aortic aneurysm rupture,,2022,Q2,2,F,,20220516.0,20220412,20220525,PER,JP-ONO-2022JP009031,JP-AMGEN-JPNNI2022062955,AMGEN,,78.0,YR,E,F,Y,41.3,KG,20220525,,MD,JP,JP,2022,Q2,Elderly
207028642,20702864,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Cold sweat,,2022,Q2,2,F,,20220516.0,20220412,20220525,PER,JP-ONO-2022JP009031,JP-AMGEN-JPNNI2022062955,AMGEN,,78.0,YR,E,F,Y,41.3,KG,20220525,,MD,JP,JP,2022,Q2,Elderly
207037921,20703792,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablets,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220406.0,20220413,20220413,EXP,,CA-BAXTER-2022BAX008069,BAXTER,,60.0,YR,,M,Y,97.0,KG,20220413,,HP,CA,CA,2022,Q2,Adult
207037921,20703792,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,Tablets,,2022,Q2,Febrile neutropenia,,2022,Q2,1,I,,20220406.0,20220413,20220413,EXP,,CA-BAXTER-2022BAX008069,BAXTER,,60.0,YR,,M,Y,97.0,KG,20220413,,HP,CA,CA,2022,Q2,Adult
207041753,20704175,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fournier's gangrene,,2022,Q2,3,F,20211101.0,20220520.0,20220413,20220525,EXP,,JP-AstraZeneca-2022A143989,ASTRAZENECA,"Yamashita Y, et al.. 229 A case of chronic heart failure and type 2 diabetes mellitus accompanied by newly developed Fournier^s gangrene while SGLT2 inhibitors were administered.. The 235th Kinki Regional Meeting of the Japanese Society of Internal Medicine; 2022 Mar 12-; (not from Embase) 2022;",1090.0,MON,,M,Y,55.0,KG,20220525,,MD,JP,,2022,Q2,Elderly
207041753,20704175,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,3,F,20211101.0,20220520.0,20220413,20220525,EXP,,JP-AstraZeneca-2022A143989,ASTRAZENECA,"Yamashita Y, et al.. 229 A case of chronic heart failure and type 2 diabetes mellitus accompanied by newly developed Fournier^s gangrene while SGLT2 inhibitors were administered.. The 235th Kinki Regional Meeting of the Japanese Society of Internal Medicine; 2022 Mar 12-; (not from Embase) 2022;",1090.0,MON,,M,Y,55.0,KG,20220525,,MD,JP,,2022,Q2,Elderly
207041762,20704176,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Facial spasm,,2022,Q2,2,F,,20220405.0,20220413,20220502,EXP,,JP-AstraZeneca-2022A144001,ASTRAZENECA,"Hagiwara Y, et al. P14-2 Three cases of euglycaemic ketoacidosis triggered by hyperinvasiveness. The 49th Annual Meeting of the Japanese Society of Intensive Care Medicine; 18-Mar-2022 2022;411-.",55.0,YR,,M,Y,,,20220502,,MD,JP,,2022,Q2,Adult
207041762,20704176,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,2,F,,20220405.0,20220413,20220502,EXP,,JP-AstraZeneca-2022A144001,ASTRAZENECA,"Hagiwara Y, et al. P14-2 Three cases of euglycaemic ketoacidosis triggered by hyperinvasiveness. The 49th Annual Meeting of the Japanese Society of Intensive Care Medicine; 18-Mar-2022 2022;411-.",55.0,YR,,M,Y,,,20220502,,MD,JP,,2022,Q2,Adult
207043331,20704333,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (daily dose: 10 Mg millgram(s) every Days)",,,,,,,,10.0,MG,,QD,2022,Q2,Lactic acidosis,,2022,Q2,1,I,20220131.0,20220404.0,20220413,20220413,EXP,,DE-MYLANLABS-2022M1025357,MYLAN,,79.0,YR,,M,Y,65.0,KG,20220413,,MD,DE,DE,2022,Q2,Elderly
207043331,20704333,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (daily dose: 10 Mg millgram(s) every Days)",,,,,,,,10.0,MG,,QD,2022,Q2,Coma,,2022,Q2,1,I,20220131.0,20220404.0,20220413,20220413,EXP,,DE-MYLANLABS-2022M1025357,MYLAN,,79.0,YR,,M,Y,65.0,KG,20220413,,MD,DE,DE,2022,Q2,Elderly
207061972,20706197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,2,F,,20220405.0,20220413,20220502,EXP,,JP-AstraZeneca-2022A143692,ASTRAZENECA,"Hagiwara Y, et al.. P14-2 Three cases of euglycaemic ketoacidosis triggered by hyperinvasiveness.. The 49th Annual Meeting of the Japanese Society of Intensive Care Medicine; 2022 Mar 18-; (not from Embase) 2022;411-.",39.0,YR,,M,Y,,,20220502,,MD,JP,,2022,Q2,Adult
207061972,20706197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Pancreatitis,,2022,Q2,2,F,,20220405.0,20220413,20220502,EXP,,JP-AstraZeneca-2022A143692,ASTRAZENECA,"Hagiwara Y, et al.. P14-2 Three cases of euglycaemic ketoacidosis triggered by hyperinvasiveness.. The 49th Annual Meeting of the Japanese Society of Intensive Care Medicine; 2022 Mar 18-; (not from Embase) 2022;411-.",39.0,YR,,M,Y,,,20220502,,MD,JP,,2022,Q2,Adult
207062031,20706203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207062031,20706203,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,,20220408.0,20220413,20220413,EXP,,FR-AstraZeneca-2022A147498,ASTRAZENECA,,89.0,YR,,F,Y,,,20220413,,MD,FR,,2022,Q2,Elderly
207079311,20707931,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",110.769,MG,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220404.0,20220414,20220414,EXP,,FR-AUROBINDO-AUR-APL-2022-012400,AUROBINDO,,46.0,YR,,F,Y,142.6,KG,20220414,,MD,FR,FR,2022,Q2,Adult
207087061,20708706,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once a Day (1 comprimido al dia)(1 tablet a day)",,,,,,,,,,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20211208.0,20220404.0,20220414,20220414,EXP,,ES-AUROBINDO-AUR-APL-2022-012311,AUROBINDO,,65.0,YR,,F,Y,,,20220414,,MD,ES,ES,2022,Q2,Elderly
207087061,20708706,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once a Day (1 comprimido al dia)(1 tablet a day)",,,,,,,,,,Tablet,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20211208.0,20220404.0,20220414,20220414,EXP,,ES-AUROBINDO-AUR-APL-2022-012311,AUROBINDO,,65.0,YR,,F,Y,,,20220414,,MD,ES,ES,2022,Q2,Elderly
207090401,20709040,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,20220214.0,20220407.0,20220414,20220414,EXP,,CN-009507513-2204CHN002690,MERCK,,73.0,YR,,F,Y,58.9,KG,20220414,,HP,CN,CN,2022,Q2,Elderly
207090401,20709040,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Gastrooesophageal reflux disease,,2022,Q2,1,I,20220214.0,20220407.0,20220414,20220414,EXP,,CN-009507513-2204CHN002690,MERCK,,73.0,YR,,F,Y,58.9,KG,20220414,,HP,CN,CN,2022,Q2,Elderly
207090401,20709040,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220214.0,20220407.0,20220414,20220414,EXP,,CN-009507513-2204CHN002690,MERCK,,73.0,YR,,F,Y,58.9,KG,20220414,,HP,CN,CN,2022,Q2,Elderly
207090401,20709040,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,20220214.0,20220407.0,20220414,20220414,EXP,,CN-009507513-2204CHN002690,MERCK,,73.0,YR,,F,Y,58.9,KG,20220414,,HP,CN,CN,2022,Q2,Elderly
207092041,20709204,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,COVID-19,,2022,Q2,1,I,20220316.0,20220407.0,20220414,20220414,EXP,,RU-AstraZeneca-2022A145166,ASTRAZENECA,,77.0,YR,,F,Y,,,20220414,,MD,RU,,2022,Q2,Elderly
207092041,20709204,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,20220316.0,20220407.0,20220414,20220414,EXP,,RU-AstraZeneca-2022A145166,ASTRAZENECA,,77.0,YR,,F,Y,,,20220414,,MD,RU,,2022,Q2,Elderly
207097001,20709700,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Abdominal pain,,2022,Q2,1,I,20211014.0,20220406.0,20220414,20220414,EXP,,AU-AstraZeneca-2022A145089,ASTRAZENECA,,61.0,YR,,M,Y,,,20220414,,MD,AU,,2022,Q2,Adult
207097001,20709700,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,20211014.0,20220406.0,20220414,20220414,EXP,,AU-AstraZeneca-2022A145089,ASTRAZENECA,,61.0,YR,,M,Y,,,20220414,,MD,AU,,2022,Q2,Adult
207097001,20709700,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Vomiting,,2022,Q2,1,I,20211014.0,20220406.0,20220414,20220414,EXP,,AU-AstraZeneca-2022A145089,ASTRAZENECA,,61.0,YR,,M,Y,,,20220414,,MD,AU,,2022,Q2,Adult
207097421,20709742,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,20220314.0,20220404.0,20220414,20220414,EXP,FR-AFSSAPS-AM20220841,FR-ROCHE-3070334,ROCHE,,74.0,YR,,M,Y,,,20220414,,MD,FR,FR,2022,Q2,Elderly
207097692,20709769,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glucose urine present,,2022,Q2,2,F,,20220414.0,20220414,20220421,EXP,,RU-AstraZeneca-2022A144957,ASTRAZENECA,,74.0,YR,,M,Y,74.0,KG,20220421,,HP,RU,,2022,Q2,Elderly
207097692,20709769,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glucose urine present,,2022,Q2,2,F,,20220414.0,20220414,20220421,EXP,,RU-AstraZeneca-2022A144957,ASTRAZENECA,,74.0,YR,,M,Y,74.0,KG,20220421,,HP,RU,,2022,Q2,Elderly
207097881,20709788,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q2,Toxic skin eruption,,2022,Q2,1,I,20220225.0,20220405.0,20220414,20220414,EXP,FR-AFSSAPS-LL20221266,FR-PFIZER INC-202200539115,PFIZER,,79.0,YR,,M,Y,92.0,KG,20220414,,PH,FR,FR,2022,Q2,Elderly
207097881,20709788,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q2,Rash maculo-papular,,2022,Q2,1,I,20220225.0,20220405.0,20220414,20220414,EXP,FR-AFSSAPS-LL20221266,FR-PFIZER INC-202200539115,PFIZER,,79.0,YR,,M,Y,92.0,KG,20220414,,PH,FR,FR,2022,Q2,Elderly
207098301,20709830,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220320.0,20220407.0,20220414,20220414,EXP,,HK-PFIZER INC-202200532991,PFIZER,,65.0,YR,,F,Y,,,20220414,,MD,HK,HK,2022,Q2,Elderly
207098301,20709830,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20220320.0,20220407.0,20220414,20220414,EXP,,HK-PFIZER INC-202200532991,PFIZER,,65.0,YR,,F,Y,,,20220414,,MD,HK,HK,2022,Q2,Elderly
207098301,20709830,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Incorrect product administration duration,,2022,Q2,1,I,20220320.0,20220407.0,20220414,20220414,EXP,,HK-PFIZER INC-202200532991,PFIZER,,65.0,YR,,F,Y,,,20220414,,MD,HK,HK,2022,Q2,Elderly
207104271,20710427,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,20190101.0,20220411.0,20220414,20220414,EXP,,FI-MYLANLABS-2022M1026961,MYLAN,,49.0,YR,,F,Y,,,20220414,,CN,FI,FI,2022,Q2,Adult
207105002,20710500,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, daily; 1 tablet daily",,,,,,,,,,Tablet,,2022,Q2,Chronic kidney disease,,2022,Q2,2,F,20211208.0,20220415.0,20220414,20220415,EXP,ES-AEMPS-1150343,ES-PFIZER INC-202200521499,PFIZER,,65.0,YR,,F,Y,,,20220415,,MD,ES,ES,2022,Q2,Elderly
207105002,20710500,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, daily; 1 tablet daily",,,,,,,,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,2,F,20211208.0,20220415.0,20220414,20220415,EXP,ES-AEMPS-1150343,ES-PFIZER INC-202200521499,PFIZER,,65.0,YR,,F,Y,,,20220415,,MD,ES,ES,2022,Q2,Elderly
207107991,20710799,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 mg, qd",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220407.0,20220414,20220414,EXP,,JP-OTSUKA-2022_023170,OTSUKA,,62.0,YR,,M,Y,,,20220414,,MD,JP,JP,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Dyspnoea paroxysmal nocturnal,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Alopecia,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Febrile neutropenia,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Thrombocytopenia,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207112121,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q2,Neutropenia,,2022,Q2,1,I,20220228.0,20220404.0,20220414,20220414,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20220414,,MD,ES,ES,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Hepatic function abnormal,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Hepatic pain,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Hypertension,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207114834,20711483,8,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Cholecystitis,,2022,Q2,4,F,20220325.0,20220501.0,20220414,20220624,PER,,ES-Eisai Medical Research-EC-2022-112523,EISAI,,60.0,YR,A,M,Y,87.0,KG,20220624,,MD,ES,,2022,Q2,Adult
207115471,20711547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Abdominal pain,,2022,Q2,1,I,,20220322.0,20220414,20220414,EXP,,SE-AstraZeneca-2022A124348,ASTRAZENECA,,56.0,YR,,M,Y,,,20220414,,MD,SE,,2022,Q2,Adult
207115471,20711547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220322.0,20220414,20220414,EXP,,SE-AstraZeneca-2022A124348,ASTRAZENECA,,56.0,YR,,M,Y,,,20220414,,MD,SE,,2022,Q2,Adult
207115471,20711547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Acidosis,,2022,Q2,1,I,,20220322.0,20220414,20220414,EXP,,SE-AstraZeneca-2022A124348,ASTRAZENECA,,56.0,YR,,M,Y,,,20220414,,MD,SE,,2022,Q2,Adult
207115471,20711547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220322.0,20220414,20220414,EXP,,SE-AstraZeneca-2022A124348,ASTRAZENECA,,56.0,YR,,M,Y,,,20220414,,MD,SE,,2022,Q2,Adult
207123391,20712339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,U,,2107166,,,5.0,MG,Tablet,QD,2022,Q2,Rash,,2022,Q2,1,I,20220323.0,20220407.0,20220415,20220415,EXP,,CN-AstraZeneca-2022A145831,ASTRAZENECA,,73.0,YR,,F,Y,54.0,KG,20220415,,MD,CN,,2022,Q2,Elderly
207123391,20712339,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25.0,MG,U,,2107166,,,5.0,MG,Tablet,QD,2022,Q2,Vulvovaginal pruritus,,2022,Q2,1,I,20220323.0,20220407.0,20220415,20220415,EXP,,CN-AstraZeneca-2022A145831,ASTRAZENECA,,73.0,YR,,F,Y,54.0,KG,20220415,,MD,CN,,2022,Q2,Elderly
207126002,20712600,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2022,Q2,Cerebral infarction,,2022,Q2,2,F,20220315.0,20220623.0,20220415,20220630,EXP,,"CN-Jiangsu Hengrui Medicine Co., Ltd.-2127787",JIANGSU HENGRUI MEDICINE,,61.0,YR,,F,Y,66.5,KG,20220630,,MD,CN,CN,2022,Q2,Adult
207127802,20712780,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,2,F,20220121.0,20220408.0,20220415,20220502,EXP,,RU-AstraZeneca-2022A147707,ASTRAZENECA,,60.0,YR,,M,Y,,,20220502,,MD,RU,,2022,Q2,Adult
207127802,20712780,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,2,F,20220121.0,20220408.0,20220415,20220502,EXP,,RU-AstraZeneca-2022A147707,ASTRAZENECA,,60.0,YR,,M,Y,,,20220502,,MD,RU,,2022,Q2,Adult
207127802,20712780,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ventricular tachycardia,,2022,Q2,2,F,20220121.0,20220408.0,20220415,20220502,EXP,,RU-AstraZeneca-2022A147707,ASTRAZENECA,,60.0,YR,,M,Y,,,20220502,,MD,RU,,2022,Q2,Adult
207127802,20712780,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Heart rate increased,,2022,Q2,2,F,20220121.0,20220408.0,20220415,20220502,EXP,,RU-AstraZeneca-2022A147707,ASTRAZENECA,,60.0,YR,,M,Y,,,20220502,,MD,RU,,2022,Q2,Adult
207129491,20712949,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Duration :7 DAYS,,,U,,Unknown,,,,,,,2022,Q2,Toxic skin eruption,,2022,Q2,1,I,20220225.0,20220407.0,20220415,20220415,EXP,FR-AFSSAPS-LL20221266,FR-TEVA-2022-FR-2026406,TEVA,,79.0,YR,E,M,Y,92.0,KG,20220415,,PH,FR,FR,2022,Q2,Elderly
207129491,20712949,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Duration :7 DAYS,,,U,,Unknown,,,,,,,2022,Q2,Rash maculo-papular,,2022,Q2,1,I,20220225.0,20220407.0,20220415,20220415,EXP,FR-AFSSAPS-LL20221266,FR-TEVA-2022-FR-2026406,TEVA,,79.0,YR,E,M,Y,92.0,KG,20220415,,PH,FR,FR,2022,Q2,Elderly
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Polyuria,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Polydipsia,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Dry mouth,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Vomiting,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Ketoacidosis,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207138321,20713832,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",95.0,MG,Y,U,,,,5.0,MG,,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220322.0,20220404.0,20220415,20220415,EXP,CN-NMPA-4403101004410202200210,CN-NOVOPROD-906509,NOVO NORDISK,,37.0,YR,,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Adult
207141951,20714195,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg od,200.0,MG,N,,,,202293.0,10.0,MG,,QD,2022,Q2,Gangrene,,2022,Q2,1,I,20220322.0,20220407.0,20220415,20220415,EXP,,GB-AstraZeneca-2022A143325,ASTRAZENECA,,53.0,YR,,M,Y,,,20220415,,MD,GB,,2022,Q2,Adult
207144071,20714407,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2022,Q2,Rash maculo-papular,,2022,Q2,1,I,20220225.0,20220412.0,20220415,20220415,EXP,FR-AFSSAPS-LL20221266,FR-MYLANLABS-2022M1027153,MYLAN,,79.0,YR,,M,Y,92.0,KG,20220415,,PH,FR,FR,2022,Q2,Elderly
207144071,20714407,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,U,,,,,,,,2022,Q2,Toxic skin eruption,,2022,Q2,1,I,20220225.0,20220412.0,20220415,20220415,EXP,FR-AFSSAPS-LL20221266,FR-MYLANLABS-2022M1027153,MYLAN,,79.0,YR,,M,Y,92.0,KG,20220415,,PH,FR,FR,2022,Q2,Elderly
207146302,20714630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Septic shock,,2022,Q2,2,F,20211212.0,20220506.0,20220415,20220513,EXP,,FR-AstraZeneca-2022A146428,ASTRAZENECA,,31859.0,DY,,M,Y,61.6,KG,20220513,,PH,FR,,2022,Q2,Elderly
207146331,20714633,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220407.0,20220415,20220415,EXP,,FR-AstraZeneca-2022A141489,ASTRAZENECA,,46.0,YR,,F,Y,64.7,KG,20220415,,MD,FR,,2022,Q2,Adult
207146331,20714633,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,,,,10.0,MG,,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220407.0,20220415,20220415,EXP,,FR-AstraZeneca-2022A141489,ASTRAZENECA,,46.0,YR,,F,Y,64.7,KG,20220415,,MD,FR,,2022,Q2,Adult
207149651,20714965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3540.0,MG,U,,,,202293.0,10.0,MG,,TID,2022,Q2,Mobility decreased,,2022,Q2,1,I,20210915.0,20220407.0,20220415,20220415,EXP,,GB-AstraZeneca-2021A729597,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20220415,,MD,GB,,2022,Q2,Elderly
207149651,20714965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3540.0,MG,U,,,,202293.0,10.0,MG,,TID,2022,Q2,Arthralgia,,2022,Q2,1,I,20210915.0,20220407.0,20220415,20220415,EXP,,GB-AstraZeneca-2021A729597,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20220415,,MD,GB,,2022,Q2,Elderly
207149651,20714965,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,,,,,,,,,,2022,Q2,Mobility decreased,,2022,Q2,1,I,20210915.0,20220407.0,20220415,20220415,EXP,,GB-AstraZeneca-2021A729597,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20220415,,MD,GB,,2022,Q2,Elderly
207149651,20714965,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,1,I,20210915.0,20220407.0,20220415,20220415,EXP,,GB-AstraZeneca-2021A729597,ASTRAZENECA,,73.0,YR,,F,Y,96.0,KG,20220415,,MD,GB,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Bacterial vaginosis,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vulvitis,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dysuria,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207149662,20714966,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract discomfort,,2022,Q2,2,F,20220207.0,20220422.0,20220415,20220429,EXP,,FR-AstraZeneca-2022A147981,ASTRAZENECA,,77.0,YR,,F,Y,78.0,KG,20220429,,MD,FR,,2022,Q2,Elderly
207153391,20715339,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day (1-0-0)",,,,,,,,,,Film-coated tablet,QD,2022,Q2,Ileus paralytic,,2022,Q2,1,I,20220325.0,20220413.0,20220415,20220415,EXP,ES-AEMPS-1161055,ES-PFIZER INC-202200569081,PFIZER,,53.0,YR,,F,Y,,,20220415,,PH,ES,ES,2022,Q2,Adult
207153761,20715376,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal failure,,2022,Q2,1,I,20220101.0,20220408.0,20220415,20220415,EXP,,SE-AstraZeneca-2022A144266,ASTRAZENECA,,67.0,YR,,M,Y,,,20220415,,MD,SE,,2022,Q2,Elderly
207181251,20718125,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",390.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Balanoposthitis,,2022,Q2,1,I,20220214.0,20220407.0,20220418,20220418,EXP,,IT-AUROBINDO-AUR-APL-2022-012943,AUROBINDO,,83.0,YR,,M,Y,,,20220418,,PH,IT,IT,2022,Q2,Elderly
207181251,20718125,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",390.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Urinary incontinence,,2022,Q2,1,I,20220214.0,20220407.0,20220418,20220418,EXP,,IT-AUROBINDO-AUR-APL-2022-012943,AUROBINDO,,83.0,YR,,M,Y,,,20220418,,PH,IT,IT,2022,Q2,Elderly
207181741,20718174,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(),,,U,,,,,,,,,2022,Q2,Toxic skin eruption,,2022,Q2,1,I,20220225.0,20220404.0,20220418,20220418,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-333576,RANBAXY,,79.0,YR,,M,Y,92.0,KG,20220418,,PH,FR,FR,2022,Q2,Elderly
207181741,20718174,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(),,,U,,,,,,,,,2022,Q2,Rash maculo-papular,,2022,Q2,1,I,20220225.0,20220404.0,20220418,20220418,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-333576,RANBAXY,,79.0,YR,,M,Y,92.0,KG,20220418,,PH,FR,FR,2022,Q2,Elderly
207183762,20718376,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,Unknown,,,10.0,MG,,,2022,Q2,Sleep apnoea syndrome,,2022,Q2,2,F,,20220613.0,20220418,20220617,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2022-05369,LUPIN,,63.0,YR,,F,Y,,,20220617,,CN,ZA,ZA,2022,Q2,Adult
207183762,20718376,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,Unknown,,,10.0,MG,,,2022,Q2,Pneumonia,,2022,Q2,2,F,,20220613.0,20220418,20220617,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2022-05369,LUPIN,,63.0,YR,,F,Y,,,20220617,,CN,ZA,ZA,2022,Q2,Adult
207183762,20718376,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,,Unknown,,,10.0,MG,,,2022,Q2,Limb injury,,2022,Q2,2,F,,20220613.0,20220418,20220617,EXP,,ZA-LUPIN PHARMACEUTICALS INC.-2022-05369,LUPIN,,63.0,YR,,F,Y,,,20220617,,CN,ZA,ZA,2022,Q2,Adult
207184522,20718452,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg once a day),,,,,,,,,,Film Coated Tablet,,2022,Q2,Confusional state,,2022,Q2,2,F,20220203.0,20220518.0,20220418,20220601,EXP,,FR-AUROBINDO-AUR-APL-2022-013114,AUROBINDO,,95.0,YR,,F,Y,63.0,KG,20220601,,PH,FR,FR,2022,Q2,Elderly
207184522,20718452,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg once a day),,,,,,,,,,Film Coated Tablet,,2022,Q2,Behaviour disorder,,2022,Q2,2,F,20220203.0,20220518.0,20220418,20220601,EXP,,FR-AUROBINDO-AUR-APL-2022-013114,AUROBINDO,,95.0,YR,,F,Y,63.0,KG,20220601,,PH,FR,FR,2022,Q2,Elderly
207184522,20718452,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg once a day),,,,,,,,,,Film Coated Tablet,,2022,Q2,Hallucination,,2022,Q2,2,F,20220203.0,20220518.0,20220418,20220601,EXP,,FR-AUROBINDO-AUR-APL-2022-013114,AUROBINDO,,95.0,YR,,F,Y,63.0,KG,20220601,,PH,FR,FR,2022,Q2,Elderly
207190031,20719003,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Febrile neutropenia,,2022,Q2,1,I,,20220406.0,20220418,20220418,EXP,CA-MHPD-000938537,CA-Accord-260682,ACCORD,,60.0,YR,,M,Y,97.0,KG,20220418,,HP,CA,CA,2022,Q2,Adult
207190031,20719003,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220406.0,20220418,20220418,EXP,CA-MHPD-000938537,CA-Accord-260682,ACCORD,,60.0,YR,,M,Y,97.0,KG,20220418,,HP,CA,CA,2022,Q2,Adult
207201251,20720125,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",110.769,MG,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220311.0,20220405.0,20220418,20220418,EXP,FR-AFSSAPS-MP20221516,FR-PFIZER INC-202200521728,PFIZER,,46.0,YR,,F,Y,142.6,KG,20220418,,MD,FR,FR,2022,Q2,Adult
207201251,20720125,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",110.769,MG,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Off label use,,2022,Q2,1,I,20220311.0,20220405.0,20220418,20220418,EXP,FR-AFSSAPS-MP20221516,FR-PFIZER INC-202200521728,PFIZER,,46.0,YR,,F,Y,142.6,KG,20220418,,MD,FR,FR,2022,Q2,Adult
207203501,20720350,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,,20220405.0,20220418,20220418,EXP,FR-AFSSAPS-AM20220841,FR-SA-2022SA125761,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20220418,,MD,FR,FR,2022,Q2,Elderly
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Cardiac disorder,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Gastritis,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Gastric hypomotility,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Off label use,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Diabetic neuropathy,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Nausea,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207205851,20720585,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q2,Vascular encephalopathy,,2022,Q2,1,I,20170901.0,20220406.0,20220418,20220418,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202204004547,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220418,,MD,HU,HU,2022,Q2,Adult
207213242,20721324,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg 1fois/J,,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,2,F,20220203.0,20220519.0,20220418,20220524,EXP,FR-AFSSAPS-TS20221035,FR-BAUSCH-BL-2022-008942,BAUSCH AND LOMB,,95.0,YR,,F,Y,63.0,KG,20220524,,PH,FR,FR,2022,Q2,Elderly
207213242,20721324,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg 1fois/J,,,,,,,,,,,,2022,Q2,Behaviour disorder,,2022,Q2,2,F,20220203.0,20220519.0,20220418,20220524,EXP,FR-AFSSAPS-TS20221035,FR-BAUSCH-BL-2022-008942,BAUSCH AND LOMB,,95.0,YR,,F,Y,63.0,KG,20220524,,PH,FR,FR,2022,Q2,Elderly
207213242,20721324,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg 1fois/J,,,,,,,,,,,,2022,Q2,Hallucination,,2022,Q2,2,F,20220203.0,20220519.0,20220418,20220524,EXP,FR-AFSSAPS-TS20221035,FR-BAUSCH-BL-2022-008942,BAUSCH AND LOMB,,95.0,YR,,F,Y,63.0,KG,20220524,,PH,FR,FR,2022,Q2,Elderly
207223891,20722389,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary incontinence,,2022,Q2,1,I,20220214.0,20220411.0,20220418,20220418,EXP,,IT-AstraZeneca-2022A145516,ASTRAZENECA,,83.0,YR,,M,Y,,,20220418,,MD,IT,,2022,Q2,Elderly
207223891,20722389,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Balanoposthitis,,2022,Q2,1,I,20220214.0,20220411.0,20220418,20220418,EXP,,IT-AstraZeneca-2022A145516,ASTRAZENECA,,83.0,YR,,M,Y,,,20220418,,MD,IT,,2022,Q2,Elderly
207226362,20722636,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Take One Daily,,,,,,,,,,,QD,2022,Q2,Pruritus,,2022,Q2,2,F,,20220602.0,20220419,20220603,EXP,GB-MHRA-TPP21355272C5902447YC1649676249453,GB-ORGANON-O2204GBR000975,ORGANON,,54.0,YR,,M,Y,68.0,KG,20220603,,MD,GB,GB,2022,Q2,Adult
207227144,20722714,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2022,Q2,Underdose,,2022,Q2,4,F,20220128.0,20220530.0,20220419,20220603,EXP,,NVSJ2022JP006171,NOVARTIS,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207227144,20722714,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2022,Q2,Pyrexia,,2022,Q2,4,F,20220128.0,20220530.0,20220419,20220603,EXP,,NVSJ2022JP006171,NOVARTIS,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207227144,20722714,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2022,Q2,Hypotension,,2022,Q2,4,F,20220128.0,20220530.0,20220419,20220603,EXP,,NVSJ2022JP006171,NOVARTIS,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207227144,20722714,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,10.0,MG,Tablet,,2022,Q2,COVID-19,,2022,Q2,4,F,20220128.0,20220530.0,20220419,20220603,EXP,,NVSJ2022JP006171,NOVARTIS,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207252682,20725268,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,20220326.0,20220411.0,20220419,20220422,EXP,,BG-AstraZeneca-2022A148001,ASTRAZENECA,,11047.0,DY,,M,Y,,,20220422,,MD,BG,,2022,Q2,Elderly
207252682,20725268,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,2,F,20220326.0,20220411.0,20220419,20220422,EXP,,BG-AstraZeneca-2022A148001,ASTRAZENECA,,11047.0,DY,,M,Y,,,20220422,,MD,BG,,2022,Q2,Elderly
207252682,20725268,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood pressure decreased,,2022,Q2,2,F,20220326.0,20220411.0,20220419,20220422,EXP,,BG-AstraZeneca-2022A148001,ASTRAZENECA,,11047.0,DY,,M,Y,,,20220422,,MD,BG,,2022,Q2,Elderly
207252682,20725268,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperhidrosis,,2022,Q2,2,F,20220326.0,20220411.0,20220419,20220422,EXP,,BG-AstraZeneca-2022A148001,ASTRAZENECA,,11047.0,DY,,M,Y,,,20220422,,MD,BG,,2022,Q2,Elderly
207252682,20725268,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Off label use,,2022,Q2,2,F,20220326.0,20220411.0,20220419,20220422,EXP,,BG-AstraZeneca-2022A148001,ASTRAZENECA,,11047.0,DY,,M,Y,,,20220422,,MD,BG,,2022,Q2,Elderly
207254062,20725406,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,720.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vulvovaginal pruritus,,2022,Q2,2,F,20220330.0,20220407.0,20220419,20220421,EXP,,GB-AstraZeneca-2022A143421,ASTRAZENECA,,38.0,YR,,F,Y,82.0,KG,20220421,,MD,GB,,2022,Q2,Adult
207254222,20725422,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Ear haemorrhage,,2022,Q2,2,F,20220101.0,20220421.0,20220419,20220426,EXP,,IL-GLAXOSMITHKLINE-IL2022EME064483,GLAXOSMITHKLINE,,68.0,YR,,M,Y,,,20220426,,CN,IL,IL,2022,Q2,Elderly
207254222,20725422,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Discomfort,,2022,Q2,2,F,20220101.0,20220421.0,20220419,20220426,EXP,,IL-GLAXOSMITHKLINE-IL2022EME064483,GLAXOSMITHKLINE,,68.0,YR,,M,Y,,,20220426,,CN,IL,IL,2022,Q2,Elderly
207254222,20725422,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Skin lesion,,2022,Q2,2,F,20220101.0,20220421.0,20220419,20220426,EXP,,IL-GLAXOSMITHKLINE-IL2022EME064483,GLAXOSMITHKLINE,,68.0,YR,,M,Y,,,20220426,,CN,IL,IL,2022,Q2,Elderly
207254222,20725422,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Impaired healing,,2022,Q2,2,F,20220101.0,20220421.0,20220419,20220426,EXP,,IL-GLAXOSMITHKLINE-IL2022EME064483,GLAXOSMITHKLINE,,68.0,YR,,M,Y,,,20220426,,CN,IL,IL,2022,Q2,Elderly
207262821,20726282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,10.0,MG,,,TAHL,,202293.0,10.0,MG,Tablet,,2022,Q2,Dysuria,,2022,Q2,1,I,20211215.0,20220411.0,20220419,20220419,EXP,,CH-AstraZeneca-2022A149588,ASTRAZENECA,,25129.0,DY,,M,Y,95.0,KG,20220419,,CN,CH,,2022,Q2,Elderly
207262821,20726282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,10.0,MG,,,TAHL,,202293.0,10.0,MG,Tablet,,2022,Q2,Penile pain,,2022,Q2,1,I,20211215.0,20220411.0,20220419,20220419,EXP,,CH-AstraZeneca-2022A149588,ASTRAZENECA,,25129.0,DY,,M,Y,95.0,KG,20220419,,CN,CH,,2022,Q2,Elderly
207262821,20726282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,10.0,MG,,,TAHL,,202293.0,10.0,MG,Tablet,,2022,Q2,Pollakiuria,,2022,Q2,1,I,20211215.0,20220411.0,20220419,20220419,EXP,,CH-AstraZeneca-2022A149588,ASTRAZENECA,,25129.0,DY,,M,Y,95.0,KG,20220419,,CN,CH,,2022,Q2,Elderly
207262821,20726282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,10.0,MG,,,TAHL,,202293.0,10.0,MG,Tablet,,2022,Q2,Pruritus genital,,2022,Q2,1,I,20211215.0,20220411.0,20220419,20220419,EXP,,CH-AstraZeneca-2022A149588,ASTRAZENECA,,25129.0,DY,,M,Y,95.0,KG,20220419,,CN,CH,,2022,Q2,Elderly
207262821,20726282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg ONCE/SINGLE ADMINISTRATION,10.0,MG,,,TAHL,,202293.0,10.0,MG,Tablet,,2022,Q2,Calcinosis,,2022,Q2,1,I,20211215.0,20220411.0,20220419,20220419,EXP,,CH-AstraZeneca-2022A149588,ASTRAZENECA,,25129.0,DY,,M,Y,95.0,KG,20220419,,CN,CH,,2022,Q2,Elderly
207271542,20727154,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q2,Nausea,,2022,Q2,2,F,20220221.0,20220425.0,20220419,20220429,EXP,,JP-009507513-2204JPN001937J,MERCK,,52.0,YR,,F,Y,,,20220429,,PH,JP,JP,2022,Q2,Adult
207271542,20727154,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q2,Headache,,2022,Q2,2,F,20220221.0,20220425.0,20220419,20220429,EXP,,JP-009507513-2204JPN001937J,MERCK,,52.0,YR,,F,Y,,,20220429,,PH,JP,JP,2022,Q2,Adult
207271542,20727154,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q2,Lactic acidosis,,2022,Q2,2,F,20220221.0,20220425.0,20220419,20220429,EXP,,JP-009507513-2204JPN001937J,MERCK,,52.0,YR,,F,Y,,,20220429,,PH,JP,JP,2022,Q2,Adult
207300041,20730004,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Sarcopenia,,2022,Q2,1,I,20210801.0,20220413.0,20220420,20220420,EXP,,IT-AstraZeneca-2022A148769,ASTRAZENECA,,69.0,YR,,F,Y,44.0,KG,20220420,,MD,IT,,2022,Q2,Elderly
207300041,20730004,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Myopathy,,2022,Q2,1,I,20210801.0,20220413.0,20220420,20220420,EXP,,IT-AstraZeneca-2022A148769,ASTRAZENECA,,69.0,YR,,F,Y,44.0,KG,20220420,,MD,IT,,2022,Q2,Elderly
207310243,20731024,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,,,,,,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,3,F,20220129.0,20220530.0,20220420,20220603,EXP,,JP-OTSUKA-2022_023865,OTSUKA,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207310243,20731024,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,,,,,,,,Tablet,,2022,Q2,N-terminal prohormone brain natriuretic peptide increased,,2022,Q2,3,F,20220129.0,20220530.0,20220420,20220603,EXP,,JP-OTSUKA-2022_023865,OTSUKA,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207310243,20731024,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,,,,,,,,Tablet,,2022,Q2,SARS-CoV-2 test positive,,2022,Q2,3,F,20220129.0,20220530.0,20220420,20220603,EXP,,JP-OTSUKA-2022_023865,OTSUKA,,82.0,YR,,M,Y,63.3,KG,20220603,,MD,JP,JP,2022,Q2,Elderly
207326201,20732620,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, (1 comprimido al dia)",,,,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,1,I,20211208.0,20220404.0,20220420,20220420,EXP,ES-AEMPS-1150343,NVSC2022ES076327,NOVARTIS,,65.0,YR,,F,Y,,,20220420,,MD,ES,ES,2022,Q2,Elderly
207326201,20732620,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, (1 comprimido al dia)",,,,,,,,,,,,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20211208.0,20220404.0,20220420,20220420,EXP,ES-AEMPS-1150343,NVSC2022ES076327,NOVARTIS,,65.0,YR,,F,Y,,,20220420,,MD,ES,ES,2022,Q2,Elderly
207338071,20733807,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Skin fissures,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic wound,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Skin fissures,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338071,20733807,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1100.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic wound,,2022,Q2,1,I,20211213.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A122301,ASTRAZENECA,,26690.0,DY,,M,Y,98.0,KG,20220421,,MD,FR,,2022,Q2,Elderly
207338682,20733868,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg/1000 mg two times daily,,,,,,,205649.0,,,Tablet,,2022,Q2,Myopathy,,2022,Q2,2,F,,20220414.0,20220421,20220422,EXP,,IT-AstraZeneca-2022A151273,ASTRAZENECA,Stella M.; Biassoni E.; Fiorillo C.; Grandis M.; Mattioli F.; Del Sette M.. A case of anti-HMGCR myopathy triggered by sodium/glucose co- transporter 2 (SGLT2) inhibitors. Neurological Sciences 2022;,76.0,YR,,F,Y,,,20220422,,HP,IT,,2022,Q2,Elderly
207338682,20733868,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg/1000 mg daily,,,,,,,205649.0,,,Tablet,,2022,Q2,Myopathy,,2022,Q2,2,F,,20220414.0,20220421,20220422,EXP,,IT-AstraZeneca-2022A151273,ASTRAZENECA,Stella M.; Biassoni E.; Fiorillo C.; Grandis M.; Mattioli F.; Del Sette M.. A case of anti-HMGCR myopathy triggered by sodium/glucose co- transporter 2 (SGLT2) inhibitors. Neurological Sciences 2022;,76.0,YR,,F,Y,,,20220422,,HP,IT,,2022,Q2,Elderly
207340341,20734034,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220418.0,20220421,20220421,PER,,US-ORGANON-O2204USA001453,ORGANON,"Kumar G S, Chaudhary C, Cheng R, Klein L.. A SURPRISING CASE OF MELAS IN A PATIENT PRESENTING WITH DECOMPENSATED HEART FAILURE.. Journal of the American College of Cardiology. 2022;79 (9):3382",31.0,YR,,F,Y,,,20220421,,HP,US,US,2022,Q2,Young Adult
207343471,20734347,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,NC2574,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,1,I,20220312.0,20220412.0,20220421,20220421,EXP,,CN-AstraZeneca-2022A152422,ASTRAZENECA,,21620.0,DY,,M,Y,69.0,KG,20220421,,MD,CN,,2022,Q2,Elderly
207343471,20734347,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,NC2574,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,1,I,20220312.0,20220412.0,20220421,20220421,EXP,,CN-AstraZeneca-2022A152422,ASTRAZENECA,,21620.0,DY,,M,Y,69.0,KG,20220421,,MD,CN,,2022,Q2,Elderly
207343471,20734347,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,U,,NC2574,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,20220312.0,20220412.0,20220421,20220421,EXP,,CN-AstraZeneca-2022A152422,ASTRAZENECA,,21620.0,DY,,M,Y,69.0,KG,20220421,,MD,CN,,2022,Q2,Elderly
207346211,20734621,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20211218.0,20220415.0,20220421,20220421,EXP,,NVSJ2022JP006319,NOVARTIS,,58.0,YR,,M,Y,75.0,KG,20220421,,PH,JP,JP,2022,Q2,Adult
207346211,20734621,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20211218.0,20220415.0,20220421,20220421,EXP,,NVSJ2022JP006319,NOVARTIS,,58.0,YR,,M,Y,75.0,KG,20220421,,PH,JP,JP,2022,Q2,Adult
207346211,20734621,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q2,Bradycardia,,2022,Q2,1,I,20211218.0,20220415.0,20220421,20220421,EXP,,NVSJ2022JP006319,NOVARTIS,,58.0,YR,,M,Y,75.0,KG,20220421,,PH,JP,JP,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Pneumonitis,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Chest pain,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Pericardial effusion,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Back pain,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,COVID-19,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Hyperviscosity syndrome,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207347071,20734707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (started year ago)",,,U,,,,,,,,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,1,I,20210101.0,20220416.0,20220421,20220421,EXP,,NVSC2022EG091283,NOVARTIS,,56.0,YR,,M,Y,,,20220421,,CN,EG,EG,2022,Q2,Adult
207355421,20735542,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220414.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152684,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,MD,FR,,2022,Q2,Elderly
207355421,20735542,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Illness,,2022,Q2,1,I,,20220414.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152684,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,MD,FR,,2022,Q2,Elderly
207355421,20735542,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220414.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152684,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,MD,FR,,2022,Q2,Elderly
207355421,20735542,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Illness,,2022,Q2,1,I,,20220414.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152684,ASTRAZENECA,,67.0,YR,,F,Y,,,20220421,,MD,FR,,2022,Q2,Elderly
207359101,20735910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/j10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q2,Osteonecrosis,,2022,Q2,1,I,20220320.0,20220414.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A150039,ASTRAZENECA,,56.0,YR,,M,Y,,,20220421,,MD,FR,,2022,Q2,Adult
207362331,20736233,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Pancreatic disorder,,2022,Q2,1,I,20220412.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152659,ASTRAZENECA,,58.0,YR,,F,Y,,,20220421,,PH,FR,,2022,Q2,Adult
207362331,20736233,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Liver function test increased,,2022,Q2,1,I,20220412.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A152659,ASTRAZENECA,,58.0,YR,,F,Y,,,20220421,,PH,FR,,2022,Q2,Adult
207372861,20737286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary incontinence,,2022,Q2,1,I,20220406.0,20220411.0,20220421,20220421,EXP,,GB-AstraZeneca-2022A146463,ASTRAZENECA,,74.0,YR,,F,Y,90.0,KG,20220422,,MD,GB,,2022,Q2,Elderly
207372861,20737286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,U,,,,202293.0,,,Tablet,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220406.0,20220411.0,20220421,20220421,EXP,,GB-AstraZeneca-2022A146463,ASTRAZENECA,,74.0,YR,,F,Y,90.0,KG,20220422,,MD,GB,,2022,Q2,Elderly
207372861,20737286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,U,,,,202293.0,,,Tablet,,2022,Q2,Genital infection,,2022,Q2,1,I,20220406.0,20220411.0,20220421,20220421,EXP,,GB-AstraZeneca-2022A146463,ASTRAZENECA,,74.0,YR,,F,Y,90.0,KG,20220422,,MD,GB,,2022,Q2,Elderly
207373161,20737316,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,34009266499 7 5,,202293.0,,,Tablet,QD,2022,Q2,Genital ulceration,,2022,Q2,1,I,20220125.0,20220413.0,20220421,20220421,EXP,,FR-AstraZeneca-2022A148924,ASTRAZENECA,,67.0,YR,,F,Y,69.0,KG,20220422,,MD,FR,,2022,Q2,Elderly
207378231,20737823,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Pancreatic carcinoma,,2022,Q2,1,I,,20220412.0,20220422,20220422,EXP,,BR-NOVOPROD-909858,NOVO NORDISK,,68.0,YR,,F,Y,73.5,KG,20220422,,MD,BR,BR,2022,Q2,Elderly
207381081,20738108,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"unit dose: 10 mg, strength: 10 mg, Frequency Time : 1 day, Duration :12 days",,,Y,,"Unknown,Unknown",,,10.0,MG,Film-coated tablet,,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220412.0,20220422,20220422,EXP,FR-AFSSAPS-MP20221516,FR-TEVA-2022-FR-2027644,TEVA,,46.0,YR,A,F,Y,142.6,KG,20220422,,MD,FR,FR,2022,Q2,Adult
207381081,20738108,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"unit dose: 10 mg, strength: 10 mg, Frequency Time : 1 day, Duration: 12 days",,,Y,,"Unknown,Unknown",,,10.0,MG,Film-coated tablet,,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220412.0,20220422,20220422,EXP,FR-AFSSAPS-MP20221516,FR-TEVA-2022-FR-2027644,TEVA,,46.0,YR,A,F,Y,142.6,KG,20220422,,MD,FR,FR,2022,Q2,Adult
207384231,20738423,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 Dosage forms Daily; DAPAGLIFLOZINA (8615A),,,,,,,,,,Tablet,,2022,Q2,Drug interaction,,2022,Q2,1,I,20211208.0,20220412.0,20220422,20220422,EXP,ES-AEMPS-1150343,ES-TEVA-2022-ES-2027817,TEVA,,65.0,YR,E,F,Y,,,20220422,,MD,ES,ES,2022,Q2,Elderly
207384231,20738423,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 Dosage forms Daily; DAPAGLIFLOZINA (8615A),,,,,,,,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,1,I,20211208.0,20220412.0,20220422,20220422,EXP,ES-AEMPS-1150343,ES-TEVA-2022-ES-2027817,TEVA,,65.0,YR,E,F,Y,,,20220422,,MD,ES,ES,2022,Q2,Elderly
207384231,20738423,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 Dosage forms Daily; DAPAGLIFLOZINA (8615A),,,,,,,,,,Tablet,,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20211208.0,20220412.0,20220422,20220422,EXP,ES-AEMPS-1150343,ES-TEVA-2022-ES-2027817,TEVA,,65.0,YR,E,F,Y,,,20220422,,MD,ES,ES,2022,Q2,Elderly
207388982,20738898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Gastrointestinal neoplasm,,2022,Q2,2,F,20210901.0,20220418.0,20220422,20220427,EXP,,CA-AstraZeneca-2022A155611,ASTRAZENECA,,58.0,YR,,M,Y,,,20220428,,CN,CA,,2022,Q2,Adult
207388982,20738898,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Decreased appetite,,2022,Q2,2,F,20210901.0,20220418.0,20220422,20220427,EXP,,CA-AstraZeneca-2022A155611,ASTRAZENECA,,58.0,YR,,M,Y,,,20220428,,CN,CA,,2022,Q2,Adult
207396492,20739649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Optic nerve disorder,,2022,Q2,2,F,,20220414.0,20220422,20220510,EXP,,BR-AstraZeneca-2022A151301,ASTRAZENECA,,83.0,YR,,F,Y,,,20220510,,CN,BR,,2022,Q2,Elderly
207396492,20739649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Cerebrovascular accident,,2022,Q2,2,F,,20220414.0,20220422,20220510,EXP,,BR-AstraZeneca-2022A151301,ASTRAZENECA,,83.0,YR,,F,Y,,,20220510,,CN,BR,,2022,Q2,Elderly
207396492,20739649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Blindness,,2022,Q2,2,F,,20220414.0,20220422,20220510,EXP,,BR-AstraZeneca-2022A151301,ASTRAZENECA,,83.0,YR,,F,Y,,,20220510,,CN,BR,,2022,Q2,Elderly
207396492,20739649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Accident at home,,2022,Q2,2,F,,20220414.0,20220422,20220510,EXP,,BR-AstraZeneca-2022A151301,ASTRAZENECA,,83.0,YR,,F,Y,,,20220510,,CN,BR,,2022,Q2,Elderly
207396492,20739649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Femur fracture,,2022,Q2,2,F,,20220414.0,20220422,20220510,EXP,,BR-AstraZeneca-2022A151301,ASTRAZENECA,,83.0,YR,,F,Y,,,20220510,,CN,BR,,2022,Q2,Elderly
207396571,20739657,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,N,,Unknown,,,,,,,2022,Q2,Sarcopenia,,2022,Q2,1,I,20210801.0,20220412.0,20220422,20220422,EXP,IT-MINISAL02-859991,IT-PFIZER INC-202200561415,PFIZER,,68.0,YR,,F,Y,44.0,KG,20220422,,MD,IT,IT,2022,Q2,Elderly
207396571,20739657,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,N,,Unknown,,,,,,,2022,Q2,Myopathy,,2022,Q2,1,I,20210801.0,20220412.0,20220422,20220422,EXP,IT-MINISAL02-859991,IT-PFIZER INC-202200561415,PFIZER,,68.0,YR,,F,Y,44.0,KG,20220422,,MD,IT,IT,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Disseminated Bacillus Calmette-Guerin infection,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Incorrect product administration duration,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Arthritis,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207415273,20741527,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,3,F,20210727.0,20220617.0,20220422,20220628,EXP,,US-GILEAD-2022-0578897,GILEAD,,77.0,YR,E,M,Y,,,20220628,,MD,US,US,2022,Q2,Elderly
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Metastases to liver,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Mitral valve incompetence,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Lung cancer metastatic,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Ventricular internal diameter abnormal,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Metastases to central nervous system,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Left ventricular dysfunction,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207418804,20741880,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Swelling face,,2022,Q2,4,F,20220201.0,20220509.0,20220423,20220514,EXP,,NVSC2022GB089674,NOVARTIS,,57.0,YR,,M,Y,86.0,KG,20220514,,HP,GB,GB,2022,Q2,Adult
207422232,20742223,9,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q2,Renal impairment,,2022,Q2,2,F,,20220509.0,20220423,20220515,EXP,,SI-JNJFOC-20220443361,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20220515,,MD,SI,SI,2022,Q2,Elderly
207423341,20742334,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Frequency time- 1 day, Duration-3 months",,,Y,,Unknown,,,10.0,MG,,,2022,Q2,Bradycardia,,2022,Q2,1,I,20220321.0,20220414.0,20220424,20220424,EXP,FR-AFSSAPS-AN20220940,FR-TEVA-2022-FR-2028964,TEVA,,81.0,YR,E,F,Y,82.4,KG,20220424,,MD,FR,FR,2022,Q2,Elderly
207449051,20744905,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,,20220421.0,20220425,20220425,EXP,,FR-009507513-2204FRA007450,MERCK,,75.0,YR,,M,Y,,,20220425,,MD,FR,FR,2022,Q2,Elderly
207489201,20748920,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Drug ineffective,,2022,Q2,1,I,20210901.0,20220418.0,20220426,20220426,EXP,,GT-AstraZeneca-2022A156571,ASTRAZENECA,,24264.0,DY,,M,Y,,,20220426,,CN,GT,,2022,Q2,Elderly
207489201,20748920,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Blood cholesterol abnormal,,2022,Q2,1,I,20210901.0,20220418.0,20220426,20220426,EXP,,GT-AstraZeneca-2022A156571,ASTRAZENECA,,24264.0,DY,,M,Y,,,20220426,,CN,GT,,2022,Q2,Elderly
207489201,20748920,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Arthritis,,2022,Q2,1,I,20210901.0,20220418.0,20220426,20220426,EXP,,GT-AstraZeneca-2022A156571,ASTRAZENECA,,24264.0,DY,,M,Y,,,20220426,,CN,GT,,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Cardiac failure chronic,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Ulcer haemorrhage,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Flatulence,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Conjunctival discolouration,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Petechiae,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Tongue dry,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Melaena,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Faeces discoloured,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Cardiac failure chronic,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Ulcer haemorrhage,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Flatulence,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Conjunctival discolouration,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Petechiae,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Tongue dry,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Melaena,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207494102,20749410,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Faeces discoloured,,2022,Q2,2,F,,20220429.0,20220426,20220514,EXP,,NVSC2022SI093669,NOVARTIS,,84.0,YR,,F,Y,,,20220514,,MD,SI,SI,2022,Q2,Elderly
207495111,20749511,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film-coated tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220107.0,20220425.0,20220426,20220426,EXP,FR-AFSSAPS-AM20221117,NVSC2022FR095158,NOVARTIS,,72.0,YR,,M,Y,78.0,KG,20220426,,PH,FR,FR,2022,Q2,Elderly
207495171,20749517,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220412.0,20220426,20220426,EXP,,US-MICRO LABS LIMITED-ML2022-01670,MICRO LABS,,31.0,YR,A,F,Y,,,20220426,,HP,US,,2022,Q2,Young Adult
207497921,20749792,21,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,20220314.0,20220420.0,20220426,20220426,EXP,FR-AFSSAPS-AM20220841,FR-MYLANLABS-2022M1029355,MYLAN,,74.0,YR,,M,Y,,,20220426,,MD,FR,FR,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Pollakiuria,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Diarrhoea,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Abdominal pain,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Colitis ulcerative,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Fatigue,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512543,20751254,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,UNK,,2022,Q2,Off label use,,2022,Q2,3,F,20170101.0,20220517.0,20220426,20220524,EXP,,CA-TAKEDA-2017TUS023171,TAKEDA,,65.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Elderly
207512681,20751268,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220416.0,20220426,20220426,EXP,,CA-TEVA-2022-CA-2029304,TEVA,,36.0,YR,A,F,Y,,,20220426,,PH,CA,CA,2022,Q2,Adult
207517941,20751794,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (1 tablet a day)",,,,,,,,,,Tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20211208.0,20220421.0,20220426,20220426,EXP,ES-AEMPS-1150343,ES-MYLANLABS-2022M1029800,MYLAN,,65.0,YR,,F,Y,,,20220426,,MD,ES,ES,2022,Q2,Elderly
207517941,20751794,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (1 tablet a day)",,,,,,,,,,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20211208.0,20220421.0,20220426,20220426,EXP,ES-AEMPS-1150343,ES-MYLANLABS-2022M1029800,MYLAN,,65.0,YR,,F,Y,,,20220426,,MD,ES,ES,2022,Q2,Elderly
207517941,20751794,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (1 tablet a day)",,,,,,,,,,Tablet,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20211208.0,20220421.0,20220426,20220426,EXP,ES-AEMPS-1150343,ES-MYLANLABS-2022M1029800,MYLAN,,65.0,YR,,F,Y,,,20220426,,MD,ES,ES,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Fatigue,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Oedema,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207548251,20754825,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220419.0,20220427,20220427,EXP,,NVSC2022SI093397,NOVARTIS,,67.0,YR,,M,Y,,,20220427,,MD,SI,SI,2022,Q2,Elderly
207560911,20756091,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,,20220420.0,20220427,20220427,EXP,DE-EMA-2022318-AUTODUP-1647636168115,DE-Accord-261986,ACCORD,,66.0,YR,,,Y,,,20220427,,MD,DE,DE,2022,Q2,Elderly
207560911,20756091,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,,20220420.0,20220427,20220427,EXP,DE-EMA-2022318-AUTODUP-1647636168115,DE-Accord-261986,ACCORD,,66.0,YR,,,Y,,,20220427,,MD,DE,DE,2022,Q2,Elderly
207571021,20757102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220401.0,20220419.0,20220427,20220427,EXP,,BG-AstraZeneca-2022A158799,ASTRAZENECA,,25649.0,DY,,M,Y,,,20220427,,MD,BG,,2022,Q2,Elderly
207577592,20757759,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Urinary retention,,2022,Q2,2,F,20220101.0,20220616.0,20220427,20220624,EXP,,JP-AstraZeneca-2022A158975,ASTRAZENECA,,87.0,YR,,M,Y,,,20220624,,MD,JP,,2022,Q2,Elderly
207577592,20757759,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Hyperhidrosis,,2022,Q2,2,F,20220101.0,20220616.0,20220427,20220624,EXP,,JP-AstraZeneca-2022A158975,ASTRAZENECA,,87.0,YR,,M,Y,,,20220624,,MD,JP,,2022,Q2,Elderly
207577592,20757759,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Postrenal failure,,2022,Q2,2,F,20220101.0,20220616.0,20220427,20220624,EXP,,JP-AstraZeneca-2022A158975,ASTRAZENECA,,87.0,YR,,M,Y,,,20220624,,MD,JP,,2022,Q2,Elderly
207577592,20757759,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Haemothorax,,2022,Q2,2,F,20220101.0,20220616.0,20220427,20220624,EXP,,JP-AstraZeneca-2022A158975,ASTRAZENECA,,87.0,YR,,M,Y,,,20220624,,MD,JP,,2022,Q2,Elderly
207581991,20758199,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Vertigo,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207584142,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207584142,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207584142,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207584142,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207584142,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207584142,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220427,20220524,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220524,,HP,CA,,2022,Q2,Adult
207585232,20758523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,20220124.0,20220419.0,20220427,20220503,EXP,,JP-AstraZeneca-2022A062322,ASTRAZENECA,,83.0,YR,,M,Y,55.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
207585232,20758523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Altered state of consciousness,,2022,Q2,2,F,20220124.0,20220419.0,20220427,20220503,EXP,,JP-AstraZeneca-2022A062322,ASTRAZENECA,,83.0,YR,,M,Y,55.0,KG,20220503,,MD,JP,,2022,Q2,Elderly
207586791,20758679,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",110.769,MG,Y,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220421.0,20220427,20220427,EXP,FR-AFSSAPS-MP20221516,FR-MYLANLABS-2022M1030021,MYLAN,,46.0,YR,,F,Y,142.6,KG,20220427,,MD,FR,FR,2022,Q2,Adult
207598861,20759886,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Peripheral arterial occlusive disease,,2022,Q2,1,I,20220201.0,20220420.0,20220427,20220427,EXP,,FR-AstraZeneca-2022A155870,ASTRAZENECA,,89.0,YR,,F,Y,,,20220428,,MD,FR,,2022,Q2,Elderly
207598861,20759886,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Peripheral arterial occlusive disease,,2022,Q2,1,I,20220201.0,20220420.0,20220427,20220427,EXP,,FR-AstraZeneca-2022A155870,ASTRAZENECA,,89.0,YR,,F,Y,,,20220428,,MD,FR,,2022,Q2,Elderly
207600262,20760026,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,,,,,,,,,,,,2022,Q2,Hallucination,,2022,Q2,2,F,20220203.0,20220520.0,20220427,20220603,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-334734,RANBAXY,,95.0,YR,,F,Y,63.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
207600262,20760026,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,,,,,,,,,,,,2022,Q2,Behaviour disorder,,2022,Q2,2,F,20220203.0,20220520.0,20220427,20220603,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-334734,RANBAXY,,95.0,YR,,F,Y,63.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
207600262,20760026,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,2,F,20220203.0,20220520.0,20220427,20220603,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-334734,RANBAXY,,95.0,YR,,F,Y,63.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
207605891,20760589,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Film-coated tablet,,2022,Q2,Hemiparesis,,2022,Q2,1,I,20220101.0,20220414.0,20220428,20220428,EXP,DK-DKMA-WBS-0099967,DK-BRISTOL-MYERS SQUIBB COMPANY-2022-026435,BRISTOL MYERS SQUIBB,,68.0,YR,E,F,Y,,,20220428,,MD,DK,DK,2022,Q2,Elderly
207605891,20760589,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Film-coated tablet,,2022,Q2,Cerebral haemorrhage,,2022,Q2,1,I,20220101.0,20220414.0,20220428,20220428,EXP,DK-DKMA-WBS-0099967,DK-BRISTOL-MYERS SQUIBB COMPANY-2022-026435,BRISTOL MYERS SQUIBB,,68.0,YR,E,F,Y,,,20220428,,MD,DK,DK,2022,Q2,Elderly
207609432,20760943,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Haematuria,,2022,Q2,2,F,20220408.0,20220519.0,20220428,20220527,EXP,,JP-009507513-2204JPN002533J,MERCK,,60.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Adult
207612231,20761223,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg once a day, 1 DF, strength: 10 mg",,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Confusional state,,2022,Q2,1,I,20220209.0,20220418.0,20220428,20220428,EXP,FR-AFSSAPS-TS20221035,FR-TEVA-2022-FR-2030408,TEVA,,95.0,YR,E,F,Y,63.0,KG,20220428,,PH,FR,FR,2022,Q2,Elderly
207612231,20761223,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg once a day, 1 DF, strength: 10 mg",,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Hallucination,,2022,Q2,1,I,20220209.0,20220418.0,20220428,20220428,EXP,FR-AFSSAPS-TS20221035,FR-TEVA-2022-FR-2030408,TEVA,,95.0,YR,E,F,Y,63.0,KG,20220428,,PH,FR,FR,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Off label use,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Coronary artery occlusion,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Anaemia,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Ventricular fibrillation,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Fall,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Cardio-respiratory arrest,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Electrocardiogram ST segment elevation,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207616833,20761683,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Loss of consciousness,,2022,Q2,3,F,20220420.0,20220531.0,20220428,20220609,EXP,,JP-009507513-2204JPN008717,MERCK,,86.0,YR,,F,Y,39.4,KG,20220609,,PH,JP,JP,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Atrial fibrillation,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Gout,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Pustular psoriasis,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Glucose tolerance impaired,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Epistaxis,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Vascular purpura,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,COVID-19,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,,,,Tablet,,2022,Q2,Vertigo,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Atrial fibrillation,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Gout,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Pustular psoriasis,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glucose tolerance impaired,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Epistaxis,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Vascular purpura,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207617962,20761796,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Vertigo,,2022,Q2,2,F,20210601.0,20220422.0,20220428,20220502,EXP,,NVSC2022FR095698,NOVARTIS,,79.0,YR,,F,Y,77.4,KG,20220502,,MD,FR,FR,2022,Q2,Elderly
207626731,20762673,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15.0,MG,Y,,N82300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220412.0,20220420.0,20220428,20220428,EXP,,CN-AstraZeneca-2022A160728,ASTRAZENECA,,24518.0,DY,,F,Y,77.5,KG,20220428,,MD,CN,,2022,Q2,Elderly
207626731,20762673,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15.0,MG,Y,,N82300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220412.0,20220420.0,20220428,20220428,EXP,,CN-AstraZeneca-2022A160728,ASTRAZENECA,,24518.0,DY,,F,Y,77.5,KG,20220428,,MD,CN,,2022,Q2,Elderly
207628453,20762845,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000 ( 2 tablets per day),,,,,UNKNOWN,,,,,,,2022,Q2,Heart valve incompetence,,2022,Q2,3,F,20211108.0,20220418.0,20220428,20220516,EXP,,BR-NOVOPROD-912318,NOVO NORDISK,,60.0,YR,,M,Y,60.0,KG,20220516,,MD,BR,BR,2022,Q2,Adult
207628453,20762845,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000 ( 2 tablets per day),,,,,UNKNOWN,,,,,,,2022,Q2,Carotid arteriosclerosis,,2022,Q2,3,F,20211108.0,20220418.0,20220428,20220516,EXP,,BR-NOVOPROD-912318,NOVO NORDISK,,60.0,YR,,M,Y,60.0,KG,20220516,,MD,BR,BR,2022,Q2,Adult
207628453,20762845,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5/1000 ( 2 tablets per day),,,,,UNKNOWN,,,,,,,2022,Q2,Heart valve calcification,,2022,Q2,3,F,20211108.0,20220418.0,20220428,20220516,EXP,,BR-NOVOPROD-912318,NOVO NORDISK,,60.0,YR,,M,Y,60.0,KG,20220516,,MD,BR,BR,2022,Q2,Adult
207628681,20762868,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Leukocyturia,,2022,Q2,1,I,,20220420.0,20220428,20220428,EXP,,RU-AstraZeneca-2022A159755,ASTRAZENECA,,67.0,YR,,F,Y,,,20220428,,MD,RU,,2022,Q2,Elderly
207636541,20763654,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Lip pruritus,,2022,Q2,1,I,20220328.0,20220422.0,20220428,20220428,EXP,,GB-AstraZeneca-2022A160440,ASTRAZENECA,,32.0,YR,,M,Y,82.0,KG,20220428,,MD,GB,,2022,Q2,Young Adult
207639031,20763903,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Skin ulcer,,2022,Q2,1,I,,20220420.0,20220428,20220428,EXP,,FR-AstraZeneca-2022A158815,ASTRAZENECA,,71.0,YR,,M,Y,,,20220428,,MD,FR,,2022,Q2,Elderly
207639031,20763903,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Atrophy,,2022,Q2,1,I,,20220420.0,20220428,20220428,EXP,,FR-AstraZeneca-2022A158815,ASTRAZENECA,,71.0,YR,,M,Y,,,20220428,,MD,FR,,2022,Q2,Elderly
207644221,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220310.0,20220421.0,20220428,20220428,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20220428,,HP,CA,,2022,Q2,Adult
207644221,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220310.0,20220421.0,20220428,20220428,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20220428,,HP,CA,,2022,Q2,Adult
207644221,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,20220310.0,20220421.0,20220428,20220428,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20220428,,HP,CA,,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Swelling face,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Metastases to liver,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Metastases to central nervous system,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Mitral valve incompetence,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Lung cancer metastatic,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Left ventricular dysfunction,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207650763,20765076,7,C,DAPAGLIFLOZIN;SAXAGLIPTIN,,1,Unknown,"10 milligram, qd (10 mg, QD)",,,,,,,,10.0,MG,,QD,2022,Q2,Ventricular internal diameter abnormal,,2022,Q2,3,F,20220201.0,20220517.0,20220428,20220523,EXP,,GB-MYLANLABS-2022M1030686,MYLAN,,57.0,YR,,M,Y,86.0,KG,20220523,,MD,GB,GB,2022,Q2,Adult
207676162,20767616,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Tubulointerstitial nephritis,,2022,Q2,2,F,,20220425.0,20220429,20220510,EXP,,PK-AstraZeneca-2022A163604,ASTRAZENECA,"Nida S ,  Saima B, Syed Nayer M, Muhammad H. Dapagliflozin Induced Acute Tubulo-Interstitial Nephritis: A Case Report and Literature Review. American Journal of Medical Case Reports, 2021;9(12):725-729.",81.0,YR,,M,Y,,,20220510,,HP,PK,,2022,Q2,Elderly
207676162,20767616,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,2,F,,20220425.0,20220429,20220510,EXP,,PK-AstraZeneca-2022A163604,ASTRAZENECA,"Nida S ,  Saima B, Syed Nayer M, Muhammad H. Dapagliflozin Induced Acute Tubulo-Interstitial Nephritis: A Case Report and Literature Review. American Journal of Medical Case Reports, 2021;9(12):725-729.",81.0,YR,,M,Y,,,20220510,,HP,PK,,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Hyperhidrosis,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Temperature intolerance,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Herpes zoster,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Pain in extremity,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Alopecia,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Hypoaesthesia,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Inflammation,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Immunodeficiency,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Fall,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Heart rate increased,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Nasopharyngitis,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Lacrimation increased,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Nervous system disorder,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Dyskinesia,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Rectal haemorrhage,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Dizziness,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Joint swelling,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Angina pectoris,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Arterial haemorrhage,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207680181,20768018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q2,Contusion,,2022,Q2,1,I,20200101.0,20220423.0,20220429,20220429,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20220429,,CN,EG,EG,2022,Q2,Elderly
207681091,20768109,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,unknown,,,N,,,,,,,Unknown,,2022,Q2,Sarcopenia,,2022,Q2,1,I,20210801.0,20220420.0,20220429,20220429,EXP,IT-MINISAL02-859991,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-22-57490,HIKMA,,68.0,YR,,F,Y,44.0,KG,20220429,,MD,IT,IT,2022,Q2,Elderly
207681091,20768109,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,unknown,,,N,,,,,,,Unknown,,2022,Q2,Myopathy,,2022,Q2,1,I,20210801.0,20220420.0,20220429,20220429,EXP,IT-MINISAL02-859991,IT-Hikma Pharmaceuticals USA Inc.-IT-H14001-22-57490,HIKMA,,68.0,YR,,F,Y,44.0,KG,20220429,,MD,IT,IT,2022,Q2,Elderly
207689211,20768921,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,510.0,MG,Y,,NB2314,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pancreatitis acute,,2022,Q2,1,I,20220315.0,20220423.0,20220429,20220429,EXP,,CN-AstraZeneca-2022A164496,ASTRAZENECA,,25680.0,DY,,F,Y,45.0,KG,20220429,,MD,CN,,2022,Q2,Elderly
207699461,20769946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,,NA2978,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypernatraemia,,2022,Q2,1,I,20220412.0,20220422.0,20220429,20220429,EXP,,CN-AstraZeneca-2022A163992,ASTRAZENECA,,83.0,YR,,F,Y,52.0,KG,20220429,,MD,CN,,2022,Q2,Elderly
207699731,20769973,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",390.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20220214.0,20220425.0,20220429,20220429,EXP,IT-MINISAL02-859117,IT-MYLANLABS-2022M1030585,MYLAN,,83.0,YR,,M,Y,,,20220429,,PH,IT,IT,2022,Q2,Elderly
207699731,20769973,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",390.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Balanoposthitis,,2022,Q2,1,I,20220214.0,20220425.0,20220429,20220429,EXP,IT-MINISAL02-859117,IT-MYLANLABS-2022M1030585,MYLAN,,83.0,YR,,M,Y,,,20220429,,PH,IT,IT,2022,Q2,Elderly
207699731,20769973,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",390.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Urinary incontinence,,2022,Q2,1,I,20220214.0,20220425.0,20220429,20220429,EXP,IT-MINISAL02-859117,IT-MYLANLABS-2022M1030585,MYLAN,,83.0,YR,,M,Y,,,20220429,,PH,IT,IT,2022,Q2,Elderly
207714031,20771403,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Film-coated tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220107.0,20220423.0,20220429,20220429,EXP,FR-AFSSAPS-AM20221117,FR-BAUSCH-BL-2022-010044,BAUSCH AND LOMB,,72.0,YR,,M,Y,78.0,KG,20220429,,PH,FR,FR,2022,Q2,Elderly
207716781,20771678,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q2,Skin discolouration,,2022,Q2,1,I,20220422.0,20220426.0,20220430,20220430,EXP,GB-MHRA-TPP24832556C5823715YC1650647906090,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-167665",BOEHRINGER INGELHEIM,,58.0,YR,A,M,Y,92.0,KG,20220430,,MD,GB,GB,2022,Q2,Adult
207716781,20771678,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q2,Skin mass,,2022,Q2,1,I,20220422.0,20220426.0,20220430,20220430,EXP,GB-MHRA-TPP24832556C5823715YC1650647906090,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-167665",BOEHRINGER INGELHEIM,,58.0,YR,A,M,Y,92.0,KG,20220430,,MD,GB,GB,2022,Q2,Adult
207716781,20771678,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q2,Cutaneous calcification,,2022,Q2,1,I,20220422.0,20220426.0,20220430,20220430,EXP,GB-MHRA-TPP24832556C5823715YC1650647906090,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-167665",BOEHRINGER INGELHEIM,,58.0,YR,A,M,Y,92.0,KG,20220430,,MD,GB,GB,2022,Q2,Adult
207727071,20772707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220423.0,20220425.0,20220502,20220502,EXP,,NVSC2022DE099100,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,MD,DE,DE,2022,Q2,Elderly
207727071,20772707,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,1,I,20220423.0,20220425.0,20220502,20220502,EXP,,NVSC2022DE099100,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,MD,DE,DE,2022,Q2,Elderly
207727071,20772707,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220423.0,20220425.0,20220502,20220502,EXP,,NVSC2022DE099100,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,MD,DE,DE,2022,Q2,Elderly
207727071,20772707,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,1,I,20220423.0,20220425.0,20220502,20220502,EXP,,NVSC2022DE099100,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,MD,DE,DE,2022,Q2,Elderly
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Coronavirus test positive,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Bacteraemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Neutropenia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Hypogammaglobulinaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Diabetic nephropathy,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Hyponatraemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Coronavirus test positive,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Bacteraemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Neutropenia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Pyrexia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Infusion related reaction,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Back pain,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Nausea,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Hypogammaglobulinaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Constipation,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Neuropathy peripheral,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Diabetic nephropathy,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Decreased appetite,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Hyponatraemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Anaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207728693,20772869,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,5.0,MG,,,2022,Q2,Hyperglycaemia,,2022,Q2,3,F,20211215.0,20220512.0,20220502,20220519,EXP,,JP-ROCHE-3086611,ROCHE,,54.0,YR,,M,Y,88.0,KG,20220519,,MD,JP,,2022,Q2,Adult
207740843,20774084,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (10mg once a day)",,,,,,,,,,,QD,2022,Q2,Hallucination,,2022,Q2,3,F,20220203.0,20220524.0,20220502,20220527,EXP,FR-AFSSAPS-TS20221035,FR-MYLANLABS-2022M1031804,MYLAN,,95.0,YR,,F,Y,63.0,KG,20220527,,PH,FR,FR,2022,Q2,Elderly
207740843,20774084,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (10mg once a day)",,,,,,,,,,,QD,2022,Q2,Confusional state,,2022,Q2,3,F,20220203.0,20220524.0,20220502,20220527,EXP,FR-AFSSAPS-TS20221035,FR-MYLANLABS-2022M1031804,MYLAN,,95.0,YR,,F,Y,63.0,KG,20220527,,PH,FR,FR,2022,Q2,Elderly
207740843,20774084,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd (10mg once a day)",,,,,,,,,,,QD,2022,Q2,Behaviour disorder,,2022,Q2,3,F,20220203.0,20220524.0,20220502,20220527,EXP,FR-AFSSAPS-TS20221035,FR-MYLANLABS-2022M1031804,MYLAN,,95.0,YR,,F,Y,63.0,KG,20220527,,PH,FR,FR,2022,Q2,Elderly
207758661,20775866,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",210.0,MG,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Right ventricular failure,,2022,Q2,1,I,20220331.0,20220427.0,20220502,20220502,EXP,,NVSC2022AU100281,NOVARTIS,,50.0,YR,,M,Y,,,20220502,,CN,AU,AU,2022,Q2,Adult
207758761,20775876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220428.0,20220502,20220502,EXP,,NVSJ2022JP003590,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,PH,JP,JP,2022,Q2,Elderly
207758761,20775876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220428.0,20220502,20220502,EXP,,NVSJ2022JP003590,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,PH,JP,JP,2022,Q2,Elderly
207758761,20775876,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,1,I,,20220428.0,20220502,20220502,EXP,,NVSJ2022JP003590,NOVARTIS,,82.0,YR,,M,Y,,,20220502,,PH,JP,JP,2022,Q2,Elderly
207772281,20777228,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,Tablet,,2022,Q2,SARS-CoV-2 test positive,,2022,Q2,1,I,20220304.0,20220502.0,20220503,20220503,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-168509",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,54.2,KG,20220503,,PH,JP,JP,2022,Q2,Elderly
207772281,20777228,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,Tablet,,2022,Q2,Hepatic enzyme increased,,2022,Q2,1,I,20220304.0,20220502.0,20220503,20220503,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-168509",BOEHRINGER INGELHEIM,,75.0,YR,E,M,Y,54.2,KG,20220503,,PH,JP,JP,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Hypertension,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Coronary artery disease,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773191,20777319,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q2,Product dispensing error,,2022,Q2,1,I,20211201.0,20220426.0,20220503,20220503,EXP,,BR-009507513-2204BRA009666,MERCK,,69.0,YR,,M,Y,76.0,KG,20220503,,CN,BR,BR,2022,Q2,Elderly
207773941,20777394,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,U,,2108060,,,,,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220415.0,20220426.0,20220503,20220503,EXP,,CN-SA-2022SA154620,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220503,,HP,CN,CN,2022,Q2,Adult
207777354,20777735,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Sepsis,,2022,Q2,4,F,20220401.0,20220616.0,20220503,20220623,EXP,,JP-AstraZeneca-2022A170332,ASTRAZENECA,,88.0,YR,,F,Y,,,20220623,,MD,JP,,2022,Q2,Elderly
207777354,20777735,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Gastroenteritis,,2022,Q2,4,F,20220401.0,20220616.0,20220503,20220623,EXP,,JP-AstraZeneca-2022A170332,ASTRAZENECA,,88.0,YR,,F,Y,,,20220623,,MD,JP,,2022,Q2,Elderly
207805791,20780579,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Pollakiuria,,2022,Q2,1,I,,20220426.0,20220504,20220504,EXP,,RU-AstraZeneca-2022A169859,ASTRAZENECA,,60.0,YR,,F,Y,70.0,KG,20220504,,HP,RU,,2022,Q2,Adult
207805791,20780579,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Leukocyturia,,2022,Q2,1,I,,20220426.0,20220504,20220504,EXP,,RU-AstraZeneca-2022A169859,ASTRAZENECA,,60.0,YR,,F,Y,70.0,KG,20220504,,HP,RU,,2022,Q2,Adult
207805791,20780579,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220426.0,20220504,20220504,EXP,,RU-AstraZeneca-2022A169859,ASTRAZENECA,,60.0,YR,,F,Y,70.0,KG,20220504,,HP,RU,,2022,Q2,Adult
207805791,20780579,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220426.0,20220504,20220504,EXP,,RU-AstraZeneca-2022A169859,ASTRAZENECA,,60.0,YR,,F,Y,70.0,KG,20220504,,HP,RU,,2022,Q2,Adult
207820622,20782062,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Formulation unknown,QD,2022,Q2,Febrile neutropenia,,2022,Q2,2,F,20220214.0,20220524.0,20220504,20220527,EXP,,JP-ASTELLAS-2022JP005430,ASTELLAS,,77.0,YR,,M,Y,,,20220527,,CN,JP,JP,2022,Q2,Elderly
207828841,20782884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Groin abscess,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Vulvovaginal mycotic infection,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Groin abscess,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Vulvovaginal mycotic infection,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Groin abscess,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207828841,20782884,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Tablet, 10 mg (milligram),10.0mg UNKNOWN",,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Vulvovaginal mycotic infection,,2022,Q2,1,I,20220401.0,20220429.0,20220504,20220504,EXP,,NL-AstraZeneca-2022A168680,ASTRAZENECA,,76.0,YR,,F,Y,99.0,KG,20220504,,MD,NL,,2022,Q2,Elderly
207829611,20782961,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-JNJFOC-20220458543,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,105.0,KG,20220504,,HP,CA,CA,2022,Q2,Elderly
207829611,20782961,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-JNJFOC-20220458543,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,105.0,KG,20220504,,HP,CA,CA,2022,Q2,Elderly
207829611,20782961,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-JNJFOC-20220458543,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,105.0,KG,20220504,,HP,CA,CA,2022,Q2,Elderly
207829611,20782961,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Clostridium difficile infection,,2022,Q2,1,I,,20220427.0,20220504,20220504,EXP,,CA-JNJFOC-20220458543,JOHNSON AND JOHNSON,,81.0,YR,E,M,Y,105.0,KG,20220504,,HP,CA,CA,2022,Q2,Elderly
207833051,20783305,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Psoriasis,,2022,Q2,1,I,20220228.0,20220426.0,20220504,20220504,EXP,,GB-AstraZeneca-2022A166582,ASTRAZENECA,,74.0,YR,,M,Y,111.0,KG,20220504,,MD,GB,,2022,Q2,Elderly
207833051,20783305,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220228.0,20220426.0,20220504,20220504,EXP,,GB-AstraZeneca-2022A166582,ASTRAZENECA,,74.0,YR,,M,Y,111.0,KG,20220504,,MD,GB,,2022,Q2,Elderly
207840251,20784025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,N,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dermatitis bullous,,2022,Q2,1,I,20220408.0,20220426.0,20220504,20220504,EXP,,DK-AstraZeneca-2022A162939,ASTRAZENECA,,56.0,YR,,M,Y,,,20220504,,MD,DK,,2022,Q2,Adult
207840251,20784025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,N,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220408.0,20220426.0,20220504,20220504,EXP,,DK-AstraZeneca-2022A162939,ASTRAZENECA,,56.0,YR,,M,Y,,,20220504,,MD,DK,,2022,Q2,Adult
207840251,20784025,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,N,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blister,,2022,Q2,1,I,20220408.0,20220426.0,20220504,20220504,EXP,,DK-AstraZeneca-2022A162939,ASTRAZENECA,,56.0,YR,,M,Y,,,20220504,,MD,DK,,2022,Q2,Adult
207853621,20785362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1010.0,MG,Y,,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dysuria,,2022,Q2,1,I,20220410.0,20220428.0,20220504,20220504,EXP,,CN-AstraZeneca-2022A170069,ASTRAZENECA,,58.0,YR,,F,Y,62.0,KG,20220505,,MD,CN,,2022,Q2,Adult
207853621,20785362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1010.0,MG,Y,,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pollakiuria,,2022,Q2,1,I,20220410.0,20220428.0,20220504,20220504,EXP,,CN-AstraZeneca-2022A170069,ASTRAZENECA,,58.0,YR,,F,Y,62.0,KG,20220505,,MD,CN,,2022,Q2,Adult
207853621,20785362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1010.0,MG,Y,,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Micturition urgency,,2022,Q2,1,I,20220410.0,20220428.0,20220504,20220504,EXP,,CN-AstraZeneca-2022A170069,ASTRAZENECA,,58.0,YR,,F,Y,62.0,KG,20220505,,MD,CN,,2022,Q2,Adult
207866311,20786631,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Adverse drug reaction,,2022,Q2,1,I,20220406.0,20220420.0,20220505,20220505,EXP,,GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-335614,RANBAXY,,65.0,YR,,M,Y,110.0,KG,20220505,,CN,GB,GB,2022,Q2,Elderly
207883801,20788380,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220504.0,20220505,20220505,EXP,DE-BFARM-22003017,NVSC2022DE102987,NOVARTIS,,75.0,YR,,F,Y,75.0,KG,20220505,,MD,DE,DE,2022,Q2,Elderly
207883801,20788380,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220504.0,20220505,20220505,EXP,DE-BFARM-22003017,NVSC2022DE102987,NOVARTIS,,75.0,YR,,F,Y,75.0,KG,20220505,,MD,DE,DE,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pruritus,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rash,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Tension headache,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vaginal haemorrhage,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207899841,20789984,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,10.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Sneezing,,2022,Q2,1,I,20220407.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164776,ASTRAZENECA,,67.0,YR,,F,Y,,,20220505,,MD,DK,,2022,Q2,Elderly
207908351,20790835,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd (each morning)",,,,,,,,10.0,MG,,QD,2022,Q2,Drug-induced liver injury,,2022,Q2,1,I,,20220501.0,20220505,20220505,EXP,GB-MHRA-MIDB-5c9995fd-dbb5-4de8-b97f-11bba92bcb7d,GB-DSJP-DSE-2022-115292,DAIICHI,,58.0,YR,,M,Y,,,20220505,,PH,GB,GB,2022,Q2,Adult
207909511,20790951,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,strength: 5 mg,2610.0,MG,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cataract,,2022,Q2,1,I,20210325.0,20220427.0,20220505,20220505,EXP,,DK-AstraZeneca-2022A164749,ASTRAZENECA,,62.0,YR,,M,Y,88.0,KG,20220505,,MD,DK,,2022,Q2,Adult
207909591,20790959,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Fracture,,2022,Q2,1,I,20220418.0,20220427.0,20220505,20220505,EXP,,JP-AstraZeneca-2022A166620,ASTRAZENECA,,100.0,YR,,F,Y,,,20220505,,MD,JP,,2022,Q2,Elderly
207909591,20790959,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Fall,,2022,Q2,1,I,20220418.0,20220427.0,20220505,20220505,EXP,,JP-AstraZeneca-2022A166620,ASTRAZENECA,,100.0,YR,,F,Y,,,20220505,,MD,JP,,2022,Q2,Elderly
207909591,20790959,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Cerebral infarction,,2022,Q2,1,I,20220418.0,20220427.0,20220505,20220505,EXP,,JP-AstraZeneca-2022A166620,ASTRAZENECA,,100.0,YR,,F,Y,,,20220505,,MD,JP,,2022,Q2,Elderly
207913671,20791367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Arthritis,,2022,Q2,1,I,,20220502.0,20220505,20220505,EXP,,DE-AstraZeneca-2022A174878,ASTRAZENECA,,63.0,YR,,M,Y,,,20220505,,MD,DE,,2022,Q2,Adult
207922171,20792217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220413.0,20220505,20220505,EXP,,US-AstraZeneca-2022A155567,ASTRAZENECA,,72.0,YR,,M,Y,106.0,KG,20220505,,MD,GB,,2022,Q2,Elderly
207922171,20792217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,TID,2022,Q2,Tachycardia,,2022,Q2,1,I,,20220413.0,20220505,20220505,EXP,,US-AstraZeneca-2022A155567,ASTRAZENECA,,72.0,YR,,M,Y,106.0,KG,20220505,,MD,GB,,2022,Q2,Elderly
207930071,20793007,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12410.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220419.0,20220429.0,20220506,20220506,EXP,,DK-AstraZeneca-2022A167074,ASTRAZENECA,,63.0,YR,,F,Y,,,20220506,,MD,DK,,2022,Q2,Adult
207930071,20793007,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12410.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Altered state of consciousness,,2022,Q2,1,I,20220419.0,20220429.0,20220506,20220506,EXP,,DK-AstraZeneca-2022A167074,ASTRAZENECA,,63.0,YR,,F,Y,,,20220506,,MD,DK,,2022,Q2,Adult
207939181,20793918,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK UNK, qd",,,,,,,,,,,QD,2022,Q2,Rash,,2022,Q2,1,I,20210730.0,20220426.0,20220506,20220506,EXP,,GB-TAKEDA-2022TEU003056,TAKEDA,,74.0,YR,,F,Y,110.0,KG,20220506,,HP,GB,GB,2022,Q2,Elderly
207939181,20793918,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK UNK, qd",,,,,,,,,,,QD,2022,Q2,Headache,,2022,Q2,1,I,20210730.0,20220426.0,20220506,20220506,EXP,,GB-TAKEDA-2022TEU003056,TAKEDA,,74.0,YR,,F,Y,110.0,KG,20220506,,HP,GB,GB,2022,Q2,Elderly
207941331,20794133,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Film Coated Tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220107.0,20220422.0,20220506,20220506,EXP,,FR-AUROBINDO-AUR-APL-2022-014935,AUROBINDO,,72.0,YR,,M,Y,78.0,KG,20220506,,PH,FR,FR,2022,Q2,Elderly
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Left ventricular dysfunction,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Mitral valve incompetence,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Lung cancer metastatic,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Swelling face,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Ventricular internal diameter abnormal,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Metastases to central nervous system,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207941353,20794135,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Metastases to liver,,2022,Q2,3,F,20220201.0,20220517.0,20220506,20220601,EXP,,GB-AUROBINDO-AUR-APL-2022-015319,AUROBINDO,,57.0,YR,,M,Y,,,20220601,,MD,GB,GB,2022,Q2,Adult
207945722,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207945722,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220527,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220527,,HP,CA,CA,2022,Q2,Adult
207946602,20794660,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220602,EXP,,CA-ALVOGEN-2022-ALVOGEN-120294,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220603,,HP,CA,CA,2022,Q2,Adult
207946602,20794660,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220602,EXP,,CA-ALVOGEN-2022-ALVOGEN-120294,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220603,,HP,CA,CA,2022,Q2,Adult
207946602,20794660,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220519.0,20220506,20220602,EXP,,CA-ALVOGEN-2022-ALVOGEN-120294,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220603,,HP,CA,CA,2022,Q2,Adult
207946921,20794692,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Rash,,2022,Q2,1,I,20220420.0,20220428.0,20220506,20220506,EXP,GB-MHRA-ADR 26870926,GB-Accord-262593,ACCORD,,46.0,YR,,M,Y,,,20220506,,HP,GB,GB,2022,Q2,Adult
207946921,20794692,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Swelling face,,2022,Q2,1,I,20220420.0,20220428.0,20220506,20220506,EXP,GB-MHRA-ADR 26870926,GB-Accord-262593,ACCORD,,46.0,YR,,M,Y,,,20220506,,HP,GB,GB,2022,Q2,Adult
207952421,20795242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Myocardial infarction,,2022,Q2,1,I,20190101.0,20220503.0,20220506,20220506,EXP,,DE-AstraZeneca-2022A175765,ASTRAZENECA,,66.0,YR,,F,Y,,,20220506,,MD,DE,,2022,Q2,Elderly
207952421,20795242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,20190101.0,20220503.0,20220506,20220506,EXP,,DE-AstraZeneca-2022A175765,ASTRAZENECA,,66.0,YR,,F,Y,,,20220506,,MD,DE,,2022,Q2,Elderly
207958401,20795840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2110.0,MG,Y,,MT3063,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ketosis,,2022,Q2,1,I,20220418.0,20220429.0,20220506,20220506,EXP,,CN-AstraZeneca-2022A172783,ASTRAZENECA,,21608.0,DY,,F,Y,58.0,KG,20220506,,MD,CN,,2022,Q2,Elderly
207959921,20795992,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Colitis ulcerative,,2022,Q2,1,I,,20220503.0,20220506,20220506,EXP,,CA-TAKEDA-2022TUS030287,TAKEDA,,45.0,YR,,M,Y,,,20220506,,MD,CA,CA,2022,Q2,Adult
207964871,20796487,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 per daily,,,N,,,,202293.0,,,Tablet,,2022,Q2,Systemic candida,,2022,Q2,1,I,20220329.0,20220428.0,20220506,20220506,EXP,,FR-AstraZeneca-2022A165547,ASTRAZENECA,,78.0,YR,,M,Y,81.0,KG,20220506,,MD,FR,,2022,Q2,Elderly
207964871,20796487,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 per daily,,,N,,,,202293.0,,,Tablet,,2022,Q2,Systemic candida,,2022,Q2,1,I,20220329.0,20220428.0,20220506,20220506,EXP,,FR-AstraZeneca-2022A165547,ASTRAZENECA,,78.0,YR,,M,Y,81.0,KG,20220506,,MD,FR,,2022,Q2,Elderly
207964871,20796487,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 per daily,,,N,,,,202293.0,,,Tablet,,2022,Q2,Systemic candida,,2022,Q2,1,I,20220329.0,20220428.0,20220506,20220506,EXP,,FR-AstraZeneca-2022A165547,ASTRAZENECA,,78.0,YR,,M,Y,81.0,KG,20220506,,MD,FR,,2022,Q2,Elderly
207978121,20797812,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220504.0,20220506,20220506,EXP,,DE-AstraZeneca-2022A173671,ASTRAZENECA,,75.0,YR,,F,Y,75.0,KG,20220506,,MD,DE,,2022,Q2,Elderly
207978121,20797812,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220504.0,20220506,20220506,EXP,,DE-AstraZeneca-2022A173671,ASTRAZENECA,,75.0,YR,,F,Y,75.0,KG,20220506,,MD,DE,,2022,Q2,Elderly
207980881,20798088,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,"Tablet, film coated",,2022,Q2,Septic shock,,2022,Q2,1,I,20220330.0,20220502.0,20220507,20220507,EXP,,FR-AMERICAN REGENT INC-2022001255,AMERICAN REGENT,,54.0,YR,,M,Y,72.3,KG,20220507,,MD,FR,FR,2022,Q2,Adult
207980881,20798088,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,"Tablet, film coated",,2022,Q2,Type I hypersensitivity,,2022,Q2,1,I,20220330.0,20220502.0,20220507,20220507,EXP,,FR-AMERICAN REGENT INC-2022001255,AMERICAN REGENT,,54.0,YR,,M,Y,72.3,KG,20220507,,MD,FR,FR,2022,Q2,Adult
207992331,20799233,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 mg film-coated tablets,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220107.0,20220428.0,20220508,20220508,EXP,FR-AFSSAPS-AM20221117,FR-TEVA-2022-FR-2033445,TEVA,,72.0,YR,E,M,Y,78.0,KG,20220507,,PH,FR,FR,2022,Q2,Elderly
207994641,20799464,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg ODS; ;,,,U,,,,202293.0,,,Tablet,,2022,Q2,Asthma,,2022,Q2,1,I,20220422.0,20220501.0,20220508,20220508,EXP,,GB-AstraZeneca-2022A169614,ASTRAZENECA,,52.0,YR,,F,Y,159.0,KG,20220509,,MD,GB,,2022,Q2,Adult
208004831,20800483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220503.0,20220509,20220509,EXP,DE-BFARM-22003017,DE-BAUSCH-BL-2022-011114,BAUSCH AND LOMB,,75.0,YR,,F,Y,75.0,KG,20220509,,MD,DE,DE,2022,Q2,Elderly
208004831,20800483,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220503.0,20220509,20220509,EXP,DE-BFARM-22003017,DE-BAUSCH-BL-2022-011114,BAUSCH AND LOMB,,75.0,YR,,F,Y,75.0,KG,20220509,,MD,DE,DE,2022,Q2,Elderly
208011061,20801106,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20220426.0,20220506.0,20220509,20220509,EXP,FR-AFSSAPS-AN20221176,NVSC2022FR104987,NOVARTIS,,54.0,YR,,M,Y,,,20220509,,MD,FR,FR,2022,Q2,Adult
208011061,20801106,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Angioedema,,2022,Q2,1,I,20220426.0,20220506.0,20220509,20220509,EXP,FR-AFSSAPS-AN20221176,NVSC2022FR104987,NOVARTIS,,54.0,YR,,M,Y,,,20220509,,MD,FR,FR,2022,Q2,Adult
208023531,20802353,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Coated tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220328.0,20220506.0,20220509,20220509,EXP,FR-AFSSAPS-AM20221118,FR-MYLANLABS-2022M1032184,MYLAN,,72.0,YR,,M,Y,78.0,KG,20220509,,PH,FR,FR,2022,Q2,Elderly
208023531,20802353,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Coated tablet,,2022,Q2,Haemoptysis,,2022,Q2,1,I,20220328.0,20220506.0,20220509,20220509,EXP,FR-AFSSAPS-AM20221118,FR-MYLANLABS-2022M1032184,MYLAN,,72.0,YR,,M,Y,78.0,KG,20220509,,PH,FR,FR,2022,Q2,Elderly
208025761,20802576,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,1,I,20220424.0,,20220509,20220509,DIR,613511,,FDA-CTU,,75.0,YR,,M,N,,,20220509,N,,US,,2022,Q2,Elderly
208025761,20802576,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20220424.0,,20220509,20220509,DIR,613511,,FDA-CTU,,75.0,YR,,M,N,,,20220509,N,,US,,2022,Q2,Elderly
208025761,20802576,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,20220424.0,,20220509,20220509,DIR,613511,,FDA-CTU,,75.0,YR,,M,N,,,20220509,N,,US,,2022,Q2,Elderly
208025761,20802576,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Leukocytosis,,2022,Q2,1,I,20220424.0,,20220509,20220509,DIR,613511,,FDA-CTU,,75.0,YR,,M,N,,,20220509,N,,US,,2022,Q2,Elderly
208025761,20802576,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,1,I,20220424.0,,20220509,20220509,DIR,613511,,FDA-CTU,,75.0,YR,,M,N,,,20220509,N,,US,,2022,Q2,Elderly
208037081,20803708,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220426.0,20220509,20220509,EXP,,IN-LUPIN PHARMACEUTICALS INC.-2022-06715,LUPIN,"Aggarwal SK, Kaur U, Talda D, Pandey A, Jaiswal S, Kanakan A, et al. Case report: Rhino-orbital mucormycosis related to COVID-19: A case series exploring risk factors. American Society of Tropical Medicine and Hygiene. 2022;106(2):566-570",33.0,YR,,M,Y,,,20220509,,HP,IN,IN,2022,Q2,Young Adult
208037081,20803708,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Rhinocerebral mucormycosis,,2022,Q2,1,I,,20220426.0,20220509,20220509,EXP,,IN-LUPIN PHARMACEUTICALS INC.-2022-06715,LUPIN,"Aggarwal SK, Kaur U, Talda D, Pandey A, Jaiswal S, Kanakan A, et al. Case report: Rhino-orbital mucormycosis related to COVID-19: A case series exploring risk factors. American Society of Tropical Medicine and Hygiene. 2022;106(2):566-570",33.0,YR,,M,Y,,,20220509,,HP,IN,IN,2022,Q2,Young Adult
208042711,20804271,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Each morning,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug-induced liver injury,,2022,Q2,1,I,,20220501.0,20220509,20220509,EXP,,GB-AstraZeneca-2022A169655,ASTRAZENECA,,58.0,YR,,M,Y,,,20220509,,MD,GB,,2022,Q2,Adult
208046301,20804630,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Death,,2022,Q2,1,I,,20220503.0,20220509,20220509,EXP,,CA-PFIZER INC-202200655246,PFIZER,,65.0,YR,,M,Y,,,20220509,,HP,CA,CA,2022,Q2,Elderly
208051922,20805192,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Every 24 hours?Ongoing,,,U,,,,,10.0,MG,,,2022,Q2,Pneumonitis,,2022,Q2,2,F,20220419.0,20220510.0,20220509,20220516,EXP,,CL-BRISTOL-MYERS SQUIBB COMPANY-2022-026097,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,79.0,KG,20220517,,HP,CL,CL,2022,Q2,Elderly
208051922,20805192,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Every 24 hours?Ongoing,,,U,,,,,10.0,MG,,,2022,Q2,Pleural effusion,,2022,Q2,2,F,20220419.0,20220510.0,20220509,20220516,EXP,,CL-BRISTOL-MYERS SQUIBB COMPANY-2022-026097,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,79.0,KG,20220517,,HP,CL,CL,2022,Q2,Elderly
208055541,20805554,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220107.0,20220426.0,20220510,20220510,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-336021,RANBAXY,,72.0,YR,,M,Y,78.0,KG,20220510,,PH,FR,FR,2022,Q2,Elderly
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Back pain,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Neurogenic bladder,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Fibromyalgia,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Memory impairment,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Breast pain,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Therapeutic product effect decreased,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Drug ineffective,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Osteoarthritis,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Finger deformity,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Pulmonary mass,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Urethral pain,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Chondropathy,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208067511,20806751,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,QD,2022,Q2,Pneumonia viral,,2022,Q2,1,I,20210401.0,20220504.0,20220510,20220510,EXP,,BR-ABBVIE-22K-020-4382870-00,ABBVIE,,57.0,YR,,F,Y,110.0,KG,20220510,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
208084521,20808452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,,20220502.0,20220510,20220510,EXP,,MQ-AstraZeneca-2022A177352,ASTRAZENECA,,60.0,YR,,F,Y,,,20220510,,MD,MQ,FR,2022,Q2,Adult
208084521,20808452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220502.0,20220510,20220510,EXP,,MQ-AstraZeneca-2022A177352,ASTRAZENECA,,60.0,YR,,F,Y,,,20220510,,MD,MQ,FR,2022,Q2,Adult
208086341,20808634,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Rash,,2022,Q2,1,I,20220420.0,20220501.0,20220510,20220510,EXP,,GB-PFIZER INC-202200644847,PFIZER,,46.0,YR,,M,Y,,,20220510,,HP,GB,GB,2022,Q2,Adult
208086341,20808634,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Swelling face,,2022,Q2,1,I,20220420.0,20220501.0,20220510,20220510,EXP,,GB-PFIZER INC-202200644847,PFIZER,,46.0,YR,,M,Y,,,20220510,,HP,GB,GB,2022,Q2,Adult
208104251,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,,20220502.0,20220510,20220510,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220510,,MD,CA,,2022,Q2,Adult
208104251,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Bacteraemia,,2022,Q2,1,I,,20220502.0,20220510,20220510,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220510,,MD,CA,,2022,Q2,Adult
208104251,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220502.0,20220510,20220510,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220510,,MD,CA,,2022,Q2,Adult
208105481,20810548,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, daily",80.0,MG,Y,U,Unknown,,,10.0,MG,,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220317.0,20220502.0,20220510,20220510,EXP,FR-AFSSAPS-MP20221491,FR-PURDUE-USA-2022-0293617,PURDUE,,46.0,YR,,F,Y,142.6,KG,20220510,,MD,FR,FR,2022,Q2,Adult
208105541,20810554,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, daily",110.768997,MG,Y,U,Unknown,,,10.0,MG,,QD,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220502.0,20220510,20220510,EXP,FR-AFSSAPS-MP20221516,FR-PURDUE-USA-2022-0293618,PURDUE,,46.0,YR,,F,Y,142.6,KG,20220510,,MD,FR,FR,2022,Q2,Adult
208107051,20810705,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Polyp,,2022,Q2,1,I,20220401.0,20220502.0,20220510,20220510,EXP,,FR-AstraZeneca-2022A177336,ASTRAZENECA,,75.0,YR,,M,Y,,,20220510,,CN,FR,,2022,Q2,Elderly
208107051,20810705,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Intentional product misuse,,2022,Q2,1,I,20220401.0,20220502.0,20220510,20220510,EXP,,FR-AstraZeneca-2022A177336,ASTRAZENECA,,75.0,YR,,M,Y,,,20220510,,CN,FR,,2022,Q2,Elderly
208117771,20811777,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,Y,,,,205649.0,,,,,2022,Q2,Acidosis,,2022,Q2,1,I,20210618.0,20220504.0,20220511,20220511,EXP,,ES-AstraZeneca-2022A174022,ASTRAZENECA,,72.0,YR,,F,Y,,,20220511,,MD,ES,,2022,Q2,Elderly
208118222,20811822,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Embedded device,,2022,Q2,2,F,20220301.0,20220512.0,20220511,20220518,EXP,,FI-ABBVIE-22K-055-4384631-00,ABBVIE,,75.0,YR,,M,Y,,,20220518,,CN,COUNTRY NOT SPECIFIED,FI,2022,Q2,Elderly
208118222,20811822,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Wrong technique in device usage process,,2022,Q2,2,F,20220301.0,20220512.0,20220511,20220518,EXP,,FI-ABBVIE-22K-055-4384631-00,ABBVIE,,75.0,YR,,M,Y,,,20220518,,CN,COUNTRY NOT SPECIFIED,FI,2022,Q2,Elderly
208118222,20811822,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20220301.0,20220512.0,20220511,20220518,EXP,,FI-ABBVIE-22K-055-4384631-00,ABBVIE,,75.0,YR,,M,Y,,,20220518,,CN,COUNTRY NOT SPECIFIED,FI,2022,Q2,Elderly
208118222,20811822,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,2,F,20220301.0,20220512.0,20220511,20220518,EXP,,FI-ABBVIE-22K-055-4384631-00,ABBVIE,,75.0,YR,,M,Y,,,20220518,,CN,COUNTRY NOT SPECIFIED,FI,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Vascular purpura,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Gout,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Atrial fibrillation,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Epistaxis,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Glucose tolerance impaired,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Pustular psoriasis,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q2,Vertigo,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Vascular purpura,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,COVID-19,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Gout,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Atrial fibrillation,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Epistaxis,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Glucose tolerance impaired,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Pustular psoriasis,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208126232,20812623,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,(stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,,,,202293.0,,,Tablet,,2022,Q2,Vertigo,,2022,Q2,2,F,20210601.0,20220506.0,20220511,20220513,EXP,,FR-AstraZeneca-2022A172194,ASTRAZENECA,,79.0,YR,,F,Y,77.4,KG,20220513,,MD,FR,,2022,Q2,Elderly
208127571,20812757,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q2,Cardiac failure acute,,2022,Q2,1,I,20210318.0,20220427.0,20220511,20220511,PER,JP-ONO-2022JP001049,JP-AMGEN-JPNNI2022081413,AMGEN,,98.0,YR,E,F,Y,55.0,KG,20220511,,MD,JP,JP,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Oedema,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Fatigue,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208145251,20814525,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,,20220503.0,20220511,20220511,EXP,,SI-PFIZER INC-202200654167,PFIZER,,67.0,YR,,M,Y,,,20220511,,MD,SI,SI,2022,Q2,Elderly
208147811,20814781,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"take one daily, to help heart/blood sugar levels",,,U,,,,202293.0,,,Tablet,,2022,Q2,Dry mouth,,2022,Q2,1,I,20220411.0,20220413.0,20220511,20220511,PER,,US-AstraZeneca-2022A155623,ASTRAZENECA,,76.0,YR,,M,Y,89.0,KG,20220511,,MD,US,,2022,Q2,Elderly
208147811,20814781,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,DOSE UNKNOWN,,,U,,,,202293.0,,,Tablet,,2022,Q2,Dry mouth,,2022,Q2,1,I,20220411.0,20220413.0,20220511,20220511,PER,,US-AstraZeneca-2022A155623,ASTRAZENECA,,76.0,YR,,M,Y,89.0,KG,20220511,,MD,US,,2022,Q2,Elderly
208154011,20815401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Myocardial infarction,,2022,Q2,1,I,20220401.0,20220506.0,20220511,20220511,EXP,,FR-AstraZeneca-2022A181754,ASTRAZENECA,,61.0,YR,,F,Y,,,20220511,,MD,FR,,2022,Q2,Adult
208154011,20815401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Ill-defined disorder,,2022,Q2,1,I,20220401.0,20220506.0,20220511,20220511,EXP,,FR-AstraZeneca-2022A181754,ASTRAZENECA,,61.0,YR,,F,Y,,,20220511,,MD,FR,,2022,Q2,Adult
208154011,20815401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Cardiogenic shock,,2022,Q2,1,I,20220401.0,20220506.0,20220511,20220511,EXP,,FR-AstraZeneca-2022A181754,ASTRAZENECA,,61.0,YR,,F,Y,,,20220511,,MD,FR,,2022,Q2,Adult
208154011,20815401,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Coma,,2022,Q2,1,I,20220401.0,20220506.0,20220511,20220511,EXP,,FR-AstraZeneca-2022A181754,ASTRAZENECA,,61.0,YR,,F,Y,,,20220511,,MD,FR,,2022,Q2,Adult
208161931,20816193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,10.0,MG,,QD,2022,Q2,Asthenia,,2022,Q2,1,I,20220101.0,20220506.0,20220511,20220511,EXP,,DE-AstraZeneca-2022A176385,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220512,,MD,DE,,2022,Q2,Elderly
208161931,20816193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,10.0,MG,,QD,2022,Q2,Aggression,,2022,Q2,1,I,20220101.0,20220506.0,20220511,20220511,EXP,,DE-AstraZeneca-2022A176385,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220512,,MD,DE,,2022,Q2,Elderly
208161931,20816193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,10.0,MG,,QD,2022,Q2,Renal failure,,2022,Q2,1,I,20220101.0,20220506.0,20220511,20220511,EXP,,DE-AstraZeneca-2022A176385,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220512,,MD,DE,,2022,Q2,Elderly
208161931,20816193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,202293.0,10.0,MG,,QD,2022,Q2,Depression,,2022,Q2,1,I,20220101.0,20220506.0,20220511,20220511,EXP,,DE-AstraZeneca-2022A176385,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220512,,MD,DE,,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Tongue dry,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Ulcer haemorrhage,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Petechiae,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Cardiac failure chronic,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Faeces discoloured,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Flatulence,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Melaena,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208171943,20817194,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Conjunctival discolouration,,2022,Q2,3,F,,20220523.0,20220512,20220527,EXP,,SI-ORGANON-O2205SVN000253,ORGANON,,84.0,YR,,F,Y,,,20220527,,MD,SI,SI,2022,Q2,Elderly
208188391,20818839,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1090.0,MG,,,J20170040,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vulvovaginal pruritus,,2022,Q2,1,I,20220201.0,20220506.0,20220512,20220512,EXP,,CN-AstraZeneca-2022A179716,ASTRAZENECA,,2960.0,WK,,F,Y,57.0,KG,20220512,,MD,CN,,2022,Q2,Elderly
208188391,20818839,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1090.0,MG,,,J20170040,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220201.0,20220506.0,20220512,20220512,EXP,,CN-AstraZeneca-2022A179716,ASTRAZENECA,,2960.0,WK,,F,Y,57.0,KG,20220512,,MD,CN,,2022,Q2,Elderly
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Wrong technique in product usage process,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Blood potassium increased,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Product use in unapproved indication,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208199983,20819998,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,3,F,20220410.0,20220602.0,20220512,20220607,EXP,,NVSC2022MX108319,NOVARTIS,,62.0,YR,,M,Y,78.0,KG,20220607,,CN,MX,MX,2022,Q2,Adult
208218401,20821840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,540.0,MG,N,,NA3040,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20220412.0,20220416.0,20220512,20220512,EXP,,CN-AstraZeneca-2022A155178,ASTRAZENECA,,27394.0,DY,,F,Y,70.0,KG,20220512,,MD,CN,,2022,Q2,Elderly
208218401,20821840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,540.0,MG,N,,NA3040,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20220412.0,20220416.0,20220512,20220512,EXP,,CN-AstraZeneca-2022A155178,ASTRAZENECA,,27394.0,DY,,F,Y,70.0,KG,20220512,,MD,CN,,2022,Q2,Elderly
208220481,20822048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,Y,D,,,,10.0,MG,,QD,2022,Q2,Metabolic encephalopathy,,2022,Q2,1,I,20220510.0,,20220512,20220512,DIR,613970,,FDA-CTU,,68.0,YR,,M,N,90.8,KG,20220512,N,PH,US,,2022,Q2,Elderly
208220481,20822048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,Y,D,,,,10.0,MG,,QD,2022,Q2,Fournier's gangrene,,2022,Q2,1,I,20220510.0,,20220512,20220512,DIR,613970,,FDA-CTU,,68.0,YR,,M,N,90.8,KG,20220512,N,PH,US,,2022,Q2,Elderly
208220481,20822048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,Y,D,,,,10.0,MG,,QD,2022,Q2,Septic shock,,2022,Q2,1,I,20220510.0,,20220512,20220512,DIR,613970,,FDA-CTU,,68.0,YR,,M,N,90.8,KG,20220512,N,PH,US,,2022,Q2,Elderly
208229322,20822932,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q2,Interstitial lung disease,,2022,Q2,2,F,20220215.0,20220607.0,20220512,20220613,EXP,,NVSJ2022JP089837,NOVARTIS,,81.0,YR,,M,Y,62.6,KG,20220613,,PH,JP,JP,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ascites,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dizziness,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Oliguria,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Lactic acidosis,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight increased,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Oedema,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypervolaemia,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237161,20823716,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,,,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hepatic function abnormal,,2022,Q2,1,I,20220301.0,20220506.0,20220513,20220513,EXP,,DK-AstraZeneca-2022A176328,ASTRAZENECA,,82.0,YR,,M,Y,63.0,KG,20220513,,MD,DK,,2022,Q2,Elderly
208237981,20823798,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Off label use,,2022,Q2,1,I,20220408.0,20220510.0,20220513,20220513,PER,FR-AFSSAPS-MP20221798,FR-AMGEN-FRASP2022081226,AMGEN,,81.0,YR,E,M,Y,90.0,KG,20220512,,PH,FR,FR,2022,Q2,Elderly
208237981,20823798,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Acute pulmonary oedema,,2022,Q2,1,I,20220408.0,20220510.0,20220513,20220513,PER,FR-AFSSAPS-MP20221798,FR-AMGEN-FRASP2022081226,AMGEN,,81.0,YR,E,M,Y,90.0,KG,20220512,,PH,FR,FR,2022,Q2,Elderly
208252681,20825268,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220506.0,20220513,20220513,EXP,DE-BFARM-22003017,DE-EMD Serono-E2B_90087733,EMD SERONO INC,,75.0,YR,E,F,Y,75.0,KG,20220513,,MD,DE,DE,2022,Q2,Elderly
208252681,20825268,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220506.0,20220513,20220513,EXP,DE-BFARM-22003017,DE-EMD Serono-E2B_90087733,EMD SERONO INC,,75.0,YR,E,F,Y,75.0,KG,20220513,,MD,DE,DE,2022,Q2,Elderly
208254561,20825456,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cystitis,,2022,Q2,1,I,20220101.0,20220505.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A178580,ASTRAZENECA,,61.0,YR,,F,Y,73.0,KG,20220513,,MD,RU,,2022,Q2,Adult
208254561,20825456,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Secretion discharge,,2022,Q2,1,I,20220101.0,20220505.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A178580,ASTRAZENECA,,61.0,YR,,F,Y,73.0,KG,20220513,,MD,RU,,2022,Q2,Adult
208254561,20825456,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cystitis haemorrhagic,,2022,Q2,1,I,20220101.0,20220505.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A178580,ASTRAZENECA,,61.0,YR,,F,Y,73.0,KG,20220513,,MD,RU,,2022,Q2,Adult
208254561,20825456,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pruritus genital,,2022,Q2,1,I,20220101.0,20220505.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A178580,ASTRAZENECA,,61.0,YR,,F,Y,73.0,KG,20220513,,MD,RU,,2022,Q2,Adult
208265491,20826549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,1,I,20220501.0,20220510.0,20220513,20220513,EXP,,CR-AstraZeneca-2022A183144,ASTRAZENECA,,29266.0,DY,,M,Y,,,20220513,,CN,CR,,2022,Q2,Elderly
208268841,20826884,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,,,,,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-06600,LUPIN,,56.0,YR,,M,Y,,,20220513,,CN,ZA,ZA,2022,Q2,Adult
208268841,20826884,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,1,I,,20220428.0,20220513,20220513,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-06600,LUPIN,,56.0,YR,,M,Y,,,20220513,,CN,ZA,ZA,2022,Q2,Adult
208273011,20827301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,06052022004,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Gastrointestinal disorder,,2022,Q2,1,I,,20220506.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A180960,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20220513,,HP,RU,,2022,Q2,Elderly
208273011,20827301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,06052022004,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220506.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A180960,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20220513,,HP,RU,,2022,Q2,Elderly
208273011,20827301,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,06052022004,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight increased,,2022,Q2,1,I,,20220506.0,20220513,20220513,EXP,,RU-AstraZeneca-2022A180960,ASTRAZENECA,,70.0,YR,,M,Y,80.0,KG,20220513,,HP,RU,,2022,Q2,Elderly
208273931,20827393,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Acute pulmonary oedema,,2022,Q2,1,I,20220408.0,20220510.0,20220513,20220513,EXP,FR-AFSSAPS-MP20221798,FR-ROCHE-3094492,ROCHE,,81.0,YR,,M,Y,90.0,KG,20220513,,PH,FR,FR,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Melaena,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Tongue dry,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Petechiae,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Faeces discoloured,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Conjunctival discolouration,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Flatulence,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Cardiac failure chronic,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Ulcer haemorrhage,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208275601,20827560,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,,20220429.0,20220513,20220513,EXP,,SI-TAKEDA-2022TUS031362,TAKEDA,,84.0,YR,,F,Y,,,20220513,,HP,SI,SI,2022,Q2,Elderly
208277092,20827709,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (one tablet)",,,,,,,,,,Tablet,QD,2022,Q2,Prostatic haemorrhage,,2022,Q2,2,F,20220401.0,20220518.0,20220513,20220524,EXP,,NVSC2022BR108314,NOVARTIS,,75.0,YR,,M,Y,65.0,KG,20220524,,CN,BR,BR,2022,Q2,Elderly
208283591,20828359,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,2106024,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dermatitis allergic,,2022,Q2,1,I,20220403.0,20220506.0,20220513,20220513,EXP,,CN-AstraZeneca-2022A181875,ASTRAZENECA,,39.0,YR,,M,Y,66.0,KG,20220513,,MD,CN,,2022,Q2,Adult
208300311,20830031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 Milligram Daily; 10 mg, QD",1520.0,MG,,U,,,,10.0,MG,Tablet,QD,2022,Q2,Orthostatic hypotension,,2022,Q2,1,I,,20220504.0,20220514,20220514,EXP,,GB-TEVA-2022-GB-2035982,TEVA,,40.0,YR,A,M,Y,,,20220514,,MD,GB,GB,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hyponatraemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hypogammaglobulinaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Neutropenia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Coronavirus test positive,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Bacteraemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,49,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Diabetic nephropathy,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Back pain,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hyponatraemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Hypogammaglobulinaemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Neutropenia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Coronavirus test positive,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Bacteraemia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208324881,20832488,50,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Diabetic nephropathy,,2022,Q2,1,I,20211215.0,20220502.0,20220516,20220516,EXP,,ROCHE-3086611,ROCHE,,54.0,YR,,,Y,88.0,KG,20220516,,,COUNTRY NOT SPECIFIED,,2022,Q2,Adult
208328833,20832883,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,#4,,,U,,,,,,,Unknown,,2022,Q2,COVID-19 pneumonia,,2022,Q2,3,F,20220404.0,20220517.0,20220516,20220530,EXP,,FI-BRISTOL-MYERS SQUIBB COMPANY-2022-034365,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,82.0,KG,20220530,,MD,FI,FI,2022,Q2,Elderly
208328833,20832883,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,3,F,20220404.0,20220517.0,20220516,20220530,EXP,,FI-BRISTOL-MYERS SQUIBB COMPANY-2022-034365,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,82.0,KG,20220530,,MD,FI,FI,2022,Q2,Elderly
208333841,20833384,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Angioedema,,2022,Q2,1,I,20220426.0,20220510.0,20220516,20220516,EXP,FR-AFSSAPS-AN20221176,FR-009507513-2205FRA002718,MERCK,,54.0,YR,,M,Y,,,20220516,,MD,FR,FR,2022,Q2,Adult
208333841,20833384,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20220426.0,20220510.0,20220516,20220516,EXP,FR-AFSSAPS-AN20221176,FR-009507513-2205FRA002718,MERCK,,54.0,YR,,M,Y,,,20220516,,MD,FR,FR,2022,Q2,Adult
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Tongue dry,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Cardiac failure chronic,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Faeces discoloured,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Ulcer haemorrhage,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Flatulence,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Conjunctival discolouration,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Melaena,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Dizziness,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208337721,20833772,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Petechiae,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,SI-MYLANLABS-2022M1034684,MYLAN,,84.0,YR,,F,Y,,,20220516,,MD,SI,SI,2022,Q2,Elderly
208339901,20833990,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperlipidaemia,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208339901,20833990,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urine protein/creatinine ratio increased,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208339901,20833990,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Albuminuria,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208339901,20833990,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperlipidaemia,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208339901,20833990,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urine protein/creatinine ratio increased,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208339901,20833990,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Albuminuria,,2022,Q2,1,I,,20220509.0,20220516,20220516,EXP,,DE-AstraZeneca-2022A180204,ASTRAZENECA,,26.0,YR,,M,Y,,,20220516,,MD,DE,,2022,Q2,Young Adult
208348201,20834820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220312.0,20220507.0,20220516,20220516,EXP,,CN-AstraZeneca-2022A183361,ASTRAZENECA,,25202.0,DY,,F,Y,60.0,KG,20220516,,MD,CN,,2022,Q2,Elderly
208364361,20836436,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220503.0,20220517,20220517,EXP,,DE-AUROBINDO-AUR-APL-2022-016677,AUROBINDO,,75.0,YR,,F,Y,75.0,KG,20220517,,MD,DE,DE,2022,Q2,Elderly
208364361,20836436,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220503.0,20220517,20220517,EXP,,DE-AUROBINDO-AUR-APL-2022-016677,AUROBINDO,,75.0,YR,,F,Y,75.0,KG,20220517,,MD,DE,DE,2022,Q2,Elderly
208366511,20836651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,Y,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyponatraemia,,2022,Q2,1,I,20220312.0,20220507.0,20220517,20220517,EXP,,CN-AstraZeneca-2022A186369,ASTRAZENECA,,25202.0,DY,,F,Y,60.0,KG,20220517,,MD,CN,,2022,Q2,Elderly
208366511,20836651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,Y,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220312.0,20220507.0,20220517,20220517,EXP,,CN-AstraZeneca-2022A186369,ASTRAZENECA,,25202.0,DY,,F,Y,60.0,KG,20220517,,MD,CN,,2022,Q2,Elderly
208366511,20836651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,280.0,MG,Y,Y,NA2991,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rash,,2022,Q2,1,I,20220312.0,20220507.0,20220517,20220517,EXP,,CN-AstraZeneca-2022A186369,ASTRAZENECA,,25202.0,DY,,F,Y,60.0,KG,20220517,,MD,CN,,2022,Q2,Elderly
208386761,20838676,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q2,Palpitations,,2022,Q2,1,I,20220224.0,20220511.0,20220517,20220517,EXP,,GB-AstraZeneca-2022A093276,ASTRAZENECA,,24390.0,DY,,F,Y,,,20220517,,MD,GB,,2022,Q2,Elderly
208388701,20838870,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,460.0,MG,U,,2107147,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,1,I,20220415.0,20220510.0,20220517,20220517,EXP,,CN-AstraZeneca-2022A183576,ASTRAZENECA,,68.0,YR,,M,Y,87.0,KG,20220517,,MD,CN,,2022,Q2,Elderly
208389311,20838931,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate abnormal,,2022,Q2,1,I,20220324.0,20220509.0,20220517,20220517,EXP,,DE-AstraZeneca-2022A180124,ASTRAZENECA,,72.0,YR,,M,Y,,,20220517,,MD,DE,,2022,Q2,Elderly
208399682,20839968,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Take one daily,,,U,,,,202293.0,,,,QD,2022,Q2,Vomiting,,2022,Q2,2,F,20220510.0,20220511.0,20220517,20220524,EXP,,GB-AstraZeneca-2022A181985,ASTRAZENECA,,67.0,YR,,F,Y,84.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208399682,20839968,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,20220510.0,20220511.0,20220517,20220524,EXP,,GB-AstraZeneca-2022A181985,ASTRAZENECA,,67.0,YR,,F,Y,84.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208406081,20840608,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,U,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,,20220511.0,20220517,20220517,EXP,DE-BFARM-22003017,DE-MYLANLABS-2022M1035452,MYLAN,,75.0,YR,,F,Y,75.0,KG,20220517,,MD,DE,DE,2022,Q2,Elderly
208406081,20840608,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,U,U,,,,10.0,MG,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220511.0,20220517,20220517,EXP,DE-BFARM-22003017,DE-MYLANLABS-2022M1035452,MYLAN,,75.0,YR,,F,Y,75.0,KG,20220517,,MD,DE,DE,2022,Q2,Elderly
208406911,20840691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,1,I,20220301.0,20220509.0,20220517,20220517,EXP,,JP-AstraZeneca-2022A126268,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220517,,MD,JP,,2022,Q2,Elderly
208406911,20840691,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,1,I,20220301.0,20220509.0,20220517,20220517,EXP,,JP-AstraZeneca-2022A126268,ASTRAZENECA,,73.0,YR,,M,Y,72.0,KG,20220517,,MD,JP,,2022,Q2,Elderly
208419872,20841987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q2,Hypoaesthesia,,2022,Q2,2,F,20220504.0,20220518.0,20220518,20220527,EXP,,CN-NOVOPROD-916806,NOVO NORDISK,,65.0,YR,,F,Y,74.0,KG,20220527,,CN,CN,CN,2022,Q2,Elderly
208419872,20841987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q2,Palpitations,,2022,Q2,2,F,20220504.0,20220518.0,20220518,20220527,EXP,,CN-NOVOPROD-916806,NOVO NORDISK,,65.0,YR,,F,Y,74.0,KG,20220527,,CN,CN,CN,2022,Q2,Elderly
208419872,20841987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q2,Nausea,,2022,Q2,2,F,20220504.0,20220518.0,20220518,20220527,EXP,,CN-NOVOPROD-916806,NOVO NORDISK,,65.0,YR,,F,Y,74.0,KG,20220527,,CN,CN,CN,2022,Q2,Elderly
208419872,20841987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,UNKNOWN,,,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,20220504.0,20220518.0,20220518,20220527,EXP,,CN-NOVOPROD-916806,NOVO NORDISK,,65.0,YR,,F,Y,74.0,KG,20220527,,CN,CN,CN,2022,Q2,Elderly
208438001,20843800,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Acute pulmonary oedema,,2022,Q2,1,I,20220408.0,20220509.0,20220518,20220518,EXP,FR-AFSSAPS-MP20221798,FR-PFIZER INC-202200685456,PFIZER,,81.0,YR,,M,Y,90.0,KG,20220518,,PH,FR,FR,2022,Q2,Elderly
208440611,20844061,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q2,Confusional state,,2022,Q2,1,I,,20220510.0,20220518,20220518,EXP,,CA-APOTEX-2022AP007832,APOTEX,,77.0,YR,,F,Y,,,20220518,,PH,CA,CA,2022,Q2,Elderly
208440611,20844061,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q2,Delirium,,2022,Q2,1,I,,20220510.0,20220518,20220518,EXP,,CA-APOTEX-2022AP007832,APOTEX,,77.0,YR,,F,Y,,,20220518,,PH,CA,CA,2022,Q2,Elderly
208440611,20844061,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q2,Abnormal behaviour,,2022,Q2,1,I,,20220510.0,20220518,20220518,EXP,,CA-APOTEX-2022AP007832,APOTEX,,77.0,YR,,F,Y,,,20220518,,PH,CA,CA,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Polyuria,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Calculus urethral,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Type 2 diabetes mellitus,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208451271,20845127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,FR-AstraZeneca-2022A186928,ASTRAZENECA,,84.0,YR,,,Y,,,20220518,,MD,FR,,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Rash,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Pneumonia,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Squamous cell carcinoma of skin,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Papule,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Performance status decreased,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Colitis,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208454941,20845494,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Tumour pseudoprogression,,2022,Q2,1,I,20220101.0,20220512.0,20220518,20220518,EXP,,"AU-REGENERON PHARMACEUTICALS, INC.-2022-066289",REGENERON,,80.0,YR,,M,Y,,,20220518,,MD,AU,AU,2022,Q2,Elderly
208464841,20846484,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,NVSJ2022JP090371,NOVARTIS,,77.0,YR,,M,Y,80.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
208464841,20846484,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,NVSJ2022JP090371,NOVARTIS,,77.0,YR,,M,Y,80.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
208464841,20846484,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,,,,5.0,MG,,,2022,Q2,Ischaemic cardiomyopathy,,2022,Q2,1,I,,20220513.0,20220518,20220518,EXP,,NVSJ2022JP090371,NOVARTIS,,77.0,YR,,M,Y,80.0,KG,20220519,,MD,JP,JP,2022,Q2,Elderly
208480051,20848005,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Immune thrombocytopenia,,2022,Q2,1,I,20220131.0,20220517.0,20220519,20220519,EXP,,FR-AstraZeneca-2022A187375,ASTRAZENECA,,65.0,YR,,F,Y,64.0,KG,20220519,,MD,FR,,2022,Q2,Elderly
208494591,20849459,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,20220517.0,,20220518,20220518,DIR,FDA-CDER-CTU-2022-38558,,FDA-CTU,,72.0,YR,,F,N,78.1,KG,20220518,N,PH,US,,2022,Q2,Elderly
208501421,20850142,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220416.0,20220511.0,20220519,20220519,EXP,,IT-AstraZeneca-2022A181312,ASTRAZENECA,,54.0,YR,,F,Y,,,20220519,,MD,IT,,2022,Q2,Adult
208504712,20850471,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Cardiac failure congestive,,2022,Q2,2,F,20220401.0,20220525.0,20220519,20220531,EXP,,JP-PFIZER INC-202200708629,PFIZER,,80.0,YR,,M,Y,80.0,KG,20220531,,MD,JP,JP,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Orthostatic hypotension,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Anaemia,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Fall,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Abdominal wall haematoma,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514511,20851451,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q2,Confusional state,,2022,Q2,1,I,,20220518.0,20220519,20220519,EXP,,CA-SA-2022SA181531,SANOFI AVENTIS,,69.0,YR,E,M,Y,74.0,KG,20220520,,HP,CA,CA,2022,Q2,Elderly
208514982,20851498,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NP0029,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20220401.0,20220513.0,20220519,20220526,PER,,US-AstraZeneca-2022A186693,ASTRAZENECA,,21133.0,DY,,M,Y,202.8,KG,20220527,,HP,US,,2022,Q2,Elderly
208514982,20851498,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NP0029,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20220401.0,20220513.0,20220519,20220526,PER,,US-AstraZeneca-2022A186693,ASTRAZENECA,,21133.0,DY,,M,Y,202.8,KG,20220527,,HP,US,,2022,Q2,Elderly
208514982,20851498,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NP0029,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20220401.0,20220513.0,20220519,20220526,PER,,US-AstraZeneca-2022A186693,ASTRAZENECA,,21133.0,DY,,M,Y,202.8,KG,20220527,,HP,US,,2022,Q2,Elderly
208515141,20851514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Hypokalaemia,,2022,Q2,1,I,20220331.0,20220513.0,20220519,20220519,EXP,CH-SM-2022-15146,CH-JNJFOC-20220538327,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220520,,MD,CH,CH,2022,Q2,Elderly
208515141,20851514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,20220331.0,20220513.0,20220519,20220519,EXP,CH-SM-2022-15146,CH-JNJFOC-20220538327,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220520,,MD,CH,CH,2022,Q2,Elderly
208515141,20851514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Electrocardiogram QT prolonged,,2022,Q2,1,I,20220331.0,20220513.0,20220519,20220519,EXP,CH-SM-2022-15146,CH-JNJFOC-20220538327,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220520,,MD,CH,CH,2022,Q2,Elderly
208515141,20851514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20220331.0,20220513.0,20220519,20220519,EXP,CH-SM-2022-15146,CH-JNJFOC-20220538327,JOHNSON AND JOHNSON,,68.0,YR,E,F,Y,,,20220520,,MD,CH,CH,2022,Q2,Elderly
208515251,20851525,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Subcutaneous,10 mg/Day,,,U,,,,,10.0,MG,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Subcutaneous,10 mg/Day,,,U,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Subcutaneous,10 mg/Day,,,U,,,,,10.0,MG,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Subcutaneous,10 mg/Day,,,U,,,,,10.0,MG,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515711,20851571,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Malignant neoplasm progression,,2022,Q2,1,I,,20220510.0,20220520,20220520,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-038460,BRISTOL MYERS SQUIBB,,62.0,YR,A,M,Y,,,20220520,,CN,US,US,2022,Q2,Adult
208515711,20851571,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Intentional product use issue,,2022,Q2,1,I,,20220510.0,20220520,20220520,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-038460,BRISTOL MYERS SQUIBB,,62.0,YR,A,M,Y,,,20220520,,CN,US,US,2022,Q2,Adult
208517891,20851789,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(after breakfast)",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Lacunar infarction,,2022,Q2,1,I,20210427.0,20220512.0,20220520,20220520,EXP,,BR-NOVOPROD-918403,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220520,,MD,BR,BR,2022,Q2,Elderly
208517891,20851789,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(after breakfast)",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Microangiopathy,,2022,Q2,1,I,20210427.0,20220512.0,20220520,20220520,EXP,,BR-NOVOPROD-918403,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220520,,MD,BR,BR,2022,Q2,Elderly
208517891,20851789,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(after breakfast)",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Prostate cancer,,2022,Q2,1,I,20210427.0,20220512.0,20220520,20220520,EXP,,BR-NOVOPROD-918403,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220520,,MD,BR,BR,2022,Q2,Elderly
208517891,20851789,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(after breakfast)",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,20210427.0,20220512.0,20220520,20220520,EXP,,BR-NOVOPROD-918403,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220520,,MD,BR,BR,2022,Q2,Elderly
208517891,20851789,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(after breakfast)",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,20210427.0,20220512.0,20220520,20220520,EXP,,BR-NOVOPROD-918403,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220520,,MD,BR,BR,2022,Q2,Elderly
208534461,20853446,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2022,Q2,Peritonitis,,2022,Q2,1,I,,20220516.0,20220520,20220520,EXP,,JP-AstraZeneca-2022A187673,ASTRAZENECA,"Wang, Qianwen, et al.. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis.. Cureus 2022;14(2): e22229.",57.0,YR,,F,Y,,,20220520,,HP,JP,,2022,Q2,Adult
208534461,20853446,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2022,Q2,Euglycaemic diabetic ketoacidosis,,2022,Q2,1,I,,20220516.0,20220520,20220520,EXP,,JP-AstraZeneca-2022A187673,ASTRAZENECA,"Wang, Qianwen, et al.. Dapagliflozin-Associated Euglycemic Diabetic Ketoacidosis Presenting With Severe Abdominal Pain Mimicking Acute Peritonitis.. Cureus 2022;14(2): e22229.",57.0,YR,,F,Y,,,20220520,,HP,JP,,2022,Q2,Adult
208534481,20853448,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220516.0,20220520,20220520,EXP,,CA-AstraZeneca-2022A188451,ASTRAZENECA,,65.0,YR,,F,Y,,,20220520,,MD,CA,,2022,Q2,Elderly
208534481,20853448,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220516.0,20220520,20220520,EXP,,CA-AstraZeneca-2022A188451,ASTRAZENECA,,65.0,YR,,F,Y,,,20220520,,MD,CA,,2022,Q2,Elderly
208547251,20854725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2108060,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220414.0,20220512.0,20220520,20220520,EXP,,CN-AstraZeneca-2022A186881,ASTRAZENECA,,3346.0,WK,,F,Y,,,20220520,,MD,CN,,2022,Q2,Elderly
208547251,20854725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2108060,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220414.0,20220512.0,20220520,20220520,EXP,,CN-AstraZeneca-2022A186881,ASTRAZENECA,,3346.0,WK,,F,Y,,,20220520,,MD,CN,,2022,Q2,Elderly
208547251,20854725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2108060,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Abdominal distension,,2022,Q2,1,I,20220414.0,20220512.0,20220520,20220520,EXP,,CN-AstraZeneca-2022A186881,ASTRAZENECA,,3346.0,WK,,F,Y,,,20220520,,MD,CN,,2022,Q2,Elderly
208550601,20855060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q2,Death,,2022,Q2,1,I,20220101.0,20220517.0,20220520,20220520,EXP,,HU-AstraZeneca-2022A191142,ASTRAZENECA,,70.0,YR,,M,Y,,,20220520,,HP,HU,,2022,Q2,Elderly
208558741,20855874,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220517.0,20220520,20220520,EXP,,ZA-AstraZeneca-2022A190349,ASTRAZENECA,,76.0,YR,,M,Y,,,20220520,,MD,ZA,,2022,Q2,Elderly
208558741,20855874,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q2,Urosepsis,,2022,Q2,1,I,,20220517.0,20220520,20220520,EXP,,ZA-AstraZeneca-2022A190349,ASTRAZENECA,,76.0,YR,,M,Y,,,20220520,,MD,ZA,,2022,Q2,Elderly
208560221,20856022,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Glycosuria,,2022,Q2,1,I,,20220512.0,20220520,20220520,EXP,,FR-AstraZeneca-2022A186948,ASTRAZENECA,,46.0,YR,,M,Y,,,20220520,,MD,FR,,2022,Q2,Adult
208570602,20857060,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,N,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,2,F,20220401.0,20220513.0,20220520,20220616,PER,,US-SA-2022SA176372,SANOFI AVENTIS,,53.0,YR,A,F,Y,105.7,KG,20220617,,CN,US,US,2022,Q2,Adult
208570602,20857060,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,N,,,,,,,,,2022,Q2,Nausea,,2022,Q2,2,F,20220401.0,20220513.0,20220520,20220616,PER,,US-SA-2022SA176372,SANOFI AVENTIS,,53.0,YR,A,F,Y,105.7,KG,20220617,,CN,US,US,2022,Q2,Adult
208570602,20857060,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,N,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,20220401.0,20220513.0,20220520,20220616,PER,,US-SA-2022SA176372,SANOFI AVENTIS,,53.0,YR,A,F,Y,105.7,KG,20220617,,CN,US,US,2022,Q2,Adult
208570602,20857060,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,N,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,2,F,20220401.0,20220513.0,20220520,20220616,PER,,US-SA-2022SA176372,SANOFI AVENTIS,,53.0,YR,A,F,Y,105.7,KG,20220617,,CN,US,US,2022,Q2,Adult
208580311,20858031,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,20220322.0,20220515.0,20220521,20220521,EXP,GB-MHRA-ADR 26841821,GB-Accord-261955,ACCORD,,65.0,YR,,M,Y,110.0,KG,20220521,,CN,GB,GB,2022,Q2,Elderly
208580311,20858031,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20220322.0,20220515.0,20220521,20220521,EXP,GB-MHRA-ADR 26841821,GB-Accord-261955,ACCORD,,65.0,YR,,M,Y,110.0,KG,20220521,,CN,GB,GB,2022,Q2,Elderly
208581201,20858120,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Rash papular,,2022,Q2,1,I,20220314.0,20220509.0,20220521,20220521,EXP,FR-AFSSAPS-AM20220841,FR-Accord-263603,ACCORD,,74.0,YR,E,M,Y,,,20220521,,MD,FR,FR,2022,Q2,Elderly
208595941,20859594,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q2,Hydrocephalus,,2022,Q2,1,I,,20220512.0,20220523,20220523,EXP,,BR-NOVOPROD-918500,NOVO NORDISK,,78.0,YR,,M,Y,67.8,KG,20220523,,MD,BR,BR,2022,Q2,Elderly
208596881,20859688,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Hypercalciuria,,2022,Q2,1,I,,20220510.0,20220523,20220523,EXP,,GR-TAKEDA-2022TUS026302,TAKEDA,,62.0,YR,,F,Y,100.0,KG,20220523,,CN,GR,GR,2022,Q2,Adult
208596881,20859688,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q2,Hypomagnesaemia,,2022,Q2,1,I,,20220510.0,20220523,20220523,EXP,,GR-TAKEDA-2022TUS026302,TAKEDA,,62.0,YR,,F,Y,100.0,KG,20220523,,CN,GR,GR,2022,Q2,Adult
208616671,20861667,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,Y,U,,,,,,Film-coated tablet,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220416.0,20220516.0,20220523,20220523,EXP,IT-MINISAL02-866149,IT-MYLANLABS-2022M1036598,MYLAN,,54.0,YR,,F,Y,,,20220523,,HP,IT,IT,2022,Q2,Adult
208617461,20861746,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20010.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dry gangrene,,2022,Q2,1,I,20220323.0,20220515.0,20220523,20220523,EXP,,GB-AstraZeneca-2022A187931,ASTRAZENECA,,68.0,YR,,M,Y,102.0,KG,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Fibrin D dimer increased,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Tachycardia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Fluid intake reduced,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Tremor,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyponatraemia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Fibrin D dimer increased,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Tachycardia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Fluid intake reduced,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Tremor,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208617511,20861751,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Hyponatraemia,,2022,Q2,1,I,20220414.0,20220512.0,20220523,20220523,EXP,,XI-AstraZeneca-2022A175511,ASTRAZENECA,,72.0,YR,,F,Y,,,20220523,,MD,GB,,2022,Q2,Elderly
208664801,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20220420.0,20220518.0,20220524,20220524,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220524,,PH,IT,IT,2022,Q2,Elderly
208664801,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220420.0,20220518.0,20220524,20220524,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220524,,PH,IT,IT,2022,Q2,Elderly
208664801,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Blood thyroid stimulating hormone increased,,2022,Q2,1,I,20220420.0,20220518.0,20220524,20220524,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220524,,PH,IT,IT,2022,Q2,Elderly
208664801,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220420.0,20220518.0,20220524,20220524,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220524,,PH,IT,IT,2022,Q2,Elderly
208668401,20866840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20210708.0,20220516.0,20220524,20220524,EXP,,JP-AstraZeneca-2022A048703,ASTRAZENECA,,28247.0,DY,,F,Y,49.0,KG,20220524,,MD,JP,,2022,Q2,Elderly
208672112,20867211,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220422.0,20220624.0,20220524,20220627,EXP,,JP-PFIZER INC-202200714146,PFIZER,,86.0,YR,,F,Y,52.9,KG,20220627,,MD,JP,JP,2022,Q2,Elderly
208677581,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,1,I,,20220518.0,20220524,20220524,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220524,,HP,CA,CA,2022,Q2,Adult
208677581,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220518.0,20220524,20220524,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220524,,HP,CA,CA,2022,Q2,Adult
208677581,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,,20220518.0,20220524,20220524,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220524,,HP,CA,CA,2022,Q2,Adult
208677581,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q2,Drug level decreased,,2022,Q2,1,I,,20220518.0,20220524,20220524,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220524,,HP,CA,CA,2022,Q2,Adult
208677581,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q2,Crohn's disease,,2022,Q2,1,I,,20220518.0,20220524,20220524,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220524,,HP,CA,CA,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Carbon dioxide abnormal,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Pneumonia,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Dysuria,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Contraindicated product prescribed,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Flank pain,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208683831,20868383,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,U,D,6902995,20221208.0,,,,,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,1,I,20211001.0,,20220524,20220524,DIR,FDA-CDER-CTU-2022-40804,,FDA-CTU,,63.0,YR,,F,N,300.0,LBS,20220523,N,CN,US,,2022,Q2,Adult
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Bradycardia,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Dizziness,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Confusional state,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Renal failure,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Urine output decreased,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Hypotension,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,COVID-19,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Pustular psoriasis,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Gout,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Off label use,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Epistaxis,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Glucose tolerance impaired,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Vertigo,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (stopped between 20 Mar 2022 and 01 Apr 2022),,,Y,U,,,,,,Tablet,,2022,Q2,Vascular purpura,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Pustular psoriasis,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Gout,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Off label use,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Epistaxis,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Glucose tolerance impaired,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Vertigo,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208688871,20868887,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 milligram, qd",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q2,Vascular purpura,,2022,Q2,1,I,20210601.0,20220511.0,20220524,20220524,EXP,,FR-MYLANLABS-2022M1035256,MYLAN,,79.0,YR,,F,Y,77.4,KG,20220524,,MD,FR,FR,2022,Q2,Elderly
208692514,20869251,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Haemophagocytic lymphohistiocytosis,,2022,Q2,4,F,20220511.0,20220608.0,20220524,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-045688,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,92.4,KG,20220623,,MD,US,US,2022,Q2,Elderly
208692514,20869251,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Sepsis,,2022,Q2,4,F,20220511.0,20220608.0,20220524,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-045688,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,92.4,KG,20220623,,MD,US,US,2022,Q2,Elderly
208696643,20869664,10,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5/1000,,,,,,,,,,Tablet,BID,2022,Q2,Angina pectoris,,2022,Q2,3,F,20220518.0,20220523.0,20220525,20220602,PER,,BR-AMGEN-BRACT2022089708,AMGEN,,62.0,YR,A,M,Y,75.0,KG,20220602,,MD,BR,BR,2022,Q2,Adult
208702461,20870246,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20220322.0,20220515.0,20220525,20220525,EXP,,GB-TEVA-2022-GB-2031292,TEVA,,65.0,YR,E,M,Y,110.0,KG,20220525,,CN,GB,GB,2022,Q2,Elderly
208702461,20870246,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,20220322.0,20220515.0,20220525,20220525,EXP,,GB-TEVA-2022-GB-2031292,TEVA,,65.0,YR,E,M,Y,110.0,KG,20220525,,CN,GB,GB,2022,Q2,Elderly
208712431,20871243,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,990.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,20220428.0,20220517.0,20220525,20220525,EXP,,FR-AstraZeneca-2022A193036,ASTRAZENECA,,26357.0,DY,,M,Y,,,20220525,,MD,FR,,2022,Q2,Elderly
208713222,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,2,F,20220515.0,20220622.0,20220525,20220630,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220630,,MD,SE,,2022,Q2,Elderly
208713222,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Renal failure,,2022,Q2,2,F,20220515.0,20220622.0,20220525,20220630,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220630,,MD,SE,,2022,Q2,Elderly
208713222,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,2,F,20220515.0,20220622.0,20220525,20220630,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220630,,MD,SE,,2022,Q2,Elderly
208713222,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q2,Renal failure,,2022,Q2,2,F,20220515.0,20220622.0,20220525,20220630,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220630,,MD,SE,,2022,Q2,Elderly
208719041,20871904,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220523.0,20220525,20220525,EXP,,DE-ORGANON-O2205DEU001752,ORGANON,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208719041,20871904,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220523.0,20220525,20220525,EXP,,DE-ORGANON-O2205DEU001752,ORGANON,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208719041,20871904,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220523.0,20220525,20220525,EXP,,DE-ORGANON-O2205DEU001752,ORGANON,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208719041,20871904,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220523.0,20220525,20220525,EXP,,DE-ORGANON-O2205DEU001752,ORGANON,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Epistaxis,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Renal pain,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Dyspnoea,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208722152,20872215,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram once daily,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypertensive crisis,,2022,Q2,2,F,20220101.0,20220607.0,20220525,20220610,EXP,DE-CADRBFARM-2022296252,DE-009507513-2205DEU006461,MERCK,,71.0,YR,,F,Y,98.0,KG,20220610,,CN,DE,DE,2022,Q2,Elderly
208724321,20872432,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220520.0,20220525,20220525,EXP,,DE-MYLANLABS-2022M1038013,MYLAN,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208724321,20872432,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220520.0,20220525,20220525,EXP,,DE-MYLANLABS-2022M1038013,MYLAN,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208724321,20872432,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220520.0,20220525,20220525,EXP,,DE-MYLANLABS-2022M1038013,MYLAN,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208724321,20872432,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220520.0,20220525,20220525,EXP,,DE-MYLANLABS-2022M1038013,MYLAN,,79.0,YR,,F,Y,56.0,KG,20220525,,MD,DE,DE,2022,Q2,Elderly
208745311,20874531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,N,,,,202293.0,10.0,MG,,QD,2022,Q2,Gangrene,,2022,Q2,1,I,,20220518.0,20220525,20220525,EXP,,GB-AstraZeneca-2022A190200,ASTRAZENECA,,71.0,YR,,M,Y,,,20220525,,MD,GB,,2022,Q2,Elderly
208745341,20874534,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1cp per day,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220520.0,20220525,20220525,EXP,,FR-AstraZeneca-2022A192069,ASTRAZENECA,,78.0,YR,,M,Y,76.0,KG,20220525,,MD,FR,,2022,Q2,Elderly
208759982,20875998,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Blood pressure increased,,2022,Q2,2,F,,20220608.0,20220526,20220616,EXP,,NVSJ2022JP090678,NOVARTIS,,47.0,YR,,M,Y,,,20220616,,MD,JP,JP,2022,Q2,Adult
208759982,20875998,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Dizziness,,2022,Q2,2,F,,20220608.0,20220526,20220616,EXP,,NVSJ2022JP090678,NOVARTIS,,47.0,YR,,M,Y,,,20220616,,MD,JP,JP,2022,Q2,Adult
208763221,20876322,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,FR-AstraZeneca-2022A193187,ASTRAZENECA,,60.0,YR,,F,Y,,,20220526,,MD,FR,,2022,Q2,Adult
208763221,20876322,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Neoplasm malignant,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,FR-AstraZeneca-2022A193187,ASTRAZENECA,,60.0,YR,,F,Y,,,20220526,,MD,FR,,2022,Q2,Adult
208763221,20876322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,FR-AstraZeneca-2022A193187,ASTRAZENECA,,60.0,YR,,F,Y,,,20220526,,MD,FR,,2022,Q2,Adult
208763221,20876322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Neoplasm malignant,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,FR-AstraZeneca-2022A193187,ASTRAZENECA,,60.0,YR,,F,Y,,,20220526,,MD,FR,,2022,Q2,Adult
208772671,20877267,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1530.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood urea increased,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,GR-AstraZeneca-2022A154127,ASTRAZENECA,,53.0,YR,,F,Y,,,20220526,,MD,GR,,2022,Q2,Adult
208772671,20877267,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1530.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,GR-AstraZeneca-2022A154127,ASTRAZENECA,,53.0,YR,,F,Y,,,20220526,,MD,GR,,2022,Q2,Adult
208772671,20877267,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1530.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Creatinine renal clearance decreased,,2022,Q2,1,I,,20220518.0,20220526,20220526,EXP,,GR-AstraZeneca-2022A154127,ASTRAZENECA,,53.0,YR,,F,Y,,,20220526,,MD,GR,,2022,Q2,Adult
208773861,20877386,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary bladder haemorrhage,,2022,Q2,1,I,,20220519.0,20220526,20220526,EXP,,ZA-AstraZeneca-2022A194496,ASTRAZENECA,,66.0,YR,,F,Y,,,20220526,,MD,ZA,,2022,Q2,Elderly
208781161,20878116,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD 1cp par jour",,,Y,,,,,10.0,MG,,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220520.0,20220526,20220526,EXP,FR-AFSSAPS-MP20221792,NVSC2022FR117606,NOVARTIS,,78.0,YR,,M,Y,76.0,KG,20220526,,PH,FR,FR,2022,Q2,Elderly
208810961,20881096,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,1,I,20220401.0,20220524.0,20220526,20220526,EXP,,NVSJ2022JP090924,NOVARTIS,,60.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Adult
208810961,20881096,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,20220401.0,20220524.0,20220526,20220526,EXP,,NVSJ2022JP090924,NOVARTIS,,60.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Adult
208813441,20881344,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220520.0,20220526,20220526,EXP,,DE-ESPERIONTHERAPEUTICS-2022DEU01112,ESPERION THERAPEUTICS,,79.0,YR,,F,Y,56.0,KG,20220527,,MD,DE,DE,2022,Q2,Elderly
208813441,20881344,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220520.0,20220526,20220526,EXP,,DE-ESPERIONTHERAPEUTICS-2022DEU01112,ESPERION THERAPEUTICS,,79.0,YR,,F,Y,56.0,KG,20220527,,MD,DE,DE,2022,Q2,Elderly
208813441,20881344,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220520.0,20220526,20220526,EXP,,DE-ESPERIONTHERAPEUTICS-2022DEU01112,ESPERION THERAPEUTICS,,79.0,YR,,F,Y,56.0,KG,20220527,,MD,DE,DE,2022,Q2,Elderly
208813441,20881344,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220520.0,20220526,20220526,EXP,,DE-ESPERIONTHERAPEUTICS-2022DEU01112,ESPERION THERAPEUTICS,,79.0,YR,,F,Y,56.0,KG,20220527,,MD,DE,DE,2022,Q2,Elderly
208816401,20881640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-AstraZeneca-2022A194155,ASTRAZENECA,,68.0,YR,,F,Y,,,20220527,,MD,JP,,2022,Q2,Elderly
208816401,20881640,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Melaena,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-AstraZeneca-2022A194155,ASTRAZENECA,,68.0,YR,,F,Y,,,20220527,,MD,JP,,2022,Q2,Elderly
208821931,20882193,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,years,,,,,,,,,,Film-coated tablet,QD,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220522.0,20220527,20220527,EXP,FR-AFSSAPS-AM20221349,FR-BAUSCH-BL-2022-012820,BAUSCH AND LOMB,,60.0,YR,,M,Y,84.0,KG,20220527,,PH,FR,FR,2022,Q2,Adult
208821931,20882193,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,years,,,,,,,,,,Film-coated tablet,QD,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220522.0,20220527,20220527,EXP,FR-AFSSAPS-AM20221349,FR-BAUSCH-BL-2022-012820,BAUSCH AND LOMB,,60.0,YR,,M,Y,84.0,KG,20220527,,PH,FR,FR,2022,Q2,Adult
208831381,20883138,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd, 1 tablet per day",,,Y,U,,,,10.0,MG,,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220523.0,20220527,20220527,EXP,FR-AFSSAPS-MP20221792,FR-MYLANLABS-2022M1038654,MYLAN,,78.0,YR,,M,Y,76.0,KG,20220527,,PH,FR,FR,2022,Q2,Elderly
208831991,20883199,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Fungal infection,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,FR-AstraZeneca-2022A194867,ASTRAZENECA,,54.0,YR,,F,Y,,,20220527,,MD,FR,,2022,Q2,Adult
208836791,20883679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary bladder haemorrhage,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,ZA-AstraZeneca-2022A199157,ASTRAZENECA,,66.0,YR,,F,Y,,,20220527,,MD,ZA,,2022,Q2,Elderly
208840262,20884026,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",,,U,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Thirst,,2022,Q2,2,F,20220319.0,20220524.0,20220527,20220601,EXP,,FI-AstraZeneca-2022A195225,ASTRAZENECA,,65.0,YR,,M,Y,,,20220601,,MD,FI,,2022,Q2,Elderly
208840262,20884026,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",,,U,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Malaise,,2022,Q2,2,F,20220319.0,20220524.0,20220527,20220601,EXP,,FI-AstraZeneca-2022A195225,ASTRAZENECA,,65.0,YR,,M,Y,,,20220601,,MD,FI,,2022,Q2,Elderly
208840262,20884026,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",,,U,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220319.0,20220524.0,20220527,20220601,EXP,,FI-AstraZeneca-2022A195225,ASTRAZENECA,,65.0,YR,,M,Y,,,20220601,,MD,FI,,2022,Q2,Elderly
208840262,20884026,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,mg,daily",,,U,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,2,F,20220319.0,20220524.0,20220527,20220601,EXP,,FI-AstraZeneca-2022A195225,ASTRAZENECA,,65.0,YR,,M,Y,,,20220601,,MD,FI,,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Bradycardia,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Syncope,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Atrioventricular block complete,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208842091,20884209,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Tablet,,2022,Q2,Aortic valve stenosis,,2022,Q2,1,I,,20220519.0,20220527,20220527,EXP,,JP-PFIZER INC-202200739613,PFIZER,,76.0,YR,,M,Y,,,20220527,,MD,JP,JP,2022,Q2,Elderly
208851611,20885161,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4060.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pyrexia,,2022,Q2,1,I,20220501.0,20220524.0,20220527,20220527,EXP,,DK-AstraZeneca-2022A195445,ASTRAZENECA,,72.0,YR,,M,Y,122.0,KG,20220527,,MD,DK,,2022,Q2,Elderly
208851611,20885161,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4060.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cough,,2022,Q2,1,I,20220501.0,20220524.0,20220527,20220527,EXP,,DK-AstraZeneca-2022A195445,ASTRAZENECA,,72.0,YR,,M,Y,122.0,KG,20220527,,MD,DK,,2022,Q2,Elderly
208851611,20885161,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4060.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urosepsis,,2022,Q2,1,I,20220501.0,20220524.0,20220527,20220527,EXP,,DK-AstraZeneca-2022A195445,ASTRAZENECA,,72.0,YR,,M,Y,122.0,KG,20220527,,MD,DK,,2022,Q2,Elderly
208851611,20885161,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4060.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220501.0,20220524.0,20220527,20220527,EXP,,DK-AstraZeneca-2022A195445,ASTRAZENECA,,72.0,YR,,M,Y,122.0,KG,20220527,,MD,DK,,2022,Q2,Elderly
208851611,20885161,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4060.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220501.0,20220524.0,20220527,20220527,EXP,,DK-AstraZeneca-2022A195445,ASTRAZENECA,,72.0,YR,,M,Y,122.0,KG,20220527,,MD,DK,,2022,Q2,Elderly
208855301,20885530,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2107166,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220426.0,20220520.0,20220527,20220527,EXP,,CN-AstraZeneca-2022A195556,ASTRAZENECA,,20454.0,DY,,F,Y,65.0,KG,20220527,,MD,CN,,2022,Q2,Elderly
208855301,20885530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2107166,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220426.0,20220520.0,20220527,20220527,EXP,,CN-AstraZeneca-2022A195556,ASTRAZENECA,,20454.0,DY,,F,Y,65.0,KG,20220527,,MD,CN,,2022,Q2,Elderly
208859931,20885993,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220420.0,20220516.0,20220527,20220527,EXP,IT-MINISAL02-867847,IT-ELI_LILLY_AND_COMPANY-IT202205006290,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20220527,,CN,IT,IT,2022,Q2,Elderly
208859931,20885993,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220420.0,20220516.0,20220527,20220527,EXP,IT-MINISAL02-867847,IT-ELI_LILLY_AND_COMPANY-IT202205006290,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20220527,,CN,IT,IT,2022,Q2,Elderly
208859931,20885993,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20220420.0,20220516.0,20220527,20220527,EXP,IT-MINISAL02-867847,IT-ELI_LILLY_AND_COMPANY-IT202205006290,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20220527,,CN,IT,IT,2022,Q2,Elderly
208859931,20885993,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Blood thyroid stimulating hormone increased,,2022,Q2,1,I,20220420.0,20220516.0,20220527,20220527,EXP,IT-MINISAL02-867847,IT-ELI_LILLY_AND_COMPANY-IT202205006290,ELI LILLY AND CO,,66.0,YR,,M,Y,100.0,KG,20220527,,CN,IT,IT,2022,Q2,Elderly
208864771,20886477,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (annees)",,,,,,,,,,Coated tablet,QD,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220523.0,20220527,20220527,EXP,FR-AFSSAPS-AM20221349,NVSC2022FR119074,NOVARTIS,,60.0,YR,,M,Y,84.0,KG,20220527,,PH,FR,FR,2022,Q2,Adult
208864771,20886477,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (annees)",,,,,,,,,,Coated tablet,QD,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220523.0,20220527,20220527,EXP,FR-AFSSAPS-AM20221349,NVSC2022FR119074,NOVARTIS,,60.0,YR,,M,Y,84.0,KG,20220527,,PH,FR,FR,2022,Q2,Adult
208871513,20887151,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Cerebral infarction,,2022,Q2,3,F,20220401.0,20220603.0,20220528,20220610,EXP,,JP-AstraZeneca-2022A198732,ASTRAZENECA,,69.0,YR,,M,Y,,,20220610,,PH,JP,,2022,Q2,Elderly
208889271,20888927,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,UNK,,,,,,,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210123.0,20220517.0,20220529,20220529,PER,,JP-AMGEN-JPNNI2022090505,AMGEN,,42.0,YR,A,M,Y,100.0,KG,20220529,,MD,JP,JP,2022,Q2,Adult
208902781,20890278,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q2,Hypoacusis,,2022,Q2,1,I,20210101.0,20220328.0,20220530,20220530,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-023570,BRISTOL MYERS SQUIBB,,80.0,YR,E,F,Y,,,20220530,,CN,US,US,2022,Q2,Elderly
208902781,20890278,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20210101.0,20220328.0,20220530,20220530,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-023570,BRISTOL MYERS SQUIBB,,80.0,YR,E,F,Y,,,20220530,,CN,US,US,2022,Q2,Elderly
208902781,20890278,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q2,Wound,,2022,Q2,1,I,20210101.0,20220328.0,20220530,20220530,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-023570,BRISTOL MYERS SQUIBB,,80.0,YR,E,F,Y,,,20220530,,CN,US,US,2022,Q2,Elderly
208902781,20890278,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q2,Fluid retention,,2022,Q2,1,I,20210101.0,20220328.0,20220530,20220530,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-023570,BRISTOL MYERS SQUIBB,,80.0,YR,E,F,Y,,,20220530,,CN,US,US,2022,Q2,Elderly
208907682,20890768,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Years,,,,,,,,,,Film-coated tablet,QD,2022,Q2,Anal abscess,,2022,Q2,2,F,20220301.0,20220530.0,20220530,20220601,EXP,FR-AFSSAPS-AM20221349,FR-EMD Serono-E2B_90087971,EMD SERONO INC,,60.0,YR,A,M,Y,84.0,KG,20220601,,PH,FR,,2022,Q2,Adult
208907682,20890768,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Years,,,,,,,,,,Film-coated tablet,QD,2022,Q2,Anal fistula,,2022,Q2,2,F,20220301.0,20220530.0,20220530,20220601,EXP,FR-AFSSAPS-AM20221349,FR-EMD Serono-E2B_90087971,EMD SERONO INC,,60.0,YR,A,M,Y,84.0,KG,20220601,,PH,FR,,2022,Q2,Adult
208910222,20891022,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood ketone body increased,,2022,Q2,2,F,20211111.0,20220527.0,20220530,20220603,EXP,,UA-AstraZeneca-2022A198082,ASTRAZENECA,,58.0,YR,,F,Y,55.0,KG,20220603,,MD,UA,,2022,Q2,Adult
208910222,20891022,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood ketone body increased,,2022,Q2,2,F,20211111.0,20220527.0,20220530,20220603,EXP,,UA-AstraZeneca-2022A198082,ASTRAZENECA,,58.0,YR,,F,Y,55.0,KG,20220603,,MD,UA,,2022,Q2,Adult
208918231,20891823,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,Y,U,Unknown,,,10.0,MG,Tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220520.0,20220530,20220530,EXP,FR-AFSSAPS-MP20221792,FR-PFIZER INC-202200740330,PFIZER,,78.0,YR,,M,Y,76.0,KG,20220530,,PH,FR,FR,2022,Q2,Elderly
208928131,20892813,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mgs,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Tongue ulceration,,2022,Q2,1,I,20220517.0,20220525.0,20220531,20220531,EXP,,GB-AstraZeneca-2022A197996,ASTRAZENECA,,56.0,YR,,F,Y,82.0,KG,20220531,,MD,GB,,2022,Q2,Adult
208938401,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Pyelonephritis,,2022,Q2,1,I,20200901.0,20220526.0,20220531,20220531,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,,,20220531,,MD,JP,,2022,Q2,Adult
208938401,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Retroperitonitis,,2022,Q2,1,I,20200901.0,20220526.0,20220531,20220531,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,,,20220531,,MD,JP,,2022,Q2,Adult
208938401,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,155.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Vulvovaginitis,,2022,Q2,1,I,20200901.0,20220526.0,20220531,20220531,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,,,20220531,,MD,JP,,2022,Q2,Adult
208940591,20894059,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"one dosage form daily, years",,,,,,,202293.0,,,,,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220524.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A195325,ASTRAZENECA,,60.0,YR,,M,Y,84.0,KG,20220531,,MD,FR,,2022,Q2,Adult
208940591,20894059,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"one dosage form daily, years",,,,,,,202293.0,,,,,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220524.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A195325,ASTRAZENECA,,60.0,YR,,M,Y,84.0,KG,20220531,,MD,FR,,2022,Q2,Adult
208942891,20894289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Sepsis,,2022,Q2,1,I,20220501.0,20220523.0,20220531,20220531,EXP,,DK-AstraZeneca-2022A193749,ASTRAZENECA,,86.0,YR,,M,Y,,,20220531,,MD,DK,,2022,Q2,Elderly
208942891,20894289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dehydration,,2022,Q2,1,I,20220501.0,20220523.0,20220531,20220531,EXP,,DK-AstraZeneca-2022A193749,ASTRAZENECA,,86.0,YR,,M,Y,,,20220531,,MD,DK,,2022,Q2,Elderly
208942891,20894289,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Infection,,2022,Q2,1,I,20220501.0,20220523.0,20220531,20220531,EXP,,DK-AstraZeneca-2022A193749,ASTRAZENECA,,86.0,YR,,M,Y,,,20220531,,MD,DK,,2022,Q2,Elderly
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Syncope,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Blood triglycerides increased,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,High density lipoprotein decreased,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Diabetic metabolic decompensation,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Bradycardia,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Treatment noncompliance,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Low density lipoprotein increased,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945701,20894570,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5 mg+100 mg - 2 tablets,,,,,UNKNOWN,,,,,,,2022,Q2,Syncope,,2022,Q2,1,I,20200101.0,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921604,NOVO NORDISK,,39.0,YR,,M,Y,44.943,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945711,20894571,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg+100 mg - 2 tablets,,,,,Unknown,,,,,,,2022,Q2,Treatment noncompliance,,2022,Q2,1,I,,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921704,NOVO NORDISK,,39.0,YR,,M,Y,99.9,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945711,20894571,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg+100 mg - 2 tablets,,,,,Unknown,,,,,,,2022,Q2,Diabetic metabolic decompensation,,2022,Q2,1,I,,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921704,NOVO NORDISK,,39.0,YR,,M,Y,99.9,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208945711,20894571,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg+100 mg - 2 tablets,,,,,Unknown,,,,,,,2022,Q2,Inability to afford medication,,2022,Q2,1,I,,20220520.0,20220531,20220531,EXP,,BR-NOVOPROD-921704,NOVO NORDISK,,39.0,YR,,M,Y,99.9,KG,20220531,,MD,BR,BR,2022,Q2,Adult
208947922,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208947922,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Septic shock,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208947922,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208947922,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208947922,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Septic shock,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208947922,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Fournier's gangrene,,2022,Q2,2,F,20220418.0,20220606.0,20220531,20220610,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,,64.0,YR,,M,Y,84.0,KG,20220610,,MD,JP,,2022,Q2,Adult
208958501,20895850,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure acute,,2022,Q2,1,I,20210918.0,20220525.0,20220531,20220531,EXP,,NVSJ2022JP089515,NOVARTIS,,79.0,YR,,F,Y,43.4,KG,20220531,,MD,JP,JP,2022,Q2,Elderly
208958501,20895850,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Cardiac failure chronic,,2022,Q2,1,I,20210918.0,20220525.0,20220531,20220531,EXP,,NVSJ2022JP089515,NOVARTIS,,79.0,YR,,F,Y,43.4,KG,20220531,,MD,JP,JP,2022,Q2,Elderly
208977592,20897759,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day (years)",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Anal abscess,,2022,Q2,2,F,20220301.0,20220525.0,20220531,20220602,EXP,FR-AFSSAPS-AM20221349,FR-PFIZER INC-202200746637,PFIZER,,60.0,YR,,M,Y,84.0,KG,20220602,,PH,FR,FR,2022,Q2,Adult
208977592,20897759,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day (years)",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Anal fistula,,2022,Q2,2,F,20220301.0,20220525.0,20220531,20220602,EXP,FR-AFSSAPS-AM20221349,FR-PFIZER INC-202200746637,PFIZER,,60.0,YR,,M,Y,84.0,KG,20220602,,PH,FR,FR,2022,Q2,Adult
208982421,20898242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,,,,,202293.0,,,Tablet,,2022,Q2,Micturition urgency,,2022,Q2,1,I,20220401.0,20220526.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A198697,ASTRAZENECA,,76.0,YR,,M,Y,,,20220601,,MD,FR,,2022,Q2,Elderly
208982421,20898242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,,,,,202293.0,,,Tablet,,2022,Q2,Confusional state,,2022,Q2,1,I,20220401.0,20220526.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A198697,ASTRAZENECA,,76.0,YR,,M,Y,,,20220601,,MD,FR,,2022,Q2,Elderly
208982421,20898242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,,,,,202293.0,,,Tablet,,2022,Q2,Asthenia,,2022,Q2,1,I,20220401.0,20220526.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A198697,ASTRAZENECA,,76.0,YR,,M,Y,,,20220601,,MD,FR,,2022,Q2,Elderly
208982421,20898242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1.0DF UNKNOWN,,,,,,,202293.0,,,Tablet,,2022,Q2,Blood glucose fluctuation,,2022,Q2,1,I,20220401.0,20220526.0,20220531,20220531,EXP,,FR-AstraZeneca-2022A198697,ASTRAZENECA,,76.0,YR,,M,Y,,,20220601,,MD,FR,,2022,Q2,Elderly
208991491,20899149,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220518.0,20220601,20220601,EXP,,DE-AUROBINDO-AUR-APL-2022-018821,AUROBINDO,,79.0,YR,,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
208991491,20899149,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220518.0,20220601,20220601,EXP,,DE-AUROBINDO-AUR-APL-2022-018821,AUROBINDO,,79.0,YR,,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
208991491,20899149,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220518.0,20220601,20220601,EXP,,DE-AUROBINDO-AUR-APL-2022-018821,AUROBINDO,,79.0,YR,,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
208991491,20899149,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220518.0,20220601,20220601,EXP,,DE-AUROBINDO-AUR-APL-2022-018821,AUROBINDO,,79.0,YR,,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
208999671,20899967,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd, years",,,,,,,,,,Coated tablet,QD,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220527.0,20220601,20220601,EXP,FR-AFSSAPS-AM20221349,FR-MYLANLABS-2022M1040044,MYLAN,,60.0,YR,,M,Y,84.0,KG,20220601,,PH,FR,FR,2022,Q2,Adult
208999671,20899967,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd, years",,,,,,,,,,Coated tablet,QD,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220527.0,20220601,20220601,EXP,FR-AFSSAPS-AM20221349,FR-MYLANLABS-2022M1040044,MYLAN,,60.0,YR,,M,Y,84.0,KG,20220601,,PH,FR,FR,2022,Q2,Adult
209004531,20900453,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220524.0,20220601,20220601,EXP,,DE-drreddys-SPO/GER/22/0150493,DR REDDYS,,79.0,YR,E,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
209004531,20900453,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220524.0,20220601,20220601,EXP,,DE-drreddys-SPO/GER/22/0150493,DR REDDYS,,79.0,YR,E,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
209004531,20900453,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220524.0,20220601,20220601,EXP,,DE-drreddys-SPO/GER/22/0150493,DR REDDYS,,79.0,YR,E,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
209004531,20900453,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220524.0,20220601,20220601,EXP,,DE-drreddys-SPO/GER/22/0150493,DR REDDYS,,79.0,YR,E,F,Y,56.0,KG,20220601,,MD,DE,DE,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Muscle fatigue,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Anaemia,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Lymphopenia,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Asthenia,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209007021,20900702,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,FORXIGA 10 MG FILM-COATED TABLETS,,,,,Unknown,,,,,Film-coated tablet,,2022,Q2,Muscular weakness,,2022,Q2,1,I,20220329.0,20220522.0,20220601,20220601,EXP,IT-MINISAL02-867280,IT-TEVA-2022-IT-2040828,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220601,,PH,IT,IT,2022,Q2,Elderly
209011081,20901108,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220518.0,20220601,20220601,PER,,IN-LUPIN PHARMACEUTICALS INC.-2022-07795,LUPIN,"Pal S, Pal RD. Covid pneumonia in a female with metabolic syndrome? A case report. The Indian Practitioner. 2022;75(4):37-40",43.0,YR,,F,Y,82.0,KG,20220601,,MD,IN,IN,2022,Q2,Adult
209015391,20901539,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Nausea,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209015391,20901539,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Vomiting,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209015391,20901539,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Hypovolaemic shock,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209015391,20901539,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Take one tablet once a day for treating heart f...,,,,,,,,,,Tablet,,2022,Q2,Nausea,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209015391,20901539,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Take one tablet once a day for treating heart f...,,,,,,,,,,Tablet,,2022,Q2,Vomiting,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209015391,20901539,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Take one tablet once a day for treating heart f...,,,,,,,,,,Tablet,,2022,Q2,Hypovolaemic shock,,2022,Q2,1,I,20220518.0,20220527.0,20220601,20220601,EXP,,GB-AstraZeneca-2022A203938,ASTRAZENECA,,71.0,YR,,M,Y,113.0,KG,20220601,,MD,GB,,2022,Q2,Elderly
209028081,20902808,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Lymphoedema,,2022,Q2,1,I,20220127.0,20220525.0,20220601,20220601,EXP,CH-SM-2022-16188,CH-PFIZER INC-202200769319,PFIZER,,57.0,YR,,M,Y,,,20220601,,PH,CH,CH,2022,Q2,Adult
209032271,20903227,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q2,Constipation,,2022,Q2,1,I,20220401.0,20220525.0,20220601,20220601,EXP,PT-INFARMED-T202205-177,PT-Vifor (International) Inc.-VIT-2022-03670,VIFOR,,79.0,YR,,M,Y,77.0,KG,20220601,,PH,PT,PT,2022,Q2,Elderly
209032271,20903227,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220401.0,20220525.0,20220601,20220601,EXP,PT-INFARMED-T202205-177,PT-Vifor (International) Inc.-VIT-2022-03670,VIFOR,,79.0,YR,,M,Y,77.0,KG,20220601,,PH,PT,PT,2022,Q2,Elderly
209036511,20903651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220513.0,20220525.0,20220602,20220602,EXP,,CN-AstraZeneca-2022A200476,ASTRAZENECA,,19060.0,DY,,M,Y,75.0,KG,20220602,,MD,CN,,2022,Q2,Elderly
209036511,20903651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dermatitis allergic,,2022,Q2,1,I,20220513.0,20220525.0,20220602,20220602,EXP,,CN-AstraZeneca-2022A200476,ASTRAZENECA,,19060.0,DY,,M,Y,75.0,KG,20220602,,MD,CN,,2022,Q2,Elderly
209036511,20903651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Erythema,,2022,Q2,1,I,20220513.0,20220525.0,20220602,20220602,EXP,,CN-AstraZeneca-2022A200476,ASTRAZENECA,,19060.0,DY,,M,Y,75.0,KG,20220602,,MD,CN,,2022,Q2,Elderly
209036511,20903651,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rash pruritic,,2022,Q2,1,I,20220513.0,20220525.0,20220602,20220602,EXP,,CN-AstraZeneca-2022A200476,ASTRAZENECA,,19060.0,DY,,M,Y,75.0,KG,20220602,,MD,CN,,2022,Q2,Elderly
209057271,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Fatigue,,2022,Q2,1,I,20220420.0,20220523.0,20220602,20220602,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220602,,PH,IT,IT,2022,Q2,Elderly
209057271,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20220420.0,20220523.0,20220602,20220602,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220602,,PH,IT,IT,2022,Q2,Elderly
209057271,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Blood thyroid stimulating hormone increased,,2022,Q2,1,I,20220420.0,20220523.0,20220602,20220602,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220602,,PH,IT,IT,2022,Q2,Elderly
209057271,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220420.0,20220523.0,20220602,20220602,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20220602,,PH,IT,IT,2022,Q2,Elderly
209057551,20905755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220507.0,20220526.0,20220602,20220602,EXP,,GB-AstraZeneca-2022A202363,ASTRAZENECA,,53.0,YR,,M,Y,,,20220602,,MD,GB,,2022,Q2,Adult
209057551,20905755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Necrotising fasciitis,,2022,Q2,1,I,20220507.0,20220526.0,20220602,20220602,EXP,,GB-AstraZeneca-2022A202363,ASTRAZENECA,,53.0,YR,,M,Y,,,20220602,,MD,GB,,2022,Q2,Adult
209072701,20907270,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1515.0,MG,U,,,,202293.0,5.0,MG,,QD,2022,Q2,Skin ulcer,,2022,Q2,1,I,,20220525.0,20220602,20220602,EXP,,GB-AstraZeneca-2022A198001,ASTRAZENECA,,60.0,YR,,M,Y,,,20220602,,MD,GB,,2022,Q2,Adult
209081341,20908134,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1Doasge form-1unit,,,U,,,,,,,,,2022,Q2,Pleural effusion,,2022,Q2,1,I,20211110.0,20220527.0,20220602,20220602,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-121501,BRISTOL MYERS SQUIBB,,53.0,YR,A,M,Y,86.0,KG,20220603,,HP,AR,AR,2022,Q2,Adult
209083841,20908384,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1cp per day)",,,Y,U,,,,10.0,MG,Film Coated Tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220519.0,20220603,20220603,EXP,,FR-AUROBINDO-AUR-APL-2022-019244,AUROBINDO,,78.0,YR,,M,Y,76.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
209084831,20908483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,5.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Swelling face,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,GB-AstraZeneca-2022A203863,ASTRAZENECA,,54.0,YR,,M,Y,111.0,KG,20220603,,MD,GB,,2022,Q2,Adult
209084831,20908483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,5.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Blood pressure increased,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,GB-AstraZeneca-2022A203863,ASTRAZENECA,,54.0,YR,,M,Y,111.0,KG,20220603,,MD,GB,,2022,Q2,Adult
209084831,20908483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,5.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Deafness,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,GB-AstraZeneca-2022A203863,ASTRAZENECA,,54.0,YR,,M,Y,111.0,KG,20220603,,MD,GB,,2022,Q2,Adult
209084831,20908483,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,5.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Constipation,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,GB-AstraZeneca-2022A203863,ASTRAZENECA,,54.0,YR,,M,Y,111.0,KG,20220603,,MD,GB,,2022,Q2,Adult
209090871,20909087,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220118.0,20220531.0,20220603,20220603,EXP,FR-AFSSAPS-RE20220757,FR-EMD Serono-E2B_90088043,EMD SERONO INC,,70.0,YR,E,M,Y,120.0,KG,20220603,,MD,FR,FR,2022,Q2,Elderly
209093171,20909317,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form,(ann?es) Once a Day",,,,,,,,,,Film Coated Tablet,QD,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220520.0,20220603,20220603,EXP,,FR-AUROBINDO-AUR-APL-2022-019401,AUROBINDO,,60.0,YR,,M,Y,84.0,KG,20220603,,PH,FR,FR,2022,Q2,Adult
209093171,20909317,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form,(ann?es) Once a Day",,,,,,,,,,Film Coated Tablet,QD,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220520.0,20220603,20220603,EXP,,FR-AUROBINDO-AUR-APL-2022-019401,AUROBINDO,,60.0,YR,,M,Y,84.0,KG,20220603,,PH,FR,FR,2022,Q2,Adult
209095161,20909516,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220525.0,20220603,20220603,EXP,,FR-BAUSCH-BL-2022-013628,BAUSCH AND LOMB,,60.0,YR,,M,Y,84.0,KG,20220603,,HP,FR,FR,2022,Q2,Adult
209095161,20909516,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220525.0,20220603,20220603,EXP,,FR-BAUSCH-BL-2022-013628,BAUSCH AND LOMB,,60.0,YR,,M,Y,84.0,KG,20220603,,HP,FR,FR,2022,Q2,Adult
209104941,20910494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NF3367,,202293.0,,,Tablet,QD,2022,Q2,Face oedema,,2022,Q2,1,I,20220511.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203758,ASTRAZENECA,,25157.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209104941,20910494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NF3367,,202293.0,,,Tablet,QD,2022,Q2,Eye oedema,,2022,Q2,1,I,20220511.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203758,ASTRAZENECA,,25157.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209104941,20910494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NF3367,,202293.0,,,Tablet,QD,2022,Q2,Lip oedema,,2022,Q2,1,I,20220511.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203758,ASTRAZENECA,,25157.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209104941,20910494,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NF3367,,202293.0,,,Tablet,QD,2022,Q2,Oedema peripheral,,2022,Q2,1,I,20220511.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203758,ASTRAZENECA,,25157.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209104961,20910496,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,1,I,,20220530.0,20220603,20220603,EXP,,RO-AstraZeneca-2022A204046,ASTRAZENECA,,75.0,YR,,F,Y,,,20220603,,MD,RO,,2022,Q2,Elderly
209106221,20910622,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A202026,ASTRAZENECA,,66.0,YR,,M,Y,,,20220603,,MD,JP,,2022,Q2,Elderly
209106221,20910622,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A202026,ASTRAZENECA,,66.0,YR,,M,Y,,,20220603,,MD,JP,,2022,Q2,Elderly
209106221,20910622,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A202026,ASTRAZENECA,,66.0,YR,,M,Y,,,20220603,,MD,JP,,2022,Q2,Elderly
209106221,20910622,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A202026,ASTRAZENECA,,66.0,YR,,M,Y,,,20220603,,MD,JP,,2022,Q2,Elderly
209112101,20911210,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20210801.0,20220524.0,20220603,20220603,EXP,,DE-TEVA-2022-DE-2041763,TEVA,,79.0,YR,E,F,Y,56.0,KG,20220603,,MD,DE,DE,2022,Q2,Elderly
209112101,20911210,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Lupus-like syndrome,,2022,Q2,1,I,20210801.0,20220524.0,20220603,20220603,EXP,,DE-TEVA-2022-DE-2041763,TEVA,,79.0,YR,E,F,Y,56.0,KG,20220603,,MD,DE,DE,2022,Q2,Elderly
209112101,20911210,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Myalgia,,2022,Q2,1,I,20210801.0,20220524.0,20220603,20220603,EXP,,DE-TEVA-2022-DE-2041763,TEVA,,79.0,YR,E,F,Y,56.0,KG,20220603,,MD,DE,DE,2022,Q2,Elderly
209112101,20911210,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,1,I,20210801.0,20220524.0,20220603,20220603,EXP,,DE-TEVA-2022-DE-2041763,TEVA,,79.0,YR,E,F,Y,56.0,KG,20220603,,MD,DE,DE,2022,Q2,Elderly
209115201,20911520,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablets,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Gastric ulcer,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Mucosal disorder,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209115201,20911520,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Stomatitis,,2022,Q2,1,I,20191201.0,20210511.0,20220603,20220603,PER,,US-Covis Pharma GmbH-2021COV00215,COVIS PHARMA,,59.0,YR,A,F,Y,94.331,KG,20220603,,HP,US,,2022,Q2,Adult
209117701,20911770,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Altered state of consciousness,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,CA-AstraZeneca-2022A199578,ASTRAZENECA,,93.0,YR,,F,Y,66.0,KG,20220603,,MD,CA,,2022,Q2,Elderly
209117701,20911770,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,CA-AstraZeneca-2022A199578,ASTRAZENECA,,93.0,YR,,F,Y,66.0,KG,20220603,,MD,CA,,2022,Q2,Elderly
209117701,20911770,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug-disease interaction,,2022,Q2,1,I,,20220526.0,20220603,20220603,EXP,,CA-AstraZeneca-2022A199578,ASTRAZENECA,,93.0,YR,,F,Y,66.0,KG,20220603,,MD,CA,,2022,Q2,Elderly
209120901,20912090,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 Milligram Daily; 1cp per day , unit dose : 10 mg , Frequency time : 1 day , strength : 10 mg",,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20220416.0,20220525.0,20220603,20220603,EXP,FR-AFSSAPS-MP20221792,FR-TEVA-2022-FR-2041732,TEVA,,78.0,YR,E,M,Y,76.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
209120901,20912090,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 Milligram Daily; 1cp per day , unit dose : 10 mg , Frequency time : 1 day , strength : 10 mg",,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220525.0,20220603,20220603,EXP,FR-AFSSAPS-MP20221792,FR-TEVA-2022-FR-2041732,TEVA,,78.0,YR,E,M,Y,76.0,KG,20220603,,PH,FR,FR,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hiccups,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Gastric cancer,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209121551,20912155,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,20220401.0,20220527.0,20220603,20220603,EXP,,JP-AstraZeneca-2022A164543,ASTRAZENECA,,72.0,YR,,M,Y,,,20220603,,PH,JP,,2022,Q2,Elderly
209122181,20912218,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,"NB2265,2107023",,202293.0,5.0,MG,Tablet,QD,2022,Q2,Blood ketone body increased,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203906,ASTRAZENECA,,21088.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209122181,20912218,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,"NB2265,2107023",,202293.0,5.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203906,ASTRAZENECA,,21088.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209122181,20912218,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,"NB2265,2107023",,202293.0,5.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203906,ASTRAZENECA,,21088.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209122181,20912218,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,"NB2265,2107023",,202293.0,5.0,MG,Tablet,QD,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,20220521.0,20220527.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A203906,ASTRAZENECA,,21088.0,DY,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209129151,20912915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,U,,2109055,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,1,I,20220523.0,20220526.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A201933,ASTRAZENECA,,88.0,YR,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209129151,20912915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,U,,2109055,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20220523.0,20220526.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A201933,ASTRAZENECA,,88.0,YR,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209129151,20912915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,U,,2109055,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Injury,,2022,Q2,1,I,20220523.0,20220526.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A201933,ASTRAZENECA,,88.0,YR,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209129151,20912915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,U,,2109055,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fall,,2022,Q2,1,I,20220523.0,20220526.0,20220603,20220603,EXP,,CN-AstraZeneca-2022A201933,ASTRAZENECA,,88.0,YR,,F,Y,,,20220603,,MD,CN,,2022,Q2,Elderly
209137411,20913741,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220301.0,20220529.0,20220604,20220604,EXP,,NVSC2022EG122591,NOVARTIS,,61.0,YR,,F,Y,,,20220604,,CN,EG,EG,2022,Q2,Adult
209137411,20913741,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,1,I,20220301.0,20220529.0,20220604,20220604,EXP,,NVSC2022EG122591,NOVARTIS,,61.0,YR,,F,Y,,,20220604,,CN,EG,EG,2022,Q2,Adult
209137411,20913741,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,20220301.0,20220529.0,20220604,20220604,EXP,,NVSC2022EG122591,NOVARTIS,,61.0,YR,,F,Y,,,20220604,,CN,EG,EG,2022,Q2,Adult
209137411,20913741,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20220301.0,20220529.0,20220604,20220604,EXP,,NVSC2022EG122591,NOVARTIS,,61.0,YR,,F,Y,,,20220604,,CN,EG,EG,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Type V hyperlipidaemia,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Non-alcoholic fatty liver,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Hyperuricaemia,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Fatigue,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Obesity,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Abdominal distension,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209163491,20916349,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,1,I,,20220530.0,20220604,20220604,EXP,PL-002147023-NVSC2021PL217368,PL-STRIDES ARCOLAB LIMITED-2021SP028375,STRIDES,,64.0,YR,,M,Y,95.0,KG,20220604,,MD,PL,PL,2022,Q2,Adult
209164621,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Mucosal inflammation,Mucosal inflammation,2022,Q2,1,I,20210815.0,20220526.0,20220604,20220604,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220605,,MD,PT,PT,2022,Q2,Elderly
209164621,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20210815.0,20220526.0,20220604,20220604,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220605,,MD,PT,PT,2022,Q2,Elderly
209164621,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,20210815.0,20220526.0,20220604,20220604,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220605,,MD,PT,PT,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Muscle spasms,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Depression,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Muscle disorder,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Somnolence,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Fall,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Musculoskeletal pain,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Feeling abnormal,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Constipation,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Spinal disorder,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Sleep talking,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Nodule,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (by mouth)",,,,,NK0089,,,,,Tablet,QD,2022,Q2,Delirium,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Muscle spasms,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Depression,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Muscle disorder,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Somnolence,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Fall,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Musculoskeletal pain,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Weight decreased,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Feeling abnormal,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Constipation,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Spinal disorder,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Sleep talking,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Nodule,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209169542,20916954,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Delirium,,2022,Q2,2,F,20220425.0,20220601.0,20220606,20220607,EXP,,NVSC2022MX128805,NOVARTIS,,75.0,YR,,F,Y,64.0,KG,20220607,,CN,MX,MX,2022,Q2,Elderly
209173951,20917395,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Coated tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220118.0,20220530.0,20220606,20220606,EXP,FR-AFSSAPS-RE20220757,NVSC2022FR124243,NOVARTIS,,70.0,YR,,M,Y,120.0,KG,20220606,,MD,FR,FR,2022,Q2,Elderly
209209962,20920996,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7310.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Liver disorder,,2022,Q2,2,F,20211201.0,20220602.0,20220606,20220608,EXP,,BE-AstraZeneca-2022A209181,ASTRAZENECA,,66.0,YR,,F,Y,78.0,KG,20220608,,MD,BE,,2022,Q2,Elderly
209213631,20921363,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,years,,,,U,Unknown,,,,,Film-coated tablet,,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220529.0,20220606,20220606,EXP,FR-AFSSAPS-AM20221349,FR-TEVA-2022-FR-2042802,TEVA,,60.0,YR,A,M,Y,84.0,KG,20220606,,PH,FR,FR,2022,Q2,Adult
209213631,20921363,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,years,,,,U,Unknown,,,,,Film-coated tablet,,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220529.0,20220606,20220606,EXP,FR-AFSSAPS-AM20221349,FR-TEVA-2022-FR-2042802,TEVA,,60.0,YR,A,M,Y,84.0,KG,20220606,,PH,FR,FR,2022,Q2,Adult
209214812,20921481,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,2,F,20211113.0,20220601.0,20220606,20220607,EXP,,JP-AstraZeneca-2022A208386,ASTRAZENECA,,79.0,YR,,M,Y,,,20220607,,MD,JP,,2022,Q2,Elderly
209214812,20921481,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Underdose,,2022,Q2,2,F,20211113.0,20220601.0,20220606,20220607,EXP,,JP-AstraZeneca-2022A208386,ASTRAZENECA,,79.0,YR,,M,Y,,,20220607,,MD,JP,,2022,Q2,Elderly
209214812,20921481,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,2,F,20211113.0,20220601.0,20220606,20220607,EXP,,JP-AstraZeneca-2022A208386,ASTRAZENECA,,79.0,YR,,M,Y,,,20220607,,MD,JP,,2022,Q2,Elderly
209214812,20921481,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Underdose,,2022,Q2,2,F,20211113.0,20220601.0,20220606,20220607,EXP,,JP-AstraZeneca-2022A208386,ASTRAZENECA,,79.0,YR,,M,Y,,,20220607,,MD,JP,,2022,Q2,Elderly
209225121,20922512,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Film-coated tablet,,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220526.0,20220607,20220607,EXP,FR-AFSSAPS-AM20221349,FR-Hikma Pharmaceuticals USA Inc.-FR-H14001-22-57801,HIKMA,,60.0,YR,,M,Y,84.0,KG,20220607,,PH,FR,FR,2022,Q2,Adult
209225121,20922512,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Film-coated tablet,,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220526.0,20220607,20220607,EXP,FR-AFSSAPS-AM20221349,FR-Hikma Pharmaceuticals USA Inc.-FR-H14001-22-57801,HIKMA,,60.0,YR,,M,Y,84.0,KG,20220607,,PH,FR,FR,2022,Q2,Adult
209229361,20922936,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (QD),2510.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q2,Syncope,,2022,Q2,1,I,20220504.0,20220524.0,20220607,20220607,EXP,,GB-AUROBINDO-AUR-APL-2022-020050,AUROBINDO,,72.0,YR,,F,Y,,,20220607,,MD,GB,GB,2022,Q2,Elderly
209232341,20923234,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1cp per day,,,Y,U,,,,10.0,MG,,,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,20220416.0,20220523.0,20220607,20220607,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-339925,RANBAXY,,78.0,YR,,M,Y,76.0,KG,20220607,,PH,FR,FR,2022,Q2,Elderly
209243601,20924360,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,NC2462,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vulvovaginal pruritus,,2022,Q2,1,I,20220504.0,20220602.0,20220607,20220607,EXP,,CN-AstraZeneca-2022A208395,ASTRAZENECA,,24343.0,DY,,,Y,67.0,KG,20220607,,MD,CN,,2022,Q2,Elderly
209243651,20924365,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg daily, 10 mg at lunchtime",,,Y,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Blood urine present,,2022,Q2,1,I,20220412.0,20220530.0,20220607,20220607,EXP,,AT-AstraZeneca-2022A201471,ASTRAZENECA,,82.0,YR,,M,Y,,,20220607,,MD,AT,,2022,Q2,Elderly
209243651,20924365,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg daily, 10 mg at lunchtime",,,Y,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Dysuria,,2022,Q2,1,I,20220412.0,20220530.0,20220607,20220607,EXP,,AT-AstraZeneca-2022A201471,ASTRAZENECA,,82.0,YR,,M,Y,,,20220607,,MD,AT,,2022,Q2,Elderly
209243651,20924365,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg daily, 10 mg at lunchtime",,,Y,,UNKNOWN,,202293.0,,,Tablet,,2022,Q2,Urethral pain,,2022,Q2,1,I,20220412.0,20220530.0,20220607,20220607,EXP,,AT-AstraZeneca-2022A201471,ASTRAZENECA,,82.0,YR,,M,Y,,,20220607,,MD,AT,,2022,Q2,Elderly
209250171,20925017,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dermatitis allergic,,2022,Q2,1,I,20220511.0,20220525.0,20220607,20220607,EXP,CN-AstraZeneca-2022A200476,CN-TOPROL-2022000175,TOPROL ACQUISITION,,52.0,YR,A,M,Y,75.0,KG,20220607,,HP,CN,CN,2022,Q2,Adult
209250171,20925017,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug eruption,,2022,Q2,1,I,20220511.0,20220525.0,20220607,20220607,EXP,CN-AstraZeneca-2022A200476,CN-TOPROL-2022000175,TOPROL ACQUISITION,,52.0,YR,A,M,Y,75.0,KG,20220607,,HP,CN,CN,2022,Q2,Adult
209250171,20925017,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Rash pruritic,,2022,Q2,1,I,20220511.0,20220525.0,20220607,20220607,EXP,CN-AstraZeneca-2022A200476,CN-TOPROL-2022000175,TOPROL ACQUISITION,,52.0,YR,A,M,Y,75.0,KG,20220607,,HP,CN,CN,2022,Q2,Adult
209250171,20925017,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Erythema,,2022,Q2,1,I,20220511.0,20220525.0,20220607,20220607,EXP,CN-AstraZeneca-2022A200476,CN-TOPROL-2022000175,TOPROL ACQUISITION,,52.0,YR,A,M,Y,75.0,KG,20220607,,HP,CN,CN,2022,Q2,Adult
209250171,20925017,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NA2988//2106216,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Product use in unapproved indication,,2022,Q2,1,I,20220511.0,20220525.0,20220607,20220607,EXP,CN-AstraZeneca-2022A200476,CN-TOPROL-2022000175,TOPROL ACQUISITION,,52.0,YR,A,M,Y,75.0,KG,20220607,,HP,CN,CN,2022,Q2,Adult
209255221,20925522,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Confusional state,,2022,Q2,1,I,,20220531.0,20220607,20220607,EXP,,CA-TEVA-2022-CA-2042972,TEVA,,77.0,YR,E,F,Y,,,20220607,,PH,CA,CA,2022,Q2,Elderly
209255221,20925522,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Abnormal behaviour,,2022,Q2,1,I,,20220531.0,20220607,20220607,EXP,,CA-TEVA-2022-CA-2042972,TEVA,,77.0,YR,E,F,Y,,,20220607,,PH,CA,CA,2022,Q2,Elderly
209255221,20925522,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Delirium,,2022,Q2,1,I,,20220531.0,20220607,20220607,EXP,,CA-TEVA-2022-CA-2042972,TEVA,,77.0,YR,E,F,Y,,,20220607,,PH,CA,CA,2022,Q2,Elderly
209258491,20925849,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220118.0,20220602.0,20220607,20220607,EXP,FR-AFSSAPS-RE20220757,FR-MYLANLABS-2022M1042214,MYLAN,,70.0,YR,,M,Y,120.0,KG,20220607,,MD,FR,FR,2022,Q2,Elderly
209258491,20925849,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Drug interaction,,2022,Q2,1,I,20220118.0,20220602.0,20220607,20220607,EXP,FR-AFSSAPS-RE20220757,FR-MYLANLABS-2022M1042214,MYLAN,,70.0,YR,,M,Y,120.0,KG,20220607,,MD,FR,FR,2022,Q2,Elderly
209292761,20929276,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220530.0,20220608,20220608,EXP,,AU-NOVOPROD-925316,NOVO NORDISK,,70.0,YR,,F,Y,,,20220608,,MD,AU,AU,2022,Q2,Elderly
209292782,20929278,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Dermal cyst,,2022,Q2,2,F,20210101.0,20220612.0,20220608,20220622,EXP,,EG-NOVOPROD-924224,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220622,,CN,EG,EG,2022,Q2,Elderly
209292782,20929278,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Eye laser surgery,,2022,Q2,2,F,20210101.0,20220612.0,20220608,20220622,EXP,,EG-NOVOPROD-924224,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220622,,CN,EG,EG,2022,Q2,Elderly
209292782,20929278,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Diabetic neuropathy,,2022,Q2,2,F,20210101.0,20220612.0,20220608,20220622,EXP,,EG-NOVOPROD-924224,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220622,,CN,EG,EG,2022,Q2,Elderly
209292782,20929278,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Eye disorder,,2022,Q2,2,F,20210101.0,20220612.0,20220608,20220622,EXP,,EG-NOVOPROD-924224,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220622,,CN,EG,EG,2022,Q2,Elderly
209292782,20929278,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q2,Cataract,,2022,Q2,2,F,20210101.0,20220612.0,20220608,20220622,EXP,,EG-NOVOPROD-924224,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220622,,CN,EG,EG,2022,Q2,Elderly
209292802,20929280,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Cataract,,2022,Q2,2,F,,20220608.0,20220608,20220615,EXP,,EG-NOVOPROD-924818,NOVO NORDISK,,69.0,YR,,M,Y,112.0,KG,20220615,,CN,EG,EG,2022,Q2,Elderly
209318971,20931897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1270.0,MG,,,NA3002,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Candida infection,,2022,Q2,1,I,20220510.0,20220601.0,20220608,20220608,EXP,,CN-AstraZeneca-2022A208842,ASTRAZENECA,,18129.0,DY,,M,Y,96.2,KG,20220608,,MD,CN,,2022,Q2,Elderly
209318971,20931897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1270.0,MG,,,NA3002,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220510.0,20220601.0,20220608,20220608,EXP,,CN-AstraZeneca-2022A208842,ASTRAZENECA,,18129.0,DY,,M,Y,96.2,KG,20220608,,MD,CN,,2022,Q2,Elderly
209335451,20933545,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220531.0,20220608,20220608,EXP,,JP-AstraZeneca-2022A207571,ASTRAZENECA,"Takemura T, et al.. P-20-3 Two cases of type 2 diabetes mellitus that led to emphysematous cystitis. Diabetes Mellitus 2022;65(S1):S239.",70.0,YR,,M,Y,,,20220608,,MD,JP,,2022,Q2,Elderly
209335451,20933545,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Emphysematous cystitis,,2022,Q2,1,I,,20220531.0,20220608,20220608,EXP,,JP-AstraZeneca-2022A207571,ASTRAZENECA,"Takemura T, et al.. P-20-3 Two cases of type 2 diabetes mellitus that led to emphysematous cystitis. Diabetes Mellitus 2022;65(S1):S239.",70.0,YR,,M,Y,,,20220608,,MD,JP,,2022,Q2,Elderly
209335451,20933545,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q2,1,I,,20220531.0,20220608,20220608,EXP,,JP-AstraZeneca-2022A207571,ASTRAZENECA,"Takemura T, et al.. P-20-3 Two cases of type 2 diabetes mellitus that led to emphysematous cystitis. Diabetes Mellitus 2022;65(S1):S239.",70.0,YR,,M,Y,,,20220608,,MD,JP,,2022,Q2,Elderly
209353721,20935372,8,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 dosage form, Daily",,,,,,,,,,,,2022,Q2,Anal fistula,,2022,Q2,1,I,20220301.0,20220525.0,20220609,20220609,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-340026,RANBAXY,,60.0,YR,,M,Y,84.0,KG,20220609,,PH,FR,FR,2022,Q2,Adult
209353721,20935372,8,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"1 dosage form, Daily",,,,,,,,,,,,2022,Q2,Anal abscess,,2022,Q2,1,I,20220301.0,20220525.0,20220609,20220609,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-340026,RANBAXY,,60.0,YR,,M,Y,84.0,KG,20220609,,PH,FR,FR,2022,Q2,Adult
209355721,20935572,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,,20220607.0,20220609,20220609,EXP,,NVSJ2022JP091863,NOVARTIS,,85.0,YR,,F,Y,,,20220609,,MD,JP,JP,2022,Q2,Elderly
209358531,20935853,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(morning)",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Diabetic metabolic decompensation,,2022,Q2,1,I,,20220530.0,20220609,20220609,EXP,,BR-NOVOPROD-924105,NOVO NORDISK,,77.0,YR,,F,Y,70.0,KG,20220609,,MD,BR,BR,2022,Q2,Elderly
209358531,20935853,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(morning)",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Diabetic nephropathy,,2022,Q2,1,I,,20220530.0,20220609,20220609,EXP,,BR-NOVOPROD-924105,NOVO NORDISK,,77.0,YR,,F,Y,70.0,KG,20220609,,MD,BR,BR,2022,Q2,Elderly
209358531,20935853,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, qd(morning)",,,,,Unknown,,,10.0,MG,,QD,2022,Q2,Diabetic retinopathy,,2022,Q2,1,I,,20220530.0,20220609,20220609,EXP,,BR-NOVOPROD-924105,NOVO NORDISK,,77.0,YR,,F,Y,70.0,KG,20220609,,MD,BR,BR,2022,Q2,Elderly
209380791,20938079,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220601.0,20220609,20220609,EXP,,JP-AstraZeneca-2022A197414,ASTRAZENECA,,73.0,YR,,F,Y,,,20220609,,HP,JP,,2022,Q2,Elderly
209380791,20938079,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Renal impairment,,2022,Q2,1,I,,20220601.0,20220609,20220609,EXP,,JP-AstraZeneca-2022A197414,ASTRAZENECA,,73.0,YR,,F,Y,,,20220609,,HP,JP,,2022,Q2,Elderly
209380821,20938082,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,U,,RY182,,202293.0,,,Tablet,,2022,Q2,Medication error,,2022,Q2,1,I,20220330.0,20220601.0,20220609,20220609,EXP,,GB-AstraZeneca-2022A205835,ASTRAZENECA,,76.0,YR,,M,Y,68.0,KG,20220609,,MD,GB,,2022,Q2,Elderly
209380821,20938082,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,U,,RY182,,202293.0,,,Tablet,,2022,Q2,Pruritus,,2022,Q2,1,I,20220330.0,20220601.0,20220609,20220609,EXP,,GB-AstraZeneca-2022A205835,ASTRAZENECA,,76.0,YR,,M,Y,68.0,KG,20220609,,MD,GB,,2022,Q2,Elderly
209383711,20938371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QOD,2022,Q2,COVID-19,,2022,Q2,1,I,,20220601.0,20220609,20220609,EXP,,ZA-AstraZeneca-2022A207515,ASTRAZENECA,,50.0,YR,,M,Y,,,20220609,,MD,ZA,,2022,Q2,Adult
209383711,20938371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QOD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220601.0,20220609,20220609,EXP,,ZA-AstraZeneca-2022A207515,ASTRAZENECA,,50.0,YR,,M,Y,,,20220609,,MD,ZA,,2022,Q2,Adult
209391231,20939123,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Accidental overdose,,2022,Q2,1,I,,20220526.0,20220609,20220609,EXP,,FR-B.Braun Medical Inc.-2129646,B BRAUN,,84.0,YR,,M,Y,,,20220609,,,FR,FR,2022,Q2,Elderly
209391231,20939123,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,1,I,,20220526.0,20220609,20220609,EXP,,FR-B.Braun Medical Inc.-2129646,B BRAUN,,84.0,YR,,M,Y,,,20220609,,,FR,FR,2022,Q2,Elderly
209391231,20939123,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Malaise,,2022,Q2,1,I,,20220526.0,20220609,20220609,EXP,,FR-B.Braun Medical Inc.-2129646,B BRAUN,,84.0,YR,,M,Y,,,20220609,,,FR,FR,2022,Q2,Elderly
209391771,20939177,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 pill a day,50.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chest pain,,2022,Q2,1,I,20220325.0,20220601.0,20220609,20220609,EXP,,ES-AstraZeneca-2022A205561,ASTRAZENECA,,56.0,YR,,F,Y,80.0,KG,20220609,,MD,ES,,2022,Q2,Adult
209405771,20940577,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,1,I,20220430.0,20220608.0,20220609,20220609,EXP,IT-MINISAL02-871241,IT-JNJFOC-20220614408,JOHNSON AND JOHNSON,,82.0,YR,E,F,Y,,,20220609,,MD,IT,IT,2022,Q2,Elderly
209446831,20944683,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MA3022,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood ketone body increased,,2022,Q2,1,I,20220501.0,20220602.0,20220610,20220610,EXP,,CN-AstraZeneca-2022A210199,ASTRAZENECA,,30.0,YR,,F,Y,75.0,KG,20220610,,MD,CN,,2022,Q2,Young Adult
209453531,20945353,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Endotracheal intubation,,2022,Q2,1,I,20220523.0,20220606.0,20220610,20220610,EXP,,IT-AstraZeneca-2022A209597,ASTRAZENECA,,74.0,YR,,F,Y,69.0,KG,20220610,,MD,IT,,2022,Q2,Elderly
209453531,20945353,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220523.0,20220606.0,20220610,20220610,EXP,,IT-AstraZeneca-2022A209597,ASTRAZENECA,,74.0,YR,,F,Y,69.0,KG,20220610,,MD,IT,,2022,Q2,Elderly
209464952,20946495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,2,F,,20220608.0,20220610,20220616,EXP,,JP-AstraZeneca-2022A203447,ASTRAZENECA,,100.0,YR,,,Y,,,20220616,,PH,JP,,2022,Q2,Elderly
209469481,20946948,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,Tablet,,2022,Q2,Limb injury,,2022,Q2,1,I,20220310.0,20220602.0,20220610,20220610,EXP,,FR-AstraZeneca-2022A206157,ASTRAZENECA,,71.0,YR,,M,Y,75.0,KG,20220610,,MD,FR,,2022,Q2,Elderly
209469481,20946948,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,Tablet,,2022,Q2,Lymphadenopathy,,2022,Q2,1,I,20220310.0,20220602.0,20220610,20220610,EXP,,FR-AstraZeneca-2022A206157,ASTRAZENECA,,71.0,YR,,M,Y,75.0,KG,20220610,,MD,FR,,2022,Q2,Elderly
209469481,20946948,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,Tablet,,2022,Q2,Fournier's gangrene,,2022,Q2,1,I,20220310.0,20220602.0,20220610,20220610,EXP,,FR-AstraZeneca-2022A206157,ASTRAZENECA,,71.0,YR,,M,Y,75.0,KG,20220610,,MD,FR,,2022,Q2,Elderly
209477661,20947766,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Therapy start date : ASKU , Frequency time : 1 day , unit dose : 10 mg , strength : 10 mg",,,,U,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220118.0,20220602.0,20220611,20220611,EXP,FR-AFSSAPS-RE20220757,FR-TEVA-2022-FR-2044625,TEVA,,70.0,YR,E,M,Y,120.0,KG,20220611,,MD,FR,FR,2022,Q2,Elderly
209477661,20947766,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Therapy start date : ASKU , Frequency time : 1 day , unit dose : 10 mg , strength : 10 mg",,,,U,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q2,Drug interaction,,2022,Q2,1,I,20220118.0,20220602.0,20220611,20220611,EXP,FR-AFSSAPS-RE20220757,FR-TEVA-2022-FR-2044625,TEVA,,70.0,YR,E,M,Y,120.0,KG,20220611,,MD,FR,FR,2022,Q2,Elderly
209509751,20950975,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Vulvovaginal pruritus,,2022,Q2,1,I,20220101.0,20220605.0,20220613,20220613,EXP,,GB-AstraZeneca-2022A209172,ASTRAZENECA,,37.0,YR,,F,Y,,,20220613,,MD,GB,,2022,Q2,Adult
209521021,20952102,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Bradycardia,,2022,Q2,1,I,20211218.0,20220607.0,20220613,20220613,EXP,JP-PMDA-i2210000413001,JP-PFIZER INC-202200805744,PFIZER,,58.0,YR,,M,Y,75.0,KG,20220613,,PH,JP,JP,2022,Q2,Adult
209521021,20952102,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20211218.0,20220607.0,20220613,20220613,EXP,JP-PMDA-i2210000413001,JP-PFIZER INC-202200805744,PFIZER,,58.0,YR,,M,Y,75.0,KG,20220613,,PH,JP,JP,2022,Q2,Adult
209521021,20952102,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20211218.0,20220607.0,20220613,20220613,EXP,JP-PMDA-i2210000413001,JP-PFIZER INC-202200805744,PFIZER,,58.0,YR,,M,Y,75.0,KG,20220613,,PH,JP,JP,2022,Q2,Adult
209521021,20952102,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20211218.0,20220607.0,20220613,20220613,EXP,JP-PMDA-i2210000413001,JP-PFIZER INC-202200805744,PFIZER,,58.0,YR,,M,Y,75.0,KG,20220613,,PH,JP,JP,2022,Q2,Adult
209521132,20952113,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,2,F,,20220613.0,20220613,20220621,EXP,,MY-AstraZeneca-2022A218016,ASTRAZENECA,,77.0,YR,,,Y,,,20220621,,MD,MY,,2022,Q2,Elderly
209531752,20953175,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q2,Ileus paralytic,,2022,Q2,2,F,20220509.0,20220609.0,20220613,20220616,EXP,ES-AEMPS-1196492,ES-SEATTLE GENETICS-2022SGN05448,SEATTLE GENETICS,,79.0,YR,,M,Y,,,20220616,,PH,ES,ES,2022,Q2,Elderly
209531752,20953175,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q2,Abdominal distension,,2022,Q2,2,F,20220509.0,20220609.0,20220613,20220616,EXP,ES-AEMPS-1196492,ES-SEATTLE GENETICS-2022SGN05448,SEATTLE GENETICS,,79.0,YR,,M,Y,,,20220616,,PH,ES,ES,2022,Q2,Elderly
209531752,20953175,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q2,Abdominal pain upper,,2022,Q2,2,F,20220509.0,20220609.0,20220613,20220616,EXP,ES-AEMPS-1196492,ES-SEATTLE GENETICS-2022SGN05448,SEATTLE GENETICS,,79.0,YR,,M,Y,,,20220616,,PH,ES,ES,2022,Q2,Elderly
209531752,20953175,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q2,Abdominal pain,,2022,Q2,2,F,20220509.0,20220609.0,20220613,20220616,EXP,ES-AEMPS-1196492,ES-SEATTLE GENETICS-2022SGN05448,SEATTLE GENETICS,,79.0,YR,,M,Y,,,20220616,,PH,ES,ES,2022,Q2,Elderly
209536011,20953601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,20220310.0,20220608.0,20220613,20220613,EXP,,CA-AstraZeneca-2022A216119,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220613,,HP,CA,,2022,Q2,Adult
209536011,20953601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220310.0,20220608.0,20220613,20220613,EXP,,CA-AstraZeneca-2022A216119,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220613,,HP,CA,,2022,Q2,Adult
209536011,20953601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220310.0,20220608.0,20220613,20220613,EXP,,CA-AstraZeneca-2022A216119,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20220613,,HP,CA,,2022,Q2,Adult
209540221,20954022,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,Unknown,,,,,,,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220501.0,20220603.0,20220614,20220614,EXP,,SE-NOVOPROD-919046,NOVO NORDISK,,78.0,YR,,M,Y,57.0,KG,20220614,,MD,SE,SE,2022,Q2,Elderly
209572371,20957237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pyrexia,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209572371,20957237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chills,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209572371,20957237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug hypersensitivity,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209572371,20957237,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pyrexia,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209572371,20957237,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chills,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209572371,20957237,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,NB2304,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Drug hypersensitivity,,2022,Q2,1,I,20220601.0,20220608.0,20220614,20220614,EXP,,CN-AstraZeneca-2022A216610,ASTRAZENECA,,77.0,YR,,M,Y,,,20220614,,MD,CN,,2022,Q2,Elderly
209614401,20961440,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Off label use,,2022,Q2,1,I,,20220607.0,20220615,20220615,EXP,,JP-AstraZeneca-2022A217242,ASTRAZENECA,,78.0,YR,,M,Y,,,20220615,,MD,JP,,2022,Q2,Elderly
209614401,20961440,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,,20220607.0,20220615,20220615,EXP,,JP-AstraZeneca-2022A217242,ASTRAZENECA,,78.0,YR,,M,Y,,,20220615,,MD,JP,,2022,Q2,Elderly
209618832,20961883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,2,F,20220510.0,20220613.0,20220615,20220621,EXP,,JP-AstraZeneca-2022A216333,ASTRAZENECA,,72.0,YR,,M,Y,,,20220621,,MD,JP,,2022,Q2,Elderly
209635951,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Cardiac sarcoidosis,,2022,Q2,1,I,,20220607.0,20220615,20220615,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220615,,MD,JP,,2022,Q2,Elderly
209635951,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Cardiac failure,,2022,Q2,1,I,,20220607.0,20220615,20220615,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220615,,MD,JP,,2022,Q2,Elderly
209635951,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q2,Renal impairment,,2022,Q2,1,I,,20220607.0,20220615,20220615,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220615,,MD,JP,,2022,Q2,Elderly
209643141,20964314,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Strength: 12.3 mg, 2 doses",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220527.0,20220613.0,20220615,20220615,EXP,IE-HPRA-2022-096268,IE-BAXTER-2022BAX012481,BAXTER,,59.0,YR,,F,Y,80.0,KG,20220615,,HP,IE,IE,2022,Q2,Adult
209643141,20964314,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Strength: 12.3 mg, 2 doses",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Anxiety,,2022,Q2,1,I,20220527.0,20220613.0,20220615,20220615,EXP,IE-HPRA-2022-096268,IE-BAXTER-2022BAX012481,BAXTER,,59.0,YR,,F,Y,80.0,KG,20220615,,HP,IE,IE,2022,Q2,Adult
209643141,20964314,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Strength: 12.3 mg, 2 doses",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220527.0,20220613.0,20220615,20220615,EXP,IE-HPRA-2022-096268,IE-BAXTER-2022BAX012481,BAXTER,,59.0,YR,,F,Y,80.0,KG,20220615,,HP,IE,IE,2022,Q2,Adult
209643141,20964314,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Strength: 12.3 mg, 2 doses",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220527.0,20220613.0,20220615,20220615,EXP,IE-HPRA-2022-096268,IE-BAXTER-2022BAX012481,BAXTER,,59.0,YR,,F,Y,80.0,KG,20220615,,HP,IE,IE,2022,Q2,Adult
209646671,20964667,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220503.0,20220608.0,20220615,20220615,EXP,,NO-AstraZeneca-2022A213624,ASTRAZENECA,,78.0,YR,,M,Y,,,20220616,,MD,NO,,2022,Q2,Elderly
209648331,20964833,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,2105203,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Renal impairment,,2022,Q2,1,I,20220413.0,20220608.0,20220616,20220616,EXP,,CN-AstraZeneca-2022A217845,ASTRAZENECA,,30934.0,DY,,F,Y,47.0,KG,20220616,,MD,CN,,2022,Q2,Elderly
209666301,20966630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Disease progression,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,MY-AstraZeneca-2022A219022,ASTRAZENECA,,65.0,YR,,,Y,,,20220616,,MD,MY,,2022,Q2,Elderly
209666301,20966630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q2,Cardiac failure acute,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,MY-AstraZeneca-2022A219022,ASTRAZENECA,,65.0,YR,,,Y,,,20220616,,MD,MY,,2022,Q2,Elderly
209674341,20967434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Hypernatraemia,,2022,Q2,1,I,,20220610.0,20220616,20220616,EXP,,SI-AstraZeneca-2022A216750,ASTRAZENECA,,70.0,YR,,M,Y,,,20220616,,MD,SI,,2022,Q2,Elderly
209682371,20968237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood glucose fluctuation,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,ZA-AstraZeneca-2022A216079,ASTRAZENECA,,54.0,YR,,M,Y,,,20220616,,CN,ZA,,2022,Q2,Adult
209682371,20968237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Syncope,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,ZA-AstraZeneca-2022A216079,ASTRAZENECA,,54.0,YR,,M,Y,,,20220616,,CN,ZA,,2022,Q2,Adult
209682371,20968237,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Amnesia,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,ZA-AstraZeneca-2022A216079,ASTRAZENECA,,54.0,YR,,M,Y,,,20220616,,CN,ZA,,2022,Q2,Adult
209685841,20968584,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q2,End stage renal disease,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,JP-AstraZeneca-2022A216941,ASTRAZENECA,,70.0,YR,,M,Y,,,20220616,,PH,JP,,2022,Q2,Elderly
209696711,20969671,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Heart valve incompetence,,2022,Q2,1,I,20220506.0,20220614.0,20220616,20220616,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176563",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,90.5,KG,20220616,,CN,MX,MX,2022,Q2,Adult
209696711,20969671,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Thrombosis,,2022,Q2,1,I,20220506.0,20220614.0,20220616,20220616,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176563",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,90.5,KG,20220616,,CN,MX,MX,2022,Q2,Adult
209696711,20969671,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Cerebellar ischaemia,,2022,Q2,1,I,20220506.0,20220614.0,20220616,20220616,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176563",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,90.5,KG,20220616,,CN,MX,MX,2022,Q2,Adult
209696711,20969671,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Aneurysm,,2022,Q2,1,I,20220506.0,20220614.0,20220616,20220616,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176563",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,90.5,KG,20220616,,CN,MX,MX,2022,Q2,Adult
209696711,20969671,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q2,Carotid artery occlusion,,2022,Q2,1,I,20220506.0,20220614.0,20220616,20220616,EXP,,"MX-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-176563",BOEHRINGER INGELHEIM,,57.0,YR,A,F,Y,90.5,KG,20220616,,CN,MX,MX,2022,Q2,Adult
209734531,20973453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"dose: 1.000000 tablet, qd",,,Y,,NA2990//2106217,,202293.0,,,Tablet,QD,2022,Q2,Escherichia sepsis,,2022,Q2,1,I,20220531.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220956,ASTRAZENECA,,73.0,YR,,F,Y,45.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209734531,20973453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"dose: 1.000000 tablet, qd",,,Y,,NA2990//2106217,,202293.0,,,Tablet,QD,2022,Q2,Bacteriuria,,2022,Q2,1,I,20220531.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220956,ASTRAZENECA,,73.0,YR,,F,Y,45.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209734531,20973453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"dose: 1.000000 tablet, qd",,,Y,,NA2990//2106217,,202293.0,,,Tablet,QD,2022,Q2,Urinary tract infection bacterial,,2022,Q2,1,I,20220531.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220956,ASTRAZENECA,,73.0,YR,,F,Y,45.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209741731,20974173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,950.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urethral pain,,2022,Q2,1,I,20220606.0,20220613.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219604,ASTRAZENECA,,26160.0,DY,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209741731,20974173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,950.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dysuria,,2022,Q2,1,I,20220606.0,20220613.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219604,ASTRAZENECA,,26160.0,DY,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urine uric acid increased,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,COVID-19,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Creatinine urine increased,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Glomerular filtration rate decreased,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209750621,20975062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,310.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urea urine increased,,2022,Q2,1,I,20220401.0,20220610.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A219569,ASTRAZENECA,,73.0,YR,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209755451,20975545,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,,,,,,10.0,MG,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220118.0,20220603.0,20220617,20220617,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-340332,RANBAXY,,70.0,YR,,M,Y,120.0,KG,20220617,,MD,FR,FR,2022,Q2,Elderly
209755761,20975576,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fistula,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209755761,20975576,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209755761,20975576,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Orchitis,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209755761,20975576,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fistula,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209755761,20975576,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209755761,20975576,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Orchitis,,2022,Q2,1,I,20220127.0,20220611.0,20220617,20220617,EXP,,AU-AstraZeneca-2022A195671,ASTRAZENECA,,62.0,YR,,M,Y,85.0,KG,20220617,,MD,AU,,2022,Q2,Adult
209756981,20975698,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,,,,,,,,Tablet,QD,2022,Q2,Erythema,,2022,Q2,1,I,20220425.0,20220607.0,20220617,20220617,EXP,,DE-MYLANLABS-2022M1039727,MYLAN,,68.0,YR,,M,Y,,,20220617,,PH,DE,DE,2022,Q2,Elderly
209756981,20975698,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,,,,,,,,Tablet,QD,2022,Q2,Product adhesion issue,,2022,Q2,1,I,20220425.0,20220607.0,20220617,20220617,EXP,,DE-MYLANLABS-2022M1039727,MYLAN,,68.0,YR,,M,Y,,,20220617,,PH,DE,DE,2022,Q2,Elderly
209756981,20975698,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,,,,,,,,Tablet,QD,2022,Q2,Skin reaction,,2022,Q2,1,I,20220425.0,20220607.0,20220617,20220617,EXP,,DE-MYLANLABS-2022M1039727,MYLAN,,68.0,YR,,M,Y,,,20220617,,PH,DE,DE,2022,Q2,Elderly
209757521,20975752,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Myalgia,,2022,Q2,1,I,20220607.0,20220610.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A217746,ASTRAZENECA,,72.0,YR,,M,Y,98.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209757521,20975752,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Malaise,,2022,Q2,1,I,20220607.0,20220610.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A217746,ASTRAZENECA,,72.0,YR,,M,Y,98.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209757521,20975752,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,.,29.0,MG,,,,,,1.0,MG,,QD,2022,Q2,Myalgia,,2022,Q2,1,I,20220607.0,20220610.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A217746,ASTRAZENECA,,72.0,YR,,M,Y,98.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209757521,20975752,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,.,29.0,MG,,,,,,1.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220607.0,20220610.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A217746,ASTRAZENECA,,72.0,YR,,M,Y,98.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209759501,20975950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,MT3055/2104246,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dysuria,,2022,Q2,1,I,20220606.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220345,ASTRAZENECA,,70.0,YR,,F,Y,69.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209759501,20975950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,MT3055/2104246,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Weight decreased,,2022,Q2,1,I,20220606.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220345,ASTRAZENECA,,70.0,YR,,F,Y,69.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209759501,20975950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,290.0,MG,Y,,MT3055/2104246,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vulvovaginal pruritus,,2022,Q2,1,I,20220606.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220345,ASTRAZENECA,,70.0,YR,,F,Y,69.0,KG,20220617,,MD,CN,,2022,Q2,Elderly
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Cough,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Hypovolaemia,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Hypophosphataemia,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Pancreatic steatosis,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Microalbuminuria,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Hypertension,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Off label use,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Hepatic steatosis,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Musculoskeletal chest pain,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209763331,20976333,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Tachypnoea,,2022,Q2,1,I,20220503.0,20220614.0,20220617,20220617,EXP,,DE-AstraZeneca-2022A177312,ASTRAZENECA,,54.0,YR,,M,Y,114.0,KG,20220617,,MD,DE,,2022,Q2,Adult
209767601,20976760,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ischaemic stroke,,2022,Q2,1,I,,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A220716,ASTRAZENECA,"Changyu L, Xiaomin L, et al.. One case report of refractory acidosis and one case of ischaemic stroke caused by dapagliflozin and review of literature. JOURNAL OF HARBIN MEDICAL UNIVERSITY 2022;56(1):99-100.",75.0,YR,,M,Y,,,20220617,,HP,CN,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Arthralgia,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Musculoskeletal discomfort,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Medication error,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Pollakiuria,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Vasculitis,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Joint swelling,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209767641,20976764,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Rash,,2022,Q2,1,I,20220520.0,20220614.0,20220617,20220617,EXP,,GB-AstraZeneca-2022A221035,ASTRAZENECA,,82.0,YR,,M,Y,70.0,KG,20220617,,MD,GB,,2022,Q2,Elderly
209768171,20976817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20220606.0,20220616.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A223930,ASTRAZENECA,,815.0,MON,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209768171,20976817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,20220606.0,20220616.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A223930,ASTRAZENECA,,815.0,MON,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209768171,20976817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,1,I,20220606.0,20220616.0,20220617,20220617,EXP,,BG-AstraZeneca-2022A223930,ASTRAZENECA,,815.0,MON,,M,Y,,,20220617,,MD,BG,,2022,Q2,Elderly
209769131,20976913,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,590.0,MG,Y,,2108250,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ketosis,,2022,Q2,1,I,20220530.0,20220610.0,20220617,20220617,EXP,,CN-AstraZeneca-2022A219931,ASTRAZENECA,,25878.0,DY,,M,Y,57.8,KG,20220617,,MD,CN,,2022,Q2,Elderly
209790531,20979053,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2022,Q2,Intestinal obstruction,,2022,Q2,1,I,,20220613.0,20220619,20220619,EXP,,NVSJ2022JP092259,NOVARTIS,,90.0,YR,,M,Y,57.0,KG,20220620,,MD,JP,JP,2022,Q2,Elderly
209790531,20979053,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q2,Intestinal obstruction,,2022,Q2,1,I,,20220613.0,20220619,20220619,EXP,,NVSJ2022JP092259,NOVARTIS,,90.0,YR,,M,Y,57.0,KG,20220620,,MD,JP,JP,2022,Q2,Elderly
209804461,20980446,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (10mg/jour, au long cours)",,,,,,,,,,Coated tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220422.0,20220617.0,20220620,20220620,EXP,FR-AFSSAPS-TO20222129,NVSC2022FR140085,NOVARTIS,,73.0,YR,,F,Y,50.0,KG,20220620,,PH,FR,FR,2022,Q2,Elderly
209804461,20980446,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (10mg/jour, au long cours)",,,,,,,,,,Coated tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220422.0,20220617.0,20220620,20220620,EXP,FR-AFSSAPS-TO20222129,NVSC2022FR140085,NOVARTIS,,73.0,YR,,F,Y,50.0,KG,20220620,,PH,FR,FR,2022,Q2,Elderly
209814741,20981474,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,20220310.0,20220608.0,20220620,20220620,EXP,,CA-ALVOGEN-2022-ALVOGEN-120548,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220620,,HP,CA,CA,2022,Q2,Adult
209814741,20981474,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220310.0,20220608.0,20220620,20220620,EXP,,CA-ALVOGEN-2022-ALVOGEN-120548,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220620,,HP,CA,CA,2022,Q2,Adult
209814741,20981474,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,,5.0,MG,Tablet,BID,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220310.0,20220608.0,20220620,20220620,EXP,,CA-ALVOGEN-2022-ALVOGEN-120548,ALVOGEN,,64.0,YR,,M,Y,89.6,KG,20220620,,HP,CA,CA,2022,Q2,Adult
209817072,20981707,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,20220310.0,20220613.0,20220620,20220623,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220623,,HP,CA,CA,2022,Q2,Adult
209817072,20981707,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Metabolic acidosis,,2022,Q2,2,F,20220310.0,20220613.0,20220620,20220623,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220623,,HP,CA,CA,2022,Q2,Adult
209817072,20981707,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q2,Pulmonary oedema,,2022,Q2,2,F,20220310.0,20220613.0,20220620,20220623,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20220623,,HP,CA,CA,2022,Q2,Adult
209833271,20983327,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Nodal arrhythmia,,2022,Q2,1,I,,20180829.0,20220620,20220620,EXP,,GB-BAUSCH-BL-2022-015470,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20220620,,PH,GB,GB,2022,Q2,Adult
209833271,20983327,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,,20180829.0,20220620,20220620,EXP,,GB-BAUSCH-BL-2022-015470,BAUSCH AND LOMB,,63.0,YR,,M,Y,,,20220620,,PH,GB,GB,2022,Q2,Adult
209843711,20984371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Death,,2022,Q2,1,I,20220615.0,20220615.0,20220621,20220621,EXP,,ZA-AstraZeneca-2022A223395,ASTRAZENECA,,25799.0,DY,,M,Y,,,20220621,,CN,ZA,,2022,Q2,Elderly
209844921,20984492,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 2 doses,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,IE-HPRA-2022-096268,NVSC2022IE135585,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20220621,,HP,IE,IE,2022,Q2,Adult
209844921,20984492,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 2 doses,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,IE-HPRA-2022-096268,NVSC2022IE135585,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20220621,,HP,IE,IE,2022,Q2,Adult
209844921,20984492,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 2 doses,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,IE-HPRA-2022-096268,NVSC2022IE135585,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20220621,,HP,IE,IE,2022,Q2,Adult
209844921,20984492,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 2 doses,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Anxiety,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,IE-HPRA-2022-096268,NVSC2022IE135585,NOVARTIS,,59.0,YR,,F,Y,80.0,KG,20220621,,HP,IE,IE,2022,Q2,Adult
209868981,20986898,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day, long term",,,,,Unknown,,,,,,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220422.0,20220617.0,20220621,20220621,EXP,FR-AFSSAPS-TO20222129,FR-PFIZER INC-202200847203,PFIZER,,73.0,YR,,F,Y,50.0,KG,20220621,,PH,FR,FR,2022,Q2,Elderly
209868981,20986898,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day, long term",,,,,Unknown,,,,,,QD,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220422.0,20220617.0,20220621,20220621,EXP,FR-AFSSAPS-TO20222129,FR-PFIZER INC-202200847203,PFIZER,,73.0,YR,,F,Y,50.0,KG,20220621,,PH,FR,FR,2022,Q2,Elderly
209881541,20988154,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Anxiety,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,,IE-AstraZeneca-2022A218683,ASTRAZENECA,,59.0,YR,,F,Y,80.0,KG,20220621,,MD,IE,,2022,Q2,Adult
209881541,20988154,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,,IE-AstraZeneca-2022A218683,ASTRAZENECA,,59.0,YR,,F,Y,80.0,KG,20220621,,MD,IE,,2022,Q2,Adult
209881541,20988154,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,,IE-AstraZeneca-2022A218683,ASTRAZENECA,,59.0,YR,,F,Y,80.0,KG,20220621,,MD,IE,,2022,Q2,Adult
209881541,20988154,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220527.0,20220613.0,20220621,20220621,EXP,,IE-AstraZeneca-2022A218683,ASTRAZENECA,,59.0,YR,,F,Y,80.0,KG,20220621,,MD,IE,,2022,Q2,Adult
209882851,20988285,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Death,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,GR-AstraZeneca-2022A225411,ASTRAZENECA,,80.0,YR,,M,Y,,,20220621,,MD,GR,,2022,Q2,Elderly
209882851,20988285,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,GR-AstraZeneca-2022A225411,ASTRAZENECA,,80.0,YR,,M,Y,,,20220621,,MD,GR,,2022,Q2,Elderly
209882851,20988285,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Overdose,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,GR-AstraZeneca-2022A225411,ASTRAZENECA,,80.0,YR,,M,Y,,,20220621,,MD,GR,,2022,Q2,Elderly
209882861,20988286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,CA-AstraZeneca-2022A225415,ASTRAZENECA,,58.0,YR,,M,Y,,,20220621,,CN,CA,,2022,Q2,Adult
209882861,20988286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,CA-AstraZeneca-2022A225415,ASTRAZENECA,,58.0,YR,,M,Y,,,20220621,,CN,CA,,2022,Q2,Adult
209882861,20988286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Small intestine carcinoma,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,CA-AstraZeneca-2022A225415,ASTRAZENECA,,58.0,YR,,M,Y,,,20220621,,CN,CA,,2022,Q2,Adult
209886881,20988688,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,PT-GILEAD-2022-0586458,GILEAD,,54.0,YR,A,F,Y,,,20220621,,MD,PT,PT,2022,Q2,Adult
209886881,20988688,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,PT-GILEAD-2022-0586458,GILEAD,,54.0,YR,A,F,Y,,,20220621,,MD,PT,PT,2022,Q2,Adult
209886881,20988688,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,Blood HIV RNA increased,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,PT-GILEAD-2022-0586458,GILEAD,,54.0,YR,A,F,Y,,,20220621,,MD,PT,PT,2022,Q2,Adult
209886881,20988688,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q2,CD4 lymphocyte percentage decreased,,2022,Q2,1,I,,20220616.0,20220621,20220621,EXP,,PT-GILEAD-2022-0586458,GILEAD,,54.0,YR,A,F,Y,,,20220621,,MD,PT,PT,2022,Q2,Adult
209900301,20990030,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Diabetic foot,,2022,Q2,1,I,,20220613.0,20220621,20220621,EXP,,SE-AstraZeneca-2022A219097,ASTRAZENECA,,71.0,YR,,M,Y,,,20220622,,MD,SE,,2022,Q2,Elderly
209902021,20990202,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Hip arthroplasty,,2022,Q2,1,I,20220401.0,20220618.0,20220621,20220621,EXP,,CA-ABBVIE-22K-028-4441489-00,ABBVIE,,90.0,YR,,M,Y,,,20220621,,HP,COUNTRY NOT SPECIFIED,CA,2022,Q2,Elderly
209902021,20990202,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,1,I,20220401.0,20220618.0,20220621,20220621,EXP,,CA-ABBVIE-22K-028-4441489-00,ABBVIE,,90.0,YR,,M,Y,,,20220621,,HP,COUNTRY NOT SPECIFIED,CA,2022,Q2,Elderly
209902021,20990202,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Hip arthroplasty,,2022,Q2,1,I,20220401.0,20220618.0,20220621,20220621,EXP,,CA-ABBVIE-22K-028-4441489-00,ABBVIE,,90.0,YR,,M,Y,,,20220621,,HP,COUNTRY NOT SPECIFIED,CA,2022,Q2,Elderly
209902021,20990202,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,1,I,20220401.0,20220618.0,20220621,20220621,EXP,,CA-ABBVIE-22K-028-4441489-00,ABBVIE,,90.0,YR,,M,Y,,,20220621,,HP,COUNTRY NOT SPECIFIED,CA,2022,Q2,Elderly
209904881,20990488,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q2,Upper limb fracture,,2022,Q2,1,I,20210610.0,20220601.0,20220622,20220622,PER,,"AU-TOLMAR, INC.-21AU029933",TOLMAR,,85.0,YR,,M,Y,81.0,KG,20220621,,HP,AU,AU,2022,Q2,Elderly
209911931,20991193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac arrest,,2022,Q2,1,I,20220525.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A225513,ASTRAZENECA,,77.0,YR,,M,Y,,,20220622,,MD,FR,,2022,Q2,Elderly
209911931,20991193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220525.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A225513,ASTRAZENECA,,77.0,YR,,M,Y,,,20220622,,MD,FR,,2022,Q2,Elderly
209911931,20991193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220525.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A225513,ASTRAZENECA,,77.0,YR,,M,Y,,,20220622,,MD,FR,,2022,Q2,Elderly
209911931,20991193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Emphysematous cystitis,,2022,Q2,1,I,20220525.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A225513,ASTRAZENECA,,77.0,YR,,M,Y,,,20220622,,MD,FR,,2022,Q2,Elderly
209913671,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Taste disorder,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Lung disorder,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Underdose,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Taste disorder,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Lung disorder,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Underdose,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209913671,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q2,Weight decreased,,2022,Q2,1,I,20220307.0,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20220622,,PH,JP,,2022,Q2,Elderly
209915981,20991598,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220210.0,20220617.0,20220622,20220622,EXP,,FR-AUROBINDO-AUR-APL-2022-023245,AUROBINDO,,62.0,YR,,M,Y,105.0,KG,20220622,,MD,FR,FR,2022,Q2,Adult
209915981,20991598,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20220210.0,20220617.0,20220622,20220622,EXP,,FR-AUROBINDO-AUR-APL-2022-023245,AUROBINDO,,62.0,YR,,M,Y,105.0,KG,20220622,,MD,FR,FR,2022,Q2,Adult
209915981,20991598,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220210.0,20220617.0,20220622,20220622,EXP,,FR-AUROBINDO-AUR-APL-2022-023245,AUROBINDO,,62.0,YR,,M,Y,105.0,KG,20220622,,MD,FR,FR,2022,Q2,Adult
209936811,20993681,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Hypotension,,2022,Q2,1,I,20211101.0,20220615.0,20220622,20220622,EXP,,NVSC2022EG139490,NOVARTIS,,71.0,YR,,M,Y,,,20220622,,CN,EG,EG,2022,Q2,Elderly
209936811,20993681,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Ejection fraction abnormal,,2022,Q2,1,I,20211101.0,20220615.0,20220622,20220622,EXP,,NVSC2022EG139490,NOVARTIS,,71.0,YR,,M,Y,,,20220622,,CN,EG,EG,2022,Q2,Elderly
209936811,20993681,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,,QD,2022,Q2,Myocardial infarction,,2022,Q2,1,I,20211101.0,20220615.0,20220622,20220622,EXP,,NVSC2022EG139490,NOVARTIS,,71.0,YR,,M,Y,,,20220622,,CN,EG,EG,2022,Q2,Elderly
209937171,20993717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg/day, long term",,,,,,,202293.0,,,Tablet,QD,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220422.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A224866,ASTRAZENECA,,73.0,YR,,F,Y,50.0,KG,20220622,,MD,FR,,2022,Q2,Elderly
209937171,20993717,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg/day, long term",,,,,,,202293.0,,,Tablet,QD,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220422.0,20220617.0,20220622,20220622,EXP,,FR-AstraZeneca-2022A224866,ASTRAZENECA,,73.0,YR,,F,Y,50.0,KG,20220622,,MD,FR,,2022,Q2,Elderly
209938561,20993856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urethral stenosis,,2022,Q2,1,I,,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A160102,ASTRAZENECA,,64.0,YR,,M,Y,,,20220622,,MD,JP,,2022,Q2,Adult
209938561,20993856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Haemorrhoids,,2022,Q2,1,I,,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A160102,ASTRAZENECA,,64.0,YR,,M,Y,,,20220622,,MD,JP,,2022,Q2,Adult
209938561,20993856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Urinary incontinence,,2022,Q2,1,I,,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A160102,ASTRAZENECA,,64.0,YR,,M,Y,,,20220622,,MD,JP,,2022,Q2,Adult
209938561,20993856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Colon cancer,,2022,Q2,1,I,,20220614.0,20220622,20220622,EXP,,JP-AstraZeneca-2022A160102,ASTRAZENECA,,64.0,YR,,M,Y,,,20220622,,MD,JP,,2022,Q2,Adult
209940921,20994092,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, (2 doses)",,,Y,U,,,,10.0,MG,Film-coated tablet,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220527.0,20220613.0,20220622,20220622,EXP,IE-HPRA-2022-096268,IE-MYLANLABS-2022M1045744,MYLAN,,59.0,YR,,F,Y,80.0,KG,20220622,,HP,IE,IE,2022,Q2,Adult
209940921,20994092,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, (2 doses)",,,Y,U,,,,10.0,MG,Film-coated tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220527.0,20220613.0,20220622,20220622,EXP,IE-HPRA-2022-096268,IE-MYLANLABS-2022M1045744,MYLAN,,59.0,YR,,F,Y,80.0,KG,20220622,,HP,IE,IE,2022,Q2,Adult
209940921,20994092,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, (2 doses)",,,Y,U,,,,10.0,MG,Film-coated tablet,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220527.0,20220613.0,20220622,20220622,EXP,IE-HPRA-2022-096268,IE-MYLANLABS-2022M1045744,MYLAN,,59.0,YR,,F,Y,80.0,KG,20220622,,HP,IE,IE,2022,Q2,Adult
209940921,20994092,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, (2 doses)",,,Y,U,,,,10.0,MG,Film-coated tablet,,2022,Q2,Anxiety,,2022,Q2,1,I,20220527.0,20220613.0,20220622,20220622,EXP,IE-HPRA-2022-096268,IE-MYLANLABS-2022M1045744,MYLAN,,59.0,YR,,F,Y,80.0,KG,20220622,,HP,IE,IE,2022,Q2,Adult
209967472,20996747,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q2,Hydronephrosis,,2022,Q2,2,F,20220606.0,20220618.0,20220623,20220628,EXP,,CN-ROCHE-3120994,ROCHE,,57.0,YR,,F,Y,87.5,KG,20220628,,MD,CN,CN,2022,Q2,Adult
210016781,21001678,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220210.0,20220619.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,FR-BAUSCH-BL-2022-015610,BAUSCH AND LOMB,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q2,Adult
210016781,21001678,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220210.0,20220619.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,FR-BAUSCH-BL-2022-015610,BAUSCH AND LOMB,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q2,Adult
210016781,21001678,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20220210.0,20220619.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,FR-BAUSCH-BL-2022-015610,BAUSCH AND LOMB,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q2,Adult
210021991,21002199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220527.0,20220616.0,20220624,20220624,EXP,IE-HPRA-2022-096268,IE-TEVA-2022-IE-2048713,TEVA,,59.0,YR,A,F,Y,80.0,KG,20220624,,HP,IE,IE,2022,Q2,Adult
210021991,21002199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q2,Chest discomfort,,2022,Q2,1,I,20220527.0,20220616.0,20220624,20220624,EXP,IE-HPRA-2022-096268,IE-TEVA-2022-IE-2048713,TEVA,,59.0,YR,A,F,Y,80.0,KG,20220624,,HP,IE,IE,2022,Q2,Adult
210021991,21002199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220527.0,20220616.0,20220624,20220624,EXP,IE-HPRA-2022-096268,IE-TEVA-2022-IE-2048713,TEVA,,59.0,YR,A,F,Y,80.0,KG,20220624,,HP,IE,IE,2022,Q2,Adult
210021991,21002199,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,2 doses,,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q2,Anxiety,,2022,Q2,1,I,20220527.0,20220616.0,20220624,20220624,EXP,IE-HPRA-2022-096268,IE-TEVA-2022-IE-2048713,TEVA,,59.0,YR,A,F,Y,80.0,KG,20220624,,HP,IE,IE,2022,Q2,Adult
210054481,21005448,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Thrombosis,,2022,Q2,1,I,,20220616.0,20220624,20220624,EXP,,BG-AstraZeneca-2022A223929,ASTRAZENECA,,80.0,YR,,M,Y,,,20220624,,MD,BG,,2022,Q2,Elderly
210055171,21005517,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q2,Cough,,2022,Q2,1,I,,20220617.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228398,ASTRAZENECA,,49.0,YR,,M,Y,96.0,KG,20220624,,MD,DE,,2022,Q2,Adult
210055171,21005517,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220617.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228398,ASTRAZENECA,,49.0,YR,,M,Y,96.0,KG,20220624,,MD,DE,,2022,Q2,Adult
210055171,21005517,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q2,Fatigue,,2022,Q2,1,I,,20220617.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228398,ASTRAZENECA,,49.0,YR,,M,Y,96.0,KG,20220624,,MD,DE,,2022,Q2,Adult
210055171,21005517,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220617.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228398,ASTRAZENECA,,49.0,YR,,M,Y,96.0,KG,20220624,,MD,DE,,2022,Q2,Adult
210055171,21005517,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q2,Coronary artery disease,,2022,Q2,1,I,,20220617.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228398,ASTRAZENECA,,49.0,YR,,M,Y,96.0,KG,20220624,,MD,DE,,2022,Q2,Adult
210055191,21005519,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,20220427.0,20220617.0,20220624,20220624,EXP,,RO-AstraZeneca-2022A228376,ASTRAZENECA,,70.0,YR,,F,Y,78.0,KG,20220624,,MD,RO,,2022,Q2,Elderly
210055191,21005519,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Fatigue,,2022,Q2,1,I,20220427.0,20220617.0,20220624,20220624,EXP,,RO-AstraZeneca-2022A228376,ASTRAZENECA,,70.0,YR,,F,Y,78.0,KG,20220624,,MD,RO,,2022,Q2,Elderly
210064171,21006417,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,,20220620.0,20220624,20220624,EXP,,DE-AstraZeneca-2022A228450,ASTRAZENECA,,81.0,YR,,M,Y,,,20220624,,MD,DE,,2022,Q2,Elderly
210082001,21008200,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg + 1000 mg 2x/day,,,,,Unknown,,,,,,,2022,Q2,Plasma cell myeloma,,2022,Q2,1,I,,20220615.0,20220627,20220627,EXP,,BR-NOVOPROD-929163,NOVO NORDISK,,59.0,YR,,M,Y,103.0,KG,20220627,,MD,BR,BR,2022,Q2,Adult
210084531,21008453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q2,Haematoma,,2022,Q2,1,I,20220620.0,20220621.0,20220627,20220627,EXP,,DE-AstraZeneca-2022A229679,ASTRAZENECA,,40.0,YR,,F,Y,,,20220627,,MD,DE,,2022,Q2,Adult
210122091,21012209,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220210.0,20220622.0,20220627,20220627,EXP,FR-AFSSAPS-RE20220880,FR-MYLANLABS-2022M1047712,MYLAN,,62.0,YR,,M,Y,105.0,KG,20220627,,MD,FR,FR,2022,Q2,Adult
210122091,21012209,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20220210.0,20220622.0,20220627,20220627,EXP,FR-AFSSAPS-RE20220880,FR-MYLANLABS-2022M1047712,MYLAN,,62.0,YR,,M,Y,105.0,KG,20220627,,MD,FR,FR,2022,Q2,Adult
210122091,21012209,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220210.0,20220622.0,20220627,20220627,EXP,FR-AFSSAPS-RE20220880,FR-MYLANLABS-2022M1047712,MYLAN,,62.0,YR,,M,Y,105.0,KG,20220627,,MD,FR,FR,2022,Q2,Adult
210153031,21015303,2,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q2,Renal pain,,2022,Q2,1,I,,20220617.0,20220628,20220628,EXP,CA-HEALTHCANVIG-E2B_04937199,CA-NOVOPROD-929991,NOVO NORDISK,,69.0,YR,,M,Y,,,20220628,,CN,CA,CA,2022,Q2,Elderly
210158501,21015850,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Strength: 10 mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220316.0,20220618.0,20220628,20220628,EXP,FR-AFSSAPS-MP20221491,FR-Accord-264352,ACCORD,,46.0,YR,A,F,Y,142.6,KG,20220628,,MD,FR,FR,2022,Q2,Adult
210158501,21015850,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Strength: 10 mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q2,Acute generalised exanthematous pustulosis,,2022,Q2,1,I,20220316.0,20220618.0,20220628,20220628,EXP,FR-AFSSAPS-MP20221491,FR-Accord-264352,ACCORD,,46.0,YR,A,F,Y,142.6,KG,20220628,,MD,FR,FR,2022,Q2,Adult
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Death,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Lung cancer metastatic,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Gait disturbance,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210159321,21015932,7,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,1,I,,20220623.0,20220628,20220628,EXP,,CA-ROCHE-3124395,ROCHE,,89.0,YR,,M,Y,,,20220628,,HP,CA,,2022,Q2,Elderly
210163821,21016382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Ejection fraction decreased,,2022,Q2,1,I,,20220620.0,20220628,20220628,EXP,,BG-AstraZeneca-2022A228484,ASTRAZENECA,,71.0,YR,,M,Y,,,20220628,,HP,BG,,2022,Q2,Elderly
210163821,21016382,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once a day,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,,20220620.0,20220628,20220628,EXP,,BG-AstraZeneca-2022A228484,ASTRAZENECA,,71.0,YR,,M,Y,,,20220628,,HP,BG,,2022,Q2,Elderly
210204551,21020455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form per day,,,D,,,,,,,,,2022,Q2,Pruritus,,2022,Q2,1,I,20220617.0,20220624.0,20220629,20220629,EXP,GB-MHRA-TPP20630017C8707796YC1655459871112,GB-STRIDES ARCOLAB LIMITED-2022SP007830,STRIDES,,75.0,YR,,F,Y,115.0,KG,20220629,,HP,GB,GB,2022,Q2,Elderly
210204551,21020455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form per day,,,D,,,,,,,,,2022,Q2,Swollen tongue,,2022,Q2,1,I,20220617.0,20220624.0,20220629,20220629,EXP,GB-MHRA-TPP20630017C8707796YC1655459871112,GB-STRIDES ARCOLAB LIMITED-2022SP007830,STRIDES,,75.0,YR,,F,Y,115.0,KG,20220629,,HP,GB,GB,2022,Q2,Elderly
210204551,21020455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form per day,,,D,,,,,,,,,2022,Q2,Sensory disturbance,,2022,Q2,1,I,20220617.0,20220624.0,20220629,20220629,EXP,GB-MHRA-TPP20630017C8707796YC1655459871112,GB-STRIDES ARCOLAB LIMITED-2022SP007830,STRIDES,,75.0,YR,,F,Y,115.0,KG,20220629,,HP,GB,GB,2022,Q2,Elderly
210204551,21020455,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form per day,,,D,,,,,,,,,2022,Q2,Eye disorder,,2022,Q2,1,I,20220617.0,20220624.0,20220629,20220629,EXP,GB-MHRA-TPP20630017C8707796YC1655459871112,GB-STRIDES ARCOLAB LIMITED-2022SP007830,STRIDES,,75.0,YR,,F,Y,115.0,KG,20220629,,HP,GB,GB,2022,Q2,Elderly
210206361,21020636,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 COMPRIMIDO cada 12 horas (5 mg/850 mg),,,Y,,,,,,,Pill,,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220318.0,20220623.0,20220629,20220629,EXP,ES-AEMPS-1172469,ES-BAUSCH-BL-2022-016082,BAUSCH AND LOMB,,79.0,YR,,M,Y,,,20220629,,PH,ES,ES,2022,Q2,Elderly
210206361,21020636,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 COMPRIMIDO cada 12 horas (5 mg/850 mg),,,Y,,,,,,,Pill,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220318.0,20220623.0,20220629,20220629,EXP,ES-AEMPS-1172469,ES-BAUSCH-BL-2022-016082,BAUSCH AND LOMB,,79.0,YR,,M,Y,,,20220629,,PH,ES,ES,2022,Q2,Elderly
210206361,21020636,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 COMPRIMIDO cada 12 horas (5 mg/850 mg),,,Y,,,,,,,Pill,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220318.0,20220623.0,20220629,20220629,EXP,ES-AEMPS-1172469,ES-BAUSCH-BL-2022-016082,BAUSCH AND LOMB,,79.0,YR,,M,Y,,,20220629,,PH,ES,ES,2022,Q2,Elderly
210228251,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Intracranial pressure increased,,2022,Q2,1,I,,20220627.0,20220629,20220629,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220629,,HP,CA,CA,2022,Q2,Elderly
210228251,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,,20220627.0,20220629,20220629,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220629,,HP,CA,CA,2022,Q2,Elderly
210228251,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Cerebral haemorrhage,,2022,Q2,1,I,,20220627.0,20220629,20220629,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220629,,HP,CA,CA,2022,Q2,Elderly
210228451,21022845,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Malaise,,2022,Q2,1,I,20220210.0,20220621.0,20220629,20220629,EXP,,FR-AstraZeneca-2022A227258,ASTRAZENECA,,62.0,YR,,M,Y,105.0,KG,20220629,,MD,FR,,2022,Q2,Adult
210228451,21022845,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220210.0,20220621.0,20220629,20220629,EXP,,FR-AstraZeneca-2022A227258,ASTRAZENECA,,62.0,YR,,M,Y,105.0,KG,20220629,,MD,FR,,2022,Q2,Adult
210228451,21022845,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20220210.0,20220621.0,20220629,20220629,EXP,,FR-AstraZeneca-2022A227258,ASTRAZENECA,,62.0,YR,,M,Y,105.0,KG,20220629,,MD,FR,,2022,Q2,Adult
210234301,21023430,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20200101.0,20220622.0,20220629,20220629,EXP,,JP-AstraZeneca-2022A233462,ASTRAZENECA,,60.0,YR,,,Y,,,20220629,,MD,JP,,2022,Q2,Adult
210234301,21023430,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Sepsis,,2022,Q2,1,I,20200101.0,20220622.0,20220629,20220629,EXP,,JP-AstraZeneca-2022A233462,ASTRAZENECA,,60.0,YR,,,Y,,,20220629,,MD,JP,,2022,Q2,Adult
210234301,21023430,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q2,Renal abscess,,2022,Q2,1,I,20200101.0,20220622.0,20220629,20220629,EXP,,JP-AstraZeneca-2022A233462,ASTRAZENECA,,60.0,YR,,,Y,,,20220629,,MD,JP,,2022,Q2,Adult
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Infective exacerbation of chronic obstructive airways disease,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pleural effusion,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Cardiac failure,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Faecaloma,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Femur fracture,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Type 1 diabetes mellitus,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Left ventricular dysfunction,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Diverticulitis,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Pneumonia,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypercholesterolaemia,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Infective exacerbation of chronic obstructive airways disease,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Pleural effusion,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Cardiac failure,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Faecaloma,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Femur fracture,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Type 1 diabetes mellitus,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Left ventricular dysfunction,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Acute myocardial infarction,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypothyroidism,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Diverticulitis,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Pneumonia,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Chronic kidney disease,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235121,21023512,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypercholesterolaemia,,2022,Q2,1,I,20190201.0,20220621.0,20220629,20220629,EXP,,DE-AstraZeneca-2022A234836,ASTRAZENECA,,93.0,YR,,M,Y,80.0,KG,20220629,,MD,DE,,2022,Q2,Elderly
210235141,21023514,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,,,2022,Q2,Necrosis,,2022,Q2,1,I,20220615.0,20220621.0,20220629,20220629,EXP,,GB-AstraZeneca-2022A228574,ASTRAZENECA,,83.0,YR,,M,Y,,,20220629,,MD,GB,,2022,Q2,Elderly
210237191,21023719,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,forxiga 10 mg half tablet per day po,920.0,MG,,,NH0300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Gastritis,,2022,Q2,1,I,20220501.0,20220617.0,20220629,20220629,EXP,,GT-TOPROL-2022000199,TOPROL ACQUISITION,,86.0,YR,E,F,Y,,,20220629,,CN,GT,GT,2022,Q2,Elderly
210237191,21023719,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,forxiga 10 mg half tablet per day po,920.0,MG,,,NH0300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220501.0,20220617.0,20220629,20220629,EXP,,GT-TOPROL-2022000199,TOPROL ACQUISITION,,86.0,YR,E,F,Y,,,20220629,,CN,GT,GT,2022,Q2,Elderly
210237191,21023719,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,forxiga 10 mg half tablet per day po,920.0,MG,,,NH0300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Cerebrovascular accident,,2022,Q2,1,I,20220501.0,20220617.0,20220629,20220629,EXP,,GT-TOPROL-2022000199,TOPROL ACQUISITION,,86.0,YR,E,F,Y,,,20220629,,CN,GT,GT,2022,Q2,Elderly
210237191,21023719,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,forxiga 10 mg half tablet per day po,920.0,MG,,,NH0300,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Skin discolouration,,2022,Q2,1,I,20220501.0,20220617.0,20220629,20220629,EXP,,GT-TOPROL-2022000199,TOPROL ACQUISITION,,86.0,YR,E,F,Y,,,20220629,,CN,GT,GT,2022,Q2,Elderly
210248501,21024850,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q2,Spinal fracture,,2022,Q2,1,I,20220426.0,20220623.0,20220629,20220629,EXP,,CH-ROCHE-3088292,ROCHE,,69.0,YR,,M,Y,102.0,KG,20220630,,MD,CH,,2022,Q2,Elderly
210248501,21024850,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q2,Lower limb fracture,,2022,Q2,1,I,20220426.0,20220623.0,20220629,20220629,EXP,,CH-ROCHE-3088292,ROCHE,,69.0,YR,,M,Y,102.0,KG,20220630,,MD,CH,,2022,Q2,Elderly
210249101,21024910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Myalgia,,2022,Q2,1,I,,20220621.0,20220629,20220629,EXP,,FR-AstraZeneca-2022A234946,ASTRAZENECA,,59.0,YR,,M,Y,,,20220630,,MD,FR,,2022,Q2,Adult
210249101,21024910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,,20220621.0,20220629,20220629,EXP,,FR-AstraZeneca-2022A234946,ASTRAZENECA,,59.0,YR,,M,Y,,,20220630,,MD,FR,,2022,Q2,Adult
210250941,21025094,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q2,Thyroid mass,,2022,Q2,1,I,20220613.0,20220624.0,20220630,20220630,EXP,,CO-ABBVIE-22K-036-4451505-00,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20220629,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
210250941,21025094,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220613.0,20220624.0,20220630,20220630,EXP,,CO-ABBVIE-22K-036-4451505-00,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20220629,,HP,COUNTRY NOT SPECIFIED,CO,2022,Q2,Elderly
210267171,21026717,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK 1 COMPRIMIDO cada d?a,,,Y,U,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-MYLANLABS-2022M1048438,MYLAN,,79.0,YR,,M,Y,,,20220630,,PH,ES,ES,2022,Q2,Elderly
210267171,21026717,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK 1 COMPRIMIDO cada d?a,,,Y,U,,,,,,Tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-MYLANLABS-2022M1048438,MYLAN,,79.0,YR,,M,Y,,,20220630,,PH,ES,ES,2022,Q2,Elderly
210267171,21026717,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK 1 COMPRIMIDO cada d?a,,,Y,U,,,,,,Tablet,,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-MYLANLABS-2022M1048438,MYLAN,,79.0,YR,,M,Y,,,20220630,,PH,ES,ES,2022,Q2,Elderly
210273031,21027303,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220627.0,20220630,20220630,EXP,,JP-PFIZER INC-202200772324,PFIZER,,86.0,YR,,M,Y,47.0,KG,20220630,,MD,JP,JP,2022,Q2,Elderly
210274271,21027427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Tachypnoea,,2022,Q2,1,I,,20220624.0,20220630,20220630,EXP,,NO-AstraZeneca-2022A231557,ASTRAZENECA,,54.0,YR,,M,Y,,,20220630,,MD,NO,,2022,Q2,Adult
210274271,21027427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Somnolence,,2022,Q2,1,I,,20220624.0,20220630,20220630,EXP,,NO-AstraZeneca-2022A231557,ASTRAZENECA,,54.0,YR,,M,Y,,,20220630,,MD,NO,,2022,Q2,Adult
210274271,21027427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Tachycardia,,2022,Q2,1,I,,20220624.0,20220630,20220630,EXP,,NO-AstraZeneca-2022A231557,ASTRAZENECA,,54.0,YR,,M,Y,,,20220630,,MD,NO,,2022,Q2,Adult
210274271,21027427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q2,Ketoacidosis,,2022,Q2,1,I,,20220624.0,20220630,20220630,EXP,,NO-AstraZeneca-2022A231557,ASTRAZENECA,,54.0,YR,,M,Y,,,20220630,,MD,NO,,2022,Q2,Adult
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Iron deficiency,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Gastric ulcer haemorrhage,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Upper gastrointestinal haemorrhage,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Duodenal ulcer haemorrhage,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Left ventricular dysfunction,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,Peripheral sensory neuropathy,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210277471,21027747,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,unknown,,202293.0,10.0,MG,Tablet,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,20220101.0,20220622.0,20220630,20220630,EXP,,DE-AstraZeneca-2022A231117,ASTRAZENECA,,75.0,YR,,M,Y,,,20220630,,MD,DE,,2022,Q2,Elderly
210286431,21028643,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"Dapagliflozin/Metformin 5 mg/850 mg, 1 tablet every 12 hours, 56 tablets",,,Y,,,,,,,Tablet,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-EMD Serono-E2B_90088307,EMD SERONO INC,,79.0,YR,E,M,Y,,,20220630,,PH,ES,,2022,Q2,Elderly
210286431,21028643,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"Dapagliflozin/Metformin 5 mg/850 mg, 1 tablet every 12 hours, 56 tablets",,,Y,,,,,,,Tablet,,2022,Q2,Metabolic acidosis,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-EMD Serono-E2B_90088307,EMD SERONO INC,,79.0,YR,E,M,Y,,,20220630,,PH,ES,,2022,Q2,Elderly
210286431,21028643,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"Dapagliflozin/Metformin 5 mg/850 mg, 1 tablet every 12 hours, 56 tablets",,,Y,,,,,,,Tablet,,2022,Q2,Hyperkalaemia,,2022,Q2,1,I,20220318.0,20220624.0,20220630,20220630,EXP,ES-AEMPS-1172469,ES-EMD Serono-E2B_90088307,EMD SERONO INC,,79.0,YR,E,M,Y,,,20220630,,PH,ES,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Hypoproteinaemia,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Blood potassium decreased,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Malnutrition,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,10.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Hypoproteinaemia,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Blood potassium decreased,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Malnutrition,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Asthenia,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Vomiting,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
210287261,21028726,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2365.0,MG,Y,,MP2243,,202293.0,5.0,MG,Tablet,QD,2022,Q2,Decreased appetite,,2022,Q2,1,I,20220605.0,20220622.0,20220630,20220630,EXP,,CN-AstraZeneca-2022A234011,ASTRAZENECA,,32002.0,DY,,M,Y,45.0,KG,20220630,,MD,CN,,2022,Q2,Elderly
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Melaena,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Eye pruritus,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Colon cancer,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malaise,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Anaphylactic reaction,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Throat tightness,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Lip swelling,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abnormal loss of weight,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1326201116,13262011,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,16,F,20170120.0,20220719.0,20170222,20220720,EXP,GB-MHRA-WEB-RADR1001405,PHHY2017GB022720,NOVARTIS,,52.0,YR,,M,Y,94.0,KG,20220720,,PH,GB,GB,2022,Q3,Adult
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Anaphylactic shock,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Malignant neoplasm progression,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Asthenia,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Decreased appetite,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Transfusion-related circulatory overload,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Arthropod sting,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Fatigue,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Blood pressure increased,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Abdominal pain,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Blood glucose abnormal,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Blood pressure systolic increased,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Eye haemorrhage,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Pruritus,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q3,Carcinoid tumour,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Anaphylactic shock,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Malignant neoplasm progression,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Decreased appetite,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Transfusion-related circulatory overload,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Arthropod sting,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Blood glucose abnormal,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Blood pressure systolic increased,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Eye haemorrhage,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Pruritus,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1440127220,14401272,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,Carcinoid tumour,,2022,Q3,20,F,20171114.0,20220923.0,20180117,20220929,EXP,,PHHY2017CA170126,NOVARTIS,,71.0,YR,,M,Y,,,20220929,,CN,CA,CA,2022,Q3,Elderly
1560450612,15604506,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Chest pain,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,21,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Headache,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1561839712,15618397,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown",,,U,U,,,,,,Tablet,,2022,Q3,Headache,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown",,,U,U,,,,,,Tablet,,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, unknown",,,U,U,,,,,,Tablet,,2022,Q3,Chest pain,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
156383793,15638379,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Ischaemic stroke,,2022,Q3,3,F,20180101.0,20220728.0,20181120,20220803,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20220803,,PH,PT,PT,2022,Q3,Adult
156383793,15638379,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,3,F,20180101.0,20220728.0,20181120,20220803,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20220803,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Chest pain,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Headache,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,16,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Ischaemic stroke,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
157199663,15719966,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Off label use,,2022,Q3,3,F,20190717.0,20220715.0,20181213,20220721,EXP,,CA-TAKEDA-2018TUS034655,TAKEDA,,55.0,YR,,M,Y,,,20220721,,CN,CA,CA,2022,Q3,Adult
157199663,15719966,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Acute kidney injury,,2022,Q3,3,F,20190717.0,20220715.0,20181213,20220721,EXP,,CA-TAKEDA-2018TUS034655,TAKEDA,,55.0,YR,,M,Y,,,20220721,,CN,CA,CA,2022,Q3,Adult
157199663,15719966,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Albuminuria,,2022,Q3,3,F,20190717.0,20220715.0,20181213,20220721,EXP,,CA-TAKEDA-2018TUS034655,TAKEDA,,55.0,YR,,M,Y,,,20220721,,CN,CA,CA,2022,Q3,Adult
157199663,15719966,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Blood albumin decreased,,2022,Q3,3,F,20190717.0,20220715.0,20181213,20220721,EXP,,CA-TAKEDA-2018TUS034655,TAKEDA,,55.0,YR,,M,Y,,,20220721,,CN,CA,CA,2022,Q3,Adult
159355645,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Haematuria,,2022,Q3,5,F,20180201.0,20220623.0,20190208,20220701,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220701,,MD,GB,GB,2022,Q3,Elderly
159355645,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Weight decreased,,2022,Q3,5,F,20180201.0,20220623.0,20190208,20220701,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220701,,MD,GB,GB,2022,Q3,Elderly
159355645,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Polyuria,,2022,Q3,5,F,20180201.0,20220623.0,20190208,20220701,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220701,,MD,GB,GB,2022,Q3,Elderly
159355645,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Also received from 01-Jan-2015,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Prostatic haemorrhage,,2022,Q3,5,F,20180201.0,20220623.0,20190208,20220701,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20220701,,MD,GB,GB,2022,Q3,Elderly
161791855,16179185,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,"Capsule, soft",,2022,Q3,Pulmonary alveolar haemorrhage,,2022,Q3,5,F,20180828.0,20220819.0,20190410,20220822,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2019-NB-001630",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,,,20220822,,MD,JP,JP,2022,Q3,Elderly
161791855,16179185,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,"Capsule, soft",,2022,Q3,Idiopathic pulmonary fibrosis,,2022,Q3,5,F,20180828.0,20220819.0,20190410,20220822,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2019-NB-001630",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,,,20220822,,MD,JP,JP,2022,Q3,Elderly
161791855,16179185,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,"Capsule, soft",,2022,Q3,Idiopathic pulmonary fibrosis,,2022,Q3,5,F,20180828.0,20220819.0,20190410,20220822,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2019-NB-001630",BOEHRINGER INGELHEIM,,69.0,YR,E,M,Y,,,20220822,,MD,JP,JP,2022,Q3,Elderly
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,COVID-19 pneumonia,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Blood potassium decreased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Heart rate increased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Ammonia increased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Injection site pain,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Blood pressure systolic increased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Polyuria,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Impaired healing,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Cellulitis,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Diabetic complication,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Altered state of consciousness,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Infection,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Nervousness,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Malaise,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Weight decreased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Respiratory rate increased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
1631112219,16311122,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,19,F,20190101.0,20220922.0,20190514,20220928,EXP,,PHHY2019CA077093,NOVARTIS,,47.0,YR,,F,Y,96.7,KG,20220928,,CN,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Joint stiffness,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Labyrinthitis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Hypertonic bladder,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Visual impairment,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Hypotension,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Trigeminal neuralgia,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Arthritis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Fatigue,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Blood pressure systolic decreased,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Erythema,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Pain,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Vomiting,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Muscle spasms,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Prostate examination abnormal,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Blood glucose abnormal,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Rheumatoid arthritis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Pain in extremity,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Nephrolithiasis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Hyperhidrosis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Blood pressure increased,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Vision blurred,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Dizziness,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Hypoglycaemia,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Myalgia,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Dysuria,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Abdominal discomfort,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Groin pain,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Cataract,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Nausea,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Headache,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Ear discomfort,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
166255132,16625513,9,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5 mg, qd",,,D,,,,,5.0,MG,,,2022,Q3,Cholelithiasis,,2022,Q3,2,F,,20220913.0,20190724,20220920,EXP,,CA-APOTEX-2019AP018593,APOTEX,,55.0,YR,,M,Y,,,20220920,,HP,CA,CA,2022,Q3,Adult
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"generic, 25 mg",,,U,,,,202293.0,,,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Scrotal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Genital abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Groin abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Abscess limb,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Perineal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Fournier's gangrene,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Necrotising fasciitis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Sepsis,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
167820283,16782028,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Anal abscess,,2022,Q3,3,F,20171028.0,20220728.0,20190906,20220804,EXP,,US-AstraZeneca-2019SF26067,ASTRAZENECA,,14567.0,DY,,M,Y,172.4,KG,20220804,,LW,US,,2022,Q3,Elderly
168727008,16872700,62,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,8,F,20190704.0,20220801.0,20191001,20220808,EXP,,AT-ROCHE-2415586,ROCHE,,67.0,YR,,F,Y,89.0,KG,20220808,,MD,AT,,2022,Q3,Elderly
175469635,17546963,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,more than one year OD,,,,,unknown,,,,,,,2022,Q3,Myocardial infarction,,2022,Q3,5,F,20200126.0,20220802.0,20200316,20220810,EXP,,PK-NOVOPROD-718224,NOVO NORDISK,,60.0,YR,,F,Y,80.0,KG,20220810,,CN,PK,PK,2022,Q3,Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Tremor,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Abdominal pain upper,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Body temperature decreased,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Disturbance in attention,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Diabetes mellitus,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Pain in extremity,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Hypoglycaemia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Musculoskeletal pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Blood pressure diastolic increased,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Eating disorder,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Osteoarthritis,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Biliary colic,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Decreased appetite,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Injection site pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Muscle hernia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Fibromyalgia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Tachycardia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Myalgia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Fatigue,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Skin plaque,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Hunger,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Back disorder,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Hyperhidrosis,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Dyspepsia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Menstrual disorder,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Anxiety,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Tinea infection,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Headache,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Oropharyngeal pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Anal incontinence,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Bone pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Injection site haemorrhage,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Back pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Needle issue,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Hepatic pain,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Concomitant disease aggravated,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Heart rate increased,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Blood pressure increased,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
1772449813,17724498,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Limb mass,,2022,Q3,13,F,20120104.0,20220915.0,20200429,20220922,EXP,,PHHY2012CA009977,NOVARTIS,,33.0,YR,,F,Y,,,20220922,,MD,CA,CA,2022,Q3,Young Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Trigeminal neuralgia,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Groin pain,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Vision blurred,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Myalgia,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Dysuria,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Trigeminal neuralgia,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Visual impairment,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Headache,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Prostate examination abnormal,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Cataract,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Labyrinthitis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Pain in extremity,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Pain,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Joint stiffness,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Hypertonic bladder,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Ear discomfort,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Erythema,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Vomiting,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Blood pressure increased,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Blood glucose abnormal,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Abdominal discomfort,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Muscle spasms,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Nephrolithiasis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Hypotension,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Arthritis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Cholelithiasis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Rheumatoid arthritis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Hypoglycaemia,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Hyperhidrosis,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Fatigue,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
178168052,17816805,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"5.0 mg, 1x/day",,,,,,,,5.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220706.0,20200522,20220711,EXP,,CA-PFIZER INC-2020202843,PFIZER,,55.0,YR,,M,Y,,,20220711,,HP,CA,CA,2022,Q3,Adult
185590122,18559012,47,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,2,F,20190704.0,20220812.0,20201130,20220816,EXP,,NVSC2020AT312310,NOVARTIS,,67.0,YR,,F,Y,89.0,KG,20220816,,MD,AT,AT,2022,Q3,Elderly
186021264,18602126,50,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,4,F,20190704.0,20220909.0,20201210,20220915,EXP,,AT-MYLANLABS-2020M1001146,MYLAN,,67.0,YR,,F,Y,89.0,KG,20220915,,MD,AT,AT,2022,Q3,Elderly
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Leukocytosis,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Hypokalaemia,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Pancreatitis acute,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
186149976,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q3,Hypophosphataemia,,2022,Q3,6,F,20171101.0,20220822.0,20201214,20220826,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20220826,,HP,US,US,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Palpitations,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Muscle spasms,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Gait disturbance,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Viral infection,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Productive cough,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Respiratory symptom,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Asthenia,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Blood potassium abnormal,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Pruritus,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Peripheral swelling,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Constipation,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Syncope,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Pain in extremity,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Hyperhidrosis,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Cough,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Skin fissures,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Fatigue,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Dry skin,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Dehydration,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q3,Rash macular,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Palpitations,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Muscle spasms,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Gait disturbance,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Viral infection,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Productive cough,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Respiratory symptom,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Asthenia,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Blood potassium abnormal,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Pruritus,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Peripheral swelling,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Constipation,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Syncope,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Pain in extremity,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Hyperhidrosis,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Cough,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Skin fissures,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Fatigue,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Dry skin,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Dehydration,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
188742528,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q3,Rash macular,,2022,Q3,8,F,20210801.0,20220726.0,20210210,20220729,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20220729,,CN,CA,CA,2022,Q3,Adult
189450935,18945093,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,dose unknown,,,,,,,,,,peroral medicine,,2022,Q3,Hepatic function abnormal,,2022,Q3,5,F,20210114.0,20220720.0,20210226,20220725,EXP,,JP-JNJFOC-20210140357,JOHNSON AND JOHNSON,,57.0,YR,A,M,Y,103.0,KG,20220726,,MD,JP,JP,2022,Q3,Adult
189450935,18945093,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,dose unknown,,,,,,,,,,peroral medicine,,2022,Q3,Stevens-Johnson syndrome,,2022,Q3,5,F,20210114.0,20220720.0,20210226,20220725,EXP,,JP-JNJFOC-20210140357,JOHNSON AND JOHNSON,,57.0,YR,A,M,Y,103.0,KG,20220726,,MD,JP,JP,2022,Q3,Adult
189450935,18945093,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,dose unknown,,,,,,,,,,peroral medicine,,2022,Q3,Urinary tract infection,,2022,Q3,5,F,20210114.0,20220720.0,20210226,20220725,EXP,,JP-JNJFOC-20210140357,JOHNSON AND JOHNSON,,57.0,YR,A,M,Y,103.0,KG,20220726,,MD,JP,JP,2022,Q3,Adult
189450935,18945093,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,dose unknown,,,,,,,,,,peroral medicine,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,5,F,20210114.0,20220720.0,20210226,20220725,EXP,,JP-JNJFOC-20210140357,JOHNSON AND JOHNSON,,57.0,YR,A,M,Y,103.0,KG,20220726,,MD,JP,JP,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Aphthous ulcer,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Influenza,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malaise,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Appetite disorder,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Decreased appetite,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abdominal discomfort,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Product after taste,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Mobility decreased,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dysgeusia,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Discouragement,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Product use issue,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Feeling of despair,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Motion sickness,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Anxiety,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cough,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Off label use,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Toothache,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Feeding disorder,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Chills,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Weight increased,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Nausea,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dry skin,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Depression,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dysphonia,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malaise,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gastrointestinal pain,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Speech disorder,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dysentery,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Swelling,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Product administration error,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Impaired healing,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Tooth abscess,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gastrointestinal disorder,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Tooth disorder,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Contusion,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
1912961214,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Somnolence,,2022,Q3,14,F,20210301.0,20220817.0,20210413,20220823,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20220823,,CN,BR,BR,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Nausea,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Gastritis,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Diabetic neuropathy,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Cardiac disorder,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Gastric hypomotility,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,,,2022,Q3,Vascular encephalopathy,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Nausea,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Gastritis,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Diabetic neuropathy,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Cardiac disorder,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Gastric hypomotility,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
191574542,19157454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q3,Vascular encephalopathy,,2022,Q3,2,F,20171001.0,20220819.0,20210420,20220901,EXP,,HU-ELI_LILLY_AND_COMPANY-HU202104004731,ELI LILLY AND CO,,49.0,YR,,F,Y,160.0,KG,20220901,,CN,HU,HU,2022,Q3,Adult
1927499912,19274999,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 mg, Everyday, Oral Drug Unspecified Form",,,U,,,,,,,,,2022,Q3,Atrial thrombosis,,2022,Q3,12,F,20210317.0,20220719.0,20210519,20220727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048529,BRISTOL MYERS SQUIBB,"Miyazaki O, et al. A case of left atrial thrombus after combination therapy with nivolumab, ipilimumab, carboplatin, and pemetrexed in a patient with lung adenocarcinoma. The 60th Tohoku Branch Meeting of the Japan Lung Cancer Society 2021;20.",72.0,YR,E,M,Y,68.0,KG,20220727,,MD,JP,JP,2022,Q3,Elderly
1927499912,19274999,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 mg, Everyday, Oral Drug Unspecified Form",,,U,,,,,,,,,2022,Q3,Malignant neoplasm progression,,2022,Q3,12,F,20210317.0,20220719.0,20210519,20220727,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-048529,BRISTOL MYERS SQUIBB,"Miyazaki O, et al. A case of left atrial thrombus after combination therapy with nivolumab, ipilimumab, carboplatin, and pemetrexed in a patient with lung adenocarcinoma. The 60th Tohoku Branch Meeting of the Japan Lung Cancer Society 2021;20.",72.0,YR,E,M,Y,68.0,KG,20220727,,MD,JP,JP,2022,Q3,Elderly
193043124,19304312,29,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q3,Adrenal insufficiency,,2022,Q3,4,F,20210405.0,20220722.0,20210525,20220802,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-050170,BRISTOL MYERS SQUIBB,,64.0,YR,A,M,Y,106.0,KG,20220802,,HP,CA,CA,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Blood creatinine increased,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Metastases to lung,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Blood urea increased,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
1936136010,19361360,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg (1 x 1 pc),,,U,,,,,10.0,MG,Tablet,,2022,Q3,White blood cell count decreased,,2022,Q3,10,F,20220601.0,20220816.0,20210601,20220817,EXP,,NVSC2021TH122255,NOVARTIS,,62.0,YR,,F,Y,,,20220817,,HP,TH,TH,2022,Q3,Adult
193697286,19369728,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2022,Q3,Hyperthyroidism,,2022,Q3,6,F,20210503.0,20220926.0,20210603,20220929,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220929,,MD,ES,ES,2022,Q3,Adult
193697286,19369728,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNK,,,,,,,2022,Q3,Aspartate aminotransferase increased,,2022,Q3,6,F,20210503.0,20220926.0,20210603,20220929,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220929,,MD,ES,ES,2022,Q3,Adult
193697286,19369728,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Hyperthyroidism,,2022,Q3,6,F,20210503.0,20220926.0,20210603,20220929,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220929,,MD,ES,ES,2022,Q3,Adult
193697286,19369728,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Aspartate aminotransferase increased,,2022,Q3,6,F,20210503.0,20220926.0,20210603,20220929,EXP,,ES-EXELIXIS-XL18421040902,EXELIXIS,,58.0,YR,,M,Y,70.8,KG,20220929,,MD,ES,ES,2022,Q3,Adult
1942203713,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Hypertension,,2022,Q3,13,F,20200715.0,20220628.0,20210616,20220704,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220704,,MD,ES,,2022,Q3,Elderly
1942203713,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20200715.0,20220628.0,20210616,20220704,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220704,,MD,ES,,2022,Q3,Elderly
1942203713,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Thrombotic microangiopathy,,2022,Q3,13,F,20200715.0,20220628.0,20210616,20220704,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220704,,MD,ES,,2022,Q3,Elderly
1942203713,19422037,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Liver function test increased,,2022,Q3,13,F,20200715.0,20220628.0,20210616,20220704,EXP,,ES-ROCHE-2737089,ROCHE,,69.0,YR,,M,Y,82.0,KG,20220704,,MD,ES,,2022,Q3,Elderly
194885402,19488540,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Rash maculo-papular,,2022,Q3,2,F,20210511.0,20220623.0,20210702,20220704,EXP,CH-SM-2021-17019,CH-LUNDBECK-DKLU3035119,LUNDBECK,,57.0,YR,A,F,Y,,,20220704,,MD,CH,CH,2022,Q3,Adult
194885402,19488540,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,2,F,20210511.0,20220623.0,20210702,20220704,EXP,CH-SM-2021-17019,CH-LUNDBECK-DKLU3035119,LUNDBECK,,57.0,YR,A,F,Y,,,20220704,,MD,CH,CH,2022,Q3,Adult
194971832,19497183,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,7157.0,,,,,2022,Q3,Rash maculo-papular,,2022,Q3,2,F,20210527.0,20220623.0,20210706,20220705,EXP,CH-SM-2021-17019,CH-UCBSA-2021031742,UCB,,58.0,YR,,F,Y,,,20220705,,MD,CH,CH,2022,Q3,Adult
197164472,19716447,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q3,Immune-mediated uveitis,,2022,Q3,2,F,20210101.0,20220726.0,20210818,20220803,EXP,,JP-009507513-2103JPN001049J,MERCK,,77.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Elderly
197164472,19716447,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q3,Immune-mediated dermatitis,,2022,Q3,2,F,20210101.0,20220726.0,20210818,20220803,EXP,,JP-009507513-2103JPN001049J,MERCK,,77.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Elderly
197164472,19716447,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q3,Hypothalamo-pituitary disorder,,2022,Q3,2,F,20210101.0,20220726.0,20210818,20220803,EXP,,JP-009507513-2103JPN001049J,MERCK,,77.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Elderly
197164472,19716447,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q3,Pulmonary sarcoidosis,,2022,Q3,2,F,20210101.0,20220726.0,20210818,20220803,EXP,,JP-009507513-2103JPN001049J,MERCK,,77.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Elderly
197164472,19716447,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,,QD,2022,Q3,Immune-mediated hypothyroidism,,2022,Q3,2,F,20210101.0,20220726.0,20210818,20220803,EXP,,JP-009507513-2103JPN001049J,MERCK,,77.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Elderly
197167003,19716700,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",50.0,MG,Y,U,,,,10.0,MG,,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,3,F,20210624.0,20220822.0,20210818,20220901,EXP,,JP-NOVOPROD-833232,NOVO NORDISK,":Hongo M., et al. A case of ketoacidosis in a patient receiving DAPA, which was triggered by GLP-R agonist-induced vomiting and poor dietary intake. Journal of the Japan Diabetes Society. 2022;65:276",73.0,YR,,F,Y,39.2,KG,20220901,,MD,JP,JP,2022,Q3,Elderly
197167003,19716700,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",50.0,MG,Y,U,,,,10.0,MG,,QD,2022,Q3,Vomiting,,2022,Q3,3,F,20210624.0,20220822.0,20210818,20220901,EXP,,JP-NOVOPROD-833232,NOVO NORDISK,":Hongo M., et al. A case of ketoacidosis in a patient receiving DAPA, which was triggered by GLP-R agonist-induced vomiting and poor dietary intake. Journal of the Japan Diabetes Society. 2022;65:276",73.0,YR,,F,Y,39.2,KG,20220901,,MD,JP,JP,2022,Q3,Elderly
197336538,19733653,28,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q3,Fulminant type 1 diabetes mellitus,,2022,Q3,8,F,20210801.0,20220922.0,20210823,20220923,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083440,BRISTOL MYERS SQUIBB,"Harada M, et al. Four cases of immune checkpoint inhibitor-induced type 1 diabetes mellitus at our hospital. The 60th Chugoku/Shikoku Branch Meeting of the Japan Lung Cancer Society. 2022; 116",82.0,YR,E,M,Y,63.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
197336538,19733653,28,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,Y,,,,,5.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,8,F,20210801.0,20220922.0,20210823,20220923,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-083440,BRISTOL MYERS SQUIBB,"Harada M, et al. Four cases of immune checkpoint inhibitor-induced type 1 diabetes mellitus at our hospital. The 60th Chugoku/Shikoku Branch Meeting of the Japan Lung Cancer Society. 2022; 116",82.0,YR,E,M,Y,63.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
198269687,19826968,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood triglycerides increased,,2022,Q3,7,F,20210903.0,20220920.0,20210914,20220922,EXP,,NVSC2021AU203112,NOVARTIS,,52.0,YR,,M,Y,,,20220922,,MD,AU,AU,2022,Q3,Adult
198706942,19870694,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,14610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,20210514.0,20220623.0,20210923,20220701,EXP,,CA-AstraZeneca-2021A727887,ASTRAZENECA,,25.0,YR,,F,Y,107.0,KG,20220701,,MD,CA,,2022,Q3,Young Adult
198706942,19870694,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,14610.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,2,F,20210514.0,20220623.0,20210923,20220701,EXP,,CA-AstraZeneca-2021A727887,ASTRAZENECA,,25.0,YR,,F,Y,107.0,KG,20220701,,MD,CA,,2022,Q3,Young Adult
198731912,19873191,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Angiopathy,,2022,Q3,2,F,20210301.0,20220623.0,20210923,20220701,EXP,,CA-AstraZeneca-2021A727940,ASTRAZENECA,,82.0,YR,,F,Y,,,20220701,,MD,CA,,2022,Q3,Elderly
198731912,19873191,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cognitive disorder,,2022,Q3,2,F,20210301.0,20220623.0,20210923,20220701,EXP,,CA-AstraZeneca-2021A727940,ASTRAZENECA,,82.0,YR,,F,Y,,,20220701,,MD,CA,,2022,Q3,Elderly
199418716,19941871,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5.0,mg,Once daily",,,,,,,,,,,,2022,Q3,Obesity,,2022,Q3,6,F,20210906.0,20220804.0,20211012,20220816,EXP,,JP-NOVOPROD-853457,NOVO NORDISK,,50.0,YR,,M,Y,81.0,KG,20220816,,MD,JP,JP,2022,Q3,Adult
200095022,20009502,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4580.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Extremity necrosis,,2022,Q3,2,F,20210429.0,20220916.0,20211028,20220923,EXP,,CA-AstraZeneca-2021A781198,ASTRAZENECA,,88.0,YR,,M,Y,82.0,KG,20220923,,MD,CA,,2022,Q3,Elderly
200459053,20045905,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Hypokalaemia,,2022,Q3,3,F,20201224.0,20220620.0,20211108,20220623,EXP,,NVSJ2021JP018219,NOVARTIS,,83.0,YR,,F,Y,,,20220624,,MD,JP,JP,2022,Q3,Elderly
200459053,20045905,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Blood pressure decreased,,2022,Q3,3,F,20201224.0,20220620.0,20211108,20220623,EXP,,NVSJ2021JP018219,NOVARTIS,,83.0,YR,,F,Y,,,20220624,,MD,JP,JP,2022,Q3,Elderly
200716635,20071663,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2022,Q3,Vertigo positional,,2022,Q3,5,F,,20220620.0,20211116,20220809,EXP,,NVSJ2021JP018756,NOVARTIS,,79.0,YR,,F,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
200716635,20071663,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2022,Q3,Blood pressure systolic increased,,2022,Q3,5,F,,20220620.0,20211116,20220809,EXP,,NVSJ2021JP018756,NOVARTIS,,79.0,YR,,F,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
200821084,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Vascular stent thrombosis,,2022,Q3,4,F,,20220809.0,20211117,20220810,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220810,,MD,JP,JP,2022,Q3,Child
200821084,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,4,F,,20220809.0,20211117,20220810,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220810,,MD,JP,JP,2022,Q3,Child
200821084,20082108,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Disseminated intravascular coagulation,,2022,Q3,4,F,,20220809.0,20211117,20220810,EXP,,JP-DAIICHI SANKYO EUROPE GMBH-DSJ-2021-137429,DAIICHI,"Nakano M, Yoshiga T, Yamaji K, Ishimatsu T, Ishizaki Y, Sasaki M, et al.. A case of a patient with a high risk of haemorrhage and thrombus who developed subacute stent thrombosis after discontinuation of aspirin due to haemorrhage of digestive tract. 33rd Met of Jpn Assoc of CVIT Kyushu/Okinawa Chapter-6th Winter Case Study Met-. 2022;20",8.0,DEC,,M,Y,58.0,KG,20220810,,MD,JP,JP,2022,Q3,Child
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Abdominal pain,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Metabolic alkalosis,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Renal failure,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Dehydration,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Lactic acidosis,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201442482,20144248,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,2,F,,20220817.0,20211203,20220822,EXP,,CA-BAUSCH-BL-2021-039642,BAUSCH AND LOMB,,52.0,YR,,F,Y,,,20220822,,PH,CA,CA,2022,Q3,Adult
201811375,20181137,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure acute,,2022,Q3,5,F,20211128.0,20220920.0,20211214,20220922,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220922,,MD,JP,JP,2022,Q3,Child
201811375,20181137,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hypothyroidism,,2022,Q3,5,F,20211128.0,20220920.0,20211214,20220922,EXP,,JP-EXELIXIS-CABO-21047143,EXELIXIS,,7.0,DEC,,F,Y,,,20220922,,MD,JP,JP,2022,Q3,Child
201858806,20185880,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardiac failure acute,,2022,Q3,6,F,20211128.0,20220920.0,20211215,20220923,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-136079,BRISTOL MYERS SQUIBB,,7.0,DEC,E,F,Y,,,20220923,,MD,JP,JP,2022,Q3,Child
201858806,20185880,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypothyroidism,,2022,Q3,6,F,20211128.0,20220920.0,20211215,20220923,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-136079,BRISTOL MYERS SQUIBB,,7.0,DEC,E,F,Y,,,20220923,,MD,JP,JP,2022,Q3,Child
202366945,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,5,F,20211101.0,20220802.0,20211228,20220808,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220808,,CN,JP,JP,2022,Q3,Elderly
202366945,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Hyperkalaemia,,2022,Q3,5,F,20211101.0,20220802.0,20211228,20220808,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220808,,CN,JP,JP,2022,Q3,Elderly
202366945,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,5,F,20211101.0,20220802.0,20211228,20220808,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220808,,CN,JP,JP,2022,Q3,Elderly
202366945,20236694,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q3,5,F,20211101.0,20220802.0,20211228,20220808,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202112010986,ELI LILLY AND CO,,76.0,YR,,F,Y,49.0,KG,20220808,,CN,JP,JP,2022,Q3,Elderly
203267242,20326724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 days,,,,,,,,10.0,MG,,,2022,Q3,Enthesopathy,,2022,Q3,2,F,,20220715.0,20220112,20220723,EXP,CA-MHPD-E2B_03554690,CA-Accord-250133,ACCORD,,55.0,YR,A,M,Y,,,20220723,,HP,CA,CA,2022,Q3,Adult
203267242,20326724,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 every 1 days,,,,,,,,10.0,MG,,,2022,Q3,Polyarthritis,,2022,Q3,2,F,,20220715.0,20220112,20220723,EXP,CA-MHPD-E2B_03554690,CA-Accord-250133,ACCORD,,55.0,YR,A,M,Y,,,20220723,,HP,CA,CA,2022,Q3,Adult
203630944,20363094,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Intestinal obstruction,,2022,Q3,4,F,20220808.0,20220919.0,20220121,20220923,EXP,,CA-TAKEDA-2022TUS003992,TAKEDA,,63.0,YR,,M,Y,,,20220923,,MD,CA,CA,2022,Q3,Adult
203630944,20363094,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,4,F,20220808.0,20220919.0,20220121,20220923,EXP,,CA-TAKEDA-2022TUS003992,TAKEDA,,63.0,YR,,M,Y,,,20220923,,MD,CA,CA,2022,Q3,Adult
203630944,20363094,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Intestinal resection,,2022,Q3,4,F,20220808.0,20220919.0,20220121,20220923,EXP,,CA-TAKEDA-2022TUS003992,TAKEDA,,63.0,YR,,M,Y,,,20220923,,MD,CA,CA,2022,Q3,Adult
203630944,20363094,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,4,F,20220808.0,20220919.0,20220121,20220923,EXP,,CA-TAKEDA-2022TUS003992,TAKEDA,,63.0,YR,,M,Y,,,20220923,,MD,CA,CA,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Sensation of foreign body,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Infection,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Decreased immune responsiveness,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Hypoaesthesia,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Abdominal pain upper,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Headache,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Weight fluctuation,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Depressed mood,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Chromaturia,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Malaise,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Illness,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Laboratory test abnormal,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Malignant neoplasm progression,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Gastritis,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Chest pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Fear,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Influenza,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Chronic myeloid leukaemia,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Bone pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Waist circumference decreased,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Drug ineffective,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Suicidal ideation,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Hydronephrosis,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Emotional disorder,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Throat irritation,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Feeling abnormal,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Blood glucose decreased,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Back pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,COVID-19,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Choking,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Drug resistance,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Pelvic pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Abdominal discomfort,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Constipation,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Pain in extremity,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Cough,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Spinal pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Anxiety,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Initial insomnia,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Fatigue,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204345715,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Oropharyngeal pain,,2022,Q3,5,F,20210501.0,20220927.0,20220206,20220930,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20220930,,CN,MX,MX,2022,Q3,Adult
204627545,20462754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204627545,20462754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Septic shock,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204627545,20462754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204627545,20462754,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204627545,20462754,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Septic shock,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204627545,20462754,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,720.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,5,F,20220111.0,20220912.0,20220211,20220915,EXP,,JP-AstraZeneca-2022A066516,ASTRAZENECA,,88.0,YR,,F,Y,,,20220915,,MD,JP,,2022,Q3,Elderly
204672974,20467297,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 df,,,,,,,,,,,,2022,Q3,International normalised ratio decreased,,2022,Q3,4,F,20211221.0,20220905.0,20220214,20220915,EXP,CH-NOVOPROD-889434,CH-NOVOPROD-889434,NOVO NORDISK,,73.0,YR,,M,Y,113.0,KG,20220915,,MD,CH,CH,2022,Q3,Elderly
204672974,20467297,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 df,,,,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,4,F,20211221.0,20220905.0,20220214,20220915,EXP,CH-NOVOPROD-889434,CH-NOVOPROD-889434,NOVO NORDISK,,73.0,YR,,M,Y,113.0,KG,20220915,,MD,CH,CH,2022,Q3,Elderly
204949853,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Pneumonia,,2022,Q3,3,F,20210821.0,20220828.0,20220221,20220901,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220901,,MD,GB,GB,2022,Q3,Adult
204949853,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Anal haemorrhage,,2022,Q3,3,F,20210821.0,20220828.0,20220221,20220901,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220901,,MD,GB,GB,2022,Q3,Adult
204949853,20494985,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (oral tablet, daily)",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Cardiomegaly,,2022,Q3,3,F,20210821.0,20220828.0,20220221,20220901,EXP,,GB-MYLANLABS-2022M1012269,MYLAN,,61.0,YR,,M,Y,,,20220901,,MD,GB,GB,2022,Q3,Adult
204994163,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Upper gastrointestinal haemorrhage,,2022,Q3,3,F,20210821.0,20220828.0,20220222,20220908,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220908,,MD,GB,GB,2022,Q3,Adult
204994163,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Anal haemorrhage,,2022,Q3,3,F,20210821.0,20220828.0,20220222,20220908,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220908,,MD,GB,GB,2022,Q3,Adult
204994163,20499416,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Pneumonia,,2022,Q3,3,F,20210821.0,20220828.0,20220222,20220908,EXP,,GB-AUROBINDO-AUR-APL-2022-005412,AUROBINDO,,61.0,YR,,M,Y,,,20220908,,MD,GB,GB,2022,Q3,Adult
205925165,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,5,F,20211213.0,20220909.0,20220314,20220914,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220915,,MD,JP,JP,2022,Q3,Adult
205925165,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,5,F,20211213.0,20220909.0,20220314,20220914,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220915,,MD,JP,JP,2022,Q3,Adult
205925165,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Breast pain,,2022,Q3,5,F,20211213.0,20220909.0,20220314,20220914,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20220915,,MD,JP,JP,2022,Q3,Adult
206144293,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q3,Hypercholesterolaemia,,2022,Q3,3,F,20180418.0,20220902.0,20220321,20220909,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20220909,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q3,Adult
206144293,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q3,Diabetes mellitus,,2022,Q3,3,F,20180418.0,20220902.0,20220321,20220909,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20220909,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q3,Adult
206144293,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q3,Atrial fibrillation,,2022,Q3,3,F,20180418.0,20220902.0,20220321,20220909,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20220909,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q3,Adult
206303492,20630349,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q3,Lactic acidosis,Lactic acidosis,2022,Q3,2,F,20220131.0,20220705.0,20220324,20220715,EXP,,DE-TEVA-2022-DE-2018352,TEVA,,79.0,YR,E,M,Y,65.0,KG,20220715,,MD,DE,DE,2022,Q3,Elderly
206303492,20630349,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q3,Drug resistance,Drug resistance,2022,Q3,2,F,20220131.0,20220705.0,20220324,20220715,EXP,,DE-TEVA-2022-DE-2018352,TEVA,,79.0,YR,E,M,Y,65.0,KG,20220715,,MD,DE,DE,2022,Q3,Elderly
206303492,20630349,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; daily dose: 10 Mg millgram(s) every Days,,,,,,,,10.0,MG,,,2022,Q3,Coma,Coma,2022,Q3,2,F,20220131.0,20220705.0,20220324,20220715,EXP,,DE-TEVA-2022-DE-2018352,TEVA,,79.0,YR,E,M,Y,65.0,KG,20220715,,MD,DE,DE,2022,Q3,Elderly
206332122,20633212,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,870.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q3,Anaemia,,2022,Q3,2,F,20210925.0,20220802.0,20220324,20220808,EXP,,GB-AstraZeneca-2021A750354,ASTRAZENECA,,20571.0,DY,,F,Y,,,20220808,,MD,GB,,2022,Q3,Elderly
206562883,20656288,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Ongoing,,,U,,,,,5.0,MG,"Nasal drops, solution",Q12H,2022,Q3,Pericardial effusion,,2022,Q3,3,F,20220302.0,20220718.0,20220331,20220725,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-012366,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,70.0,KG,20220725,,HP,ES,ES,2022,Q3,Adult
206562883,20656288,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Ongoing,,,U,,,,,5.0,MG,"Nasal drops, solution",Q12H,2022,Q3,Asthenia,,2022,Q3,3,F,20220302.0,20220718.0,20220331,20220725,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-012366,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,70.0,KG,20220725,,HP,ES,ES,2022,Q3,Adult
206649542,20664954,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Deep vein thrombosis,,2022,Q3,2,F,20220121.0,20220706.0,20220401,20220714,EXP,,CN-JNJFOC-20220353799,JOHNSON AND JOHNSON,,69.0,YR,E,F,Y,53.3,KG,20220714,,MD,CN,CN,2022,Q3,Elderly
206730712,20673071,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Flatulence,,2022,Q3,2,F,,20220714.0,20220405,20220722,EXP,,DE-PFIZER INC-2021415958,PFIZER,,87.0,YR,,M,Y,80.0,KG,20220722,,CN,DE,DE,2022,Q3,Elderly
206730712,20673071,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Hepatic enzyme increased,,2022,Q3,2,F,,20220714.0,20220405,20220722,EXP,,DE-PFIZER INC-2021415958,PFIZER,,87.0,YR,,M,Y,80.0,KG,20220722,,CN,DE,DE,2022,Q3,Elderly
207107992,20710799,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10mg, daily dose, UNK",,,U,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,2,F,,20220805.0,20220414,20220811,EXP,,JP-OTSUKA-2022_023170,OTSUKA,,62.0,YR,,M,Y,,,20220811,,MD,JP,JP,2022,Q3,Adult
207126003,20712600,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2022,Q3,Cerebral infarction,,2022,Q3,3,F,20220315.0,20220725.0,20220415,20220729,EXP,,"CN-Jiangsu Hengrui Medicine Co., Ltd.-2127787",JIANGSU HENGRUI MEDICINE,,61.0,YR,,F,Y,66.5,KG,20220729,,MD,CN,CN,2022,Q3,Adult
207278382,20727838,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"5 mg, QD",,,,,,,,5.0,MG,,QD,2022,Q3,Acute myocardial infarction,,2022,Q3,2,F,20220414.0,20220627.0,20220419,20220702,EXP,,CN-JNJFOC-20220435651,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,,,20220702,,MD,CN,CN,2022,Q3,Adult
207700193,20770019,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q3,Purpura,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q3,Toxic skin eruption,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q3,Erythema,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,40,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q3,Pruritus,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,41,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q3,Purpura,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,41,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q3,Toxic skin eruption,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,41,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q3,Erythema,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207700193,20770019,41,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q3,Pruritus,,2022,Q3,3,F,20220331.0,20220907.0,20220429,20220912,EXP,,JP-009507513-2204JPN009018,MERCK,,66.0,YR,,M,Y,39.9,KG,20220912,,PH,JP,JP,2022,Q3,Elderly
207819852,20781985,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"strength: 10 mg, 10 mg 1 time/d",,,,,,,,,,Film-coated tablet,,2022,Q3,Behaviour disorder,,2022,Q3,2,F,20220203.0,20220628.0,20220504,20220706,EXP,FR-AFSSAPS-TS20221035,FR-Accord-262635,ACCORD,,95.0,YR,E,F,Y,63.0,KG,20220706,,PH,FR,FR,2022,Q3,Elderly
207819852,20781985,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"strength: 10 mg, 10 mg 1 time/d",,,,,,,,,,Film-coated tablet,,2022,Q3,Confusional state,,2022,Q3,2,F,20220203.0,20220628.0,20220504,20220706,EXP,FR-AFSSAPS-TS20221035,FR-Accord-262635,ACCORD,,95.0,YR,E,F,Y,63.0,KG,20220706,,PH,FR,FR,2022,Q3,Elderly
207819852,20781985,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"strength: 10 mg, 10 mg 1 time/d",,,,,,,,,,Film-coated tablet,,2022,Q3,Hallucination,,2022,Q3,2,F,20220203.0,20220628.0,20220504,20220706,EXP,FR-AFSSAPS-TS20221035,FR-Accord-262635,ACCORD,,95.0,YR,E,F,Y,63.0,KG,20220706,,PH,FR,FR,2022,Q3,Elderly
207959922,20795992,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Therapy non-responder,,2022,Q3,2,F,,20220811.0,20220506,20220816,EXP,,CA-TAKEDA-2022TUS030287,TAKEDA,,45.0,YR,,M,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
207959922,20795992,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Colitis ulcerative,,2022,Q3,2,F,,20220811.0,20220506,20220816,EXP,,CA-TAKEDA-2022TUS030287,TAKEDA,,45.0,YR,,M,Y,,,20220816,,MD,CA,CA,2022,Q3,Adult
208104252,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,2,F,20211029.0,20220809.0,20220510,20220817,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220817,,MD,CA,,2022,Q3,Adult
208104252,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Bacteraemia,,2022,Q3,2,F,20211029.0,20220809.0,20220510,20220817,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220817,,MD,CA,,2022,Q3,Adult
208104252,20810425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,20211029.0,20220809.0,20220510,20220817,EXP,,CA-AstraZeneca-2022A173083,ASTRAZENECA,,45.0,YR,,F,Y,,,20220817,,MD,CA,,2022,Q3,Adult
208126003,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q3,Rhabdomyolysis,,2022,Q3,3,F,20220427.0,20220803.0,20220511,20220808,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,74.0,YR,,F,Y,,,20220808,,MD,JP,JP,2022,Q3,Elderly
208126003,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q3,Diarrhoea,,2022,Q3,3,F,20220427.0,20220803.0,20220511,20220808,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,74.0,YR,,F,Y,,,20220808,,MD,JP,JP,2022,Q3,Elderly
208126003,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q3,Dehydration,,2022,Q3,3,F,20220427.0,20220803.0,20220511,20220808,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,74.0,YR,,F,Y,,,20220808,,MD,JP,JP,2022,Q3,Elderly
208126003,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q3,Pyrexia,,2022,Q3,3,F,20220427.0,20220803.0,20220511,20220808,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,74.0,YR,,F,Y,,,20220808,,MD,JP,JP,2022,Q3,Elderly
208328834,20832883,19,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,#4,,,U,,,,,,,Unknown,,2022,Q3,COVID-19 pneumonia,,2022,Q3,4,F,20220404.0,20220909.0,20220516,20220919,EXP,,FI-BRISTOL-MYERS SQUIBB COMPANY-2022-034365,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,82.0,KG,20220920,,HP,FI,FI,2022,Q3,Elderly
208471642,20847164,2,C,DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE,,2,Unknown,5/1000 1-0-1,,,,,,,,,,,,2022,Q3,Diabetic metabolic decompensation,,2022,Q3,2,F,,20220701.0,20220519,20220711,EXP,,BR-NOVOPROD-917584,NOVO NORDISK,,43.0,YR,,M,Y,112.0,KG,20220711,,MD,BR,BR,2022,Q3,Adult
208471642,20847164,2,C,DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE,,2,Unknown,5/1000 1-0-1,,,,,,,,,,,,2022,Q3,Metabolic syndrome,,2022,Q3,2,F,,20220701.0,20220519,20220711,EXP,,BR-NOVOPROD-917584,NOVO NORDISK,,43.0,YR,,M,Y,112.0,KG,20220711,,MD,BR,BR,2022,Q3,Adult
208471642,20847164,2,C,DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE,,2,Unknown,5/1000 1-0-1,,,,,,,,,,,,2022,Q3,Treatment noncompliance,,2022,Q3,2,F,,20220701.0,20220519,20220711,EXP,,BR-NOVOPROD-917584,NOVO NORDISK,,43.0,YR,,M,Y,112.0,KG,20220711,,MD,BR,BR,2022,Q3,Adult
208515104,20851510,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 UNK, QD",,,,,,,,,,Tablet,QD,2022,Q3,Contraindicated product administered,,2022,Q3,4,F,20211224.0,20220915.0,20220519,20220921,EXP,,NVSJ2022JP090282,NOVARTIS,,74.0,YR,,M,Y,61.0,KG,20220922,,MD,JP,JP,2022,Q3,Elderly
208515104,20851510,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 UNK, QD",,,,,,,,,,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,4,F,20211224.0,20220915.0,20220519,20220921,EXP,,NVSJ2022JP090282,NOVARTIS,,74.0,YR,,M,Y,61.0,KG,20220922,,MD,JP,JP,2022,Q3,Elderly
208515104,20851510,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 UNK, QD",,,,,,,,,,Tablet,QD,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,4,F,20211224.0,20220915.0,20220519,20220921,EXP,,NVSJ2022JP090282,NOVARTIS,,74.0,YR,,M,Y,61.0,KG,20220922,,MD,JP,JP,2022,Q3,Elderly
208515104,20851510,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 UNK, QD",,,,,,,,,,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,4,F,20211224.0,20220915.0,20220519,20220921,EXP,,NVSJ2022JP090282,NOVARTIS,,74.0,YR,,M,Y,61.0,KG,20220922,,MD,JP,JP,2022,Q3,Elderly
208515104,20851510,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 UNK, QD",,,,,,,,,,Tablet,QD,2022,Q3,Blood pressure increased,,2022,Q3,4,F,20211224.0,20220915.0,20220519,20220921,EXP,,NVSJ2022JP090282,NOVARTIS,,74.0,YR,,M,Y,61.0,KG,20220922,,MD,JP,JP,2022,Q3,Elderly
208664802,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Peripheral swelling,,2022,Q3,2,F,20220420.0,20220919.0,20220524,20220923,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220923,,PH,IT,IT,2022,Q3,Elderly
208664802,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Hypothyroidism,,2022,Q3,2,F,20220420.0,20220919.0,20220524,20220923,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220923,,PH,IT,IT,2022,Q3,Elderly
208664802,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,2,F,20220420.0,20220919.0,20220524,20220923,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220923,,PH,IT,IT,2022,Q3,Elderly
208664802,20866480,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Fatigue,,2022,Q3,2,F,20220420.0,20220919.0,20220524,20220923,EXP,IT-MINISAL02-867847,IT-009507513-2205ITA005193,MERCK,,66.0,YR,,M,Y,100.0,KG,20220923,,PH,IT,IT,2022,Q3,Elderly
208669772,20866977,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,20220503.0,20220704.0,20220524,20220708,EXP,,CA-PFIZER INC-202200730740,PFIZER,,74.0,YR,,F,Y,,,20220708,,HP,CA,CA,2022,Q3,Elderly
208669772,20866977,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Palpitations,,2022,Q3,2,F,20220503.0,20220704.0,20220524,20220708,EXP,,CA-PFIZER INC-202200730740,PFIZER,,74.0,YR,,F,Y,,,20220708,,HP,CA,CA,2022,Q3,Elderly
208669772,20866977,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,2,F,20220503.0,20220704.0,20220524,20220708,EXP,,CA-PFIZER INC-202200730740,PFIZER,,74.0,YR,,F,Y,,,20220708,,HP,CA,CA,2022,Q3,Elderly
208669772,20866977,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Supraventricular tachycardia,,2022,Q3,2,F,20220503.0,20220704.0,20220524,20220708,EXP,,CA-PFIZER INC-202200730740,PFIZER,,74.0,YR,,F,Y,,,20220708,,HP,CA,CA,2022,Q3,Elderly
208677582,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Crohn's disease,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Drug level decreased,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Crohn's disease,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208677582,20867758,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unknown,,,,,,,,,,,,2022,Q3,Drug level decreased,,2022,Q3,2,F,,20220913.0,20220524,20220922,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-12224,SAMSUNG BIOEPIS,,61.0,YR,A,F,Y,92.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
208713224,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,4,F,20220515.0,20220824.0,20220525,20220831,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
208713224,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220515.0,20220824.0,20220525,20220831,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
208713224,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,4,F,20220515.0,20220824.0,20220525,20220831,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
208713224,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220515.0,20220824.0,20220525,20220831,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
208854583,20885458,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2590.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dehydration,,2022,Q3,3,F,20211226.0,20220902.0,20220527,20220907,EXP,,JP-AstraZeneca-2022A197498,ASTRAZENECA,,85.0,YR,,M,Y,48.0,KG,20220907,,MD,JP,,2022,Q3,Elderly
208854583,20885458,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2590.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cerebral infarction,,2022,Q3,3,F,20211226.0,20220902.0,20220527,20220907,EXP,,JP-AstraZeneca-2022A197498,ASTRAZENECA,,85.0,YR,,M,Y,48.0,KG,20220907,,MD,JP,,2022,Q3,Elderly
208917523,20891752,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Ill-defined disorder,,2022,Q3,3,F,,20220721.0,20220530,20220728,PER,,CN-AMGEN-CHNSP2022088945,AMGEN,,62.0,YR,A,M,Y,,,20220728,,MD,CN,CN,2022,Q3,Adult
208918142,20891814,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,FC8286,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,20210614.0,20220701.0,20220530,20220701,EXP,,CA-PFIZER INC-202200742952,PFIZER,,45.0,YR,,F,Y,60.0,KG,20220701,,MD,CA,CA,2022,Q3,Adult
208918142,20891814,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,FC8286,,,,,,,2022,Q3,Mycobacterium avium complex infection,,2022,Q3,2,F,20210614.0,20220701.0,20220530,20220701,EXP,,CA-PFIZER INC-202200742952,PFIZER,,45.0,YR,,F,Y,60.0,KG,20220701,,MD,CA,CA,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Drug ineffective,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Retroperitonitis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Vulvovaginitis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Vulval oedema,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Pyelonephritis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hypertonic bladder,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Drug ineffective,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Retroperitonitis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Vulvovaginitis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Vulval oedema,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Pyelonephritis,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
208938403,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hypertonic bladder,,2022,Q3,3,F,20200901.0,20220922.0,20220531,20220927,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,,58.0,YR,,F,Y,64.0,KG,20220927,,MD,JP,,2022,Q3,Adult
209032272,20903227,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q3,Constipation,,2022,Q3,2,F,20220401.0,20220707.0,20220601,20220803,EXP,PT-INFARMED-T202205-177,PT-Vifor (International) Inc.-VIT-2022-03670,VIFOR,,79.0,YR,,M,Y,77.0,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
209032272,20903227,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q3,Metabolic acidosis,,2022,Q3,2,F,20220401.0,20220707.0,20220601,20220803,EXP,PT-INFARMED-T202205-177,PT-Vifor (International) Inc.-VIT-2022-03670,VIFOR,,79.0,YR,,M,Y,77.0,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
209041262,20904126,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,Y,,,,,10.0,MG,,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,20220207.0,20220623.0,20220602,20220704,EXP,,IE-NOVOPROD-903603,NOVO NORDISK,,45.0,YR,,F,Y,48.4,KG,20220704,,HP,IE,IE,2022,Q3,Adult
209041262,20904126,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,Y,,,,,10.0,MG,,QD,2022,Q3,Abdominal distension,,2022,Q3,2,F,20220207.0,20220623.0,20220602,20220704,EXP,,IE-NOVOPROD-903603,NOVO NORDISK,,45.0,YR,,F,Y,48.4,KG,20220704,,HP,IE,IE,2022,Q3,Adult
209041262,20904126,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,Y,,,,,10.0,MG,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,20220207.0,20220623.0,20220602,20220704,EXP,,IE-NOVOPROD-903603,NOVO NORDISK,,45.0,YR,,F,Y,48.4,KG,20220704,,HP,IE,IE,2022,Q3,Adult
209066604,20906660,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Transplant rejection,,2022,Q3,4,F,20210501.0,20220809.0,20220602,20220817,EXP,,DE-VELOXIS PHARMACEUTICALS-2022VELDE-000261,VELOXIS PHARMACEUTICALS,,46.0,YR,,M,Y,,,20220817,,CN,DE,DE,2022,Q3,Adult
209066604,20906660,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Off label use,,2022,Q3,4,F,20210501.0,20220809.0,20220602,20220817,EXP,,DE-VELOXIS PHARMACEUTICALS-2022VELDE-000261,VELOXIS PHARMACEUTICALS,,46.0,YR,,M,Y,,,20220817,,CN,DE,DE,2022,Q3,Adult
209066604,20906660,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Blood pressure increased,,2022,Q3,4,F,20210501.0,20220809.0,20220602,20220817,EXP,,DE-VELOXIS PHARMACEUTICALS-2022VELDE-000261,VELOXIS PHARMACEUTICALS,,46.0,YR,,M,Y,,,20220817,,CN,DE,DE,2022,Q3,Adult
209066604,20906660,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Anal abscess,,2022,Q3,4,F,20210501.0,20220809.0,20220602,20220817,EXP,,DE-VELOXIS PHARMACEUTICALS-2022VELDE-000261,VELOXIS PHARMACEUTICALS,,46.0,YR,,M,Y,,,20220817,,CN,DE,DE,2022,Q3,Adult
209066604,20906660,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Fluid retention,,2022,Q3,4,F,20210501.0,20220809.0,20220602,20220817,EXP,,DE-VELOXIS PHARMACEUTICALS-2022VELDE-000261,VELOXIS PHARMACEUTICALS,,46.0,YR,,M,Y,,,20220817,,CN,DE,DE,2022,Q3,Adult
209164622,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Lymphopenia,,2022,Q3,2,F,20210815.0,20220815.0,20220604,20220824,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220824,,MD,PT,PT,2022,Q3,Elderly
209164622,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Mucosal inflammation,Mucosal inflammation,2022,Q3,2,F,20210815.0,20220815.0,20220604,20220824,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220824,,MD,PT,PT,2022,Q3,Elderly
209164622,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,2,F,20210815.0,20220815.0,20220604,20220824,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220824,,MD,PT,PT,2022,Q3,Elderly
209164622,20916462,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Decreased appetite,Decreased appetite,2022,Q3,2,F,20210815.0,20220815.0,20220604,20220824,EXP,PT-INFARMED-J202205-57,PT-TEVA-2022-PT-2041974,TEVA,,70.0,YR,E,M,Y,,,20220824,,MD,PT,PT,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Jaundice,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Decreased appetite,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Weight decreased,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Depression,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Mood altered,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Haematemesis,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Haematemesis,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Decreased appetite,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Arthralgia,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209220102,20922010,12,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"(2 tablets), qd",,,,,Unknown,,,,,Tablet,,2022,Q3,Somnolence,,2022,Q3,2,F,20210501.0,20220708.0,20220607,20220719,EXP,,CO-NOVOPROD-894484,NOVO NORDISK,,72.0,YR,,F,Y,80.0,KG,20220719,,CN,CO,CO,2022,Q3,Elderly
209469464,20946946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,4,F,20220424.0,20220822.0,20220610,20220830,EXP,,JP-AstraZeneca-2022A203330,ASTRAZENECA,,85.0,YR,,M,Y,,,20220830,,MD,JP,,2022,Q3,Elderly
209469464,20946946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Testicular swelling,,2022,Q3,4,F,20220424.0,20220822.0,20220610,20220830,EXP,,JP-AstraZeneca-2022A203330,ASTRAZENECA,,85.0,YR,,M,Y,,,20220830,,MD,JP,,2022,Q3,Elderly
209469464,20946946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,4,F,20220424.0,20220822.0,20220610,20220830,EXP,,JP-AstraZeneca-2022A203330,ASTRAZENECA,,85.0,YR,,M,Y,,,20220830,,MD,JP,,2022,Q3,Elderly
209469464,20946946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,4,F,20220424.0,20220822.0,20220610,20220830,EXP,,JP-AstraZeneca-2022A203330,ASTRAZENECA,,85.0,YR,,M,Y,,,20220830,,MD,JP,,2022,Q3,Elderly
209536092,20953609,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q3,Peritonitis,,2022,Q3,2,F,20220509.0,20220714.0,20220613,20220725,EXP,,JP-ROCHE-3113709,ROCHE,,69.0,YR,,F,Y,63.1,KG,20220725,,MD,JP,JP,2022,Q3,Elderly
209536092,20953609,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q3,Enterocolitis,,2022,Q3,2,F,20220509.0,20220714.0,20220613,20220725,EXP,,JP-ROCHE-3113709,ROCHE,,69.0,YR,,F,Y,63.1,KG,20220725,,MD,JP,JP,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Constipation,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Deafness,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Hyperhidrosis,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Back pain,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209547934,20954793,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet every morning,,,U,,,,,,,Tablet,,2022,Q3,Pollakiuria,,2022,Q3,4,F,20220101.0,20220727.0,20220614,20220805,EXP,,CN-SA-2022SA205018,SANOFI AVENTIS,,90.0,YR,E,F,Y,,,20220805,,HP,CN,CN,2022,Q3,Elderly
209610783,20961078,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q3,Blood pressure increased,,2022,Q3,3,F,20210501.0,20220804.0,20220615,20220810,EXP,,NVSC2022DE133186,NOVARTIS,,46.0,YR,,M,Y,,,20220810,,CN,DE,DE,2022,Q3,Adult
209610783,20961078,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q3,Fluid retention,,2022,Q3,3,F,20210501.0,20220804.0,20220615,20220810,EXP,,NVSC2022DE133186,NOVARTIS,,46.0,YR,,M,Y,,,20220810,,CN,DE,DE,2022,Q3,Adult
209610783,20961078,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q3,Off label use,,2022,Q3,3,F,20210501.0,20220804.0,20220615,20220810,EXP,,NVSC2022DE133186,NOVARTIS,,46.0,YR,,M,Y,,,20220810,,CN,DE,DE,2022,Q3,Adult
209610783,20961078,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q3,Transplant rejection,,2022,Q3,3,F,20210501.0,20220804.0,20220615,20220810,EXP,,NVSC2022DE133186,NOVARTIS,,46.0,YR,,M,Y,,,20220810,,CN,DE,DE,2022,Q3,Adult
209610783,20961078,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,10.0,MG,,,2022,Q3,Anal abscess,,2022,Q3,3,F,20210501.0,20220804.0,20220615,20220810,EXP,,NVSC2022DE133186,NOVARTIS,,46.0,YR,,M,Y,,,20220810,,CN,DE,DE,2022,Q3,Adult
209619244,20961924,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",3620.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220515.0,20220906.0,20220615,20220908,EXP,,NVSC2022SE124311,NOVARTIS,,78.0,YR,,F,Y,,,20220908,,MD,SE,SE,2022,Q3,Elderly
209619244,20961924,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",3620.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,4,F,20220515.0,20220906.0,20220615,20220908,EXP,,NVSC2022SE124311,NOVARTIS,,78.0,YR,,F,Y,,,20220908,,MD,SE,SE,2022,Q3,Elderly
209619244,20961924,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",3620.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220515.0,20220906.0,20220615,20220908,EXP,,NVSC2022SE124311,NOVARTIS,,78.0,YR,,F,Y,,,20220908,,MD,SE,SE,2022,Q3,Elderly
209619244,20961924,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",3620.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,4,F,20220515.0,20220906.0,20220615,20220908,EXP,,NVSC2022SE124311,NOVARTIS,,78.0,YR,,F,Y,,,20220908,,MD,SE,SE,2022,Q3,Elderly
209635952,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q3,Cardiac failure,,2022,Q3,2,F,,20220713.0,20220615,20220721,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220721,,MD,JP,,2022,Q3,Elderly
209635952,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q3,Renal impairment,,2022,Q3,2,F,,20220713.0,20220615,20220721,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220721,,MD,JP,,2022,Q3,Elderly
209635952,20963595,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q3,Cardiac sarcoidosis,,2022,Q3,2,F,,20220713.0,20220615,20220721,EXP,,JP-AstraZeneca-2022A216953,ASTRAZENECA,,100.0,YR,,M,Y,,,20220721,,MD,JP,,2022,Q3,Elderly
209690044,20969004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,,,,,,,QD,2022,Q3,Bladder cancer,,2022,Q3,4,F,20211012.0,20220713.0,20220616,20220720,EXP,,JP-UROVANT SCIENCES GMBH-202206-URV-000743,UROVANT SCIENCES,,82.0,YR,,M,Y,,,20220720,,MD,JP,JP,2022,Q3,Elderly
209722922,20972292,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,2,F,20220414.0,20220922.0,20220616,20220925,EXP,,NVSJ2022JP092445,NOVARTIS,,60.0,YR,,M,Y,,,20220926,,MD,JP,JP,2022,Q3,Adult
209722922,20972292,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Blood urea increased,,2022,Q3,2,F,20220414.0,20220922.0,20220616,20220925,EXP,,NVSJ2022JP092445,NOVARTIS,,60.0,YR,,M,Y,,,20220926,,MD,JP,JP,2022,Q3,Adult
209722922,20972292,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Cardiopulmonary failure,,2022,Q3,2,F,20220414.0,20220922.0,20220616,20220925,EXP,,NVSJ2022JP092445,NOVARTIS,,60.0,YR,,M,Y,,,20220926,,MD,JP,JP,2022,Q3,Adult
209722922,20972292,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Dehydration,,2022,Q3,2,F,20220414.0,20220922.0,20220616,20220925,EXP,,NVSJ2022JP092445,NOVARTIS,,60.0,YR,,M,Y,,,20220926,,MD,JP,JP,2022,Q3,Adult
209790532,20979053,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2022,Q3,Intestinal obstruction,,2022,Q3,2,F,,20220719.0,20220619,20220722,EXP,,NVSJ2022JP092259,NOVARTIS,,90.0,YR,,M,Y,57.0,KG,20220722,,MD,JP,JP,2022,Q3,Elderly
209790532,20979053,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Intestinal obstruction,,2022,Q3,2,F,,20220719.0,20220619,20220722,EXP,,NVSJ2022JP092259,NOVARTIS,,90.0,YR,,M,Y,57.0,KG,20220722,,MD,JP,JP,2022,Q3,Elderly
209790714,20979071,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Transplant rejection,,2022,Q3,4,F,20210501.0,20220822.0,20220619,20220829,PER,,DE-AMGEN-DEUSP2022100078,AMGEN,,46.0,YR,A,M,Y,,,20220829,,CN,DE,DE,2022,Q3,Adult
209790714,20979071,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Off label use,,2022,Q3,4,F,20210501.0,20220822.0,20220619,20220829,PER,,DE-AMGEN-DEUSP2022100078,AMGEN,,46.0,YR,A,M,Y,,,20220829,,CN,DE,DE,2022,Q3,Adult
209790714,20979071,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Anal abscess,,2022,Q3,4,F,20210501.0,20220822.0,20220619,20220829,PER,,DE-AMGEN-DEUSP2022100078,AMGEN,,46.0,YR,A,M,Y,,,20220829,,CN,DE,DE,2022,Q3,Adult
209790714,20979071,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Fluid retention,,2022,Q3,4,F,20210501.0,20220822.0,20220619,20220829,PER,,DE-AMGEN-DEUSP2022100078,AMGEN,,46.0,YR,A,M,Y,,,20220829,,CN,DE,DE,2022,Q3,Adult
209790714,20979071,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,unknown,,,10.0,MG,,,2022,Q3,Blood pressure increased,,2022,Q3,4,F,20210501.0,20220822.0,20220619,20220829,PER,,DE-AMGEN-DEUSP2022100078,AMGEN,,46.0,YR,A,M,Y,,,20220829,,CN,DE,DE,2022,Q3,Adult
209865646,20986564,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2022,Q3,Thrombocytopenia,,2022,Q3,6,F,20220610.0,20220915.0,20220621,20220916,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2022-059458,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,85.0,KG,20220916,,HP,FR,FR,2022,Q3,Elderly
209870522,20987052,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,,20220822.0,20220621,20220824,EXP,,CA-PFIZER INC-202101487765,PFIZER,,70.0,YR,,M,Y,,,20220824,,HP,CA,CA,2022,Q3,Elderly
209870522,20987052,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug ineffective for unapproved indication,,2022,Q3,2,F,,20220822.0,20220621,20220824,EXP,,CA-PFIZER INC-202101487765,PFIZER,,70.0,YR,,M,Y,,,20220824,,HP,CA,CA,2022,Q3,Elderly
209870522,20987052,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Suspected COVID-19,,2022,Q3,2,F,,20220822.0,20220621,20220824,EXP,,CA-PFIZER INC-202101487765,PFIZER,,70.0,YR,,M,Y,,,20220824,,HP,CA,CA,2022,Q3,Elderly
209870522,20987052,15,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,2,F,,20220822.0,20220621,20220824,EXP,,CA-PFIZER INC-202101487765,PFIZER,,70.0,YR,,M,Y,,,20220824,,HP,CA,CA,2022,Q3,Elderly
209988293,20998829,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,850.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,3,F,20220214.0,20220711.0,20220623,20220727,EXP,,JP-AstraZeneca-2022A225111,ASTRAZENECA,,58.0,YR,,M,Y,,,20220727,,MD,JP,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Amylase increased,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Retinal vein occlusion,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Lipase increased,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Leukocyturia,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Retinal haemorrhage,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood thyroid stimulating hormone decreased,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
209992022,20999202,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2400.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Glycosuria,,2022,Q3,2,F,20211111.0,20220624.0,20220623,20220701,EXP,,SI-AstraZeneca-2022A224747,ASTRAZENECA,,46.0,YR,,M,Y,,,20220702,,MD,SI,,2022,Q3,Adult
210041672,21004167,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Capsule,BID,2022,Q3,Pneumonia,,2022,Q3,2,F,20211206.0,20220713.0,20220624,20220718,EXP,,MX-ROCHE-3123914,ROCHE,,63.0,YR,,F,Y,75.9,KG,20220719,,MD,MX,,2022,Q3,Adult
210053061,21005306,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220210.0,20220620.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,NVSC2022FR141727,NOVARTIS,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q3,Adult
210053061,21005306,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220210.0,20220620.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,NVSC2022FR141727,NOVARTIS,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q3,Adult
210053061,21005306,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,1,I,20220210.0,20220620.0,20220624,20220624,EXP,FR-AFSSAPS-RE20220880,NVSC2022FR141727,NOVARTIS,,62.0,YR,,M,Y,105.0,KG,20220624,,MD,FR,FR,2022,Q3,Adult
210170141,21017014,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada 12 horas (56 comprimidos),,,Y,,Unknown,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220318.0,20220623.0,20220628,20220628,EXP,ES-AEMPS-1172469,NVSC2022ES144647,NOVARTIS,,79.0,YR,,M,Y,,,20220628,,PH,ES,ES,2022,Q3,Elderly
210170141,21017014,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada 12 horas (56 comprimidos),,,Y,,Unknown,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220318.0,20220623.0,20220628,20220628,EXP,ES-AEMPS-1172469,NVSC2022ES144647,NOVARTIS,,79.0,YR,,M,Y,,,20220628,,PH,ES,ES,2022,Q3,Elderly
210170141,21017014,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 COMPRIMIDO cada 12 horas (56 comprimidos),,,Y,,Unknown,,,,,,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220318.0,20220623.0,20220628,20220628,EXP,ES-AEMPS-1172469,NVSC2022ES144647,NOVARTIS,,79.0,YR,,M,Y,,,20220628,,PH,ES,ES,2022,Q3,Elderly
210209122,21020912,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Suspected COVID-19,,2022,Q3,2,F,,20220726.0,20220629,20220729,EXP,,CA-ROCHE-3042633,ROCHE,,70.0,YR,,M,Y,,,20220729,,HP,CA,,2022,Q3,Elderly
210209122,21020912,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,2,F,,20220726.0,20220629,20220729,EXP,,CA-ROCHE-3042633,ROCHE,,70.0,YR,,M,Y,,,20220729,,HP,CA,,2022,Q3,Elderly
210209122,21020912,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220726.0,20220629,20220729,EXP,,CA-ROCHE-3042633,ROCHE,,70.0,YR,,M,Y,,,20220729,,HP,CA,,2022,Q3,Elderly
210209122,21020912,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,,20220726.0,20220629,20220729,EXP,,CA-ROCHE-3042633,ROCHE,,70.0,YR,,M,Y,,,20220729,,HP,CA,,2022,Q3,Elderly
210228252,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q3,Cerebral haemorrhage,,2022,Q3,2,F,,20220928.0,20220629,20220930,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220930,,HP,CA,CA,2022,Q3,Elderly
210228252,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q3,Intracranial pressure increased,,2022,Q3,2,F,,20220928.0,20220629,20220930,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220930,,HP,CA,CA,2022,Q3,Elderly
210228252,21022825,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,Tablet,,2022,Q3,General physical health deterioration,,2022,Q3,2,F,,20220928.0,20220629,20220930,EXP,,CA-PFIZER INC-202200902402,PFIZER,,80.0,YR,,F,Y,61.0,KG,20220930,,HP,CA,CA,2022,Q3,Elderly
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Anxiety,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Chest pain,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Fatigue,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Vasoconstriction,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Dyspnoea exertional,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q3,Thrombosis,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Anxiety,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Chest pain,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Fatigue,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Vasoconstriction,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Dyspnoea exertional,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210238151,21023815,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,Y,,,,,,,Tablet,QD,2022,Q3,Thrombosis,,2022,Q3,1,I,20211201.0,20220622.0,20220629,20220629,EXP,,NVSC2022EG144638,NOVARTIS,,45.0,YR,,M,Y,,,20220629,,CN,EG,EG,2022,Q3,Adult
210242982,21024298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q3,Rhabdomyolysis,,2022,Q3,2,F,20220617.0,20220621.0,20220629,20220701,EXP,,GB-AstraZeneca-2022A228581,ASTRAZENECA,,59.0,YR,,M,Y,,,20220701,,MD,GB,,2022,Q3,Adult
210248503,21024850,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q3,Spinal fracture,,2022,Q3,3,F,20220425.0,20220905.0,20220629,20220909,EXP,,CH-ROCHE-3088292,ROCHE,,69.0,YR,,M,Y,102.0,KG,20220909,,MD,CH,,2022,Q3,Elderly
210248503,21024850,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q3,Lower limb fracture,,2022,Q3,3,F,20220425.0,20220905.0,20220629,20220909,EXP,,CH-ROCHE-3088292,ROCHE,,69.0,YR,,M,Y,102.0,KG,20220909,,MD,CH,,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Tachycardia,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Head injury,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fall,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210253782,21025378,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood urea increased,,2022,Q3,2,F,20210201.0,20220707.0,20220630,20220712,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20220712,,CN,AR,AR,2022,Q3,Elderly
210313891,21031389,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220101.0,20220620.0,20220701,20220701,EXP,,BR-NOVOPROD-927528,NOVO NORDISK,,56.0,YR,,M,Y,108.0,KG,20220701,,MD,BR,BR,2022,Q3,Adult
210313891,21031389,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,unknown,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220101.0,20220620.0,20220701,20220701,EXP,,BR-NOVOPROD-927528,NOVO NORDISK,,56.0,YR,,M,Y,108.0,KG,20220701,,MD,BR,BR,2022,Q3,Adult
210313891,21031389,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,Unknown,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220101.0,20220620.0,20220701,20220701,EXP,,BR-NOVOPROD-927528,NOVO NORDISK,,56.0,YR,,M,Y,108.0,KG,20220701,,MD,BR,BR,2022,Q3,Adult
210313891,21031389,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,Unknown,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220101.0,20220620.0,20220701,20220701,EXP,,BR-NOVOPROD-927528,NOVO NORDISK,,56.0,YR,,M,Y,108.0,KG,20220701,,MD,BR,BR,2022,Q3,Adult
210327541,21032754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,Y,,,,202293.0,,,,,2022,Q3,Periorbital oedema,,2022,Q3,1,I,20220621.0,20220624.0,20220701,20220701,EXP,,GB-AstraZeneca-2022A239220,ASTRAZENECA,,83.0,YR,,M,Y,58.0,KG,20220701,,MD,GB,,2022,Q3,Elderly
210327541,21032754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,Y,,,,202293.0,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220621.0,20220624.0,20220701,20220701,EXP,,GB-AstraZeneca-2022A239220,ASTRAZENECA,,83.0,YR,,M,Y,58.0,KG,20220701,,MD,GB,,2022,Q3,Elderly
210327541,21032754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,Y,,,,202293.0,,,,,2022,Q3,Lip swelling,,2022,Q3,1,I,20220621.0,20220624.0,20220701,20220701,EXP,,GB-AstraZeneca-2022A239220,ASTRAZENECA,,83.0,YR,,M,Y,58.0,KG,20220701,,MD,GB,,2022,Q3,Elderly
210333061,21033306,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4430.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Septic shock,,2022,Q3,1,I,20201201.0,20220627.0,20220701,20220701,EXP,,ES-AstraZeneca-2022A236136,ASTRAZENECA,,88.0,YR,,F,Y,66.0,KG,20220701,,MD,ES,,2022,Q3,Elderly
210337211,21033721,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2109124,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,20220617.0,20220624.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A239296,ASTRAZENECA,,58.0,YR,,F,Y,,,20220701,,MD,CN,,2022,Q3,Adult
210337211,21033721,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2109124,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20220617.0,20220624.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A239296,ASTRAZENECA,,58.0,YR,,F,Y,,,20220701,,MD,CN,,2022,Q3,Adult
210338551,21033855,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220318.0,20220623.0,20220701,20220701,EXP,,ES-AstraZeneca-2022A230275,ASTRAZENECA,,79.0,YR,,M,Y,,,20220701,,MD,ES,,2022,Q3,Elderly
210338551,21033855,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220318.0,20220623.0,20220701,20220701,EXP,,ES-AstraZeneca-2022A230275,ASTRAZENECA,,79.0,YR,,M,Y,,,20220701,,MD,ES,,2022,Q3,Elderly
210338551,21033855,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220318.0,20220623.0,20220701,20220701,EXP,,ES-AstraZeneca-2022A230275,ASTRAZENECA,,79.0,YR,,M,Y,,,20220701,,MD,ES,,2022,Q3,Elderly
210341311,21034131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, bid (1000 every 12 h)",,,U,,,,,,,,BID,2022,Q3,Nausea,,2022,Q3,1,I,20220602.0,20220622.0,20220701,20220701,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202206011300,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220701,,CN,ES,ES,2022,Q3,Adult
210341311,21034131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, bid (1000 every 12 h)",,,U,,,,,,,,BID,2022,Q3,Malaise,,2022,Q3,1,I,20220602.0,20220622.0,20220701,20220701,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202206011300,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220701,,CN,ES,ES,2022,Q3,Adult
210341311,21034131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, bid (1000 every 12 h)",,,U,,,,,,,,BID,2022,Q3,Dehydration,,2022,Q3,1,I,20220602.0,20220622.0,20220701,20220701,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202206011300,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220701,,CN,ES,ES,2022,Q3,Adult
210341311,21034131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, bid (1000 every 12 h)",,,U,,,,,,,,BID,2022,Q3,Dizziness,,2022,Q3,1,I,20220602.0,20220622.0,20220701,20220701,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202206011300,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220701,,CN,ES,ES,2022,Q3,Adult
210341311,21034131,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, bid (1000 every 12 h)",,,U,,,,,,,,BID,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220602.0,20220622.0,20220701,20220701,EXP,,ES-ELI_LILLY_AND_COMPANY-ES202206011300,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220701,,CN,ES,ES,2022,Q3,Adult
210348353,21034835,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q3,Pemphigoid,,2022,Q3,3,F,20220618.0,20220831.0,20220701,20220905,EXP,,JP-AstraZeneca-2022A230398,ASTRAZENECA,,87.0,YR,,F,Y,,,20220905,,MD,JP,,2022,Q3,Elderly
210352171,21035217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"dose-10, unit-3",,,U,,,,202293.0,,,Tablet,,2022,Q3,Orthostatic hypotension,,2022,Q3,1,I,20220620.0,20220623.0,20220701,20220701,EXP,,GB-AstraZeneca-2022A231259,ASTRAZENECA,,63.0,YR,,M,Y,73.0,KG,20220701,,MD,GB,,2022,Q3,Adult
210352171,21035217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"dose-10, unit-3",,,U,,,,202293.0,,,Tablet,,2022,Q3,Dizziness,,2022,Q3,1,I,20220620.0,20220623.0,20220701,20220701,EXP,,GB-AstraZeneca-2022A231259,ASTRAZENECA,,63.0,YR,,M,Y,73.0,KG,20220701,,MD,GB,,2022,Q3,Adult
210354991,21035499,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,16.8,GM,Y,,AB2107022,,202293.0,0.4,GM,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220520.0,20220625.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A238232,ASTRAZENECA,,45.0,YR,,M,Y,56.0,KG,20220701,,MD,CN,,2022,Q3,Adult
210354991,21035499,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,16.8,GM,Y,,AB2107022,,202293.0,0.4,GM,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220520.0,20220625.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A238232,ASTRAZENECA,,45.0,YR,,M,Y,56.0,KG,20220701,,MD,CN,,2022,Q3,Adult
210354991,21035499,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,16.8,GM,Y,,AB2107022,,202293.0,0.4,GM,Tablet,QD,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,20220520.0,20220625.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A238232,ASTRAZENECA,,45.0,YR,,M,Y,56.0,KG,20220701,,MD,CN,,2022,Q3,Adult
210354991,21035499,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,16.8,GM,Y,,AB2107022,,202293.0,0.4,GM,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220520.0,20220625.0,20220701,20220701,EXP,,CN-AstraZeneca-2022A238232,ASTRAZENECA,,45.0,YR,,M,Y,56.0,KG,20220701,,MD,CN,,2022,Q3,Adult
210364111,21036411,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,,,,,,10.0,MG,Coated tablet,,2022,Q3,Balanoposthitis,,2022,Q3,1,I,20220214.0,20220621.0,20220702,20220702,EXP,IT-MINISAL02-859117,IT-Accord-267642,ACCORD,,83.0,YR,,M,Y,,,20220702,,PH,IT,IT,2022,Q3,Elderly
210364111,21036411,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,,,,,,10.0,MG,Coated tablet,,2022,Q3,Urinary incontinence,,2022,Q3,1,I,20220214.0,20220621.0,20220702,20220702,EXP,IT-MINISAL02-859117,IT-Accord-267642,ACCORD,,83.0,YR,,M,Y,,,20220702,,PH,IT,IT,2022,Q3,Elderly
210364563,21036456,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q3,Fall,,2022,Q3,3,F,20211201.0,20220909.0,20220702,20220927,EXP,,JP-ABBVIE-22P-087-4454113-00,ABBVIE,,62.0,YR,,M,Y,,,20220927,,MD,JP,JP,2022,Q3,Adult
210364563,21036456,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q3,Ankle fracture,,2022,Q3,3,F,20211201.0,20220909.0,20220702,20220927,EXP,,JP-ABBVIE-22P-087-4454113-00,ABBVIE,,62.0,YR,,M,Y,,,20220927,,MD,JP,JP,2022,Q3,Adult
210368261,21036826,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,1,I,20210801.0,20220624.0,20220702,20220702,EXP,DE-BFARM-22003327,DE-Accord-268068,ACCORD,,79.0,YR,E,F,Y,56.0,KG,20220702,,MD,DE,DE,2022,Q3,Elderly
210368261,21036826,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,20210801.0,20220624.0,20220702,20220702,EXP,DE-BFARM-22003327,DE-Accord-268068,ACCORD,,79.0,YR,E,F,Y,56.0,KG,20220702,,MD,DE,DE,2022,Q3,Elderly
210368261,21036826,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Weight decreased,,2022,Q3,1,I,20210801.0,20220624.0,20220702,20220702,EXP,DE-BFARM-22003327,DE-Accord-268068,ACCORD,,79.0,YR,E,F,Y,56.0,KG,20220702,,MD,DE,DE,2022,Q3,Elderly
210368261,21036826,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Lupus-like syndrome,,2022,Q3,1,I,20210801.0,20220624.0,20220702,20220702,EXP,DE-BFARM-22003327,DE-Accord-268068,ACCORD,,79.0,YR,E,F,Y,56.0,KG,20220702,,MD,DE,DE,2022,Q3,Elderly
210369872,21036987,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Sudden death,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Underdose,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sudden death,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Underdose,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Sudden death,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210369872,21036987,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Underdose,,2022,Q3,2,F,20220101.0,20220701.0,20220702,20220706,EXP,,JP-AstraZeneca-2022A238530,ASTRAZENECA,,57.0,YR,,F,Y,,,20220706,,MD,JP,,2022,Q3,Adult
210375522,21037552,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,2,F,20220628.0,20220810.0,20220703,20220814,EXP,,NVSJ2022JP093320,NOVARTIS,,84.0,YR,,M,Y,,,20220815,,MD,JP,JP,2022,Q3,Elderly
210375522,21037552,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,2,F,20220628.0,20220810.0,20220703,20220814,EXP,,NVSJ2022JP093320,NOVARTIS,,84.0,YR,,M,Y,,,20220815,,MD,JP,JP,2022,Q3,Elderly
210382421,21038242,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 TABLET every 12 hours),,,Y,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220318.0,20220621.0,20220704,20220704,EXP,,ES-AUROBINDO-AUR-APL-2022-023776,AUROBINDO,,79.0,YR,,M,Y,,,20220704,,PH,ES,ES,2022,Q3,Elderly
210382421,21038242,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 TABLET every 12 hours),,,Y,,,,,,,Tablet,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220318.0,20220621.0,20220704,20220704,EXP,,ES-AUROBINDO-AUR-APL-2022-023776,AUROBINDO,,79.0,YR,,M,Y,,,20220704,,PH,ES,ES,2022,Q3,Elderly
210382421,21038242,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 TABLET every 12 hours),,,Y,,,,,,,Tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220318.0,20220621.0,20220704,20220704,EXP,,ES-AUROBINDO-AUR-APL-2022-023776,AUROBINDO,,79.0,YR,,M,Y,,,20220704,,PH,ES,ES,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Muscle fatigue,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Lymphopenia,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Asthenia,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Anaemia,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Muscular weakness,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Hypothyroidism,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Fatigue,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210391992,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,,,Film-coated tablet,,2022,Q3,Peripheral swelling,,2022,Q3,2,F,20220329.0,20220719.0,20220704,20220801,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20220801,,PH,IT,IT,2022,Q3,Elderly
210392501,21039250,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,2110166,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Abdominal distension,,2022,Q3,1,I,20220621.0,20220626.0,20220704,20220704,EXP,,CN-AstraZeneca-2022A238660,ASTRAZENECA,,2694.0,WK,,F,Y,65.0,KG,20220704,,MD,CN,,2022,Q3,Elderly
210392501,21039250,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,2110166,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Constipation,,2022,Q3,1,I,20220621.0,20220626.0,20220704,20220704,EXP,,CN-AstraZeneca-2022A238660,ASTRAZENECA,,2694.0,WK,,F,Y,65.0,KG,20220704,,MD,CN,,2022,Q3,Elderly
210393913,21039391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Catatonia,,2022,Q3,3,F,20220623.0,20220810.0,20220704,20220815,EXP,,IT-AstraZeneca-2022A239315,ASTRAZENECA,,27917.0,DY,,F,Y,,,20220815,,MD,IT,,2022,Q3,Elderly
210393913,21039391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,3,F,20220623.0,20220810.0,20220704,20220815,EXP,,IT-AstraZeneca-2022A239315,ASTRAZENECA,,27917.0,DY,,F,Y,,,20220815,,MD,IT,,2022,Q3,Elderly
210393913,21039391,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Coma,,2022,Q3,3,F,20220623.0,20220810.0,20220704,20220815,EXP,,IT-AstraZeneca-2022A239315,ASTRAZENECA,,27917.0,DY,,F,Y,,,20220815,,MD,IT,,2022,Q3,Elderly
210399781,21039978,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20210511.0,20220628.0,20220704,20220704,EXP,,CH-ABBVIE-21K-151-3973433-00,ABBVIE,,57.0,YR,,F,Y,,,20220704,,HP,CH,CH,2022,Q3,Adult
210399781,21039978,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Rash macular,,2022,Q3,1,I,20210511.0,20220628.0,20220704,20220704,EXP,,CH-ABBVIE-21K-151-3973433-00,ABBVIE,,57.0,YR,,F,Y,,,20220704,,HP,CH,CH,2022,Q3,Adult
210403193,21040319,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,710.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,3,F,20220409.0,20220727.0,20220704,20220729,EXP,,SE-AstraZeneca-2022A241971,ASTRAZENECA,,25326.0,DY,,M,Y,,,20220729,,MD,SE,,2022,Q3,Elderly
210403193,21040319,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,710.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,3,F,20220409.0,20220727.0,20220704,20220729,EXP,,SE-AstraZeneca-2022A241971,ASTRAZENECA,,25326.0,DY,,M,Y,,,20220729,,MD,SE,,2022,Q3,Elderly
210411881,21041188,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Death,,2022,Q3,1,I,20220629.0,20220630.0,20220705,20220705,EXP,,BG-AstraZeneca-2022A240535,ASTRAZENECA,,83.0,YR,,F,Y,,,20220705,,MD,BG,,2022,Q3,Elderly
210413552,21041355,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q3,Dyspepsia,,2022,Q3,2,F,20220401.0,20220729.0,20220705,20220809,EXP,,RU-NOVOPROD-932295,NOVO NORDISK,,73.0,YR,,F,Y,86.0,KG,20220809,,MD,RU,RU,2022,Q3,Elderly
210413552,21041355,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20220401.0,20220729.0,20220705,20220809,EXP,,RU-NOVOPROD-932295,NOVO NORDISK,,73.0,YR,,F,Y,86.0,KG,20220809,,MD,RU,RU,2022,Q3,Elderly
210427131,21042713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Compression fracture,,2022,Q3,1,I,,20220627.0,20220705,20220705,EXP,,JP-AstraZeneca-2022A230785,ASTRAZENECA,,100.0,YR,,F,Y,,,20220705,,MD,JP,,2022,Q3,Elderly
210427131,21042713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Underdose,,2022,Q3,1,I,,20220627.0,20220705,20220705,EXP,,JP-AstraZeneca-2022A230785,ASTRAZENECA,,100.0,YR,,F,Y,,,20220705,,MD,JP,,2022,Q3,Elderly
210427131,21042713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Dehydration,,2022,Q3,1,I,,20220627.0,20220705,20220705,EXP,,JP-AstraZeneca-2022A230785,ASTRAZENECA,,100.0,YR,,F,Y,,,20220705,,MD,JP,,2022,Q3,Elderly
210427131,21042713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Decreased appetite,,2022,Q3,1,I,,20220627.0,20220705,20220705,EXP,,JP-AstraZeneca-2022A230785,ASTRAZENECA,,100.0,YR,,F,Y,,,20220705,,MD,JP,,2022,Q3,Elderly
210442371,21044237,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Torsade de pointes,,2022,Q3,1,I,20220510.0,20220704.0,20220705,20220705,EXP,PT-INFARMED-G202205-493,NVSC2022PT152943,NOVARTIS,,69.0,YR,,F,Y,,,20220705,,MD,PT,PT,2022,Q3,Elderly
210442371,21044237,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Electrocardiogram QT prolonged,,2022,Q3,1,I,20220510.0,20220704.0,20220705,20220705,EXP,PT-INFARMED-G202205-493,NVSC2022PT152943,NOVARTIS,,69.0,YR,,F,Y,,,20220705,,MD,PT,PT,2022,Q3,Elderly
210443861,21044386,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220622.0,20220705,20220705,EXP,,CA-B.Braun Medical Inc.-2130548,B BRAUN,,80.0,YR,,F,Y,61.0,KG,20220705,,,CA,CA,2022,Q3,Elderly
210443861,21044386,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220622.0,20220705,20220705,EXP,,CA-B.Braun Medical Inc.-2130548,B BRAUN,,80.0,YR,,F,Y,61.0,KG,20220705,,,CA,CA,2022,Q3,Elderly
210443861,21044386,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Intracranial pressure increased,,2022,Q3,1,I,,20220622.0,20220705,20220705,EXP,,CA-B.Braun Medical Inc.-2130548,B BRAUN,,80.0,YR,,F,Y,61.0,KG,20220705,,,CA,CA,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Expired product administered,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Renal disorder,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Diabetic coma,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210443971,21044397,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,MH0249,,202293.0,,,Tablet,QD,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,20210501.0,20220623.0,20220705,20220705,EXP,,MX-AstraZeneca-2022A234937,ASTRAZENECA,,870.0,MON,,F,Y,157.0,KG,20220705,,CN,MX,,2022,Q3,Elderly
210449901,21044990,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 TABLET each day,200.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,20201223.0,20220627.0,20220705,20220705,EXP,,ES-AstraZeneca-2022A236437,ASTRAZENECA,,91.0,YR,,F,Y,70.0,KG,20220705,,MD,ES,,2022,Q3,Elderly
210450752,21045075,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 mg,,,U,,,,,5.0,MG,,,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,2,F,,20220713.0,20220705,20220721,EXP,,NVSJ2022JP093345,NOVARTIS,,65.0,YR,,M,Y,,,20220722,,MD,JP,JP,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Tongue dry,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Ulcer haemorrhage,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Flatulence,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dyspnoea exertional,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure chronic,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Petechiae,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Conjunctival discolouration,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Melaena,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Faeces discoloured,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Tongue dry,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Ulcer haemorrhage,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Flatulence,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dyspnoea exertional,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure chronic,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Petechiae,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Conjunctival discolouration,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Melaena,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210466311,21046631,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Faeces discoloured,,2022,Q3,1,I,,20220624.0,20220706,20220706,EXP,SI-EMA-2022515-AUTODUP-1652643539284,SI-Accord-267957,ACCORD,,84.0,YR,,F,Y,,,20220706,,MD,SI,SI,2022,Q3,Elderly
210471781,21047178,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood creatinine increased,,2022,Q3,1,I,20220617.0,20220628.0,20220706,20220706,EXP,,RU-AstraZeneca-2022A243677,ASTRAZENECA,,1639.0,WK,,M,Y,,,20220706,,MD,RU,,2022,Q3,Elderly
210471781,21047178,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood urea increased,,2022,Q3,1,I,20220617.0,20220628.0,20220706,20220706,EXP,,RU-AstraZeneca-2022A243677,ASTRAZENECA,,1639.0,WK,,M,Y,,,20220706,,MD,RU,,2022,Q3,Elderly
210471781,21047178,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,1,I,20220617.0,20220628.0,20220706,20220706,EXP,,RU-AstraZeneca-2022A243677,ASTRAZENECA,,1639.0,WK,,M,Y,,,20220706,,MD,RU,,2022,Q3,Elderly
210473971,21047397,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,,,,,,,205649.0,,,Tablet,Q12H,2022,Q3,Toe amputation,,2022,Q3,1,I,20201221.0,20220628.0,20220706,20220706,EXP,,ES-AstraZeneca-2022A236092,ASTRAZENECA,,46.0,YR,,M,Y,103.0,KG,20220706,,MD,ES,,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Left ventricular dysfunction,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Dizziness postural,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Underdose,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Heart rate decreased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Ventricular hypokinesia,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Syncope,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Left ventricular dilatation,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Ejection fraction decreased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Rales,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Blood cholesterol increased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Blood triglycerides increased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Respiratory rate increased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Low density lipoprotein increased,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210476161,21047616,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Oedema,,2022,Q3,1,I,,20220628.0,20220706,20220706,EXP,,NVSC2022TH149298,NOVARTIS,,62.0,YR,,F,Y,,,20220706,,MD,TH,TH,2022,Q3,Adult
210483721,21048372,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,890.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ulcer,,2022,Q3,1,I,20201229.0,20220628.0,20220706,20220706,EXP,,ES-AstraZeneca-2022A236072,ASTRAZENECA,,65.0,YR,,F,Y,78.0,KG,20220706,,MD,ES,,2022,Q3,Elderly
210512181,21051218,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unit dose, Strength: 10 mg, Therapy Start date: ASKU",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,20220210.0,20220627.0,20220707,20220707,EXP,FR-AFSSAPS-RE20220880,FR-TEVA-2022-FR-2051324,TEVA,,62.0,YR,A,M,Y,105.0,KG,20220707,,MD,FR,FR,2022,Q3,Adult
210512181,21051218,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unit dose, Strength: 10 mg, Therapy Start date: ASKU",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Malaise,,2022,Q3,1,I,20220210.0,20220627.0,20220707,20220707,EXP,FR-AFSSAPS-RE20220880,FR-TEVA-2022-FR-2051324,TEVA,,62.0,YR,A,M,Y,105.0,KG,20220707,,MD,FR,FR,2022,Q3,Adult
210512181,21051218,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Unit dose, Strength: 10 mg, Therapy Start date: ASKU",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220210.0,20220627.0,20220707,20220707,EXP,FR-AFSSAPS-RE20220880,FR-TEVA-2022-FR-2051324,TEVA,,62.0,YR,A,M,Y,105.0,KG,20220707,,MD,FR,FR,2022,Q3,Adult
210513761,21051376,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2106219,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hyperthyroidism,,2022,Q3,1,I,20220610.0,20220628.0,20220707,20220707,EXP,,CN-AstraZeneca-2022A240026,ASTRAZENECA,,14368.0,DY,,F,Y,53.0,KG,20220707,,MD,CN,,2022,Q3,Elderly
210513761,21051376,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2106219,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Palpitations,,2022,Q3,1,I,20220610.0,20220628.0,20220707,20220707,EXP,,CN-AstraZeneca-2022A240026,ASTRAZENECA,,14368.0,DY,,F,Y,53.0,KG,20220707,,MD,CN,,2022,Q3,Elderly
210513761,21051376,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2106219,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220610.0,20220628.0,20220707,20220707,EXP,,CN-AstraZeneca-2022A240026,ASTRAZENECA,,14368.0,DY,,F,Y,53.0,KG,20220707,,MD,CN,,2022,Q3,Elderly
210538201,21053820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Renal impairment,,2022,Q3,1,I,20220501.0,20220629.0,20220707,20220707,EXP,,JP-AstraZeneca-2022A204432,ASTRAZENECA,,58.0,YR,,M,Y,,,20220707,,PH,JP,,2022,Q3,Adult
210538201,21053820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q3,COVID-19,,2022,Q3,1,I,20220501.0,20220629.0,20220707,20220707,EXP,,JP-AstraZeneca-2022A204432,ASTRAZENECA,,58.0,YR,,M,Y,,,20220707,,PH,JP,,2022,Q3,Adult
210538201,21053820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220501.0,20220629.0,20220707,20220707,EXP,,JP-AstraZeneca-2022A204432,ASTRAZENECA,,58.0,YR,,M,Y,,,20220707,,PH,JP,,2022,Q3,Adult
210538201,21053820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Blood creatine increased,,2022,Q3,1,I,20220501.0,20220629.0,20220707,20220707,EXP,,JP-AstraZeneca-2022A204432,ASTRAZENECA,,58.0,YR,,M,Y,,,20220707,,PH,JP,,2022,Q3,Adult
210538201,21053820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,1,I,20220501.0,20220629.0,20220707,20220707,EXP,,JP-AstraZeneca-2022A204432,ASTRAZENECA,,58.0,YR,,M,Y,,,20220707,,PH,JP,,2022,Q3,Adult
210542991,21054299,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 MG/1.000 MG; 1 TABLET every 12 hours,,,,,,,205649.0,,,,Q12H,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20200216.0,20220703.0,20220707,20220707,EXP,,ES-AstraZeneca-2022A242246,ASTRAZENECA,,48.0,YR,,F,Y,83.0,KG,20220707,,MD,ES,,2022,Q3,Adult
210557302,21055730,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Restlessness,,2022,Q3,2,F,20220307.0,20220825.0,20220708,20220907,EXP,NL-LRB-00815487,NL-Hikma Pharmaceuticals USA Inc.-NL-H14001-22-58101,HIKMA,,81.0,YR,,M,Y,83.0,KG,20220907,,CN,NL,,2022,Q3,Elderly
210557302,21055730,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Negative thoughts,,2022,Q3,2,F,20220307.0,20220825.0,20220708,20220907,EXP,NL-LRB-00815487,NL-Hikma Pharmaceuticals USA Inc.-NL-H14001-22-58101,HIKMA,,81.0,YR,,M,Y,83.0,KG,20220907,,CN,NL,,2022,Q3,Elderly
210557302,21055730,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Poor quality sleep,,2022,Q3,2,F,20220307.0,20220825.0,20220708,20220907,EXP,NL-LRB-00815487,NL-Hikma Pharmaceuticals USA Inc.-NL-H14001-22-58101,HIKMA,,81.0,YR,,M,Y,83.0,KG,20220907,,CN,NL,,2022,Q3,Elderly
210557302,21055730,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Hallucination,,2022,Q3,2,F,20220307.0,20220825.0,20220708,20220907,EXP,NL-LRB-00815487,NL-Hikma Pharmaceuticals USA Inc.-NL-H14001-22-58101,HIKMA,,81.0,YR,,M,Y,83.0,KG,20220907,,CN,NL,,2022,Q3,Elderly
210557302,21055730,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Nervousness,,2022,Q3,2,F,20220307.0,20220825.0,20220708,20220907,EXP,NL-LRB-00815487,NL-Hikma Pharmaceuticals USA Inc.-NL-H14001-22-58101,HIKMA,,81.0,YR,,M,Y,83.0,KG,20220907,,CN,NL,,2022,Q3,Elderly
210560162,21056016,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5+1000mg BID,,,,,unknown,,,,,,,2022,Q3,COVID-19,,2022,Q3,2,F,,20220707.0,20220708,20220715,EXP,,BR-NOVOPROD-935369,NOVO NORDISK,,50.0,YR,,M,Y,84.0,KG,20220715,,MD,BR,BR,2022,Q3,Adult
210579371,21057937,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110062,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Shock,,2022,Q3,1,I,20220627.0,20220702.0,20220708,20220708,EXP,,CN-AstraZeneca-2022A246548,ASTRAZENECA,,69.0,YR,,F,Y,,,20220708,,MD,CN,,2022,Q3,Elderly
210587551,21058755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chronic lymphocytic leukaemia,,2022,Q3,1,I,20220601.0,20220701.0,20220708,20220708,EXP,,FR-AstraZeneca-2022A245607,ASTRAZENECA,,811.0,MON,,M,Y,,,20220708,,MD,FR,,2022,Q3,Elderly
210587551,21058755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ulcer,,2022,Q3,1,I,20220601.0,20220701.0,20220708,20220708,EXP,,FR-AstraZeneca-2022A245607,ASTRAZENECA,,811.0,MON,,M,Y,,,20220708,,MD,FR,,2022,Q3,Elderly
210587551,21058755,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220601.0,20220701.0,20220708,20220708,EXP,,FR-AstraZeneca-2022A245607,ASTRAZENECA,,811.0,MON,,M,Y,,,20220708,,MD,FR,,2022,Q3,Elderly
210591705,21059170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Myositis,,2022,Q3,5,F,20220628.0,20220809.0,20220708,20220818,EXP,,JP-AstraZeneca-2022A245165,ASTRAZENECA,,29569.0,DY,,M,Y,56.0,KG,20220818,,MD,JP,,2022,Q3,Elderly
210591705,21059170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,5,F,20220628.0,20220809.0,20220708,20220818,EXP,,JP-AstraZeneca-2022A245165,ASTRAZENECA,,29569.0,DY,,M,Y,56.0,KG,20220818,,MD,JP,,2022,Q3,Elderly
210591705,21059170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intervertebral discitis,,2022,Q3,5,F,20220628.0,20220809.0,20220708,20220818,EXP,,JP-AstraZeneca-2022A245165,ASTRAZENECA,,29569.0,DY,,M,Y,56.0,KG,20220818,,MD,JP,,2022,Q3,Elderly
210591705,21059170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Infective spondylitis,,2022,Q3,5,F,20220628.0,20220809.0,20220708,20220818,EXP,,JP-AstraZeneca-2022A245165,ASTRAZENECA,,29569.0,DY,,M,Y,56.0,KG,20220818,,MD,JP,,2022,Q3,Elderly
210591705,21059170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,250.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Prostatitis,,2022,Q3,5,F,20220628.0,20220809.0,20220708,20220818,EXP,,JP-AstraZeneca-2022A245165,ASTRAZENECA,,29569.0,DY,,M,Y,56.0,KG,20220818,,MD,JP,,2022,Q3,Elderly
210614932,21061493,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",710.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20220409.0,20220718.0,20220709,20220719,EXP,,NVSC2022SE156510,NOVARTIS,,25326.0,DY,,M,Y,,,20220719,,MD,SE,SE,2022,Q3,Elderly
210614932,21061493,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",710.0,MG,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Rhabdomyolysis,,2022,Q3,2,F,20220409.0,20220718.0,20220709,20220719,EXP,,NVSC2022SE156510,NOVARTIS,,25326.0,DY,,M,Y,,,20220719,,MD,SE,SE,2022,Q3,Elderly
210632272,21063227,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Film-coated tablet,,2022,Q3,Atrial fibrillation,,2022,Q3,2,F,20220502.0,20220714.0,20220711,20220724,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-032377,BRISTOL MYERS SQUIBB,,42.0,YR,A,M,Y,,,20220725,,HP,DE,DE,2022,Q3,Adult
210632272,21063227,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Film-coated tablet,,2022,Q3,Ejection fraction decreased,,2022,Q3,2,F,20220502.0,20220714.0,20220711,20220724,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-032377,BRISTOL MYERS SQUIBB,,42.0,YR,A,M,Y,,,20220725,,HP,DE,DE,2022,Q3,Adult
210636281,21063628,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220707.0,20220711,20220711,EXP,FR-AFSSAPS-MP20222305,NVSC2022FR156337,NOVARTIS,,61.0,YR,,F,Y,79.0,KG,20220711,,PH,FR,FR,2022,Q3,Adult
210665941,21066594,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Psychiatric symptom,,2022,Q3,1,I,,20220707.0,20220711,20220711,EXP,,NVSJ2022JP093734,NOVARTIS,,83.0,YR,,M,Y,,,20220712,,PH,JP,JP,2022,Q3,Elderly
210671071,21067107,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20191126.0,20220704.0,20220712,20220712,PER,,GB-AMGEN-GBRSP2022115109,AMGEN,,60.0,YR,A,M,Y,82.0,KG,20220711,,HP,GB,GB,2022,Q3,Adult
210671701,21067170,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NB2264,,,10.0,MG,Tablet,QD,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220701.0,20220707.0,20220712,20220712,EXP,,CN-EMD Serono-9335995,EMD SERONO INC,,51.0,YR,A,F,Y,50.0,KG,20220712,,HP,CN,,2022,Q3,Adult
210673132,21067313,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Spinal osteoarthritis,,2022,Q3,2,F,20220301.0,20220714.0,20220712,20220722,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-047965,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,85.0,KG,20220722,,MD,JP,JP,2022,Q3,Elderly
210679411,21067941,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1cp per day, strength 10 mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Rhabdomyolysis,,2022,Q3,1,I,20220416.0,20220701.0,20220712,20220712,EXP,FR-AFSSAPS-MP20221792,FR-Accord-268889,ACCORD,,78.0,YR,E,M,Y,76.0,KG,20220712,,PH,FR,FR,2022,Q3,Elderly
210679411,21067941,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1cp per day, strength 10 mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220416.0,20220701.0,20220712,20220712,EXP,FR-AFSSAPS-MP20221792,FR-Accord-268889,ACCORD,,78.0,YR,E,M,Y,76.0,KG,20220712,,PH,FR,FR,2022,Q3,Elderly
210684372,21068437,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Lymphopenia,,2022,Q3,2,F,20210815.0,20220914.0,20220712,20220924,EXP,PT-INFARMED-J202205-57,PT-Accord-268910,ACCORD,,70.0,YR,E,M,Y,,,20220924,,MD,PT,PT,2022,Q3,Elderly
210684372,21068437,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Asthenia,,2022,Q3,2,F,20210815.0,20220914.0,20220712,20220924,EXP,PT-INFARMED-J202205-57,PT-Accord-268910,ACCORD,,70.0,YR,E,M,Y,,,20220924,,MD,PT,PT,2022,Q3,Elderly
210684372,21068437,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Mucosal inflammation,,2022,Q3,2,F,20210815.0,20220914.0,20220712,20220924,EXP,PT-INFARMED-J202205-57,PT-Accord-268910,ACCORD,,70.0,YR,E,M,Y,,,20220924,,MD,PT,PT,2022,Q3,Elderly
210684372,21068437,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Decreased appetite,,2022,Q3,2,F,20210815.0,20220914.0,20220712,20220924,EXP,PT-INFARMED-J202205-57,PT-Accord-268910,ACCORD,,70.0,YR,E,M,Y,,,20220924,,MD,PT,PT,2022,Q3,Elderly
210686611,21068661,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,35.0,MG,Y,,NB2315,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Dermatitis,,2022,Q3,1,I,20220608.0,20220704.0,20220712,20220712,EXP,,CN-AstraZeneca-2022A248029,ASTRAZENECA,,22141.0,DY,,F,Y,80.0,KG,20220712,,MD,CN,,2022,Q3,Elderly
210687881,21068788,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,Y,U,,,,10.0,MG,Film-coated tablet,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220708.0,20220712,20220712,EXP,FR-AFSSAPS-MP20222305,FR-MYLANLABS-2022M1051910,MYLAN,,61.0,YR,,F,Y,79.0,KG,20220712,,PH,FR,FR,2022,Q3,Adult
210689971,21068997,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220708.0,20220712,20220712,EXP,FR-AFSSAPS-MP20222305,FR-EMD Serono-E2B_90088431,EMD SERONO INC,,61.0,YR,A,F,Y,79.0,KG,20220712,,PH,FR,FR,2022,Q3,Adult
210690561,21069056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cerebral artery occlusion,,2022,Q3,1,I,20220615.0,20220704.0,20220712,20220712,EXP,,CN-AstraZeneca-2022A247848,ASTRAZENECA,,64.0,YR,,M,Y,60.5,KG,20220712,,MD,CN,,2022,Q3,Adult
210690561,21069056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cerebral infarction,,2022,Q3,1,I,20220615.0,20220704.0,20220712,20220712,EXP,,CN-AstraZeneca-2022A247848,ASTRAZENECA,,64.0,YR,,M,Y,60.5,KG,20220712,,MD,CN,,2022,Q3,Adult
210690561,21069056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketosis,,2022,Q3,1,I,20220615.0,20220704.0,20220712,20220712,EXP,,CN-AstraZeneca-2022A247848,ASTRAZENECA,,64.0,YR,,M,Y,60.5,KG,20220712,,MD,CN,,2022,Q3,Adult
210690561,21069056,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cerebral artery stenosis,,2022,Q3,1,I,20220615.0,20220704.0,20220712,20220712,EXP,,CN-AstraZeneca-2022A247848,ASTRAZENECA,,64.0,YR,,M,Y,60.5,KG,20220712,,MD,CN,,2022,Q3,Adult
210702171,21070217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 COMPRIMIDO cada d?a,10680.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20201226.0,20220707.0,20220712,20220712,EXP,,ES-AstraZeneca-2022A247390,ASTRAZENECA,,86.0,YR,,F,Y,66.0,KG,20220712,,MD,ES,,2022,Q3,Elderly
210704602,21070460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,1690.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pancytopenia,,2022,Q3,2,F,20210507.0,20220826.0,20220712,20220831,EXP,,JP-AstraZeneca-2022A249507,ASTRAZENECA,,86.0,YR,,M,Y,,,20220831,,MD,JP,,2022,Q3,Elderly
210704602,21070460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,1690.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Atrial flutter,,2022,Q3,2,F,20210507.0,20220826.0,20220712,20220831,EXP,,JP-AstraZeneca-2022A249507,ASTRAZENECA,,86.0,YR,,M,Y,,,20220831,,MD,JP,,2022,Q3,Elderly
210711921,21071192,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Hypokalaemia,,2022,Q3,1,I,,20220704.0,20220712,20220712,EXP,,FR-AstraZeneca-2022A249619,ASTRAZENECA,,72.0,YR,,F,Y,,,20220712,,MD,FR,,2022,Q3,Elderly
210717341,21071734,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,FORXIGA,1030.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Fungal infection,,2022,Q3,1,I,20220228.0,20220708.0,20220712,20220712,EXP,,ES-AstraZeneca-2022A248488,ASTRAZENECA,,58.0,YR,,M,Y,,,20220712,,MD,ES,,2022,Q3,Adult
210727991,21072799,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 tablet, qd, oral",,,,,2109121,,,,,Tablet,QD,2022,Q3,Herpes virus infection,,2022,Q3,1,I,20220624.0,20220707.0,20220712,20220712,EXP,,CN-009507513-2207CHN003490,MERCK,,76.0,YR,,M,Y,70.0,KG,20220712,,HP,CN,CN,2022,Q3,Elderly
210727991,21072799,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 tablet, qd, oral",,,,,2109121,,,,,Tablet,QD,2022,Q3,Skin ulcer,,2022,Q3,1,I,20220624.0,20220707.0,20220712,20220712,EXP,,CN-009507513-2207CHN003490,MERCK,,76.0,YR,,M,Y,70.0,KG,20220712,,HP,CN,CN,2022,Q3,Elderly
210732711,21073271,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20211026.0,20220705.0,20220712,20220712,EXP,,FR-AstraZeneca-2022A244858,ASTRAZENECA,,73.0,YR,,M,Y,,,20220713,,MD,FR,,2022,Q3,Elderly
210736211,21073621,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Hepatic function abnormal,,2022,Q3,1,I,20220120.0,20220704.0,20220713,20220713,EXP,CN-NMPA-3408011027115202200312,CN-NOVOPROD-935733,NOVO NORDISK,,67.0,YR,,M,Y,70.0,KG,20220713,,HP,CN,CN,2022,Q3,Elderly
210741691,21074169,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Coated tablet,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220707.0,20220713,20220713,EXP,FR-AFSSAPS-MP20222305,FR-BAUSCH-BL-2022-017467,BAUSCH AND LOMB,,61.0,YR,,F,Y,79.0,KG,20220713,,PH,FR,FR,2022,Q3,Adult
210747631,21074763,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220210.0,20220628.0,20220713,20220713,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-344399,RANBAXY,,62.0,YR,,M,Y,105.0,KG,20220713,,MD,FR,FR,2022,Q3,Adult
210747631,21074763,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,20220210.0,20220628.0,20220713,20220713,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-344399,RANBAXY,,62.0,YR,,M,Y,105.0,KG,20220713,,MD,FR,FR,2022,Q3,Adult
210747631,21074763,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q3,Malaise,,2022,Q3,1,I,20220210.0,20220628.0,20220713,20220713,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-344399,RANBAXY,,62.0,YR,,M,Y,105.0,KG,20220713,,MD,FR,FR,2022,Q3,Adult
210754591,21075459,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,NH2988,,202293.0,,,Tablet,QD,2022,Q3,Liver injury,,2022,Q3,1,I,20220620.0,20220705.0,20220713,20220713,EXP,,CN-AstraZeneca-2022A249540,ASTRAZENECA,,49.0,YR,,F,Y,74.0,KG,20220713,,MD,CN,,2022,Q3,Adult
210755121,21075512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,1,I,,20220705.0,20220713,20220713,EXP,,RU-AstraZeneca-2022A249896,ASTRAZENECA,,64.0,YR,,F,Y,,,20220713,,HP,RU,,2022,Q3,Adult
210755121,21075512,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220705.0,20220713,20220713,EXP,,RU-AstraZeneca-2022A249896,ASTRAZENECA,,64.0,YR,,F,Y,,,20220713,,HP,RU,,2022,Q3,Adult
210755131,21075513,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,U,,,,202293.0,,,Tablet,,2022,Q3,Peripheral ischaemia,,2022,Q3,1,I,20220701.0,20220710.0,20220713,20220713,EXP,,GB-AstraZeneca-2022A250021,ASTRAZENECA,,67.0,YR,,M,Y,120.0,KG,20220713,,MD,GB,,2022,Q3,Elderly
210759262,21075926,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, 1x/day",,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Myelopathy,,2022,Q3,2,F,20220301.0,20220714.0,20220713,20220714,EXP,,JP-PFIZER INC-202200751795,PFIZER,,8.0,DEC,,M,Y,85.0,KG,20220714,,MD,JP,JP,2022,Q3,Child
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Post-traumatic stress disorder,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Septic shock,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Post intensive care syndrome,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210785201,21078520,5,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Acute stress disorder,,2022,Q3,1,I,20190101.0,20220706.0,20220713,20220713,EXP,,CH-DSJP-DSE-2022-124313,DAIICHI,Benzakour L; Kakoraiti E; Perrin A; Cereghetti S; Assal F. Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019: a case report. Journal of Medical Case Reports. 2022;16:263,67.0,YR,,M,Y,,,20220713,,MD,CH,CH,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Cough,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Blood pressure abnormal,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Rhinorrhoea,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,COVID-19,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Body height decreased,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Laziness,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Endocarditis,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210786131,21078613,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q3,Tendonitis,,2022,Q3,1,I,20220601.0,20220707.0,20220713,20220713,EXP,,MX-AstraZeneca-2022A251437,ASTRAZENECA,,20576.0,DY,,F,Y,94.0,KG,20220714,,CN,MX,,2022,Q3,Elderly
210811161,21081116,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Confusional state,,2022,Q3,1,I,20220623.0,20220702.0,20220714,20220714,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-068733,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,83.0,KG,20220714,,HP,US,US,2022,Q3,Elderly
210814301,21081430,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2017025,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal failure,,2022,Q3,1,I,20220624.0,20220705.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249548,ASTRAZENECA,,63.0,YR,,M,Y,80.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure fluctuation,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210814351,21081435,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,nc2501,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood pressure fluctuation,,2022,Q3,1,I,20220612.0,20220706.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A249529,ASTRAZENECA,,37.0,YR,,M,Y,60.0,KG,20220714,,MD,CN,,2022,Q3,Adult
210815645,21081564,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q3,Pneumonia bacterial,,2022,Q3,5,F,20220628.0,20220819.0,20220714,20220826,EXP,,BR-TAKEDA-2022TUS045672,TAKEDA,,71.0,YR,,M,Y,55.4,KG,20220826,,MD,BR,BR,2022,Q3,Elderly
210816131,21081613,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,SARS-CoV-2 test negative,,2022,Q3,1,I,20220525.0,20220706.0,20220714,20220714,EXP,,JP-AstraZeneca-2022A208078,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220714,,MD,JP,,2022,Q3,Elderly
210816131,21081613,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Prerenal failure,,2022,Q3,1,I,20220525.0,20220706.0,20220714,20220714,EXP,,JP-AstraZeneca-2022A208078,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220714,,MD,JP,,2022,Q3,Elderly
210816131,21081613,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220525.0,20220706.0,20220714,20220714,EXP,,JP-AstraZeneca-2022A208078,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220714,,MD,JP,,2022,Q3,Elderly
210816131,21081613,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Dehydration,,2022,Q3,1,I,20220525.0,20220706.0,20220714,20220714,EXP,,JP-AstraZeneca-2022A208078,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220714,,MD,JP,,2022,Q3,Elderly
210819181,21081918,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, 1x/j",,,,,,,,,,,,2022,Q3,Interstitial lung disease,,2022,Q3,1,I,20220515.0,20220708.0,20220714,20220714,EXP,FR-AFSSAPS-LL20222043,FR-MYLANLABS-2022M1051992,MYLAN,,70.0,YR,,M,Y,107.0,KG,20220714,,PH,FR,FR,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Anal haemorrhage,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Constipation,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Dry skin,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Abdominal discomfort,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Throat tightness,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Oesophagitis,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Tracheal pain,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Urticaria,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Pharyngeal inflammation,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Blister,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Oropharyngeal pain,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Eyelid injury,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Odynophagia,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Pharyngeal hypoaesthesia,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Skin lesion,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Oesophageal pain,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Eructation,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Platelet count decreased,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Paralysis,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Yellow skin,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Abnormal faeces,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Flatulence,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210831343,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,,,,,,,,,,,,,2022,Q3,Gastrointestinal disorder,,2022,Q3,3,F,20220101.0,20220915.0,20220714,20220919,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20220919,,CN,PE,PE,2022,Q3,Elderly
210835641,21083564,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,,2022,Q3,Peripheral ischaemia,,2022,Q3,1,I,20220630.0,20220707.0,20220714,20220714,EXP,,GB-AstraZeneca-2022A251023,ASTRAZENECA,,75.0,YR,,M,Y,,,20220714,,MD,GB,,2022,Q3,Elderly
210835681,21083568,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220527.0,20220711.0,20220714,20220714,EXP,,FR-AstraZeneca-2022A250934,ASTRAZENECA,,67.0,YR,,F,Y,54.0,KG,20220714,,MD,FR,,2022,Q3,Elderly
210835681,21083568,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal tubular acidosis,,2022,Q3,1,I,20220527.0,20220711.0,20220714,20220714,EXP,,FR-AstraZeneca-2022A250934,ASTRAZENECA,,67.0,YR,,F,Y,54.0,KG,20220714,,MD,FR,,2022,Q3,Elderly
210847531,21084753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NA3031,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pruritus,,2022,Q3,1,I,20220612.0,20220708.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A251570,ASTRAZENECA,,16282.0,DY,,M,Y,,,20220714,,MD,CN,,2022,Q3,Elderly
210847531,21084753,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NA3031,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Erythema,,2022,Q3,1,I,20220612.0,20220708.0,20220714,20220714,EXP,,CN-AstraZeneca-2022A251570,ASTRAZENECA,,16282.0,DY,,M,Y,,,20220714,,MD,CN,,2022,Q3,Elderly
210847822,21084782,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q3,Interstitial lung disease,,2022,Q3,2,F,20210402.0,20220922.0,20220714,20220930,EXP,,JP-AstraZeneca-2022A250369,ASTRAZENECA,,53.0,YR,,M,Y,,,20220930,,MD,JP,,2022,Q3,Adult
210847921,21084792,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20211220.0,20220706.0,20220714,20220714,EXP,PT-INFARMED-T202202-264,PT-Vifor (International) Inc.-VIT-2022-04837,VIFOR,,77.0,YR,,M,Y,80.0,KG,20220714,,PH,PT,PT,2022,Q3,Elderly
210851931,21085193,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Dry mouth,,2022,Q3,1,I,,20220707.0,20220714,20220714,EXP,,SE-AstraZeneca-2022A247528,ASTRAZENECA,,66.0,YR,,F,Y,,,20220714,,MD,SE,,2022,Q3,Elderly
210868956,21086895,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Drug eruption,,2022,Q3,6,F,20220616.0,20220805.0,20220715,20220812,EXP,,JP-AstraZeneca-2022A252486,ASTRAZENECA,,74.0,YR,,F,Y,54.0,KG,20220812,,MD,JP,,2022,Q3,Elderly
210873701,21087370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,Y,D,,,,,,,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,1,I,20220216.0,,20220714,20220714,DIR,FDA-CDER-CTU-2022-55822,,FDA-CTU,,45.0,YR,,M,N,94.0,KG,20220418,N,PH,US,,2022,Q3,Adult
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Oedema,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Blood potassium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Blood sodium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Sleep apnoea syndrome,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Blood iron decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Decreased appetite,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210873931,21087393,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q3,Blood magnesium decreased,,2022,Q3,1,I,20220101.0,20220706.0,20220715,20220715,EXP,,US-Inventia-000564,INVENTIA HEALTHCARE,,76.0,YR,E,M,Y,97.5,KG,20220715,,CN,US,US,2022,Q3,Elderly
210878652,21087865,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q3,Renal impairment,,2022,Q3,2,F,,20220728.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A245164,ASTRAZENECA,,88.0,YR,,M,Y,,,20220805,,PH,JP,,2022,Q3,Elderly
210885972,21088597,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,,20220720.0,20220715,20220725,EXP,,GB-AstraZeneca-2022A251413,ASTRAZENECA,,68.0,YR,,F,Y,,,20220725,,MD,GB,,2022,Q3,Elderly
210885972,21088597,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Cardiac arrest,,2022,Q3,2,F,,20220720.0,20220715,20220725,EXP,,GB-AstraZeneca-2022A251413,ASTRAZENECA,,68.0,YR,,F,Y,,,20220725,,MD,GB,,2022,Q3,Elderly
210885972,21088597,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,,20220720.0,20220715,20220725,EXP,,GB-AstraZeneca-2022A251413,ASTRAZENECA,,68.0,YR,,F,Y,,,20220725,,MD,GB,,2022,Q3,Elderly
210885972,21088597,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Cardiac arrest,,2022,Q3,2,F,,20220720.0,20220715,20220725,EXP,,GB-AstraZeneca-2022A251413,ASTRAZENECA,,68.0,YR,,F,Y,,,20220725,,MD,GB,,2022,Q3,Elderly
210886962,21088696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Thirst,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Weight increased,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Thirst,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Weight increased,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210886962,21088696,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,20220601.0,20220729.0,20220715,20220805,EXP,,JP-AstraZeneca-2022A252495,ASTRAZENECA,,46.0,YR,,F,Y,91.0,KG,20220805,,MD,JP,,2022,Q3,Adult
210887191,21088719,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg DAILY,,,Y,N,,,,,,,,2022,Q3,Renal tubular acidosis,,2022,Q3,1,I,20220527.0,20220711.0,20220715,20220715,EXP,,FR-ANIPHARMA-2022-FR-000134,ANI,,67.0,YR,,F,Y,64.0,KG,20220715,,MD,FR,FR,2022,Q3,Elderly
210887191,21088719,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg DAILY,,,Y,N,,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220527.0,20220711.0,20220715,20220715,EXP,,FR-ANIPHARMA-2022-FR-000134,ANI,,67.0,YR,,F,Y,64.0,KG,20220715,,MD,FR,FR,2022,Q3,Elderly
210897581,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Lactic acidosis,,2022,Q3,1,I,20220520.0,20220713.0,20220715,20220715,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20220715,,CN,ES,ES,2022,Q3,Elderly
210897581,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220520.0,20220713.0,20220715,20220715,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20220715,,CN,ES,ES,2022,Q3,Elderly
210897581,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,1,I,20220520.0,20220713.0,20220715,20220715,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20220715,,CN,ES,ES,2022,Q3,Elderly
210897581,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20220520.0,20220713.0,20220715,20220715,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20220715,,CN,ES,ES,2022,Q3,Elderly
210909032,21090903,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"unit dose : 10 mg , frequency time : 1 day",,,D,,UNKNOWN,,,10.0,MG,,,2022,Q3,Ischaemic stroke,,2022,Q3,2,F,20210518.0,20220901.0,20220716,20220909,EXP,FR-AFSSAPS-TS20221513,FR-TEVA-2022-FR-2054558,TEVA,,57.0,YR,A,M,Y,,,20220909,,MD,FR,FR,2022,Q3,Adult
210910251,21091025,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK (1x/d),,,,,,,,,,,,2022,Q3,Interstitial lung disease,,2022,Q3,1,I,20220515.0,20220705.0,20220716,20220716,EXP,,FR-AUROBINDO-AUR-APL-2022-026125,AUROBINDO,,70.0,YR,,M,Y,107.0,KG,20220716,,PH,FR,FR,2022,Q3,Elderly
210910791,21091079,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",70.0,MG,D,,,,,10.0,MG,,QD,2022,Q3,Hepatitis acute,,2022,Q3,1,I,20220523.0,20220715.0,20220716,20220716,EXP,FR-AFSSAPS-TS20221674,NVSC2022FR161328,NOVARTIS,,33.0,YR,,F,Y,,,20220716,,MD,FR,FR,2022,Q3,Young Adult
210919211,21091921,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 TABLET every 12 hours,,,,,,,205649.0,,,Tablet,Q12H,2022,Q3,Pyelonephritis acute,,2022,Q3,1,I,20210616.0,20220711.0,20220717,20220717,EXP,,ES-AstraZeneca-2022A251175,ASTRAZENECA,,55.0,YR,,F,Y,117.0,KG,20220718,,MD,ES,,2022,Q3,Adult
210919211,21091921,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 TABLET every 12 hours,,,,,,,205649.0,,,Tablet,Q12H,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20210616.0,20220711.0,20220717,20220717,EXP,,ES-AstraZeneca-2022A251175,ASTRAZENECA,,55.0,YR,,F,Y,117.0,KG,20220718,,MD,ES,,2022,Q3,Adult
210919211,21091921,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,1 TABLET every 12 hours,,,,,,,205649.0,,,Tablet,Q12H,2022,Q3,Candida infection,,2022,Q3,1,I,20210616.0,20220711.0,20220717,20220717,EXP,,ES-AstraZeneca-2022A251175,ASTRAZENECA,,55.0,YR,,F,Y,117.0,KG,20220718,,MD,ES,,2022,Q3,Adult
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Oedema peripheral,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Prescribed overdose,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Fatigue,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Dyspnoea,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Abdominal mass,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Infection,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Fear,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Anxiety,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Pyrexia,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Cough,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Insomnia,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Weight decreased,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Weight increased,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210935315,21093531,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Rash pruritic,,2022,Q3,5,F,20220510.0,20220823.0,20220718,20220831,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-042306,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,91.0,KG,20220831,,CN,CA,CA,2022,Q3,Elderly
210936555,21093655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Platelet count decreased,,2022,Q3,5,F,20220703.0,20220802.0,20220718,20220809,EXP,,CN-ROCHE-3139932,ROCHE,,79.0,YR,,F,Y,60.7,KG,20220809,,MD,CN,,2022,Q3,Elderly
210941701,21094170,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Death,,2022,Q3,1,I,20220713.0,20220713.0,20220718,20220718,EXP,,ZA-AstraZeneca-2022A255848,ASTRAZENECA,,26943.0,DY,,M,Y,,,20220718,,CN,ZA,,2022,Q3,Elderly
210954903,21095490,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Anaphylactic shock,,2022,Q3,3,F,20220712.0,20220812.0,20220718,20220819,EXP,,CH-BRACCO-2022CH02749,BRACCO,,65.0,YR,,M,Y,,,20220819,,PH,CH,CH,2022,Q3,Elderly
210977071,21097707,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pneumonitis,,2022,Q3,1,I,,20220707.0,20220719,20220719,EXP,,GB-AUROBINDO-AUR-APL-2022-026337,AUROBINDO,,79.0,YR,,M,Y,,,20220719,,PH,GB,GB,2022,Q3,Elderly
210978681,21097868,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Decreased appetite,,2022,Q3,1,I,20220501.0,20220712.0,20220719,20220719,EXP,,FR-AstraZeneca-2022A251752,ASTRAZENECA,,40.0,YR,,F,Y,83.0,KG,20220719,,MD,FR,,2022,Q3,Adult
210978681,21097868,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220501.0,20220712.0,20220719,20220719,EXP,,FR-AstraZeneca-2022A251752,ASTRAZENECA,,40.0,YR,,F,Y,83.0,KG,20220719,,MD,FR,,2022,Q3,Adult
210978681,21097868,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,20220501.0,20220712.0,20220719,20220719,EXP,,FR-AstraZeneca-2022A251752,ASTRAZENECA,,40.0,YR,,F,Y,83.0,KG,20220719,,MD,FR,,2022,Q3,Adult
210983091,21098309,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, per 24 hour",,,,,,,,5.0,MG,,,2022,Q3,Clostridium difficile infection,,2022,Q3,1,I,,20211015.0,20220719,20220719,PER,US-MLMSERVICE-20211011-3160637-1,US-STRIDES ARCOLAB LIMITED-2021SP029019,STRIDES,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor?Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings. 2021",55.0,YR,,M,Y,,,20220719,,MD,US,US,2022,Q3,Adult
210983091,21098309,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, per day",,,,,,,,10.0,MG,,,2022,Q3,Clostridium difficile infection,,2022,Q3,1,I,,20211015.0,20220719,20220719,PER,US-MLMSERVICE-20211011-3160637-1,US-STRIDES ARCOLAB LIMITED-2021SP029019,STRIDES,"Cha BM, Davoudi R, DiVita MC, Fan AM, Kamath MY. Sodium-Glucose Cotransporter-2 Inhibitor?Associated Euglycemic Diabetic Ketoacidosis After Orthotopic Heart Transplant in a Prediabetic Patient: A Case Report.. Transplantation Proceedings. 2021",55.0,YR,,M,Y,,,20220719,,MD,US,US,2022,Q3,Adult
210987321,21098732,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (ONE tablet to be taken ONCE  a day for diabetes)",,,,,,,,,,Tablet,QD,2022,Q3,Suicidal ideation,,2022,Q3,1,I,20220714.0,20220717.0,20220719,20220719,EXP,GB-MHRA-TPP9761699C7406336YC1657803951532,GB-MYLANLABS-2022M1079080,MYLAN,,79.0,YR,,M,Y,82.0,KG,20220719,,PH,GB,GB,2022,Q3,Elderly
210990393,21099039,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,3,F,20210119.0,20220901.0,20220719,20220906,EXP,,CN-ROCHE-2762299,ROCHE,,57.0,YR,,M,Y,80.0,KG,20220906,,MD,CN,,2022,Q3,Adult
211013321,21101332,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 DF every 12 hours,,,U,,,,,,,,BID,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20210523.0,20220711.0,20220719,20220719,EXP,ES-AEMPS-915528,ES-PFIZER INC-202200945586,PFIZER,,80.0,YR,,M,Y,,,20220719,,PH,ES,ES,2022,Q3,Elderly
211013321,21101332,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 DF every 12 hours,,,U,,,,,,,,BID,2022,Q3,Atrioventricular block,,2022,Q3,1,I,20210523.0,20220711.0,20220719,20220719,EXP,ES-AEMPS-915528,ES-PFIZER INC-202200945586,PFIZER,,80.0,YR,,M,Y,,,20220719,,PH,ES,ES,2022,Q3,Elderly
211013321,21101332,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 DF every 12 hours,,,U,,,,,,,,BID,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20210523.0,20220711.0,20220719,20220719,EXP,ES-AEMPS-915528,ES-PFIZER INC-202200945586,PFIZER,,80.0,YR,,M,Y,,,20220719,,PH,ES,ES,2022,Q3,Elderly
211013321,21101332,3,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 DF every 12 hours,,,U,,,,,,,,BID,2022,Q3,Blood creatinine increased,,2022,Q3,1,I,20210523.0,20220711.0,20220719,20220719,EXP,ES-AEMPS-915528,ES-PFIZER INC-202200945586,PFIZER,,80.0,YR,,M,Y,,,20220719,,PH,ES,ES,2022,Q3,Elderly
211014152,21101415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20220301.0,20220707.0,20220719,20220720,EXP,,FR-AstraZeneca-2022A251408,ASTRAZENECA,,85.0,YR,,F,Y,,,20220721,,MD,FR,,2022,Q3,Elderly
211014152,21101415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,2,F,20220301.0,20220707.0,20220719,20220720,EXP,,FR-AstraZeneca-2022A251408,ASTRAZENECA,,85.0,YR,,F,Y,,,20220721,,MD,FR,,2022,Q3,Elderly
211014152,21101415,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,2,F,20220301.0,20220707.0,20220719,20220720,EXP,,FR-AstraZeneca-2022A251408,ASTRAZENECA,,85.0,YR,,F,Y,,,20220721,,MD,FR,,2022,Q3,Elderly
211016932,21101693,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1740.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Skin necrosis,,2022,Q3,2,F,20220627.0,20220714.0,20220719,20220726,EXP,,NO-AstraZeneca-2022A254659,ASTRAZENECA,,69.0,YR,,M,Y,,,20220726,,MD,NO,,2022,Q3,Elderly
211016932,21101693,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1740.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal abscess,,2022,Q3,2,F,20220627.0,20220714.0,20220719,20220726,EXP,,NO-AstraZeneca-2022A254659,ASTRAZENECA,,69.0,YR,,M,Y,,,20220726,,MD,NO,,2022,Q3,Elderly
211016932,21101693,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1740.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,2,F,20220627.0,20220714.0,20220719,20220726,EXP,,NO-AstraZeneca-2022A254659,ASTRAZENECA,,69.0,YR,,M,Y,,,20220726,,MD,NO,,2022,Q3,Elderly
211016952,21101695,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5 MG/1.000 MG, 1 TABLET every 12 hours",,,Y,,,,205649.0,,,,Q12H,2022,Q3,Metabolic acidosis,,2022,Q3,2,F,20210521.0,20220711.0,20220719,20220726,EXP,,ES-AstraZeneca-2022A250909,ASTRAZENECA,,80.0,YR,,F,Y,55.0,KG,20220726,,MD,ES,,2022,Q3,Elderly
211022811,21102281,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,U,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220304.0,20220718.0,20220719,20220719,EXP,FR-AFSSAPS-RE20221027,NVSC2022FR162587,NOVARTIS,,83.0,YR,,F,Y,90.0,KG,20220719,,MD,FR,FR,2022,Q3,Elderly
211027371,21102737,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg od;,,,,,,,202293.0,,,,,2022,Q3,Skin ulcer,,2022,Q3,1,I,20220510.0,20220712.0,20220720,20220720,EXP,,GB-AstraZeneca-2022A255613,ASTRAZENECA,,52.0,YR,,F,Y,,,20220720,,MD,GB,,2022,Q3,Adult
211030221,21103022,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,unit dose and strength : 10 mg,,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220713.0,20220720,20220720,EXP,FR-AFSSAPS-MP20222305,FR-TEVA-2022-FR-2056164,TEVA,,61.0,YR,A,F,Y,79.0,KG,20220720,,PH,FR,FR,2022,Q3,Adult
211030581,21103058,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20220601.0,20220713.0,20220720,20220720,EXP,SE-MPA-2022-016866,SE-TEVA-2022-SE-2055647,TEVA,,78.0,YR,E,F,Y,,,20220720,,MD,SE,SE,2022,Q3,Elderly
211030581,21103058,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q3,Gastrointestinal inflammation,,2022,Q3,1,I,20220601.0,20220713.0,20220720,20220720,EXP,SE-MPA-2022-016866,SE-TEVA-2022-SE-2055647,TEVA,,78.0,YR,E,F,Y,,,20220720,,MD,SE,SE,2022,Q3,Elderly
211038122,21103812,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood creatine phosphokinase increased,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Immune-mediated myositis,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg/1000 mg,,,Y,,,,,,,,BID,2022,Q3,Fatigue,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg/1000 mg,,,Y,,,,,,,,BID,2022,Q3,Muscular weakness,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg/1000 mg,,,Y,,,,,,,,BID,2022,Q3,Blood creatine phosphokinase increased,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211038122,21103812,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,5 mg/1000 mg,,,Y,,,,,,,,BID,2022,Q3,Immune-mediated myositis,,2022,Q3,2,F,,20220720.0,20220720,20220804,EXP,,IT-AUROBINDO-AUR-APL-2022-028188,AUROBINDO,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F, Del Sette M. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors.. Neurological Sciences. 2022;43:4567?4570",76.0,YR,,F,Y,,,20220804,,HP,IT,IT,2022,Q3,Elderly
211039921,21103992,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",70.0,MG,D,,,,,10.0,MG,,QD,2022,Q3,Hepatitis acute,,2022,Q3,1,I,20220523.0,20220718.0,20220720,20220720,EXP,FR-AFSSAPS-TS20221674,FR-MYLANLABS-2022M1079287,MYLAN,,33.0,YR,,F,Y,,,20220720,,MD,FR,FR,2022,Q3,Young Adult
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,Post intensive care syndrome,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,Acute stress disorder,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,Post-traumatic stress disorder,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211040011,21104001,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,Unknown,,,,,,,2022,Q3,Septic shock,,2022,Q3,1,I,20190101.0,20220706.0,20220720,20220720,EXP,,CH-COSETTE-CP2022CH000055,COSETTE PHARMACEUTICALS,Benzakour L.Psychiatric reaction of an intensive care unit survivor in the context of coronavirus disease 2019.Journal of Medical Case Reports.2022;16,67.0,YR,E,M,Y,,,20220720,,MD,CH,CH,2022,Q3,Elderly
211043371,21104337,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,years; strength: 10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Anal abscess,,2022,Q3,1,I,20220301.0,20220713.0,20220720,20220720,EXP,FR-AFSSAPS-AM20221349,FR-Accord-269843,ACCORD,,60.0,YR,A,M,Y,84.0,KG,20220720,,PH,FR,FR,2022,Q3,Adult
211043371,21104337,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,years; strength: 10 mg,,,,,,,,,,Film-coated tablet,,2022,Q3,Anal fistula,,2022,Q3,1,I,20220301.0,20220713.0,20220720,20220720,EXP,FR-AFSSAPS-AM20221349,FR-Accord-269843,ACCORD,,60.0,YR,A,M,Y,84.0,KG,20220720,,PH,FR,FR,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Flushing,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Feeling hot,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211045221,21104522,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Infusion related reaction,,2022,Q3,1,I,20220703.0,,20220719,20220719,DIR,623690,,FDA-CTU,,52.0,YR,,M,N,78.0,KG,20220719,N,PH,US,,2022,Q3,Adult
211046351,21104635,4,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,,UNK,,,,,,,,,,,,2022,Q3,Sneezing,,2022,Q3,1,I,20220717.0,20220718.0,20220720,20220720,PER,,US-PFIZER INC-202200978394,PFIZER,,68.0,YR,,F,Y,,,20220720,,CN,US,US,2022,Q3,Elderly
211046351,21104635,4,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,,UNK,,,,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,20220717.0,20220718.0,20220720,20220720,PER,,US-PFIZER INC-202200978394,PFIZER,,68.0,YR,,F,Y,,,20220720,,CN,US,US,2022,Q3,Elderly
211046351,21104635,4,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,,UNK,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20220717.0,20220718.0,20220720,20220720,PER,,US-PFIZER INC-202200978394,PFIZER,,68.0,YR,,F,Y,,,20220720,,CN,US,US,2022,Q3,Elderly
211046351,21104635,4,C,QTERN [DAPAGLIFLOZIN PROPANEDIOL MONOHYDRATE;SAXAGLIPTIN HYDROCHLORIDE,,2,,UNK,,,,,,,,,,,,2022,Q3,Rhinorrhoea,,2022,Q3,1,I,20220717.0,20220718.0,20220720,20220720,PER,,US-PFIZER INC-202200978394,PFIZER,,68.0,YR,,F,Y,,,20220720,,CN,US,US,2022,Q3,Elderly
211046452,21104645,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,2,F,20220601.0,20220712.0,20220720,20220727,EXP,,RU-AstraZeneca-2022A258447,ASTRAZENECA,,80.0,YR,,F,Y,88.0,KG,20220727,,HP,RU,,2022,Q3,Elderly
211046452,21104645,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Constipation,,2022,Q3,2,F,20220601.0,20220712.0,20220720,20220727,EXP,,RU-AstraZeneca-2022A258447,ASTRAZENECA,,80.0,YR,,F,Y,88.0,KG,20220727,,HP,RU,,2022,Q3,Elderly
211051091,21105109,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Abnormal behaviour,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,,CA-PFIZER INC-202200961167,PFIZER,,77.0,YR,,F,Y,,,20220720,,PH,CA,CA,2022,Q3,Elderly
211051091,21105109,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Confusional state,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,,CA-PFIZER INC-202200961167,PFIZER,,77.0,YR,,F,Y,,,20220720,,PH,CA,CA,2022,Q3,Elderly
211051091,21105109,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Delirium,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,,CA-PFIZER INC-202200961167,PFIZER,,77.0,YR,,F,Y,,,20220720,,PH,CA,CA,2022,Q3,Elderly
211060842,21106084,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,Q12H,2022,Q3,Blood creatinine increased,,2022,Q3,2,F,20210523.0,20220712.0,20220720,20220727,EXP,,ES-AstraZeneca-2022A251713,ASTRAZENECA,,80.0,YR,,M,Y,,,20220727,,MD,ES,,2022,Q3,Elderly
211060842,21106084,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,Q12H,2022,Q3,Hyperkalaemia,,2022,Q3,2,F,20210523.0,20220712.0,20220720,20220727,EXP,,ES-AstraZeneca-2022A251713,ASTRAZENECA,,80.0,YR,,M,Y,,,20220727,,MD,ES,,2022,Q3,Elderly
211060842,21106084,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,1 TABLET every 12 hours,,,Y,,,,205649.0,,,Tablet,Q12H,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20210523.0,20220712.0,20220720,20220727,EXP,,ES-AstraZeneca-2022A251713,ASTRAZENECA,,80.0,YR,,M,Y,,,20220727,,MD,ES,,2022,Q3,Elderly
211061941,21106194,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"1 TABLET every 12 hours, Tablet 1 DF BID, 5 mg/1,000 mg 56 tablets",,,U,,,,,,,Tablet,Q12H,2022,Q3,Blood creatinine increased,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,ES-AEMPS-915528,ES-BAUSCH-BL-2022-018206,BAUSCH AND LOMB,,80.0,YR,,M,Y,,,20220720,,PH,ES,ES,2022,Q3,Elderly
211061941,21106194,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"1 TABLET every 12 hours, Tablet 1 DF BID, 5 mg/1,000 mg 56 tablets",,,U,,,,,,,Tablet,Q12H,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,ES-AEMPS-915528,ES-BAUSCH-BL-2022-018206,BAUSCH AND LOMB,,80.0,YR,,M,Y,,,20220720,,PH,ES,ES,2022,Q3,Elderly
211061941,21106194,4,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"1 TABLET every 12 hours, Tablet 1 DF BID, 5 mg/1,000 mg 56 tablets",,,U,,,,,,,Tablet,Q12H,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,,20220713.0,20220720,20220720,EXP,ES-AEMPS-915528,ES-BAUSCH-BL-2022-018206,BAUSCH AND LOMB,,80.0,YR,,M,Y,,,20220720,,PH,ES,ES,2022,Q3,Elderly
211065092,21106509,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ventricular tachycardia,,2022,Q3,2,F,20191201.0,20220712.0,20220720,20220727,EXP,,DE-AstraZeneca-2022A255277,ASTRAZENECA,,21.0,YR,,M,Y,,,20220727,,MD,DE,,2022,Q3,Youth
211065092,21106509,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Atypical pneumonia,,2022,Q3,2,F,20191201.0,20220712.0,20220720,20220727,EXP,,DE-AstraZeneca-2022A255277,ASTRAZENECA,,21.0,YR,,M,Y,,,20220727,,MD,DE,,2022,Q3,Youth
211065092,21106509,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,2,F,20191201.0,20220712.0,20220720,20220727,EXP,,DE-AstraZeneca-2022A255277,ASTRAZENECA,,21.0,YR,,M,Y,,,20220727,,MD,DE,,2022,Q3,Youth
211065092,21106509,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,2,F,20191201.0,20220712.0,20220720,20220727,EXP,,DE-AstraZeneca-2022A255277,ASTRAZENECA,,21.0,YR,,M,Y,,,20220727,,MD,DE,,2022,Q3,Youth
211065092,21106509,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Bundle branch block left,,2022,Q3,2,F,20191201.0,20220712.0,20220720,20220727,EXP,,DE-AstraZeneca-2022A255277,ASTRAZENECA,,21.0,YR,,M,Y,,,20220727,,MD,DE,,2022,Q3,Youth
211065362,21106536,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hepatitis acute,,2022,Q3,2,F,20220523.0,20220715.0,20220720,20220727,EXP,,FR-AstraZeneca-2022A256209,ASTRAZENECA,,33.0,YR,,F,Y,,,20220727,,MD,FR,,2022,Q3,Young Adult
211081562,21108156,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5780.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,2,F,20220703.0,20220715.0,20220720,20220727,EXP,,NO-AstraZeneca-2022A256444,ASTRAZENECA,,73.0,YR,,F,Y,,,20220727,,MD,NO,,2022,Q3,Elderly
211081562,21108156,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5780.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,2,F,20220703.0,20220715.0,20220720,20220727,EXP,,NO-AstraZeneca-2022A256444,ASTRAZENECA,,73.0,YR,,F,Y,,,20220727,,MD,NO,,2022,Q3,Elderly
211081562,21108156,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,5780.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tachypnoea,,2022,Q3,2,F,20220703.0,20220715.0,20220720,20220727,EXP,,NO-AstraZeneca-2022A256444,ASTRAZENECA,,73.0,YR,,F,Y,,,20220727,,MD,NO,,2022,Q3,Elderly
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Asthenia,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Malaise,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Osteoarthritis,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Hypertensive crisis,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Femoroacetabular impingement,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Paraesthesia,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Diplopia,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Carotid arteriosclerosis,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211083722,21108372,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,Unknown,,,10.0,MG,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,2,F,,20220715.0,20220720,20220726,EXP,,BR-NOVOPROD-937699,NOVO NORDISK,,64.0,YR,,F,Y,74.0,KG,20220726,,MD,BR,BR,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Fall,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Injection site haemorrhage,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Musculoskeletal discomfort,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Skin discolouration,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Injury,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Injection site bruising,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Gastrointestinal pain,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Injection site swelling,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Ligament rupture,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Joint dislocation,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Injection site pain,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Internal haemorrhage,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Needle issue,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Incorrect dose administered,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211114612,21111461,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Psoriasis,,2022,Q3,2,F,20200331.0,20220713.0,20220721,20220725,EXP,,NVSC2020CA090535,NOVARTIS,,63.0,YR,,F,Y,,,20220725,,CN,CA,CA,2022,Q3,Adult
211120891,21112089,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10mg,,,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Diabetic hyperosmolar coma,,2022,Q3,1,I,,20220714.0,20220721,20220721,EXP,,DK-AstraZeneca-2022A254381,ASTRAZENECA,,70.0,YR,,M,Y,,,20220721,,MD,DK,,2022,Q3,Elderly
211122171,21112217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,D,,,,,,,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,20220102.0,,20220721,20220721,DIR,623930,,FDA-CTU,,75.0,YR,,M,N,74.25,KG,20220721,N,CN,US,,2022,Q3,Elderly
211167703,21116770,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,U,,,,,,,,,2022,Q3,Intentional overdose,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211167703,21116770,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211186203,21118620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Myelopathy,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urine ketone body present,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood insulin decreased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After lunch,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Myelopathy,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After lunch,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urine ketone body present,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After lunch,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After lunch,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood insulin decreased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Myelopathy,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urine ketone body present,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186203,21118620,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood insulin decreased,,2022,Q3,3,F,20220527.0,20220830.0,20220722,20220907,EXP,,JP-AstraZeneca-2022A258792,ASTRAZENECA,,71.0,YR,,M,Y,,,20220907,,MD,JP,,2022,Q3,Elderly
211186511,21118651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"40 mg, QD",,,Y,U,,,,40.0,MG,,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220718.0,20220722,20220722,EXP,FR-AFSSAPS-LM20222269,NVSC2022FR164483,NOVARTIS,,66.0,YR,,M,Y,,,20220722,,MD,FR,FR,2022,Q3,Elderly
211186511,21118651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"40 mg, QD",,,Y,U,,,,40.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220601.0,20220718.0,20220722,20220722,EXP,FR-AFSSAPS-LM20222269,NVSC2022FR164483,NOVARTIS,,66.0,YR,,M,Y,,,20220722,,MD,FR,FR,2022,Q3,Elderly
211187691,21118769,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,,,,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-EMD Serono-9338341,EMD SERONO INC,,75.0,YR,E,F,Y,,,20220722,,HP,CN,,2022,Q3,Elderly
211187691,21118769,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,,,,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-EMD Serono-9338341,EMD SERONO INC,,75.0,YR,E,F,Y,,,20220722,,HP,CN,,2022,Q3,Elderly
211187691,21118769,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,2107150/NB2315,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-EMD Serono-9338341,EMD SERONO INC,,75.0,YR,E,F,Y,,,20220722,,HP,CN,,2022,Q3,Elderly
211187691,21118769,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,2107150/NB2315,,,,,,,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-EMD Serono-9338341,EMD SERONO INC,,75.0,YR,E,F,Y,,,20220722,,HP,CN,,2022,Q3,Elderly
211195482,21119548,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,Y,,,,,5.0,MG,,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,20220522.0,20220818.0,20220722,20220829,EXP,,JP-NOVOPROD-939094,NOVO NORDISK,,68.0,YR,,F,Y,62.7,KG,20220829,,MD,JP,JP,2022,Q3,Elderly
211197281,21119728,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220713.0,20220717.0,20220722,20220722,EXP,GB-MHRA-APPCOVID-20220715094700,GB-009507513-2207GBR005310,MERCK,,31.0,YR,,,Y,115.0,KG,20220722,,CN,GB,GB,2022,Q3,Young Adult
211197281,21119728,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220713.0,20220717.0,20220722,20220722,EXP,GB-MHRA-APPCOVID-20220715094700,GB-009507513-2207GBR005310,MERCK,,31.0,YR,,,Y,115.0,KG,20220722,,CN,GB,GB,2022,Q3,Young Adult
211197281,21119728,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Aerophagia,,2022,Q3,1,I,20220713.0,20220717.0,20220722,20220722,EXP,GB-MHRA-APPCOVID-20220715094700,GB-009507513-2207GBR005310,MERCK,,31.0,YR,,,Y,115.0,KG,20220722,,CN,GB,GB,2022,Q3,Young Adult
211197281,21119728,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220713.0,20220717.0,20220722,20220722,EXP,GB-MHRA-APPCOVID-20220715094700,GB-009507513-2207GBR005310,MERCK,,31.0,YR,,,Y,115.0,KG,20220722,,CN,GB,GB,2022,Q3,Young Adult
211197281,21119728,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220713.0,20220717.0,20220722,20220722,EXP,GB-MHRA-APPCOVID-20220715094700,GB-009507513-2207GBR005310,MERCK,,31.0,YR,,,Y,115.0,KG,20220722,,CN,GB,GB,2022,Q3,Young Adult
211205111,21120511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Surgery,,2022,Q3,1,I,,20220715.0,20220722,20220722,EXP,,JP-AstraZeneca-2022A260021,ASTRAZENECA,,74.0,YR,,M,Y,,,20220722,,PH,JP,,2022,Q3,Elderly
211205111,21120511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220715.0,20220722,20220722,EXP,,JP-AstraZeneca-2022A260021,ASTRAZENECA,,74.0,YR,,M,Y,,,20220722,,PH,JP,,2022,Q3,Elderly
211205111,21120511,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Haematuria,,2022,Q3,1,I,,20220715.0,20220722,20220722,EXP,,JP-AstraZeneca-2022A260021,ASTRAZENECA,,74.0,YR,,M,Y,,,20220722,,PH,JP,,2022,Q3,Elderly
211208911,21120891,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,202293.0,,,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-AstraZeneca-2022A261233,ASTRAZENECA,,27403.0,DY,,F,Y,,,20220722,,MD,CN,,2022,Q3,Elderly
211208911,21120891,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,202293.0,,,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-AstraZeneca-2022A261233,ASTRAZENECA,,27403.0,DY,,F,Y,,,20220722,,MD,CN,,2022,Q3,Elderly
211208911,21120891,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,202293.0,,,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-AstraZeneca-2022A261233,ASTRAZENECA,,27403.0,DY,,F,Y,,,20220722,,MD,CN,,2022,Q3,Elderly
211208911,21120891,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2107150/NB2315,,202293.0,,,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220610.0,20220719.0,20220722,20220722,EXP,,CN-AstraZeneca-2022A261233,ASTRAZENECA,,27403.0,DY,,F,Y,,,20220722,,MD,CN,,2022,Q3,Elderly
211213571,21121357,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,1,I,,20220714.0,20220722,20220722,EXP,CA-MHPD-000960372,CA-Accord-270086,ACCORD,,57.0,YR,A,F,Y,,,20220722,,HP,CA,CA,2022,Q3,Adult
211213571,21121357,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Immunosuppressant drug level increased,,2022,Q3,1,I,,20220714.0,20220722,20220722,EXP,CA-MHPD-000960372,CA-Accord-270086,ACCORD,,57.0,YR,A,F,Y,,,20220722,,HP,CA,CA,2022,Q3,Adult
211213571,21121357,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Liver injury,,2022,Q3,1,I,,20220714.0,20220722,20220722,EXP,CA-MHPD-000960372,CA-Accord-270086,ACCORD,,57.0,YR,A,F,Y,,,20220722,,HP,CA,CA,2022,Q3,Adult
211213571,21121357,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Device related infection,,2022,Q3,1,I,,20220714.0,20220722,20220722,EXP,CA-MHPD-000960372,CA-Accord-270086,ACCORD,,57.0,YR,A,F,Y,,,20220722,,HP,CA,CA,2022,Q3,Adult
211213571,21121357,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220714.0,20220722,20220722,EXP,CA-MHPD-000960372,CA-Accord-270086,ACCORD,,57.0,YR,A,F,Y,,,20220722,,HP,CA,CA,2022,Q3,Adult
211224531,21122453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Bradycardia,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cyanosis,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q3,Bradycardia,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224531,21122453,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1-0-0,,,,,,,,10.0,MG,,,2022,Q3,Cyanosis,,2022,Q3,1,I,,20220719.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A263200,ASTRAZENECA,,87.0,YR,,F,Y,,,20220723,,MD,DE,,2022,Q3,Elderly
211224771,21122477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Intentional product misuse,,2022,Q3,1,I,,20220715.0,20220723,20220723,EXP,,CN-AstraZeneca-2022A255266,ASTRAZENECA,,64.0,YR,,M,Y,65.0,KG,20220723,,CN,CN,,2022,Q3,Adult
211224771,21122477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,,20220715.0,20220723,20220723,EXP,,CN-AstraZeneca-2022A255266,ASTRAZENECA,,64.0,YR,,M,Y,65.0,KG,20220723,,CN,CN,,2022,Q3,Adult
211224771,21122477,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220715.0,20220723,20220723,EXP,,CN-AstraZeneca-2022A255266,ASTRAZENECA,,64.0,YR,,M,Y,65.0,KG,20220723,,CN,CN,,2022,Q3,Adult
211224921,21122492,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2290.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Candida urethritis,,2022,Q3,1,I,20211208.0,20220715.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A258398,ASTRAZENECA,,24734.0,DY,,M,Y,70.0,KG,20220723,,MD,DE,,2022,Q3,Elderly
211224921,21122492,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2290.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Bladder candidiasis,,2022,Q3,1,I,20211208.0,20220715.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A258398,ASTRAZENECA,,24734.0,DY,,M,Y,70.0,KG,20220723,,MD,DE,,2022,Q3,Elderly
211224921,21122492,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2290.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,20211208.0,20220715.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A258398,ASTRAZENECA,,24734.0,DY,,M,Y,70.0,KG,20220723,,MD,DE,,2022,Q3,Elderly
211224921,21122492,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2290.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,20211208.0,20220715.0,20220723,20220723,EXP,,DE-AstraZeneca-2022A258398,ASTRAZENECA,,24734.0,DY,,M,Y,70.0,KG,20220723,,MD,DE,,2022,Q3,Elderly
211229881,21122988,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,Y,NB2308,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Vision blurred,,2022,Q3,1,I,20220628.0,20220715.0,20220724,20220724,EXP,,CN-AstraZeneca-2022A259130,ASTRAZENECA,,20089.0,DY,,F,Y,55.0,KG,20220724,,MD,CN,,2022,Q3,Elderly
211229881,21122988,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,Y,NB2308,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital infection female,,2022,Q3,1,I,20220628.0,20220715.0,20220724,20220724,EXP,,CN-AstraZeneca-2022A259130,ASTRAZENECA,,20089.0,DY,,F,Y,55.0,KG,20220724,,MD,CN,,2022,Q3,Elderly
211229881,21122988,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,Y,NB2308,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Retinal haemorrhage,,2022,Q3,1,I,20220628.0,20220715.0,20220724,20220724,EXP,,CN-AstraZeneca-2022A259130,ASTRAZENECA,,20089.0,DY,,F,Y,55.0,KG,20220724,,MD,CN,,2022,Q3,Elderly
211229881,21122988,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,320.0,MG,Y,Y,NB2308,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,20220628.0,20220715.0,20220724,20220724,EXP,,CN-AstraZeneca-2022A259130,ASTRAZENECA,,20089.0,DY,,F,Y,55.0,KG,20220724,,MD,CN,,2022,Q3,Elderly
211245962,21124596,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q3,Decreased appetite,,2022,Q3,2,F,20211101.0,20220902.0,20220725,20220913,EXP,,JP-NOVOPROD-940614,NOVO NORDISK,,86.0,YR,,M,Y,,,20220913,,HP,JP,JP,2022,Q3,Elderly
211245962,21124596,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q3,Femur fracture,,2022,Q3,2,F,20211101.0,20220902.0,20220725,20220913,EXP,,JP-NOVOPROD-940614,NOVO NORDISK,,86.0,YR,,M,Y,,,20220913,,HP,JP,JP,2022,Q3,Elderly
211249102,21124910,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Pancytopenia,,2022,Q3,2,F,20210507.0,20220826.0,20220725,20220902,EXP,,JP-AMGEN-JPNSP2022008185,AMGEN,,86.0,YR,E,M,Y,,,20220902,,MD,JP,JP,2022,Q3,Elderly
211249102,21124910,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Atrial flutter,,2022,Q3,2,F,20210507.0,20220826.0,20220725,20220902,EXP,,JP-AMGEN-JPNSP2022008185,AMGEN,,86.0,YR,E,M,Y,,,20220902,,MD,JP,JP,2022,Q3,Elderly
211250151,21125015,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2107145,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Suffocation feeling,,2022,Q3,1,I,20220709.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A260841,ASTRAZENECA,,25395.0,DY,,M,Y,77.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211250151,21125015,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2107145,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,1,I,20220709.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A260841,ASTRAZENECA,,25395.0,DY,,M,Y,77.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211250151,21125015,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2107145,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220709.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A260841,ASTRAZENECA,,25395.0,DY,,M,Y,77.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211250151,21125015,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,2107145,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,1,I,20220709.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A260841,ASTRAZENECA,,25395.0,DY,,M,Y,77.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Perineal cellulitis,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Enteritis infectious,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Perineal ulceration,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Depressed mood,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Perineal infection,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211263141,21126314,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,125.0,MG,U,,2107096,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220625.0,20220717.0,20220725,20220725,EXP,,CN-AstraZeneca-2022A262277,ASTRAZENECA,,30584.0,DY,,F,Y,47.0,KG,20220725,,MD,CN,,2022,Q3,Elderly
211280861,21128086,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220304.0,20220715.0,20220725,20220725,EXP,FR-AFSSAPS-RE20221027,FR-PFIZER INC-202200963484,PFIZER,,83.0,YR,,F,Y,90.0,KG,20220725,,MD,FR,FR,2022,Q3,Elderly
211291831,21129183,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,40.0,MG,,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220718.0,20220725,20220725,EXP,,FR-AstraZeneca-2022A257848,ASTRAZENECA,,66.0,YR,,M,Y,,,20220725,,MD,FR,,2022,Q3,Elderly
211291831,21129183,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,40.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220601.0,20220718.0,20220725,20220725,EXP,,FR-AstraZeneca-2022A257848,ASTRAZENECA,,66.0,YR,,M,Y,,,20220725,,MD,FR,,2022,Q3,Elderly
211303281,21130328,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",70.0,MG,D,,,,,10.0,MG,,QD,2022,Q3,Hepatitis acute,,2022,Q3,1,I,20220523.0,20220713.0,20220726,20220726,EXP,,FR-AUROBINDO-AUR-APL-2022-027874,AUROBINDO,,33.0,YR,,F,Y,,,20220726,,MD,FR,FR,2022,Q3,Young Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Anaphylactic reaction,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Eye pruritus,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Lip swelling,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Throat tightness,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211306192,21130619,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,2,F,20220629.0,20220728.0,20220726,20220804,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAUSCH-BL-2022-018666,BAUSCH AND LOMB,,52.0,YR,,M,Y,94.0,KG,20220804,,PH,GB,GB,2022,Q3,Adult
211310551,21131055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,450.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220703.0,20220719.0,20220726,20220726,EXP,,ES-AstraZeneca-2022A259708,ASTRAZENECA,,71.0,YR,,F,Y,109.0,KG,20220726,,MD,ES,,2022,Q3,Elderly
211310551,21131055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,450.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220703.0,20220719.0,20220726,20220726,EXP,,ES-AstraZeneca-2022A259708,ASTRAZENECA,,71.0,YR,,F,Y,109.0,KG,20220726,,MD,ES,,2022,Q3,Elderly
211310551,21131055,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,450.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fatigue,,2022,Q3,1,I,20220703.0,20220719.0,20220726,20220726,EXP,,ES-AstraZeneca-2022A259708,ASTRAZENECA,,71.0,YR,,F,Y,109.0,KG,20220726,,MD,ES,,2022,Q3,Elderly
211320611,21132061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 32 (unit),,,Y,,,,202293.0,,,Tablet,,2022,Q3,Fatigue,,2022,Q3,1,I,20220711.0,20220719.0,20220726,20220726,EXP,,GB-AstraZeneca-2022A260463,ASTRAZENECA,,73.0,YR,,F,Y,94.0,KG,20220726,,MD,GB,,2022,Q3,Elderly
211320611,21132061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 32 (unit),,,Y,,,,202293.0,,,Tablet,,2022,Q3,Vomiting,,2022,Q3,1,I,20220711.0,20220719.0,20220726,20220726,EXP,,GB-AstraZeneca-2022A260463,ASTRAZENECA,,73.0,YR,,F,Y,94.0,KG,20220726,,MD,GB,,2022,Q3,Elderly
211320611,21132061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 32 (unit),,,Y,,,,202293.0,,,Tablet,,2022,Q3,Dizziness postural,,2022,Q3,1,I,20220711.0,20220719.0,20220726,20220726,EXP,,GB-AstraZeneca-2022A260463,ASTRAZENECA,,73.0,YR,,F,Y,94.0,KG,20220726,,MD,GB,,2022,Q3,Elderly
211320611,21132061,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 32 (unit),,,Y,,,,202293.0,,,Tablet,,2022,Q3,Nausea,,2022,Q3,1,I,20220711.0,20220719.0,20220726,20220726,EXP,,GB-AstraZeneca-2022A260463,ASTRAZENECA,,73.0,YR,,F,Y,94.0,KG,20220726,,MD,GB,,2022,Q3,Elderly
211320621,21132062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,QD,2022,Q3,Intentional overdose,,2022,Q3,1,I,20220615.0,20220718.0,20220726,20220726,EXP,,HR-AstraZeneca-2022A258231,ASTRAZENECA,,27.0,YR,,F,Y,,,20220726,,MD,HR,,2022,Q3,Young Adult
211320621,21132062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,QD,2022,Q3,Suicide attempt,,2022,Q3,1,I,20220615.0,20220718.0,20220726,20220726,EXP,,HR-AstraZeneca-2022A258231,ASTRAZENECA,,27.0,YR,,F,Y,,,20220726,,MD,HR,,2022,Q3,Young Adult
211320621,21132062,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,QD,2022,Q3,Somnolence,,2022,Q3,1,I,20220615.0,20220718.0,20220726,20220726,EXP,,HR-AstraZeneca-2022A258231,ASTRAZENECA,,27.0,YR,,F,Y,,,20220726,,MD,HR,,2022,Q3,Young Adult
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Rash maculo-papular,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Drug ineffective,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Trimethylaminuria,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Urine odour abnormal,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211329764,21132976,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD,(10 mg/24 h)",,,U,,,,,10.0,MG,,QD,2022,Q3,Condition aggravated,,2022,Q3,4,F,,20220728.0,20220726,20220803,EXP,,NVSC2022PL161017,NOVARTIS,Woron J. Farmakoterapia [Pharmacotherapy]. MEDYCYNA PO DYPLOMIE. 2022;6:37642,68.0,YR,,F,Y,,,20220803,,HP,PL,PL,2022,Q3,Elderly
211334372,21133437,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,2,F,20211212.0,20220718.0,20220726,20220728,EXP,,FR-AstraZeneca-2022A258097,ASTRAZENECA,,87.0,YR,,M,Y,61.0,KG,20220728,,MD,FR,,2022,Q3,Elderly
211334372,21133437,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,2,F,20211212.0,20220718.0,20220726,20220728,EXP,,FR-AstraZeneca-2022A258097,ASTRAZENECA,,87.0,YR,,M,Y,61.0,KG,20220728,,MD,FR,,2022,Q3,Elderly
211334911,21133491,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220721.0,20220726,20220726,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20220726,,CN,CA,CA,2022,Q3,Elderly
211334911,21133491,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q3,Suspected COVID-19,,2022,Q3,1,I,,20220721.0,20220726,20220726,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20220726,,CN,CA,CA,2022,Q3,Elderly
211334911,21133491,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q3,Pulmonary embolism,,2022,Q3,1,I,,20220721.0,20220726,20220726,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20220726,,CN,CA,CA,2022,Q3,Elderly
211334911,21133491,12,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q3,Off label use,,2022,Q3,1,I,,20220721.0,20220726,20220726,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20220726,,CN,CA,CA,2022,Q3,Elderly
211338561,21133856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,QD,2022,Q3,Starvation,,2022,Q3,1,I,20220420.0,20220718.0,20220726,20220726,EXP,,FR-AstraZeneca-2022A257967,ASTRAZENECA,,85.0,YR,,F,Y,,,20220726,,MD,FR,,2022,Q3,Elderly
211338561,21133856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,QD,2022,Q3,Vomiting,,2022,Q3,1,I,20220420.0,20220718.0,20220726,20220726,EXP,,FR-AstraZeneca-2022A257967,ASTRAZENECA,,85.0,YR,,F,Y,,,20220726,,MD,FR,,2022,Q3,Elderly
211338561,21133856,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,,QD,2022,Q3,Dehydration,,2022,Q3,1,I,20220420.0,20220718.0,20220726,20220726,EXP,,FR-AstraZeneca-2022A257967,ASTRAZENECA,,85.0,YR,,F,Y,,,20220726,,MD,FR,,2022,Q3,Elderly
211346503,21134650,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Colon cancer,,2022,Q3,3,F,20220121.0,20220921.0,20220727,20220928,PER,JP-ONO-2022JP020085,JP-AMGEN-JPNNI2022126327,AMGEN,,52.0,YR,A,M,Y,65.4,KG,20220928,,MD,JP,JP,2022,Q3,Adult
211346503,21134650,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,3,F,20220121.0,20220921.0,20220727,20220928,PER,JP-ONO-2022JP020085,JP-AMGEN-JPNNI2022126327,AMGEN,,52.0,YR,A,M,Y,65.4,KG,20220928,,MD,JP,JP,2022,Q3,Adult
211347061,21134706,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, UNK",,,Y,,,,,10.0,MG,,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220624.0,20220712.0,20220727,20220727,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-346139,RANBAXY,,61.0,YR,,F,Y,79.0,KG,20220727,,PH,FR,FR,2022,Q3,Adult
211349462,21134946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4380.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tubulointerstitial nephritis,,2022,Q3,2,F,20220618.0,20220725.0,20220727,20220802,EXP,,JP-AstraZeneca-2022A259599,ASTRAZENECA,,50.0,YR,,F,Y,,,20220802,,MD,JP,,2022,Q3,Adult
211349462,21134946,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4380.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,2,F,20220618.0,20220725.0,20220727,20220802,EXP,,JP-AstraZeneca-2022A259599,ASTRAZENECA,,50.0,YR,,F,Y,,,20220802,,MD,JP,,2022,Q3,Adult
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Irritable bowel syndrome,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Arthritis,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211349701,21134970,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Rheumatoid arthritis,,2022,Q3,1,I,,20220722.0,20220727,20220727,EXP,,CA-APOTEX-2022AP010317,APOTEX,,67.0,YR,,F,Y,,,20220727,,HP,CA,CA,2022,Q3,Elderly
211350411,21135041,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"2 doses, strength 12.3 Mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Anxiety,,2022,Q3,1,I,20220527.0,20220718.0,20220727,20220727,EXP,IE-HPRA-2022-096268,IE-Accord-270847,ACCORD,,59.0,YR,A,F,Y,80.0,KG,20220727,,HP,IE,IE,2022,Q3,Adult
211350411,21135041,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"2 doses, strength 12.3 Mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220527.0,20220718.0,20220727,20220727,EXP,IE-HPRA-2022-096268,IE-Accord-270847,ACCORD,,59.0,YR,A,F,Y,80.0,KG,20220727,,HP,IE,IE,2022,Q3,Adult
211350411,21135041,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"2 doses, strength 12.3 Mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220527.0,20220718.0,20220727,20220727,EXP,IE-HPRA-2022-096268,IE-Accord-270847,ACCORD,,59.0,YR,A,F,Y,80.0,KG,20220727,,HP,IE,IE,2022,Q3,Adult
211350411,21135041,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"2 doses, strength 12.3 Mg",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Paraesthesia,,2022,Q3,1,I,20220527.0,20220718.0,20220727,20220727,EXP,IE-HPRA-2022-096268,IE-Accord-270847,ACCORD,,59.0,YR,A,F,Y,80.0,KG,20220727,,HP,IE,IE,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Anaphylactic reaction,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Throat tightness,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Eye pruritus,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211351321,21135132,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form (DF) once a day,,,,,,,,,,,,2022,Q3,Lip swelling,,2022,Q3,1,I,20220629.0,20220719.0,20220727,20220727,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-BAXTER-2022BAX015272,BAXTER,,52.0,YR,,M,Y,94.0,KG,20220727,,PH,GB,GB,2022,Q3,Adult
211355201,21135520,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,UNKNOWN,,,40.0,MG,,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220719.0,20220727,20220727,EXP,FR-AFSSAPS-LM20222269,FR-ROCHE-3143009,ROCHE,,66.0,YR,,M,Y,,,20220727,,MD,FR,FR,2022,Q3,Elderly
211355201,21135520,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,UNKNOWN,,,40.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220601.0,20220719.0,20220727,20220727,EXP,FR-AFSSAPS-LM20222269,FR-ROCHE-3143009,ROCHE,,66.0,YR,,M,Y,,,20220727,,MD,FR,FR,2022,Q3,Elderly
211361021,21136102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NB2301,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pruritus,,2022,Q3,1,I,20220705.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A263798,ASTRAZENECA,,71.0,YR,,M,Y,65.3,KG,20220727,,MD,CN,,2022,Q3,Elderly
211361021,21136102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NB2301,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash erythematous,,2022,Q3,1,I,20220705.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A263798,ASTRAZENECA,,71.0,YR,,M,Y,65.3,KG,20220727,,MD,CN,,2022,Q3,Elderly
211361021,21136102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NB2301,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash maculo-papular,,2022,Q3,1,I,20220705.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A263798,ASTRAZENECA,,71.0,YR,,M,Y,65.3,KG,20220727,,MD,CN,,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Snoring,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Palpitations,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dysuria,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Anxiety,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sleep apnoea syndrome,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hyperlipidaemia,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Activated partial thromboplastin time prolonged,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyslipidaemia,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardiomegaly,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Peripheral vascular disorder,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardiomyopathy,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Basal cell carcinoma,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malignant melanoma,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Depression,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Respiratory distress,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arteriosclerosis coronary artery,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Amnesia,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211361491,21136149,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Left ventricular failure,,2022,Q3,1,I,20211205.0,20220719.0,20220727,20220727,EXP,,NVSC2022US128930,NOVARTIS,,72.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Elderly
211375491,21137549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sensory loss,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tongue oedema,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Paralysis recurrent laryngeal nerve,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Laryngeal oedema,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Headache,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sensory loss,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tongue oedema,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Paralysis recurrent laryngeal nerve,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Laryngeal oedema,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211375491,21137549,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Headache,,2022,Q3,1,I,20220702.0,20220720.0,20220727,20220727,EXP,,SI-AstraZeneca-2022A261175,ASTRAZENECA,,76.0,YR,,M,Y,,,20220727,,MD,SI,,2022,Q3,Elderly
211379312,21137931,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,20 Unknown,,,,,,,,,,,,2022,Q3,Small intestinal haemorrhage,,2022,Q3,2,F,20220724.0,20220901.0,20220727,20220905,EXP,,JP-ABBVIE-22K-087-4483365-00,ABBVIE,,69.0,YR,,M,Y,,,20220905,,MD,JP,JP,2022,Q3,Elderly
211379312,21137931,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,20 Unknown,,,,,,,,,,,,2022,Q3,Gastritis erosive,,2022,Q3,2,F,20220724.0,20220901.0,20220727,20220905,EXP,,JP-ABBVIE-22K-087-4483365-00,ABBVIE,,69.0,YR,,M,Y,,,20220905,,MD,JP,JP,2022,Q3,Elderly
211379312,21137931,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,20 Unknown,,,,,,,,,,,,2022,Q3,Gastrointestinal ulcer,,2022,Q3,2,F,20220724.0,20220901.0,20220727,20220905,EXP,,JP-ABBVIE-22K-087-4483365-00,ABBVIE,,69.0,YR,,M,Y,,,20220905,,MD,JP,JP,2022,Q3,Elderly
211379312,21137931,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,20 Unknown,,,,,,,,,,,,2022,Q3,Melaena,,2022,Q3,2,F,20220724.0,20220901.0,20220727,20220905,EXP,,JP-ABBVIE-22K-087-4483365-00,ABBVIE,,69.0,YR,,M,Y,,,20220905,,MD,JP,JP,2022,Q3,Elderly
211386371,21138637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tachypnoea,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood ketone body increased,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Heart rate increased,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Tachypnoea,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood ketone body increased,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386371,21138637,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15590.0,MG,Y,,NB2264,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Heart rate increased,,2022,Q3,1,I,20220621.0,20220719.0,20220727,20220727,EXP,,CN-AstraZeneca-2022A264725,ASTRAZENECA,,28413.0,DY,,M,Y,65.0,KG,20220727,,MD,CN,,2022,Q3,Elderly
211386381,21138638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220701.0,20220719.0,20220727,20220727,EXP,,AT-AstraZeneca-2022A262998,ASTRAZENECA,,65.0,YR,,M,Y,,,20220727,,MD,AT,,2022,Q3,Elderly
211386381,21138638,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Fall,,2022,Q3,1,I,20220701.0,20220719.0,20220727,20220727,EXP,,AT-AstraZeneca-2022A262998,ASTRAZENECA,,65.0,YR,,M,Y,,,20220727,,MD,AT,,2022,Q3,Elderly
211414961,21141496,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1510.0,MG,Y,,NB2260,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Marasmus,,2022,Q3,1,I,20220702.0,20220720.0,20220728,20220728,EXP,,CN-AstraZeneca-2022A265345,ASTRAZENECA,,18431.0,DY,,M,Y,62.0,KG,20220728,,MD,CN,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fall,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Headache,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Malaise,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Balance disorder,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Syncope,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fall,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Headache,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Malaise,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Balance disorder,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211426433,21142643,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Syncope,,2022,Q3,3,F,20220117.0,20220719.0,20220728,20220730,EXP,,FR-AstraZeneca-2022A066536,ASTRAZENECA,,65.0,YR,,M,Y,62.0,KG,20220730,,MD,FR,,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Confusional state,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Impatience,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Dysuria,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211458541,21145854,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,Unknown,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,1,I,20220414.0,20220716.0,20220729,20220729,EXP,,PT-NOVOPROD-912390,NOVO NORDISK,,74.0,YR,,M,Y,92.8,KG,20220729,,PH,PT,PT,2022,Q3,Elderly
211472423,21147242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 x 10, administration",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,3,F,20210501.0,20220825.0,20220729,20220830,EXP,,PL-AstraZeneca-2022A267070,ASTRAZENECA,,830.0,MON,,M,Y,,,20220830,,MD,PL,,2022,Q3,Elderly
211472423,21147242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 x 10, administration",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Craniofacial injury,,2022,Q3,3,F,20210501.0,20220825.0,20220729,20220830,EXP,,PL-AstraZeneca-2022A267070,ASTRAZENECA,,830.0,MON,,M,Y,,,20220830,,MD,PL,,2022,Q3,Elderly
211472423,21147242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 x 10, administration",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fall,,2022,Q3,3,F,20210501.0,20220825.0,20220729,20220830,EXP,,PL-AstraZeneca-2022A267070,ASTRAZENECA,,830.0,MON,,M,Y,,,20220830,,MD,PL,,2022,Q3,Elderly
211472423,21147242,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 x 10, administration",,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Electrocardiogram ambulatory abnormal,,2022,Q3,3,F,20210501.0,20220825.0,20220729,20220830,EXP,,PL-AstraZeneca-2022A267070,ASTRAZENECA,,830.0,MON,,M,Y,,,20220830,,MD,PL,,2022,Q3,Elderly
211474442,21147444,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Death,,2022,Q3,2,F,20220605.0,20220729.0,20220729,20220803,EXP,,BG-AstraZeneca-2022A267241,ASTRAZENECA,,73.0,YR,,M,Y,85.0,KG,20220803,,MD,BG,,2022,Q3,Elderly
211484543,21148454,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, each morning",,,U,,,,,10.0,MG,,QD,2022,Q3,Gastrointestinal disorder,,2022,Q3,3,F,20220406.0,20220920.0,20220729,20220930,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202207007771,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220930,,MD,FR,FR,2022,Q3,Adult
211486591,21148659,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, each morning",,,,,,,,,,,QD,2022,Q3,Protein urine present,,2022,Q3,1,I,,20220718.0,20220729,20220729,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202207007763,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220729,,CN,CN,CN,2022,Q3,Adult
211486591,21148659,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 dosage form, each morning",,,,,,,,,,,QD,2022,Q3,Osteoporosis,,2022,Q3,1,I,,20220718.0,20220729,20220729,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202207007763,ELI LILLY AND CO,,58.0,YR,,M,Y,,,20220729,,CN,CN,CN,2022,Q3,Adult
211492002,21149200,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,130.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urosepsis,,2022,Q3,2,F,20220701.0,20220914.0,20220729,20220921,EXP,,FR-AstraZeneca-2022A267364,ASTRAZENECA,,94.0,YR,,M,Y,74.0,KG,20220921,,MD,FR,,2022,Q3,Elderly
211492002,21149200,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,130.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pyelonephritis,,2022,Q3,2,F,20220701.0,20220914.0,20220729,20220921,EXP,,FR-AstraZeneca-2022A267364,ASTRAZENECA,,94.0,YR,,M,Y,74.0,KG,20220921,,MD,FR,,2022,Q3,Elderly
211492002,21149200,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,130.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,2,F,20220701.0,20220914.0,20220729,20220921,EXP,,FR-AstraZeneca-2022A267364,ASTRAZENECA,,94.0,YR,,M,Y,74.0,KG,20220921,,MD,FR,,2022,Q3,Elderly
211494031,21149403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220722.0,20220729,20220729,EXP,,FR-AstraZeneca-2022A267363,ASTRAZENECA,,71.0,YR,,M,Y,,,20220729,,MD,FR,,2022,Q3,Elderly
211494091,21149409,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Neuroleptic malignant syndrome,,2022,Q3,1,I,20220715.0,20220726.0,20220729,20220729,EXP,,GB-OTSUKA-2022_038504,OTSUKA,,46.0,YR,,M,Y,89.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211494091,21149409,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Acute hepatic failure,,2022,Q3,1,I,20220715.0,20220726.0,20220729,20220729,EXP,,GB-OTSUKA-2022_038504,OTSUKA,,46.0,YR,,M,Y,89.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211495911,21149591,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,202293.0,10.0,MG,Tablet,,2022,Q3,Acidosis,,2022,Q3,1,I,20220414.0,20220721.0,20220729,20220729,EXP,,DE-AstraZeneca-2022A262573,ASTRAZENECA,,67.0,YR,,M,Y,88.0,KG,20220729,,MD,DE,,2022,Q3,Elderly
211495921,21149592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ascites,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ascites,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211495921,21149592,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20220715.0,20220721.0,20220729,20220729,EXP,,RU-AstraZeneca-2022A265147,ASTRAZENECA,,78.0,YR,,F,Y,104.0,KG,20220729,,HP,RU,,2022,Q3,Elderly
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Anaphylactic reaction,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Eye pruritus,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Lip swelling,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Swollen tongue,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Throat tightness,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211502361,21150236,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (once a day)",,,,,,,,,,,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220629.0,20220728.0,20220729,20220729,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-MYLANLABS-2022M1082367,MYLAN,,52.0,YR,,M,Y,94.0,KG,20220729,,PH,GB,GB,2022,Q3,Adult
211511375,21151137,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Ongoing,,,U,,,,,10.0,MG,,,2022,Q3,Immune-mediated hepatitis,,2022,Q3,5,F,20220713.0,20220905.0,20220730,20220912,EXP,,IL-BRISTOL-MYERS SQUIBB COMPANY-2022-074993,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,77.0,KG,20220912,,HP,IL,IL,2022,Q3,Elderly
211511861,21151186,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,U,,,,10.0,MG,,,2022,Q3,Rhabdomyolysis,,2022,Q3,1,I,,20220720.0,20220730,20220730,EXP,,"JP-Innogenix, LLC-2131394",INNOGENIX,"Takada K, Sada Y, Samura M, Matsuura M, Hirose N, Kurata T, et al. A Case of Exacerbation of Haloperidol-Induced Rhabdomyolysis Following the Onset of COVID-19. American Journal of Case Reports 23: 20-JUN-2022. URL: http://doi.org/10.12659/AJCR.936589",52.0,YR,,M,Y,85.0,KG,20220730,,HP,JP,JP,2022,Q3,Adult
211514361,21151436,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (10 mg 1 cp ore 8)",,,U,,,,,10.0,MG,,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220504.0,20220729.0,20220730,20220730,EXP,IT-MINISAL02-878499,NVSC2022IT172358,NOVARTIS,,80.0,YR,,M,Y,,,20220730,,PH,IT,IT,2022,Q3,Elderly
211514361,21151436,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (10 mg 1 cp ore 8)",,,U,,,,,10.0,MG,,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220504.0,20220729.0,20220730,20220730,EXP,IT-MINISAL02-878499,NVSC2022IT172358,NOVARTIS,,80.0,YR,,M,Y,,,20220730,,PH,IT,IT,2022,Q3,Elderly
211514361,21151436,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (10 mg 1 cp ore 8)",,,U,,,,,10.0,MG,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,20220504.0,20220729.0,20220730,20220730,EXP,IT-MINISAL02-878499,NVSC2022IT172358,NOVARTIS,,80.0,YR,,M,Y,,,20220730,,PH,IT,IT,2022,Q3,Elderly
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Lip swelling,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Swollen tongue,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Anaphylactic reaction,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Throat tightness,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Eye pruritus,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211514821,21151482,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,20220629.0,20220719.0,20220730,20220730,EXP,,GB-AUROBINDO-AUR-APL-2022-028496,AUROBINDO,,52.0,YR,,M,Y,94.0,KG,20220730,,PH,GB,GB,2022,Q3,Adult
211515931,21151593,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"Strength: 10 mg, 10mg / day, In the long term",,,,,,,,,,Film-coated tablet,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220422.0,20220720.0,20220730,20220730,EXP,FR-AFSSAPS-TO20222129,FR-Accord-271291,ACCORD,,73.0,YR,E,F,Y,50.0,KG,20220730,,PH,FR,FR,2022,Q3,Elderly
211515931,21151593,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"Strength: 10 mg, 10mg / day, In the long term",,,,,,,,,,Film-coated tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220422.0,20220720.0,20220730,20220730,EXP,FR-AFSSAPS-TO20222129,FR-Accord-271291,ACCORD,,73.0,YR,E,F,Y,50.0,KG,20220730,,PH,FR,FR,2022,Q3,Elderly
211532051,21153205,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Malaise,,2022,Q3,1,I,20220711.0,20220712.0,20220731,20220731,PER,,US-AstraZeneca-2022A255738,ASTRAZENECA,,72.0,YR,,M,Y,68.0,KG,20220731,,MD,US,,2022,Q3,Elderly
211532051,21153205,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Take one tablet daily in the morning,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,20220711.0,20220712.0,20220731,20220731,PER,,US-AstraZeneca-2022A255738,ASTRAZENECA,,72.0,YR,,M,Y,68.0,KG,20220731,,MD,US,,2022,Q3,Elderly
211535681,21153568,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,20220330.0,20220718.0,20220731,20220731,EXP,,"BE-ESPERION THERAPEUTICS, INC-2022BEL01505",ESPERION THERAPEUTICS,,56.0,YR,,M,Y,,,20220801,,MD,BE,BE,2022,Q3,Adult
211535681,21153568,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,20220330.0,20220718.0,20220731,20220731,EXP,,"BE-ESPERION THERAPEUTICS, INC-2022BEL01505",ESPERION THERAPEUTICS,,56.0,YR,,M,Y,,,20220801,,MD,BE,BE,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Neurogenic bladder,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Large intestine perforation,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Abdominal wall abscess,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Blood albumin decreased,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Ileal perforation,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Haemoglobin decreased,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Ileus,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Physical deconditioning,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Enterocolitis,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Disease progression,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Staphylococcal infection,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Familial mediterranean fever,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Blood potassium decreased,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Postoperative wound infection,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Disease progression,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Impaired healing,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211556662,21155666,20,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q3,Familial mediterranean fever,,2022,Q3,2,F,20200325.0,20220722.0,20220801,20220803,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,,,20220803,,MD,JP,JP,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Blood parathyroid hormone increased,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Mouth ulceration,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Hypertension,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Blood cholesterol increased,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Mobility decreased,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Insomnia,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Disease recurrence,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Blood sodium increased,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211557183,21155718,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD (at night)",,,,,,,,,,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,3,F,20220601.0,20220803.0,20220801,20220805,EXP,,NVSC2022EG171651,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,CN,EG,EG,2022,Q3,Adult
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Irritable bowel syndrome,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Rheumatoid arthritis,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211560711,21156071,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthritis,,2022,Q3,1,I,,20220726.0,20220801,20220801,EXP,,CA-BAUSCH-BL-2022-018929,BAUSCH AND LOMB,,67.0,YR,,F,Y,,,20220801,,HP,CA,CA,2022,Q3,Elderly
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Bacterial infection,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Musculoskeletal stiffness,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211572861,21157286,5,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,,,,,,,,,2022,Q3,Joint swelling,,2022,Q3,1,I,,20220725.0,20220801,20220801,EXP,,CA-BAYER-2022A105385,BAYER,,48.0,YR,A,M,Y,,,20220801,,CN,CA,CA,2022,Q3,Adult
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Myositis,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Hepatic encephalopathy,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Hypothyroidism,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Constipation,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Multiple organ dysfunction syndrome,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Rhabdomyolysis,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Non-cardiogenic pulmonary oedema,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Liver disorder,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583312,21158331,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,UNKNOWN,,,,,,,2022,Q3,Renal disorder,,2022,Q3,2,F,20220620.0,20220909.0,20220801,20220918,EXP,,JP-ROCHE-3150410,ROCHE,,79.0,YR,,F,Y,55.2,KG,20220918,,PH,JP,JP,2022,Q3,Elderly
211583321,21158332,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,,,2022,Q3,Hepatitis acute,,2022,Q3,1,I,20220702.0,20220725.0,20220801,20220801,EXP,,FR-AstraZeneca-2022A265378,ASTRAZENECA,,73.0,YR,,M,Y,,,20220801,,MD,FR,,2022,Q3,Elderly
211583321,21158332,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,,,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,1,I,20220702.0,20220725.0,20220801,20220801,EXP,,FR-AstraZeneca-2022A265378,ASTRAZENECA,,73.0,YR,,M,Y,,,20220801,,MD,FR,,2022,Q3,Elderly
211587211,21158721,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220725.0,20220726.0,20220802,20220802,EXP,,GB-AstraZeneca-2022A267381,ASTRAZENECA,,81.0,YR,,F,Y,60.0,KG,20220802,,MD,GB,,2022,Q3,Elderly
211587211,21158721,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220725.0,20220726.0,20220802,20220802,EXP,,GB-AstraZeneca-2022A267381,ASTRAZENECA,,81.0,YR,,F,Y,60.0,KG,20220802,,MD,GB,,2022,Q3,Elderly
211587211,21158721,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220725.0,20220726.0,20220802,20220802,EXP,,GB-AstraZeneca-2022A267381,ASTRAZENECA,,81.0,YR,,F,Y,60.0,KG,20220802,,MD,GB,,2022,Q3,Elderly
211587211,21158721,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220725.0,20220726.0,20220802,20220802,EXP,,GB-AstraZeneca-2022A267381,ASTRAZENECA,,81.0,YR,,F,Y,60.0,KG,20220802,,MD,GB,,2022,Q3,Elderly
211590631,21159063,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Anxiety,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Malaise,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Headache,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211590631,21159063,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, qd",,,,,,,,,,,QD,2022,Q3,Nausea,,2022,Q3,1,I,20220531.0,20220722.0,20220802,20220802,EXP,GB-MHRA-ADR 27131574,GB-NOVOPROD-941694,NOVO NORDISK,,49.0,YR,,F,Y,76.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Joint swelling,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Musculoskeletal stiffness,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211596211,21159621,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,U,,,,,,,,,2022,Q3,Bacterial infection,,2022,Q3,1,I,,20220720.0,20220802,20220802,EXP,,CA-AUROBINDO-AUR-APL-2022-028978,AUROBINDO,,48.0,YR,,M,Y,,,20220802,,HP,CA,CA,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Lip swelling,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Anaphylactic reaction,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Eye pruritus,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211599771,21159977,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form (DF) qd,once a day",,,D,,,,,,,,,2022,Q3,Throat tightness,,2022,Q3,1,I,20220629.0,20220729.0,20220802,20220802,EXP,GB-MHRA-TPP44869870C8317175YC1657724040316,GB-STRIDES ARCOLAB LIMITED-2022SP009612,STRIDES,,52.0,YR,,M,Y,94.0,KG,20220802,,PH,GB,GB,2022,Q3,Adult
211604262,21160426,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,,1710.0,MG,,,SA514,,205649.0,855.0,MG,Tablet,BID,2022,Q3,Genital rash,,2022,Q3,2,F,20220223.0,20220909.0,20220802,20220915,EXP,,PT-AstraZeneca-2022A265368,ASTRAZENECA,,66.0,YR,,M,Y,65.0,KG,20220915,,MD,PT,,2022,Q3,Elderly
211622321,21162232,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Death,,2022,Q3,1,I,20220726.0,20220728.0,20220802,20220802,EXP,,ZA-AstraZeneca-2022A271458,ASTRAZENECA,,81.0,YR,,M,Y,,,20220802,,CN,ZA,,2022,Q3,Elderly
211626331,21162633,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1870.0,MG,U,,2109177,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220702.0,20220725.0,20220802,20220802,EXP,,CN-AstraZeneca-2022A268282,ASTRAZENECA,,29950.0,DY,,F,Y,55.0,KG,20220802,,MD,CN,,2022,Q3,Elderly
211634651,21163465,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,560.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pancreatitis acute,,2022,Q3,1,I,20220705.0,20220725.0,20220802,20220802,EXP,,FR-AstraZeneca-2022A271546,ASTRAZENECA,,62.0,YR,,M,Y,,,20220802,,MD,FR,,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Bacterial infection,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Joint swelling,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Musculoskeletal stiffness,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645721,21164572,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,D,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220728.0,20220803,20220803,EXP,,CA-APOTEX-2022AP010559,APOTEX,,48.0,YR,,M,Y,,,20220803,,HP,CA,CA,2022,Q3,Adult
211645891,21164589,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 dosage form, qd",,,,,,,,,,,QD,2022,Q3,Myocardial infarction,,2022,Q3,1,I,20220101.0,20220728.0,20220803,20220803,PER,,ZA-AMGEN-ZAFNI2022132427,AMGEN,,58.0,YR,A,M,Y,,,20220803,,CN,ZA,ZA,2022,Q3,Adult
211654361,21165436,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Comprimido revestido por pelicula,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220125.0,20220530.0,20220803,20220803,EXP,PT-INFARMED-T202205-252,PT-Vifor (International) Inc.-VIT-2022-03776,VIFOR,,85.0,YR,,M,Y,65.0,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211654361,21165436,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Comprimido revestido por pelicula,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220125.0,20220530.0,20220803,20220803,EXP,PT-INFARMED-T202205-252,PT-Vifor (International) Inc.-VIT-2022-03776,VIFOR,,85.0,YR,,M,Y,65.0,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211654361,21165436,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Comprimido revestido por pelicula,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220125.0,20220530.0,20220803,20220803,EXP,PT-INFARMED-T202205-252,PT-Vifor (International) Inc.-VIT-2022-03776,VIFOR,,85.0,YR,,M,Y,65.0,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211660211,21166021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Hepatic function abnormal,,2022,Q3,1,I,20210101.0,20220726.0,20220803,20220803,EXP,,JP-AstraZeneca-2022A188445,ASTRAZENECA,,64.0,YR,,F,Y,,,20220803,,MD,JP,,2022,Q3,Adult
211660211,21166021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Pneumonia,,2022,Q3,1,I,20210101.0,20220726.0,20220803,20220803,EXP,,JP-AstraZeneca-2022A188445,ASTRAZENECA,,64.0,YR,,F,Y,,,20220803,,MD,JP,,2022,Q3,Adult
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Dysuria,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Impatience,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Vertigo,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211676141,21167614,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,UNK (1 + 1),,,U,,Unknown,,,,,,,2022,Q3,Confusional state,,2022,Q3,1,I,20220414.0,20220801.0,20220803,20220803,EXP,,NVSC2022PT104838,NOVARTIS,,74.0,YR,,M,Y,92.8,KG,20220803,,PH,PT,PT,2022,Q3,Elderly
211722003,21172200,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure congestive,,2022,Q3,3,F,20211122.0,20220906.0,20220804,20220913,EXP,,BR-DSJP-DSE-2021-140789,DAIICHI,,75.0,YR,,M,Y,75.2,KG,20220913,,MD,BR,BR,2022,Q3,Elderly
211722003,21172200,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac arrest,,2022,Q3,3,F,20211122.0,20220906.0,20220804,20220913,EXP,,BR-DSJP-DSE-2021-140789,DAIICHI,,75.0,YR,,M,Y,75.2,KG,20220913,,MD,BR,BR,2022,Q3,Elderly
211722003,21172200,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure congestive,,2022,Q3,3,F,20211122.0,20220906.0,20220804,20220913,EXP,,BR-DSJP-DSE-2021-140789,DAIICHI,,75.0,YR,,M,Y,75.2,KG,20220913,,MD,BR,BR,2022,Q3,Elderly
211725532,21172553,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,2,F,20220601.0,20220804.0,20220804,20220812,EXP,,JP-AstraZeneca-2022A269943,ASTRAZENECA,,73.0,YR,,M,Y,,,20220812,,MD,JP,,2022,Q3,Elderly
211725532,21172553,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220804.0,20220804,20220812,EXP,,JP-AstraZeneca-2022A269943,ASTRAZENECA,,73.0,YR,,M,Y,,,20220812,,MD,JP,,2022,Q3,Elderly
211725532,21172553,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dehydration,,2022,Q3,2,F,20220601.0,20220804.0,20220804,20220812,EXP,,JP-AstraZeneca-2022A269943,ASTRAZENECA,,73.0,YR,,M,Y,,,20220812,,MD,JP,,2022,Q3,Elderly
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Erythema,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Skin plaque,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Arthralgia,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Alopecia,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Weight decreased,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Paradoxical drug reaction,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Paradoxical drug reaction,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Skin disorder,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Erythema,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Arthritis,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211737211,21173721,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 tablet in hte morning,,,,,,,,10.0,MG,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220101.0,20220711.0,20220804,20220804,EXP,,FR-ABBVIE-22K-056-4475898-00,ABBVIE,,47.0,YR,,M,Y,,,20220804,,CN,FR,FR,2022,Q3,Adult
211745401,21174540,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Polycythaemia,,2022,Q3,1,I,20220217.0,20220730.0,20220805,20220805,EXP,,AU-AstraZeneca-2022A274239,ASTRAZENECA,,28354.0,DY,,M,Y,,,20220805,,MD,AU,,2022,Q3,Elderly
211745401,21174540,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Drug intolerance,,2022,Q3,1,I,20220217.0,20220730.0,20220805,20220805,EXP,,AU-AstraZeneca-2022A274239,ASTRAZENECA,,28354.0,DY,,M,Y,,,20220805,,MD,AU,,2022,Q3,Elderly
211745401,21174540,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Polycythaemia,,2022,Q3,1,I,20220217.0,20220730.0,20220805,20220805,EXP,,AU-AstraZeneca-2022A274239,ASTRAZENECA,,28354.0,DY,,M,Y,,,20220805,,MD,AU,,2022,Q3,Elderly
211745401,21174540,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Drug intolerance,,2022,Q3,1,I,20220217.0,20220730.0,20220805,20220805,EXP,,AU-AstraZeneca-2022A274239,ASTRAZENECA,,28354.0,DY,,M,Y,,,20220805,,MD,AU,,2022,Q3,Elderly
211746062,21174606,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Dizziness,,2022,Q3,2,F,20220501.0,20220901.0,20220805,20220908,EXP,,NVSJ2022JP095292,NOVARTIS,,83.0,YR,,M,Y,,,20220908,,MD,JP,JP,2022,Q3,Elderly
211746062,21174606,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Sinus arrest,,2022,Q3,2,F,20220501.0,20220901.0,20220805,20220908,EXP,,NVSJ2022JP095292,NOVARTIS,,83.0,YR,,M,Y,,,20220908,,MD,JP,JP,2022,Q3,Elderly
211750902,21175090,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20220628.0,20220824.0,20220805,20220826,EXP,,DE-ROCHE-3150252,ROCHE,,53.0,YR,,F,Y,87.0,KG,20220826,,MD,DE,,2022,Q3,Adult
211753861,21175386,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,D,,,,,10.0,MG,,,2022,Q3,Hepatitis acute,,2022,Q3,1,I,20220523.0,20220721.0,20220805,20220805,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-347283,RANBAXY,,33.0,YR,,F,Y,,,20220805,,MD,FR,FR,2022,Q3,Young Adult
211755041,21175504,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Death,,2022,Q3,1,I,20220731.0,20220802.0,20220805,20220805,EXP,,ZA-AstraZeneca-2022A275294,ASTRAZENECA,,27288.0,DY,,M,Y,,,20220805,,CN,ZA,,2022,Q3,Elderly
211784041,21178404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Hepatitis,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211784041,21178404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Transaminases increased,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211784041,21178404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Gamma-glutamyltransferase increased,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211784041,21178404,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Hepatitis,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211784041,21178404,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Transaminases increased,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211784041,21178404,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,280.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Gamma-glutamyltransferase increased,,2022,Q3,1,I,20220721.0,20220801.0,20220805,20220805,EXP,,DE-AstraZeneca-2022A272321,ASTRAZENECA,,82.0,YR,,F,Y,96.0,KG,20220805,,MD,DE,,2022,Q3,Elderly
211835801,21183580,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q3,Right ventricular failure,,2022,Q3,1,I,,20220727.0,20220808,20220808,EXP,,AU-ALKEM LABORATORIES LIMITED-AU-ALKEM-2022-07998,ALKEM,,50.0,YR,,M,Y,,,20220808,,HP,AU,AU,2022,Q3,Adult
211857591,21185759,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd (in am)",,,,,,,,,,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,20220722.0,20220802.0,20220808,20220808,EXP,GB-MHRA-TPP21344299C966245YC1658492027245,GB-MYLANLABS-2022M1083631,MYLAN,,78.0,YR,,M,Y,57.0,KG,20220808,,MD,GB,GB,2022,Q3,Elderly
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Product colour issue,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Illness,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Anal incontinence,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211873211,21187321,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 tablet daily; ;,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220709.0,20220715.0,20220808,20220808,EXP,,GB-PURDUE-USA-2022-0295792,PURDUE,,31.0,YR,,M,Y,,,20220808,,PH,GB,GB,2022,Q3,Young Adult
211878831,21187883,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095656,NOVARTIS,,84.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211878831,21187883,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095656,NOVARTIS,,84.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211886871,21188687,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095661,NOVARTIS,,86.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211886871,21188687,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Sinus node dysfunction,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095661,NOVARTIS,,86.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211886871,21188687,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Gastric cancer,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095661,NOVARTIS,,86.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211886871,21188687,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Brain natriuretic peptide increased,,2022,Q3,1,I,,20220803.0,20220809,20220809,EXP,,NVSJ2022JP095661,NOVARTIS,,86.0,YR,,M,Y,,,20220809,,MD,JP,JP,2022,Q3,Elderly
211919401,21191940,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,in am,,,,,,,,,,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,20220722.0,20220802.0,20220809,20220809,EXP,GB-MHRA-TPP21344299C966245YC1658492027245,GB-EMD Serono-E2B_90088640,EMD SERONO INC,,78.0,YR,E,M,Y,57.0,KG,20220809,,MD,GB,GB,2022,Q3,Elderly
211926701,21192670,1,PS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5/1000 milligram,,,,,,,,,,,,2022,Q3,Immune-mediated myositis,,2022,Q3,1,I,,20220726.0,20220810,20220810,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347629,RANBAXY,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors. Neurol Sci. 2022;43:4567-70",76.0,YR,,F,Y,,,20220810,,HP,IT,IT,2022,Q3,Elderly
211926701,21192670,2,SS,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,5/1000 milligram,,,,,,,,,,,Q12H,2022,Q3,Immune-mediated myositis,,2022,Q3,1,I,,20220726.0,20220810,20220810,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-347629,RANBAXY,"Stella M, Biassoni E, Fiorillo C, Grandis M, Mattioli F. A case of anti-HMGCR myopathy triggered by sodium/glucose co-transporter 2 (SGLT2) inhibitors. Neurol Sci. 2022;43:4567-70",76.0,YR,,F,Y,,,20220810,,HP,IT,IT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Impatience,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Confusional state,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Vertigo,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211931201,21193120,11,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 + 1,,,,,,,,,,,,2022,Q3,Dysuria,,2022,Q3,1,I,20220414.0,20220804.0,20220810,20220810,EXP,,PT-ORGANON-O2205PRT000336,ORGANON,,74.0,YR,,M,Y,92.8,KG,20220810,,PH,PT,PT,2022,Q3,Elderly
211945091,21194509,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,D,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220801.0,20220810,20220810,EXP,,JP-MYLANLABS-2022M1084621,MYLAN,"Hashimoto N, Kitano D, Tamaki T, Koyama Y, Yamada A, Hatakeyama K, et al. Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy. J-Cardiovasc-Dev-Dis 2022;9(7):208.. 2022;9(7):208",69.0,YR,,F,Y,,,20220810,,HP,JP,JP,2022,Q3,Elderly
211947301,21194730,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Death,,2022,Q3,1,I,20220805.0,20220805.0,20220810,20220810,EXP,,ZA-AstraZeneca-2022A280378,ASTRAZENECA,,11096.0,DY,,M,Y,,,20220810,,CN,ZA,,2022,Q3,Elderly
211947311,21194731,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4820.0,MG,Y,,HJ20170119,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220720.0,20220802.0,20220810,20220810,EXP,,CN-AstraZeneca-2022A276460,ASTRAZENECA,,29624.0,DY,,F,Y,45.0,KG,20220810,,MD,CN,,2022,Q3,Elderly
211947311,21194731,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,4820.0,MG,Y,,HJ20170119,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Escherichia urinary tract infection,,2022,Q3,1,I,20220720.0,20220802.0,20220810,20220810,EXP,,CN-AstraZeneca-2022A276460,ASTRAZENECA,,29624.0,DY,,F,Y,45.0,KG,20220810,,MD,CN,,2022,Q3,Elderly
211948221,21194822,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20211123.0,20220802.0,20220810,20220810,EXP,,JP-EMD Serono-9290078,EMD SERONO INC,,76.0,YR,E,F,Y,49.0,KG,20220810,,MD,JP,,2022,Q3,Elderly
211948221,21194822,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20211123.0,20220802.0,20220810,20220810,EXP,,JP-EMD Serono-9290078,EMD SERONO INC,,76.0,YR,E,F,Y,49.0,KG,20220810,,MD,JP,,2022,Q3,Elderly
211948221,21194822,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20211123.0,20220802.0,20220810,20220810,EXP,,JP-EMD Serono-9290078,EMD SERONO INC,,76.0,YR,E,F,Y,49.0,KG,20220810,,MD,JP,,2022,Q3,Elderly
211948221,21194822,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q3,1,I,20211123.0,20220802.0,20220810,20220810,EXP,,JP-EMD Serono-9290078,EMD SERONO INC,,76.0,YR,E,F,Y,49.0,KG,20220810,,MD,JP,,2022,Q3,Elderly
211952963,21195296,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Disorientation,,2022,Q3,3,F,,20220915.0,20220810,20220921,EXP,,JP-OTSUKA-2022_039616,OTSUKA,,89.0,YR,,M,Y,,,20220921,,PH,JP,JP,2022,Q3,Elderly
211952963,21195296,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Prescribed underdose,,2022,Q3,3,F,,20220915.0,20220810,20220921,EXP,,JP-OTSUKA-2022_039616,OTSUKA,,89.0,YR,,M,Y,,,20220921,,PH,JP,JP,2022,Q3,Elderly
211952963,21195296,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg/day,,,,,,,,,,,,2022,Q3,Hallucination,,2022,Q3,3,F,,20220915.0,20220810,20220921,EXP,,JP-OTSUKA-2022_039616,OTSUKA,,89.0,YR,,M,Y,,,20220921,,PH,JP,JP,2022,Q3,Elderly
211956741,21195674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg once a day,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220802.0,20220807.0,20220810,20220810,EXP,,GB-AstraZeneca-2022A279321,ASTRAZENECA,,65.0,YR,,M,Y,70.0,KG,20220810,,MD,GB,,2022,Q3,Elderly
211956741,21195674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg once a day,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Medication error,,2022,Q3,1,I,20220802.0,20220807.0,20220810,20220810,EXP,,GB-AstraZeneca-2022A279321,ASTRAZENECA,,65.0,YR,,M,Y,70.0,KG,20220810,,MD,GB,,2022,Q3,Elderly
211971491,21197149,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,,,Tablet,QD,2022,Q3,Gynaecomastia,,2022,Q3,1,I,20220720.0,20220808.0,20220810,20220810,EXP,,FR-AstraZeneca-2022A279408,ASTRAZENECA,,66.0,YR,,M,Y,83.5,KG,20220810,,MD,FR,,2022,Q3,Elderly
211976423,21197642,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Renal impairment,,2022,Q3,3,F,20220202.0,20220825.0,20220810,20220906,EXP,PT-INFARMED-T202207-5745,PT-Vifor (International) Inc.-VIT-2022-05507,VIFOR,,62.0,YR,,M,Y,102.0,KG,20220906,,PH,PT,PT,2022,Q3,Adult
211985921,21198592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,as per cardio",,,Y,,,,202293.0,,,Tablet,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220722.0,20220805.0,20220811,20220811,EXP,,GB-AstraZeneca-2022A279207,ASTRAZENECA,,72.0,YR,,M,Y,83.5,KG,20220811,,MD,GB,,2022,Q3,Elderly
211985921,21198592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,as per cardio",,,Y,,,,202293.0,,,Tablet,,2022,Q3,Abdominal pain,,2022,Q3,1,I,20220722.0,20220805.0,20220811,20220811,EXP,,GB-AstraZeneca-2022A279207,ASTRAZENECA,,72.0,YR,,M,Y,83.5,KG,20220811,,MD,GB,,2022,Q3,Elderly
211985921,21198592,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10,as per cardio",,,Y,,,,202293.0,,,Tablet,,2022,Q3,Vomiting,,2022,Q3,1,I,20220722.0,20220805.0,20220811,20220811,EXP,,GB-AstraZeneca-2022A279207,ASTRAZENECA,,72.0,YR,,M,Y,83.5,KG,20220811,,MD,GB,,2022,Q3,Elderly
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Cardiovascular disorder,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Rash,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Back pain,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Pericarditis,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Inflammation,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Herpes zoster,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Excessive cerumen production,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Neuropathy peripheral,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
211986461,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q3,Ill-defined disorder,,2022,Q3,1,I,,20220730.0,20220811,20220811,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20220811,,HP,CA,,2022,Q3,Adult
212000211,21200021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NC24782107172,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,20220728.0,20220803.0,20220811,20220811,EXP,,CN-AstraZeneca-2022A278716,ASTRAZENECA,,73.0,YR,,M,Y,70.0,KG,20220811,,MD,CN,,2022,Q3,Elderly
212000211,21200021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NC24782107172,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220728.0,20220803.0,20220811,20220811,EXP,,CN-AstraZeneca-2022A278716,ASTRAZENECA,,73.0,YR,,M,Y,70.0,KG,20220811,,MD,CN,,2022,Q3,Elderly
212002241,21200224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Foreskin oedema,,2022,Q3,1,I,20220727.0,20220802.0,20220811,20220811,EXP,,GB-AUROBINDO-AUR-APL-2022-031329,AUROBINDO,,76.0,YR,,M,Y,96.0,KG,20220811,,MD,GB,GB,2022,Q3,Elderly
212002531,21200253,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day (in am)",,,U,,,,,,,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,20220722.0,20220802.0,20220811,20220811,EXP,,GB-AUROBINDO-AUR-APL-2022-031342,AUROBINDO,,78.0,YR,,M,Y,57.0,KG,20220811,,MD,GB,GB,2022,Q3,Elderly
212003541,21200354,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220805.0,20220811,20220811,EXP,FR-AFSSAPS-NC20222464,FR-SA-2022SA331043,SANOFI AVENTIS,,64.0,YR,A,M,Y,76.0,KG,20220811,,PH,FR,FR,2022,Q3,Adult
212003541,21200354,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220805.0,20220811,20220811,EXP,FR-AFSSAPS-NC20222464,FR-SA-2022SA331043,SANOFI AVENTIS,,64.0,YR,A,M,Y,76.0,KG,20220811,,PH,FR,FR,2022,Q3,Adult
212003541,21200354,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220805.0,20220811,20220811,EXP,FR-AFSSAPS-NC20222464,FR-SA-2022SA331043,SANOFI AVENTIS,,64.0,YR,A,M,Y,76.0,KG,20220811,,PH,FR,FR,2022,Q3,Adult
212030841,21203084,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Thrombosis,,2022,Q3,1,I,20220421.0,20220802.0,20220811,20220811,EXP,FR-AFSSAPS-AM20221866,FR-SA-2022SA328392,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20220811,,MD,FR,FR,2022,Q3,Elderly
212030841,21203084,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220421.0,20220802.0,20220811,20220811,EXP,FR-AFSSAPS-AM20221866,FR-SA-2022SA328392,SANOFI AVENTIS,,75.0,YR,E,F,Y,73.0,KG,20220811,,MD,FR,FR,2022,Q3,Elderly
212049061,21204906,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,,,,,2022,Q3,Myocardial infarction,,2022,Q3,1,I,20220216.0,20220802.0,20220812,20220812,EXP,,BR-NOVOPROD-946216,NOVO NORDISK,,54.0,YR,,M,Y,78.0,KG,20220812,,CN,BR,BR,2022,Q3,Adult
212049061,21204906,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,,,,,2022,Q3,Blood glucose fluctuation,,2022,Q3,1,I,20220216.0,20220802.0,20220812,20220812,EXP,,BR-NOVOPROD-946216,NOVO NORDISK,,54.0,YR,,M,Y,78.0,KG,20220812,,CN,BR,BR,2022,Q3,Adult
212049061,21204906,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220216.0,20220802.0,20220812,20220812,EXP,,BR-NOVOPROD-946216,NOVO NORDISK,,54.0,YR,,M,Y,78.0,KG,20220812,,CN,BR,BR,2022,Q3,Adult
212054892,21205489,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,take one daily,,,,,,,,,,,QD,2022,Q3,Atrial fibrillation,,2022,Q3,2,F,20220726.0,20220823.0,20220812,20220831,EXP,GB-MHRA-TPP13841372C5136343YC1658857837479,GB-EMD Serono-E2B_90088670,EMD SERONO INC,,63.0,YR,A,F,Y,121.0,KG,20220831,,MD,GB,,2022,Q3,Adult
212054892,21205489,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,take one daily,,,,,,,,,,,QD,2022,Q3,Palpitations,,2022,Q3,2,F,20220726.0,20220823.0,20220812,20220831,EXP,GB-MHRA-TPP13841372C5136343YC1658857837479,GB-EMD Serono-E2B_90088670,EMD SERONO INC,,63.0,YR,A,F,Y,121.0,KG,20220831,,MD,GB,,2022,Q3,Adult
212072821,21207282,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 Dosage forms Daily; in am, 1 DF, QD",,,,,,,,,,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,20220722.0,20220802.0,20220812,20220812,EXP,GB-MHRA-TPP21344299C966245YC1658492027245,GB-TEVA-2022-GB-2062283,TEVA,,78.0,YR,E,M,Y,57.0,KG,20220812,,MD,GB,GB,2022,Q3,Elderly
212083941,21208394,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220810.0,20220812,20220812,EXP,FR-AFSSAPS-NC20222464,FR-TAKEDA-2022TUS055440,TAKEDA,,64.0,YR,,M,Y,76.0,KG,20220812,,HP,FR,FR,2022,Q3,Adult
212083941,21208394,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220810.0,20220812,20220812,EXP,FR-AFSSAPS-NC20222464,FR-TAKEDA-2022TUS055440,TAKEDA,,64.0,YR,,M,Y,76.0,KG,20220812,,HP,FR,FR,2022,Q3,Adult
212083941,21208394,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220810.0,20220812,20220812,EXP,FR-AFSSAPS-NC20222464,FR-TAKEDA-2022TUS055440,TAKEDA,,64.0,YR,,M,Y,76.0,KG,20220812,,HP,FR,FR,2022,Q3,Adult
212092101,21209210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Hyponatraemia,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212092101,21209210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Hyponatraemic seizure,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212092101,21209210,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Hyponatraemia,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212092101,21209210,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Hyponatraemic seizure,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212092101,21209210,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Hyponatraemia,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212092101,21209210,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,Y,,,,202293.0,5.0,MG,Tablet,,2022,Q3,Hyponatraemic seizure,,2022,Q3,1,I,20220624.0,20220808.0,20220813,20220813,EXP,,DE-AstraZeneca-2022A279459,ASTRAZENECA,,64.0,YR,,F,Y,67.0,KG,20220813,,MD,DE,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Blood cholesterol increased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Bursitis,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Product dose omission issue,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Alopecia,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Pancreatic failure,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,COVID-19,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Weight decreased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Lung opacity,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Blood triglycerides increased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Blood cholesterol increased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Bursitis,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Product dose omission issue,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Alopecia,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Pancreatic failure,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,COVID-19,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Weight decreased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Lung opacity,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212093642,21209364,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Blood triglycerides increased,,2022,Q3,2,F,20210301.0,20220812.0,20220813,20220818,EXP,,BR-AstraZeneca-2022A280754,ASTRAZENECA,,50.0,YR,,F,Y,74.0,KG,20220818,,CN,BR,,2022,Q3,Adult
212095691,21209569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,1,I,20220804.0,20220805.0,20220813,20220813,EXP,,FR-AstraZeneca-2022A280619,ASTRAZENECA,,26887.0,DY,,F,Y,,,20220813,,MD,FR,,2022,Q3,Elderly
212095691,21209569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,920.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Lipase increased,,2022,Q3,1,I,20220804.0,20220805.0,20220813,20220813,EXP,,FR-AstraZeneca-2022A280619,ASTRAZENECA,,26887.0,DY,,F,Y,,,20220813,,MD,FR,,2022,Q3,Elderly
212099231,21209923,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q3,Haemodynamic instability,,2022,Q3,1,I,,20220812.0,20220813,20220813,EXP,,NVSC2022CN183394,NOVARTIS,"Han J, Xie S, Jiao H. Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. 2022;1-4",74.0,YR,,M,Y,,,20220813,,HP,CN,CN,2022,Q3,Elderly
212101732,21210173,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q3,Immune-mediated dermatitis,,2022,Q3,2,F,20220616.0,20220812.0,20220814,20220822,EXP,,JP-ROCHE-3158587,ROCHE,,75.0,YR,,F,Y,43.9,KG,20220822,,MD,JP,JP,2022,Q3,Elderly
212101732,21210173,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q3,Hypoaesthesia,,2022,Q3,2,F,20220616.0,20220812.0,20220814,20220822,EXP,,JP-ROCHE-3158587,ROCHE,,75.0,YR,,F,Y,43.9,KG,20220822,,MD,JP,JP,2022,Q3,Elderly
212101732,21210173,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q3,Decreased appetite,,2022,Q3,2,F,20220616.0,20220812.0,20220814,20220822,EXP,,JP-ROCHE-3158587,ROCHE,,75.0,YR,,F,Y,43.9,KG,20220822,,MD,JP,JP,2022,Q3,Elderly
212107832,21210783,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Concomitant disease aggravated,,2022,Q3,2,F,,20220824.0,20220815,20220829,EXP,,NVSJ2022JP095886,NOVARTIS,,54.0,YR,,M,Y,74.0,KG,20220829,,MD,JP,JP,2022,Q3,Adult
212107832,21210783,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,2,F,,20220824.0,20220815,20220829,EXP,,NVSJ2022JP095886,NOVARTIS,,54.0,YR,,M,Y,74.0,KG,20220829,,MD,JP,JP,2022,Q3,Adult
212107832,21210783,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,2,F,,20220824.0,20220815,20220829,EXP,,NVSJ2022JP095886,NOVARTIS,,54.0,YR,,M,Y,74.0,KG,20220829,,MD,JP,JP,2022,Q3,Adult
212107832,21210783,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220824.0,20220815,20220829,EXP,,NVSJ2022JP095886,NOVARTIS,,54.0,YR,,M,Y,74.0,KG,20220829,,MD,JP,JP,2022,Q3,Adult
212119861,21211986,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",770.0,MG,N,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Gynaecomastia,,2022,Q3,1,I,20220720.0,20220808.0,20220815,20220815,EXP,FR-AFSSAPS-AM20221905,FR-PFIZER INC-202201042134,PFIZER,,66.0,YR,,M,Y,83.5,KG,20220815,,MD,FR,FR,2022,Q3,Elderly
212119861,21211986,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",770.0,MG,N,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,1,I,20220720.0,20220808.0,20220815,20220815,EXP,FR-AFSSAPS-AM20221905,FR-PFIZER INC-202201042134,PFIZER,,66.0,YR,,M,Y,83.5,KG,20220815,,MD,FR,FR,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Transaminases increased,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Ocular icterus,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Bilirubinuria,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hyperbilirubinaemia,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Abdominal pain,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212132982,21213298,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Drug-induced liver injury,,2022,Q3,2,F,20220616.0,20220812.0,20220815,20220818,EXP,,DE-AstraZeneca-2022A282467,ASTRAZENECA,,87.0,YR,,M,Y,62.0,KG,20220818,,MD,DE,,2022,Q3,Elderly
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Excessive cerumen production,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Pericarditis,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Ill-defined disorder,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Back pain,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Inflammation,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Malaise,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Neuropathy peripheral,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Herpes zoster,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Rash,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212161661,21216166,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cardiovascular disorder,,2022,Q3,1,I,,20220803.0,20220816,20220816,EXP,CA-MHPD-E2B_05399342,CA-Accord-272761,ACCORD,,58.0,YR,A,F,Y,,,20220816,,HP,CA,CA,2022,Q3,Adult
212188622,21218862,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Renal impairment,,2022,Q3,2,F,20050101.0,20220816.0,20220816,20220819,EXP,,US-PFIZER INC-2018072376,PFIZER,,60.0,YR,,M,Y,,,20220819,,CN,US,US,2022,Q3,Adult
212188622,21218862,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20050101.0,20220816.0,20220816,20220819,EXP,,US-PFIZER INC-2018072376,PFIZER,,60.0,YR,,M,Y,,,20220819,,CN,US,US,2022,Q3,Adult
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Angioedema,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Psychomotor hyperactivity,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Insomnia,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Confusional state,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Blood pressure systolic decreased,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Contraindicated product administered,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212191901,21219190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, UNKNOWN",,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Dizziness,,2022,Q3,1,I,20220607.0,20220810.0,20220816,20220816,EXP,,RO-AstraZeneca-2022A282232,ASTRAZENECA,,79.0,YR,,F,Y,80.0,KG,20220817,,MD,RO,,2022,Q3,Elderly
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Off label use,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Anal abscess,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Blood pressure increased,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Fluid retention,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Transplant rejection,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212195172,21219517,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,Unknown,,,10.0,MG,,,2022,Q3,Fluid retention,,2022,Q3,2,F,20210501.0,20220818.0,20220817,20220901,EXP,,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-05908,ALKEM,,46.0,YR,,M,Y,,,20220901,,CN,DE,DE,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Hepatic failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Pulmonary embolism,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Atrial fibrillation,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Hepatitis E,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Hepatic failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Dyspnoea,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Pulmonary embolism,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Cardiac failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Atrial fibrillation,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,D,,,,,,,Tablet,,2022,Q3,Hepatitis E,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Hepatic failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212199412,21219941,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Hepatitis E,,2022,Q3,2,F,20180719.0,20220916.0,20220817,20220920,EXP,,NVSC2022HU185474,NOVARTIS,,54.0,YR,,M,Y,100.0,KG,20220920,,HP,HU,HU,2022,Q3,Adult
212208311,21220831,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, 1 every 5 days",,,U,,,,202293.0,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220812.0,20220817,20220817,EXP,,CA-AstraZeneca-2022A285938,ASTRAZENECA,,64.0,YR,,M,Y,90.0,KG,20220817,,MD,CA,,2022,Q3,Adult
212208311,21220831,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, 1 every 5 days",,,U,,,,202293.0,,,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220812.0,20220817,20220817,EXP,,CA-AstraZeneca-2022A285938,ASTRAZENECA,,64.0,YR,,M,Y,90.0,KG,20220817,,MD,CA,,2022,Q3,Adult
212208311,21220831,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, 1 every 5 days",,,U,,,,202293.0,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220812.0,20220817,20220817,EXP,,CA-AstraZeneca-2022A285938,ASTRAZENECA,,64.0,YR,,M,Y,90.0,KG,20220817,,MD,CA,,2022,Q3,Adult
212208753,21220875,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Biliary obstruction,,2022,Q3,3,F,20180823.0,20220824.0,20220817,20220901,EXP,,JP-AstraZeneca-2022A285488,ASTRAZENECA,,74.0,YR,,F,Y,43.0,KG,20220901,,MD,JP,,2022,Q3,Elderly
212208753,21220875,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,3,F,20180823.0,20220824.0,20220817,20220901,EXP,,JP-AstraZeneca-2022A285488,ASTRAZENECA,,74.0,YR,,F,Y,43.0,KG,20220901,,MD,JP,,2022,Q3,Elderly
212208753,21220875,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Cholangitis,,2022,Q3,3,F,20180823.0,20220824.0,20220817,20220901,EXP,,JP-AstraZeneca-2022A285488,ASTRAZENECA,,74.0,YR,,F,Y,43.0,KG,20220901,,MD,JP,,2022,Q3,Elderly
212220071,21222007,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,1,I,20220101.0,20220809.0,20220817,20220817,PER,,GB-AMGEN-GBRSP2022137038,AMGEN,,80.0,YR,E,M,Y,90.0,KG,20220817,,HP,GB,GB,2022,Q3,Elderly
212220071,21222007,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,1,I,20220101.0,20220809.0,20220817,20220817,PER,,GB-AMGEN-GBRSP2022137038,AMGEN,,80.0,YR,E,M,Y,90.0,KG,20220817,,HP,GB,GB,2022,Q3,Elderly
212220071,21222007,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,20220101.0,20220809.0,20220817,20220817,PER,,GB-AMGEN-GBRSP2022137038,AMGEN,,80.0,YR,E,M,Y,90.0,KG,20220817,,HP,GB,GB,2022,Q3,Elderly
212231483,21223148,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Tablets,,2022,Q3,Urinary tract infection,,2022,Q3,3,F,20220810.0,20220913.0,20220817,20220920,PER,,DK-Eisai Medical Research-EC-2022-121386,EISAI,,64.0,YR,A,M,Y,85.0,KG,20220920,,MD,DK,,2022,Q3,Adult
212233232,21223323,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q3,Abdominal distension,,2022,Q3,2,F,20220101.0,20220809.0,20220817,20220915,EXP,,CA-AstraZeneca-2022A283446,ASTRAZENECA,,755.0,MON,,F,Y,70.3,KG,20220916,,HP,CA,,2022,Q3,Elderly
212233232,21223323,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220101.0,20220809.0,20220817,20220915,EXP,,CA-AstraZeneca-2022A283446,ASTRAZENECA,,755.0,MON,,F,Y,70.3,KG,20220916,,HP,CA,,2022,Q3,Elderly
212233232,21223323,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q3,Faeces soft,,2022,Q3,2,F,20220101.0,20220809.0,20220817,20220915,EXP,,CA-AstraZeneca-2022A283446,ASTRAZENECA,,755.0,MON,,F,Y,70.3,KG,20220916,,HP,CA,,2022,Q3,Elderly
212234561,21223456,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q3,Cardiac disorder,,2022,Q3,1,I,,20220805.0,20220817,20220817,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202208002999,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20220817,,PH,DE,DE,2022,Q3,Elderly
212261091,21226109,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220817.0,20220818,20220818,EXP,,CA-BAUSCH-BL-2022-020411,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220818,,HP,CA,CA,2022,Q3,Adult
212261091,21226109,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220817.0,20220818,20220818,EXP,,CA-BAUSCH-BL-2022-020411,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220818,,HP,CA,CA,2022,Q3,Adult
212261091,21226109,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220817.0,20220818,20220818,EXP,,CA-BAUSCH-BL-2022-020411,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220818,,HP,CA,CA,2022,Q3,Adult
212261211,21226121,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220817.0,20220818,20220818,EXP,,CA-BAUSCH-BL-2022-020433,BAUSCH AND LOMB,,70.0,YR,,F,Y,98.0,KG,20220818,,HP,CA,CA,2022,Q3,Elderly
212266592,21226659,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Transitional cell carcinoma,,2022,Q3,2,F,20220426.0,20220829.0,20220818,20220905,EXP,,FR-TAKEDA-2022TUS056985,TAKEDA,,75.0,YR,,M,Y,,,20220905,,HP,FR,FR,2022,Q3,Elderly
212270801,21227080,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220731.0,20220809.0,20220818,20220818,EXP,,EG-AstraZeneca-2022A285054,ASTRAZENECA,,82.0,YR,,F,Y,95.0,KG,20220818,,MD,EG,,2022,Q3,Elderly
212270801,21227080,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220731.0,20220809.0,20220818,20220818,EXP,,EG-AstraZeneca-2022A285054,ASTRAZENECA,,82.0,YR,,F,Y,95.0,KG,20220818,,MD,EG,,2022,Q3,Elderly
212271711,21227171,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Symptom recurrence,,2022,Q3,1,I,20220809.0,,20220817,20220817,DIR,627880,,FDA-CTU,,66.0,YR,,M,N,67.2,KG,20220817,N,PH,US,,2022,Q3,Elderly
212271711,21227171,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,20220809.0,,20220817,20220817,DIR,627880,,FDA-CTU,,66.0,YR,,M,N,67.2,KG,20220817,N,PH,US,,2022,Q3,Elderly
212271711,21227171,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cardiac arrest,,2022,Q3,1,I,20220809.0,,20220817,20220817,DIR,627880,,FDA-CTU,,66.0,YR,,M,N,67.2,KG,20220817,N,PH,US,,2022,Q3,Elderly
212271711,21227171,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20220809.0,,20220817,20220817,DIR,627880,,FDA-CTU,,66.0,YR,,M,N,67.2,KG,20220817,N,PH,US,,2022,Q3,Elderly
212271711,21227171,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Torsade de pointes,,2022,Q3,1,I,20220809.0,,20220817,20220817,DIR,627880,,FDA-CTU,,66.0,YR,,M,N,67.2,KG,20220817,N,PH,US,,2022,Q3,Elderly
212333431,21233343,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,2110060,,202293.0,,,Tablet,BID,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220717.0,20220810.0,20220819,20220819,EXP,,CN-AstraZeneca-2022A285465,ASTRAZENECA,,43.0,YR,,F,Y,57.0,KG,20220819,,MD,CN,,2022,Q3,Adult
212340341,21234034,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220816.0,20220819,20220819,EXP,,FR-AstraZeneca-2022A287641,ASTRAZENECA,,64.0,YR,,M,Y,76.0,KG,20220819,,MD,FR,,2022,Q3,Adult
212340341,21234034,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220816.0,20220819,20220819,EXP,,FR-AstraZeneca-2022A287641,ASTRAZENECA,,64.0,YR,,M,Y,76.0,KG,20220819,,MD,FR,,2022,Q3,Adult
212340341,21234034,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220816.0,20220819,20220819,EXP,,FR-AstraZeneca-2022A287641,ASTRAZENECA,,64.0,YR,,M,Y,76.0,KG,20220819,,MD,FR,,2022,Q3,Adult
212341141,21234114,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,Y,,,202293.0,10.0,MG,Tablet,,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20220419.0,20220812.0,20220819,20220819,EXP,,CH-AstraZeneca-2022A285738,ASTRAZENECA,Scheen AJ. An update on the safety of SGLT2 inhibitors. Expert Opin Drug Saf 2019;18(4):295-311.,75.0,YR,,M,Y,73.0,KG,20220819,,MD,CH,,2022,Q3,Elderly
212341141,21234114,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,Y,,,202293.0,10.0,MG,Tablet,,2022,Q3,Balanoposthitis,,2022,Q3,1,I,20220419.0,20220812.0,20220819,20220819,EXP,,CH-AstraZeneca-2022A285738,ASTRAZENECA,Scheen AJ. An update on the safety of SGLT2 inhibitors. Expert Opin Drug Saf 2019;18(4):295-311.,75.0,YR,,M,Y,73.0,KG,20220819,,MD,CH,,2022,Q3,Elderly
212341141,21234114,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,Y,,,202293.0,10.0,MG,Tablet,,2022,Q3,Sepsis,,2022,Q3,1,I,20220419.0,20220812.0,20220819,20220819,EXP,,CH-AstraZeneca-2022A285738,ASTRAZENECA,Scheen AJ. An update on the safety of SGLT2 inhibitors. Expert Opin Drug Saf 2019;18(4):295-311.,75.0,YR,,M,Y,73.0,KG,20220819,,MD,CH,,2022,Q3,Elderly
212341751,21234175,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Fungal infection,,2022,Q3,1,I,,20220812.0,20220819,20220819,EXP,,CA-AstraZeneca-2022A285928,ASTRAZENECA,,63.0,YR,,F,Y,,,20220819,,MD,CA,,2022,Q3,Adult
212346313,21234631,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q3,Pulmonary oedema,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q3,Hyperglycaemia,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q3,Metabolic acidosis,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Pulmonary oedema,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Hyperglycaemia,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Pulmonary oedema,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Hyperglycaemia,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Pulmonary oedema,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Hyperglycaemia,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212346313,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,3,F,,20220919.0,20220820,20220929,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20220929,,HP,CA,CA,2022,Q3,Adult
212363641,21236364,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,,20220809.0,20220822,20220822,EXP,,CA-AUROBINDO-AUR-APL-2022-032558,AUROBINDO,,70.0,YR,,F,Y,98.0,KG,20220822,,HP,CA,CA,2022,Q3,Elderly
212363641,21236364,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,Tablet,,2022,Q3,Tremor,,2022,Q3,1,I,,20220809.0,20220822,20220822,EXP,,CA-AUROBINDO-AUR-APL-2022-032558,AUROBINDO,,70.0,YR,,F,Y,98.0,KG,20220822,,HP,CA,CA,2022,Q3,Elderly
212383701,21238370,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220720.0,20220817.0,20220822,20220822,EXP,IT-MINISAL02-881589,IT-PFIZER INC-202201065563,PFIZER,,53.0,YR,,F,Y,,,20220822,,MD,IT,IT,2022,Q3,Adult
212383701,21238370,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220720.0,20220817.0,20220822,20220822,EXP,IT-MINISAL02-881589,IT-PFIZER INC-202201065563,PFIZER,,53.0,YR,,F,Y,,,20220822,,MD,IT,IT,2022,Q3,Adult
212390962,21239096,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,,,,,,5.0,MG,Tablet,QD,2022,Q3,Anaphylactic reaction,,2022,Q3,2,F,20220816.0,20220926.0,20220822,20220930,EXP,,JP-009507513-2208JPN002285J,MERCK,,69.0,YR,,F,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
212402491,21240249,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220817.0,20220822,20220822,EXP,,CA-BAUSCH-BL-2022-020590,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220822,,HP,CA,CA,2022,Q3,Adult
212402491,21240249,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220817.0,20220822,20220822,EXP,,CA-BAUSCH-BL-2022-020590,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220822,,HP,CA,CA,2022,Q3,Adult
212402491,21240249,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220817.0,20220822,20220822,EXP,,CA-BAUSCH-BL-2022-020590,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20220822,,HP,CA,CA,2022,Q3,Adult
212403871,21240387,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 cp/J,160.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypercreatinaemia,,2022,Q3,1,I,20220525.0,20220816.0,20220822,20220822,EXP,,FR-AstraZeneca-2022A287569,ASTRAZENECA,,63.0,YR,,M,Y,147.0,KG,20220823,,MD,FR,,2022,Q3,Adult
212403871,21240387,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 cp/J,160.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220525.0,20220816.0,20220822,20220822,EXP,,FR-AstraZeneca-2022A287569,ASTRAZENECA,,63.0,YR,,M,Y,147.0,KG,20220823,,MD,FR,,2022,Q3,Adult
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Diabetic metabolic decompensation,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,COVID-19 pneumonia,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Drug-induced liver injury,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Portal hypertension,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Urinary tract infection,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Sepsis,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Hepatic cirrhosis,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446782,21244678,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5/1000 mg, bid",,,,,,,,,,,BID,2022,Q3,Hypercoagulation,,2022,Q3,2,F,20211201.0,20220914.0,20220823,20220921,EXP,,LV-ELI_LILLY_AND_COMPANY-LV202208006393,ELI LILLY AND CO,,74.0,YR,,M,Y,89.0,KG,20220921,,CN,LV,LV,2022,Q3,Elderly
212446951,21244695,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,700.0,MG,Y,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,1,I,20220101.0,20220819.0,20220823,20220823,EXP,,DE-AstraZeneca-2022A292243,ASTRAZENECA,,69.0,YR,,M,Y,101.0,KG,20220823,,MD,DE,,2022,Q3,Elderly
212446951,21244695,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,700.0,MG,Y,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Intentional product misuse,,2022,Q3,1,I,20220101.0,20220819.0,20220823,20220823,EXP,,DE-AstraZeneca-2022A292243,ASTRAZENECA,,69.0,YR,,M,Y,101.0,KG,20220823,,MD,DE,,2022,Q3,Elderly
212446951,21244695,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,700.0,MG,Y,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Phimosis,,2022,Q3,1,I,20220101.0,20220819.0,20220823,20220823,EXP,,DE-AstraZeneca-2022A292243,ASTRAZENECA,,69.0,YR,,M,Y,101.0,KG,20220823,,MD,DE,,2022,Q3,Elderly
212446951,21244695,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,700.0,MG,Y,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Fungal infection,,2022,Q3,1,I,20220101.0,20220819.0,20220823,20220823,EXP,,DE-AstraZeneca-2022A292243,ASTRAZENECA,,69.0,YR,,M,Y,101.0,KG,20220823,,MD,DE,,2022,Q3,Elderly
212446951,21244695,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,700.0,MG,Y,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220101.0,20220819.0,20220823,20220823,EXP,,DE-AstraZeneca-2022A292243,ASTRAZENECA,,69.0,YR,,M,Y,101.0,KG,20220823,,MD,DE,,2022,Q3,Elderly
212450202,21245020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,2,F,20220622.0,20220825.0,20220823,20220830,EXP,,JP-AstraZeneca-2022A292841,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20220830,,MD,JP,,2022,Q3,Elderly
212450202,21245020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood creatinine increased,,2022,Q3,2,F,20220622.0,20220825.0,20220823,20220830,EXP,,JP-AstraZeneca-2022A292841,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20220830,,MD,JP,,2022,Q3,Elderly
212450202,21245020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,2,F,20220622.0,20220825.0,20220823,20220830,EXP,,JP-AstraZeneca-2022A292841,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20220830,,MD,JP,,2022,Q3,Elderly
212450202,21245020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,430.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urine protein/creatinine ratio increased,,2022,Q3,2,F,20220622.0,20220825.0,20220823,20220830,EXP,,JP-AstraZeneca-2022A292841,ASTRAZENECA,,72.0,YR,,M,Y,65.0,KG,20220830,,MD,JP,,2022,Q3,Elderly
212483842,21248384,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,20210101.0,20220829.0,20220824,20220906,EXP,,BR-009507513-2208BRA006186,MERCK,,72.0,YR,,M,Y,,,20220906,,CN,BR,BR,2022,Q3,Elderly
212483842,21248384,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Aortic valve replacement,,2022,Q3,2,F,20210101.0,20220829.0,20220824,20220906,EXP,,BR-009507513-2208BRA006186,MERCK,,72.0,YR,,M,Y,,,20220906,,CN,BR,BR,2022,Q3,Elderly
212483842,21248384,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Erythema,,2022,Q3,2,F,20210101.0,20220829.0,20220824,20220906,EXP,,BR-009507513-2208BRA006186,MERCK,,72.0,YR,,M,Y,,,20220906,,CN,BR,BR,2022,Q3,Elderly
212483842,21248384,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,2,F,20210101.0,20220829.0,20220824,20220906,EXP,,BR-009507513-2208BRA006186,MERCK,,72.0,YR,,M,Y,,,20220906,,CN,BR,BR,2022,Q3,Elderly
212491023,21249102,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intestinal ischaemia,,2022,Q3,3,F,,20220830.0,20220824,20220902,EXP,,JP-AstraZeneca-2022A293036,ASTRAZENECA,,84.0,YR,,,Y,,,20220902,,MD,JP,,2022,Q3,Elderly
212498891,21249889,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Drug intolerance,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,RU-AstraZeneca-2022A290730,ASTRAZENECA,,72.0,YR,,M,Y,,,20220824,,MD,RU,,2022,Q3,Elderly
212498891,21249889,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,RU-AstraZeneca-2022A290730,ASTRAZENECA,,72.0,YR,,M,Y,,,20220824,,MD,RU,,2022,Q3,Elderly
212498891,21249889,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Drug intolerance,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,RU-AstraZeneca-2022A290730,ASTRAZENECA,,72.0,YR,,M,Y,,,20220824,,MD,RU,,2022,Q3,Elderly
212498891,21249889,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220816.0,20220824,20220824,EXP,,RU-AstraZeneca-2022A290730,ASTRAZENECA,,72.0,YR,,M,Y,,,20220824,,MD,RU,,2022,Q3,Elderly
212524271,21252427,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,N,,,,,10.0,MG,,QD,2022,Q3,Hypercreatinaemia,,2022,Q3,1,I,20220525.0,20220816.0,20220825,20220825,EXP,,FR-AUROBINDO-AUR-APL-2022-033238,AUROBINDO,,63.0,YR,,M,Y,147.0,KG,20220825,,PH,FR,FR,2022,Q3,Adult
212524271,21252427,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,N,,,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220525.0,20220816.0,20220825,20220825,EXP,,FR-AUROBINDO-AUR-APL-2022-033238,AUROBINDO,,63.0,YR,,M,Y,147.0,KG,20220825,,PH,FR,FR,2022,Q3,Adult
212535471,21253547,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,20220823.0,20220825,20220825,EXP,,CA-PFIZER INC-202201087447,PFIZER,,64.0,YR,,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Adult
212537961,21253796,3,I,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5 mg/1,000 mg, 56 tablets, 1 tablet every 12 hours",,,Y,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20210523.0,20220817.0,20220825,20220825,EXP,ES-AEMPS-915528,ES-Accord-274643,ACCORD,,80.0,YR,E,M,Y,,,20220825,,PH,ES,ES,2022,Q3,Elderly
212537961,21253796,3,I,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5 mg/1,000 mg, 56 tablets, 1 tablet every 12 hours",,,Y,,,,,,,,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20210523.0,20220817.0,20220825,20220825,EXP,ES-AEMPS-915528,ES-Accord-274643,ACCORD,,80.0,YR,E,M,Y,,,20220825,,PH,ES,ES,2022,Q3,Elderly
212537961,21253796,3,I,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5 mg/1,000 mg, 56 tablets, 1 tablet every 12 hours",,,Y,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,1,I,20210523.0,20220817.0,20220825,20220825,EXP,ES-AEMPS-915528,ES-Accord-274643,ACCORD,,80.0,YR,E,M,Y,,,20220825,,PH,ES,ES,2022,Q3,Elderly
212537961,21253796,3,I,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5 mg/1,000 mg, 56 tablets, 1 tablet every 12 hours",,,Y,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20210523.0,20220817.0,20220825,20220825,EXP,ES-AEMPS-915528,ES-Accord-274643,ACCORD,,80.0,YR,E,M,Y,,,20220825,,PH,ES,ES,2022,Q3,Elderly
212568641,21256864,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Eosinophilic colitis,,2022,Q3,1,I,20220705.0,20220812.0,20220826,20220826,EXP,,CH-AstraZeneca-2022A292916,ASTRAZENECA,,74.0,YR,,F,Y,,,20220826,,MD,CH,,2022,Q3,Elderly
212572521,21257252,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220816.0,20220826,20220826,EXP,FR-AFSSAPS-NC20222464,FR-AUROBINDO-AUR-APL-2022-033233,AUROBINDO,,64.0,YR,,M,Y,76.0,KG,20220826,,PH,FR,FR,2022,Q3,Adult
212572521,21257252,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220816.0,20220826,20220826,EXP,FR-AFSSAPS-NC20222464,FR-AUROBINDO-AUR-APL-2022-033233,AUROBINDO,,64.0,YR,,M,Y,76.0,KG,20220826,,PH,FR,FR,2022,Q3,Adult
212572521,21257252,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220816.0,20220826,20220826,EXP,FR-AFSSAPS-NC20222464,FR-AUROBINDO-AUR-APL-2022-033233,AUROBINDO,,64.0,YR,,M,Y,76.0,KG,20220826,,PH,FR,FR,2022,Q3,Adult
212573621,21257362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1 tablett /dag,20.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital infection,,2022,Q3,1,I,20220101.0,20220823.0,20220826,20220826,EXP,,SE-AstraZeneca-2022A227775,ASTRAZENECA,,54.0,YR,,M,Y,82.0,KG,20220826,,MD,SE,,2022,Q3,Adult
212573621,21257362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1 tablett /dag,20.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220101.0,20220823.0,20220826,20220826,EXP,,SE-AstraZeneca-2022A227775,ASTRAZENECA,,54.0,YR,,M,Y,82.0,KG,20220826,,MD,SE,,2022,Q3,Adult
212580211,21258021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,NAZ3007,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Nasal vestibulitis,,2022,Q3,1,I,20220810.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A293545,ASTRAZENECA,,3654.0,WK,,M,Y,51.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Cardiac failure,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Acute pulmonary oedema,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Restlessness,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Duodenal ulcer,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Blood pressure decreased,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Delirium,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Bacterial test positive,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Prerenal failure,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212592814,21259281,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20220313.0,20220928.0,20220826,20220930,EXP,,JP-PFIZER INC-PV202200049399,PFIZER,,84.0,YR,,F,Y,47.5,KG,20220930,,MD,JP,JP,2022,Q3,Elderly
212596521,21259652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hyponatraemia,,2022,Q3,1,I,20220713.0,20220818.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A278102,ASTRAZENECA,,85.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212596521,21259652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,20220713.0,20220818.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A278102,ASTRAZENECA,,85.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212596521,21259652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Heat illness,,2022,Q3,1,I,20220713.0,20220818.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A278102,ASTRAZENECA,,85.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212596521,21259652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Feeding disorder,,2022,Q3,1,I,20220713.0,20220818.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A278102,ASTRAZENECA,,85.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212596581,21259658,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,50.0,MG,Tablet,QD,2022,Q3,Overdose,,2022,Q3,1,I,20220726.0,20220819.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A294776,ASTRAZENECA,,94.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212596581,21259658,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,50.0,MG,Tablet,QD,2022,Q3,Ileus,,2022,Q3,1,I,20220726.0,20220819.0,20220826,20220826,EXP,,JP-AstraZeneca-2022A294776,ASTRAZENECA,,94.0,YR,,F,Y,,,20220826,,MD,JP,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Somnolence,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hyperlactacidaemia,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Decreased appetite,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Condition aggravated,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212605741,21260574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3060.0,MG,Y,,MK2963,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Retching,,2022,Q3,1,I,20211105.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296600,ASTRAZENECA,,82.0,YR,,M,Y,57.0,KG,20220826,,MD,CN,,2022,Q3,Elderly
212606721,21260672,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NF3404,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Pyrexia,,2022,Q3,1,I,20220804.0,20220818.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A293767,ASTRAZENECA,,25441.0,DY,,F,Y,,,20220826,,MD,CN,,2022,Q3,Elderly
212606721,21260672,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NF3404,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Urinary tract infection fungal,,2022,Q3,1,I,20220804.0,20220818.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A293767,ASTRAZENECA,,25441.0,DY,,F,Y,,,20220826,,MD,CN,,2022,Q3,Elderly
212608771,21260877,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2760.0,MG,,,2110024,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,20220812.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296588,ASTRAZENECA,,24106.0,DY,,M,Y,,,20220826,,MD,CN,,2022,Q3,Elderly
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Oesophageal carcinoma,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cholecystitis,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Back pain,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212610521,21261052,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2108057,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220807.0,20220820.0,20220826,20220826,EXP,,CN-AstraZeneca-2022A296924,ASTRAZENECA,,59.0,YR,,F,Y,70.0,KG,20220826,,MD,CN,,2022,Q3,Adult
212631113,21263111,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Prescribed underdose,,2022,Q3,3,F,,20220912.0,20220828,20220915,EXP,,NVSJ2022JP096336,NOVARTIS,,61.0,YR,,F,Y,,,20220916,,MD,JP,JP,2022,Q3,Adult
212631113,21263111,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,,20220912.0,20220828,20220915,EXP,,NVSJ2022JP096336,NOVARTIS,,61.0,YR,,F,Y,,,20220916,,MD,JP,JP,2022,Q3,Adult
212631113,21263111,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Blood pressure decreased,,2022,Q3,3,F,,20220912.0,20220828,20220915,EXP,,NVSJ2022JP096336,NOVARTIS,,61.0,YR,,F,Y,,,20220916,,MD,JP,JP,2022,Q3,Adult
212631113,21263111,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Malaise,,2022,Q3,3,F,,20220912.0,20220828,20220915,EXP,,NVSJ2022JP096336,NOVARTIS,,61.0,YR,,F,Y,,,20220916,,MD,JP,JP,2022,Q3,Adult
212631113,21263111,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Product use in unapproved indication,,2022,Q3,3,F,,20220912.0,20220828,20220915,EXP,,NVSJ2022JP096336,NOVARTIS,,61.0,YR,,F,Y,,,20220916,,MD,JP,JP,2022,Q3,Adult
212634021,21263402,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1 cp/d, Duration 15 days",,,N,U,UNKNOWN,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220525.0,20220821.0,20220829,20220829,EXP,FR-AFSSAPS-TO20222808,FR-TEVA-2022-FR-2067482,TEVA,,63.0,YR,A,M,Y,147.0,KG,20220829,,PH,FR,FR,2022,Q3,Adult
212634021,21263402,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1 cp/d, Duration 15 days",,,N,U,UNKNOWN,,,10.0,MG,,QD,2022,Q3,Hypercreatinaemia,,2022,Q3,1,I,20220525.0,20220821.0,20220829,20220829,EXP,FR-AFSSAPS-TO20222808,FR-TEVA-2022-FR-2067482,TEVA,,63.0,YR,A,M,Y,147.0,KG,20220829,,PH,FR,FR,2022,Q3,Adult
212642901,21264290,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220816.0,20220829,20220829,EXP,,JP-ROCHE-3168463,ROCHE,"Hashimoto N, Hashimoto N, Kitano D, Tamaki T, Koyama Y, Yamada A, Hatakeyama K et al. Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy. DOI: 10.3390/jcdd9070208. Journal of Cardiovascular Development and Disease 2022;9 (208):-.",69.0,YR,,F,Y,,,20220829,,HP,JP,,2022,Q3,Elderly
212642901,21264290,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Cardiotoxicity,,2022,Q3,1,I,,20220816.0,20220829,20220829,EXP,,JP-ROCHE-3168463,ROCHE,"Hashimoto N, Hashimoto N, Kitano D, Tamaki T, Koyama Y, Yamada A, Hatakeyama K et al. Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy. DOI: 10.3390/jcdd9070208. Journal of Cardiovascular Development and Disease 2022;9 (208):-.",69.0,YR,,F,Y,,,20220829,,HP,JP,,2022,Q3,Elderly
212642901,21264290,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Disease progression,,2022,Q3,1,I,,20220816.0,20220829,20220829,EXP,,JP-ROCHE-3168463,ROCHE,"Hashimoto N, Hashimoto N, Kitano D, Tamaki T, Koyama Y, Yamada A, Hatakeyama K et al. Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy. DOI: 10.3390/jcdd9070208. Journal of Cardiovascular Development and Disease 2022;9 (208):-.",69.0,YR,,F,Y,,,20220829,,HP,JP,,2022,Q3,Elderly
212642901,21264290,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Left ventricular enlargement,,2022,Q3,1,I,,20220816.0,20220829,20220829,EXP,,JP-ROCHE-3168463,ROCHE,"Hashimoto N, Hashimoto N, Kitano D, Tamaki T, Koyama Y, Yamada A, Hatakeyama K et al. Autopsy and Cardiac Magnetic Resonance Image Case of Bevacizumab-Related Cardiomyopathy. DOI: 10.3390/jcdd9070208. Journal of Cardiovascular Development and Disease 2022;9 (208):-.",69.0,YR,,F,Y,,,20220829,,HP,JP,,2022,Q3,Elderly
212666301,21266630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2109181,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dysuria,,2022,Q3,1,I,20220720.0,20220821.0,20220829,20220829,EXP,,CN-AstraZeneca-2022A297064,ASTRAZENECA,,68.0,YR,,F,Y,,,20220829,,MD,CN,,2022,Q3,Elderly
212666301,21266630,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2109181,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220720.0,20220821.0,20220829,20220829,EXP,,CN-AstraZeneca-2022A297064,ASTRAZENECA,,68.0,YR,,F,Y,,,20220829,,MD,CN,,2022,Q3,Elderly
212666301,21266630,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2109181,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dysuria,,2022,Q3,1,I,20220720.0,20220821.0,20220829,20220829,EXP,,CN-AstraZeneca-2022A297064,ASTRAZENECA,,68.0,YR,,F,Y,,,20220829,,MD,CN,,2022,Q3,Elderly
212666301,21266630,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2109181,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220720.0,20220821.0,20220829,20220829,EXP,,CN-AstraZeneca-2022A297064,ASTRAZENECA,,68.0,YR,,F,Y,,,20220829,,MD,CN,,2022,Q3,Elderly
212670411,21267041,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknwon,,,,,,,202293.0,,,Tablet,,2022,Q3,Ventricular extrasystoles,,2022,Q3,1,I,,20220821.0,20220829,20220829,EXP,,IQ-AstraZeneca-2022A294822,ASTRAZENECA,,60.0,YR,,F,Y,88.0,KG,20220829,,MD,IQ,,2022,Q3,Adult
212670411,21267041,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknwon,,,,,,,202293.0,,,Tablet,,2022,Q3,Sinus tachycardia,,2022,Q3,1,I,,20220821.0,20220829,20220829,EXP,,IQ-AstraZeneca-2022A294822,ASTRAZENECA,,60.0,YR,,F,Y,88.0,KG,20220829,,MD,IQ,,2022,Q3,Adult
212677291,21267729,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Leukopenia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212677291,21267729,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Anaemia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212677291,21267729,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212677291,21267729,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Leukopenia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212677291,21267729,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Anaemia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212677291,21267729,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg once a day,360.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,20220625.0,20220823.0,20220829,20220829,EXP,,IT-AstraZeneca-2022A294181,ASTRAZENECA,,51.0,YR,,F,Y,118.0,KG,20220829,,MD,IT,,2022,Q3,Adult
212687341,21268734,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220825.0,20220830,20220830,EXP,FR-AFSSAPS-NC20222464,NVSC2022FR190681,NOVARTIS,,64.0,YR,,M,Y,76.0,KG,20220830,,PH,FR,FR,2022,Q3,Adult
212687341,21268734,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220825.0,20220830,20220830,EXP,FR-AFSSAPS-NC20222464,NVSC2022FR190681,NOVARTIS,,64.0,YR,,M,Y,76.0,KG,20220830,,PH,FR,FR,2022,Q3,Adult
212687341,21268734,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220825.0,20220830,20220830,EXP,FR-AFSSAPS-NC20222464,NVSC2022FR190681,NOVARTIS,,64.0,YR,,M,Y,76.0,KG,20220830,,PH,FR,FR,2022,Q3,Adult
212693091,21269309,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220101.0,20220822.0,20220830,20220830,EXP,,JP-AstraZeneca-2022A282030,ASTRAZENECA,,64.0,YR,,F,Y,,,20220830,,MD,JP,,2022,Q3,Adult
212695551,21269555,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Strength: 10 mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220304.0,20220819.0,20220830,20220830,EXP,FR-AFSSAPS-RE20221027,FR-Accord-275137,ACCORD,,83.0,YR,E,F,Y,90.0,KG,20220830,,MD,FR,FR,2022,Q3,Elderly
212695742,21269574,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Seizure,,2022,Q3,2,F,20220825.0,20220828.0,20220830,20220902,EXP,,GB-AstraZeneca-2022A299410,ASTRAZENECA,,64.0,YR,,M,Y,111.0,KG,20220902,,MD,GB,,2022,Q3,Adult
212702361,21270236,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,455.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Amylase increased,,2022,Q3,1,I,20220810.0,20220823.0,20220830,20220830,EXP,,GB-AstraZeneca-2022A295360,ASTRAZENECA,,79.0,YR,,F,Y,61.0,KG,20220830,,MD,GB,,2022,Q3,Elderly
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Bacterial infection,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Joint swelling,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Musculoskeletal stiffness,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212707861,21270786,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-PFIZER INC-202201093389,PFIZER,,48.0,YR,,M,Y,,,20220830,,HP,CA,CA,2022,Q3,Adult
212721223,21272122,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,U,Unknown,,,,,Tablet,,2022,Q3,Pancreatitis,,2022,Q3,3,F,20220414.0,20220831.0,20220830,20220902,EXP,,GB-GILEAD-2022-0595648,GILEAD,,79.0,YR,E,F,Y,61.0,KG,20220902,,PH,GB,GB,2022,Q3,Elderly
212721223,21272122,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,U,Unknown,,,,,Tablet,,2022,Q3,Off label use,,2022,Q3,3,F,20220414.0,20220831.0,20220830,20220902,EXP,,GB-GILEAD-2022-0595648,GILEAD,,79.0,YR,E,F,Y,61.0,KG,20220902,,PH,GB,GB,2022,Q3,Elderly
212721223,21272122,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,U,Unknown,,,,,Tablet,,2022,Q3,Amylase increased,,2022,Q3,3,F,20220414.0,20220831.0,20220830,20220902,EXP,,GB-GILEAD-2022-0595648,GILEAD,,79.0,YR,E,F,Y,61.0,KG,20220902,,PH,GB,GB,2022,Q3,Elderly
212725432,21272543,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intentional dose omission,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Motor dysfunction,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pain in extremity,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intentional dose omission,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Motor dysfunction,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pain in extremity,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intentional dose omission,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Motor dysfunction,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212725432,21272543,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pain in extremity,,2022,Q3,2,F,20220701.0,20220905.0,20220830,20220913,EXP,,FR-AstraZeneca-2022A299337,ASTRAZENECA,,818.0,MON,,M,Y,103.0,KG,20220913,,MD,FR,,2022,Q3,Elderly
212726332,21272633,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,,20220912.0,20220830,20220914,EXP,,NVSJ2022JP096341,NOVARTIS,,74.0,YR,,M,Y,,,20220915,,MD,JP,JP,2022,Q3,Elderly
212726332,21272633,4,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Blood pressure decreased,,2022,Q3,2,F,,20220912.0,20220830,20220914,EXP,,NVSJ2022JP096341,NOVARTIS,,74.0,YR,,M,Y,,,20220915,,MD,JP,JP,2022,Q3,Elderly
212729851,21272985,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1x1,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220806.0,20220824.0,20220831,20220831,EXP,,SE-AstraZeneca-2022A295756,ASTRAZENECA,,84.0,YR,,M,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
212729851,21272985,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1x1,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Angioedema,,2022,Q3,1,I,20220806.0,20220824.0,20220831,20220831,EXP,,SE-AstraZeneca-2022A295756,ASTRAZENECA,,84.0,YR,,M,Y,,,20220831,,MD,SE,,2022,Q3,Elderly
212741531,21274153,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (1x1),,,Y,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220806.0,20220829.0,20220831,20220831,EXP,SE-MPA-2022-018038,NVSC2022SE193889,NOVARTIS,,84.0,YR,,M,Y,,,20220831,,MD,SE,SE,2022,Q3,Elderly
212741531,21274153,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (1x1),,,Y,,,,,,,,,2022,Q3,Angioedema,,2022,Q3,1,I,20220806.0,20220829.0,20220831,20220831,EXP,SE-MPA-2022-018038,NVSC2022SE193889,NOVARTIS,,84.0,YR,,M,Y,,,20220831,,MD,SE,SE,2022,Q3,Elderly
212742461,21274246,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q3,Vertigo,,2022,Q3,1,I,20220603.0,20220823.0,20220831,20220831,EXP,,FR-AstraZeneca-2022A294227,ASTRAZENECA,,73.0,YR,,F,Y,55.0,KG,20220831,,MD,FR,,2022,Q3,Elderly
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Hypokalaemia,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Condition aggravated,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Leukocytosis,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Renal cyst,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Hyperbilirubinaemia,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Hypomagnesaemia,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Anaemia,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212753002,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q3,Gastroenteritis,,2022,Q3,2,F,20220709.0,20220908.0,20220831,20220914,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20220914,,HP,US,US,2022,Q3,Adult
212799951,21279995,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal cyst,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,RU-AstraZeneca-2022A299475,ASTRAZENECA,,82.0,YR,,F,Y,,,20220901,,MD,RU,,2022,Q3,Elderly
212800741,21280074,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/d,,,Y,,,,202293.0,,,,QD,2022,Q3,Heterophoria,,2022,Q3,1,I,20220505.0,20220825.0,20220901,20220901,EXP,,FR-AstraZeneca-2022A297145,ASTRAZENECA,,66.0,YR,,M,Y,,,20220901,,MD,FR,,2022,Q3,Elderly
212800741,21280074,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/d,,,Y,,,,202293.0,,,,QD,2022,Q3,Diplopia,,2022,Q3,1,I,20220505.0,20220825.0,20220901,20220901,EXP,,FR-AstraZeneca-2022A297145,ASTRAZENECA,,66.0,YR,,M,Y,,,20220901,,MD,FR,,2022,Q3,Elderly
212800821,21280082,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Necrotising fasciitis,,2022,Q3,1,I,20220711.0,20220826.0,20220901,20220901,EXP,,FR-AstraZeneca-2022A298292,ASTRAZENECA,,55.0,YR,,M,Y,,,20220901,,MD,FR,,2022,Q3,Adult
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Coronary artery stenosis,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ejection fraction decreased,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Atrial pressure increased,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pulmonary arterial hypertension,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ventricular hypokinesia,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212804031,21280403,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Mitral valve incompetence,,2022,Q3,1,I,,20220824.0,20220901,20220901,EXP,,DE-AstraZeneca-2022A297586,ASTRAZENECA,,84.0,YR,,F,Y,,,20220901,,MD,DE,,2022,Q3,Elderly
212826991,21282699,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220701.0,20220829.0,20220901,20220901,EXP,,DE-PFIZER INC-PV202200053670,PFIZER,,87.0,YR,,M,Y,74.0,KG,20220901,,HP,DE,DE,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Left ventricular end-diastolic pressure increased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Blood urea increased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Cardiomyopathy,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Weight decreased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,N-terminal prohormone brain natriuretic peptide increased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Hypovolaemia,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Blood creatinine increased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Ventricular hypokinesia,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Ejection fraction abnormal,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Glomerular filtration rate decreased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Weight increased,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212849402,21284940,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,2,F,,20220827.0,20220902,20220908,EXP,,NVSC2022TH194298,NOVARTIS,,68.0,YR,,F,Y,,,20220908,,MD,TH,TH,2022,Q3,Elderly
212851801,21285180,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1x1,,,Y,,UNKNOWN,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220806.0,20220829.0,20220902,20220902,EXP,SE-MPA-2022-018038,SE-TEVA-2022-SE-2069552,TEVA,,84.0,YR,E,M,Y,,,20220902,,MD,SE,SE,2022,Q3,Elderly
212851801,21285180,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1x1,,,Y,,UNKNOWN,,,,,,,2022,Q3,Angioedema,,2022,Q3,1,I,20220806.0,20220829.0,20220902,20220902,EXP,SE-MPA-2022-018038,SE-TEVA-2022-SE-2069552,TEVA,,84.0,YR,E,M,Y,,,20220902,,MD,SE,SE,2022,Q3,Elderly
212856321,21285632,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3246,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,20220616.0,20220823.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A299334,ASTRAZENECA,,24472.0,DY,,F,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212856321,21285632,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3246,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urine ketone body present,,2022,Q3,1,I,20220616.0,20220823.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A299334,ASTRAZENECA,,24472.0,DY,,F,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212862321,21286232,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,90.0,MG,Y,,2110106,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketosis,,2022,Q3,1,I,20220823.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A303725,ASTRAZENECA,,17815.0,DY,,F,Y,76.0,KG,20220902,,MD,CN,,2022,Q3,Elderly
212870432,21287043,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Arthralgia,,2022,Q3,2,F,20220506.0,20220912.0,20220902,20220920,EXP,,FR-AstraZeneca-2022A301835,ASTRAZENECA,,71.0,YR,,M,Y,70.0,KG,20220920,,MD,FR,,2022,Q3,Elderly
212886921,21288692,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Alanine aminotransferase increased,,2022,Q3,1,I,20220201.0,20220603.0,20220902,20220902,PER,,US-ABBVIE-22K-163-4420404-00,ABBVIE,,85.0,YR,,F,Y,61.0,KG,20220901,,PH,US,US,2022,Q3,Elderly
212886921,21288692,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Hepatic enzyme increased,,2022,Q3,1,I,20220201.0,20220603.0,20220902,20220902,PER,,US-ABBVIE-22K-163-4420404-00,ABBVIE,,85.0,YR,,F,Y,61.0,KG,20220901,,PH,US,US,2022,Q3,Elderly
212896621,21289662,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220829.0,20220902,20220902,EXP,,ZA-AstraZeneca-2022A302499,ASTRAZENECA,,79.0,YR,,F,Y,,,20220902,,CN,ZA,,2022,Q3,Elderly
212897301,21289730,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3230,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypersensitivity,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302205,ASTRAZENECA,,42.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Adult
212897301,21289730,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3230,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pruritus,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302205,ASTRAZENECA,,42.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Adult
212897301,21289730,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3230,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302205,ASTRAZENECA,,42.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Adult
212897301,21289730,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,NH3230,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash erythematous,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302205,ASTRAZENECA,,42.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Adult
212899601,21289960,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Hepatitis,,2022,Q3,1,I,,20220829.0,20220902,20220902,EXP,,IL-BRISTOL-MYERS SQUIBB COMPANY-2022-099888,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20220902,,HP,IL,IL,2022,Q3,Elderly
212901081,21290108,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1920.0,MG,,,2110120,,,10.0,MG,Tablet,QD,2022,Q3,Hyperhidrosis,,2022,Q3,1,I,20220819.0,20220901.0,20220902,20220902,EXP,,CN-BAYER-2022A123461,BAYER,,59.0,YR,A,M,Y,,,20220902,,HP,CN,CN,2022,Q3,Adult
212901081,21290108,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1920.0,MG,,,2110120,,,10.0,MG,Tablet,QD,2022,Q3,Altered state of consciousness,,2022,Q3,1,I,20220819.0,20220901.0,20220902,20220902,EXP,,CN-BAYER-2022A123461,BAYER,,59.0,YR,A,M,Y,,,20220902,,HP,CN,CN,2022,Q3,Adult
212901081,21290108,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1920.0,MG,,,2110120,,,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220819.0,20220901.0,20220902,20220902,EXP,,CN-BAYER-2022A123461,BAYER,,59.0,YR,A,M,Y,,,20220902,,HP,CN,CN,2022,Q3,Adult
212902222,21290222,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,10.0,MG,Tablet,QD,2022,Q3,Fall,,2022,Q3,2,F,20210501.0,20220905.0,20220902,20220905,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190301",BOEHRINGER INGELHEIM,,830.0,MON,E,M,Y,,,20220905,,MD,PL,PL,2022,Q3,Elderly
212902222,21290222,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,10.0,MG,Tablet,QD,2022,Q3,Craniofacial injury,,2022,Q3,2,F,20210501.0,20220905.0,20220902,20220905,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190301",BOEHRINGER INGELHEIM,,830.0,MON,E,M,Y,,,20220905,,MD,PL,PL,2022,Q3,Elderly
212902222,21290222,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,10.0,MG,Tablet,QD,2022,Q3,Loss of consciousness,,2022,Q3,2,F,20210501.0,20220905.0,20220902,20220905,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190301",BOEHRINGER INGELHEIM,,830.0,MON,E,M,Y,,,20220905,,MD,PL,PL,2022,Q3,Elderly
212902222,21290222,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,,10.0,MG,Tablet,QD,2022,Q3,Electrocardiogram ambulatory abnormal,,2022,Q3,2,F,20210501.0,20220905.0,20220902,20220905,EXP,,"PL-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190301",BOEHRINGER INGELHEIM,,830.0,MON,E,M,Y,,,20220905,,MD,PL,PL,2022,Q3,Elderly
212902401,21290240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,,2106099,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Eyelid oedema,,2022,Q3,1,I,20220822.0,20220827.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A304323,ASTRAZENECA,,62.0,YR,,F,Y,45.0,KG,20220902,,MD,CN,,2022,Q3,Adult
212902401,21290240,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,,2106099,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal failure,,2022,Q3,1,I,20220822.0,20220827.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A304323,ASTRAZENECA,,62.0,YR,,F,Y,45.0,KG,20220902,,MD,CN,,2022,Q3,Adult
212902411,21290241,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6140.0,MG,Y,,2109154,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic neuropathy,,2022,Q3,1,I,20220816.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302237,ASTRAZENECA,,66.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212902411,21290241,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6140.0,MG,Y,,2109154,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,1,I,20220816.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302237,ASTRAZENECA,,66.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212902411,21290241,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6140.0,MG,Y,,2109154,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic ketosis,,2022,Q3,1,I,20220816.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302237,ASTRAZENECA,,66.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212902411,21290241,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6140.0,MG,Y,,2109154,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypertension,,2022,Q3,1,I,20220816.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302237,ASTRAZENECA,,66.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212902411,21290241,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6140.0,MG,Y,,2109154,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diabetic vascular disorder,,2022,Q3,1,I,20220816.0,20220826.0,20220902,20220902,EXP,,CN-AstraZeneca-2022A302237,ASTRAZENECA,,66.0,YR,,M,Y,,,20220902,,MD,CN,,2022,Q3,Elderly
212914031,21291403,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Q24H",,,U,,,,,10.0,MG,Coated tablet,,2022,Q3,Rectal haemorrhage,,2022,Q3,1,I,20220630.0,20220829.0,20220903,20220903,EXP,IT-MINISAL02-882019,NVSC2022IT195144,NOVARTIS,,69.0,YR,,M,Y,95.0,KG,20220903,,PH,IT,IT,2022,Q3,Elderly
212914031,21291403,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, Q24H",,,U,,,,,10.0,MG,Coated tablet,,2022,Q3,Hypotension,,2022,Q3,1,I,20220630.0,20220829.0,20220903,20220903,EXP,IT-MINISAL02-882019,NVSC2022IT195144,NOVARTIS,,69.0,YR,,M,Y,95.0,KG,20220903,,PH,IT,IT,2022,Q3,Elderly
212920211,21292021,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220824.0,20220904,20220904,EXP,,CA-APOTEX-2022AP012045,APOTEX,,70.0,YR,,F,Y,98.0,KG,20220904,,HP,CA,CA,2022,Q3,Elderly
212920211,21292021,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,,20220824.0,20220904,20220904,EXP,,CA-APOTEX-2022AP012045,APOTEX,,70.0,YR,,F,Y,98.0,KG,20220904,,HP,CA,CA,2022,Q3,Elderly
212920211,21292021,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,Tablet,,2022,Q3,Tremor,,2022,Q3,1,I,,20220824.0,20220904,20220904,EXP,,CA-APOTEX-2022AP012045,APOTEX,,70.0,YR,,F,Y,98.0,KG,20220904,,HP,CA,CA,2022,Q3,Elderly
212936291,21293629,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212936291,21293629,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypokalaemia,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212936291,21293629,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood osmolarity increased,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212936291,21293629,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212936291,21293629,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypokalaemia,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212936291,21293629,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2018123,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood osmolarity increased,,2022,Q3,1,I,20220824.0,20220827.0,20220905,20220905,EXP,,CN-AstraZeneca-2022A303810,ASTRAZENECA,,78.0,YR,,F,Y,50.0,KG,20220905,,MD,CN,,2022,Q3,Elderly
212948051,21294805,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1600.0,MG,,,,,202293.0,10.0,MG,,QD,2022,Q3,Septic shock,,2022,Q3,1,I,20220811.0,20220902.0,20220905,20220905,EXP,,ES-AstraZeneca-2022A305218,ASTRAZENECA,,76.0,YR,,M,Y,,,20220905,,MD,ES,,2022,Q3,Elderly
212948051,21294805,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1600.0,MG,,,,,202293.0,10.0,MG,,QD,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220811.0,20220902.0,20220905,20220905,EXP,,ES-AstraZeneca-2022A305218,ASTRAZENECA,,76.0,YR,,M,Y,,,20220905,,MD,ES,,2022,Q3,Elderly
212950001,21295000,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,Unknown,,202293.0,10.0,MG,,QD,2022,Q3,Ischaemic stroke,,2022,Q3,1,I,20210518.0,20220829.0,20220905,20220905,EXP,,FR-AstraZeneca-2022A300542,ASTRAZENECA,,57.0,YR,,M,Y,,,20220905,,MD,FR,,2022,Q3,Adult
212984221,21298422,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,,20220901.0,20220906,20220906,EXP,,CA-PFIZER INC-202201114365,PFIZER,,70.0,YR,,F,Y,98.0,KG,20220906,,HP,CA,CA,2022,Q3,Elderly
212984221,21298422,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Tremor,,2022,Q3,1,I,,20220901.0,20220906,20220906,EXP,,CA-PFIZER INC-202201114365,PFIZER,,70.0,YR,,F,Y,98.0,KG,20220906,,HP,CA,CA,2022,Q3,Elderly
212985572,21298557,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Decreased appetite,,2022,Q3,2,F,20200701.0,20220920.0,20220906,20220929,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202208014158,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20220929,,CN,JP,JP,2022,Q3,Elderly
212985572,21298557,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Acute myocardial infarction,,2022,Q3,2,F,20200701.0,20220920.0,20220906,20220929,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202208014158,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20220929,,CN,JP,JP,2022,Q3,Elderly
212985572,21298557,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, daily",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,2,F,20200701.0,20220920.0,20220906,20220929,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202208014158,ELI LILLY AND CO,,85.0,YR,,M,Y,,,20220929,,CN,JP,JP,2022,Q3,Elderly
212989671,21298967,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Autoimmune haemolytic anaemia,,2022,Q3,1,I,,20220830.0,20220906,20220906,EXP,,NVSC2022CN199804,NOVARTIS,"Yi-jiong T, Wen-qian R, Shuang-Shuang Y, Yun-hong H, Xiao-yun F, Ning-guang F. A Case Analysis of Hemolytic Anemia Caused by Atorvastatin Calcium Tablets in 1 Case. CENTRAL SOUTH PHARMACY. 2022;20(7):1-7",57.0,YR,,M,Y,69.9,KG,20220906,,HP,CN,CN,2022,Q3,Adult
213003531,21300353,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,as per heart failure specilist,,,,,,,,,,,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220801.0,20220826.0,20220907,20220907,EXP,GB-MHRA-ADR 27232542,GB-Accord-276374,ACCORD,,58.0,YR,A,M,Y,83.0,KG,20220906,,HP,GB,GB,2022,Q3,Adult
213005201,21300520,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-100311,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20220907,,CN,CA,CA,2022,Q3,Elderly
213005201,21300520,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Pain,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-100311,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20220907,,CN,CA,CA,2022,Q3,Elderly
213005201,21300520,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220902.0,20220907,20220907,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-100311,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20220907,,CN,CA,CA,2022,Q3,Elderly
213015812,21301581,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,Tablet,,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,2,F,20220824.0,20220902.0,20220907,20220912,EXP,,CN-ROCHE-3171405,ROCHE,,58.0,YR,,M,Y,70.0,KG,20220912,,MD,CN,,2022,Q3,Adult
213028841,21302884,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220902.0,20220906.0,20220907,20220907,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-102105,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20220907,,CN,CA,CA,2022,Q3,Elderly
213034341,21303434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,1,I,20220401.0,20220830.0,20220907,20220907,EXP,,FR-AstraZeneca-2022A307108,ASTRAZENECA,,1119.0,MON,,F,Y,,,20220907,,MD,FR,,2022,Q3,Elderly
213034341,21303434,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220401.0,20220830.0,20220907,20220907,EXP,,FR-AstraZeneca-2022A307108,ASTRAZENECA,,1119.0,MON,,F,Y,,,20220907,,MD,FR,,2022,Q3,Elderly
213053731,21305373,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,35.0,MG,Y,,2110106,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220807.0,20220831.0,20220908,20220908,EXP,,CN-AstraZeneca-2022A306963,ASTRAZENECA,,42.0,YR,,F,Y,,,20220908,,MD,CN,,2022,Q3,Adult
213053731,21305373,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,35.0,MG,Y,,2110106,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220807.0,20220831.0,20220908,20220908,EXP,,CN-AstraZeneca-2022A306963,ASTRAZENECA,,42.0,YR,,F,Y,,,20220908,,MD,CN,,2022,Q3,Adult
213058331,21305833,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,UNKOWN,,,,,,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,,20220829.0,20220908,20220908,EXP,,AT-NOVOPROD-954479,NOVO NORDISK,,50.0,YR,,F,Y,,,20220908,,MD,AT,AT,2022,Q3,Adult
213067891,21306789,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Dry skin,,2022,Q3,1,I,20210903.0,20220902.0,20220908,20220908,EXP,,DE-AstraZeneca-2022A305885,ASTRAZENECA,,52.0,YR,,M,Y,128.0,KG,20220908,,MD,DE,,2022,Q3,Adult
213067891,21306789,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Steatorrhoea,,2022,Q3,1,I,20210903.0,20220902.0,20220908,20220908,EXP,,DE-AstraZeneca-2022A305885,ASTRAZENECA,,52.0,YR,,M,Y,128.0,KG,20220908,,MD,DE,,2022,Q3,Adult
213067891,21306789,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Hypercholesterolaemia,,2022,Q3,1,I,20210903.0,20220902.0,20220908,20220908,EXP,,DE-AstraZeneca-2022A305885,ASTRAZENECA,,52.0,YR,,M,Y,128.0,KG,20220908,,MD,DE,,2022,Q3,Adult
213067891,21306789,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Hypertriglyceridaemia,,2022,Q3,1,I,20210903.0,20220902.0,20220908,20220908,EXP,,DE-AstraZeneca-2022A305885,ASTRAZENECA,,52.0,YR,,M,Y,128.0,KG,20220908,,MD,DE,,2022,Q3,Adult
213116521,21311652,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1920.0,MG,U,,2110120,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220819.0,20220901.0,20220909,20220909,EXP,,CN-AstraZeneca-2022A308649,ASTRAZENECA,,3129.0,WK,,M,Y,,,20220909,,MD,CN,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Hyperhidrosis,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Feeling abnormal,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Dizziness,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213116531,21311653,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,PB0125,,202293.0,,,Tablet,Q12H,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220901.0,20220902.0,20220909,20220909,EXP,,MX-AstraZeneca-2022A310752,ASTRAZENECA,,3258.0,WK,,F,Y,63.0,KG,20220909,,CN,MX,,2022,Q3,Elderly
213128651,21312865,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11360.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Yellow skin,,2022,Q3,1,I,20220817.0,20220901.0,20220909,20220909,EXP,,CO-AstraZeneca-2022A308398,ASTRAZENECA,,27973.0,DY,,M,Y,70.0,KG,20220909,,CN,CO,,2022,Q3,Elderly
213130041,21313004,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220902.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A306005,ASTRAZENECA,,22.0,YR,,M,Y,62.0,KG,20220909,,MD,DE,,2022,Q3,Youth
213132911,21313291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25570.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25570.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Erythema,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25570.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal swelling,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25570.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Scrotal abscess,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,25570.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Intertrigo,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213138422,21313842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pneumonia bacterial,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,COVID-19 pneumonia,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,COVID-19,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pneumonia bacterial,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,COVID-19 pneumonia,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,COVID-19,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213138422,21313842,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure chronic,,2022,Q3,2,F,,20220901.0,20220909,20220930,EXP,,RU-AstraZeneca-2022A307138,ASTRAZENECA,,82.0,YR,,F,Y,56.0,KG,20220930,,MD,RU,,2022,Q3,Elderly
213139651,21313965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,150.0,MG,Y,,2108121,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220730.0,20220901.0,20220909,20220909,EXP,,CN-AstraZeneca-2022A308122,ASTRAZENECA,,23299.0,DY,,M,Y,,,20220909,,MD,CN,,2022,Q3,Elderly
213149611,21314961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NC2438,,202293.0,10.0,MG,Tablet,BID,2022,Q3,Cardiac flutter,,2022,Q3,1,I,20220817.0,20220901.0,20220909,20220909,EXP,,CN-AstraZeneca-2022A308719,ASTRAZENECA,,21560.0,DY,,M,Y,85.0,KG,20220909,,MD,CN,,2022,Q3,Elderly
213149611,21314961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NC2438,,202293.0,10.0,MG,Tablet,BID,2022,Q3,Dizziness,,2022,Q3,1,I,20220817.0,20220901.0,20220909,20220909,EXP,,CN-AstraZeneca-2022A308719,ASTRAZENECA,,21560.0,DY,,M,Y,85.0,KG,20220909,,MD,CN,,2022,Q3,Elderly
213158401,21315840,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q3,Anal haemorrhage,,2022,Q3,1,I,20210821.0,20220828.0,20220910,20220910,EXP,,"GB-Canton Laboratories, LLC-2132727",CANTON LABORATORIES,,61.0,YR,,M,Y,,,20220910,,HP,GB,GB,2022,Q3,Adult
213158401,21315840,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q3,Pneumonia,,2022,Q3,1,I,20210821.0,20220828.0,20220910,20220910,EXP,,"GB-Canton Laboratories, LLC-2132727",CANTON LABORATORIES,,61.0,YR,,M,Y,,,20220910,,HP,GB,GB,2022,Q3,Adult
213206821,21320682,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220101.0,20220901.0,20220912,20220912,EXP,,JP-ROCHE-3175202,ROCHE,,75.0,YR,,M,Y,,,20220912,,MD,JP,JP,2022,Q3,Elderly
213218241,21321824,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220908.0,20220912,20220912,PER,JP-ONO-2022JP024913,JP-AMGEN-JPNNI2022156387,AMGEN,,90.0,YR,E,M,Y,54.6,KG,20220912,,MD,JP,JP,2022,Q3,Elderly
213235401,21323540,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,20220909.0,,20220909,20220909,DIR,FDA-CDER-CTU-2022-72578,,FDA-CTU,,65.0,YR,,F,N,70.0,KG,20220909,N,HP,US,,2022,Q3,Elderly
213235401,21323540,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Electrolyte imbalance,,2022,Q3,1,I,20220909.0,,20220909,20220909,DIR,FDA-CDER-CTU-2022-72578,,FDA-CTU,,65.0,YR,,F,N,70.0,KG,20220909,N,HP,US,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Epilepsy,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypovolaemic shock,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Escherichia urinary tract infection,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypernatraemia,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213235691,21323569,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,"NC2449,2107174",,202293.0,10.0,MG,Tablet,QD,2022,Q3,Soft tissue infection,,2022,Q3,1,I,20220822.0,20220907.0,20220912,20220912,EXP,,CN-AstraZeneca-2022A311968,ASTRAZENECA,,17114.0,DY,,F,Y,,,20220912,,MD,CN,,2022,Q3,Elderly
213267172,21326717,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,U,Unknown,,,10.0,MG,Tablet,,2022,Q3,Uveitis,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,U,Unknown,,,10.0,MG,Tablet,,2022,Q3,Rash,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,U,Unknown,,,10.0,MG,Tablet,,2022,Q3,Liver disorder,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,Y,U,Unknown,,,10.0,MG,Tablet,,2022,Q3,Adrenal insufficiency,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,U,,,,,,,,2022,Q3,Uveitis,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,U,,,,,,,,2022,Q3,Rash,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,U,,,,,,,,2022,Q3,Liver disorder,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213267172,21326717,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,U,,,,,,,,2022,Q3,Adrenal insufficiency,,2022,Q3,2,F,,20220926.0,20220913,20220930,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-008627,BRISTOL MYERS SQUIBB,Fujii T. Initial experience of nivolumab/ipilimumab combination therapy for advanced renal cancer in our hospital. The 109th Annual Meeting of the Japanese Urological Association. 2021; 01-,74.0,YR,E,M,Y,,,20220930,,MD,JP,JP,2022,Q3,Elderly
213269761,21326976,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q3,Renal failure,,2022,Q3,1,I,20220101.0,20220907.0,20220913,20220913,EXP,,DE-AstraZeneca-2022A310441,ASTRAZENECA,,78.0,YR,,M,Y,,,20220913,,MD,DE,,2022,Q3,Elderly
213272821,21327282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Seizure,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Polyuria,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Seizure,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Polyuria,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Seizure,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Polyuria,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Seizure,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213272821,21327282,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Polyuria,,2022,Q3,1,I,20220801.0,20220905.0,20220913,20220913,EXP,,UA-AstraZeneca-2022A309633,ASTRAZENECA,,27.0,YR,,F,Y,,,20220913,,MD,UA,,2022,Q3,Young Adult
213284292,21328429,11,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q3,Constipation,,2022,Q3,2,F,20220101.0,20220907.0,20220913,20220916,EXP,CH-SM-2022-19087,CH-MYLANLABS-2022M1093263,MYLAN,,73.0,YR,,F,Y,,,20220916,,MD,CH,CH,2022,Q3,Elderly
213284292,21328429,11,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q3,Drug interaction,,2022,Q3,2,F,20220101.0,20220907.0,20220913,20220916,EXP,CH-SM-2022-19087,CH-MYLANLABS-2022M1093263,MYLAN,,73.0,YR,,F,Y,,,20220916,,MD,CH,CH,2022,Q3,Elderly
213303621,21330362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urosepsis,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213303621,21330362,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213303621,21330362,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl ? temporarily discontinued, to be included on an outpatient basis,",,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urosepsis,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213303621,21330362,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl ? temporarily discontinued, to be included on an outpatient basis,",,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213303621,21330362,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl,",,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urosepsis,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213303621,21330362,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl,",,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A315684,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Off label use,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urosepsis,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl ? temporarily discontinued, to be included on an outpatient basis,",,,,,,,202293.0,,,Tablet,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl ? temporarily discontinued, to be included on an outpatient basis,",,,,,,,202293.0,,,Tablet,,2022,Q3,Off label use,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl ? temporarily discontinued, to be included on an outpatient basis,",,,,,,,202293.0,,,Tablet,,2022,Q3,Urosepsis,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl,",,,,,,,202293.0,,,Tablet,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl,",,,,,,,202293.0,,,Tablet,,2022,Q3,Off label use,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213304441,21330444,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10mg 1x1tabl,",,,,,,,202293.0,,,Tablet,,2022,Q3,Urosepsis,,2022,Q3,1,I,20190101.0,20220905.0,20220913,20220913,EXP,,PL-AstraZeneca-2022A313400,ASTRAZENECA,,76.0,YR,,M,Y,82.0,KG,20220913,,MD,PL,,2022,Q3,Elderly
213321201,21332120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Pleural effusion,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Off label use,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5.0mg UNKNOWN,,,,,,,,5.0,MG,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5.0mg UNKNOWN,,,,,,,,5.0,MG,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5.0mg UNKNOWN,,,,,,,,5.0,MG,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5.0mg UNKNOWN,,,,,,,,5.0,MG,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213321201,21332120,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5.0mg UNKNOWN,,,,,,,,5.0,MG,,,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,DE-AstraZeneca-2022A313417,ASTRAZENECA,,82.0,YR,,,Y,107.0,KG,20220914,,MD,DE,,2022,Q3,Elderly
213322771,21332277,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,FR-AstraZeneca-2022A312723,ASTRAZENECA,,70.0,YR,,M,Y,,,20220914,,MD,FR,,2022,Q3,Elderly
213322771,21332277,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,FR-AstraZeneca-2022A312723,ASTRAZENECA,,70.0,YR,,M,Y,,,20220914,,MD,FR,,2022,Q3,Elderly
213322771,21332277,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220906.0,20220914,20220914,EXP,,FR-AstraZeneca-2022A312723,ASTRAZENECA,,70.0,YR,,M,Y,,,20220914,,MD,FR,,2022,Q3,Elderly
213322862,21332286,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,Tablet,,2022,Q3,Type 2 diabetes mellitus,,2022,Q3,2,F,20220128.0,20220916.0,20220914,20220922,EXP,,CN-ROCHE-3014587,ROCHE,,58.0,YR,,M,Y,71.0,KG,20220922,,MD,CN,,2022,Q3,Adult
213322862,21332286,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,Tablet,,2022,Q3,Hyperthyroidism,,2022,Q3,2,F,20220128.0,20220916.0,20220914,20220922,EXP,,CN-ROCHE-3014587,ROCHE,,58.0,YR,,M,Y,71.0,KG,20220922,,MD,CN,,2022,Q3,Adult
213354662,21335466,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,,2022,Q3,Cardiac tamponade,,2022,Q3,2,F,20220909.0,20220927.0,20220915,20220929,EXP,,"JP-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-192316",BOEHRINGER INGELHEIM,,71.0,YR,E,F,Y,37.0,KG,20220929,,MD,JP,JP,2022,Q3,Elderly
213370061,21337006,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,,20220908.0,20220915,20220915,EXP,,FR-AstraZeneca-2022A315336,ASTRAZENECA,,67.0,YR,,M,Y,62.0,KG,20220915,,MD,FR,,2022,Q3,Elderly
213370061,21337006,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220908.0,20220915,20220915,EXP,,FR-AstraZeneca-2022A315336,ASTRAZENECA,,67.0,YR,,M,Y,62.0,KG,20220915,,MD,FR,,2022,Q3,Elderly
213370061,21337006,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,,20220908.0,20220915,20220915,EXP,,FR-AstraZeneca-2022A315336,ASTRAZENECA,,67.0,YR,,M,Y,62.0,KG,20220915,,MD,FR,,2022,Q3,Elderly
213370061,21337006,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220908.0,20220915,20220915,EXP,,FR-AstraZeneca-2022A315336,ASTRAZENECA,,67.0,YR,,M,Y,62.0,KG,20220915,,MD,FR,,2022,Q3,Elderly
213383841,21338384,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220907.0,20220915,20220915,EXP,,CH-AstraZeneca-2022A311215,ASTRAZENECA,,73.0,YR,,F,Y,,,20220915,,MD,CH,,2022,Q3,Elderly
213383841,21338384,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q3,Constipation,,2022,Q3,1,I,20220101.0,20220907.0,20220915,20220915,EXP,,CH-AstraZeneca-2022A311215,ASTRAZENECA,,73.0,YR,,F,Y,,,20220915,,MD,CH,,2022,Q3,Elderly
213386021,21338602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,2109160,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urine ketone body present,,2022,Q3,1,I,20220829.0,20220907.0,20220915,20220915,EXP,,CN-AstraZeneca-2022A314930,ASTRAZENECA,,52.0,YR,,F,Y,60.0,KG,20220915,,MD,CN,,2022,Q3,Adult
213386021,21338602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,,,2109160,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220829.0,20220907.0,20220915,20220915,EXP,,CN-AstraZeneca-2022A314930,ASTRAZENECA,,52.0,YR,,F,Y,60.0,KG,20220915,,MD,CN,,2022,Q3,Adult
213391822,21339182,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Neoplasm malignant,,2022,Q3,2,F,20220814.0,20220914.0,20220915,20220918,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-104134,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20220919,,CN,CA,CA,2022,Q3,Elderly
213391822,21339182,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Myocardial infarction,,2022,Q3,2,F,20220814.0,20220914.0,20220915,20220918,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-104134,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,,,20220919,,CN,CA,CA,2022,Q3,Elderly
213419261,21341926,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q3,Constipation,,2022,Q3,1,I,20220101.0,20220907.0,20220916,20220916,EXP,CH-SM-2022-19087,CH-PFIZER INC-202201137831,PFIZER,,73.0,YR,,F,Y,,,20220916,,MD,CH,CH,2022,Q3,Elderly
213419261,21341926,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220907.0,20220916,20220916,EXP,CH-SM-2022-19087,CH-PFIZER INC-202201137831,PFIZER,,73.0,YR,,F,Y,,,20220916,,MD,CH,CH,2022,Q3,Elderly
213427621,21342762,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD  (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Waist circumference increased,,2022,Q3,1,I,,20220915.0,20220916,20220916,EXP,,NVSC2022DE208495,NOVARTIS,,72.0,YR,,F,Y,100.0,KG,20220916,,PH,DE,DE,2022,Q3,Elderly
213427621,21342762,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD  (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220915.0,20220916,20220916,EXP,,NVSC2022DE208495,NOVARTIS,,72.0,YR,,F,Y,100.0,KG,20220916,,PH,DE,DE,2022,Q3,Elderly
213427621,21342762,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD  (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Back pain,,2022,Q3,1,I,,20220915.0,20220916,20220916,EXP,,NVSC2022DE208495,NOVARTIS,,72.0,YR,,F,Y,100.0,KG,20220916,,PH,DE,DE,2022,Q3,Elderly
213427621,21342762,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD  (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Bradyarrhythmia,,2022,Q3,1,I,,20220915.0,20220916,20220916,EXP,,NVSC2022DE208495,NOVARTIS,,72.0,YR,,F,Y,100.0,KG,20220916,,PH,DE,DE,2022,Q3,Elderly
213427621,21342762,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD  (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220916,20220916,EXP,,NVSC2022DE208495,NOVARTIS,,72.0,YR,,F,Y,100.0,KG,20220916,,PH,DE,DE,2022,Q3,Elderly
213428271,21342827,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220528.0,20220908.0,20220916,20220916,EXP,,GB-AstraZeneca-2022A311437,ASTRAZENECA,,72.0,YR,,M,Y,91.0,KG,20220916,,MD,GB,,2022,Q3,Elderly
213428271,21342827,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Headache,,2022,Q3,1,I,20220528.0,20220908.0,20220916,20220916,EXP,,GB-AstraZeneca-2022A311437,ASTRAZENECA,,72.0,YR,,M,Y,91.0,KG,20220916,,MD,GB,,2022,Q3,Elderly
213433681,21343368,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"unspecified , Duration : 2 months",,,N,U,UNKNOWN,,,,,,,2022,Q3,Cholestatic liver injury,,2022,Q3,1,I,20220810.0,20220908.0,20220916,20220916,EXP,FR-AFSSAPS-NT20222419,FR-TEVA-2022-FR-2073431,TEVA,,66.0,YR,E,M,Y,56.0,KG,20220916,,MD,FR,FR,2022,Q3,Elderly
213461181,21346118,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",2980.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q3,Head injury,,2022,Q3,1,I,20220818.0,20220907.0,20220917,20220917,EXP,,SE-AUROBINDO-AUR-APL-2022-036424,AUROBINDO,,75.0,YR,,M,Y,,,20220917,,MD,SE,SE,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,33,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood creatinine increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Heart rate decreased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213464643,21346464,36,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (5),,,U,,,,,,,,,2022,Q3,Wrong technique in product usage process,,2022,Q3,3,F,20201130.0,20220914.0,20220917,20220927,EXP,,NVSC2022TH207686,NOVARTIS,,73.0,YR,,F,Y,,,20220927,,MD,TH,TH,2022,Q3,Elderly
213465801,21346580,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Unit dose :10 mg  , frequency time : 1 day",,,,,UNKNOWN,,,10.0,MG,,,2022,Q3,Constipation,,2022,Q3,1,I,20220101.0,20220907.0,20220917,20220917,EXP,CH-SM-2022-19087,CH-TEVA-2022-CH-2072124,TEVA,,73.0,YR,E,F,Y,,,20220917,,MD,CH,CH,2022,Q3,Elderly
213465801,21346580,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"Unit dose :10 mg  , frequency time : 1 day",,,,,UNKNOWN,,,10.0,MG,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20220101.0,20220907.0,20220917,20220917,EXP,CH-SM-2022-19087,CH-TEVA-2022-CH-2072124,TEVA,,73.0,YR,E,F,Y,,,20220917,,MD,CH,CH,2022,Q3,Elderly
213501811,21350181,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Coated tablet,QD,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220420.0,20220916.0,20220919,20220919,EXP,IT-MINISAL02-867847,NVSC2022IT114010,NOVARTIS,,66.0,YR,,M,Y,100.0,KG,20220919,,PH,IT,IT,2022,Q3,Elderly
213501811,21350181,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Coated tablet,QD,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,1,I,20220420.0,20220916.0,20220919,20220919,EXP,IT-MINISAL02-867847,NVSC2022IT114010,NOVARTIS,,66.0,YR,,M,Y,100.0,KG,20220919,,PH,IT,IT,2022,Q3,Elderly
213501811,21350181,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Coated tablet,QD,2022,Q3,Fatigue,,2022,Q3,1,I,20220420.0,20220916.0,20220919,20220919,EXP,IT-MINISAL02-867847,NVSC2022IT114010,NOVARTIS,,66.0,YR,,M,Y,100.0,KG,20220919,,PH,IT,IT,2022,Q3,Elderly
213501811,21350181,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Coated tablet,QD,2022,Q3,Hypothyroidism,,2022,Q3,1,I,20220420.0,20220916.0,20220919,20220919,EXP,IT-MINISAL02-867847,NVSC2022IT114010,NOVARTIS,,66.0,YR,,M,Y,100.0,KG,20220919,,PH,IT,IT,2022,Q3,Elderly
213510141,21351014,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, daily",,,,,,,,,,,QD,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,1,I,20220801.0,20220907.0,20220919,20220919,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202209003447,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220919,,CN,EG,EG,2022,Q3,Elderly
213510141,21351014,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, daily",,,,,,,,,,,QD,2022,Q3,Sleep disorder due to a general medical condition,,2022,Q3,1,I,20220801.0,20220907.0,20220919,20220919,EXP,,EG-ELI_LILLY_AND_COMPANY-EG202209003447,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220919,,CN,EG,EG,2022,Q3,Elderly
213527961,21352796,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,20220128.0,20220914.0,20220920,20220920,EXP,,NVSC2022GB208428,NOVARTIS,,59.0,YR,,F,Y,108.0,KG,20220920,,HP,GB,GB,2022,Q3,Adult
213527961,21352796,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cough,,2022,Q3,1,I,20220128.0,20220914.0,20220920,20220920,EXP,,NVSC2022GB208428,NOVARTIS,,59.0,YR,,F,Y,108.0,KG,20220920,,HP,GB,GB,2022,Q3,Adult
213527961,21352796,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Viral infection,,2022,Q3,1,I,20220128.0,20220914.0,20220920,20220920,EXP,,NVSC2022GB208428,NOVARTIS,,59.0,YR,,F,Y,108.0,KG,20220920,,HP,GB,GB,2022,Q3,Adult
213527961,21352796,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220128.0,20220914.0,20220920,20220920,EXP,,NVSC2022GB208428,NOVARTIS,,59.0,YR,,F,Y,108.0,KG,20220920,,HP,GB,GB,2022,Q3,Adult
213527961,21352796,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20220128.0,20220914.0,20220920,20220920,EXP,,NVSC2022GB208428,NOVARTIS,,59.0,YR,,F,Y,108.0,KG,20220920,,HP,GB,GB,2022,Q3,Adult
213537821,21353782,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,not specified,,,N,,,,,,,,,2022,Q3,Cholestatic liver injury,,2022,Q3,1,I,20220810.0,20220906.0,20220920,20220920,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-355149,RANBAXY,,66.0,YR,,M,Y,56.0,KG,20220920,,MD,FR,FR,2022,Q3,Elderly
213547481,21354748,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Neoplasm malignant,,2022,Q3,1,I,20220210.0,20220914.0,20220920,20220920,PER,,GB-AMGEN-GBRSP2022159009,AMGEN,,71.0,YR,E,F,Y,88.0,KG,20220920,,HP,GB,GB,2022,Q3,Elderly
213553471,21355347,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,including nephro-protection,,,,,,,,10.0,MG,,QD,2022,Q3,Sinus tachycardia,,2022,Q3,1,I,,20220912.0,20220920,20220920,EXP,,DE-AstraZeneca-2022A317704,ASTRAZENECA,,45.0,YR,,F,Y,,,20220920,,MD,DE,,2022,Q3,Adult
213553471,21355347,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,including nephro-protection,,,,,,,,10.0,MG,,QD,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220912.0,20220920,20220920,EXP,,DE-AstraZeneca-2022A317704,ASTRAZENECA,,45.0,YR,,F,Y,,,20220920,,MD,DE,,2022,Q3,Adult
213553811,21355381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 cp/J,,,N,U,,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220525.0,20220914.0,20220920,20220920,EXP,FR-AFSSAPS-TO20222808,FR-MYLANLABS-2022M1094889,MYLAN,,63.0,YR,,M,Y,147.0,KG,20220920,,PH,FR,FR,2022,Q3,Adult
213553811,21355381,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 cp/J,,,N,U,,,,10.0,MG,,QD,2022,Q3,Hypercreatinaemia,,2022,Q3,1,I,20220525.0,20220914.0,20220920,20220920,EXP,FR-AFSSAPS-TO20222808,FR-MYLANLABS-2022M1094889,MYLAN,,63.0,YR,,M,Y,147.0,KG,20220920,,PH,FR,FR,2022,Q3,Adult
213559121,21355912,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Petechiae,,2022,Q3,1,I,20220810.0,20220915.0,20220920,20220920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-106925,BRISTOL MYERS SQUIBB,,88.0,YR,E,M,Y,67.0,KG,20220920,,MD,DE,DE,2022,Q3,Elderly
213559121,21355912,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Skin ulcer,,2022,Q3,1,I,20220810.0,20220915.0,20220920,20220920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-106925,BRISTOL MYERS SQUIBB,,88.0,YR,E,M,Y,67.0,KG,20220920,,MD,DE,DE,2022,Q3,Elderly
213559121,21355912,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Proteinuria,,2022,Q3,1,I,20220810.0,20220915.0,20220920,20220920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-106925,BRISTOL MYERS SQUIBB,,88.0,YR,E,M,Y,67.0,KG,20220920,,MD,DE,DE,2022,Q3,Elderly
213559121,21355912,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Cutaneous vasculitis,,2022,Q3,1,I,20220810.0,20220915.0,20220920,20220920,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-106925,BRISTOL MYERS SQUIBB,,88.0,YR,E,M,Y,67.0,KG,20220920,,MD,DE,DE,2022,Q3,Elderly
213564071,21356407,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q3,Back pain,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,DE-ADRED-07531-01,DE-PFIZER INC-202201164334,PFIZER,,72.0,YR,,F,Y,100.0,KG,20220920,,PH,DE,DE,2022,Q3,Elderly
213564071,21356407,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,DE-ADRED-07531-01,DE-PFIZER INC-202201164334,PFIZER,,72.0,YR,,F,Y,100.0,KG,20220920,,PH,DE,DE,2022,Q3,Elderly
213564071,21356407,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,DE-ADRED-07531-01,DE-PFIZER INC-202201164334,PFIZER,,72.0,YR,,F,Y,100.0,KG,20220920,,PH,DE,DE,2022,Q3,Elderly
213564071,21356407,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q3,Waist circumference increased,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,DE-ADRED-07531-01,DE-PFIZER INC-202201164334,PFIZER,,72.0,YR,,F,Y,100.0,KG,20220920,,PH,DE,DE,2022,Q3,Elderly
213564071,21356407,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q3,Bradyarrhythmia,,2022,Q3,1,I,,20220915.0,20220920,20220920,EXP,DE-ADRED-07531-01,DE-PFIZER INC-202201164334,PFIZER,,72.0,YR,,F,Y,100.0,KG,20220920,,PH,DE,DE,2022,Q3,Elderly
213565841,21356584,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/Tag,630.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Phimosis,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,,DE-AstraZeneca-2022A314406,ASTRAZENECA,,71.0,YR,,M,Y,124.0,KG,20220920,,MD,DE,,2022,Q3,Elderly
213565841,21356584,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/Tag,630.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Skin fissures,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,,DE-AstraZeneca-2022A314406,ASTRAZENECA,,71.0,YR,,M,Y,124.0,KG,20220920,,MD,DE,,2022,Q3,Elderly
213565841,21356584,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/Tag,630.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q3,Balanoposthitis,,2022,Q3,1,I,20220725.0,20220912.0,20220920,20220920,EXP,,DE-AstraZeneca-2022A314406,ASTRAZENECA,,71.0,YR,,M,Y,124.0,KG,20220920,,MD,DE,,2022,Q3,Elderly
213574011,21357401,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,10+1000mg per day,,,,,Unknown,,,,,,,2022,Q3,Intestinal polyp,,2022,Q3,1,I,,20220911.0,20220921,20220921,EXP,,BR-NOVOPROD-958286,NOVO NORDISK,,57.0,YR,,M,Y,76.0,KG,20220921,,MD,BR,BR,2022,Q3,Adult
213574011,21357401,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,10+1000mg per day,,,,,Unknown,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220911.0,20220921,20220921,EXP,,BR-NOVOPROD-958286,NOVO NORDISK,,57.0,YR,,M,Y,76.0,KG,20220921,,MD,BR,BR,2022,Q3,Adult
213574011,21357401,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,10+1000mg per day,,,,,Unknown,,,,,,,2022,Q3,Neuroendocrine tumour,,2022,Q3,1,I,,20220911.0,20220921,20220921,EXP,,BR-NOVOPROD-958286,NOVO NORDISK,,57.0,YR,,M,Y,76.0,KG,20220921,,MD,BR,BR,2022,Q3,Adult
213584101,21358410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Sepsis,,2022,Q3,1,I,,20220916.0,20220921,20220921,EXP,,GB-AstraZeneca-2022A320099,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20220921,,MD,GB,,2022,Q3,Adult
213584101,21358410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Genital candidiasis,,2022,Q3,1,I,,20220916.0,20220921,20220921,EXP,,GB-AstraZeneca-2022A320099,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20220921,,MD,GB,,2022,Q3,Adult
213584101,21358410,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fungaemia,,2022,Q3,1,I,,20220916.0,20220921,20220921,EXP,,GB-AstraZeneca-2022A320099,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20220921,,MD,GB,,2022,Q3,Adult
213592441,21359244,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"Tablet, 10 mg (milligram)",,,,,,,,,,Tablet,,2022,Q3,Renal failure,,2022,Q3,1,I,20220726.0,20220909.0,20220921,20220921,EXP,NL-LRB-00823524,NL-Accord-277846,ACCORD,,84.0,YR,E,M,Y,75.6,KG,20220921,,MD,NL,NL,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Hypothyroidism,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Fatigue,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Renal disorder,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Blood creatinine increased,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213592571,21359257,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220420.0,20220916.0,20220921,20220921,EXP,IT-MINISAL02-867847,IT-PFIZER INC-202200722953,PFIZER,,66.0,YR,,M,Y,100.0,KG,20220921,,PH,IT,IT,2022,Q3,Elderly
213595631,21359563,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary mass,,2022,Q3,1,I,20220710.0,20220914.0,20220921,20220921,EXP,FR-AFSSAPS-NC20222464,FR-MYLANLABS-2022M1094777,MYLAN,,64.0,YR,,M,Y,76.0,KG,20220921,,PH,FR,FR,2022,Q3,Adult
213595631,21359563,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Sepsis,,2022,Q3,1,I,20220710.0,20220914.0,20220921,20220921,EXP,FR-AFSSAPS-NC20222464,FR-MYLANLABS-2022M1094777,MYLAN,,64.0,YR,,M,Y,76.0,KG,20220921,,PH,FR,FR,2022,Q3,Adult
213595631,21359563,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heparin-induced thrombocytopenia,,2022,Q3,1,I,20220710.0,20220914.0,20220921,20220921,EXP,FR-AFSSAPS-NC20222464,FR-MYLANLABS-2022M1094777,MYLAN,,64.0,YR,,M,Y,76.0,KG,20220921,,PH,FR,FR,2022,Q3,Adult
213598891,21359889,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,,QD,2022,Q3,Chronic obstructive pulmonary disease,,2022,Q3,1,I,20220729.0,20220919.0,20220921,20220921,EXP,FR-AFSSAPS-AM20222129,FR-PFIZER INC-202201170778,PFIZER,,86.0,YR,,M,Y,82.0,KG,20220921,,PH,FR,FR,2022,Q3,Elderly
213598891,21359889,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,,QD,2022,Q3,Sepsis,,2022,Q3,1,I,20220729.0,20220919.0,20220921,20220921,EXP,FR-AFSSAPS-AM20222129,FR-PFIZER INC-202201170778,PFIZER,,86.0,YR,,M,Y,82.0,KG,20220921,,PH,FR,FR,2022,Q3,Elderly
213598891,21359889,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220729.0,20220919.0,20220921,20220921,EXP,FR-AFSSAPS-AM20222129,FR-PFIZER INC-202201170778,PFIZER,,86.0,YR,,M,Y,82.0,KG,20220921,,PH,FR,FR,2022,Q3,Elderly
213600481,21360048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ejection fraction decreased,,2022,Q3,1,I,20220501.0,20220913.0,20220921,20220921,EXP,,DE-AstraZeneca-2022A319880,ASTRAZENECA,,50.0,YR,,M,Y,,,20220921,,MD,DE,,2022,Q3,Adult
213600481,21360048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ischaemic cardiomyopathy,,2022,Q3,1,I,20220501.0,20220913.0,20220921,20220921,EXP,,DE-AstraZeneca-2022A319880,ASTRAZENECA,,50.0,YR,,M,Y,,,20220921,,MD,DE,,2022,Q3,Adult
213600481,21360048,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Mitral valve incompetence,,2022,Q3,1,I,20220501.0,20220913.0,20220921,20220921,EXP,,DE-AstraZeneca-2022A319880,ASTRAZENECA,,50.0,YR,,M,Y,,,20220921,,MD,DE,,2022,Q3,Adult
213604071,21360407,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,D,,,,,,,Film-coated tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220729.0,20220919.0,20220921,20220921,EXP,FR-AFSSAPS-AM20222129,NVSC2022FR212084,NOVARTIS,,86.0,YR,,M,Y,82.0,KG,20220921,,PH,FR,FR,2022,Q3,Elderly
213607771,21360777,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once a day,48600.0,MG,,,,,202293.0,100.0,MG,Tablet,QD,2022,Q3,Vaginal haemorrhage,,2022,Q3,1,I,20220501.0,20220913.0,20220921,20220921,EXP,,GB-AstraZeneca-2022A316415,ASTRAZENECA,,74.0,YR,,F,Y,89.0,KG,20220921,,MD,GB,,2022,Q3,Elderly
213610612,21361061,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Myocardial infarction,,2022,Q3,2,F,20220101.0,20220920.0,20220921,20220928,EXP,,GB-AstraZeneca-2022A320089,ASTRAZENECA,,81.0,YR,,,Y,,,20220928,,MD,GB,,2022,Q3,Elderly
213610612,21361061,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,2,F,20220101.0,20220920.0,20220921,20220928,EXP,,GB-AstraZeneca-2022A320089,ASTRAZENECA,,81.0,YR,,,Y,,,20220928,,MD,GB,,2022,Q3,Elderly
213610612,21361061,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q3,Platelet count decreased,,2022,Q3,2,F,20220101.0,20220920.0,20220921,20220928,EXP,,GB-AstraZeneca-2022A320089,ASTRAZENECA,,81.0,YR,,,Y,,,20220928,,MD,GB,,2022,Q3,Elderly
213615431,21361543,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220729.0,20220919.0,20220921,20220921,EXP,,FR-AstraZeneca-2022A321391,ASTRAZENECA,,86.0,YR,,M,Y,82.0,KG,20220921,,MD,FR,,2022,Q3,Elderly
213618241,21361824,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day in the morning; ;,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220902.0,20220914.0,20220922,20220922,EXP,,GB-AstraZeneca-2022A317728,ASTRAZENECA,,63.0,YR,,M,Y,82.0,KG,20220922,,MD,GB,,2022,Q3,Adult
213618551,21361855,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,705.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220603.0,20220914.0,20220922,20220922,EXP,,JP-AstraZeneca-2022A260858,ASTRAZENECA,,50.0,YR,,F,Y,61.0,KG,20220922,,MD,JP,,2022,Q3,Adult
213618551,21361855,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,705.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Underdose,,2022,Q3,1,I,20220603.0,20220914.0,20220922,20220922,EXP,,JP-AstraZeneca-2022A260858,ASTRAZENECA,,50.0,YR,,F,Y,61.0,KG,20220922,,MD,JP,,2022,Q3,Adult
213618551,21361855,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,705.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,20220603.0,20220914.0,20220922,20220922,EXP,,JP-AstraZeneca-2022A260858,ASTRAZENECA,,50.0,YR,,F,Y,61.0,KG,20220922,,MD,JP,,2022,Q3,Adult
213618551,21361855,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,705.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Underdose,,2022,Q3,1,I,20220603.0,20220914.0,20220922,20220922,EXP,,JP-AstraZeneca-2022A260858,ASTRAZENECA,,50.0,YR,,F,Y,61.0,KG,20220922,,MD,JP,,2022,Q3,Adult
213619241,21361924,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, (1-0-0-0)",,,U,,,,,10.0,MG,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,DE-AUROBINDO-AUR-APL-2022-037410,AUROBINDO,,72.0,YR,,F,Y,100.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213619241,21361924,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, (1-0-0-0)",,,U,,,,,10.0,MG,,,2022,Q3,Back pain,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,DE-AUROBINDO-AUR-APL-2022-037410,AUROBINDO,,72.0,YR,,F,Y,100.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213619241,21361924,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, (1-0-0-0)",,,U,,,,,10.0,MG,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,DE-AUROBINDO-AUR-APL-2022-037410,AUROBINDO,,72.0,YR,,F,Y,100.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213619241,21361924,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, (1-0-0-0)",,,U,,,,,10.0,MG,,,2022,Q3,Bradyarrhythmia,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,DE-AUROBINDO-AUR-APL-2022-037410,AUROBINDO,,72.0,YR,,F,Y,100.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213619241,21361924,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, (1-0-0-0)",,,U,,,,,10.0,MG,,,2022,Q3,Waist circumference increased,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,DE-AUROBINDO-AUR-APL-2022-037410,AUROBINDO,,72.0,YR,,F,Y,100.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213622281,21362228,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram(once a day),,,U,,,,,5.0,MG,Tablets,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,CA-AUROBINDO-AUR-APL-2022-038069,AUROBINDO,,58.0,YR,,M,Y,,,20220922,,CN,CA,CA,2022,Q3,Adult
213622281,21362228,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 milligram(once a day),,,U,,,,,5.0,MG,Tablets,,2022,Q3,Small intestine carcinoma,,2022,Q3,1,I,,20220913.0,20220922,20220922,EXP,,CA-AUROBINDO-AUR-APL-2022-038069,AUROBINDO,,58.0,YR,,M,Y,,,20220922,,CN,CA,CA,2022,Q3,Adult
213624501,21362450,5,C,DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE,,2,,5+1000mg bid,,,,,,,,,,,,2022,Q3,Non-proliferative retinopathy,,2022,Q3,1,I,20201001.0,20220912.0,20220922,20220922,EXP,,BR-NOVOPROD-958841,NOVO NORDISK,,69.0,YR,,M,Y,86.5,KG,20220922,,MD,BR,BR,2022,Q3,Elderly
213624501,21362450,5,C,DAPAGLIFLOZIN;METFORMIN HYDROCHLORIDE,,2,,5+1000mg bid,,,,,,,,,,,,2022,Q3,Stent placement,,2022,Q3,1,I,20201001.0,20220912.0,20220922,20220922,EXP,,BR-NOVOPROD-958841,NOVO NORDISK,,69.0,YR,,M,Y,86.5,KG,20220922,,MD,BR,BR,2022,Q3,Elderly
213625901,21362590,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220912.0,20220922,20220922,EXP,,CA-TEVA-2022-CA-2074019,TEVA,,64.0,YR,A,M,Y,90.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
213625901,21362590,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220912.0,20220922,20220922,EXP,,CA-TEVA-2022-CA-2074019,TEVA,,64.0,YR,A,M,Y,90.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
213625901,21362590,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220912.0,20220922,20220922,EXP,,CA-TEVA-2022-CA-2074019,TEVA,,64.0,YR,A,M,Y,90.0,KG,20220922,,HP,CA,CA,2022,Q3,Adult
213643882,21364388,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2680.0,MG,Y,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketosis,,2022,Q3,2,F,20220824.0,20220910.0,20220922,20220926,EXP,,CN-AstraZeneca-2022A317274,ASTRAZENECA,,37.0,YR,,F,Y,63.0,KG,20220926,,MD,CN,,2022,Q3,Adult
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Pallor,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Tachypnoea,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Shock haemorrhagic,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213644901,21364490,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Anaemia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,NVSC2022DE210306,NOVARTIS,,68.0,YR,,M,Y,75.0,KG,20220922,,PH,DE,DE,2022,Q3,Elderly
213649221,21364922,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220920.0,20220922,20220922,EXP,,DE-SA-2022SA391134,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220922,,PH,DE,DE,2022,Q3,Elderly
213649221,21364922,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220920.0,20220922,20220922,EXP,,DE-SA-2022SA391134,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220922,,PH,DE,DE,2022,Q3,Elderly
213649221,21364922,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220920.0,20220922,20220922,EXP,,DE-SA-2022SA391134,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220922,,PH,DE,DE,2022,Q3,Elderly
213649221,21364922,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,D,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220920.0,20220922,20220922,EXP,,DE-SA-2022SA391134,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220922,,PH,DE,DE,2022,Q3,Elderly
213657971,21365797,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Pemphigoid,,2022,Q3,1,I,20220101.0,20220914.0,20220922,20220922,EXP,,JP-AstraZeneca-2022A319713,ASTRAZENECA,,53.0,YR,,M,Y,,,20220922,,MD,JP,,2022,Q3,Adult
213665621,21366562,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Candida infection,,2022,Q3,1,I,20211115.0,20220915.0,20220923,20220923,EXP,,AU-AstraZeneca-2022A322012,ASTRAZENECA,,3001.0,WK,,F,Y,,,20220923,,MD,AU,,2022,Q3,Elderly
213665621,21366562,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,100.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Candida infection,,2022,Q3,1,I,20211115.0,20220915.0,20220923,20220923,EXP,,AU-AstraZeneca-2022A322012,ASTRAZENECA,,3001.0,WK,,F,Y,,,20220923,,MD,AU,,2022,Q3,Elderly
213674351,21367435,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablet",,,U,,,,,,,Tablet,,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220919.0,20220923,20220923,EXP,,DE-009507513-2209DEU006748,MERCK,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213674351,21367435,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablet",,,U,,,,,,,Tablet,,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220919.0,20220923,20220923,EXP,,DE-009507513-2209DEU006748,MERCK,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213674351,21367435,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablet",,,U,,,,,,,Tablet,,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220919.0,20220923,20220923,EXP,,DE-009507513-2209DEU006748,MERCK,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213674351,21367435,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablet",,,U,,,,,,,Tablet,,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220919.0,20220923,20220923,EXP,,DE-009507513-2209DEU006748,MERCK,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213686261,21368626,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,NA3007//2108066,,,10.0,MG,Tablet,QD,2022,Q3,Palpitations,,2022,Q3,1,I,20220910.0,20220919.0,20220923,20220923,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-193197",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,64.0,KG,20220923,,CN,CN,CN,2022,Q3,Adult
213686261,21368626,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,NA3007//2108066,,,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220910.0,20220919.0,20220923,20220923,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-193197",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,64.0,KG,20220923,,CN,CN,CN,2022,Q3,Adult
213686261,21368626,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,NA3007//2108066,,,10.0,MG,Tablet,QD,2022,Q3,Product use issue,,2022,Q3,1,I,20220910.0,20220919.0,20220923,20220923,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-193197",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,64.0,KG,20220923,,CN,CN,CN,2022,Q3,Adult
213686261,21368626,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,NA3007//2108066,,,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220910.0,20220919.0,20220923,20220923,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-193197",BOEHRINGER INGELHEIM,,62.0,YR,A,M,Y,64.0,KG,20220923,,CN,CN,CN,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Weight increased,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Chest pain,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Pain,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,Unknown,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213699671,21369967,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NF3387//2109105,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20220905.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321137,ASTRAZENECA,,22428.0,DY,,M,Y,65.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213699671,21369967,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NF3387//2109105,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220905.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321137,ASTRAZENECA,,22428.0,DY,,M,Y,65.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213699671,21369967,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NF3387//2109105,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketosis,,2022,Q3,1,I,20220905.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321137,ASTRAZENECA,,22428.0,DY,,M,Y,65.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213699671,21369967,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NF3387//2109105,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Decreased appetite,,2022,Q3,1,I,20220905.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321137,ASTRAZENECA,,22428.0,DY,,M,Y,65.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pruritus,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pruritus,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Rash,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Dizziness,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213704601,21370460,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,20220729.0,20220915.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A321954,ASTRAZENECA,,69.0,YR,,F,Y,63.0,KG,20220923,,MD,CN,,2022,Q3,Elderly
213709291,21370929,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q3,Death,,2022,Q3,1,I,20220101.0,20220920.0,20220923,20220923,EXP,,HU-AstraZeneca-2022A326128,ASTRAZENECA,,80.0,YR,,F,Y,,,20220923,,CN,HU,,2022,Q3,Elderly
213713291,21371329,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Death,,2022,Q3,1,I,20220624.0,20220919.0,20220923,20220923,EXP,,ZA-AstraZeneca-2022A322647,ASTRAZENECA,,78.0,YR,,M,Y,,,20220923,,CN,ZA,,2022,Q3,Elderly
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Vomiting,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Gastroenteritis,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hyperthyroidism,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Ketoacidosis,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213713301,21371330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2360.0,MG,U,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Nausea,,2022,Q3,1,I,20220823.0,20220917.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A324879,ASTRAZENECA,,55.0,YR,,F,Y,55.0,KG,20220923,,MD,CN,,2022,Q3,Adult
213718011,21371801,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2104200,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood ketone body increased,,2022,Q3,1,I,20220825.0,20220916.0,20220923,20220923,EXP,,CN-AstraZeneca-2022A323565,ASTRAZENECA,,21662.0,DY,,F,Y,59.4,KG,20220923,,MD,CN,,2022,Q3,Elderly
213719801,21371980,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220918.0,20220923,20220923,EXP,DE-ADRED-07903-01,DE-BAUSCH-BL-2022-022175,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213719801,21371980,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220918.0,20220923,20220923,EXP,DE-ADRED-07903-01,DE-BAUSCH-BL-2022-022175,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213719801,21371980,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220918.0,20220923,20220923,EXP,DE-ADRED-07903-01,DE-BAUSCH-BL-2022-022175,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213719801,21371980,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220918.0,20220923,20220923,EXP,DE-ADRED-07903-01,DE-BAUSCH-BL-2022-022175,BAUSCH AND LOMB,,70.0,YR,,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213725201,21372520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220919.0,20220924,20220924,EXP,,NVSC2022DE211439,NOVARTIS,,70.0,YR,,M,Y,,,20220924,,PH,DE,DE,2022,Q3,Elderly
213725201,21372520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220919.0,20220924,20220924,EXP,,NVSC2022DE211439,NOVARTIS,,70.0,YR,,M,Y,,,20220924,,PH,DE,DE,2022,Q3,Elderly
213725201,21372520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220919.0,20220924,20220924,EXP,,NVSC2022DE211439,NOVARTIS,,70.0,YR,,M,Y,,,20220924,,PH,DE,DE,2022,Q3,Elderly
213725201,21372520,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220919.0,20220924,20220924,EXP,,NVSC2022DE211439,NOVARTIS,,70.0,YR,,M,Y,,,20220924,,PH,DE,DE,2022,Q3,Elderly
213726491,21372649,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220913.0,20220924,20220924,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-11220,LUPIN,,54.0,YR,,F,Y,,,20220924,,CN,ZA,ZA,2022,Q3,Adult
213726491,21372649,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Treatment noncompliance,,2022,Q3,1,I,,20220913.0,20220924,20220924,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-11220,LUPIN,,54.0,YR,,F,Y,,,20220924,,CN,ZA,ZA,2022,Q3,Adult
213726491,21372649,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q3,Emotional disorder,,2022,Q3,1,I,,20220913.0,20220924,20220924,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-11220,LUPIN,,54.0,YR,,F,Y,,,20220924,,CN,ZA,ZA,2022,Q3,Adult
213727151,21372715,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,,20220922.0,20220924,20220924,EXP,,NVSC2022DE216087,NOVARTIS,,84.0,YR,,M,Y,,,20220924,,MD,DE,DE,2022,Q3,Elderly
213727571,21372757,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1160.0,MG,Y,,,,,10.0,MG,,QD,2022,Q3,Shock,,2022,Q3,1,I,20220320.0,20220922.0,20220924,20220924,EXP,FR-AFSSAPS-LY20223182,NVSC2022FR214454,NOVARTIS,,69.0,YR,,M,Y,75.0,KG,20220924,,PH,FR,FR,2022,Q3,Elderly
213727571,21372757,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1160.0,MG,Y,,,,,10.0,MG,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220320.0,20220922.0,20220924,20220924,EXP,FR-AFSSAPS-LY20223182,NVSC2022FR214454,NOVARTIS,,69.0,YR,,M,Y,75.0,KG,20220924,,PH,FR,FR,2022,Q3,Elderly
213728831,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q3,Thyroid operation,,2022,Q3,1,I,20220901.0,20220916.0,20220924,20220924,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20220924,,HP,CO,CO,2022,Q3,Elderly
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Weight increased,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Chest pain,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Pain,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD ( 1-0-0-0)",,,U,,,,,10.0,MG,,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213749251,21374925,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Syncope,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022TH214861,NOVARTIS,,50.0,YR,,F,Y,54.9,KG,20220926,,MD,TH,TH,2022,Q3,Adult
213749251,21374925,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022TH214861,NOVARTIS,,50.0,YR,,F,Y,54.9,KG,20220926,,MD,TH,TH,2022,Q3,Adult
213749251,21374925,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Hypotension,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022TH214861,NOVARTIS,,50.0,YR,,F,Y,54.9,KG,20220926,,MD,TH,TH,2022,Q3,Adult
213749251,21374925,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD",,,U,,,,,,,,QD,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022TH214861,NOVARTIS,,50.0,YR,,F,Y,54.9,KG,20220926,,MD,TH,TH,2022,Q3,Adult
213751441,21375144,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,,NA3007//2108066,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220910.0,20220917.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A323974,ASTRAZENECA,,62.0,YR,,M,Y,64.0,KG,20220926,,MD,CN,,2022,Q3,Adult
213751441,21375144,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,,NA3007//2108066,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Palpitations,,2022,Q3,1,I,20220910.0,20220917.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A323974,ASTRAZENECA,,62.0,YR,,M,Y,64.0,KG,20220926,,MD,CN,,2022,Q3,Adult
213751441,21375144,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,U,,NA3007//2108066,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220910.0,20220917.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A323974,ASTRAZENECA,,62.0,YR,,M,Y,64.0,KG,20220926,,MD,CN,,2022,Q3,Adult
213756161,21375616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Ovarian cancer,,2022,Q3,1,I,,20220913.0,20220926,20220926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202209008113,ELI LILLY AND CO,,77.0,YR,,F,Y,58.0,KG,20220926,,CN,CN,CN,2022,Q3,Elderly
213756161,21375616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220913.0,20220926,20220926,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202209008113,ELI LILLY AND CO,,77.0,YR,,F,Y,58.0,KG,20220926,,CN,CN,CN,2022,Q3,Elderly
213757551,21375755,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0,,,,,,,,5.0,MG,,QD,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,20220720.0,20220920.0,20220926,20220926,EXP,DE-BFARM-22007095,DE-009507513-2209DEU007018,MERCK,,80.0,YR,,F,Y,72.5,KG,20220926,,PH,DE,DE,2022,Q3,Elderly
213765231,21376523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NC25722108162,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cold sweat,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NC25722108162,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NC25722108162,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Lacunar infarction,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NC25722108162,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cold sweat,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Lacunar infarction,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213765231,21376523,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Asthenia,,2022,Q3,1,I,20220913.0,20220918.0,20220926,20220926,EXP,,CN-AstraZeneca-2022A325825,ASTRAZENECA,,53.0,YR,,M,Y,,,20220926,,MD,CN,,2022,Q3,Adult
213780112,21378011,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,2,F,20220106.0,20220923.0,20220926,20220929,EXP,PT-INFARMED-T202209-638,PT-Vifor (International) Inc.-VIT-2022-06575,VIFOR,,71.0,YR,,M,Y,86.0,KG,20220929,,PH,PT,PT,2022,Q3,Elderly
213780112,21378011,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220106.0,20220923.0,20220926,20220929,EXP,PT-INFARMED-T202209-638,PT-Vifor (International) Inc.-VIT-2022-06575,VIFOR,,71.0,YR,,M,Y,86.0,KG,20220929,,PH,PT,PT,2022,Q3,Elderly
213780122,21378012,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet at lunch,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,2,F,20210616.0,20220923.0,20220926,20220930,EXP,PT-INFARMED-T202209-640,PT-Vifor (International) Inc.-VIT-2022-06515,VIFOR,,71.0,YR,,M,Y,100.0,KG,20220930,,PH,PT,PT,2022,Q3,Elderly
213780122,21378012,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet at lunch,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Renal impairment,,2022,Q3,2,F,20210616.0,20220923.0,20220926,20220930,EXP,PT-INFARMED-T202209-640,PT-Vifor (International) Inc.-VIT-2022-06515,VIFOR,,71.0,YR,,M,Y,100.0,KG,20220930,,PH,PT,PT,2022,Q3,Elderly
213797111,21379711,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (1-0-0-0),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210101.0,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038108,AUROBINDO,,83.0,YR,,F,Y,80.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213797111,21379711,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (1-0-0-0),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210101.0,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038108,AUROBINDO,,83.0,YR,,F,Y,80.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213797111,21379711,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (1-0-0-0),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Haematochezia,,2022,Q3,1,I,20210101.0,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038108,AUROBINDO,,83.0,YR,,F,Y,80.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213797111,21379711,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (1-0-0-0),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Constipation,,2022,Q3,1,I,20210101.0,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038108,AUROBINDO,,83.0,YR,,F,Y,80.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213797111,21379711,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram (1-0-0-0),,,U,,,,,10.0,MG,Tablet,,2022,Q3,Abdominal pain lower,,2022,Q3,1,I,20210101.0,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038108,AUROBINDO,,83.0,YR,,F,Y,80.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213804231,21380423,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,ONCE/SINGLE ADMINISTRATION,,,,,,,202293.0,,,Tablet,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,FR-AstraZeneca-2022A327442,ASTRAZENECA,,77.0,YR,,F,Y,49.0,KG,20220927,,MD,FR,,2022,Q3,Elderly
213804231,21380423,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,ONCE/SINGLE ADMINISTRATION,,,,,,,202293.0,,,Tablet,,2022,Q3,Feeling abnormal,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,FR-AstraZeneca-2022A327442,ASTRAZENECA,,77.0,YR,,F,Y,49.0,KG,20220927,,MD,FR,,2022,Q3,Elderly
213804231,21380423,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,ONCE/SINGLE ADMINISTRATION,,,,,,,202293.0,,,Tablet,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,FR-AstraZeneca-2022A327442,ASTRAZENECA,,77.0,YR,,F,Y,49.0,KG,20220927,,MD,FR,,2022,Q3,Elderly
213804271,21380427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,170.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Cutaneous vasculitis,,2022,Q3,1,I,20220810.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A321182,ASTRAZENECA,,88.0,YR,,M,Y,67.0,KG,20220927,,MD,DE,,2022,Q3,Elderly
213804271,21380427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,170.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Skin ulcer,,2022,Q3,1,I,20220810.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A321182,ASTRAZENECA,,88.0,YR,,M,Y,67.0,KG,20220927,,MD,DE,,2022,Q3,Elderly
213804271,21380427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,170.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Petechiae,,2022,Q3,1,I,20220810.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A321182,ASTRAZENECA,,88.0,YR,,M,Y,67.0,KG,20220927,,MD,DE,,2022,Q3,Elderly
213804271,21380427,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,170.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Proteinuria,,2022,Q3,1,I,20220810.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A321182,ASTRAZENECA,,88.0,YR,,M,Y,67.0,KG,20220927,,MD,DE,,2022,Q3,Elderly
213805521,21380552,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,1,I,20220830.0,20220921.0,20220927,20220927,EXP,,SE-AstraZeneca-2022A324187,ASTRAZENECA,,40.0,YR,,M,Y,110.0,KG,20220927,,MD,SE,,2022,Q3,Adult
213805521,21380552,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220830.0,20220921.0,20220927,20220927,EXP,,SE-AstraZeneca-2022A324187,ASTRAZENECA,,40.0,YR,,M,Y,110.0,KG,20220927,,MD,SE,,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Atrial enlargement,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Glomerular filtration rate increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Cardiac failure congestive,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Atrial flutter,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ventricular tachycardia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ventricular extrasystoles,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,International normalised ratio fluctuation,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Haemoglobin decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Supraventricular extrasystoles,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Sinus arrest,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Bundle branch block left,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Troponin T increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Condition aggravated,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Chest pain,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Fatigue,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Mean cell haemoglobin increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Heart rate increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Hydrocholecystis,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Drug effect less than expected,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Congestive cardiomyopathy,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Anaemia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Extrasystoles,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Electrocardiogram ST segment abnormal,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Atrial flutter,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Heart rate irregular,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ejection fraction decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Sciatica,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ventricular fibrillation,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Red cell distribution width increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ventricular tachycardia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Asthenia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Hyperlipidaemia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Platelet count decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Transferrin saturation decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Inflammatory marker increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Cholelithiasis,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Arrhythmia supraventricular,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Mean cell volume increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Exercise tolerance decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Vitamin B12 deficiency,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Weight increased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Ventricular extrasystoles,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213806921,21380692,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q3,Electrocardiogram T wave amplitude decreased,,2022,Q3,1,I,20140101.0,20220920.0,20220927,20220927,EXP,,NVSC2022HU216711,NOVARTIS,,53.0,YR,,M,Y,118.0,KG,20220927,,MD,HU,HU,2022,Q3,Adult
213808991,21380899,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Fall,,2022,Q3,1,I,20210630.0,20220926.0,20220927,20220927,EXP,,NVSC2022DE217179,NOVARTIS,,79.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213808991,21380899,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q3,Subgaleal haematoma,,2022,Q3,1,I,20210630.0,20220926.0,20220927,20220927,EXP,,NVSC2022DE217179,NOVARTIS,,79.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213809541,21380954,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, bid (5|1000 mg, 1-0-1)",,,,,,,,,,,BID,2022,Q3,Fall,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, bid (5|1000 mg, 1-0-1)",,,,,,,,,,,BID,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, bid (5|1000 mg, 1-0-1)",,,,,,,,,,,BID,2022,Q3,Death,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"UNK UNK, bid (5|1000 mg, 1-0-1)",,,,,,,,,,,BID,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213812841,21381284,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Irritability,,2022,Q3,1,I,20220403.0,20220919.0,20220927,20220927,EXP,,BE-AstraZeneca-2022A321112,ASTRAZENECA,,46.0,YR,,M,Y,104.0,KG,20220927,,MD,BE,,2022,Q3,Adult
213812841,21381284,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Mood altered,,2022,Q3,1,I,20220403.0,20220919.0,20220927,20220927,EXP,,BE-AstraZeneca-2022A321112,ASTRAZENECA,,46.0,YR,,M,Y,104.0,KG,20220927,,MD,BE,,2022,Q3,Adult
213820841,21382084,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,,,,,10.0,MG,Tablet,,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A320698,ASTRAZENECA,,70.0,YR,,M,Y,,,20220927,,MD,DE,,2022,Q3,Elderly
213820841,21382084,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,,,,,10.0,MG,Tablet,,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A320698,ASTRAZENECA,,70.0,YR,,M,Y,,,20220927,,MD,DE,,2022,Q3,Elderly
213820841,21382084,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,,,,,10.0,MG,Tablet,,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A320698,ASTRAZENECA,,70.0,YR,,M,Y,,,20220927,,MD,DE,,2022,Q3,Elderly
213820841,21382084,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,,,,,10.0,MG,Tablet,,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220919.0,20220927,20220927,EXP,,DE-AstraZeneca-2022A320698,ASTRAZENECA,,70.0,YR,,M,Y,,,20220927,,MD,DE,,2022,Q3,Elderly
213825131,21382513,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablets,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220921.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022390,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20220927,,HP,CA,CA,2022,Q3,Adult
213825131,21382513,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablets,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220921.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022390,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20220927,,HP,CA,CA,2022,Q3,Adult
213825131,21382513,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablets,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220921.0,20220927,20220927,EXP,,CA-BAUSCH-BL-2022-022390,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20220927,,HP,CA,CA,2022,Q3,Adult
213837881,21383788,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q3,Eczema,,2022,Q3,1,I,20220807.0,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A322173,ASTRAZENECA,,84.0,YR,,F,Y,62.4,KG,20220928,,MD,FR,,2022,Q3,Elderly
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Chest pain,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Pain,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Weight increased,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q3,Nausea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213847171,21384717,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220915.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037906,AUROBINDO,,70.0,YR,,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Elderly
213847171,21384717,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220915.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037906,AUROBINDO,,70.0,YR,,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Elderly
213847171,21384717,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220915.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037906,AUROBINDO,,70.0,YR,,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Elderly
213847171,21384717,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220915.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037906,AUROBINDO,,70.0,YR,,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Elderly
213850391,21385039,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1605.0,MG,,,NH3208,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Weight decreased,,2022,Q3,1,I,20220906.0,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A326660,ASTRAZENECA,,62.0,YR,,M,Y,90.0,KG,20220928,,MD,CN,,2022,Q3,Adult
213851331,21385133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Small intestine carcinoma,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328493,ASTRAZENECA,,58.0,YR,,M,Y,,,20220928,,MD,CA,,2022,Q3,Adult
213851331,21385133,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328493,ASTRAZENECA,,58.0,YR,,M,Y,,,20220928,,MD,CA,,2022,Q3,Adult
213857891,21385789,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220918.0,20220928,20220928,EXP,,CA-TEVA-2022-CA-2076225,TEVA,,70.0,YR,E,F,Y,98.0,KG,20220928,,HP,CA,CA,2022,Q3,Elderly
213857921,21385792,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Serotonin syndrome,,2022,Q3,1,I,,20220918.0,20220928,20220928,EXP,,CA-TEVA-2022-CA-2076167,TEVA,,70.0,YR,E,F,Y,98.0,KG,20220928,,HP,CA,CA,2022,Q3,Elderly
213857921,21385792,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablet,,2022,Q3,Tremor,,2022,Q3,1,I,,20220918.0,20220928,20220928,EXP,,CA-TEVA-2022-CA-2076167,TEVA,,70.0,YR,E,F,Y,98.0,KG,20220928,,HP,CA,CA,2022,Q3,Elderly
213859771,21385977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once/Single administration,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Muscle atrophy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A326642,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220928,,MD,FR,,2022,Q3,Elderly
213859771,21385977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once/Single administration,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A326642,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220928,,MD,FR,,2022,Q3,Elderly
213859771,21385977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once/Single administration,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A326642,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220928,,MD,FR,,2022,Q3,Elderly
213859771,21385977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once/Single administration,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Feeling abnormal,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A326642,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220928,,MD,FR,,2022,Q3,Elderly
213859771,21385977,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Once/Single administration,,,Y,,,,202293.0,,,Tablet,,2022,Q3,Gammopathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,FR-AstraZeneca-2022A326642,ASTRAZENECA,,79.0,YR,,F,Y,49.0,KG,20220928,,MD,FR,,2022,Q3,Elderly
213864981,21386498,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK 1x1,,,Y,,,,,,,,,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,1,I,20220830.0,20220919.0,20220928,20220928,EXP,SE-MPA-2022-018754,SE-NOVOPROD-960691,NOVO NORDISK,,40.0,YR,,M,Y,110.0,KG,20220928,,MD,SE,SE,2022,Q3,Adult
213864981,21386498,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK 1x1,,,Y,,,,,,,,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220830.0,20220919.0,20220928,20220928,EXP,SE-MPA-2022-018754,SE-NOVOPROD-960691,NOVO NORDISK,,40.0,YR,,M,Y,110.0,KG,20220928,,MD,SE,SE,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Diabetic metabolic decompensation,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Macroangiopathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Polyneuropathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Vitamin D deficiency,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Hypothyroidism,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Obesity,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Retinopathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Ischaemic cardiomyopathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Hyperparathyroidism secondary,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Obstructive sleep apnoea syndrome,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Hyperlipidaemia,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Hypertension,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213866491,21386649,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q3,Nephropathy,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,DE-AstraZeneca-2022A328304,ASTRAZENECA,,60.0,YR,,M,Y,156.1,KG,20220928,,MD,DE,,2022,Q3,Adult
213872741,21387274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet of Forxiga in the morning,,,U,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Hunger,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A317354,ASTRAZENECA,,65.0,YR,,M,Y,,,20220928,,CN,CN,,2022,Q3,Elderly
213872741,21387274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet of Forxiga in the morning,,,U,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Heart rate decreased,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A317354,ASTRAZENECA,,65.0,YR,,M,Y,,,20220928,,CN,CN,,2022,Q3,Elderly
213872741,21387274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet of Forxiga in the morning,,,U,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A317354,ASTRAZENECA,,65.0,YR,,M,Y,,,20220928,,CN,CN,,2022,Q3,Elderly
213872741,21387274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet of Forxiga in the morning,,,U,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A317354,ASTRAZENECA,,65.0,YR,,M,Y,,,20220928,,CN,CN,,2022,Q3,Elderly
213872741,21387274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,one tablet of Forxiga in the morning,,,U,,Unknown,,202293.0,,,Tablet,QD,2022,Q3,Heart rate irregular,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,CN-AstraZeneca-2022A317354,ASTRAZENECA,,65.0,YR,,M,Y,,,20220928,,CN,CN,,2022,Q3,Elderly
213876681,21387668,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,,,Tablet,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220920.0,20220928,20220928,EXP,,MX-AstraZeneca-2022A329193,ASTRAZENECA,,68.0,YR,,F,Y,,,20220928,,CN,MX,,2022,Q3,Elderly
213879501,21387950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A329984,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213879501,21387950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A329984,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213879501,21387950,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A329984,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885122,21388512,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1 dosage form), qd",50.0,MG,Y,,,,,10.0,MG,"Tablet, film coated",,2022,Q3,Eczema,,2022,Q3,2,F,20220807.0,20220929.0,20220928,20220930,EXP,,FR-AMERICAN REGENT INC-2022002820,AMERICAN REGENT,,84.0,YR,,F,Y,62.4,KG,20220930,,MD,FR,FR,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Euglycaemic diabetic ketoacidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pneumonia,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Electrocardiogram change,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Blood ketone body increased,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Hallucination,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Confusional state,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885211,21388521,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Fall,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328476,ASTRAZENECA,,74.0,YR,,M,Y,86.0,KG,20220928,,MD,CA,,2022,Q3,Elderly
213885501,21388550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Pulmonary oedema,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213885501,21388550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,,20220923.0,20220928,20220928,EXP,,CA-AstraZeneca-2022A328479,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20220928,,MD,CA,,2022,Q3,Adult
213891011,21389101,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",1360.0,MG,U,,,,,10.0,MG,Film-coated tablet,QD,2022,Q3,Abortion spontaneous,,2022,Q3,1,I,20220728.0,20220923.0,20220929,20220929,EXP,FR-AFSSAPS-LY20224135,NVSC2022FR215651,NOVARTIS,,42.0,YR,,F,Y,54.0,KG,20220929,,MD,FR,FR,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213897921,21389792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Pyelonephritis,,2022,Q3,1,I,20220628.0,20220926.0,20220929,20220929,EXP,,FR-AstraZeneca-2022A329098,ASTRAZENECA,,74.0,YR,,M,Y,42.4,KG,20220929,,MD,FR,,2022,Q3,Elderly
213897921,21389792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q3,Septic shock,,2022,Q3,1,I,20220628.0,20220926.0,20220929,20220929,EXP,,FR-AstraZeneca-2022A329098,ASTRAZENECA,,74.0,YR,,M,Y,42.4,KG,20220929,,MD,FR,,2022,Q3,Elderly
213903851,21390385,14,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,DAPAGLIFLOZIN PROPYLENE GLYCOLATE HYDRATE?Daily; Per Day?Ongoing,,,U,,,,,,,,QD,2022,Q3,Pleurisy,,2022,Q3,1,I,20220909.0,20220921.0,20220929,20220929,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-110037,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,66.0,KG,20220929,,HP,JP,JP,2022,Q3,Elderly
213904831,21390483,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 g, QD",,,U,,,,,10.0,GM,,QD,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,NVSC2022KE217618,NOVARTIS,,67.0,YR,,F,Y,,,20220929,,HP,KE,KE,2022,Q3,Elderly
213904831,21390483,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 g, QD",,,U,,,,,10.0,GM,,QD,2022,Q3,Myoclonus,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,NVSC2022KE217618,NOVARTIS,,67.0,YR,,F,Y,,,20220929,,HP,KE,KE,2022,Q3,Elderly
213904831,21390483,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 g, QD",,,U,,,,,10.0,GM,,QD,2022,Q3,Angioedema,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,NVSC2022KE217618,NOVARTIS,,67.0,YR,,F,Y,,,20220929,,HP,KE,KE,2022,Q3,Elderly
213904831,21390483,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 g, QD",,,U,,,,,10.0,GM,,QD,2022,Q3,Swelling face,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,NVSC2022KE217618,NOVARTIS,,67.0,YR,,F,Y,,,20220929,,HP,KE,KE,2022,Q3,Elderly
213904831,21390483,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 g, QD",,,U,,,,,10.0,GM,,QD,2022,Q3,Seizure,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,NVSC2022KE217618,NOVARTIS,,67.0,YR,,F,Y,,,20220929,,HP,KE,KE,2022,Q3,Elderly
213909041,21390904,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 mg, 1-0-1-0",,,U,,,,,,,UNK,BID,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213909041,21390904,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 mg, 1-0-1-0",,,U,,,,,,,UNK,BID,2022,Q3,Fall,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213909041,21390904,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 mg, 1-0-1-0",,,U,,,,,,,UNK,BID,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213911811,21391181,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular swelling,,2022,Q3,1,I,20210527.0,20220920.0,20220929,20220929,EXP,,DE-EMD Serono-E2B_90089141,EMD SERONO INC,,70.0,YR,E,M,Y,,,20220929,,PH,DE,,2022,Q3,Elderly
213911811,21391181,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Labelled drug-drug interaction medication error,,2022,Q3,1,I,20210527.0,20220920.0,20220929,20220929,EXP,,DE-EMD Serono-E2B_90089141,EMD SERONO INC,,70.0,YR,E,M,Y,,,20220929,,PH,DE,,2022,Q3,Elderly
213911811,21391181,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Product monitoring error,,2022,Q3,1,I,20210527.0,20220920.0,20220929,20220929,EXP,,DE-EMD Serono-E2B_90089141,EMD SERONO INC,,70.0,YR,E,M,Y,,,20220929,,PH,DE,,2022,Q3,Elderly
213911811,21391181,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q3,Testicular pain,,2022,Q3,1,I,20210527.0,20220920.0,20220929,20220929,EXP,,DE-EMD Serono-E2B_90089141,EMD SERONO INC,,70.0,YR,E,M,Y,,,20220929,,PH,DE,,2022,Q3,Elderly
213915161,21391516,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q3,Disease recurrence,,2022,Q3,1,I,20220901.0,20220926.0,20220929,20220929,EXP,,GB-PFIZER INC-202201192279,PFIZER,,63.0,YR,,F,Y,,,20220929,,HP,GB,GB,2022,Q3,Adult
213915161,21391516,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q3,COVID-19,,2022,Q3,1,I,20220901.0,20220926.0,20220929,20220929,EXP,,GB-PFIZER INC-202201192279,PFIZER,,63.0,YR,,F,Y,,,20220929,,HP,GB,GB,2022,Q3,Adult
213916641,21391664,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK, mg",,,,,,,,,,,,2022,Q3,Duodenal ulcer,,2022,Q3,1,I,20220828.0,20220920.0,20220929,20220929,EXP,,CO-DAIICHI SANKYO EUROPE GMBH-DSE-2022-134546,DAIICHI,,66.0,YR,,M,Y,,,20220929,,CN,CO,CO,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Portal hypertension,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Hepatic cirrhosis,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Drug-induced liver injury,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Diabetic metabolic decompensation,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Hypercoagulation,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Sepsis,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213917881,21391788,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD (5/1000 mg, bid)",,,U,,,,,,,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20211201.0,20220926.0,20220929,20220929,EXP,,NVSC2022LV218667,NOVARTIS,,74.0,YR,,M,Y,89.0,KG,20220929,,MD,LV,LV,2022,Q3,Elderly
213920961,21392096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1160.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220320.0,20220922.0,20220929,20220929,EXP,,FR-AstraZeneca-2022A325799,ASTRAZENECA,,69.0,YR,,M,Y,75.0,KG,20220929,,MD,FR,,2022,Q3,Elderly
213920961,21392096,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1160.0,MG,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Shock,,2022,Q3,1,I,20220320.0,20220922.0,20220929,20220929,EXP,,FR-AstraZeneca-2022A325799,ASTRAZENECA,,69.0,YR,,M,Y,75.0,KG,20220929,,MD,FR,,2022,Q3,Elderly
213921971,21392197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,202293.0,,,,,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,,20220922.0,20220929,20220929,EXP,,DE-AstraZeneca-2022A325754,ASTRAZENECA,,63.0,YR,,M,Y,,,20220929,,MD,DE,,2022,Q3,Adult
213921971,21392197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,202293.0,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220922.0,20220929,20220929,EXP,,DE-AstraZeneca-2022A325754,ASTRAZENECA,,63.0,YR,,M,Y,,,20220929,,MD,DE,,2022,Q3,Adult
213921971,21392197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,202293.0,,,,,2022,Q3,Cellulitis,,2022,Q3,1,I,,20220922.0,20220929,20220929,EXP,,DE-AstraZeneca-2022A325754,ASTRAZENECA,,63.0,YR,,M,Y,,,20220929,,MD,DE,,2022,Q3,Adult
213921971,21392197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,202293.0,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220922.0,20220929,20220929,EXP,,DE-AstraZeneca-2022A325754,ASTRAZENECA,,63.0,YR,,M,Y,,,20220929,,MD,DE,,2022,Q3,Adult
213921971,21392197,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,202293.0,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220922.0,20220929,20220929,EXP,,DE-AstraZeneca-2022A325754,ASTRAZENECA,,63.0,YR,,M,Y,,,20220929,,MD,DE,,2022,Q3,Adult
213927301,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Pseudoparalysis,,2022,Q3,1,I,20220101.0,20220919.0,20220929,20220929,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,81.0,YR,,M,Y,,,20220929,,MD,FR,FR,2022,Q3,Elderly
213927301,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220101.0,20220919.0,20220929,20220929,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,81.0,YR,,M,Y,,,20220929,,MD,FR,FR,2022,Q3,Elderly
213927301,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,20220101.0,20220919.0,20220929,20220929,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,81.0,YR,,M,Y,,,20220929,,MD,FR,FR,2022,Q3,Elderly
213934521,21393452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Start between 07.09.2022 and 08.09.2022,,,U,,,,202293.0,,,Tablet,,2022,Q3,Rash,,2022,Q3,1,I,20220908.0,20220928.0,20220929,20220929,EXP,,CH-AstraZeneca-2022A332145,ASTRAZENECA,,43.0,YR,,F,Y,,,20220930,,MD,CH,,2022,Q3,Adult
213934521,21393452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Start between 07.09.2022 and 08.09.2022,,,U,,,,202293.0,,,Tablet,,2022,Q3,Pruritus,,2022,Q3,1,I,20220908.0,20220928.0,20220929,20220929,EXP,,CH-AstraZeneca-2022A332145,ASTRAZENECA,,43.0,YR,,F,Y,,,20220930,,MD,CH,,2022,Q3,Adult
213937191,21393719,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,20211107.0,20220923.0,20220930,20220930,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-2022-111280,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,,,20220930,,HP,IT,IT,2022,Q3,Elderly
213941811,21394181,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 milligram, Two Times a Day (1-0-1-0)",,,U,,,,,,,,BID,2022,Q3,Fall,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941811,21394181,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 milligram, Two Times a Day (1-0-1-0)",,,U,,,,,,,,BID,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941811,21394181,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,"5/1000 milligram, Two Times a Day (1-0-1-0)",,,U,,,,,,,,BID,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941931,21394193,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, Forxiga 10mg",,,,,,,,10.0,MG,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076048,TEVA,,72.0,YR,E,F,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941931,21394193,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, Forxiga 10mg",,,,,,,,10.0,MG,,QD,2022,Q3,Bradyarrhythmia,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076048,TEVA,,72.0,YR,E,F,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941931,21394193,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, Forxiga 10mg",,,,,,,,10.0,MG,,QD,2022,Q3,Oedema peripheral,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076048,TEVA,,72.0,YR,E,F,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941931,21394193,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, Forxiga 10mg",,,,,,,,10.0,MG,,QD,2022,Q3,Waist circumference increased,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076048,TEVA,,72.0,YR,E,F,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941931,21394193,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, Forxiga 10mg",,,,,,,,10.0,MG,,QD,2022,Q3,Back pain,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076048,TEVA,,72.0,YR,E,F,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213961981,21396198,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Phimosis,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,,SG-AstraZeneca-2022A330707,ASTRAZENECA,,40.0,YR,,M,Y,,,20220930,,MD,SG,,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Nausea,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Leukocyturia,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Cough,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Decreased appetite,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Weight decreased,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Infection,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Dizziness,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970831,21397083,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,,,U,,,,,10.0,MG,Tablet,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220924.0,20220930,20220930,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-022572,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Portal hypertension,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Hypercoagulation,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Diabetic metabolic decompensation,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Urinary tract infection,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Hepatic cirrhosis,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Sepsis,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213970941,21397094,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,,,,,,,,,QD,2022,Q3,Drug-induced liver injury,,2022,Q3,1,I,20211201.0,20220926.0,20220930,20220930,EXP,,LV-BAUSCH-BL-2022-022671,BAUSCH AND LOMB,,74.0,YR,,M,Y,89.0,KG,20220930,,MD,LV,LV,2022,Q3,Elderly
213971041,21397104,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,QD,,,Y,,,,,10.0,MG,,,2022,Q3,Shock,,2022,Q3,1,I,20220320.0,20220923.0,20220930,20220930,EXP,FR-AFSSAPS-LY20223182,FR-BAUSCH-BL-2022-022805,BAUSCH AND LOMB,,69.0,YR,,M,Y,75.0,KG,20220930,,PH,FR,FR,2022,Q3,Elderly
213971041,21397104,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,QD,,,Y,,,,,10.0,MG,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220320.0,20220923.0,20220930,20220930,EXP,FR-AFSSAPS-LY20223182,FR-BAUSCH-BL-2022-022805,BAUSCH AND LOMB,,69.0,YR,,M,Y,75.0,KG,20220930,,PH,FR,FR,2022,Q3,Elderly
213975001,21397500,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Pancreatitis acute,,2022,Q3,1,I,20220823.0,20220922.0,20220930,20220930,EXP,,FR-AstraZeneca-2022A325663,ASTRAZENECA,,61.0,YR,,M,Y,,,20220930,,MD,FR,,2022,Q3,Adult
213975251,21397525,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,Y,U,,,,,,Film-coated tablet,QD,2022,Q3,Renal failure,,2022,Q3,1,I,20220804.0,20220929.0,20220930,20220930,EXP,FR-AFSSAPS-PO20221742,NVSC2022FR220385,NOVARTIS,,80.0,YR,,M,Y,,,20220930,,CN,FR,FR,2022,Q3,Elderly
213977251,21397725,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1350.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Abortion spontaneous,,2022,Q3,1,I,20220728.0,20220923.0,20220930,20220930,EXP,,FR-AstraZeneca-2022A327091,ASTRAZENECA,,42.0,YR,,F,Y,54.0,KG,20220930,,MD,FR,,2022,Q3,Adult
213979741,21397974,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,UNK,,,,,,,2022,Q3,Polydipsia,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,,PT-NOVAST LABORATORIES INC.-2022NOV000305,NOVAST,"Pombo F, Seabra C, S? AJ, Ferreira I.. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report.. Cureus.. 2022;14(8)",67.0,YR,,M,Y,,,20220930,,HP,PT,PT,2022,Q3,Elderly
213979741,21397974,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,UNK,,,,,,,2022,Q3,Dysgeusia,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,,PT-NOVAST LABORATORIES INC.-2022NOV000305,NOVAST,"Pombo F, Seabra C, S? AJ, Ferreira I.. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report.. Cureus.. 2022;14(8)",67.0,YR,,M,Y,,,20220930,,HP,PT,PT,2022,Q3,Elderly
213983421,21398342,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NH3223,,,10.0,MG,Tablet,QD,2022,Q3,Chest discomfort,,2022,Q3,1,I,20220825.0,20220924.0,20220930,20220930,EXP,,CN-AstraZeneca-2022A333351,ASTRAZENECA,,15706.0,DY,,M,Y,70.0,KG,20220930,,MD,CN,,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Musculoskeletal pain,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213983571,21398357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,1,I,,20220923.0,20220930,20220930,EXP,DE-BFARM-22007811,DE-Taiho Oncology Inc-2022-001100,TAIHO ONCOLOGY INC,,71.0,YR,E,M,Y,100.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213984951,21398495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q3,Myocardial infarction,,2022,Q3,1,I,,20220926.0,20220930,20220930,EXP,,ZA-AstraZeneca-2022A333563,ASTRAZENECA,,59.0,YR,,M,Y,,,20220930,,CN,ZA,,2022,Q3,Adult
121336525,12133652,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,maternal dose: 10 mg every,,,D,,,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,5,F,,20221222.0,20160301,20221229,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,NOVARTIS,,4.0,MON,,,Y,,,20221229,,MD,GB,GB,2022,Q4,Child
121336525,12133652,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,maternal dose: 10 mg every,,,D,,,,,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,5,F,,20221222.0,20160301,20221229,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,NOVARTIS,,4.0,MON,,,Y,,,20221229,,MD,GB,GB,2022,Q4,Child
121336525,12133652,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,Maternal dose: 10 mg,,,D,,,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,5,F,,20221222.0,20160301,20221229,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,NOVARTIS,,4.0,MON,,,Y,,,20221229,,MD,GB,GB,2022,Q4,Child
121336525,12133652,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,Maternal dose: 10 mg,,,D,,,,,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,5,F,,20221222.0,20160301,20221229,EXP,GB-MHRA-ADR 23357992,PHHY2016GB024615,NOVARTIS,,4.0,MON,,,Y,,,20221229,,MD,GB,GB,2022,Q4,Child
121379633,12137963,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,3,F,,20221215.0,20160302,20221220,EXP,,GB-AstraZeneca-2016SE19198,ASTRAZENECA,,20.0,WK,,,Y,,,20221219,,MD,GB,,2022,Q4,Youth
121379633,12137963,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,3,F,,20221215.0,20160302,20221220,EXP,,GB-AstraZeneca-2016SE19198,ASTRAZENECA,,20.0,WK,,,Y,,,20221219,,MD,GB,,2022,Q4,Youth
122367384,12236738,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10 milligram,,,,U,,,,10.0,MG,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,4,F,,20221213.0,20160405,20221226,EXP,,GB-AUROBINDO-AUR-APL-2016-02203,AUROBINDO,,20.0,WK,,,Y,,,20221226,,MD,GB,GB,2022,Q4,Youth
122367384,12236738,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10 milligram,,,,U,,,,10.0,MG,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,4,F,,20221213.0,20160405,20221226,EXP,,GB-AUROBINDO-AUR-APL-2016-02203,AUROBINDO,,20.0,WK,,,Y,,,20221226,,MD,GB,GB,2022,Q4,Youth
122367384,12236738,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10 milligram,,,,U,unk,,,10.0,MG,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,4,F,,20221213.0,20160405,20221226,EXP,,GB-AUROBINDO-AUR-APL-2016-02203,AUROBINDO,,20.0,WK,,,Y,,,20221226,,MD,GB,GB,2022,Q4,Youth
122367384,12236738,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,10 milligram,,,,U,unk,,,10.0,MG,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,4,F,,20221213.0,20160405,20221226,EXP,,GB-AUROBINDO-AUR-APL-2016-02203,AUROBINDO,,20.0,WK,,,Y,,,20221226,,MD,GB,GB,2022,Q4,Youth
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Sinusitis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Arthritis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Dysuria,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Psoriasis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Eye pain,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Product storage error,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Weight decreased,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Blood pressure fluctuation,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Tumour marker increased,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Hypoacusis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Insomnia,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Aphonia,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Lower respiratory tract congestion,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Clubbing,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Pneumonia,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Upper respiratory tract infection,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Rhinorrhoea,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Pain,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Headache,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Respiratory tract infection,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Pancreatic carcinoma,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,COVID-19,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Influenza,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Productive cough,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Pain in extremity,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Hypertension,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Rheumatoid arthritis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Off label use,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Blood urine present,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Nasopharyngitis,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Malaise,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Immune system disorder,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Nail disorder,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Diabetes mellitus,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
1393032821,13930328,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,Swelling,,2022,Q4,21,F,20161031.0,20221020.0,20170901,20221102,EXP,,PHHY2016CA151784,NOVARTIS,,65.0,YR,,M,Y,,,20221102,,CN,CA,CA,2022,Q4,Elderly
148220379,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Blood urine present,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram(Unknown/Also received from 01-Jan-2015, 10 mg)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Blood urine present,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, unknown",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Blood urine present,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148220379,14822037,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Blood urine present,,2022,Q4,9,F,20180201.0,20220930.0,20180427,20221012,EXP,,GB-AUROBINDO-AUR-APL-2018-017843,AUROBINDO,,72.0,YR,,M,Y,93.2,KG,20221012,,MD,GB,GB,2022,Q4,Elderly
148944153,14894415,134,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Nephrogenic anaemia,,2022,Q4,3,F,20091008.0,20221111.0,20180515,20221118,EXP,,US-AstraZeneca-2018SE63055,ASTRAZENECA,,16882.0,DY,,F,Y,173.3,KG,20221118,,LW,US,,2022,Q4,Elderly
148944153,14894415,134,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,3,F,20091008.0,20221111.0,20180515,20221118,EXP,,US-AstraZeneca-2018SE63055,ASTRAZENECA,,16882.0,DY,,F,Y,173.3,KG,20221118,,LW,US,,2022,Q4,Elderly
148944153,14894415,134,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease-mineral and bone disorder,,2022,Q4,3,F,20091008.0,20221111.0,20180515,20221118,EXP,,US-AstraZeneca-2018SE63055,ASTRAZENECA,,16882.0,DY,,F,Y,173.3,KG,20221118,,LW,US,,2022,Q4,Elderly
148944153,14894415,134,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease,,2022,Q4,3,F,20091008.0,20221111.0,20180515,20221118,EXP,,US-AstraZeneca-2018SE63055,ASTRAZENECA,,16882.0,DY,,F,Y,173.3,KG,20221118,,LW,US,,2022,Q4,Elderly
159355646,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Also received from 01-Jan-2015, also received 01-Jun-2015",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,6,F,20180201.0,20221119.0,20190208,20221202,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20221202,,MD,GB,GB,2022,Q4,Elderly
159355646,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Also received from 01-Jan-2015, also received 01-Jun-2015",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,6,F,20180201.0,20221119.0,20190208,20221202,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20221202,,MD,GB,GB,2022,Q4,Elderly
159355646,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Also received from 01-Jan-2015, also received 01-Jun-2015",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,6,F,20180201.0,20221119.0,20190208,20221202,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20221202,,MD,GB,GB,2022,Q4,Elderly
159355646,15935564,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Also received from 01-Jan-2015, also received 01-Jun-2015",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,6,F,20180201.0,20221119.0,20190208,20221202,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-Accord-105428,ACCORD,,72.0,YR,E,M,Y,93.2,KG,20221202,,MD,GB,GB,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Haematological malignancy,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Frequent bowel movements,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
162304842,16230484,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Gastrointestinal pain,,2022,Q4,2,F,20170601.0,20221003.0,20190423,20221006,EXP,,CA-TAKEDA-2017TUS012807,TAKEDA,,68.0,YR,,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Elderly
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Eye disorder,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Drug effective for unapproved indication,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Malaise,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Visual impairment,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Depression,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Pneumonia,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Ear discomfort,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Off label use,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Eosinophil count increased,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Illness,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Nasopharyngitis,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Weight increased,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Thinking abnormal,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Neutrophil percentage increased,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
1648059332,16480593,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Crying,,2022,Q4,32,F,20150101.0,20221103.0,20190626,20221114,EXP,,US-PFIZER INC-2019260541,PFIZER,,53.0,YR,,F,Y,113.0,KG,20221114,,CN,US,US,2022,Q4,Adult
168727009,16872700,62,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,9,F,20190704.0,20221126.0,20191001,20221129,EXP,,AT-ROCHE-2415586,ROCHE,,67.0,YR,,F,Y,89.0,KG,20221129,,MD,AT,,2022,Q4,Elderly
169043817,16904381,49,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,7,F,20190704.0,20221202.0,20191010,20221212,PER,,AT-AMGEN-AUTNI2019165404,AMGEN,,67.0,YR,E,F,Y,89.0,KG,20221212,,MD,AT,AT,2022,Q4,Elderly
173511383,17351138,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,,,,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,3,F,,20221223.0,20200130,20221227,EXP,GB-EMA-DD-20200117-ZAVIOUR_N-164821,GB-STRIDES ARCOLAB LIMITED-2020SP000855,STRIDES,,20.0,WK,,,Y,,,20221228,,MD,GB,GB,2022,Q4,Youth
173511383,17351138,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,,,,,,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,3,F,,20221223.0,20200130,20221227,EXP,GB-EMA-DD-20200117-ZAVIOUR_N-164821,GB-STRIDES ARCOLAB LIMITED-2020SP000855,STRIDES,,20.0,WK,,,Y,,,20221228,,MD,GB,GB,2022,Q4,Youth
173511383,17351138,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,3,F,,20221223.0,20200130,20221227,EXP,GB-EMA-DD-20200117-ZAVIOUR_N-164821,GB-STRIDES ARCOLAB LIMITED-2020SP000855,STRIDES,,20.0,WK,,,Y,,,20221228,,MD,GB,GB,2022,Q4,Youth
173511383,17351138,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,3,F,,20221223.0,20200130,20221227,EXP,GB-EMA-DD-20200117-ZAVIOUR_N-164821,GB-STRIDES ARCOLAB LIMITED-2020SP000855,STRIDES,,20.0,WK,,,Y,,,20221228,,MD,GB,GB,2022,Q4,Youth
174776066,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Prostatic haemorrhage,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Polyuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
174776066,17477606,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Haematuria,,2022,Q4,6,F,20180201.0,20221124.0,20200228,20221130,EXP,GB-EMA-DD-20180528-KHAREEVHP-094504,GB-MYLANLABS-2020M1021400,MYLAN,,72.0,YR,,M,Y,93.2,KG,20221130,,MD,GB,GB,2022,Q4,Elderly
178618354,17861835,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Blood pressure increased,,2022,Q4,4,F,20190730.0,20221213.0,20200604,20221219,EXP,,CA-TAKEDA-2019TUS046356,TAKEDA,,58.0,YR,,M,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
178618354,17861835,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Coronary artery occlusion,,2022,Q4,4,F,20190730.0,20221213.0,20200604,20221219,EXP,,CA-TAKEDA-2019TUS046356,TAKEDA,,58.0,YR,,M,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
178618354,17861835,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Breast pain,,2022,Q4,4,F,20190730.0,20221213.0,20200604,20221219,EXP,,CA-TAKEDA-2019TUS046356,TAKEDA,,58.0,YR,,M,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
178618354,17861835,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Blood pressure diastolic increased,,2022,Q4,4,F,20190730.0,20221213.0,20200604,20221219,EXP,,CA-TAKEDA-2019TUS046356,TAKEDA,,58.0,YR,,M,Y,,,20221219,,CN,CA,CA,2022,Q4,Adult
184780852,18478085,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,2,F,20201005.0,20221025.0,20201108,20221108,EXP,,GB-AUROBINDO-AUR-APL-2020-054653,AUROBINDO,,73.0,YR,,M,Y,,,20221108,,PH,GB,GB,2022,Q4,Elderly
184936634,18493663,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,U,,,,5.0,MG,,QD,2022,Q4,Cystitis,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,U,,,,5.0,MG,,QD,2022,Q4,Blood cholesterol abnormal,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,U,,,,5.0,MG,,QD,2022,Q4,Lung disorder,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,U,,,,5.0,MG,,QD,2022,Q4,Diabetes mellitus,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
185590123,18559012,46,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,20190704.0,20221202.0,20201130,20221208,EXP,,NVSC2020AT312310,NOVARTIS,,67.0,YR,,F,Y,89.0,KG,20221208,,MD,AT,AT,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Obesity,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Interstitial lung disease,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Hypothyroidism,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Secondary adrenocortical insufficiency,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Rash maculo-papular,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Pneumonitis,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Arthralgia,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Hypophysitis,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Colitis ulcerative,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Lymphocytic hypophysitis,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
185834246,18583424,15,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,Unknown,,,5.0,MG,Tablets,QD,2022,Q4,Thyroiditis,,2022,Q4,6,F,20210216.0,20220930.0,20201206,20221013,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2020-101830,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,72.3,KG,20221013,,MD,JP,JP,2022,Q4,Elderly
186064596,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q4,White blood cell count decreased,,2022,Q4,6,F,20201124.0,20220928.0,20201211,20221007,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20221007,,MD,JP,JP,2022,Q4,Elderly
186064596,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q4,Neutropenia,,2022,Q4,6,F,20201124.0,20220928.0,20201211,20221007,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20221007,,MD,JP,JP,2022,Q4,Elderly
186064596,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q4,Rash,,2022,Q4,6,F,20201124.0,20220928.0,20201211,20221007,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20221007,,MD,JP,JP,2022,Q4,Elderly
186064596,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q4,Treatment noncompliance,,2022,Q4,6,F,20201124.0,20220928.0,20201211,20221007,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20221007,,MD,JP,JP,2022,Q4,Elderly
186064596,18606459,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,dose unknown,,,,,,,,,,Unknown,,2022,Q4,Malaise,,2022,Q4,6,F,20201124.0,20220928.0,20201211,20221007,EXP,,JP-JNJFOC-20201218096,JOHNSON AND JOHNSON,,72.0,YR,E,M,Y,,,20221007,,MD,JP,JP,2022,Q4,Elderly
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Hypokalaemia,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Hypovolaemia,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Leukocytosis,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Hypophosphataemia,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Pancreatitis acute,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
186149977,18614997,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,7,F,20171101.0,20221122.0,20201214,20221129,EXP,,US-SHIRE-US201844848,TAKEDA,,59.0,YR,,F,Y,43.99,KG,20221129,,HP,US,US,2022,Q4,Adult
187380024,18738002,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Sepsis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
187380024,18738002,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cystitis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
187380024,18738002,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pyelonephritis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
187380024,18738002,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Sepsis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
187380024,18738002,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cystitis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
187380024,18738002,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pyelonephritis,,2022,Q4,4,F,20201231.0,20221007.0,20210114,20221014,EXP,,JP-AstraZeneca-2021A002778,ASTRAZENECA,,69.0,YR,,F,Y,90.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Constipation,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Pruritus,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Hunger,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Peripheral swelling,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Cough,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Rash macular,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Skin fissures,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Dehydration,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Viral infection,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Muscle spasms,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Productive cough,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Gait disturbance,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Respiratory symptom,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Pain in extremity,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Dry skin,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Blood potassium abnormal,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Abdominal pain lower,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,U,,,,,5.0,MG,,QD,2022,Q4,Syncope,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Constipation,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Pruritus,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Hunger,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Peripheral swelling,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Cough,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Rash macular,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Skin fissures,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Dehydration,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Viral infection,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Muscle spasms,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Productive cough,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Gait disturbance,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Respiratory symptom,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Pain in extremity,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Dry skin,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Blood potassium abnormal,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain lower,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
188742529,18874252,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Syncope,,2022,Q4,9,F,20210801.0,20221124.0,20210210,20221205,EXP,,CA-TAKEDA-2020TUS030806,TAKEDA,,59.0,YR,,M,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dysgeusia,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Discouragement,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Anxiety,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Malaise,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Toothache,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Malaise,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Contusion,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Gastrointestinal disorder,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Osteonecrosis of jaw,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Influenza,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dysentery,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Swelling,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Muscular weakness,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Speech disorder,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal discomfort,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Depression,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dry skin,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Gastrointestinal pain,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product administration error,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Feeding disorder,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Motion sickness,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Aphthous ulcer,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Mobility decreased,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dysphonia,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Feeling of despair,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Nausea,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Chills,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Tooth disorder,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Tooth abscess,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product use issue,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Somnolence,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Impaired healing,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Appetite disorder,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
1912961216,19129612,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fall,,2022,Q4,16,F,20210301.0,20221108.0,20210413,20221118,EXP,,NVSC2021BR077550,NOVARTIS,,62.0,YR,,F,Y,,,20221118,,CN,BR,BR,2022,Q4,Adult
193169455,19316945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,COVID-19 pneumonia,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193169455,19316945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Diabetic ketoacidosis,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193169455,19316945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193169455,19316945,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,COVID-19 pneumonia,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193169455,19316945,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193169455,19316945,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Hypoglycaemia,,2022,Q4,5,F,20210115.0,20221004.0,20210527,20221011,EXP,,JP-AstraZeneca-2021A448256,ASTRAZENECA,,26993.0,DY,,F,Y,41.0,KG,20221012,,MD,JP,,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Blood pressure increased,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Diarrhoea,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,General physical health deterioration,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Malignant neoplasm progression,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Lymphadenopathy,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Arthralgia,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Injection site warmth,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Heart rate increased,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Osteoarthritis,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Carcinoid tumour,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Stress,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193820097,19382009,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, QD",,,U,,,,,,,,QD,2022,Q4,Blood insulin increased,,2022,Q4,7,F,20160401.0,20221109.0,20210607,20221116,EXP,,PHHY2016CA056013,NOVARTIS,,74.0,YR,,F,Y,,,20221116,,CN,CA,CA,2022,Q4,Elderly
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Gastrooesophageal reflux disease,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Ligament rupture,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Haematoma,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal discomfort,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Contusion,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Colitis,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
193948263,19394826,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,3,F,20210603.0,20221018.0,20210609,20221021,EXP,,CA-TAKEDA-2020TUS022222,TAKEDA,,63.0,YR,,M,Y,,,20221021,,MD,CA,CA,2022,Q4,Adult
194174482,19417448,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q4,Gangrene,,2022,Q4,2,F,,20220923.0,20210615,20221007,EXP,,KR-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-300199,RANBAXY,"Moon JY, Lee MR, Kim JH, Ha GW. Fournier Gangrene in a Patient With Type 2 Diabetes Mellitus Treated With Dapagliflozin: A Case Report. Ann Coloproctol. 2021;37:S48-S50",66.0,YR,,M,Y,,,20221007,,HP,KR,KR,2022,Q4,Elderly
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Appendicitis,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Hepatic steatosis,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Appendix disorder,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Procedural pain,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Appendicitis,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain lower,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
194606164,19460616,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Gastrointestinal wall thickening,,2022,Q4,4,F,20210331.0,20221124.0,20210625,20221128,EXP,,DE-ABBVIE-21K-062-3964077-00,ABBVIE,,55.0,YR,,M,Y,116.0,KG,20221128,,MD,DE,DE,2022,Q4,Adult
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Arthralgia,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Fatigue,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Balance disorder,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Headache,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Somnolence,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Malaise,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Feeling jittery,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Feeling drunk,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Faeces soft,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Pruritus,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Acne,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Petechiae,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Rash,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
196924962,19692496,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,N,,,,,,,UNK,,2022,Q4,Colitis ulcerative,,2022,Q4,2,F,20180101.0,20221108.0,20210812,20221111,EXP,,CA-TAKEDA-2018TUS006172,TAKEDA,,69.0,YR,,F,Y,,,20221111,,CN,CA,CA,2022,Q4,Elderly
197913953,19791395,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,,,,,2022,Q4,Drug-induced liver injury,,2022,Q4,3,F,20210824.0,20221107.0,20210906,20221117,EXP,,JP-NOVOPROD-842421,NOVO NORDISK,,66.0,YR,,M,Y,86.7,KG,20221117,,MD,JP,JP,2022,Q4,Elderly
197913953,19791395,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,,,,,2022,Q4,Hepatitis E,,2022,Q4,3,F,20210824.0,20221107.0,20210906,20221117,EXP,,JP-NOVOPROD-842421,NOVO NORDISK,,66.0,YR,,M,Y,86.7,KG,20221117,,MD,JP,JP,2022,Q4,Elderly
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Therapeutic reaction time decreased,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Weight decreased,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Off label use,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Faeces discoloured,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Nausea,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Decreased appetite,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
198779373,19877937,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Colitis ulcerative,,2022,Q4,3,F,20211108.0,20221222.0,20210923,20221227,EXP,,CA-TAKEDA-2020TUS002069,TAKEDA,,64.0,YR,,F,Y,,,20221227,,MD,CA,CA,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Rash,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Ill-defined disorder,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Neck pain,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiovascular disorder,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Muscular weakness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Memory impairment,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Inflammation,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Excessive cerumen production,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Muscle tightness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Rash,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pericarditis,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Muscle tightness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back disorder,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Inflammation,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Herpes zoster,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Ear infection,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cataract,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Influenza,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Illness,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Neuropathy peripheral,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Eye haemorrhage,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Swollen tongue,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Spinal pain,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Mouth ulceration,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
200591205,20059120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,5,F,20210914.0,20220929.0,20211111,20221007,EXP,,CA-ROCHE-2918760,ROCHE,,58.0,YR,,F,Y,,,20221007,,CN,CA,,2022,Q4,Adult
201006213,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Atrial flutter,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypophagia,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Toxicity to various agents,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Atrial flutter,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypophagia,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Toxicity to various agents,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Atrial flutter,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypophagia,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Toxicity to various agents,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201006213,20100621,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,3,F,,20221024.0,20211123,20221102,EXP,,JP-AstraZeneca-2021A816864,ASTRAZENECA,,70.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
201133153,20113315,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q4,Renal pain,,2022,Q4,3,F,20210707.0,20221114.0,20211125,20221118,EXP,,CA-AstraZeneca-2021A810073,ASTRAZENECA,,69.0,YR,,M,Y,,,20221118,,MD,CA,,2022,Q4,Elderly
2013512910,20135129,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,10,F,20211127.0,20221012.0,20211201,20221014,EXP,,NVSC2021KR272983,NOVARTIS,,61.0,YR,,F,Y,59.3,KG,20221014,,MD,KR,KR,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Creatinine renal clearance decreased,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Toxic skin eruption,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hydrothorax,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Brain oedema,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Rash,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pruritus,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Nephropathy toxic,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperthermia,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Skin lesion,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperglycaemia,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Malaise,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperglycaemia,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pericarditis,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
2023632210,20236322,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Rash papular,,2022,Q4,10,F,20210927.0,20221228.0,20211228,20221229,EXP,,NVSC2021RU223646,NOVARTIS,,57.0,YR,,F,Y,65.0,KG,20221229,,MD,RU,RU,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Underdose,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Anxiety,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Femoral neck fracture,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
203535113,20353511,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,3,F,20190729.0,20221209.0,20220119,20221214,EXP,,US-ABBVIE-22K-163-4238623-00,ABBVIE,,64.0,YR,,M,Y,,,20221214,,HP,US,US,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Bone pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Infection,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Pharyngitis,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Chromaturia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Throat irritation,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Toothache,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Suicidal ideation,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Pain in extremity,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Drug resistance,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Headache,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ageusia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Blood glucose decreased,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Fear,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Blood glucose increased,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Chest pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Renal pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Feeling abnormal,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Anosmia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Weight fluctuation,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Chronic myeloid leukaemia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Depressed mood,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Sensation of foreign body,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Cough,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Influenza,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Spinal pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Constipation,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Decreased immune responsiveness,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Waist circumference decreased,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Gastritis,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Initial insomnia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Malaise,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Laboratory test abnormal,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,COVID-19,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal discomfort,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Illness,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Back pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Malignant neoplasm progression,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Anxiety,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Pelvic pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Pulmonary pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Emotional disorder,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Oropharyngeal pain,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hypoaesthesia,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hydronephrosis,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
204345716,20434571,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Choking,,2022,Q4,6,F,20210501.0,20221115.0,20220206,20221118,EXP,,NVSC2021MX047722,NOVARTIS,,57.0,YR,,F,Y,,,20221118,,CN,MX,MX,2022,Q4,Adult
205251077,20525107,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Tablets,,2022,Q4,Fournier's gangrene,,2022,Q4,7,F,20220211.0,20221020.0,20220228,20221024,EXP,,IT-Eisai Medical Research-EC-2022-109549,EISAI,,67.0,YR,E,M,Y,77.0,KG,20221024,,MD,IT,,2022,Q4,Elderly
205915184,20591518,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Pill,QD,2022,Q4,COVID-19,,2022,Q4,4,F,20220225.0,20221014.0,20220314,20221018,EXP,,CH-ROCHE-3042825,ROCHE,,69.0,YR,,M,Y,102.4,KG,20221018,,MD,CH,,2022,Q4,Elderly
205925166,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,6,F,20211213.0,20221221.0,20220314,20221222,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20221223,,MD,JP,JP,2022,Q4,Adult
205925166,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,6,F,20211213.0,20221221.0,20220314,20221222,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20221223,,MD,JP,JP,2022,Q4,Adult
205925166,20592516,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Breast pain,,2022,Q4,6,F,20211213.0,20221221.0,20220314,20221222,EXP,,NVSJ2021JP021106,NOVARTIS,,52.0,YR,,M,Y,50.4,KG,20221223,,MD,JP,JP,2022,Q4,Adult
205958223,20595822,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,3,F,20210706.0,20221215.0,20220315,20221220,EXP,,US-PFIZER INC-202100963505,PFIZER,,57.0,YR,,F,Y,,,20221220,,HP,US,US,2022,Q4,Adult
205958223,20595822,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,5 mg,,,,,,,,5.0,MG,Tablet,,2022,Q4,Knee arthroplasty,,2022,Q4,3,F,20210706.0,20221215.0,20220315,20221220,EXP,,US-PFIZER INC-202100963505,PFIZER,,57.0,YR,,F,Y,,,20221220,,HP,US,US,2022,Q4,Adult
206144296,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q4,Atrial fibrillation,,2022,Q4,6,F,20180418.0,20221212.0,20220321,20221219,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20221219,,MD,JP,JP,2022,Q4,Adult
206144296,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q4,Hypercholesterolaemia,,2022,Q4,6,F,20180418.0,20221212.0,20220321,20221219,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20221219,,MD,JP,JP,2022,Q4,Adult
206144296,20614429,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,,,,,,5.0,MG,UNK,,2022,Q4,Diabetes mellitus,,2022,Q4,6,F,20180418.0,20221212.0,20220321,20221219,EXP,,JP-ABBVIE-22P-087-4321839-00,ABBVIE,,53.0,YR,,M,Y,96.0,KG,20221219,,MD,JP,JP,2022,Q4,Adult
206282274,20628227,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,QD,2022,Q4,COVID-19,,2022,Q4,4,F,20220101.0,20221018.0,20220323,20221020,EXP,,CA-ROCHE-3055597,ROCHE,,43.0,YR,,F,Y,,,20221020,,CN,CA,,2022,Q4,Adult
206702913,20670291,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, PM (10 mg (early afternoon))",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20211008.0,20221012.0,20220404,20221017,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20221017,,CN,GB,GB,2022,Q4,Adult
206702913,20670291,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, PM (10 mg (early afternoon))",,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,3,F,20211008.0,20221012.0,20220404,20221017,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20221017,,CN,GB,GB,2022,Q4,Adult
206702913,20670291,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,Tablet,,2022,Q4,Pneumonia,,2022,Q4,3,F,20211008.0,20221012.0,20220404,20221017,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20221017,,CN,GB,GB,2022,Q4,Adult
206702913,20670291,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,U,,,,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,3,F,20211008.0,20221012.0,20220404,20221017,EXP,,GB-MYLANLABS-2022M1024355,MYLAN,,39.0,YR,,M,Y,,,20221017,,CN,GB,GB,2022,Q4,Adult
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Confusional state,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Agranulocytosis,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pancytopenia,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Agranulocytosis,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Bicytopenia,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pancytopenia,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pancytopenia,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206902182,20690218,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Agranulocytosis,,2022,Q4,2,F,20220308.0,20221012.0,20220408,20221018,EXP,CH-SM-2022-13968,CH-009507513-2204CHE001353,MERCK,,79.0,YR,,M,Y,,,20221018,,MD,CH,CH,2022,Q4,Elderly
206935293,20693529,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q4,Pneumonia,,2022,Q4,3,F,20211008.0,20221012.0,20220411,20221021,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20221021,,MD,GB,GB,2022,Q4,Adult
206935293,20693529,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,3,F,20211008.0,20221012.0,20220411,20221021,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20221021,,MD,GB,GB,2022,Q4,Adult
206935293,20693529,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q4,Pneumonia,,2022,Q4,3,F,20211008.0,20221012.0,20220411,20221021,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20221021,,MD,GB,GB,2022,Q4,Adult
206935293,20693529,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,3,F,20211008.0,20221012.0,20220411,20221021,EXP,,GB-AUROBINDO-AUR-APL-2022-011916,AUROBINDO,,39.0,YR,,M,Y,,,20221021,,MD,GB,GB,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Influenza,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Thrombocytopenia,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Alopecia,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Febrile neutropenia,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Anaemia,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Neutropenia,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Dyspnoea paroxysmal nocturnal,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207112124,20711212,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK, 1x/day",,,,,,,,,,,QD,2022,Q4,Diarrhoea,,2022,Q4,4,F,20220228.0,20221121.0,20220414,20221123,EXP,,ES-PFIZER INC-202200487813,PFIZER,,64.0,YR,,M,Y,,,20221123,,MD,ES,ES,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Hypotension,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Headache,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Dyspnoea,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,C-reactive protein increased,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,2,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Hypotension,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Headache,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Dyspnoea,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,C-reactive protein increased,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207584145,20758414,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,21915.0,MG,Y,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,20220310.0,20221018.0,20220427,20221021,EXP,,CA-AstraZeneca-2022A160539,ASTRAZENECA,,64.0,YR,,M,Y,89.6,KG,20221021,,HP,CA,,2022,Q4,Adult
207644223,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,20220310.0,20221018.0,20220428,20221027,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20221027,,HP,CA,,2022,Q4,Adult
207644223,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,20220310.0,20221018.0,20220428,20221027,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20221027,,HP,CA,,2022,Q4,Adult
207644223,20764422,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Pill,,,Y,,,,,5.0,MG,,,2022,Q4,Hypotension,,2022,Q4,3,F,20220310.0,20221018.0,20220428,20221027,EXP,,CA-EMD Serono-9315855,EMD SERONO INC,,64.0,YR,A,M,Y,90.0,KG,20221027,,HP,CA,,2022,Q4,Adult
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Chest discomfort,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Inflammation,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Heart rate increased,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Contusion,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Herpes zoster,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Colitis,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Alopecia,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Rectal haemorrhage,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Immunodeficiency,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Fall,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Joint swelling,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Dyskinesia,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Lacrimation increased,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Nervous system disorder,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Temperature intolerance,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Psychiatric symptom,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Hypoaesthesia,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Hypotension,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Pain in extremity,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain upper,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Arterial haemorrhage,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Decreased appetite,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Nasopharyngitis,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207680182,20768018,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Angina pectoris,,2022,Q4,2,F,20200101.0,20221001.0,20220429,20221007,EXP,,NVSC2022EG096800,NOVARTIS,,70.0,YR,,F,Y,,,20221007,,CN,EG,EG,2022,Q4,Elderly
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hypotension,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Dyspnoea,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Headache,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,C-reactive protein increased,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Headache,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,C-reactive protein increased,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Headache,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,C-reactive protein increased,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
207945725,20794572,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,20220310.0,20221018.0,20220506,20221031,EXP,,CA-BAUSCH-BL-2022-011231,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221031,,HP,CA,CA,2022,Q4,Adult
208066024,20806602,22,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,4,F,20220404.0,20220908.0,20220510,20221003,EXP,,FI-ROCHE-3091585,ROCHE,,73.0,YR,,M,Y,82.0,KG,20221003,,HP,FI,,2022,Q4,Elderly
208126004,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q4,Diarrhoea,,2022,Q4,4,F,20220425.0,20221116.0,20220511,20221121,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,72.0,YR,,F,Y,44.1,KG,20221121,,MD,JP,JP,2022,Q4,Elderly
208126004,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q4,Dehydration,,2022,Q4,4,F,20220425.0,20221116.0,20220511,20221121,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,72.0,YR,,F,Y,44.1,KG,20221121,,MD,JP,JP,2022,Q4,Elderly
208126004,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q4,Rhabdomyolysis,,2022,Q4,4,F,20220425.0,20221116.0,20220511,20221121,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,72.0,YR,,F,Y,44.1,KG,20221121,,MD,JP,JP,2022,Q4,Elderly
208126004,20812600,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,UNK,,2022,Q4,Pyrexia,,2022,Q4,4,F,20220425.0,20221116.0,20220511,20221121,EXP,,JP-TAKEDA-2022TJP045758,TAKEDA,,72.0,YR,,F,Y,44.1,KG,20221121,,MD,JP,JP,2022,Q4,Elderly
208382614,20838261,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Death,,2022,Q4,4,F,20220301.0,20221027.0,20220517,20221102,EXP,,JP-AstraZeneca-2022A185098,ASTRAZENECA,,54.0,YR,,M,Y,88.0,KG,20221102,,MD,JP,,2022,Q4,Adult
208382614,20838261,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Death,,2022,Q4,4,F,20220301.0,20221027.0,20220517,20221102,EXP,,JP-AstraZeneca-2022A185098,ASTRAZENECA,,54.0,YR,,M,Y,88.0,KG,20221102,,MD,JP,,2022,Q4,Adult
208382614,20838261,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,5.0,MG,Tablet,BID,2022,Q4,Death,,2022,Q4,4,F,20220301.0,20221027.0,20220517,20221102,EXP,,JP-AstraZeneca-2022A185098,ASTRAZENECA,,54.0,YR,,M,Y,88.0,KG,20221102,,MD,JP,,2022,Q4,Adult
208441215,20844121,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Neoplasm progression,,2022,Q4,5,F,20210924.0,20221117.0,20220518,20221128,EXP,,JP-ROCHE-3097879,ROCHE,OTAKE S. . 2022;11:-.,74.0,YR,,M,Y,83.0,KG,20221129,,MD,JP,JP,2022,Q4,Elderly
208713225,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,5,F,20220515.0,20221026.0,20220525,20221104,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20221104,,MD,SE,,2022,Q4,Elderly
208713225,20871322,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,5,F,20220515.0,20221026.0,20220525,20221104,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20221104,,MD,SE,,2022,Q4,Elderly
208713225,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,5,F,20220515.0,20221026.0,20220525,20221104,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20221104,,MD,SE,,2022,Q4,Elderly
208713225,20871322,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,U,,,,10.0,MG,Tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,5,F,20220515.0,20221026.0,20220525,20221104,EXP,,SE-AstraZeneca-2022A189651,ASTRAZENECA,,28706.0,DY,,F,Y,,,20221104,,MD,SE,,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Cardiac failure congestive,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Drug ineffective,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Cardiac disorder,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Off label use,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Skin cancer,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Fatigue,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Blood pressure diastolic decreased,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Weight increased,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Pain,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Muscular weakness,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Oxygen saturation decreased,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Insomnia,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Dyspnoea,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Immobilisation syndrome,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Back pain,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Weight decreased,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208819269,20881926,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,5.0,MG,Unknown,,2022,Q4,Arthralgia,,2022,Q4,9,F,20220101.0,20221123.0,20220527,20221125,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-020542,BRISTOL MYERS SQUIBB,,84.0,YR,E,F,Y,116.0,KG,20221125,,HP,CA,CA,2022,Q4,Elderly
208889272,20888927,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,UNK,,,,,Tablet,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20210123.0,20221003.0,20220529,20221021,PER,,JP-AMGEN-JPNNI2022090505,AMGEN,,42.0,YR,A,M,Y,100.0,KG,20221020,,MD,JP,JP,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vulvovaginitis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypertonic bladder,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Pyelonephritis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Retroperitonitis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vulval oedema,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vulvovaginitis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypertonic bladder,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Pyelonephritis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Retroperitonitis,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208938404,20893840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vulval oedema,,2022,Q4,4,F,20200801.0,20221108.0,20220531,20221111,EXP,,JP-AstraZeneca-2022A160079,ASTRAZENECA,Nakata M. O-042 Severe GMS in patients with SGLT-2 inhibitor use.. The journal of Japan Society for Menopause and Women^s Health 2022;30(1):111-.,58.0,YR,,F,Y,64.0,KG,20221111,,MD,JP,,2022,Q4,Adult
208947923,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208947923,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Septic shock,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208947923,20894792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Fournier's gangrene,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208947923,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208947923,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Septic shock,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208947923,20894792,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10260.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fournier's gangrene,,2022,Q4,3,F,20220418.0,20221101.0,20220531,20221104,EXP,,JP-AstraZeneca-2022A164528,ASTRAZENECA,"shimaya s, et al.. P7-24 A type 2 diabetes mellitus patient who developed Fournier^s gangrene during oral administration of an SGLT2 inhibitor drug.. The Japanese journal of endocrinology 2022 2022;98(2):622.",64.0,YR,,M,Y,84.0,KG,20221104,,MD,JP,,2022,Q4,Adult
208987385,20898738,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,5,F,20220526.0,20221010.0,20220601,20221012,EXP,,NVSC2022AR123870,NOVARTIS,,18.0,YR,,F,Y,79.9,KG,20221012,,MD,AR,AR,2022,Q4,Youth
209057272,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q4,Fatigue,,2022,Q4,2,F,20220420.0,20220921.0,20220602,20221001,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20221001,,PH,IT,IT,2022,Q4,Elderly
209057272,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q4,Peripheral swelling,,2022,Q4,2,F,20220420.0,20220921.0,20220602,20221001,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20221001,,PH,IT,IT,2022,Q4,Elderly
209057272,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypothyroidism,,2022,Q4,2,F,20220420.0,20220921.0,20220602,20221001,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20221001,,PH,IT,IT,2022,Q4,Elderly
209057272,20905727,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"unit dose : 10 mg , strength : 10 mg , frequency time : 1 day",,,,,Unknown,,,10.0,MG,Film-coated tablet,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,2,F,20220420.0,20220921.0,20220602,20221001,EXP,IT-MINISAL02-867847,IT-TEVA-2022-IT-2041552,TEVA,,66.0,YR,E,M,Y,100.0,KG,20221001,,PH,IT,IT,2022,Q4,Elderly
209081345,20908134,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1Doasge form-1unit nos, ongoing",,,U,,,,,,,,,2022,Q4,Pleural effusion,,2022,Q4,5,F,20211110.0,20221024.0,20220602,20221101,EXP,,AR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-121501,BRISTOL MYERS SQUIBB,,53.0,YR,A,M,Y,86.0,KG,20221101,,HP,AR,AR,2022,Q4,Adult
209536093,20953609,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Enterocolitis,,2022,Q4,3,F,20220509.0,20221228.0,20220613,20221230,EXP,,JP-ROCHE-3113709,ROCHE,"PRIVACY P, Takahata Y, Hayashi M, Sekine R, Otomo K, Fujita M, Gunji N, et al.. A Case of Hepatocellular Carcinoma Complicated by Enterocolitis and Spontaneous Bacterial Peritonitis during Atezolizumab + Bevacizumab Therapy... The 44th Meeting of Eastern Branch of the Japan Society of Hepatology. 2022;63(S3):A818-.",69.0,YR,,F,Y,63.1,KG,20221230,,MD,JP,JP,2022,Q4,Elderly
209536093,20953609,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Spontaneous bacterial peritonitis,,2022,Q4,3,F,20220509.0,20221228.0,20220613,20221230,EXP,,JP-ROCHE-3113709,ROCHE,"PRIVACY P, Takahata Y, Hayashi M, Sekine R, Otomo K, Fujita M, Gunji N, et al.. A Case of Hepatocellular Carcinoma Complicated by Enterocolitis and Spontaneous Bacterial Peritonitis during Atezolizumab + Bevacizumab Therapy... The 44th Meeting of Eastern Branch of the Japan Society of Hepatology. 2022;63(S3):A818-.",69.0,YR,,F,Y,63.1,KG,20221230,,MD,JP,JP,2022,Q4,Elderly
209536093,20953609,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Hepatic function abnormal,,2022,Q4,3,F,20220509.0,20221228.0,20220613,20221230,EXP,,JP-ROCHE-3113709,ROCHE,"PRIVACY P, Takahata Y, Hayashi M, Sekine R, Otomo K, Fujita M, Gunji N, et al.. A Case of Hepatocellular Carcinoma Complicated by Enterocolitis and Spontaneous Bacterial Peritonitis during Atezolizumab + Bevacizumab Therapy... The 44th Meeting of Eastern Branch of the Japan Society of Hepatology. 2022;63(S3):A818-.",69.0,YR,,F,Y,63.1,KG,20221230,,MD,JP,JP,2022,Q4,Elderly
209817073,20981707,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209817073,20981707,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209817073,20981707,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209817073,20981707,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209817073,20981707,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209817073,20981707,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,20220310.0,20221015.0,20220620,20221020,EXP,,CA-BAUSCH-BL-2022-015318,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.6,KG,20221020,,HP,CA,CA,2022,Q4,Adult
209913672,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Taste disorder,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Underdose,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Lung disorder,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,285.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,285.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Taste disorder,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,285.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Underdose,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
209913672,20991367,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,285.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Lung disorder,,2022,Q4,2,F,20220307.0,20221013.0,20220622,20221018,EXP,,JP-AstraZeneca-2022A110316,ASTRAZENECA,,80.0,YR,,M,Y,,,20221018,,PH,JP,,2022,Q4,Elderly
210235132,21023513,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,790.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Amaurosis,,2022,Q4,2,F,20220214.0,20221220.0,20220629,20221228,EXP,,FR-AstraZeneca-2022A234955,ASTRAZENECA,,29152.0,DY,,F,Y,98.0,KG,20221228,,MD,FR,,2022,Q4,Elderly
210235132,21023513,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,790.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,2,F,20220214.0,20221220.0,20220629,20221228,EXP,,FR-AstraZeneca-2022A234955,ASTRAZENECA,,29152.0,DY,,F,Y,98.0,KG,20221228,,MD,FR,,2022,Q4,Elderly
210235132,21023513,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,790.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Amaurosis,,2022,Q4,2,F,20220214.0,20221220.0,20220629,20221228,EXP,,FR-AstraZeneca-2022A234955,ASTRAZENECA,,29152.0,DY,,F,Y,98.0,KG,20221228,,MD,FR,,2022,Q4,Elderly
210235132,21023513,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,790.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,2,F,20220214.0,20221220.0,20220629,20221228,EXP,,FR-AstraZeneca-2022A234955,ASTRAZENECA,,29152.0,DY,,F,Y,98.0,KG,20221228,,MD,FR,,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Arrhythmia,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Blood urea increased,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fall,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Head injury,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Blood creatinine increased,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210253783,21025378,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Infarction,,2022,Q4,3,F,20210201.0,20220623.0,20220630,20221121,EXP,,NVSC2022AR147087,NOVARTIS,,65.0,YR,,M,Y,,,20221121,,CN,AR,AR,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Lymphopenia,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Muscle fatigue,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Asthenia,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Fatigue,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Muscular weakness,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Peripheral swelling,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypothyroidism,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210391993,21039199,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 MG,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Anaemia,,2022,Q4,3,F,20220329.0,20221108.0,20220704,20221121,EXP,IT-MINISAL02-867280,IT-Accord-268252,ACCORD,,66.0,YR,E,M,Y,100.0,KG,20221121,,PH,IT,IT,2022,Q4,Elderly
210540912,21054091,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,D,,,,,10.0,MG,,QD,2022,Q4,Ischaemic stroke,,2022,Q4,2,F,20210518.0,20221003.0,20220707,20221010,EXP,FR-AFSSAPS-TS20221513,FR-MYLANLABS-2022M1050737,MYLAN,,57.0,YR,,M,Y,,,20221010,,MD,FR,FR,2022,Q4,Adult
210671072,21067107,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,2,F,20191126.0,20221130.0,20220712,20221210,PER,,GB-AMGEN-GBRSP2022115109,AMGEN,,60.0,YR,A,M,Y,82.0,KG,20221210,,HP,GB,GB,2022,Q4,Adult
210735412,21073541,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (after breakfast)",,,U,,,,,,,,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20220928.0,20221004.0,20220713,20221006,EXP,,NVSC2021TH053790,NOVARTIS,,82.0,YR,,F,Y,,,20221006,,CN,TH,TH,2022,Q4,Elderly
210735412,21073541,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (after breakfast)",,,U,,,,,,,,QD,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,20220928.0,20221004.0,20220713,20221006,EXP,,NVSC2021TH053790,NOVARTIS,,82.0,YR,,F,Y,,,20221006,,CN,TH,TH,2022,Q4,Elderly
210735412,21073541,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, QD (after breakfast)",,,U,,,,,,,,QD,2022,Q4,Coronary artery stenosis,,2022,Q4,2,F,20220928.0,20221004.0,20220713,20221006,EXP,,NVSC2021TH053790,NOVARTIS,,82.0,YR,,F,Y,,,20221006,,CN,TH,TH,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Eyelid injury,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Oesophagitis,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Oropharyngeal pain,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Abnormal faeces,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Oesophageal pain,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Urticaria,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal discomfort,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Anal haemorrhage,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Tracheal pain,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pharyngeal hypoaesthesia,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Flatulence,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Yellow skin,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Paralysis,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Odynophagia,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Dry skin,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Gastrointestinal disorder,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Blister,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Skin lesion,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Throat tightness,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Platelet count decreased,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Eructation,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210831344,21083134,4,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,UNK,,,,,,,,,,,,2022,Q4,Pharyngeal inflammation,,2022,Q4,4,F,20220101.0,20221116.0,20220714,20221118,EXP,,PE-PFIZER INC-PV202200011385,PFIZER,,68.0,YR,,M,Y,,,20221118,,CN,PE,PE,2022,Q4,Elderly
210897582,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,20220520.0,20221111.0,20220715,20221116,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20221116,,CN,ES,ES,2022,Q4,Elderly
210897582,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,20220520.0,20221111.0,20220715,20221116,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20221116,,CN,ES,ES,2022,Q4,Elderly
210897582,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20220520.0,20221111.0,20220715,20221116,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20221116,,CN,ES,ES,2022,Q4,Elderly
210897582,21089758,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,2,F,20220520.0,20221111.0,20220715,20221116,EXP,,ES-TAKEDA-2022TUS047571,TAKEDA,,88.0,YR,,M,Y,,,20221116,,CN,ES,ES,2022,Q4,Elderly
210936556,21093655,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Platelet count decreased,Platelet count decreased,2022,Q4,6,F,20220703.0,20221027.0,20220718,20221102,EXP,,CN-ROCHE-3139932,ROCHE,,79.0,YR,,F,Y,59.8,KG,20221102,,MD,CN,,2022,Q4,Elderly
210990394,21099039,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease,,2022,Q4,4,F,20210105.0,20221223.0,20220719,20221229,EXP,,CN-ROCHE-2762299,ROCHE,,57.0,YR,,M,Y,80.0,KG,20221229,,MD,CN,,2022,Q4,Adult
210990394,21099039,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Proteinuria,,2022,Q4,4,F,20210105.0,20221223.0,20220719,20221229,EXP,,CN-ROCHE-2762299,ROCHE,,57.0,YR,,M,Y,80.0,KG,20221229,,MD,CN,,2022,Q4,Adult
210990394,21099039,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,4,F,20210105.0,20221223.0,20220719,20221229,EXP,,CN-ROCHE-2762299,ROCHE,,57.0,YR,,M,Y,80.0,KG,20221229,,MD,CN,,2022,Q4,Adult
211090543,21109054,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Pyrexia,,2022,Q4,3,F,20220610.0,20221007.0,20220721,20221013,EXP,,NVSJ2022JP094402,NOVARTIS,,68.0,YR,,M,Y,,,20221013,,MD,JP,JP,2022,Q4,Elderly
211090543,21109054,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Drug-induced liver injury,,2022,Q4,3,F,20220610.0,20221007.0,20220721,20221013,EXP,,NVSJ2022JP094402,NOVARTIS,,68.0,YR,,M,Y,,,20221013,,MD,JP,JP,2022,Q4,Elderly
211090543,21109054,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hepatic function abnormal,,2022,Q4,3,F,20220610.0,20221007.0,20220721,20221013,EXP,,NVSJ2022JP094402,NOVARTIS,,68.0,YR,,M,Y,,,20221013,,MD,JP,JP,2022,Q4,Elderly
211282422,21128242,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q4,Prostate cancer,,2022,Q4,2,F,20220501.0,20221006.0,20220725,20221012,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-2022-076545,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20221012,,CN,GB,GB,2022,Q4,Elderly
211334912,21133491,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221124.0,20220726,20221130,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20221130,,CN,CA,CA,2022,Q4,Elderly
211334912,21133491,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Suspected COVID-19,,2022,Q4,2,F,,20221124.0,20220726,20221130,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20221130,,CN,CA,CA,2022,Q4,Elderly
211334912,21133491,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Off label use,,2022,Q4,2,F,,20221124.0,20220726,20221130,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20221130,,CN,CA,CA,2022,Q4,Elderly
211334912,21133491,11,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Pulmonary embolism,,2022,Q4,2,F,,20221124.0,20220726,20221130,EXP,,CA-ASTELLAS-2021US043763,ASTELLAS,,70.0,YR,,M,Y,,,20221130,,CN,CA,CA,2022,Q4,Elderly
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Staphylococcal infection,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Blood albumin decreased,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Physical deconditioning,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Feeding disorder,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Ileal perforation,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Abdominal wall abscess,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Ileus,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Impaired healing,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Haemoglobin decreased,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Blood potassium decreased,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Behcet's syndrome,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Postoperative wound infection,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Enterocolitis,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Neurogenic bladder,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Large intestine perforation,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211556663,21155666,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20220801,20221122,EXP,,NVSJ2022JP004968,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221122,,MD,JP,JP,2022,Q4,Adult
211567952,21156795,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (early afternoon) (blinded (dapagliflozin)),,,Y,,,,,10.0,MG,Tablet,,2022,Q4,Pneumonia,,2022,Q4,2,F,20211008.0,20221013.0,20220801,20221019,EXP,,NVSC2022GB172723,NOVARTIS,,39.0,YR,,M,Y,,,20221019,,MD,GB,GB,2022,Q4,Adult
211567952,21156795,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (early afternoon) (blinded (dapagliflozin)),,,Y,,,,,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,2,F,20211008.0,20221013.0,20220801,20221019,EXP,,NVSC2022GB172723,NOVARTIS,,39.0,YR,,M,Y,,,20221019,,MD,GB,GB,2022,Q4,Adult
211588232,21158823,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q4,Thrombocytopenia,,2022,Q4,2,F,20220724.0,20221023.0,20220802,20221025,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-082974,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Elderly
211588232,21158823,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q4,Small intestinal haemorrhage,,2022,Q4,2,F,20220724.0,20221023.0,20220802,20221025,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-082974,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Feeding disorder,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Underdose,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Emphysematous cystitis,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Feeding disorder,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Underdose,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Emphysematous cystitis,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Feeding disorder,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Underdose,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Emphysematous cystitis,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211862944,21186294,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,305.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,4,F,20220404.0,20221213.0,20220808,20221220,EXP,,JP-AstraZeneca-2022A184508,ASTRAZENECA,"Hibi K,. A case of an elderly type 2 diabetes mellitus patient who developed acute kidney injury after dapagliflozin was started.. The 96th Chubu Regional Meeting of the Japan Diabetes Society 2022;97-..",29643.0,DY,,F,Y,35.0,KG,20221216,,MD,JP,,2022,Q4,Elderly
211877682,21187768,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Gastroenteritis radiation,,2022,Q4,2,F,20210716.0,20221003.0,20220809,20221006,EXP,,JP-TAKEDA-2022TJP069048,TAKEDA,,80.0,YR,,F,Y,,,20221006,,MD,JP,JP,2022,Q4,Elderly
211877682,21187768,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Cardiac failure acute,,2022,Q4,2,F,20210716.0,20221003.0,20220809,20221006,EXP,,JP-TAKEDA-2022TJP069048,TAKEDA,,80.0,YR,,F,Y,,,20221006,,MD,JP,JP,2022,Q4,Elderly
211877682,21187768,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Abdominal pain,,2022,Q4,2,F,20210716.0,20221003.0,20220809,20221006,EXP,,JP-TAKEDA-2022TJP069048,TAKEDA,,80.0,YR,,F,Y,,,20221006,,MD,JP,JP,2022,Q4,Elderly
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Excessive cerumen production,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Back disorder,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Swollen tongue,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Ear infection,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Ill-defined disorder,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Muscular weakness,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Herpes zoster,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Illness,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Pericarditis,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Influenza,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Rash,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Neuropathy peripheral,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Muscle tightness,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Cardiovascular disorder,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
211986462,21198646,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Inflammation,,2022,Q4,2,F,,20221031.0,20220811,20221102,EXP,,CA-ROCHE-3151484,ROCHE,,58.0,YR,,F,Y,,,20221101,,HP,CA,,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Platelet count decreased,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Colitis,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Oesophageal varices haemorrhage,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212231857,21223185,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Hypophosphataemia,,2022,Q4,7,F,20220718.0,20221214.0,20220817,20221220,EXP,,GB-PFIZER INC-202201057310,PFIZER,,62.0,YR,,M,Y,89.2,KG,20221220,,MD,GB,GB,2022,Q4,Adult
212302222,21230222,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Rectal haemorrhage,,2022,Q4,2,F,20220622.0,20221028.0,20220818,20221109,EXP,,MX-BAYER-2022A088484,BAYER,,58.0,YR,A,M,Y,,,20221109,,CN,MX,MX,2022,Q4,Adult
212302222,21230222,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,2,F,20220622.0,20221028.0,20220818,20221109,EXP,,MX-BAYER-2022A088484,BAYER,,58.0,YR,A,M,Y,,,20221109,,CN,MX,MX,2022,Q4,Adult
212302222,21230222,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Anal fistula,,2022,Q4,2,F,20220622.0,20221028.0,20220818,20221109,EXP,,MX-BAYER-2022A088484,BAYER,,58.0,YR,A,M,Y,,,20221109,,CN,MX,MX,2022,Q4,Adult
212325735,21232573,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,Neutropenic sepsis,,2022,Q4,5,F,20220725.0,20221109.0,20220819,20221114,EXP,,DE-ROCHE-3162747,ROCHE,,85.0,YR,,M,Y,66.0,KG,20221114,,MD,DE,,2022,Q4,Elderly
212325735,21232573,34,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,,QD,2022,Q4,COVID-19 pneumonia,,2022,Q4,5,F,20220725.0,20221109.0,20220819,20221114,EXP,,DE-ROCHE-3162747,ROCHE,,85.0,YR,,M,Y,66.0,KG,20221114,,MD,DE,,2022,Q4,Elderly
212346315,21234631,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,6,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212346315,21234631,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,5,F,,20221206.0,20220820,20221220,EXP,,CA-AUROBINDO-AUR-APL-2022-032508,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221220,,HP,CA,CA,2022,Q4,Adult
212349912,21234991,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,NC2522,,,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,2,F,20220807.0,20220812.0,20220821,20221006,EXP,,CN-SA-2022SA341615,SANOFI AVENTIS,,79.0,YR,E,F,Y,54.3,KG,20221006,,HP,CN,CN,2022,Q4,Elderly
212386452,21238645,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,2,F,20220803.0,20221011.0,20220822,20221017,EXP,,FR-ROCHE-3159677,ROCHE,,78.0,YR,,M,Y,,,20221017,,MD,FR,,2022,Q4,Elderly
212386452,21238645,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Encephalopathy,,2022,Q4,2,F,20220803.0,20221011.0,20220822,20221017,EXP,,FR-ROCHE-3159677,ROCHE,,78.0,YR,,M,Y,,,20221017,,MD,FR,,2022,Q4,Elderly
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Platelet count decreased,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Oesophageal varices haemorrhage,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypophosphataemia,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Colitis,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212430045,21243004,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",6700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,5,F,20220718.0,20221004.0,20220823,20221012,PER,,GB-AMGEN-GBRNI2022140412,AMGEN,,62.0,YR,A,M,Y,89.2,KG,20221012,,MD,GB,GB,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Dysgeusia,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Feeling cold,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Bone disorder,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Alopecia,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Urinary tract inflammation,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Musculoskeletal discomfort,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Acne,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Dry mouth,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Movement disorder,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Dry skin,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Hypersensitivity,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Nausea,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Skin discolouration,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Infection,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212654513,21265451,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,20220601.0,20220926.0,20220829,20221003,EXP,,NVSC2022BR148333,NOVARTIS,,59.0,YR,,F,Y,65.0,KG,20221003,,CN,BR,BR,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hyperbilirubinaemia,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Renal cyst,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypokalaemia,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Leukocytosis,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Gastroenteritis,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypomagnesaemia,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212753006,21275300,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,6,F,20220709.0,20221125.0,20220831,20221206,EXP,,US-TAKEDA-2022TUS058501,TAKEDA,,64.0,YR,,F,Y,47.0,KG,20221206,,HP,US,US,2022,Q4,Adult
212786345,21278634,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",10.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Hepatic function abnormal,,2022,Q4,5,F,20220822.0,20221017.0,20220901,20221024,EXP,,JP-009507513-2208JPN003666J,MERCK,,86.0,YR,,M,Y,,,20221024,,MD,JP,JP,2022,Q4,Elderly
212786345,21278634,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",10.0,MG,,,,,,5.0,MG,Tablet,QD,2022,Q4,Off label use,,2022,Q4,5,F,20220822.0,20221017.0,20220901,20221024,EXP,,JP-009507513-2208JPN003666J,MERCK,,86.0,YR,,M,Y,,,20221024,,MD,JP,JP,2022,Q4,Elderly
212846073,21284607,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, bid",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846073,21284607,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221026.0,20220902,20221031,EXP,,CA-APOTEX-2022AP012073,APOTEX,,64.0,YR,,M,Y,89.0,KG,20221031,,HP,CA,CA,2022,Q4,Adult
212846932,21284693,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,2,F,20220708.0,20220930.0,20220902,20221010,EXP,,UA-NOVOPROD-951861,NOVO NORDISK,,55.0,YR,,M,Y,151.0,KG,20221010,,CN,UA,UA,2022,Q4,Adult
212846932,21284693,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,2,F,20220708.0,20220930.0,20220902,20221010,EXP,,UA-NOVOPROD-951861,NOVO NORDISK,,55.0,YR,,M,Y,151.0,KG,20221010,,CN,UA,UA,2022,Q4,Adult
212895984,21289598,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Respiratory (inhalation),UNK,,,,,,,,,,,,2022,Q4,Mucous stools,,2022,Q4,4,F,20221003.0,20221115.0,20220902,20221122,EXP,,CA-TAKEDA-2022TUS035058,TAKEDA,,68.0,YR,,M,Y,,,20221122,,CN,CA,CA,2022,Q4,Elderly
212895984,21289598,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Respiratory (inhalation),UNK,,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,4,F,20221003.0,20221115.0,20220902,20221122,EXP,,CA-TAKEDA-2022TUS035058,TAKEDA,,68.0,YR,,M,Y,,,20221122,,CN,CA,CA,2022,Q4,Elderly
212895984,21289598,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Respiratory (inhalation),UNK,,,,,,,,,,,,2022,Q4,Frequent bowel movements,,2022,Q4,4,F,20221003.0,20221115.0,20220902,20221122,EXP,,CA-TAKEDA-2022TUS035058,TAKEDA,,68.0,YR,,M,Y,,,20221122,,CN,CA,CA,2022,Q4,Elderly
212895984,21289598,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Respiratory (inhalation),UNK,,,,,,,,,,,,2022,Q4,Drug level decreased,,2022,Q4,4,F,20221003.0,20221115.0,20220902,20221122,EXP,,CA-TAKEDA-2022TUS035058,TAKEDA,,68.0,YR,,M,Y,,,20221122,,CN,CA,CA,2022,Q4,Elderly
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Pollakiuria,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Dyshidrotic eczema,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Adverse drug reaction,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Dry skin,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212932013,21293201,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,3,F,20210801.0,20221109.0,20220905,20221118,EXP,,BR-EMD Serono-9347932,EMD SERONO INC,,58.0,YR,A,M,Y,,,20221118,,CN,BR,,2022,Q4,Adult
212947202,21294720,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Bone marrow failure,,2022,Q4,2,F,20220831.0,20220930.0,20220905,20221004,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-099640,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20221004,,MD,DE,DE,2022,Q4,Elderly
212947202,21294720,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Pneumonia,,2022,Q4,2,F,20220831.0,20220930.0,20220905,20221004,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-099640,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20221004,,MD,DE,DE,2022,Q4,Elderly
212947202,21294720,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Death,,2022,Q4,2,F,20220831.0,20220930.0,20220905,20221004,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-099640,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20221004,,MD,DE,DE,2022,Q4,Elderly
212947202,21294720,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Sepsis,,2022,Q4,2,F,20220831.0,20220930.0,20220905,20221004,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-099640,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20221004,,MD,DE,DE,2022,Q4,Elderly
212948082,21294808,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2110120,,,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,2,F,20220819.0,20220902.0,20220905,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190377",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,,,20221018,,CN,CN,CN,2022,Q4,Adult
212948082,21294808,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2110120,,,10.0,MG,Tablet,QD,2022,Q4,Hyperhidrosis,,2022,Q4,2,F,20220819.0,20220902.0,20220905,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190377",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,,,20221018,,CN,CN,CN,2022,Q4,Adult
212948082,21294808,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2110120,,,10.0,MG,Tablet,QD,2022,Q4,Product use issue,,2022,Q4,2,F,20220819.0,20220902.0,20220905,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190377",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,,,20221018,,CN,CN,CN,2022,Q4,Adult
212948082,21294808,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,2110120,,,10.0,MG,Tablet,QD,2022,Q4,Confusional state,,2022,Q4,2,F,20220819.0,20220902.0,20220905,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-190377",BOEHRINGER INGELHEIM,,60.0,YR,A,M,Y,,,20221018,,CN,CN,CN,2022,Q4,Adult
213076836,21307683,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Tablet,,2022,Q4,Immune-mediated lung disease,,2022,Q4,6,F,20220906.0,20221125.0,20220908,20221125,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-2022-102519,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20221125,,HP,CN,CN,2022,Q4,Elderly
213099594,21309959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Aortic aneurysm,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypovolaemic shock,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Aortic aneurysm,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypovolaemic shock,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
213099594,21309959,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",4700.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,4,F,20220715.0,20221207.0,20220909,20221215,EXP,,BE-JNJFOC-20220743086,JOHNSON AND JOHNSON,,74.0,YR,E,F,Y,60.0,KG,20221216,,MD,BE,BE,2022,Q4,Elderly
2131417310,21314173,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Blood bilirubin increased,,2022,Q4,10,F,20220831.0,20221124.0,20220909,20221206,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-2022-102326,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,75.8,KG,20221206,,HP,KR,KR,2022,Q4,Elderly
2131417310,21314173,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Immune-mediated hepatitis,,2022,Q4,10,F,20220831.0,20221124.0,20220909,20221206,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-2022-102326,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,75.8,KG,20221206,,HP,KR,KR,2022,Q4,Elderly
2131417310,21314173,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hepatic infection,,2022,Q4,10,F,20220831.0,20221124.0,20220909,20221206,EXP,,KR-BRISTOL-MYERS SQUIBB COMPANY-2022-102326,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,75.8,KG,20221206,,HP,KR,KR,2022,Q4,Elderly
213206822,21320682,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q4,Fournier's gangrene,,2022,Q4,2,F,20220101.0,20221222.0,20220912,20221227,EXP,,JP-ROCHE-3175202,ROCHE,,75.0,YR,,M,Y,,,20221227,,MD,JP,JP,2022,Q4,Elderly
213267612,21326761,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Erythema multiforme,,2022,Q4,2,F,20220418.0,20221012.0,20220913,20221019,EXP,,JP-ROCHE-3175225,ROCHE,,82.0,YR,,M,Y,40.2,KG,20221019,,PH,JP,JP,2022,Q4,Elderly
213267612,21326761,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Diverticulum intestinal haemorrhagic,,2022,Q4,2,F,20220418.0,20221012.0,20220913,20221019,EXP,,JP-ROCHE-3175225,ROCHE,,82.0,YR,,M,Y,40.2,KG,20221019,,PH,JP,JP,2022,Q4,Elderly
213267612,21326761,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Platelet count decreased,,2022,Q4,2,F,20220418.0,20221012.0,20220913,20221019,EXP,,JP-ROCHE-3175225,ROCHE,,82.0,YR,,M,Y,40.2,KG,20221019,,PH,JP,JP,2022,Q4,Elderly
213303612,21330361,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,2,F,20220201.0,20221006.0,20220913,20221014,EXP,,IT-TEVA-2022-IT-2073358,TEVA,,53.0,YR,A,M,Y,,,20221014,,MD,IT,IT,2022,Q4,Adult
213303612,21330361,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,2,F,20220201.0,20221006.0,20220913,20221014,EXP,,IT-TEVA-2022-IT-2073358,TEVA,,53.0,YR,A,M,Y,,,20221014,,MD,IT,IT,2022,Q4,Adult
213433682,21343368,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"unspecified , Duration : 2 months",,,Y,U,UNKNOWN,,,,,,,2022,Q4,Cholestatic liver injury,,2022,Q4,2,F,20220810.0,20221221.0,20220916,20221231,EXP,FR-AFSSAPS-NT20222419,FR-TEVA-2022-FR-2073431,TEVA,,66.0,YR,E,M,Y,56.0,KG,20221231,,MD,FR,FR,2022,Q4,Elderly
213475222,21347522,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q4,Cerebral haemorrhage,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q4,Liver disorder,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213475222,21347522,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20211214.0,20221004.0,20220919,20221017,EXP,,JP-NOVOPROD-957632,NOVO NORDISK,,62.0,YR,,F,Y,,,20221017,,MD,JP,JP,2022,Q4,Adult
213496062,21349606,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"50 milligram, qd",,,U,,UNKNOWN,,,50.0,MG,Tablet,QD,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20220908.0,20221011.0,20220919,20221014,EXP,,JP-ROCHE-3180220,ROCHE,,85.0,YR,,F,Y,40.0,KG,20221014,,MD,JP,JP,2022,Q4,Elderly
213511702,21351170,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,D,,UNKNOWN,,,5.0,MG,Tablet,QD,2022,Q4,Pneumothorax,,2022,Q4,2,F,20220906.0,20221004.0,20220919,20221013,EXP,,JP-ROCHE-3179130,ROCHE,,76.0,YR,,F,Y,71.5,KG,20221012,,MD,JP,JP,2022,Q4,Elderly
213570685,21357068,25,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Unknown,QD,2022,Q4,COVID-19,,2022,Q4,5,F,20220907.0,20221118.0,20220921,20221121,EXP,,DE-JNJFOC-20220924436,JOHNSON AND JOHNSON,,82.0,YR,E,M,Y,65.0,KG,20221121,,MD,DE,DE,2022,Q4,Elderly
213589602,21358960,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,,2022,Q4,Waist circumference increased,,2022,Q4,2,F,,20221004.0,20220921,20221014,EXP,DE-ADRED-07531-01,DE-TORRENT-00023098,TORRENT,,72.0,YR,E,F,Y,100.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213589602,21358960,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221004.0,20220921,20221014,EXP,DE-ADRED-07531-01,DE-TORRENT-00023098,TORRENT,,72.0,YR,E,F,Y,100.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213589602,21358960,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,,2022,Q4,Back pain,,2022,Q4,2,F,,20221004.0,20220921,20221014,EXP,DE-ADRED-07531-01,DE-TORRENT-00023098,TORRENT,,72.0,YR,E,F,Y,100.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213589602,21358960,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,,2022,Q4,Bradyarrhythmia,,2022,Q4,2,F,,20221004.0,20220921,20221014,EXP,DE-ADRED-07531-01,DE-TORRENT-00023098,TORRENT,,72.0,YR,E,F,Y,100.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213589602,21358960,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,UNK,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221004.0,20220921,20221014,EXP,DE-ADRED-07531-01,DE-TORRENT-00023098,TORRENT,,72.0,YR,E,F,Y,100.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213598092,21359809,24,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,2,F,20220404.0,20221006.0,20220921,20221006,EXP,,FI-PFIZER INC-202201170747,PFIZER,,73.0,YR,,M,Y,82.0,KG,20221006,,HP,FI,FI,2022,Q4,Elderly
213614593,21361459,18,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20221005.0,20221010.0,20220921,20221013,EXP,,MX-JNJFOC-20220940147,JOHNSON AND JOHNSON,,72.0,YR,E,F,Y,67.2,KG,20221013,,MD,MX,MX,2022,Q4,Elderly
213622282,21362228,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,U,,,,,5.0,MG,Tablets,QD,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221202.0,20220922,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-038069,AUROBINDO,,58.0,YR,,M,Y,,,20221216,,CN,CA,CA,2022,Q4,Adult
213622282,21362228,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, Once a Day",,,U,,,,,5.0,MG,Tablets,QD,2022,Q4,Small intestine carcinoma,,2022,Q4,2,F,,20221202.0,20220922,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-038069,AUROBINDO,,58.0,YR,,M,Y,,,20221216,,CN,CA,CA,2022,Q4,Adult
213681225,21368122,26,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,,QD,2022,Q4,COVID-19,,2022,Q4,5,F,20220907.0,20221122.0,20220923,20221124,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-110497,BRISTOL MYERS SQUIBB,,82.0,YR,E,M,Y,65.0,KG,20221124,,MD,DE,DE,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Cough,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Lymphoedema,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Cellulitis,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Erysipelas,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Arthralgia,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213728832,21372883,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,,2022,Q4,Thyroid operation,,2022,Q4,2,F,20220901.0,20221207.0,20220924,20221215,EXP,,CO-ABBVIE-4130076,ABBVIE,,72.0,YR,,F,Y,73.0,KG,20221215,,HP,CO,CO,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematochezia,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Constipation,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haemorrhagic diathesis,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Abdominal pain lower,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213733572,21373357,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Product monitoring error,,2022,Q4,2,F,20210101.0,20221004.0,20220925,20221014,EXP,DE-ADRED-07931-01,DE-TORRENT-00023236,TORRENT,,83.0,YR,E,F,Y,80.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
213736192,21373619,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,COVID-19 pneumonia,,2022,Q4,2,F,20220404.0,20221004.0,20220925,20221012,EXP,,FI-BRISTOL-MYERS SQUIBB COMPANY-2022-107952,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,82.0,KG,20221013,,HP,FI,FI,2022,Q4,Elderly
213780123,21378012,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet at lunch,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Renal impairment,,2022,Q4,3,F,20210616.0,20221114.0,20220926,20221118,EXP,PT-INFARMED-T202209-640,PT-Vifor (International) Inc.-VIT-2022-06515,VIFOR,,71.0,YR,,M,Y,100.0,KG,20221118,,PH,PT,PT,2022,Q4,Elderly
213780123,21378012,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet at lunch,,,,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,3,F,20210616.0,20221114.0,20220926,20221118,EXP,PT-INFARMED-T202209-640,PT-Vifor (International) Inc.-VIT-2022-06515,VIFOR,,71.0,YR,,M,Y,100.0,KG,20221118,,PH,PT,PT,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Weight fluctuation,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Lethargy,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Hypothyroidism,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Bradyarrhythmia,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213869713,21386971,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,,,,,,10.0,MG,,QD,2022,Q4,Syncope,,2022,Q4,3,F,20220801.0,20221208.0,20220928,20221213,EXP,,JP-PFIZER INC-PV202200067857,PFIZER,,72.0,YR,,M,Y,66.6,KG,20221213,,PH,JP,JP,2022,Q4,Elderly
213883524,21388352,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Liver injury,,2022,Q4,4,F,,20221115.0,20220928,20221123,EXP,,ES-AstraZeneca-2022A328730,ASTRAZENECA,,76.0,YR,,M,Y,,,20221123,,MD,ES,,2022,Q4,Elderly
213927302,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,2,F,20220601.0,20221220.0,20220929,20221227,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,80.0,YR,,M,Y,90.0,KG,20221227,,MD,FR,FR,2022,Q4,Elderly
213927302,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pseudoparalysis,,2022,Q4,2,F,20220601.0,20221220.0,20220929,20221227,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,80.0,YR,,M,Y,90.0,KG,20221227,,MD,FR,FR,2022,Q4,Elderly
213927302,21392730,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,2,F,20220601.0,20221220.0,20220929,20221227,EXP,,FR-ORGANON-O2209FRA001878,ORGANON,,80.0,YR,,M,Y,90.0,KG,20221227,,MD,FR,FR,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Loss of consciousness,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood glucose increased,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Product outer packaging issue,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Heart rate increased,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Inability to afford medication,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Product packaging issue,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypertension,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213929743,21392974,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,FDY016,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,3,F,20220909.0,20221102.0,20220929,20221110,EXP,,US-AstraZeneca-2022A329335,ASTRAZENECA,,28047.0,DY,,M,Y,70.8,KG,20221110,,CN,US,,2022,Q4,Elderly
213931352,21393135,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg/day (10 mg tablet split),,,,,Unknown,,202293.0,5.0,MG,Tablet,,2022,Q4,Toxic skin eruption,,2022,Q4,2,F,20220902.0,20220921.0,20220929,20221012,EXP,,PT-AstraZeneca-2022A324152,ASTRAZENECA,,74.0,YR,,F,Y,,,20221012,,MD,PT,,2022,Q4,Elderly
213978852,21397885,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hepatic cytolysis,,2022,Q4,2,F,20220921.0,20221102.0,20220930,20221110,EXP,,FR-AstraZeneca-2022A330028,ASTRAZENECA,,23858.0,DY,,M,Y,105.0,KG,20221110,,MD,FR,,2022,Q4,Elderly
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213990761,21399076,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220926.0,20221001,20221001,EXP,,NVSC2022DE217145,NOVARTIS,,62.0,YR,,F,Y,75.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213991111,21399111,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",1350.0,MG,D,,,,,10.0,MG,Film Coated Tablet,QD,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20220921.0,20221001,20221001,EXP,,FR-AUROBINDO-AUR-APL-2022-039477,AUROBINDO,,42.0,YR,,F,Y,54.0,KG,20221001,,MD,FR,FR,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Pain,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Haematochezia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Pyrexia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Weight increased,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,COVID-19 pneumonia,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
213997731,21399773,2,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,1 Dosage forms Daily; 1-0-0-0,,,,,,,,,,,QD,2022,Q4,Tachypnoea,,2022,Q4,1,I,,20220922.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077716,TEVA,,62.0,YR,A,M,Y,,,20221001,,PH,DE,DE,2022,Q4,Adult
214000191,21400019,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,1,I,20210527.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077720,TEVA,,70.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000191,21400019,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Testicular swelling,,2022,Q4,1,I,20210527.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077720,TEVA,,70.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000191,21400019,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Testicular pain,,2022,Q4,1,I,20210527.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077720,TEVA,,70.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000191,21400019,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Product monitoring error,,2022,Q4,1,I,20210527.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077720,TEVA,,70.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000221,21400022,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Product monitoring error,,2022,Q4,1,I,20210101.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077719,TEVA,,83.0,YR,E,F,Y,80.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000221,21400022,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Constipation,,2022,Q4,1,I,20210101.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077719,TEVA,,83.0,YR,E,F,Y,80.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000221,21400022,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Haematochezia,,2022,Q4,1,I,20210101.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077719,TEVA,,83.0,YR,E,F,Y,80.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000221,21400022,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain lower,,2022,Q4,1,I,20210101.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077719,TEVA,,83.0,YR,E,F,Y,80.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000221,21400022,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0, tablets",,,,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,1,I,20210101.0,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077719,TEVA,,83.0,YR,E,F,Y,80.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000781,21400078,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220926.0,20221002,20221002,EXP,,NVSC2022DE217140,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214000781,21400078,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20220926.0,20221002,20221002,EXP,,NVSC2022DE217140,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20221002,,PH,DE,DE,2022,Q4,Elderly
214008391,21400839,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",1150.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220320.0,20220920.0,20221003,20221003,EXP,,FR-AUROBINDO-AUR-APL-2022-039084,AUROBINDO,,69.0,YR,,M,Y,75.0,KG,20221003,,PH,FR,FR,2022,Q4,Elderly
214008391,21400839,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",1150.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Shock,,2022,Q4,1,I,20220320.0,20220920.0,20221003,20221003,EXP,,FR-AUROBINDO-AUR-APL-2022-039084,AUROBINDO,,69.0,YR,,M,Y,75.0,KG,20221003,,PH,FR,FR,2022,Q4,Elderly
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214015921,21401592,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (1-0-0-0, Tabletten)",,,U,,,,,10.0,MG,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221003,20221003,EXP,,DE-AUROBINDO-AUR-APL-2022-039953,AUROBINDO,,62.0,YR,,F,Y,75.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214019421,21401942,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Haematochezia,,2022,Q4,1,I,20210101.0,20220919.0,20221003,20221003,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356291,RANBAXY,,83.0,YR,,F,Y,80.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214019421,21401942,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Constipation,,2022,Q4,1,I,20210101.0,20220919.0,20221003,20221003,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356291,RANBAXY,,83.0,YR,,F,Y,80.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214019421,21401942,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Product monitoring error,,2022,Q4,1,I,20210101.0,20220919.0,20221003,20221003,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356291,RANBAXY,,83.0,YR,,F,Y,80.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214019421,21401942,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Abdominal pain lower,,2022,Q4,1,I,20210101.0,20220919.0,20221003,20221003,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356291,RANBAXY,,83.0,YR,,F,Y,80.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214019421,21401942,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,10.0,MG,Tablet,,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,1,I,20210101.0,20220919.0,20221003,20221003,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356291,RANBAXY,,83.0,YR,,F,Y,80.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214023551,21402355,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,DE-AstraZeneca-2022A329108,ASTRAZENECA,,62.0,YR,,F,Y,75.0,KG,20221003,,MD,DE,,2022,Q4,Adult
214032151,21403215,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg, 1-0-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Fall,,2022,Q4,1,I,20210630.0,20220922.0,20221003,20221003,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2022-11518,LUPIN,,79.0,YR,,M,Y,,,20221003,,PH,DE,DE,2022,Q4,Elderly
214032151,21403215,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg, 1-0-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Subgaleal haematoma,,2022,Q4,1,I,20210630.0,20220922.0,20221003,20221003,EXP,,DE-LUPIN PHARMACEUTICALS INC.-2022-11518,LUPIN,,79.0,YR,,M,Y,,,20221003,,PH,DE,DE,2022,Q4,Elderly
214036961,21403696,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20220101.0,20220928.0,20221003,20221003,EXP,,GB-MYLANLABS-2022M1097711,MYLAN,,81.0,YR,,,Y,,,20221003,,MD,GB,GB,2022,Q4,Elderly
214036961,21403696,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220101.0,20220928.0,20221003,20221003,EXP,,GB-MYLANLABS-2022M1097711,MYLAN,,81.0,YR,,,Y,,,20221003,,MD,GB,GB,2022,Q4,Elderly
214036961,21403696,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Platelet count decreased,,2022,Q4,1,I,20220101.0,20220928.0,20221003,20221003,EXP,,GB-MYLANLABS-2022M1097711,MYLAN,,81.0,YR,,,Y,,,20221003,,MD,GB,GB,2022,Q4,Elderly
214038661,21403866,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,NA3007,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketosis,,2022,Q4,1,I,20220920.0,20220925.0,20221003,20221003,EXP,,CN-AstraZeneca-2022A333995,ASTRAZENECA,,76.0,YR,,F,Y,40.0,KG,20221003,,MD,CN,,2022,Q4,Elderly
214038661,21403866,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,NA3007,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Sinus bradycardia,,2022,Q4,1,I,20220920.0,20220925.0,20221003,20221003,EXP,,CN-AstraZeneca-2022A333995,ASTRAZENECA,,76.0,YR,,F,Y,40.0,KG,20221003,,MD,CN,,2022,Q4,Elderly
214045561,21404556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Joint swelling,,2022,Q4,1,I,,20220906.0,20221003,20221003,EXP,,GB-AstraZeneca-2022A311069,ASTRAZENECA,,78.0,YR,,F,Y,,,20221003,,HP,GB,,2022,Q4,Elderly
214045561,21404556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Peripheral swelling,,2022,Q4,1,I,,20220906.0,20221003,20221003,EXP,,GB-AstraZeneca-2022A311069,ASTRAZENECA,,78.0,YR,,F,Y,,,20221003,,HP,GB,,2022,Q4,Elderly
214047492,21404749,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,2,F,20190101.0,20221005.0,20221003,20221007,EXP,,"AR-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195363",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,,,20221007,,MD,AR,AR,2022,Q4,Elderly
214047492,21404749,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,20190101.0,20221005.0,20221003,20221007,EXP,,"AR-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195363",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,,,20221007,,MD,AR,AR,2022,Q4,Elderly
214047492,21404749,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,2,F,20190101.0,20221005.0,20221003,20221007,EXP,,"AR-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195363",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,,,20221007,,MD,AR,AR,2022,Q4,Elderly
214047492,21404749,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Ketoacidosis,,2022,Q4,2,F,20190101.0,20221005.0,20221003,20221007,EXP,,"AR-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-195363",BOEHRINGER INGELHEIM,,73.0,YR,E,M,Y,,,20221007,,MD,AR,AR,2022,Q4,Elderly
214052891,21405289,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hypokalaemia,,2022,Q4,1,I,20220711.0,20220922.0,20221004,20221004,EXP,,FR-AUROBINDO-AUR-APL-2022-039735,AUROBINDO,,75.0,YR,,F,Y,68.6,KG,20221004,,PH,FR,FR,2022,Q4,Elderly
214052891,21405289,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220711.0,20220922.0,20221004,20221004,EXP,,FR-AUROBINDO-AUR-APL-2022-039735,AUROBINDO,,75.0,YR,,F,Y,68.6,KG,20221004,,PH,FR,FR,2022,Q4,Elderly
214054091,21405409,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Myocardial infarction,,2022,Q4,1,I,,20220926.0,20221004,20221004,EXP,,ZA-AstraZeneca-2022A334262,ASTRAZENECA,,61.0,YR,,M,Y,,,20221004,,CN,ZA,,2022,Q4,Adult
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Chest pain,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Acute myocardial infarction,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Pyrexia,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Coronavirus infection,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Respiratory arrest,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214055733,21405573,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,D,,,,,5.0,MG,Tablet,,2022,Q4,Pneumonia,,2022,Q4,3,F,20220531.0,20221114.0,20221004,20221115,EXP,,NVSJ2022JP098517,NOVARTIS,,80.0,YR,,M,Y,80.0,KG,20221116,,MD,JP,JP,2022,Q4,Elderly
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Non-pitting oedema,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Fear of injection,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Urine output decreased,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Distractibility,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Rash,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Rash papular,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Renal failure,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Anxiety,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Poor quality sleep,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Decreased appetite,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Depressed mood,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Renal impairment,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Tremor,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214059313,21405931,6,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Infusion site pain,,2022,Q4,3,F,20220101.0,20221011.0,20221004,20221020,EXP,,CA-TAKEDA-2022TUS064672,TAKEDA,,40.0,YR,,F,Y,,,20221019,,CN,CA,CA,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Pyrexia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Weight increased,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Pain,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Haematochezia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214071121,21407112,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Colon cancer,,2022,Q4,1,I,,20220926.0,20221004,20221004,EXP,,ZA-AstraZeneca-2022A334372,ASTRAZENECA,,70.0,YR,,M,Y,,,20221004,,CN,ZA,,2022,Q4,Elderly
214071121,21407112,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pleural effusion,,2022,Q4,1,I,,20220926.0,20221004,20221004,EXP,,ZA-AstraZeneca-2022A334372,ASTRAZENECA,,70.0,YR,,M,Y,,,20221004,,CN,ZA,,2022,Q4,Elderly
214080111,21408011,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,,20220929.0,20221004,20221004,EXP,,ZA-AstraZeneca-2022A335267,ASTRAZENECA,,64.0,YR,,F,Y,,,20221004,,CN,ZA,,2022,Q4,Adult
214081381,21408138,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",1350.0,MG,U,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20220927.0,20221004,20221004,EXP,FR-AFSSAPS-LY20224135,FR-ORGANON-O2209FRA002219,ORGANON,,42.0,YR,,F,Y,54.0,KG,20221004,,MD,FR,FR,2022,Q4,Adult
214081701,21408170,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20220926.0,20221004,20221004,EXP,FR-AFSSAPS-LY20224135,FR-US-Provell Pharmaceuticals LLC-E2B_90089234,PROVELL PHARMACEUTICALS,,42.0,YR,A,F,Y,54.0,KG,20221004,,MD,FR,,2022,Q4,Adult
214082521,21408252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,1,I,20220919.0,20220929.0,20221004,20221004,EXP,,NVSC2022FR223253,NOVARTIS,,59.0,YR,,M,Y,,,20221004,,MD,FR,FR,2022,Q4,Adult
214082521,21408252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220919.0,20220929.0,20221004,20221004,EXP,,NVSC2022FR223253,NOVARTIS,,59.0,YR,,M,Y,,,20221004,,MD,FR,FR,2022,Q4,Adult
214082521,21408252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Blood test abnormal,,2022,Q4,1,I,20220919.0,20220929.0,20221004,20221004,EXP,,NVSC2022FR223253,NOVARTIS,,59.0,YR,,M,Y,,,20221004,,MD,FR,FR,2022,Q4,Adult
214082521,21408252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pancreatic carcinoma,,2022,Q4,1,I,20220919.0,20220929.0,20221004,20221004,EXP,,NVSC2022FR223253,NOVARTIS,,59.0,YR,,M,Y,,,20221004,,MD,FR,FR,2022,Q4,Adult
214085041,21408504,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood glucose decreased,,2022,Q4,1,I,20220923.0,20220926.0,20221004,20221004,EXP,,BG-AstraZeneca-2022A331294,ASTRAZENECA,,55.0,YR,,F,Y,,,20221004,,MD,BG,,2022,Q4,Adult
214085041,21408504,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Loss of consciousness,,2022,Q4,1,I,20220923.0,20220926.0,20221004,20221004,EXP,,BG-AstraZeneca-2022A331294,ASTRAZENECA,,55.0,YR,,F,Y,,,20221004,,MD,BG,,2022,Q4,Adult
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Portal hypertension,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Hepatic cirrhosis,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Hypercoagulation,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,COVID-19 pneumonia,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Diabetic metabolic decompensation,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Drug-induced liver injury,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214092761,21409276,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,"5/1000 mg, bid",,,U,,unknown,,,,,Unknown,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20211201.0,20220926.0,20221004,20221004,EXP,,LV-FreseniusKabi-FK202213245,FRESENIUS KABI,,74.0,YR,E,M,Y,89.0,KG,20221004,,CN,LV,LV,2022,Q4,Elderly
214106201,21410620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Fatigue,,2022,Q4,1,I,20211201.0,20220930.0,20221005,20221005,EXP,,CH-AstraZeneca-2022A334873,ASTRAZENECA,,73.0,YR,,M,Y,,,20221005,,MD,CH,,2022,Q4,Elderly
214106201,21410620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20211201.0,20220930.0,20221005,20221005,EXP,,CH-AstraZeneca-2022A334873,ASTRAZENECA,,73.0,YR,,M,Y,,,20221005,,MD,CH,,2022,Q4,Elderly
214106201,21410620,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Depressed mood,,2022,Q4,1,I,20211201.0,20220930.0,20221005,20221005,EXP,,CH-AstraZeneca-2022A334873,ASTRAZENECA,,73.0,YR,,M,Y,,,20221005,,MD,CH,,2022,Q4,Elderly
214109141,21410914,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20220928.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022960,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214109141,21410914,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20220928.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022960,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214109141,21410914,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220928.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022960,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214111781,21411178,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-AstraZeneca-2022A330198,ASTRAZENECA,,81.0,YR,,M,Y,100.0,KG,20221005,,MD,DE,,2022,Q4,Elderly
214111781,21411178,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,202293.0,,,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-AstraZeneca-2022A330198,ASTRAZENECA,,81.0,YR,,M,Y,100.0,KG,20221005,,MD,DE,,2022,Q4,Elderly
214112511,21411251,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220829.0,20220930.0,20221005,20221005,EXP,,RU-AstraZeneca-2022A335286,ASTRAZENECA,,42.0,YR,,M,Y,,,20221005,,MD,RU,,2022,Q4,Adult
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Somnolence,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pollakiuria,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Malaise,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Feeling abnormal,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal disorder,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Apathy,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118533,21411853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Skin cancer,,2022,Q4,3,F,20220913.0,20221005.0,20221005,20221013,EXP,,PL-AstraZeneca-2022A335120,ASTRAZENECA,,75.0,YR,,M,Y,,,20221013,,MD,PL,,2022,Q4,Elderly
214118991,21411899,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220928.0,20221005,20221005,EXP,,ZA-AstraZeneca-2022A334452,ASTRAZENECA,,52.0,YR,,M,Y,,,20221005,,CN,ZA,,2022,Q4,Adult
214118991,21411899,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Chest pain,,2022,Q4,1,I,,20220928.0,20221005,20221005,EXP,,ZA-AstraZeneca-2022A334452,ASTRAZENECA,,52.0,YR,,M,Y,,,20221005,,CN,ZA,,2022,Q4,Adult
214120081,21412008,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg qd, on June 17",,,Y,,ML3043,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,CN-AstraZeneca-2022A334691,ASTRAZENECA,"Junqing Z, Liping Y, et al.. Rhabdomyolysis caused by Memantine combined with Dapagliflozin: a case report. Chin J Mod Appl Pharm 2022;39(17):2268-2270..",89.0,YR,,M,Y,,,20221005,,HP,CN,,2022,Q4,Elderly
214120081,21412008,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg qd, on June 17",,,Y,,ML3043,,202293.0,,,Tablet,,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,CN-AstraZeneca-2022A334691,ASTRAZENECA,"Junqing Z, Liping Y, et al.. Rhabdomyolysis caused by Memantine combined with Dapagliflozin: a case report. Chin J Mod Appl Pharm 2022;39(17):2268-2270..",89.0,YR,,M,Y,,,20221005,,HP,CN,,2022,Q4,Elderly
214128661,21412866,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128661,21412866,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220923.0,20221005,20221005,EXP,,CA-BAUSCH-BL-2022-022962,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221005,,HP,CA,CA,2022,Q4,Adult
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Headache,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214128841,21412884,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,TALA,,202293.0,,,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,1,I,20220820.0,20220929.0,20221005,20221005,EXP,,FR-AstraZeneca-2022A332893,ASTRAZENECA,,69.0,YR,,F,Y,76.0,KG,20221005,,MD,FR,,2022,Q4,Elderly
214130821,21413082,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,,2022,Q4,Palpitations,,2022,Q4,1,I,20211117.0,20220926.0,20221005,20221005,EXP,,"JP-BIOCRYST PHARMACEUTICALS, INC.-2021BCR00576",BIOCRYST PHARMACEUTICALS,,60.0,YR,,M,Y,64.0,KG,20221005,,PH,JP,JP,2022,Q4,Adult
214130821,21413082,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,,2022,Q4,Cardiomyopathy,,2022,Q4,1,I,20211117.0,20220926.0,20221005,20221005,EXP,,"JP-BIOCRYST PHARMACEUTICALS, INC.-2021BCR00576",BIOCRYST PHARMACEUTICALS,,60.0,YR,,M,Y,64.0,KG,20221005,,PH,JP,JP,2022,Q4,Adult
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Muscular weakness,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Internal haemorrhage,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Haemothorax,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Hypotension,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214130841,21413084,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, OM",,,,,,,,10.0,MG,,QD,2022,Q4,Cold sweat,,2022,Q4,1,I,,20220927.0,20221005,20221005,EXP,,DE-JNJFOC-20220962944,JOHNSON AND JOHNSON,,70.0,YR,E,M,Y,125.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214132121,21413212,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,Y,,,,202293.0,,,,,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,1,I,20200627.0,20220928.0,20221006,20221006,EXP,,GB-AstraZeneca-2022A332679,ASTRAZENECA,,56.0,YR,,M,Y,,,20221006,,MD,GB,,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Infection,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Cough,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214148041,21414804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220927.0,20221006,20221006,EXP,,DE-EMD Serono-E2B_90089242,EMD SERONO INC,,62.0,YR,A,F,Y,75.0,KG,20221006,,PH,DE,DE,2022,Q4,Adult
214158801,21415880,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,,,Unknown,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,ZA-HORMOSAN PHARMA GMBH-2022-11584,LUPIN,,61.0,YR,,M,Y,,,20221006,,CN,ZA,ZA,2022,Q4,Adult
214165141,21416514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,,20220925.0,20221006,20221006,EXP,,PT-Accord-279940,ACCORD,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022 Aug 11;14(8):e27908.",67.0,YR,E,M,Y,,,20221006,,HP,PT,PT,2022,Q4,Elderly
214165141,21416514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dysgeusia,,2022,Q4,1,I,,20220925.0,20221006,20221006,EXP,,PT-Accord-279940,ACCORD,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022 Aug 11;14(8):e27908.",67.0,YR,E,M,Y,,,20221006,,HP,PT,PT,2022,Q4,Elderly
214165141,21416514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Polydipsia,,2022,Q4,1,I,,20220925.0,20221006,20221006,EXP,,PT-Accord-279940,ACCORD,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022 Aug 11;14(8):e27908.",67.0,YR,E,M,Y,,,20221006,,HP,PT,PT,2022,Q4,Elderly
214165141,21416514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q4,1,I,,20220925.0,20221006,20221006,EXP,,PT-Accord-279940,ACCORD,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022 Aug 11;14(8):e27908.",67.0,YR,E,M,Y,,,20221006,,HP,PT,PT,2022,Q4,Elderly
214165141,21416514,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Respiratory failure,,2022,Q4,1,I,,20220925.0,20221006,20221006,EXP,,PT-Accord-279940,ACCORD,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022 Aug 11;14(8):e27908.",67.0,YR,E,M,Y,,,20221006,,HP,PT,PT,2022,Q4,Elderly
214166061,21416606,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Renal failure,,2022,Q4,1,I,20220804.0,20220929.0,20221006,20221006,EXP,,FR-AstraZeneca-2022A332967,ASTRAZENECA,,80.0,YR,,M,Y,,,20221006,,MD,FR,,2022,Q4,Elderly
214175591,21417559,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the evening,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Gingival recession,,2022,Q4,1,I,20220702.0,20220928.0,20221006,20221006,EXP,,FR-AstraZeneca-2022A331622,ASTRAZENECA,,58.0,YR,,M,Y,97.0,KG,20221006,,MD,FR,,2022,Q4,Adult
214175591,21417559,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the evening,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Vision blurred,,2022,Q4,1,I,20220702.0,20220928.0,20221006,20221006,EXP,,FR-AstraZeneca-2022A331622,ASTRAZENECA,,58.0,YR,,M,Y,97.0,KG,20221006,,MD,FR,,2022,Q4,Adult
214175591,21417559,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the evening,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Vertigo,,2022,Q4,1,I,20220702.0,20220928.0,20221006,20221006,EXP,,FR-AstraZeneca-2022A331622,ASTRAZENECA,,58.0,YR,,M,Y,97.0,KG,20221006,,MD,FR,,2022,Q4,Adult
214181701,21418170,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"2 Dosage forms Daily; 5|1000 mg, 1-0-1-0",,,,,,,,,,,BID,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214181701,21418170,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"2 Dosage forms Daily; 5|1000 mg, 1-0-1-0",,,,,,,,,,,BID,2022,Q4,Fall,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214181701,21418170,20,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"2 Dosage forms Daily; 5|1000 mg, 1-0-1-0",,,,,,,,,,,BID,2022,Q4,Cerebral haemorrhage,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Urticaria,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Oedema peripheral,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Vasculitis,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Nodule,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Contusion,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214181801,21418180,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0175,,202293.0,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220928.0,20221006,20221006,EXP,,AR-AstraZeneca-2022A335933,ASTRAZENECA,,62.0,YR,,M,Y,,,20221006,,CN,AR,,2022,Q4,Adult
214190242,21419024,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20221001.0,20221108.0,20221006,20221111,EXP,,JP-PFIZER INC-202201205412,PFIZER,,74.0,YR,,F,Y,59.0,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
214190242,21419024,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,20221001.0,20221108.0,20221006,20221111,EXP,,JP-PFIZER INC-202201205412,PFIZER,,74.0,YR,,F,Y,59.0,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
214190242,21419024,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,2,F,20221001.0,20221108.0,20221006,20221111,EXP,,JP-PFIZER INC-202201205412,PFIZER,,74.0,YR,,F,Y,59.0,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
214190749,21419074,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Tablets,,2022,Q4,Fournier's gangrene,,2022,Q4,9,F,20220924.0,20221128.0,20221006,20221201,EXP,,MX-Eisai Medical Research-EC-2022-125313,EISAI,,75.0,YR,E,M,Y,60.0,KG,20221201,,MD,MX,,2022,Q4,Elderly
214192071,21419207,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20220602.0,20221003.0,20221006,20221006,EXP,FR-AFSSAPS-TO20223127,FR-PFIZER INC-202201198259,PFIZER,,86.0,YR,,F,Y,,,20221006,,MD,FR,FR,2022,Q4,Elderly
214193051,21419305,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q4,Vasculitic rash,,2022,Q4,1,I,20220922.0,20221004.0,20221006,20221006,EXP,GB-MHRA-TPP565484C10144725YC1663843365122,GB-MYLANLABS-2022M1111524,MYLAN,,75.0,YR,,F,Y,97.0,KG,20221006,,MD,GB,GB,2022,Q4,Elderly
214193051,21419305,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, qd",,,,,,,,,,,QD,2022,Q4,Drug eruption,,2022,Q4,1,I,20220922.0,20221004.0,20221006,20221006,EXP,GB-MHRA-TPP565484C10144725YC1663843365122,GB-MYLANLABS-2022M1111524,MYLAN,,75.0,YR,,F,Y,97.0,KG,20221006,,MD,GB,GB,2022,Q4,Elderly
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Cough,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Nausea,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Infection,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214197492,21419749,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221003.0,20221006,20221011,EXP,DE-ADRED-08438-01,DE-BAUSCH-BL-2022-023076,BAUSCH AND LOMB,,62.0,YR,,F,Y,75.0,KG,20221011,,PH,DE,DE,2022,Q4,Adult
214208161,21420816,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,750.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urosepsis,,2022,Q4,1,I,20220907.0,20220930.0,20221007,20221007,EXP,,GB-AstraZeneca-2022A326677,ASTRAZENECA,,81.0,YR,,M,Y,67.0,KG,20221007,,HP,GB,,2022,Q4,Elderly
214208161,21420816,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,750.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Syncope,,2022,Q4,1,I,20220907.0,20220930.0,20221007,20221007,EXP,,GB-AstraZeneca-2022A326677,ASTRAZENECA,,81.0,YR,,M,Y,67.0,KG,20221007,,HP,GB,,2022,Q4,Elderly
214208161,21420816,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,750.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urosepsis,,2022,Q4,1,I,20220907.0,20220930.0,20221007,20221007,EXP,,GB-AstraZeneca-2022A326677,ASTRAZENECA,,81.0,YR,,M,Y,67.0,KG,20221007,,HP,GB,,2022,Q4,Elderly
214208161,21420816,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,750.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Syncope,,2022,Q4,1,I,20220907.0,20220930.0,20221007,20221007,EXP,,GB-AstraZeneca-2022A326677,ASTRAZENECA,,81.0,YR,,M,Y,67.0,KG,20221007,,HP,GB,,2022,Q4,Elderly
214211911,21421191,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Death,,2022,Q4,1,I,20221003.0,20221003.0,20221007,20221007,EXP,,ZA-AstraZeneca-2022A338066,ASTRAZENECA,,27749.0,DY,,F,Y,,,20221007,,CN,ZA,,2022,Q4,Elderly
214216961,21421696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"Unit dose: 10 mg, Freq time 1 day, Duration 115 days",,,Y,,UNKNOWN,,,10.0,MG,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220320.0,20220927.0,20221007,20221007,EXP,FR-AFSSAPS-LY20223182,FR-TEVA-2022-FR-2079438,TEVA,,69.0,YR,E,M,Y,75.0,KG,20221007,,PH,FR,FR,2022,Q4,Elderly
214216961,21421696,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"Unit dose: 10 mg, Freq time 1 day, Duration 115 days",,,Y,,UNKNOWN,,,10.0,MG,,,2022,Q4,Shock,,2022,Q4,1,I,20220320.0,20220927.0,20221007,20221007,EXP,FR-AFSSAPS-LY20223182,FR-TEVA-2022-FR-2079438,TEVA,,69.0,YR,E,M,Y,75.0,KG,20221007,,PH,FR,FR,2022,Q4,Elderly
214219881,21421988,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5mg,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Necrotising fasciitis,,2022,Q4,1,I,20220919.0,20221004.0,20221007,20221007,EXP,,GB-AstraZeneca-2022A337614,ASTRAZENECA,,55.0,YR,,F,Y,102.0,KG,20221007,,MD,GB,,2022,Q4,Adult
214226242,21422624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Injury,,2022,Q4,2,F,20220701.0,20221104.0,20221007,20221108,EXP,,FR-AstraZeneca-2022A337161,ASTRAZENECA,,849.0,MON,,M,Y,,,20221108,,MD,FR,,2022,Q4,Elderly
214226242,21422624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Erectile dysfunction,,2022,Q4,2,F,20220701.0,20221104.0,20221007,20221108,EXP,,FR-AstraZeneca-2022A337161,ASTRAZENECA,,849.0,MON,,M,Y,,,20221108,,MD,FR,,2022,Q4,Elderly
214226242,21422624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,in the morning,1830.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Phimosis,,2022,Q4,2,F,20220701.0,20221104.0,20221007,20221108,EXP,,FR-AstraZeneca-2022A337161,ASTRAZENECA,,849.0,MON,,M,Y,,,20221108,,MD,FR,,2022,Q4,Elderly
214226252,21422625,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3050.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Tubulointerstitial nephritis,,2022,Q4,2,F,20220715.0,20221007.0,20221007,20221012,EXP,,FR-AstraZeneca-2022A336063,ASTRAZENECA,,22780.0,DY,,M,Y,90.0,KG,20221012,,MD,FR,,2022,Q4,Elderly
214226252,21422625,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3050.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20220715.0,20221007.0,20221007,20221012,EXP,,FR-AstraZeneca-2022A336063,ASTRAZENECA,,22780.0,DY,,M,Y,90.0,KG,20221012,,MD,FR,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Dehydration,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Altered state of consciousness,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Blood pressure increased,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Extremity contracture,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214227831,21422783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg every day In the morning,,,,,,,202293.0,,,Tablet,,2022,Q4,Paralysis,,2022,Q4,1,I,20220101.0,20220929.0,20221007,20221007,EXP,,JP-AstraZeneca-2022A335585,ASTRAZENECA,,71.0,YR,,M,Y,68.0,KG,20221007,,MD,JP,,2022,Q4,Elderly
214232861,21423286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NL3881,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dry mouth,,2022,Q4,1,I,20220923.0,20221001.0,20221007,20221007,EXP,,CN-AstraZeneca-2022A339117,ASTRAZENECA,,64.0,YR,,M,Y,82.0,KG,20221007,,MD,CN,,2022,Q4,Adult
214232861,21423286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NL3881,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nocturia,,2022,Q4,1,I,20220923.0,20221001.0,20221007,20221007,EXP,,CN-AstraZeneca-2022A339117,ASTRAZENECA,,64.0,YR,,M,Y,82.0,KG,20221007,,MD,CN,,2022,Q4,Adult
214232861,21423286,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,NL3881,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Micturition disorder,,2022,Q4,1,I,20220923.0,20221001.0,20221007,20221007,EXP,,CN-AstraZeneca-2022A339117,ASTRAZENECA,,64.0,YR,,M,Y,82.0,KG,20221007,,MD,CN,,2022,Q4,Adult
214238541,21423854,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,Unknown,,,10.0,MG,Tablet,,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20220929.0,20221007,20221007,EXP,,DE-GILEAD-2022-0600648,GILEAD,,81.0,YR,E,M,Y,100.0,KG,20221007,,PH,DE,DE,2022,Q4,Elderly
214238541,21423854,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,Unknown,,,10.0,MG,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220929.0,20221007,20221007,EXP,,DE-GILEAD-2022-0600648,GILEAD,,81.0,YR,E,M,Y,100.0,KG,20221007,,PH,DE,DE,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Dyslipidaemia,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Dementia Alzheimer's type,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Hyperuricaemia,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Benign prostatic hyperplasia,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Arteriosclerosis coronary artery,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Arrhythmia,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Myocardial necrosis marker increased,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Acute myocardial infarction,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Dysarthria,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Parkinson's disease,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Apathy,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Cardiomegaly,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Chronic kidney disease,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Acute myocardial infarction,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,NYHA classification,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Blood creatine phosphokinase increased,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Atrioventricular block first degree,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Extensor plantar response,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214242243,21424224,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,ML3043,,,5.0,MG,Tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,3,F,20210527.0,20221010.0,20221007,20221018,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-194930",BOEHRINGER INGELHEIM,"Zhang J, Sun Z, Yang G, Ren G, Xu Y, Wu L, et al. A case of rhabdomyolysis caused by memantine combined with dapagliflozin. Chinese Journal of Modern Applied Pharmacy. 2022 Sep; 39:172268-2270.",89.0,YR,E,M,Y,,,20221018,,PH,CN,CN,2022,Q4,Elderly
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Shock,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Product use issue,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Shock,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Anuria,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Prescribed underdose,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214250182,21425018,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Anuria,,2022,Q4,2,F,20220115.0,20221118.0,20221008,20221119,EXP,,NVSC2022NG227582,NOVARTIS,,26.0,YR,,F,Y,,,20221119,,MD,NG,NG,2022,Q4,Young Adult
214256061,21425606,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,10.0,MG,U,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,20220905.0,20221003.0,20221008,20221008,EXP,IT-MINISAL02-886558,NVSC2022IT223960,NOVARTIS,,76.0,YR,,M,Y,,,20221008,,MD,IT,IT,2022,Q4,Elderly
214256061,21425606,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,10.0,MG,U,,,,,,,,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,1,I,20220905.0,20221003.0,20221008,20221008,EXP,IT-MINISAL02-886558,NVSC2022IT223960,NOVARTIS,,76.0,YR,,M,Y,,,20221008,,MD,IT,IT,2022,Q4,Elderly
214260651,21426065,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"form strength :  10 mg, Unit dose: 10 mg, Freq time 1 day, Duration 135 days",,,U,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20220928.0,20221008,20221008,EXP,FR-AFSSAPS-LY20224135,FR-TEVA-2022-FR-2080067,TEVA,,42.0,YR,A,F,Y,54.0,KG,20221008,,MD,FR,FR,2022,Q4,Adult
214261211,21426121,2,SS,DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE\SAXAGLIPTIN HYDROCHLORIDE,DAPAGLIFLOZIN\METFORMIN HYDROCHLORIDE\SAXAGLIPTIN HYDROCHLORIDE,1,Oral,,,,D,,Not Available,,,,,,,2022,Q4,Adverse drug reaction,,2022,Q4,1,I,,20220923.0,20221008,20221008,EXP,,US-ABBVIE-4146007,ABBVIE,"Gummin DD, Mowry JB, Beuhler MC, et al. 2020 annual report of the american association of poison control centers^ national poison data system (Npds): 38th annual report. Clinical Toxicology. 2021;59(12):1282-1501.",60.0,YR,,F,Y,,,20221008,,MD,US,US,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Infection,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302151,21430215,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Cough,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080971,TEVA,,62.0,YR,A,F,Y,75.0,KG,20221009,,PH,DE,DE,2022,Q4,Adult
214302171,21430217,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Fall,,2022,Q4,1,I,20210630.0,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2081005,TEVA,,79.0,YR,E,M,Y,,,20221009,,PH,DE,DE,2022,Q4,Elderly
214302171,21430217,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Subgaleal haematoma,,2022,Q4,1,I,20210630.0,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2081005,TEVA,,79.0,YR,E,M,Y,,,20221009,,PH,DE,DE,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypokalaemia,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypotension,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypochloraemia,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypocalcaemia,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214338921,21433892,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,Unknown,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Blood creatine increased,,2022,Q4,1,I,20220912.0,20220930.0,20221010,20221010,EXP,HR-HALMED-300057494,HR-NOVOPROD-964627,NOVO NORDISK,,68.0,YR,,M,Y,125.0,KG,20221010,,MD,HR,HR,2022,Q4,Elderly
214362981,21436298,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220930.0,20221010,20221010,EXP,,JP-OTSUKA-2022_047290,OTSUKA,,87.0,YR,,M,Y,,,20221010,,MD,JP,JP,2022,Q4,Elderly
214362981,21436298,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20220930.0,20221010,20221010,EXP,,JP-OTSUKA-2022_047290,OTSUKA,,87.0,YR,,M,Y,,,20221010,,MD,JP,JP,2022,Q4,Elderly
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Insomnia,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Psychomotor hyperactivity,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Intentional product use issue,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Nervousness,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Therapeutic product effect increased,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Contusion,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214369194,21436919,13,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,4,F,,20221110.0,20221010,20221114,EXP,,GR-MYLANLABS-2022M1111126,MYLAN,,64.0,YR,,F,Y,,,20221114,,CN,GR,GR,2022,Q4,Adult
214375881,21437588,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,Unknown,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220928.0,20221011,20221011,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-11641,LUPIN,,52.0,YR,,M,Y,,,20221011,,CN,ZA,ZA,2022,Q4,Adult
214375881,21437588,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5 mg,,,U,,Unknown,,,,,,,2022,Q4,Chest pain,,2022,Q4,1,I,,20220928.0,20221011,20221011,PER,,ZA-LUPIN PHARMACEUTICALS INC.-2022-11641,LUPIN,,52.0,YR,,M,Y,,,20221011,,CN,ZA,ZA,2022,Q4,Adult
214376923,21437692,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,Unknown,,,,,,,2022,Q4,Stevens-Johnson syndrome,,2022,Q4,3,F,20220919.0,20221026.0,20221011,20221107,EXP,,JP-NOVOPROD-965395,NOVO NORDISK,,43.0,YR,,F,Y,,,20221107,,MD,JP,JP,2022,Q4,Adult
214387131,21438713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thrombocytosis,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339420,ASTRAZENECA,,68.0,YR,,M,Y,,,20221011,,MD,RU,,2022,Q4,Elderly
214387631,21438763,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20220602.0,20220930.0,20221011,20221011,EXP,,FR-AUROBINDO-AUR-APL-2022-041337,AUROBINDO,,86.0,YR,,F,Y,,,20221011,,MD,FR,FR,2022,Q4,Elderly
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Pruritus genital,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Fluid retention,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Genital erythema,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Intentional product misuse,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,COVID-19,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214390161,21439016,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Genital tract inflammation,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A339520,ASTRAZENECA,,40.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Adult
214393941,21439394,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Adrenal insufficiency,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,JP-AstraZeneca-2022A341302,ASTRAZENECA,,72.0,YR,,F,Y,,,20221011,,MD,JP,,2022,Q4,Elderly
214397071,21439707,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood glucose decreased,,2022,Q4,1,I,20220901.0,20221006.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A341490,ASTRAZENECA,,96.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Elderly
214397071,21439707,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220901.0,20221006.0,20221011,20221011,EXP,,RU-AstraZeneca-2022A341490,ASTRAZENECA,,96.0,YR,,M,Y,,,20221011,,HP,RU,,2022,Q4,Elderly
214400511,21440051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,NJ2303//2110159,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220921.0,20221002.0,20221011,20221011,EXP,,CN-AstraZeneca-2022A340805,ASTRAZENECA,,58.0,YR,,M,Y,50.0,KG,20221011,,MD,CN,,2022,Q4,Adult
214400511,21440051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,NJ2303//2110159,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Prostatomegaly,,2022,Q4,1,I,20220921.0,20221002.0,20221011,20221011,EXP,,CN-AstraZeneca-2022A340805,ASTRAZENECA,,58.0,YR,,M,Y,50.0,KG,20221011,,MD,CN,,2022,Q4,Adult
214400511,21440051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,NJ2303//2110159,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dysarthria,,2022,Q4,1,I,20220921.0,20221002.0,20221011,20221011,EXP,,CN-AstraZeneca-2022A340805,ASTRAZENECA,,58.0,YR,,M,Y,50.0,KG,20221011,,MD,CN,,2022,Q4,Adult
214400511,21440051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,NJ2303//2110159,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hemiparesis,,2022,Q4,1,I,20220921.0,20221002.0,20221011,20221011,EXP,,CN-AstraZeneca-2022A340805,ASTRAZENECA,,58.0,YR,,M,Y,50.0,KG,20221011,,MD,CN,,2022,Q4,Adult
214400511,21440051,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,230.0,MG,Y,,NJ2303//2110159,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonitis,,2022,Q4,1,I,20220921.0,20221002.0,20221011,20221011,EXP,,CN-AstraZeneca-2022A340805,ASTRAZENECA,,58.0,YR,,M,Y,50.0,KG,20221011,,MD,CN,,2022,Q4,Adult
214409271,21440927,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,IT-MYLANLABS-2022M1112869,MYLAN,"Sani E, Prato GD, Zenti MG, Bordugo A, Trombetta M, Bonora E. Effects of Semaglutide on Glycemic Control and Weight Loss in a Patient with Prader-Willi Syndrome: A Case Report. Endocr-Metab-Immune-Disord-Drug-Targets 2022;22(10):1053-1057.",33.0,YR,,M,Y,90.0,KG,20221011,,HP,IT,IT,2022,Q4,Young Adult
214410671,21441067,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,U,,,,202293.0,,,Tablet,,2022,Q4,Candida infection,,2022,Q4,1,I,,20221003.0,20221011,20221011,EXP,,GB-AstraZeneca-2022A342675,ASTRAZENECA,,73.0,YR,,F,Y,107.0,KG,20221011,,MD,GB,,2022,Q4,Elderly
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Weight increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Arrhythmia supraventricular,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Heart rate increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Troponin T increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram T wave amplitude decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Mean cell haemoglobin increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Vitamin B12 deficiency,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hyperlipidaemia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial enlargement,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Heart rate irregular,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram ST segment abnormal,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hydrocholecystis,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Transferrin saturation decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Chest pain,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Congestive cardiomyopathy,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular fibrillation,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Exercise tolerance decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Sciatica,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,International normalised ratio fluctuation,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Red cell distribution width increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Inflammatory marker increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Drug effect less than expected,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Sinus arrest,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Bundle branch block left,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Platelet count decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Anaemia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Pancreatitis,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cholelithiasis,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Mean cell volume increased,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Extrasystoles,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214419171,21441917,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cardiac failure congestive,,2022,Q4,1,I,20140101.0,20221002.0,20221011,20221011,EXP,,HU-BAUSCH-BL-2022-023008,BAUSCH AND LOMB,,53.0,YR,,M,Y,118.0,KG,20221011,,MD,HU,HU,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Ventricular fibrillation,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Unresponsive to stimuli,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Cyanosis,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Sinus rhythm,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Torsade de pointes,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Supraventricular extrasystoles,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214427961,21442796,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (more than 1.5 months)",,,U,,,,,10.0,MG,,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20220909.0,20220930.0,20221012,20221012,EXP,,DE-AUROBINDO-AUR-APL-2022-041100,AUROBINDO,,59.0,YR,,F,Y,86.0,KG,20221012,,PH,DE,DE,2022,Q4,Adult
214429441,21442944,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20220927.0,20221012,20221012,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358283,RANBAXY,,42.0,YR,,F,Y,54.0,KG,20221012,,MD,FR,FR,2022,Q4,Adult
214429541,21442954,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,for about 10 years,,,,,57559,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Heart valve stenosis,,2022,Q4,1,I,20220201.0,20221004.0,20221012,20221012,EXP,,BR-AstraZeneca-2022A340262,ASTRAZENECA,,67.0,YR,,M,Y,,,20221012,,CN,BR,,2022,Q4,Elderly
214439431,21443943,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Phimosis,,2022,Q4,1,I,20220701.0,20221004.0,20221012,20221012,EXP,,FR-AstraZeneca-2022A336603,ASTRAZENECA,,70.0,YR,,M,Y,,,20221012,,MD,FR,,2022,Q4,Elderly
214440692,21444069,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q4,Cardiac failure,,2022,Q4,2,F,,20221118.0,20221012,20221123,EXP,,FR-AstraZeneca-2022A341633,ASTRAZENECA,,89.0,YR,,M,Y,,,20221123,,MD,FR,,2022,Q4,Elderly
214440692,21444069,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,,,202293.0,,,Tablet,,2022,Q4,Oedema,,2022,Q4,2,F,,20221118.0,20221012,20221123,EXP,,FR-AstraZeneca-2022A341633,ASTRAZENECA,,89.0,YR,,M,Y,,,20221123,,MD,FR,,2022,Q4,Elderly
214444572,21444457,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1 dosage form,,,,,,,,,,Tablet,,2022,Q4,Pneumonia,,2022,Q4,2,F,,20221028.0,20221012,20221108,PER,,JP-AMGEN-JPNSP2022174779,AMGEN,,106.0,YR,E,F,Y,,,20221108,,MD,JP,JP,2022,Q4,Elderly
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,International normalised ratio fluctuation,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Platelet count decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Chest pain,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Heart rate increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Bundle branch block left,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Congestive cardiomyopathy,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Exercise tolerance decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Mean cell volume increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Hydrocholecystis,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Anaemia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Red cell distribution width increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Ventricular extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Weight increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Pancreatitis,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Ventricular fibrillation,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Cholelithiasis,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Inflammatory marker increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Sciatica,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Electrocardiogram T wave amplitude decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Vitamin B12 deficiency,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Sinus arrest,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Electrocardiogram ST segment abnormal,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Drug effect less than expected,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Atrial enlargement,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Heart rate irregular,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Hyperlipidaemia,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Arrhythmia supraventricular,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Mean cell haemoglobin increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Transferrin saturation decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453572,21445357,32,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,D,,,,,10.0,MG,,,2022,Q4,Troponin T increased,,2022,Q4,2,F,20140101.0,20221006.0,20221012,20221028,EXP,HU-002147023-NVSC2022HU216711,HU-STRIDES ARCOLAB LIMITED-2022SP012859,STRIDES,,53.0,YR,,M,Y,118.0,KG,20221029,,MD,HU,HU,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Unresponsive to stimuli,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Ventricular extrasystoles,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Palpitations,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Circulatory collapse,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Sinus rhythm,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Ventricular tachycardia,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Ventricular fibrillation,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Torsade de pointes,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Hyperhidrosis,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214453662,21445366,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0; more than 1.5 months,,,U,,,,,10.0,MG,UNK,,2022,Q4,Cyanosis,,2022,Q4,2,F,20220909.0,20221014.0,20221012,20221021,EXP,DE-AMK-260463,DE-TORRENT-00023560,TORRENT,,59.0,YR,A,F,Y,86.0,KG,20221021,,PH,DE,DE,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Platelet count decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Bundle branch block left,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Sciatica,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Cholelithiasis,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Heart rate irregular,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Mean cell volume increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,International normalised ratio fluctuation,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Inflammatory marker increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Weight increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Exercise tolerance decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Vitamin B12 deficiency,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Heart rate increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Chest pain,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Cardiac failure congestive,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram T wave amplitude decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Atrial enlargement,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Troponin T increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Red cell distribution width increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Hyperlipidaemia,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Sinus arrest,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram ST segment abnormal,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Anaemia,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Mean cell haemoglobin increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Ventricular fibrillation,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Arrhythmia supraventricular,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Extrasystoles,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Congestive cardiomyopathy,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Pancreatitis,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Transferrin saturation decreased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Drug effect less than expected,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214455491,21445549,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Hydrocholecystis,,2022,Q4,1,I,20140101.0,20221004.0,20221012,20221012,EXP,,HU-AstraZeneca-2022A336305,ASTRAZENECA,,53.0,YR,,M,Y,118.0,KG,20221012,,MD,HU,,2022,Q4,Adult
214459413,21445941,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,3,F,,20221005.0,20221012,20221012,EXP,,CN-PFIZER INC-PV202200074228,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",61.0,YR,,F,Y,65.0,KG,20221012,,HP,CN,CN,2022,Q4,Adult
214459413,21445941,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,3,F,,20221005.0,20221012,20221012,EXP,,CN-PFIZER INC-PV202200074228,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",61.0,YR,,F,Y,65.0,KG,20221012,,HP,CN,CN,2022,Q4,Adult
214459413,21445941,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,D,,,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,3,F,,20221005.0,20221012,20221012,EXP,,CN-PFIZER INC-PV202200074228,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",61.0,YR,,F,Y,65.0,KG,20221012,,HP,CN,CN,2022,Q4,Adult
214462221,21446222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Septic shock,,2022,Q4,1,I,20220820.0,20221007.0,20221012,20221012,EXP,,IT-AstraZeneca-2022A340452,ASTRAZENECA,,76.0,YR,,F,Y,,,20221012,,MD,IT,,2022,Q4,Elderly
214462221,21446222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pancreatitis,,2022,Q4,1,I,20220820.0,20221007.0,20221012,20221012,EXP,,IT-AstraZeneca-2022A340452,ASTRAZENECA,,76.0,YR,,F,Y,,,20221012,,MD,IT,,2022,Q4,Elderly
214466731,21446673,3,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,CN-HQ-20220034,HQ SPECIALTY,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17. DOI: 10.2147/IDR.S375694.",61.0,YR,A,F,Y,65.0,KG,20221006,,MD,CN,,2022,Q4,Adult
214466731,21446673,3,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,CN-HQ-20220034,HQ SPECIALTY,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17. DOI: 10.2147/IDR.S375694.",61.0,YR,A,F,Y,65.0,KG,20221006,,MD,CN,,2022,Q4,Adult
214466741,21446674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,CN-HQ-20220035,HQ SPECIALTY,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17. DOI: 10.2147/IDR.S375694.",71.0,YR,E,F,Y,110.0,KG,20221006,,MD,CN,,2022,Q4,Elderly
214466741,21446674,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,CN-HQ-20220035,HQ SPECIALTY,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17. DOI: 10.2147/IDR.S375694.",71.0,YR,E,F,Y,110.0,KG,20221006,,MD,CN,,2022,Q4,Elderly
214468001,21446800,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082019,TEVA,,81.0,YR,E,M,Y,100.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214468001,21446800,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 Milligram Daily; 10 mg, 1-0-0-0",,,U,,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082019,TEVA,,81.0,YR,E,M,Y,100.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214470383,21447038,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,3,F,,20221005.0,20221012,20221013,EXP,,CN-PFIZER INC-202201196613,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",71.0,YR,,F,Y,110.0,KG,20221013,,HP,CN,CN,2022,Q4,Elderly
214470383,21447038,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,3,F,,20221005.0,20221012,20221013,EXP,,CN-PFIZER INC-202201196613,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",71.0,YR,,F,Y,110.0,KG,20221013,,HP,CN,CN,2022,Q4,Elderly
214470383,21447038,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,3,F,,20221005.0,20221012,20221013,EXP,,CN-PFIZER INC-202201196613,PFIZER,"Li, M.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance.. 2022;15:5509-5517",71.0,YR,,F,Y,110.0,KG,20221013,,HP,CN,CN,2022,Q4,Elderly
214470782,21447078,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Dose 10, unit 3",,,Y,,,,202293.0,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,2,F,20220830.0,20221101.0,20221012,20221109,EXP,,GB-AstraZeneca-2022A340045,ASTRAZENECA,,76.0,YR,,M,Y,,,20221109,,MD,GB,,2022,Q4,Elderly
214470782,21447078,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Dose 10, unit 3",,,Y,,,,202293.0,,,,,2022,Q4,Liver function test increased,,2022,Q4,2,F,20220830.0,20221101.0,20221012,20221109,EXP,,GB-AstraZeneca-2022A340045,ASTRAZENECA,,76.0,YR,,M,Y,,,20221109,,MD,GB,,2022,Q4,Elderly
214470782,21447078,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Dose 10, unit 3",,,Y,,,,202293.0,,,,,2022,Q4,Hepatitis,,2022,Q4,2,F,20220830.0,20221101.0,20221012,20221109,EXP,,GB-AstraZeneca-2022A340045,ASTRAZENECA,,76.0,YR,,M,Y,,,20221109,,MD,GB,,2022,Q4,Elderly
214470782,21447078,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"Dose 10, unit 3",,,Y,,,,202293.0,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,20220830.0,20221101.0,20221012,20221109,EXP,,GB-AstraZeneca-2022A340045,ASTRAZENECA,,76.0,YR,,M,Y,,,20221109,,MD,GB,,2022,Q4,Elderly
214478341,21447834,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082015,TEVA,,75.0,YR,E,M,Y,,,20221012,,MD,DE,DE,2022,Q4,Elderly
214478341,21447834,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082015,TEVA,,75.0,YR,E,M,Y,,,20221012,,MD,DE,DE,2022,Q4,Elderly
214478341,21447834,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Hypotension,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082015,TEVA,,75.0,YR,E,M,Y,,,20221012,,MD,DE,DE,2022,Q4,Elderly
214478341,21447834,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Cold sweat,,2022,Q4,1,I,,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2082015,TEVA,,75.0,YR,E,M,Y,,,20221012,,MD,DE,DE,2022,Q4,Elderly
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214491751,21449175,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablets",,,U,,,,,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20220928.0,20221013,20221013,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358130,RANBAXY,,62.0,YR,,F,Y,75.0,KG,20221013,,PH,DE,DE,2022,Q4,Adult
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Heart valve stenosis,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Clostridium difficile infection,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Inflammation,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Suspected COVID-19,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Oxygen saturation decreased,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Bone pain,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214498451,21449845,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,Unknown,,,,,,,,,,,,2022,Q4,Myalgia,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-SAMSUNG BIOEPIS-SB-2022-25584,SAMSUNG BIOEPIS,,81.0,YR,E,M,Y,105.0,KG,20221013,,HP,CA,CA,2022,Q4,Elderly
214500902,21450090,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,4350.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20220913.0,20221011.0,20221013,20221019,EXP,,JP-AstraZeneca-2022A319818,ASTRAZENECA,,89.0,YR,,F,Y,,,20221019,,MD,JP,,2022,Q4,Elderly
214500902,21450090,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,4350.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,2,F,20220913.0,20221011.0,20221013,20221019,EXP,,JP-AstraZeneca-2022A319818,ASTRAZENECA,,89.0,YR,,F,Y,,,20221019,,MD,JP,,2022,Q4,Elderly
214501642,21450164,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,"Tablet, film coated",,2022,Q4,Fatigue,,2022,Q4,2,F,20220228.0,20221010.0,20221013,20221014,EXP,PT-INFARMED-T202209-1388,PT-ASTELLAS-2022US036103,ASTELLAS,,77.0,YR,,M,Y,,,20221014,,CN,PT,PT,2022,Q4,Elderly
214501642,21450164,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,"Tablet, film coated",,2022,Q4,Psychomotor retardation,,2022,Q4,2,F,20220228.0,20221010.0,20221013,20221014,EXP,PT-INFARMED-T202209-1388,PT-ASTELLAS-2022US036103,ASTELLAS,,77.0,YR,,M,Y,,,20221014,,CN,PT,PT,2022,Q4,Elderly
214509811,21450981,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20221007.0,20221013,20221013,EXP,,CA-TAKEDA-2022TUS072645,TAKEDA,,76.0,YR,,M,Y,,,20221013,,CN,CA,CA,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fall,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Discomfort,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Injury,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524352,21452435,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2111169,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,2,F,20220929.0,20221005.0,20221013,20221017,EXP,,CN-AstraZeneca-2022A340790,ASTRAZENECA,,18262.0,DY,,F,Y,51.0,KG,20221017,,MD,CN,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Deep vein thrombosis,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pain in extremity,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214524382,21452438,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Altered state of consciousness,,2022,Q4,2,F,20210101.0,20221207.0,20221013,20221220,EXP,,JP-AstraZeneca-2022A339355,ASTRAZENECA,"Ishizeki K, et al.. 33 A case of deep vein thrombosis in which HIF-PH inhibitor, SGLT2 inhibitor, loop diuretic, and theophylline poisoning were considered involved.. The 237th Kinki regional meeting of the Japanese Society of Internal Medicine 2022 Sep 10 2022;",85.0,YR,,F,Y,43.0,KG,20221218,,MD,JP,,2022,Q4,Elderly
214529311,21452931,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,QD,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20220816.0,20221012.0,20221013,20221013,EXP,FR-AFSSAPS-NY20222704,FR-ROCHE-3198334,ROCHE,,58.0,YR,,F,Y,78.0,KG,20221013,,MD,FR,FR,2022,Q4,Adult
214534474,21453447,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Type 1 diabetes mellitus,,2022,Q4,4,F,,20221220.0,20221013,20221229,EXP,,CA-PFIZER INC-202201212921,PFIZER,,69.0,YR,,F,Y,,,20221229,,MD,CA,CA,2022,Q4,Elderly
214534474,21453447,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,4,F,,20221220.0,20221013,20221229,EXP,,CA-PFIZER INC-202201212921,PFIZER,,69.0,YR,,F,Y,,,20221229,,MD,CA,CA,2022,Q4,Elderly
214534474,21453447,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Thyroid disorder,,2022,Q4,4,F,,20221220.0,20221013,20221229,EXP,,CA-PFIZER INC-202201212921,PFIZER,,69.0,YR,,F,Y,,,20221229,,MD,CA,CA,2022,Q4,Elderly
214534474,21453447,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,4,F,,20221220.0,20221013,20221229,EXP,,CA-PFIZER INC-202201212921,PFIZER,,69.0,YR,,F,Y,,,20221229,,MD,CA,CA,2022,Q4,Elderly
214534474,21453447,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Addison's disease,,2022,Q4,4,F,,20221220.0,20221013,20221229,EXP,,CA-PFIZER INC-202201212921,PFIZER,,69.0,YR,,F,Y,,,20221229,,MD,CA,CA,2022,Q4,Elderly
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Pancreatitis,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Weight increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Heart rate irregular,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Hyperlipidaemia,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Sinus arrest,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Atrial enlargement,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Cholelithiasis,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Congestive cardiomyopathy,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Heart rate increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Cardiac failure congestive,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Exercise tolerance decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,International normalised ratio fluctuation,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram ST segment abnormal,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Mean cell volume increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Vitamin B12 deficiency,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Arrhythmia supraventricular,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Transferrin saturation decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Red cell distribution width increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Chest pain,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Platelet count decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Anaemia,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Drug effect less than expected,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Troponin T increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Inflammatory marker increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Extrasystoles,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram T wave amplitude decreased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Mean cell haemoglobin increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Ventricular extrasystoles,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Hydrocholecystis,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Ventricular fibrillation,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Sciatica,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214534654,21453465,31,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,,,,10.0,MG,,,2022,Q4,Bundle branch block left,,2022,Q4,4,F,20140101.0,20221027.0,20221013,20221102,EXP,,HU-PFIZER INC-202201199112,PFIZER,,53.0,YR,,M,Y,118.0,KG,20221102,,MD,HU,HU,2022,Q4,Adult
214537031,21453703,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, 1x/day",,,,,Unknown,,,,,Film-coated tablet,QD,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20220816.0,20221010.0,20221013,20221013,EXP,FR-AFSSAPS-NY20222704,FR-PFIZER INC-202201214052,PFIZER,,58.0,YR,,F,Y,78.0,KG,20221013,,MD,FR,FR,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Drug effect less than expected,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial enlargement,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Congestive cardiomyopathy,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Supraventricular extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial flutter,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram T wave amplitude decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular tachycardia,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Arrhythmia,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Heart rate increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Red cell distribution width increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ejection fraction decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Mean cell volume increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Arrhythmia supraventricular,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Bundle branch block left,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Exercise tolerance decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Platelet count decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Blood thyroid stimulating hormone increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,International normalised ratio fluctuation,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hydrocholecystis,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Sciatica,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Transferrin saturation decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Vitamin B12 deficiency,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Inflammatory marker increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Anaemia,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Extrasystoles,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Sinus arrest,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram ST segment abnormal,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Pancreatitis,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Troponin T increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cholelithiasis,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Mean cell haemoglobin increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hyperlipidaemia,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Ventricular fibrillation,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Heart rate irregular,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Chest pain,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214537902,21453790,30,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Weight increased,,2022,Q4,2,F,20140101.0,20221006.0,20221013,20221021,EXP,,HU-MYLANLABS-2022M1112807,MYLAN,,53.0,YR,,M,Y,118.0,KG,20221021,,MD,HU,HU,2022,Q4,Adult
214559871,21455987,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,,,Tablet,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358792,RANBAXY,,75.0,YR,,M,Y,,,20221014,,MD,DE,DE,2022,Q4,Elderly
214559871,21455987,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,,,Tablet,,2022,Q4,Cold sweat,,2022,Q4,1,I,,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358792,RANBAXY,,75.0,YR,,M,Y,,,20221014,,MD,DE,DE,2022,Q4,Elderly
214559871,21455987,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,1,I,,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358792,RANBAXY,,75.0,YR,,M,Y,,,20221014,,MD,DE,DE,2022,Q4,Elderly
214559871,21455987,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, tablets",,,U,,,,,,,Tablet,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358792,RANBAXY,,75.0,YR,,M,Y,,,20221014,,MD,DE,DE,2022,Q4,Elderly
214565121,21456512,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Deafness,,2022,Q4,1,I,20220805.0,20221004.0,20221014,20221014,EXP,,GB-AUROBINDO-AUR-APL-2022-041937,AUROBINDO,,86.0,YR,,M,Y,,,20221014,,HP,GB,GB,2022,Q4,Elderly
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Hypophosphataemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Intentional product misuse,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Hypomagnesaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Hypokalaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Hypocalcaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,5.0,MG,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypophosphataemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Intentional product misuse,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypomagnesaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypokalaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypocalcaemia,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214572921,21457292,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,US-SCIEGENP-2022SCLIT00639,SCIEGEN,"Sharma A, et al..An old friend turned foe: Metformin-induced diarrhea with resultant symptomatic hypokalemia, hypomagnesemia, hypocalcemia, and hypophosphatemia.Clinical Case Reports.Aug-2021;9 (8)",54.0,YR,A,F,Y,,,20221014,,HP,US,US,2022,Q4,Adult
214575801,21457580,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,20220321.0,20221011.0,20221014,20221014,EXP,,CN-AstraZeneca-2022A344649,ASTRAZENECA,,27950.0,DY,,M,Y,68.0,KG,20221014,,MD,CN,,2022,Q4,Elderly
214575801,21457580,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,NF3350,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Muscular weakness,,2022,Q4,1,I,20220321.0,20221011.0,20221014,20221014,EXP,,CN-AstraZeneca-2022A344649,ASTRAZENECA,,27950.0,DY,,M,Y,68.0,KG,20221014,,MD,CN,,2022,Q4,Elderly
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Unresponsive to stimuli,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Ventricular fibrillation,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Torsade de pointes,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Cyanosis,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Supraventricular extrasystoles,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214581281,21458128,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0mehr als 1,5 Monate",,,,,,,,10.0,MG,,QD,2022,Q4,Sinus rhythm,,2022,Q4,1,I,20220909.0,20221003.0,20221014,20221014,EXP,DE-AMK-260463,DE-MYLANLABS-2022M1113601,MYLAN,,59.0,YR,,F,Y,86.0,KG,20221014,,PH,DE,DE,2022,Q4,Adult
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Polydipsia,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Drug monitoring procedure incorrectly performed,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Thirst,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Fluid intake reduced,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214583361,21458336,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Insomnia,,2022,Q4,1,I,20220901.0,20221007.0,20221014,20221014,EXP,,JP-OTSUKA-2022_046791,OTSUKA,,9.0,DEC,,F,Y,,,20221014,,PH,JP,JP,2022,Q4,Child
214591392,21459139,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20220905.0,20221013.0,20221014,20221110,EXP,,GB-BRACCO-2022GB04179,BRACCO,,58.0,YR,,F,Y,,,20221110,,MD,GB,GB,2022,Q4,Adult
214591392,21459139,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Asthma,,2022,Q4,2,F,20220905.0,20221013.0,20221014,20221110,EXP,,GB-BRACCO-2022GB04179,BRACCO,,58.0,YR,,F,Y,,,20221110,,MD,GB,GB,2022,Q4,Adult
214591392,21459139,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,2,F,20220905.0,20221013.0,20221014,20221110,EXP,,GB-BRACCO-2022GB04179,BRACCO,,58.0,YR,,F,Y,,,20221110,,MD,GB,GB,2022,Q4,Adult
214593331,21459333,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,,2022,Q4,Hepatic function abnormal,,2022,Q4,1,I,20210728.0,20221007.0,20221014,20221014,EXP,,JP-EMD Serono-9357253,EMD SERONO INC,,68.0,YR,E,,Y,61.0,KG,20221014,,MD,JP,,2022,Q4,Elderly
214593542,21459354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Off label use,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Fungal infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Off label use,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Fungal infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Off label use,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Fungal infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214593542,21459354,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,2,F,20220701.0,20221215.0,20221014,20221223,EXP,,FR-AstraZeneca-2022A343996,ASTRAZENECA,,962.0,MON,,F,Y,,,20221223,,MD,FR,,2022,Q4,Elderly
214597811,21459781,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"5 milligram, qd",,,,U,,,,5.0,MG,,QD,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221006.0,20221014,20221014,EXP,,CN-MYLANLABS-2022M1114227,MYLAN,"Han J, Xie S, Jiao H. Sodium-glucose cotransporter-2 inhibitor-induced euglycemic diabetic ketoacidosis: A case report. J-Clin-Pharm-Ther 2022;47(9):1482-1485.",74.0,YR,,M,Y,,,20221014,,MD,CN,CN,2022,Q4,Elderly
214612661,21461266,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, Once a Day",,,U,,,,,,,Film Coated Tablet,QD,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20220816.0,20221007.0,20221015,20221015,EXP,,FR-AUROBINDO-AUR-APL-2022-042344,AUROBINDO,,58.0,YR,,F,Y,78.0,KG,20221015,,MD,FR,FR,2022,Q4,Adult
214638772,21463877,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20220531.0,20221201.0,20221017,20221205,EXP,,JP-AstraZeneca-2022A272580,ASTRAZENECA,,29735.0,DY,,M,Y,80.0,KG,20221205,,MD,JP,,2022,Q4,Elderly
214638772,21463877,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20220531.0,20221201.0,20221017,20221205,EXP,,JP-AstraZeneca-2022A272580,ASTRAZENECA,,29735.0,DY,,M,Y,80.0,KG,20221205,,MD,JP,,2022,Q4,Elderly
214638772,21463877,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,2,F,20220531.0,20221201.0,20221017,20221205,EXP,,JP-AstraZeneca-2022A272580,ASTRAZENECA,,29735.0,DY,,M,Y,80.0,KG,20221205,,MD,JP,,2022,Q4,Elderly
214638772,21463877,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ischaemia,,2022,Q4,2,F,20220531.0,20221201.0,20221017,20221205,EXP,,JP-AstraZeneca-2022A272580,ASTRAZENECA,,29735.0,DY,,M,Y,80.0,KG,20221205,,MD,JP,,2022,Q4,Elderly
214650581,21465058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q4,Bile duct cancer,,2022,Q4,1,I,20220905.0,20221004.0,20221017,20221017,EXP,GB-MHRA-ADR 27357017,GB-NOVOPROD-965811,NOVO NORDISK,,60.0,YR,,F,Y,98.0,KG,20221017,,HP,GB,GB,2022,Q4,Adult
214650581,21465058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q4,Jaundice,,2022,Q4,1,I,20220905.0,20221004.0,20221017,20221017,EXP,GB-MHRA-ADR 27357017,GB-NOVOPROD-965811,NOVO NORDISK,,60.0,YR,,F,Y,98.0,KG,20221017,,HP,GB,GB,2022,Q4,Adult
214650581,21465058,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q4,Pancreatic carcinoma,,2022,Q4,1,I,20220905.0,20221004.0,20221017,20221017,EXP,GB-MHRA-ADR 27357017,GB-NOVOPROD-965811,NOVO NORDISK,,60.0,YR,,F,Y,98.0,KG,20221017,,HP,GB,GB,2022,Q4,Adult
214669911,21466991,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10mg once a day,a stomach medication",,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Hernia,,2022,Q4,1,I,,20221012.0,20221017,20221017,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-120606,BRISTOL MYERS SQUIBB,,76.0,YR,E,F,Y,79.38,KG,20221017,,CN,CA,CA,2022,Q4,Elderly
214669911,21466991,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10mg once a day,a stomach medication",,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,COVID-19,,2022,Q4,1,I,,20221012.0,20221017,20221017,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-120606,BRISTOL MYERS SQUIBB,,76.0,YR,E,F,Y,79.38,KG,20221017,,CN,CA,CA,2022,Q4,Elderly
214669911,21466991,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10mg once a day,a stomach medication",,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Cardiac disorder,,2022,Q4,1,I,,20221012.0,20221017,20221017,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-120606,BRISTOL MYERS SQUIBB,,76.0,YR,E,F,Y,79.38,KG,20221017,,CN,CA,CA,2022,Q4,Elderly
214678461,21467846,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20221011.0,20221017,20221017,EXP,,FR-PFIZER INC-PV202200081176,PFIZER,,73.0,YR,,M,Y,,,20221017,,CN,FR,FR,2022,Q4,Elderly
214678461,21467846,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221011.0,20221017,20221017,EXP,,FR-PFIZER INC-PV202200081176,PFIZER,,73.0,YR,,M,Y,,,20221017,,CN,FR,FR,2022,Q4,Elderly
214678461,21467846,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Incoherent,,2022,Q4,1,I,,20221011.0,20221017,20221017,EXP,,FR-PFIZER INC-PV202200081176,PFIZER,,73.0,YR,,M,Y,,,20221017,,CN,FR,FR,2022,Q4,Elderly
214678461,21467846,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Erythema,,2022,Q4,1,I,,20221011.0,20221017,20221017,EXP,,FR-PFIZER INC-PV202200081176,PFIZER,,73.0,YR,,M,Y,,,20221017,,CN,FR,FR,2022,Q4,Elderly
214678461,21467846,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Amnesia,,2022,Q4,1,I,,20221011.0,20221017,20221017,EXP,,FR-PFIZER INC-PV202200081176,PFIZER,,73.0,YR,,M,Y,,,20221017,,CN,FR,FR,2022,Q4,Elderly
214685052,21468505,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Blood pressure systolic increased,,2022,Q4,2,F,,20221021.0,20221017,20221027,EXP,,NVSJ2022JP098988,NOVARTIS,,70.0,YR,,M,Y,,,20221028,,MD,JP,JP,2022,Q4,Elderly
214688031,21468803,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Platelet count decreased,,2022,Q4,1,I,20220601.0,20221013.0,20221018,20221018,EXP,,NVSJ2022JP099260,NOVARTIS,,58.0,YR,,M,Y,,,20221018,,MD,JP,JP,2022,Q4,Adult
214688132,21468813,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Cellulitis,,2022,Q4,2,F,20220301.0,20221010.0,20221018,20221209,EXP,,EE-JNJFOC-20221032168,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20221209,,MD,EE,EE,2022,Q4,Elderly
214688132,21468813,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure,,2022,Q4,2,F,20220301.0,20221010.0,20221018,20221209,EXP,,EE-JNJFOC-20221032168,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20221209,,MD,EE,EE,2022,Q4,Elderly
214688132,21468813,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Peripheral swelling,,2022,Q4,2,F,20220301.0,20221010.0,20221018,20221209,EXP,,EE-JNJFOC-20221032168,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20221209,,MD,EE,EE,2022,Q4,Elderly
214688132,21468813,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Ascites,,2022,Q4,2,F,20220301.0,20221010.0,20221018,20221209,EXP,,EE-JNJFOC-20221032168,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20221209,,MD,EE,EE,2022,Q4,Elderly
214688132,21468813,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, QD",,,,,,,,10.0,MG,,QD,2022,Q4,Renal failure,,2022,Q4,2,F,20220301.0,20221010.0,20221018,20221209,EXP,,EE-JNJFOC-20221032168,JOHNSON AND JOHNSON,,66.0,YR,E,M,Y,,,20221209,,MD,EE,EE,2022,Q4,Elderly
214689361,21468936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,2109103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221006.0,20221010.0,20221018,20221018,EXP,,CN-AstraZeneca-2022A344558,ASTRAZENECA,,27439.0,DY,,F,Y,58.0,KG,20221018,,MD,CN,,2022,Q4,Elderly
214689361,21468936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,2109103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dysarthria,,2022,Q4,1,I,20221006.0,20221010.0,20221018,20221018,EXP,,CN-AstraZeneca-2022A344558,ASTRAZENECA,,27439.0,DY,,F,Y,58.0,KG,20221018,,MD,CN,,2022,Q4,Elderly
214689361,21468936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,2109103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20221006.0,20221010.0,20221018,20221018,EXP,,CN-AstraZeneca-2022A344558,ASTRAZENECA,,27439.0,DY,,F,Y,58.0,KG,20221018,,MD,CN,,2022,Q4,Elderly
214689361,21468936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,390.0,MG,Y,,2109103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221006.0,20221010.0,20221018,20221018,EXP,,CN-AstraZeneca-2022A344558,ASTRAZENECA,,27439.0,DY,,F,Y,58.0,KG,20221018,,MD,CN,,2022,Q4,Elderly
214692362,21469236,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,unknown,,,,,,,2022,Q4,Device mechanical issue,,2022,Q4,2,F,20221001.0,20221124.0,20221018,20221202,30DAY,,MX-NOVOPROD-968612,NOVO NORDISK,,54.0,YR,,M,Y,140.0,KG,20221202,,CN,MX,MX,2022,Q4,Adult
214692362,21469236,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,unknown,,,,,,,2022,Q4,Device malfunction,,2022,Q4,2,F,20221001.0,20221124.0,20221018,20221202,30DAY,,MX-NOVOPROD-968612,NOVO NORDISK,,54.0,YR,,M,Y,140.0,KG,20221202,,CN,MX,MX,2022,Q4,Adult
214692362,21469236,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,unknown,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20221001.0,20221124.0,20221018,20221202,30DAY,,MX-NOVOPROD-968612,NOVO NORDISK,,54.0,YR,,M,Y,140.0,KG,20221202,,CN,MX,MX,2022,Q4,Adult
214692362,21469236,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,unknown,,,,,,,2022,Q4,Incorrect dose administered by device,,2022,Q4,2,F,20221001.0,20221124.0,20221018,20221202,30DAY,,MX-NOVOPROD-968612,NOVO NORDISK,,54.0,YR,,M,Y,140.0,KG,20221202,,CN,MX,MX,2022,Q4,Adult
214708401,21470840,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20211111.0,20221013.0,20221018,20221018,EXP,,JP-AstraZeneca-2022A198882,ASTRAZENECA,,83.0,YR,,M,Y,54.0,KG,20221018,,MD,JP,,2022,Q4,Elderly
214708401,21470840,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,195.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20211111.0,20221013.0,20221018,20221018,EXP,,JP-AstraZeneca-2022A198882,ASTRAZENECA,,83.0,YR,,M,Y,54.0,KG,20221018,,MD,JP,,2022,Q4,Elderly
214715701,21471570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,N,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20220901.0,20221010.0,20221018,20221018,EXP,,DK-AstraZeneca-2022A341898,ASTRAZENECA,,74.0,YR,,M,Y,71.0,KG,20221018,,MD,DK,,2022,Q4,Elderly
214715701,21471570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,N,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20220901.0,20221010.0,20221018,20221018,EXP,,DK-AstraZeneca-2022A341898,ASTRAZENECA,,74.0,YR,,M,Y,71.0,KG,20221018,,MD,DK,,2022,Q4,Elderly
214715701,21471570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,N,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urosepsis,,2022,Q4,1,I,20220901.0,20221010.0,20221018,20221018,EXP,,DK-AstraZeneca-2022A341898,ASTRAZENECA,,74.0,YR,,M,Y,71.0,KG,20221018,,MD,DK,,2022,Q4,Elderly
214715701,21471570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,N,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Sluggishness,,2022,Q4,1,I,20220901.0,20221010.0,20221018,20221018,EXP,,DK-AstraZeneca-2022A341898,ASTRAZENECA,,74.0,YR,,M,Y,71.0,KG,20221018,,MD,DK,,2022,Q4,Elderly
214715701,21471570,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2740.0,MG,N,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220901.0,20221010.0,20221018,20221018,EXP,,DK-AstraZeneca-2022A341898,ASTRAZENECA,,74.0,YR,,M,Y,71.0,KG,20221018,,MD,DK,,2022,Q4,Elderly
214715711,21471571,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Blood test abnormal,,2022,Q4,1,I,20220919.0,20221010.0,20221018,20221018,EXP,,FR-AstraZeneca-2022A341851,ASTRAZENECA,,59.0,YR,,M,Y,,,20221018,,MD,FR,,2022,Q4,Adult
214715711,21471571,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Fatigue,,2022,Q4,1,I,20220919.0,20221010.0,20221018,20221018,EXP,,FR-AstraZeneca-2022A341851,ASTRAZENECA,,59.0,YR,,M,Y,,,20221018,,MD,FR,,2022,Q4,Adult
214715711,21471571,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Pancreatic carcinoma,,2022,Q4,1,I,20220919.0,20221010.0,20221018,20221018,EXP,,FR-AstraZeneca-2022A341851,ASTRAZENECA,,59.0,YR,,M,Y,,,20221018,,MD,FR,,2022,Q4,Adult
214715711,21471571,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,20220919.0,20221010.0,20221018,20221018,EXP,,FR-AstraZeneca-2022A341851,ASTRAZENECA,,59.0,YR,,M,Y,,,20221018,,MD,FR,,2022,Q4,Adult
214722011,21472201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Hepatic enzyme increased,,2022,Q4,1,I,20220524.0,20221011.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A344757,ASTRAZENECA,,50.0,YR,,F,Y,,,20221018,,MD,DE,,2022,Q4,Adult
214722011,21472201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Nephrotic syndrome,,2022,Q4,1,I,20220524.0,20221011.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A344757,ASTRAZENECA,,50.0,YR,,F,Y,,,20221018,,MD,DE,,2022,Q4,Adult
214722011,21472201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Off label use,,2022,Q4,1,I,20220524.0,20221011.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A344757,ASTRAZENECA,,50.0,YR,,F,Y,,,20221018,,MD,DE,,2022,Q4,Adult
214722011,21472201,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Hepatic function abnormal,,2022,Q4,1,I,20220524.0,20221011.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A344757,ASTRAZENECA,,50.0,YR,,F,Y,,,20221018,,MD,DE,,2022,Q4,Adult
214723961,21472396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketonuria,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dry mouth,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketonuria,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dry mouth,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214723961,21472396,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A345427,ASTRAZENECA,,68.0,YR,,M,Y,92.0,KG,20221018,,MD,RU,,2022,Q4,Elderly
214724021,21472402,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,0000,,202293.0,,,Tablet,,2022,Q4,Stomatitis,,2022,Q4,1,I,20221004.0,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A347533,ASTRAZENECA,,74.0,YR,,F,Y,,,20221018,,MD,RU,,2022,Q4,Elderly
214724021,21472402,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,0000,,202293.0,,,Tablet,,2022,Q4,Herpes virus infection,,2022,Q4,1,I,20221004.0,20221011.0,20221018,20221018,EXP,,RU-AstraZeneca-2022A347533,ASTRAZENECA,,74.0,YR,,F,Y,,,20221018,,MD,RU,,2022,Q4,Elderly
214730541,21473054,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220824.0,20221013.0,20221018,20221018,EXP,,FR-PFIZER INC-PV202200075418,PFIZER,,52.0,YR,,M,Y,70.0,KG,20221018,,MD,FR,FR,2022,Q4,Adult
214730541,21473054,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220824.0,20221013.0,20221018,20221018,EXP,,FR-PFIZER INC-PV202200075418,PFIZER,,52.0,YR,,M,Y,70.0,KG,20221018,,MD,FR,FR,2022,Q4,Adult
214730541,21473054,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,1,I,20220824.0,20221013.0,20221018,20221018,EXP,,FR-PFIZER INC-PV202200075418,PFIZER,,52.0,YR,,M,Y,70.0,KG,20221018,,MD,FR,FR,2022,Q4,Adult
214730541,21473054,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221013.0,20221018,20221018,EXP,,FR-PFIZER INC-PV202200075418,PFIZER,,52.0,YR,,M,Y,70.0,KG,20221018,,MD,FR,FR,2022,Q4,Adult
214734211,21473421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Fournier's gangrene,,2022,Q4,1,I,20220910.0,20221013.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A345783,ASTRAZENECA,,76.0,YR,,M,Y,,,20221018,,MD,DE,,2022,Q4,Elderly
214734211,21473421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Sepsis,,2022,Q4,1,I,20220910.0,20221013.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A345783,ASTRAZENECA,,76.0,YR,,M,Y,,,20221018,,MD,DE,,2022,Q4,Elderly
214734211,21473421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Multiple organ dysfunction syndrome,,2022,Q4,1,I,20220910.0,20221013.0,20221018,20221018,EXP,,DE-AstraZeneca-2022A345783,ASTRAZENECA,,76.0,YR,,M,Y,,,20221018,,MD,DE,,2022,Q4,Elderly
214773081,21477308,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,10.0,MG,,,2022,Q4,Ischaemic stroke,,2022,Q4,1,I,20210518.0,20221008.0,20221019,20221019,EXP,FR-AFSSAPS-TS20221513,FR-Accord-282135,ACCORD,,57.0,YR,A,M,Y,,,20221019,,MD,FR,FR,2022,Q4,Adult
214784041,21478404,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,,,,,2022,Q4,Dermatitis exfoliative generalised,,2022,Q4,1,I,20220901.0,20221011.0,20221019,20221019,EXP,,PT-AstraZeneca-2022A343107,ASTRAZENECA,,81.0,YR,,M,Y,,,20221019,,MD,PT,,2022,Q4,Elderly
214784113,21478411,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,10.0,MG,Unknown,,2022,Q4,Maternal exposure during pregnancy,,2022,Q4,3,F,20221012.0,20221122.0,20221019,20221207,EXP,,"KR-VIVUS, Inc.-2022V1000528",VIVUS,,42.0,YR,A,F,Y,,,20221207,,HP,KR,KR,2022,Q4,Adult
214784113,21478411,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,10.0,MG,Unknown,,2022,Q4,Contraindicated product administered,,2022,Q4,3,F,20221012.0,20221122.0,20221019,20221207,EXP,,"KR-VIVUS, Inc.-2022V1000528",VIVUS,,42.0,YR,A,F,Y,,,20221207,,HP,KR,KR,2022,Q4,Adult
214784113,21478411,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,UNKNOWN,,,10.0,MG,Unknown,,2022,Q4,Abortion missed,,2022,Q4,3,F,20221012.0,20221122.0,20221019,20221207,EXP,,"KR-VIVUS, Inc.-2022V1000528",VIVUS,,42.0,YR,A,F,Y,,,20221207,,HP,KR,KR,2022,Q4,Adult
214787491,21478749,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,100.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20210623.0,20221016.0,20221019,20221019,EXP,,GB-PFIZER INC-202201233035,PFIZER,,70.0,YR,,F,Y,,,20221019,,MD,GB,GB,2022,Q4,Elderly
214787491,21478749,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,100.0,MG,Y,,,,,10.0,MG,Tablet,,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,20210623.0,20221016.0,20221019,20221019,EXP,,GB-PFIZER INC-202201233035,PFIZER,,70.0,YR,,F,Y,,,20221019,,MD,GB,GB,2022,Q4,Elderly
214787751,21478775,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,Y,,,,,,,,,2022,Q4,Dermatitis exfoliative generalised,,2022,Q4,1,I,20220901.0,20221012.0,20221019,20221019,EXP,PT-INFARMED-J202209-1492,PT-SA-2022SA421976,SANOFI AVENTIS,,81.0,YR,E,M,Y,,,20221019,,MD,PT,PT,2022,Q4,Elderly
214797621,21479762,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,U,,,,202293.0,,,Tablet,,2022,Q4,Mouth swelling,,2022,Q4,1,I,20221005.0,20221014.0,20221019,20221019,EXP,,GB-AstraZeneca-2022A347294,ASTRAZENECA,,89.0,YR,,F,Y,64.0,KG,20221019,,MD,GB,,2022,Q4,Elderly
214797621,21479762,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1, for treating heart f...",,,,,,,,,,,,2022,Q4,Mouth swelling,,2022,Q4,1,I,20221005.0,20221014.0,20221019,20221019,EXP,,GB-AstraZeneca-2022A347294,ASTRAZENECA,,89.0,YR,,F,Y,64.0,KG,20221019,,MD,GB,,2022,Q4,Elderly
214801861,21480186,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Microalbuminuria,,2022,Q4,1,I,,20221014.0,20221019,20221019,EXP,,BG-AstraZeneca-2022A347348,ASTRAZENECA,,73.0,YR,,M,Y,,,20221019,,MD,BG,,2022,Q4,Elderly
214801861,21480186,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Off label use,,2022,Q4,1,I,,20221014.0,20221019,20221019,EXP,,BG-AstraZeneca-2022A347348,ASTRAZENECA,,73.0,YR,,M,Y,,,20221019,,MD,BG,,2022,Q4,Elderly
214809591,21480959,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Other,,,,,,,,,10.0,MG,Unknown,QD,2022,Q4,Multiple sclerosis,,2022,Q4,1,I,20210901.0,20221004.0,20221019,20221019,EXP,,PT-BIOGEN-2022BI01159949,BIOGEN,,58.0,YR,,M,Y,,,20221019,,CN,PT,PT,2022,Q4,Adult
214809591,21480959,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Other,,,,,,,,,10.0,MG,Unknown,QD,2022,Q4,Drug ineffective,,2022,Q4,1,I,20210901.0,20221004.0,20221019,20221019,EXP,,PT-BIOGEN-2022BI01159949,BIOGEN,,58.0,YR,,M,Y,,,20221019,,CN,PT,PT,2022,Q4,Adult
214829191,21482919,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-2,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10879,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",71.0,YR,,F,Y,110.0,KG,20221020,,MD,CN,CN,2022,Q4,Elderly
214829191,21482919,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-2,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10879,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",71.0,YR,,F,Y,110.0,KG,20221020,,MD,CN,CN,2022,Q4,Elderly
214829191,21482919,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-2,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10879,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",71.0,YR,,F,Y,110.0,KG,20221020,,MD,CN,CN,2022,Q4,Elderly
214829191,21482919,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-2,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10879,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",71.0,YR,,F,Y,110.0,KG,20221020,,MD,CN,CN,2022,Q4,Elderly
214829201,21482920,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,1,I,,20221010.0,20221020,20221020,EXP,CN-MLMSERVICE-20221003-3833366-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10882,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829201,21482920,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221010.0,20221020,20221020,EXP,CN-MLMSERVICE-20221003-3833366-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10882,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829201,21482920,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221010.0,20221020,20221020,EXP,CN-MLMSERVICE-20221003-3833366-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10882,ALKEM,"Li MM, Shen WC, Li YJ, Teng J. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829211,21482921,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10878,ALKEM,"Li MM, Shen WC, Li YJ, Teng J.et.al.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829211,21482921,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10878,ALKEM,"Li MM, Shen WC, Li YJ, Teng J.et.al.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829211,21482921,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10878,ALKEM,"Li MM, Shen WC, Li YJ, Teng J.et.al.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829211,21482921,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10878,ALKEM,"Li MM, Shen WC, Li YJ, Teng J.et.al.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214829211,21482921,1,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q4,Renal failure,,2022,Q4,1,I,,20221006.0,20221020,20221020,EXP,CN-MLMSERVICE-20220929-3827222-1,CN-ALKEM LABORATORIES LIMITED-CN-ALKEM-2022-10878,ALKEM,"Li MM, Shen WC, Li YJ, Teng J.et.al.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance. 2022;15:5509-17",61.0,YR,,F,Y,65.0,KG,20221020,,MD,CN,CN,2022,Q4,Adult
214840471,21484047,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Drug-induced liver injury,,2022,Q4,1,I,20220908.0,20221018.0,20221020,20221020,EXP,,JP-GILEAD-2022-0601708,GILEAD,,89.0,YR,E,M,Y,43.5,KG,20221020,,PH,JP,JP,2022,Q4,Elderly
214840471,21484047,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Drug-induced liver injury,,2022,Q4,1,I,20220908.0,20221018.0,20221020,20221020,EXP,,JP-GILEAD-2022-0601708,GILEAD,,89.0,YR,E,M,Y,43.5,KG,20221020,,PH,JP,JP,2022,Q4,Elderly
214841001,21484100,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NH3210,,,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220925.0,20221015.0,20221020,20221020,EXP,,CN-EMD Serono-9358783,EMD SERONO INC,,55.0,YR,A,M,Y,72.0,KG,20221020,,HP,CN,,2022,Q4,Adult
214841001,21484100,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,NH3210,,,10.0,MG,Tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20220925.0,20221015.0,20221020,20221020,EXP,,CN-EMD Serono-9358783,EMD SERONO INC,,55.0,YR,A,M,Y,72.0,KG,20221020,,HP,CN,,2022,Q4,Adult
214844881,21484488,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,"UNKNOWN,Unknown",,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20220602.0,20221012.0,20221020,20221020,EXP,FR-AFSSAPS-TO20223127,FR-TEVA-2022-FR-2817173,TEVA,,86.0,YR,E,F,Y,,,20221020,,MD,FR,FR,2022,Q4,Elderly
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Cyanosis,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Unresponsive to stimuli,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Sinus rhythm,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Supraventricular extrasystoles,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Torsade de pointes,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Ventricular fibrillation,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Electrocardiogram QT prolonged,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846351,21484635,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 1-0-0, more than 1.5 months, Strength : 10 mg",,,,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Palpitations,,2022,Q4,1,I,20220909.0,20221012.0,20221020,20221020,EXP,DE-AMK-260463,DE-TEVA-2022-DE-2817041,TEVA,,59.0,YR,A,F,Y,86.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Electrolyte imbalance,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Cough,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214846911,21484691,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817036,TEVA,,76.0,YR,E,M,Y,77.0,KG,20221020,,PH,DE,DE,2022,Q4,Elderly
214852522,21485252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221026.0,20221020,20221031,EXP,,CA-APOTEX-2022AP014297,APOTEX,,58.0,YR,,M,Y,,,20221031,,CN,CA,CA,2022,Q4,Adult
214852522,21485252,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 milligram, qd",,,U,,,,,5.0,MG,Tablet,,2022,Q4,Small intestine carcinoma,,2022,Q4,2,F,,20221026.0,20221020,20221031,EXP,,CA-APOTEX-2022AP014297,APOTEX,,58.0,YR,,M,Y,,,20221031,,CN,CA,CA,2022,Q4,Adult
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pulse absent,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Haemodynamic instability,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Unresponsive to stimuli,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Electrocardiogram ST segment elevation,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Coronary artery disease,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Respiratory distress,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Anuria,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Electrocardiogram T wave inversion,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myoclonus,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Shock,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214863742,21486374,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,2,F,20221017.0,20221027.0,20221020,20221101,EXP,,GR-PFIZER INC-PV202200084941,PFIZER,,75.0,YR,,M,Y,,,20221101,,MD,GR,GR,2022,Q4,Elderly
214867681,21486768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,,NJ2418/2204018,,202293.0,10.0,MG,Tablet,BID,2022,Q4,Quadriplegia,,2022,Q4,1,I,20220911.0,20221012.0,20221020,20221020,EXP,,CN-AstraZeneca-2022A347023,ASTRAZENECA,,25202.0,DY,,F,Y,42.0,KG,20221020,,MD,CN,,2022,Q4,Elderly
214867681,21486768,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,,,NJ2418/2204018,,202293.0,10.0,MG,Tablet,BID,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,20220911.0,20221012.0,20221020,20221020,EXP,,CN-AstraZeneca-2022A347023,ASTRAZENECA,,25202.0,DY,,F,Y,42.0,KG,20221020,,MD,CN,,2022,Q4,Elderly
214877051,21487705,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817703,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877051,21487705,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817703,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877051,21487705,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817703,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 Milligram Daily; 6.0 Years,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214877061,21487706,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221011.0,20221020,20221020,EXP,,CA-TEVA-2022-CA-2817714,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221020,,HP,CA,CA,2022,Q4,Adult
214880452,21488045,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q4,Blood pressure decreased,,2022,Q4,2,F,20220804.0,20221207.0,20221020,20221208,EXP,,NVSJ2022JP099463,NOVARTIS,,84.0,YR,,,Y,,,20221209,,PH,JP,JP,2022,Q4,Elderly
214880452,21488045,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,U,,,,,,,Tablet,,2022,Q4,Visual impairment,,2022,Q4,2,F,20220804.0,20221207.0,20221020,20221208,EXP,,NVSJ2022JP099463,NOVARTIS,,84.0,YR,,,Y,,,20221209,,PH,JP,JP,2022,Q4,Elderly
214899611,21489961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg; ; UNKNOWN,,,Y,,,,202293.0,,,,,2022,Q4,Reflexes abnormal,,2022,Q4,1,I,20220912.0,20221014.0,20221021,20221021,EXP,,GB-AstraZeneca-2022A347298,ASTRAZENECA,,56.0,YR,,M,Y,,,20221021,,MD,GB,,2022,Q4,Adult
214899611,21489961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg; ; UNKNOWN,,,Y,,,,202293.0,,,,,2022,Q4,Rash erythematous,,2022,Q4,1,I,20220912.0,20221014.0,20221021,20221021,EXP,,GB-AstraZeneca-2022A347298,ASTRAZENECA,,56.0,YR,,M,Y,,,20221021,,MD,GB,,2022,Q4,Adult
214899611,21489961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg; ; UNKNOWN,,,Y,,,,202293.0,,,,,2022,Q4,Diabetic ketosis,,2022,Q4,1,I,20220912.0,20221014.0,20221021,20221021,EXP,,GB-AstraZeneca-2022A347298,ASTRAZENECA,,56.0,YR,,M,Y,,,20221021,,MD,GB,,2022,Q4,Adult
214899611,21489961,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg; ; UNKNOWN,,,Y,,,,202293.0,,,,,2022,Q4,Dysarthria,,2022,Q4,1,I,20220912.0,20221014.0,20221021,20221021,EXP,,GB-AstraZeneca-2022A347298,ASTRAZENECA,,56.0,YR,,M,Y,,,20221021,,MD,GB,,2022,Q4,Adult
214905021,21490502,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,NH3210,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20220925.0,20221015.0,20221021,20221021,EXP,,CN-AstraZeneca-2022A350567,ASTRAZENECA,,20174.0,DY,,M,Y,72.0,KG,20221021,,MD,CN,,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Therapy partial responder,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pleural thickening,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pericardial effusion,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Haemothorax,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pleural calcification,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malignant neoplasm progression,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Gallbladder disorder,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Nephrolithiasis,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vocal cord paresis,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909661,21490966,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dysphonia,,2022,Q4,1,I,20220828.0,20221014.0,20221021,20221021,EXP,,PT-009507513-2210PRT006867,MERCK,,67.0,YR,,M,Y,,,20221021,,MD,PT,PT,2022,Q4,Elderly
214909861,21490986,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",100.0,MG,Y,U,,,,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20210623.0,20221016.0,20221021,20221021,EXP,,GB-MYLANLABS-2022M1115401,MYLAN,,70.0,YR,,F,Y,,,20221021,,MD,GB,GB,2022,Q4,Elderly
214909861,21490986,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",100.0,MG,Y,U,,,,10.0,MG,,QD,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,20210623.0,20221016.0,20221021,20221021,EXP,,GB-MYLANLABS-2022M1115401,MYLAN,,70.0,YR,,F,Y,,,20221021,,MD,GB,GB,2022,Q4,Elderly
214909902,21490990,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,,,,,,,,Tablet,,2022,Q4,Dyspnoea exertional,,2022,Q4,2,F,20221013.0,20221028.0,20221021,20221108,EXP,,JP-MYLANLABS-2022M1115283,MYLAN,,9.0,DEC,,F,Y,,,20221108,,MD,JP,JP,2022,Q4,Child
214909902,21490990,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10,,,,,,,,,,Tablet,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20221013.0,20221028.0,20221021,20221108,EXP,,JP-MYLANLABS-2022M1115283,MYLAN,,9.0,DEC,,F,Y,,,20221108,,MD,JP,JP,2022,Q4,Child
214911772,21491177,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Film-coated tablet,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20220103.0,20221011.0,20221021,20221101,EXP,FR-AFSSAPS-PC20222502,FR-MYLANLABS-2022M1116084,MYLAN,,58.0,YR,,F,Y,63.0,KG,20221101,,CN,FR,FR,2022,Q4,Adult
214911772,21491177,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Film-coated tablet,,2022,Q4,Burning sensation,,2022,Q4,2,F,20220103.0,20221011.0,20221021,20221101,EXP,FR-AFSSAPS-PC20222502,FR-MYLANLABS-2022M1116084,MYLAN,,58.0,YR,,F,Y,63.0,KG,20221101,,CN,FR,FR,2022,Q4,Adult
214911772,21491177,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Film-coated tablet,,2022,Q4,Limb discomfort,,2022,Q4,2,F,20220103.0,20221011.0,20221021,20221101,EXP,FR-AFSSAPS-PC20222502,FR-MYLANLABS-2022M1116084,MYLAN,,58.0,YR,,F,Y,63.0,KG,20221101,,CN,FR,FR,2022,Q4,Adult
214911772,21491177,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,Film-coated tablet,,2022,Q4,Mobility decreased,,2022,Q4,2,F,20220103.0,20221011.0,20221021,20221101,EXP,FR-AFSSAPS-PC20222502,FR-MYLANLABS-2022M1116084,MYLAN,,58.0,YR,,F,Y,63.0,KG,20221101,,CN,FR,FR,2022,Q4,Adult
214918811,21491881,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Amaurosis,,2022,Q4,1,I,20220214.0,20221014.0,20221021,20221021,EXP,,FR-AstraZeneca-2022A349792,ASTRAZENECA,,80.0,YR,,F,Y,,,20221021,,MD,FR,,2022,Q4,Elderly
214929351,21492935,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Gamma-glutamyltransferase increased,,2022,Q4,1,I,,20221014.0,20221021,20221021,EXP,,FR-AstraZeneca-2022A350387,ASTRAZENECA,,64.0,YR,,M,Y,,,20221021,,MD,FR,,2022,Q4,Adult
214929361,21492936,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Genital erythema,,2022,Q4,1,I,20220624.0,20221014.0,20221021,20221021,EXP,,FR-AstraZeneca-2022A346402,ASTRAZENECA,,67.0,YR,,M,Y,80.0,KG,20221021,,MD,FR,,2022,Q4,Elderly
214935992,21493599,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,2,F,20221008.0,20221015.0,20221021,20221024,EXP,,CN-AstraZeneca-2022A349954,ASTRAZENECA,,22047.0,DY,,M,Y,76.0,KG,20221024,,MD,CN,,2022,Q4,Elderly
214935992,21493599,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pancreatitis acute,,2022,Q4,2,F,20221008.0,20221015.0,20221021,20221024,EXP,,CN-AstraZeneca-2022A349954,ASTRAZENECA,,22047.0,DY,,M,Y,76.0,KG,20221024,,MD,CN,,2022,Q4,Elderly
214940761,21494076,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,20220830.0,20221012.0,20221021,20221021,EXP,,CH-AstraZeneca-2022A353064,ASTRAZENECA,,74.0,YR,,F,Y,,,20221021,,MD,CH,,2022,Q4,Elderly
214940761,21494076,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,20220830.0,20221012.0,20221021,20221021,EXP,,CH-AstraZeneca-2022A353064,ASTRAZENECA,,74.0,YR,,F,Y,,,20221021,,MD,CH,,2022,Q4,Elderly
214940761,21494076,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Confusional state,,2022,Q4,1,I,20220830.0,20221012.0,20221021,20221021,EXP,,CH-AstraZeneca-2022A353064,ASTRAZENECA,,74.0,YR,,F,Y,,,20221021,,MD,CH,,2022,Q4,Elderly
214959671,21495967,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (early afternoon),,,Y,,,,,10.0,MG,,,2022,Q4,Pneumonia,,2022,Q4,1,I,20211008.0,20221013.0,20221022,20221022,EXP,GB-MHRA-ADR 26770854,GB-Accord-282589,ACCORD,,39.0,YR,,M,Y,,,20221022,,MD,GB,GB,2022,Q4,Adult
214959671,21495967,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg (early afternoon),,,Y,,,,,10.0,MG,,,2022,Q4,Dizziness,,2022,Q4,1,I,20211008.0,20221013.0,20221022,20221022,EXP,GB-MHRA-ADR 26770854,GB-Accord-282589,ACCORD,,39.0,YR,,M,Y,,,20221022,,MD,GB,GB,2022,Q4,Adult
214966671,21496667,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1x/day)",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221021.0,20221022,20221022,EXP,,NVSC2022FR237556,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221022,,MD,FR,FR,2022,Q4,Adult
214966671,21496667,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1x/day)",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,1,I,20220824.0,20221021.0,20221022,20221022,EXP,,NVSC2022FR237556,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221022,,MD,FR,FR,2022,Q4,Adult
214966671,21496667,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1x/day)",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220824.0,20221021.0,20221022,20221022,EXP,,NVSC2022FR237556,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221022,,MD,FR,FR,2022,Q4,Adult
214966671,21496667,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD (1x/day)",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220824.0,20221021.0,20221022,20221022,EXP,,NVSC2022FR237556,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221022,,MD,FR,FR,2022,Q4,Adult
214991261,21499126,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,Tablet,QD,2022,Q4,Gingival bleeding,,2022,Q4,1,I,,20221020.0,20221024,20221024,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-198821",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,,,20221024,,HP,CA,CA,2022,Q4,Elderly
214991261,21499126,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221020.0,20221024,20221024,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-198821",BOEHRINGER INGELHEIM,,73.0,YR,E,F,Y,,,20221024,,HP,CA,CA,2022,Q4,Elderly
214992901,21499290,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10mg QD)",30.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,20211118.0,20221019.0,20221024,20221024,EXP,,GB-MYLANLABS-2022M1116778,MYLAN,,64.0,YR,,M,Y,,,20221024,,MD,GB,GB,2022,Q4,Adult
214995411,21499541,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5mg/day,,,,,,,,,,,,2022,Q4,Intracardiac mass,,2022,Q4,1,I,,20221019.0,20221024,20221024,EXP,,JP-DSJP-DSJ-2022-137868,DAIICHI,"Fukudome Y, Hieda M, Masui S, Yokoyama T, Futami S, Moriyama S, et al.. Case Report: Bronchogenic Cyst in the Right Atrium of a Young Woman. Frontiers in Cardiovascular Medicine. 2022;1-7",31.0,YR,,F,Y,64.6,KG,20221024,,MD,JP,JP,2022,Q4,Young Adult
215014591,21501459,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",110.0,MG,,,,,,5.0,MG,,QD,2022,Q4,Prerenal failure,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215014591,21501459,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",110.0,MG,,,,,,5.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215014591,21501459,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",110.0,MG,,,,,,5.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215014591,21501459,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK (restarted),110.0,MG,,,,,,,,,,2022,Q4,Prerenal failure,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215014591,21501459,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK (restarted),110.0,MG,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215014591,21501459,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK (restarted),110.0,MG,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20220801.0,20221014.0,20221025,20221025,EXP,,JP-NOVOPROD-960341,NOVO NORDISK,,44.0,YR,,M,Y,,,20221025,,MD,JP,JP,2022,Q4,Adult
215018431,21501843,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day,10 mg/jour",,,Y,,,,,10.0,MG,Coated tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221017.0,20221025,20221025,EXP,,FR-AUROBINDO-AUR-APL-2022-044162,AUROBINDO,,76.0,YR,,F,Y,75.0,KG,20221025,,PH,FR,FR,2022,Q4,Elderly
215018431,21501843,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day,10 mg/jour",,,Y,,,,,10.0,MG,Coated tablet,QD,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221017.0,20221025,20221025,EXP,,FR-AUROBINDO-AUR-APL-2022-044162,AUROBINDO,,76.0,YR,,F,Y,75.0,KG,20221025,,PH,FR,FR,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Regurgitation,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Tooth disorder,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Haemoglobin increased,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Constipation,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Muscle spasms,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Product use issue,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Dry mouth,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Increased appetite,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Headache,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Pain,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Flatulence,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Inflammation,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Gastritis,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Dysgeusia,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Gastrointestinal sounds abnormal,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Weight increased,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Drug intolerance,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215034131,21503413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PF0064,,202293.0,,,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220501.0,20221017.0,20221025,20221025,EXP,,MX-AstraZeneca-2022A353001,ASTRAZENECA,,699.0,MON,,F,Y,63.0,KG,20221025,,CN,MX,,2022,Q4,Elderly
215038541,21503854,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Bronchitis,,2022,Q4,1,I,,20221017.0,20221025,20221025,EXP,,ZA-AstraZeneca-2022A348667,ASTRAZENECA,,60.0,YR,,F,Y,,,20221025,,CN,ZA,,2022,Q4,Adult
215038541,21503854,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20221017.0,20221025,20221025,EXP,,ZA-AstraZeneca-2022A348667,ASTRAZENECA,,60.0,YR,,F,Y,,,20221025,,CN,ZA,,2022,Q4,Adult
215040881,21504088,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Phimosis,,2022,Q4,1,I,,20221017.0,20221025,20221025,EXP,,FR-AstraZeneca-2022A351039,ASTRAZENECA,,72.0,YR,,M,Y,,,20221025,,MD,FR,,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal distension,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Chest discomfort,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215041581,21504158,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",80.0,MG,U,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220203.0,20221022.0,20221025,20221025,EXP,,CN-PFIZER INC-PV202200088138,PFIZER,,75.0,YR,,F,Y,63.0,KG,20221025,,HP,CN,CN,2022,Q4,Elderly
215042981,21504298,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Syncope,,2022,Q4,1,I,20221019.0,20221019.0,20221025,20221025,EXP,,NVSC2022EG238884,NOVARTIS,,77.0,YR,,F,Y,,,20221025,,CN,EG,EG,2022,Q4,Elderly
215042981,21504298,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20221019.0,20221019.0,20221025,20221025,EXP,,NVSC2022EG238884,NOVARTIS,,77.0,YR,,F,Y,,,20221025,,CN,EG,EG,2022,Q4,Elderly
215042981,21504298,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20221019.0,20221019.0,20221025,20221025,EXP,,NVSC2022EG238884,NOVARTIS,,77.0,YR,,F,Y,,,20221025,,CN,EG,EG,2022,Q4,Elderly
215042981,21504298,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Somnolence,,2022,Q4,1,I,20221019.0,20221019.0,20221025,20221025,EXP,,NVSC2022EG238884,NOVARTIS,,77.0,YR,,F,Y,,,20221025,,CN,EG,EG,2022,Q4,Elderly
215043542,21504354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketoacidosis,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Interstitial lung disease,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketoacidosis,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215043542,21504354,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Interstitial lung disease,,2022,Q4,2,F,20220517.0,20221221.0,20221025,20221227,EXP,,JP-AstraZeneca-2022A264123,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,MD,JP,,2022,Q4,Elderly
215044602,21504460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1120.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Bladder cancer,,2022,Q4,2,F,20220720.0,20221212.0,20221025,20221220,EXP,,JP-AstraZeneca-2022A265722,ASTRAZENECA,,80.0,YR,,M,Y,,,20221220,,MD,JP,,2022,Q4,Elderly
215044602,21504460,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1120.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,2,F,20220720.0,20221212.0,20221025,20221220,EXP,,JP-AstraZeneca-2022A265722,ASTRAZENECA,,80.0,YR,,M,Y,,,20221220,,MD,JP,,2022,Q4,Elderly
215055831,21505583,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,100.0,MG,Y,U,,,,10.0,MG,Tablet,,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,20210623.0,20221016.0,20221026,20221026,EXP,,GB-AUROBINDO-AUR-APL-2022-043919,AUROBINDO,,70.0,YR,,F,Y,,,20221026,,MD,GB,GB,2022,Q4,Elderly
215055831,21505583,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,100.0,MG,Y,U,,,,10.0,MG,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20210623.0,20221016.0,20221026,20221026,EXP,,GB-AUROBINDO-AUR-APL-2022-043919,AUROBINDO,,70.0,YR,,F,Y,,,20221026,,MD,GB,GB,2022,Q4,Elderly
215064281,21506428,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Genital candidiasis,,2022,Q4,1,I,,20221021.0,20221026,20221026,EXP,,GB-AstraZeneca-2022A352962,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20221026,,MD,GB,,2022,Q4,Adult
215064281,21506428,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fungaemia,,2022,Q4,1,I,,20221021.0,20221026,20221026,EXP,,GB-AstraZeneca-2022A352962,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20221026,,MD,GB,,2022,Q4,Adult
215064281,21506428,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Candida sepsis,,2022,Q4,1,I,,20221021.0,20221026,20221026,EXP,,GB-AstraZeneca-2022A352962,ASTRAZENECA,,56.0,YR,,F,Y,66.4,KG,20221026,,MD,GB,,2022,Q4,Adult
215064332,21506433,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",170.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,2,F,20220824.0,20221109.0,20221026,20221114,EXP,,FR-AstraZeneca-2022A352252,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221114,,MD,FR,,2022,Q4,Adult
215064332,21506433,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",170.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,2,F,20220824.0,20221109.0,20221026,20221114,EXP,,FR-AstraZeneca-2022A352252,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221114,,MD,FR,,2022,Q4,Adult
215064332,21506433,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",170.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Malnutrition,,2022,Q4,2,F,20220824.0,20221109.0,20221026,20221114,EXP,,FR-AstraZeneca-2022A352252,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221114,,MD,FR,,2022,Q4,Adult
215064332,21506433,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",170.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,2,F,20220824.0,20221109.0,20221026,20221114,EXP,,FR-AstraZeneca-2022A352252,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221114,,MD,FR,,2022,Q4,Adult
215080221,21508022,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221019.0,20221026,20221026,EXP,,FR-AstraZeneca-2022A350102,ASTRAZENECA,,76.0,YR,,F,Y,75.0,KG,20221026,,MD,FR,,2022,Q4,Elderly
215080221,21508022,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221019.0,20221026,20221026,EXP,,FR-AstraZeneca-2022A350102,ASTRAZENECA,,76.0,YR,,F,Y,75.0,KG,20221026,,MD,FR,,2022,Q4,Elderly
215085912,21508591,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,2,F,20220401.0,20221026.0,20221026,20221103,EXP,,JP-AstraZeneca-2022A265801,ASTRAZENECA,,90.0,YR,,M,Y,,,20221103,,MD,JP,,2022,Q4,Elderly
215085912,21508591,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q4,Hypokalaemia,,2022,Q4,2,F,20220401.0,20221026.0,20221026,20221103,EXP,,JP-AstraZeneca-2022A265801,ASTRAZENECA,,90.0,YR,,M,Y,,,20221103,,MD,JP,,2022,Q4,Elderly
215085912,21508591,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablet,QD,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,20220401.0,20221026.0,20221026,20221103,EXP,,JP-AstraZeneca-2022A265801,ASTRAZENECA,,90.0,YR,,M,Y,,,20221103,,MD,JP,,2022,Q4,Elderly
215088591,21508859,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,,20221018.0,20221026,20221026,EXP,,ZA-AstraZeneca-2022A350190,ASTRAZENECA,,81.0,YR,,M,Y,,,20221026,,CN,ZA,,2022,Q4,Elderly
215090702,21509070,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,,QD,2022,Q4,Cardiac disorder,,2022,Q4,2,F,,20221103.0,20221026,20221108,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2022-127055,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,92.0,KG,20221108,,MD,FR,FR,2022,Q4,Elderly
215109871,21510987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,QD,2022,Q4,Arthropathy,,2022,Q4,1,I,20220101.0,20221019.0,20221026,20221026,EXP,,US-JNJFOC-20221037708,JOHNSON AND JOHNSON,,9.0,DEC,E,M,Y,85.352,KG,20221027,,CN,US,US,2022,Q4,Child
215109871,21510987,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,5.0,MG,,QD,2022,Q4,Haemarthrosis,Haemarthrosis,2022,Q4,1,I,20220101.0,20221019.0,20221026,20221026,EXP,,US-JNJFOC-20221037708,JOHNSON AND JOHNSON,,9.0,DEC,E,M,Y,85.352,KG,20221027,,CN,US,US,2022,Q4,Child
215119851,21511985,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",60.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Syncope,,2022,Q4,1,I,20220825.0,20221018.0,20221027,20221027,EXP,,GB-AUROBINDO-AUR-APL-2022-044215,AUROBINDO,,83.0,YR,,F,Y,,,20221027,,MD,GB,GB,2022,Q4,Elderly
215126772,21512677,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Fatigue,,2022,Q4,2,F,20220101.0,20221130.0,20221027,20221207,EXP,,NVSC2022PT239457,NOVARTIS,,62.0,YR,,F,Y,,,20221207,,PH,PT,PT,2022,Q4,Adult
215126772,21512677,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Blood loss anaemia,,2022,Q4,2,F,20220101.0,20221130.0,20221027,20221207,EXP,,NVSC2022PT239457,NOVARTIS,,62.0,YR,,F,Y,,,20221207,,PH,PT,PT,2022,Q4,Adult
215126772,21512677,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Aortic perforation,,2022,Q4,2,F,20220101.0,20221130.0,20221027,20221207,EXP,,NVSC2022PT239457,NOVARTIS,,62.0,YR,,F,Y,,,20221207,,PH,PT,PT,2022,Q4,Adult
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Malaise,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Back pain,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Product physical issue,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Dyspnoea,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Chest discomfort,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product physical issue,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product physical issue,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malaise,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Back pain,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product physical issue,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215129062,21512906,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221006.0,20221116.0,20221027,20221124,EXP,,NVSC2022BR229920,NOVARTIS,,78.0,YR,,F,Y,59.0,KG,20221124,,CN,BR,BR,2022,Q4,Elderly
215136331,21513633,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Palpitations,,2022,Q4,1,I,,20221017.0,20221027,20221027,EXP,,CA-TEVA-2022-CA-2819633,TEVA,,74.0,YR,E,F,Y,,,20221027,,HP,CA,CA,2022,Q4,Elderly
215137871,21513787,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,,20221017.0,20221027,20221027,EXP,,CA-TEVA-2022-CA-2819627,TEVA,,65.0,YR,E,M,Y,,,20221027,,HP,CA,CA,2022,Q4,Elderly
215141411,21514141,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"strength : 10 mg, Unit dose: 1 DF , frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,Film-coated tablet,,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20220816.0,20221017.0,20221027,20221027,EXP,FR-AFSSAPS-NY20222704,FR-TEVA-2022-FR-2819164,TEVA,,58.0,YR,A,F,Y,78.0,KG,20221027,,MD,FR,FR,2022,Q4,Adult
215141841,21514184,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,Tablet,,2022,Q4,Angina pectoris,,2022,Q4,1,I,20221022.0,20221024.0,20221027,20221027,EXP,,GB-AstraZeneca-2022A355852,ASTRAZENECA,,18149.0,DY,,F,Y,,,20221027,,MD,GB,,2022,Q4,Elderly
215142181,21514218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",80.0,MG,Y,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220212.0,20221022.0,20221027,20221027,EXP,,NVSC2022CN241035,NOVARTIS,,77.0,YR,,M,Y,70.0,KG,20221027,,HP,CN,CN,2022,Q4,Elderly
215142181,21514218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",80.0,MG,Y,,2107142,,,10.0,MG,Tablet,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220212.0,20221022.0,20221027,20221027,EXP,,NVSC2022CN241035,NOVARTIS,,77.0,YR,,M,Y,70.0,KG,20221027,,HP,CN,CN,2022,Q4,Elderly
215145992,21514599,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7310.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood uric acid increased,,2022,Q4,2,F,20220101.0,20221019.0,20221027,20221104,EXP,,BG-AstraZeneca-2022A353472,ASTRAZENECA,,72.0,YR,,F,Y,75.0,KG,20221104,,MD,BG,,2022,Q4,Elderly
215149412,21514941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,2107142,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Anaemia,,2022,Q4,2,F,20220203.0,20221022.0,20221027,20221028,EXP,,CN-AstraZeneca-2022A357324,ASTRAZENECA,,27517.0,DY,,F,Y,63.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215149412,21514941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,2107142,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Chest discomfort,,2022,Q4,2,F,20220203.0,20221022.0,20221027,20221028,EXP,,CN-AstraZeneca-2022A357324,ASTRAZENECA,,27517.0,DY,,F,Y,63.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215149412,21514941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,U,,2107142,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,2,F,20220203.0,20221022.0,20221027,20221028,EXP,,CN-AstraZeneca-2022A357324,ASTRAZENECA,,27517.0,DY,,F,Y,63.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215151131,21515113,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,NC2572,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hepatic function abnormal,,2022,Q4,1,I,20221015.0,20221019.0,20221027,20221027,EXP,,CN-AstraZeneca-2022A352963,ASTRAZENECA,,21550.0,DY,,M,Y,73.0,KG,20221027,,MD,CN,,2022,Q4,Elderly
215159331,21515933,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Unknown,,,U,,,,202293.0,,,,,2022,Q4,Vision blurred,,2022,Q4,1,I,20221019.0,20221021.0,20221027,20221027,EXP,,GB-AstraZeneca-2022A352953,ASTRAZENECA,,53.0,YR,,F,Y,,,20221027,,MD,GB,,2022,Q4,Adult
215159331,21515933,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,take one daily,,,,,,,,,,,,2022,Q4,Vision blurred,,2022,Q4,1,I,20221019.0,20221021.0,20221027,20221027,EXP,,GB-AstraZeneca-2022A352953,ASTRAZENECA,,53.0,YR,,F,Y,,,20221027,,MD,GB,,2022,Q4,Adult
215165522,21516552,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Blood pressure systolic increased,,2022,Q4,2,F,,20221121.0,20221027,20221125,EXP,,NVSJ2022JP099795,NOVARTIS,,85.0,YR,,F,Y,,,20221125,,MD,JP,JP,2022,Q4,Elderly
215165522,21516552,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Delirium,,2022,Q4,2,F,,20221121.0,20221027,20221125,EXP,,NVSJ2022JP099795,NOVARTIS,,85.0,YR,,F,Y,,,20221125,,MD,JP,JP,2022,Q4,Elderly
215165522,21516552,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Blood pressure systolic decreased,,2022,Q4,2,F,,20221121.0,20221027,20221125,EXP,,NVSJ2022JP099795,NOVARTIS,,85.0,YR,,F,Y,,,20221125,,MD,JP,JP,2022,Q4,Elderly
215165522,21516552,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Mental disorder,,2022,Q4,2,F,,20221121.0,20221027,20221125,EXP,,NVSJ2022JP099795,NOVARTIS,,85.0,YR,,F,Y,,,20221125,,MD,JP,JP,2022,Q4,Elderly
215165522,21516552,14,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Concomitant disease aggravated,,2022,Q4,2,F,,20221121.0,20221027,20221125,EXP,,NVSJ2022JP099795,NOVARTIS,,85.0,YR,,F,Y,,,20221125,,MD,JP,JP,2022,Q4,Elderly
215167892,21516789,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,2,F,,20221122.0,20221028,20221128,EXP,,NVSJ2022JP099894,NOVARTIS,,89.0,YR,,F,Y,,,20221129,,MD,JP,JP,2022,Q4,Elderly
215167892,21516789,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,2,F,,20221122.0,20221028,20221128,EXP,,NVSJ2022JP099894,NOVARTIS,,89.0,YR,,F,Y,,,20221129,,MD,JP,JP,2022,Q4,Elderly
215167892,21516789,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,2,F,,20221122.0,20221028,20221128,EXP,,NVSJ2022JP099894,NOVARTIS,,89.0,YR,,F,Y,,,20221129,,MD,JP,JP,2022,Q4,Elderly
215167892,21516789,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,2,F,,20221122.0,20221028,20221128,EXP,,NVSJ2022JP099894,NOVARTIS,,89.0,YR,,F,Y,,,20221129,,MD,JP,JP,2022,Q4,Elderly
215170454,21517045,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,4,F,20220824.0,20221217.0,20221028,20221231,EXP,,FR-AUROBINDO-AUR-APL-2022-044843,AUROBINDO,,52.0,YR,,M,Y,70.0,KG,20221231,,MD,FR,FR,2022,Q4,Adult
215170454,21517045,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,4,F,20220824.0,20221217.0,20221028,20221231,EXP,,FR-AUROBINDO-AUR-APL-2022-044843,AUROBINDO,,52.0,YR,,M,Y,70.0,KG,20221231,,MD,FR,FR,2022,Q4,Adult
215170454,21517045,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,4,F,20220824.0,20221217.0,20221028,20221231,EXP,,FR-AUROBINDO-AUR-APL-2022-044843,AUROBINDO,,52.0,YR,,M,Y,70.0,KG,20221231,,MD,FR,FR,2022,Q4,Adult
215170454,21517045,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,4,F,20220824.0,20221217.0,20221028,20221231,EXP,,FR-AUROBINDO-AUR-APL-2022-044843,AUROBINDO,,52.0,YR,,M,Y,70.0,KG,20221231,,MD,FR,FR,2022,Q4,Adult
215180271,21518027,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Neoplasm malignant,,2022,Q4,1,I,,20221025.0,20221028,20221028,EXP,,ZA-AstraZeneca-2022A358935,ASTRAZENECA,,70.0,YR,,F,Y,,,20221028,,CN,ZA,,2022,Q4,Elderly
215180271,21518027,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Organ failure,,2022,Q4,1,I,,20221025.0,20221028,20221028,EXP,,ZA-AstraZeneca-2022A358935,ASTRAZENECA,,70.0,YR,,F,Y,,,20221028,,CN,ZA,,2022,Q4,Elderly
215191121,21519112,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,20220920.0,20221025.0,20221028,20221028,EXP,,RU-AstraZeneca-2022A358766,ASTRAZENECA,,28930.0,DY,,M,Y,65.0,KG,20221028,,MD,RU,,2022,Q4,Elderly
215191121,21519112,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,COVID-19,,2022,Q4,1,I,20220920.0,20221025.0,20221028,20221028,EXP,,RU-AstraZeneca-2022A358766,ASTRAZENECA,,28930.0,DY,,M,Y,65.0,KG,20221028,,MD,RU,,2022,Q4,Elderly
215193981,21519398,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Pancreatitis acute,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Renal failure,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Pancreatitis acute,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Renal failure,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215193981,21519398,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,65.0,MG,Y,,NH3268,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220921.0,20221021.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A355260,ASTRAZENECA,,84.0,YR,,F,Y,50.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215194193,21519419,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Febrile neutropenia,,2022,Q4,3,F,20220901.0,20221206.0,20221028,20221212,EXP,,JP-ROCHE-3206665,ROCHE,,78.0,YR,,M,Y,52.0,KG,20221212,,PH,JP,JP,2022,Q4,Elderly
215194193,21519419,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Myelosuppression,,2022,Q4,3,F,20220901.0,20221206.0,20221028,20221212,EXP,,JP-ROCHE-3206665,ROCHE,,78.0,YR,,M,Y,52.0,KG,20221212,,PH,JP,JP,2022,Q4,Elderly
215194193,21519419,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,UNKNOWN,,,,,Tablet,,2022,Q4,Platelet count decreased,,2022,Q4,3,F,20220901.0,20221206.0,20221028,20221212,EXP,,JP-ROCHE-3206665,ROCHE,,78.0,YR,,M,Y,52.0,KG,20221212,,PH,JP,JP,2022,Q4,Elderly
215198572,21519857,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Tablets,,2022,Q4,Hypoxia,,2022,Q4,2,F,20221020.0,20221026.0,20221028,20221102,EXP,,NO-Eisai Medical Research-EC-2022-126720,EISAI,,70.0,YR,E,M,Y,78.6,KG,20221102,,MD,NO,,2022,Q4,Elderly
215198572,21519857,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,10.0,MG,Tablets,,2022,Q4,Infection,,2022,Q4,2,F,20221020.0,20221026.0,20221028,20221102,EXP,,NO-Eisai Medical Research-EC-2022-126720,EISAI,,70.0,YR,E,M,Y,78.6,KG,20221102,,MD,NO,,2022,Q4,Elderly
215210641,21521064,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1140.0,MG,Y,,2010046,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketosis,,2022,Q4,1,I,20220922.0,20221022.0,20221028,20221028,EXP,,CN-AstraZeneca-2022A357213,ASTRAZENECA,,17167.0,DY,,M,Y,90.0,KG,20221028,,MD,CN,,2022,Q4,Elderly
215211302,21521130,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,620.0,MG,Y,,NJ2403,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,20221008.0,20221021.0,20221028,20221117,EXP,,CN-AstraZeneca-2022A355619,ASTRAZENECA,,24486.0,DY,,F,Y,55.0,KG,20221117,,MD,CN,,2022,Q4,Elderly
215211302,21521130,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,620.0,MG,Y,,NJ2403,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,2,F,20221008.0,20221021.0,20221028,20221117,EXP,,CN-AstraZeneca-2022A355619,ASTRAZENECA,,24486.0,DY,,F,Y,55.0,KG,20221117,,MD,CN,,2022,Q4,Elderly
215217311,21521731,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,Y,N,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221028.0,20221028,20221028,EXP,,JP-ANIPHARMA-2022-JP-000457,ANI,"Seki H, Watanabe H, Yorozu T.Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report..A + A Practice.2022;16(3):.",83.0,YR,,F,Y,,,20221028,,MD,JP,JP,2022,Q4,Elderly
215217311,21521731,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,Y,N,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221028.0,20221028,20221028,EXP,,JP-ANIPHARMA-2022-JP-000457,ANI,"Seki H, Watanabe H, Yorozu T.Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report..A + A Practice.2022;16(3):.",83.0,YR,,F,Y,,,20221028,,MD,JP,JP,2022,Q4,Elderly
215217311,21521731,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,Y,N,,,,,,,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,,20221028.0,20221028,20221028,EXP,,JP-ANIPHARMA-2022-JP-000457,ANI,"Seki H, Watanabe H, Yorozu T.Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report..A + A Practice.2022;16(3):.",83.0,YR,,F,Y,,,20221028,,MD,JP,JP,2022,Q4,Elderly
215234251,21523425,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,unknown,,202293.0,,,Tablet,,2022,Q4,Hyperglobulinaemia,,2022,Q4,1,I,,20221021.0,20221029,20221029,EXP,,DE-AstraZeneca-2022A354524,ASTRAZENECA,,60.0,YR,,M,Y,,,20221029,,MD,DE,,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Bacterial infection,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Joint swelling,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236121,21523612,4,C,DAPAGLIFLOZIN PROPANEDIOL MONOH,,2,Oral,,,,,,,,,,,,,2022,Q4,Musculoskeletal stiffness,,2022,Q4,1,I,,20221022.0,20221029,20221029,EXP,CA-MHPD-E2B_05337378,CA-Accord-283832,ACCORD,,48.0,YR,A,M,Y,,,20221029,,HP,CA,CA,2022,Q4,Adult
215236142,21523614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 every 1 Days, also received 1 every .5 Days",,,U,,,,,5.0,MG,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,2,F,,20221102.0,20221029,20221115,EXP,CA-MHPD-E2B_05509952,CA-Accord-283850,ACCORD,,64.0,YR,A,M,Y,89.0,KG,20221115,,HP,CA,CA,2022,Q4,Adult
215236142,21523614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 every 1 Days, also received 1 every .5 Days",,,U,,,,,5.0,MG,Tablet,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221102.0,20221029,20221115,EXP,CA-MHPD-E2B_05509952,CA-Accord-283850,ACCORD,,64.0,YR,A,M,Y,89.0,KG,20221115,,HP,CA,CA,2022,Q4,Adult
215236142,21523614,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"2 every 1 Days, also received 1 every .5 Days",,,U,,,,,5.0,MG,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,,20221102.0,20221029,20221115,EXP,CA-MHPD-E2B_05509952,CA-Accord-283850,ACCORD,,64.0,YR,A,M,Y,89.0,KG,20221115,,HP,CA,CA,2022,Q4,Adult
215237811,21523781,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 Milligram Daily; Therapy end date : Not Asked, unit dose : 10 mg, frequency ; 1 , frequency time",30.0,MG,,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Lower respiratory tract infection,,2022,Q4,1,I,20211118.0,20221019.0,20221029,20221029,EXP,,GB-TEVA-2022-GB-2820231,TEVA,,64.0,YR,A,M,Y,,,20221029,,MD,GB,GB,2022,Q4,Adult
215246951,21524695,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,UNKNOWN,,,,,,,2022,Q4,Diverticulitis,,2022,Q4,1,I,20220927.0,20221027.0,20221030,20221030,EXP,FR-AFSSAPS-TO20223247,FR-ROCHE-3208609,ROCHE,,84.0,YR,,M,Y,102.0,KG,20221030,,MD,FR,FR,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Nephrolithiasis,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Haemothorax,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dysphonia,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pleural calcification,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pericardial effusion,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Gallbladder disorder,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Therapy partial responder,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pleural thickening,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Vocal cord paresis,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215253351,21525335,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Malignant neoplasm progression,,2022,Q4,1,I,20220828.0,20221025.0,20221030,20221030,EXP,,NVSC2022PT240134,NOVARTIS,,67.0,YR,,M,Y,,,20221031,,MD,PT,PT,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Coronary artery stenosis,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiac resynchronisation therapy,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293181,21529318,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Creatinine renal clearance decreased,,2022,Q4,1,I,20220601.0,20221022.0,20221031,20221031,EXP,,ME-JNJFOC-20221058535,JOHNSON AND JOHNSON,,73.0,YR,E,M,Y,100.0,KG,20221031,,MD,ME,ME,2022,Q4,Elderly
215293761,21529376,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",240.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q4,Chest discomfort,,2022,Q4,1,I,20220202.0,20221025.0,20221031,20221031,EXP,,GB-MYLANLABS-2022M1118360,MYLAN,,61.0,YR,,M,Y,,,20221031,,MD,GB,GB,2022,Q4,Adult
215295361,21529536,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q4,Renal failure,,2022,Q4,1,I,20220101.0,20221026.0,20221031,20221031,EXP,,DE-MYLANLABS-2022M1118734,MYLAN,,78.0,YR,,M,Y,,,20221031,,MD,DE,DE,2022,Q4,Elderly
215297841,21529784,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221026.0,20221031,20221031,EXP,,JP-AstraZeneca-2021A803526,ASTRAZENECA,,90.0,YR,,F,Y,,,20221031,,MD,JP,,2022,Q4,Elderly
215297841,21529784,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,,20221026.0,20221031,20221031,EXP,,JP-AstraZeneca-2021A803526,ASTRAZENECA,,90.0,YR,,F,Y,,,20221031,,MD,JP,,2022,Q4,Elderly
215297841,21529784,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oedema,,2022,Q4,1,I,,20221026.0,20221031,20221031,EXP,,JP-AstraZeneca-2021A803526,ASTRAZENECA,,90.0,YR,,F,Y,,,20221031,,MD,JP,,2022,Q4,Elderly
215313711,21531371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,2107142,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220212.0,20221022.0,20221031,20221031,EXP,,CN-AstraZeneca-2022A356673,ASTRAZENECA,,28429.0,DY,,M,Y,70.0,KG,20221031,,MD,CN,,2022,Q4,Elderly
215313711,21531371,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,80.0,MG,Y,,2107142,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220212.0,20221022.0,20221031,20221031,EXP,,CN-AstraZeneca-2022A356673,ASTRAZENECA,,28429.0,DY,,M,Y,70.0,KG,20221031,,MD,CN,,2022,Q4,Elderly
215321761,21532176,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221026.0,20221101,20221101,EXP,,CA-AstraZeneca-2022A358678,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20221101,,MD,CA,,2022,Q4,Adult
215321761,21532176,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221026.0,20221101,20221101,EXP,,CA-AstraZeneca-2022A358678,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20221101,,MD,CA,,2022,Q4,Adult
215321761,21532176,1,PS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221026.0,20221101,20221101,EXP,,CA-AstraZeneca-2022A358678,ASTRAZENECA,,64.0,YR,,M,Y,89.0,KG,20221101,,MD,CA,,2022,Q4,Adult
215323271,21532327,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,20221012.0,20221024.0,20221101,20221101,EXP,,GB-AstraZeneca-2022A354591,ASTRAZENECA,,51.0,YR,,F,Y,71.0,KG,20221101,,MD,GB,,2022,Q4,Adult
215323271,21532327,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20221012.0,20221024.0,20221101,20221101,EXP,,GB-AstraZeneca-2022A354591,ASTRAZENECA,,51.0,YR,,F,Y,71.0,KG,20221101,,MD,GB,,2022,Q4,Adult
215323271,21532327,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,310.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Swelling face,,2022,Q4,1,I,20221012.0,20221024.0,20221101,20221101,EXP,,GB-AstraZeneca-2022A354591,ASTRAZENECA,,51.0,YR,,F,Y,71.0,KG,20221101,,MD,GB,,2022,Q4,Adult
215364561,21536456,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pancreatitis,,2022,Q4,1,I,,20221024.0,20221101,20221101,EXP,,BE-AstraZeneca-2022A356252,ASTRAZENECA,,50.0,YR,,F,Y,108.0,KG,20221101,,MD,BE,,2022,Q4,Adult
215364561,21536456,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pancreatitis,,2022,Q4,1,I,,20221024.0,20221101,20221101,EXP,,BE-AstraZeneca-2022A356252,ASTRAZENECA,,50.0,YR,,F,Y,108.0,KG,20221101,,MD,BE,,2022,Q4,Adult
215379831,21537983,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q4,Urinary retention,,2022,Q4,1,I,,20221024.0,20221101,20221101,EXP,,DE-AstraZeneca-2022A354697,ASTRAZENECA,,82.0,YR,,M,Y,,,20221102,,PH,DE,,2022,Q4,Elderly
215379831,21537983,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,Unknown,,202293.0,,,Tablet,,2022,Q4,Pyuria,,2022,Q4,1,I,,20221024.0,20221101,20221101,EXP,,DE-AstraZeneca-2022A354697,ASTRAZENECA,,82.0,YR,,M,Y,,,20221102,,PH,DE,,2022,Q4,Elderly
215409381,21540938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg AS REQUIRED,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Blood creatinine increased,,2022,Q4,1,I,20220901.0,20221024.0,20221102,20221102,EXP,,BG-AstraZeneca-2022A357048,ASTRAZENECA,,71.0,YR,,M,Y,84.0,KG,20221102,,MD,BG,,2022,Q4,Elderly
215409381,21540938,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg AS REQUIRED,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Blood urea increased,,2022,Q4,1,I,20220901.0,20221024.0,20221102,20221102,EXP,,BG-AstraZeneca-2022A357048,ASTRAZENECA,,71.0,YR,,M,Y,84.0,KG,20221102,,MD,BG,,2022,Q4,Elderly
215412481,21541248,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412481,21541248,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A358695,ASTRAZENECA,,75.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215412541,21541254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,J20170040,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221025.0,20221102,20221102,EXP,,CN-AstraZeneca-2022A358494,ASTRAZENECA,,25202.0,DY,,M,Y,71.0,KG,20221102,,MD,CN,,2022,Q4,Elderly
215412541,21541254,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,J20170040,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220824.0,20221025.0,20221102,20221102,EXP,,CN-AstraZeneca-2022A358494,ASTRAZENECA,,25202.0,DY,,M,Y,71.0,KG,20221102,,MD,CN,,2022,Q4,Elderly
215413401,21541340,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Tubulointerstitial nephritis,,2022,Q4,1,I,,20221025.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A359471,ASTRAZENECA,,77.0,YR,,F,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215416421,21541642,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,1,I,20220101.0,20221024.0,20221102,20221102,EXP,,JP-AstraZeneca-2022A359549,ASTRAZENECA,,80.0,YR,,M,Y,,,20221102,,MD,JP,,2022,Q4,Elderly
215428404,21542840,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,,2022,Q4,Central serous chorioretinopathy,,2022,Q4,4,F,20220702.0,20221219.0,20221102,20221230,EXP,,AU-Calliditas-2022CAL00478,CALLIDITAS THERAPEUTICS,,40.0,YR,A,M,Y,88.0,KG,20221230,,MD,AU,AU,2022,Q4,Adult
215428404,21542840,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,,,,,,10.0,MG,,,2022,Q4,Central serous chorioretinopathy,,2022,Q4,4,F,20220702.0,20221219.0,20221102,20221230,EXP,,AU-Calliditas-2022CAL00478,CALLIDITAS THERAPEUTICS,,40.0,YR,A,M,Y,88.0,KG,20221230,,MD,AU,AU,2022,Q4,Adult
215451652,21545165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cerebral infarction,,2022,Q4,2,F,,20221101.0,20221103,20221109,EXP,,JP-AstraZeneca-2022A360157,ASTRAZENECA,,70.0,YR,,M,Y,,,20221109,,MD,JP,,2022,Q4,Elderly
215451652,21545165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,2,F,,20221101.0,20221103,20221109,EXP,,JP-AstraZeneca-2022A360157,ASTRAZENECA,,70.0,YR,,M,Y,,,20221109,,MD,JP,,2022,Q4,Elderly
215451652,21545165,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood pressure decreased,,2022,Q4,2,F,,20221101.0,20221103,20221109,EXP,,JP-AstraZeneca-2022A360157,ASTRAZENECA,,70.0,YR,,M,Y,,,20221109,,MD,JP,,2022,Q4,Elderly
215456981,21545698,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",240.0,MG,,,,,,10.0,MG,Tablet,QD,2022,Q4,Chest discomfort,,2022,Q4,1,I,20220202.0,20221025.0,20221103,20221103,EXP,,GB-AUROBINDO-AUR-APL-2022-046068,AUROBINDO,,61.0,YR,,M,Y,,,20221103,,MD,GB,GB,2022,Q4,Adult
215470821,21547082,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10mg/day  , form strength : 10 mg",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221024.0,20221103,20221103,EXP,FR-AFSSAPS-GR20222273,FR-TEVA-2022-FR-2820947,TEVA,,76.0,YR,E,F,Y,75.0,KG,20221103,,PH,FR,FR,2022,Q4,Elderly
215470821,21547082,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; 10mg/day  , form strength : 10 mg",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221024.0,20221103,20221103,EXP,FR-AFSSAPS-GR20222273,FR-TEVA-2022-FR-2820947,TEVA,,76.0,YR,E,F,Y,75.0,KG,20221103,,PH,FR,FR,2022,Q4,Elderly
215472051,21547205,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Illness,,2022,Q4,1,I,,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357794,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476281,21547628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,COVID-19,,2022,Q4,1,I,20210101.0,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357743,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476281,21547628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Coma,,2022,Q4,1,I,20210101.0,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357743,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476281,21547628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20210101.0,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357743,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476281,21547628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Asthenia,,2022,Q4,1,I,20210101.0,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357743,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476281,21547628,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Total lung capacity decreased,,2022,Q4,1,I,20210101.0,20221026.0,20221103,20221103,EXP,,ZA-AstraZeneca-2022A357743,ASTRAZENECA,,63.0,YR,,M,Y,,,20221103,,CN,ZA,,2022,Q4,Adult
215476311,21547631,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221026.0,20221103,20221103,EXP,,CA-AstraZeneca-2022A357558,ASTRAZENECA,,73.0,YR,,F,Y,,,20221103,,MD,CA,,2022,Q4,Elderly
215476311,21547631,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,5.0mg UNKNOWN,,,U,,,,202293.0,5.0,MG,Tablet,,2022,Q4,Treatment noncompliance,,2022,Q4,1,I,,20221026.0,20221103,20221103,EXP,,CA-AstraZeneca-2022A357558,ASTRAZENECA,,73.0,YR,,F,Y,,,20221103,,MD,CA,,2022,Q4,Elderly
215485931,21548593,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,5250.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Anxiety,,2022,Q4,1,I,20220207.0,20221026.0,20221103,20221103,EXP,,GB-AstraZeneca-2022A357379,ASTRAZENECA,,58.0,YR,,F,Y,69.0,KG,20221103,,MD,GB,,2022,Q4,Adult
215485931,21548593,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg once a day,5250.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Medication error,,2022,Q4,1,I,20220207.0,20221026.0,20221103,20221103,EXP,,GB-AstraZeneca-2022A357379,ASTRAZENECA,,58.0,YR,,F,Y,69.0,KG,20221103,,MD,GB,,2022,Q4,Adult
215487871,21548787,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pancreatitis acute,,2022,Q4,1,I,,20221026.0,20221103,20221103,EXP,,CA-AstraZeneca-2022A358629,ASTRAZENECA,,75.0,YR,,M,Y,,,20221103,,MD,CA,,2022,Q4,Elderly
215488911,21548891,7,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,"5mg/1.000 ,5 mg, Twice weekly",,,,,,,,,,,,2022,Q4,Psoriatic arthropathy,,2022,Q4,1,I,,20221025.0,20221103,20221103,EXP,,IE-JNJFOC-20221058850,JOHNSON AND JOHNSON,,44.0,YR,A,F,Y,,,20221103,,HP,IE,IE,2022,Q4,Adult
215498041,21549804,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,Unknown,,,,,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,20221017.0,20221031.0,20221103,20221103,EXP,GR-GREOF-202202178,GR-PFIZER INC-202201267696,PFIZER,,74.0,YR,,M,Y,90.0,KG,20221103,,MD,GR,GR,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Intentional dose omission,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash pruritic,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thirst,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Herpes zoster,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash macular,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blister,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pollakiuria,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rhinorrhoea,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215500122,21550012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,NL0281,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Parosmia,,2022,Q4,2,F,20220501.0,20221028.0,20221103,20221104,EXP,,CA-AstraZeneca-2022A346283,ASTRAZENECA,,71.0,YR,,M,Y,,,20221104,,CN,CA,,2022,Q4,Elderly
215515331,21551533,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1660.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Interstitial lung disease,,2022,Q4,1,I,20201002.0,20221101.0,20221103,20221103,EXP,,CA-ABBVIE-21K-028-3894095-00,ABBVIE,,47.0,YR,,F,Y,,,20221103,,MD,CA,CA,2022,Q4,Adult
215518631,21551863,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1260.0,MG,,,2110161,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,20221023.0,20221027.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A361033,ASTRAZENECA,,53.0,YR,,M,Y,53.0,KG,20221104,,MD,CN,,2022,Q4,Adult
215532691,21553269,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Bacteraemia,,2022,Q4,1,I,20220711.0,20221027.0,20221104,20221104,EXP,,JP-AstraZeneca-2022A329508,ASTRAZENECA,,82.0,YR,,F,Y,,,20221104,,MD,JP,,2022,Q4,Elderly
215532691,21553269,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,270.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220711.0,20221027.0,20221104,20221104,EXP,,JP-AstraZeneca-2022A329508,ASTRAZENECA,,82.0,YR,,F,Y,,,20221104,,MD,JP,,2022,Q4,Elderly
215537131,21553713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20221006.0,20221029.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A363389,ASTRAZENECA,,2511.0,WK,,M,Y,50.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215537131,21553713,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,650.0,MG,Y,U,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,20221006.0,20221029.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A363389,ASTRAZENECA,,2511.0,WK,,M,Y,50.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215538281,21553828,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 Milligram Daily; 10 mg, QD",240.0,MG,,U,,,,10.0,MG,Tablet,QD,2022,Q4,Chest discomfort,,2022,Q4,1,I,20220202.0,20221025.0,20221104,20221104,EXP,,GB-TEVA-2022-GB-2821639,TEVA,,61.0,YR,A,M,Y,,,20221104,,MD,GB,GB,2022,Q4,Adult
215541061,21554106,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CN-ROCHE-3211475,ROCHE,,53.0,YR,,F,Y,,,20221103,,MD,CN,,2022,Q4,Adult
215541061,21554106,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myelosuppression,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CN-ROCHE-3211475,ROCHE,,53.0,YR,,F,Y,,,20221103,,MD,CN,,2022,Q4,Adult
215541061,21554106,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CN-ROCHE-3211475,ROCHE,,53.0,YR,,F,Y,,,20221103,,MD,CN,,2022,Q4,Adult
215542411,21554241,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Treatment failure,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,US-ROCHE-3211981,ROCHE,,64.0,YR,,,Y,,,20221104,,HP,US,,2022,Q4,Adult
215542411,21554241,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cytomegalovirus infection,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,US-ROCHE-3211981,ROCHE,,64.0,YR,,,Y,,,20221104,,HP,US,,2022,Q4,Adult
215552382,21555238,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg OM)",,,,,,,,10.0,MG,,QD,2022,Q4,Jaundice,,2022,Q4,2,F,20220101.0,20221111.0,20221104,20221114,EXP,,GB-MYLANLABS-2022M1121182,MYLAN,,49.0,YR,,M,Y,144.8,KG,20221114,,HP,GB,GB,2022,Q4,Adult
215552382,21555238,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg OM)",,,,,,,,10.0,MG,,QD,2022,Q4,Biliary obstruction,,2022,Q4,2,F,20220101.0,20221111.0,20221104,20221114,EXP,,GB-MYLANLABS-2022M1121182,MYLAN,,49.0,YR,,M,Y,144.8,KG,20221114,,HP,GB,GB,2022,Q4,Adult
215552382,21555238,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg OM)",,,,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain,,2022,Q4,2,F,20220101.0,20221111.0,20221104,20221114,EXP,,GB-MYLANLABS-2022M1121182,MYLAN,,49.0,YR,,M,Y,144.8,KG,20221114,,HP,GB,GB,2022,Q4,Adult
215554851,21555485,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221021.0,20221104,20221104,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-362400,RANBAXY,,76.0,YR,,F,Y,75.0,KG,20221104,,PH,FR,FR,2022,Q4,Elderly
215554851,21555485,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221021.0,20221104,20221104,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-362400,RANBAXY,,76.0,YR,,F,Y,75.0,KG,20221104,,PH,FR,FR,2022,Q4,Elderly
215557271,21555727,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,2107103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash maculo-papular,,2022,Q4,1,I,20221026.0,20221028.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A361392,ASTRAZENECA,,18366.0,DY,,M,Y,60.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215557271,21555727,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,2107103,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pruritus,,2022,Q4,1,I,20221026.0,20221028.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A361392,ASTRAZENECA,,18366.0,DY,,M,Y,60.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215557281,21555728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In hospitalization from 14/10/2022 to 16/10/2022 administers FORXIGA* 28CPR RIV 10MG: DAPAGLIFLOZ...,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,20221015.0,20221028.0,20221104,20221104,EXP,,IT-AstraZeneca-2022A358738,ASTRAZENECA,,81.0,YR,,M,Y,60.0,KG,20221104,,MD,IT,,2022,Q4,Elderly
215557281,21555728,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In hospitalization from 14/10/2022 to 16/10/2022 administers FORXIGA* 28CPR RIV 10MG: DAPAGLIFLOZ...,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,20221015.0,20221028.0,20221104,20221104,EXP,,IT-AstraZeneca-2022A358738,ASTRAZENECA,,81.0,YR,,M,Y,60.0,KG,20221104,,MD,IT,,2022,Q4,Elderly
215557281,21555728,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In hospitalization from 14/10/2022 to 16/10/2022 administers FORXIGA* 28CPR RIV 10MG: DAPAGLIFLOZ...,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,20221015.0,20221028.0,20221104,20221104,EXP,,IT-AstraZeneca-2022A358738,ASTRAZENECA,,81.0,YR,,M,Y,60.0,KG,20221104,,MD,IT,,2022,Q4,Elderly
215557281,21555728,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In hospitalization from 14/10/2022 to 16/10/2022 administers FORXIGA* 28CPR RIV 10MG: DAPAGLIFLOZ...,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,20221015.0,20221028.0,20221104,20221104,EXP,,IT-AstraZeneca-2022A358738,ASTRAZENECA,,81.0,YR,,M,Y,60.0,KG,20221104,,MD,IT,,2022,Q4,Elderly
215558321,21555832,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20220928.0,20221028.0,20221104,20221104,EXP,,ZA-AstraZeneca-2022A360151,ASTRAZENECA,,26764.0,DY,,F,Y,,,20221104,,CN,ZA,,2022,Q4,Elderly
215558492,21555849,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,920.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ureterolithiasis,,2022,Q4,2,F,20220101.0,20221118.0,20221104,20221125,EXP,,JP-AstraZeneca-2022A324629,ASTRAZENECA,,60.0,YR,,M,Y,,,20221125,,MD,JP,,2022,Q4,Adult
215558492,21555849,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,920.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,2,F,20220101.0,20221118.0,20221104,20221125,EXP,,JP-AstraZeneca-2022A324629,ASTRAZENECA,,60.0,YR,,M,Y,,,20221125,,MD,JP,,2022,Q4,Adult
215558492,21555849,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,After breakfast,920.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hydronephrosis,,2022,Q4,2,F,20220101.0,20221118.0,20221104,20221125,EXP,,JP-AstraZeneca-2022A324629,ASTRAZENECA,,60.0,YR,,M,Y,,,20221125,,MD,JP,,2022,Q4,Adult
215560901,21556090,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,U,2110182,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Escherichia sepsis,,2022,Q4,1,I,,20221028.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A362026,ASTRAZENECA,,81.0,YR,,F,Y,40.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215560901,21556090,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,45.0,MG,Y,U,2110182,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Fungal urethritis,,2022,Q4,1,I,,20221028.0,20221104,20221104,EXP,,CN-AstraZeneca-2022A362026,ASTRAZENECA,,81.0,YR,,F,Y,40.0,KG,20221104,,MD,CN,,2022,Q4,Elderly
215565061,21556506,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Forxiga 10?mg tbl 1-0-0,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,20220201.0,20221104.0,20221104,20221104,EXP,,"CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-201065",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20221104,,MD,CZ,CZ,2022,Q4,Adult
215565061,21556506,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Forxiga 10?mg tbl 1-0-0,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Angina pectoris,,2022,Q4,1,I,20220201.0,20221104.0,20221104,20221104,EXP,,"CZ-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-201065",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20221104,,MD,CZ,CZ,2022,Q4,Adult
215569921,21556992,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CA-BAUSCH-BL-2022-024747,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221104,,HP,CA,CA,2022,Q4,Adult
215569921,21556992,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CA-BAUSCH-BL-2022-024747,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221104,,HP,CA,CA,2022,Q4,Adult
215569921,21556992,3,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221101.0,20221104,20221104,EXP,,CA-BAUSCH-BL-2022-024747,BAUSCH AND LOMB,,64.0,YR,,M,Y,89.0,KG,20221104,,HP,CA,CA,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Infection,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Cough,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215586511,21558651,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20221029.0,20221107,20221107,EXP,,DE-drreddys-SPO/GER/22/0156739,DR REDDYS,,62.0,YR,A,F,Y,75.0,KG,20221107,,PH,DE,DE,2022,Q4,Adult
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Seizure,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Wrong patient received product,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215597222,21559722,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20221009.0,20221123.0,20221107,20221125,EXP,,IE-AstraZeneca-2022A362670,ASTRAZENECA,,73.0,YR,,F,Y,60.0,KG,20221125,,MD,IE,,2022,Q4,Elderly
215600201,21560020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2205018,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dermatitis exfoliative,,2022,Q4,1,I,20221026.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362620,ASTRAZENECA,,24105.0,DY,,M,Y,,,20221107,,MD,CN,,2022,Q4,Elderly
215600201,21560020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2205018,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Haematuria,,2022,Q4,1,I,20221026.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362620,ASTRAZENECA,,24105.0,DY,,M,Y,,,20221107,,MD,CN,,2022,Q4,Elderly
215600201,21560020,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2205018,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,20221026.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362620,ASTRAZENECA,,24105.0,DY,,M,Y,,,20221107,,MD,CN,,2022,Q4,Elderly
215603051,21560305,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Injury,,2022,Q4,1,I,,20221104.0,20221107,20221107,EXP,,NVSC2022AU249556,NOVARTIS,,56.0,YR,,M,Y,,,20221107,,CN,AU,AU,2022,Q4,Adult
215603051,21560305,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Mobility decreased,,2022,Q4,1,I,,20221104.0,20221107,20221107,EXP,,NVSC2022AU249556,NOVARTIS,,56.0,YR,,M,Y,,,20221107,,CN,AU,AU,2022,Q4,Adult
215603051,21560305,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221104.0,20221107,20221107,EXP,,NVSC2022AU249556,NOVARTIS,,56.0,YR,,M,Y,,,20221107,,CN,AU,AU,2022,Q4,Adult
215603051,21560305,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Disturbance in attention,,2022,Q4,1,I,,20221104.0,20221107,20221107,EXP,,NVSC2022AU249556,NOVARTIS,,56.0,YR,,M,Y,,,20221107,,CN,AU,AU,2022,Q4,Adult
215603051,21560305,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,,20221104.0,20221107,20221107,EXP,,NVSC2022AU249556,NOVARTIS,,56.0,YR,,M,Y,,,20221107,,CN,AU,AU,2022,Q4,Adult
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pleural thickening,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Therapy partial responder,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dysphonia,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pericardial effusion,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vocal cord paresis,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Gallbladder disorder,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pleural calcification,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Haemothorax,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Malignant neoplasm progression,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215604841,21560484,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Nephrolithiasis,,2022,Q4,1,I,20220828.0,20221024.0,20221107,20221107,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202210011238,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20221107,,CN,PT,PT,2022,Q4,Elderly
215607941,21560794,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1,,,,,,,,,,,QD,2022,Q4,Dyspepsia,,2022,Q4,1,I,20221012.0,20221028.0,20221107,20221107,EXP,SE-MPA-2022-020453,SE-EMD Serono-E2B_90089565,EMD SERONO INC,,73.0,YR,E,M,Y,87.0,KG,20221107,,MD,SE,SE,2022,Q4,Elderly
215607941,21560794,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1,,,,,,,,,,,QD,2022,Q4,Back pain,,2022,Q4,1,I,20221012.0,20221028.0,20221107,20221107,EXP,SE-MPA-2022-020453,SE-EMD Serono-E2B_90089565,EMD SERONO INC,,73.0,YR,E,M,Y,87.0,KG,20221107,,MD,SE,SE,2022,Q4,Elderly
215607941,21560794,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1,,,,,,,,,,,QD,2022,Q4,Abdominal discomfort,,2022,Q4,1,I,20221012.0,20221028.0,20221107,20221107,EXP,SE-MPA-2022-020453,SE-EMD Serono-E2B_90089565,EMD SERONO INC,,73.0,YR,E,M,Y,87.0,KG,20221107,,MD,SE,SE,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Pain in extremity,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Nephropathy toxic,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Alanine aminotransferase increased,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Aspartate aminotransferase increased,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215608151,21560815,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,55.0,MG,Y,,NJ2430,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vision blurred,,2022,Q4,1,I,20221006.0,20221030.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A362611,ASTRAZENECA,,24472.0,DY,,M,Y,55.0,KG,20221107,,MD,CN,,2022,Q4,Elderly
215613572,21561357,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10mg/day, UNK",,,D,,,,,,,,,2022,Q4,Sudden cardiac death,,2022,Q4,2,F,,20221115.0,20221107,20221117,EXP,,JP-OTSUKA-2022_050960,OTSUKA,,78.0,YR,,M,Y,,,20221117,,MD,JP,JP,2022,Q4,Elderly
215617011,21561701,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366497,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",61.0,YR,,F,Y,65.0,KG,20221107,,HP,CN,,2022,Q4,Adult
215617011,21561701,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366497,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",61.0,YR,,F,Y,65.0,KG,20221107,,HP,CN,,2022,Q4,Adult
215617011,21561701,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366497,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",61.0,YR,,F,Y,65.0,KG,20221107,,HP,CN,,2022,Q4,Adult
215617011,21561701,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366497,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",61.0,YR,,F,Y,65.0,KG,20221107,,HP,CN,,2022,Q4,Adult
215617021,21561702,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366534,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",71.0,YR,,F,Y,110.0,KG,20221107,,HP,CN,,2022,Q4,Elderly
215617021,21561702,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366534,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",71.0,YR,,F,Y,110.0,KG,20221107,,HP,CN,,2022,Q4,Elderly
215617021,21561702,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366534,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",71.0,YR,,F,Y,110.0,KG,20221107,,HP,CN,,2022,Q4,Elderly
215617021,21561702,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Pancytopenia,,2022,Q4,1,I,,20220930.0,20221107,20221107,EXP,,CN-AstraZeneca-2022A366534,ASTRAZENECA,"Teng J., Li YJ., Shen WC., Li MM.. Linezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series. Infection and Drug Resistance 2022;15:5509-5517.",71.0,YR,,F,Y,110.0,KG,20221107,,HP,CN,,2022,Q4,Elderly
215634131,21563413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg OD,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Vision blurred,,2022,Q4,1,I,20220927.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361103,ASTRAZENECA,,22.0,YR,,F,Y,93.0,KG,20221108,,MD,GB,,2022,Q4,Youth
215634131,21563413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg OD,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,1,I,20220927.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361103,ASTRAZENECA,,22.0,YR,,F,Y,93.0,KG,20221108,,MD,GB,,2022,Q4,Youth
215634131,21563413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg OD,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220927.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361103,ASTRAZENECA,,22.0,YR,,F,Y,93.0,KG,20221108,,MD,GB,,2022,Q4,Youth
215634131,21563413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg OD,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Anuria,,2022,Q4,1,I,20220927.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361103,ASTRAZENECA,,22.0,YR,,F,Y,93.0,KG,20221108,,MD,GB,,2022,Q4,Youth
215634131,21563413,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg OD,10.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Headache,,2022,Q4,1,I,20220927.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361103,ASTRAZENECA,,22.0,YR,,F,Y,93.0,KG,20221108,,MD,GB,,2022,Q4,Youth
215638381,21563838,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,20220620.0,20221027.0,20221108,20221108,EXP,IT-MINISAL02-890429,IT-SA-2022SA446738,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221108,,MD,IT,IT,2022,Q4,Elderly
215640601,21564060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,202293.0,5.0,MG,,QD,2022,Q4,Necrotising fasciitis,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361090,ASTRAZENECA,,88.0,YR,,F,Y,69.0,KG,20221108,,MD,GB,,2022,Q4,Elderly
215649541,21564954,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20221018.0,20221104.0,20221108,20221108,EXP,,US-AstraZeneca-2022A365610,ASTRAZENECA,,756.0,MON,,F,Y,66.1,KG,20221108,,MD,US,,2022,Q4,Elderly
215658901,21565890,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,,2022,Q4,Urosepsis,,2022,Q4,1,I,,20221101.0,20221108,20221108,PER,,US-AstraZeneca-2022A362978,ASTRAZENECA,,86.0,YR,,F,Y,86.6,KG,20221108,,HP,US,,2022,Q4,Elderly
215665322,21566532,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q4,Escherichia bacteraemia,,2022,Q4,2,F,20220922.0,20221114.0,20221108,20221122,EXP,,FR-AstraZeneca-2022A359996,ASTRAZENECA,,89.0,YR,,F,Y,67.0,KG,20221122,,MD,FR,,2022,Q4,Elderly
215665322,21566532,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q4,Pyelonephritis,,2022,Q4,2,F,20220922.0,20221114.0,20221108,20221122,EXP,,FR-AstraZeneca-2022A359996,ASTRAZENECA,,89.0,YR,,F,Y,67.0,KG,20221122,,MD,FR,,2022,Q4,Elderly
215665322,21566532,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q4,Vulvovaginitis,,2022,Q4,2,F,20220922.0,20221114.0,20221108,20221122,EXP,,FR-AstraZeneca-2022A359996,ASTRAZENECA,,89.0,YR,,F,Y,67.0,KG,20221122,,MD,FR,,2022,Q4,Elderly
215667052,21566705,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,"10mg, UNK",,,,,,,,,,,,2022,Q4,Marasmus,,2022,Q4,2,F,,20221115.0,20221108,20221117,EXP,,JP-OTSUKA-2022_050961,OTSUKA,,92.0,YR,,F,Y,,,20221117,,MD,JP,JP,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Seizure,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215675832,21567583,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Wrong patient received product,,2022,Q4,2,F,20221009.0,20221125.0,20221108,20221129,EXP,IE-HPRA-2022-099851,IE-009507513-2211IRL001121,MERCK,,73.0,YR,,F,Y,60.0,KG,20221129,,PH,IE,IE,2022,Q4,Elderly
215677061,21567706,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Feeling abnormal,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,ZA-AstraZeneca-2022A364687,ASTRAZENECA,,45.0,YR,,M,Y,,,20221108,,CN,ZA,,2022,Q4,Adult
215677061,21567706,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,ZA-AstraZeneca-2022A364687,ASTRAZENECA,,45.0,YR,,M,Y,,,20221108,,CN,ZA,,2022,Q4,Adult
215677061,21567706,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,ZA-AstraZeneca-2022A364687,ASTRAZENECA,,45.0,YR,,M,Y,,,20221108,,CN,ZA,,2022,Q4,Adult
215677061,21567706,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,ZA-AstraZeneca-2022A364687,ASTRAZENECA,,45.0,YR,,M,Y,,,20221108,,CN,ZA,,2022,Q4,Adult
215677111,21567711,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,Y,,NC2501,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketosis,,2022,Q4,1,I,20221014.0,20221101.0,20221108,20221108,EXP,,CN-AstraZeneca-2022A364008,ASTRAZENECA,,52.0,YR,,M,Y,66.0,KG,20221108,,MD,CN,,2022,Q4,Adult
215677151,21567715,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Syncope,,2022,Q4,1,I,,20221031.0,20221108,20221108,EXP,,ZA-AstraZeneca-2022A367099,ASTRAZENECA,,55.0,YR,,M,Y,,,20221108,,CN,ZA,,2022,Q4,Adult
215679191,21567919,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,N,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Decubitus ulcer,,2022,Q4,1,I,,20221014.0,20221108,20221108,EXP,,JP-AstraZeneca-2022A347934,ASTRAZENECA,,80.0,YR,,M,Y,,,20221108,,PH,JP,,2022,Q4,Elderly
215680901,21568090,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,N,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Phimosis,,2022,Q4,1,I,20221014.0,20221031.0,20221108,20221108,EXP,,GB-AstraZeneca-2022A361137,ASTRAZENECA,,57.0,YR,,M,Y,110.0,KG,20221108,,MD,GB,,2022,Q4,Adult
215686892,21568689,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Haemoglobin decreased,,2022,Q4,2,F,20220412.0,20221111.0,20221108,20221116,EXP,,NVSJ2022JP100512,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221117,,MD,JP,JP,2022,Q4,Elderly
215686892,21568689,2,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,2,F,20220412.0,20221111.0,20221108,20221116,EXP,,NVSJ2022JP100512,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221117,,MD,JP,JP,2022,Q4,Elderly
215688832,21568883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Hypernatraemia,,2022,Q4,2,F,20221019.0,20221109.0,20221108,20221117,EXP,,JP-AstraZeneca-2022A365347,ASTRAZENECA,,52.0,YR,,M,Y,,,20221117,,PH,JP,,2022,Q4,Adult
215688832,21568883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20221019.0,20221109.0,20221108,20221117,EXP,,JP-AstraZeneca-2022A365347,ASTRAZENECA,,52.0,YR,,M,Y,,,20221117,,PH,JP,,2022,Q4,Adult
215688832,21568883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Dehydration,,2022,Q4,2,F,20221019.0,20221109.0,20221108,20221117,EXP,,JP-AstraZeneca-2022A365347,ASTRAZENECA,,52.0,YR,,M,Y,,,20221117,,PH,JP,,2022,Q4,Adult
215688832,21568883,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Femur fracture,,2022,Q4,2,F,20221019.0,20221109.0,20221108,20221117,EXP,,JP-AstraZeneca-2022A365347,ASTRAZENECA,,52.0,YR,,M,Y,,,20221117,,PH,JP,,2022,Q4,Adult
215711211,21571121,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,220.0,MG,Y,,NF2507//2110128,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketosis,,2022,Q4,1,I,20221020.0,20221101.0,20221109,20221109,EXP,,CN-AstraZeneca-2022A365488,ASTRAZENECA,,14210.0,DY,,M,Y,75.0,KG,20221109,,MD,CN,,2022,Q4,Elderly
215719194,21571919,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg,QD (10 MG, 1X/DAY)",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,4,F,20220824.0,20221219.0,20221109,20221220,EXP,,NVSC2022FR251468,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221220,,MD,FR,FR,2022,Q4,Adult
215719194,21571919,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg,QD (10 MG, 1X/DAY)",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,4,F,20220824.0,20221219.0,20221109,20221220,EXP,,NVSC2022FR251468,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221220,,MD,FR,FR,2022,Q4,Adult
215719194,21571919,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg,QD (10 MG, 1X/DAY)",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,4,F,20220824.0,20221219.0,20221109,20221220,EXP,,NVSC2022FR251468,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221220,,MD,FR,FR,2022,Q4,Adult
215719194,21571919,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg,QD (10 MG, 1X/DAY)",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,4,F,20220824.0,20221219.0,20221109,20221220,EXP,,NVSC2022FR251468,NOVARTIS,,52.0,YR,,M,Y,70.0,KG,20221220,,MD,FR,FR,2022,Q4,Adult
215726901,21572690,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221104.0,20221109,20221109,EXP,,RO-AstraZeneca-2022A367385,ASTRAZENECA,,50.0,YR,,M,Y,95.0,KG,20221109,,MD,RO,,2022,Q4,Adult
215726901,21572690,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oedema,,2022,Q4,1,I,,20221104.0,20221109,20221109,EXP,,RO-AstraZeneca-2022A367385,ASTRAZENECA,,50.0,YR,,M,Y,95.0,KG,20221109,,MD,RO,,2022,Q4,Adult
215726901,21572690,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pulmonary hypertension,,2022,Q4,1,I,,20221104.0,20221109,20221109,EXP,,RO-AstraZeneca-2022A367385,ASTRAZENECA,,50.0,YR,,M,Y,95.0,KG,20221109,,MD,RO,,2022,Q4,Adult
215726901,21572690,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221104.0,20221109,20221109,EXP,,RO-AstraZeneca-2022A367385,ASTRAZENECA,,50.0,YR,,M,Y,95.0,KG,20221109,,MD,RO,,2022,Q4,Adult
215732122,21573212,23,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,2,F,20220404.0,20221129.0,20221109,20221202,EXP,,FI-MYLANLABS-2022M1123142,MYLAN,,73.0,YR,,M,Y,82.0,KG,20221202,,HP,FI,FI,2022,Q4,Elderly
215758901,21575890,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,N,,,,10.0,MG,Film Coated Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220906.0,20221103.0,20221110,20221110,EXP,,FR-AUROBINDO-AUR-APL-2022-047610,AUROBINDO,,66.0,YR,,M,Y,103.0,KG,20221110,,MD,FR,FR,2022,Q4,Elderly
215758901,21575890,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,Y,N,,,,10.0,MG,Film Coated Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220906.0,20221103.0,20221110,20221110,EXP,,FR-AUROBINDO-AUR-APL-2022-047610,AUROBINDO,,66.0,YR,,M,Y,103.0,KG,20221110,,MD,FR,FR,2022,Q4,Elderly
215766571,21576657,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg; daily,,,U,,,,,10.0,MG,,,2022,Q4,Body mass index increased,,2022,Q4,1,I,20221010.0,20221101.0,20221110,20221110,EXP,,ZA-SA-2022SA458537,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20221110,,MD,ZA,ZA,2022,Q4,Adult
215766571,21576657,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg; daily,,,U,,,,,10.0,MG,,,2022,Q4,COVID-19,,2022,Q4,1,I,20221010.0,20221101.0,20221110,20221110,EXP,,ZA-SA-2022SA458537,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20221110,,MD,ZA,ZA,2022,Q4,Adult
215766571,21576657,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg; daily,,,U,,,,,10.0,MG,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20221010.0,20221101.0,20221110,20221110,EXP,,ZA-SA-2022SA458537,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20221110,,MD,ZA,ZA,2022,Q4,Adult
215766571,21576657,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg; daily,,,U,,,,,10.0,MG,,,2022,Q4,Pulmonary embolism,,2022,Q4,1,I,20221010.0,20221101.0,20221110,20221110,EXP,,ZA-SA-2022SA458537,SANOFI AVENTIS,,63.0,YR,A,M,Y,,,20221110,,MD,ZA,ZA,2022,Q4,Adult
215768212,21576821,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,,20221108.0,20221110,20221116,EXP,,ZA-AstraZeneca-2022A366366,ASTRAZENECA,,93.0,YR,,F,Y,,,20221116,,MD,ZA,,2022,Q4,Elderly
215768212,21576821,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Choking,,2022,Q4,2,F,,20221108.0,20221110,20221116,EXP,,ZA-AstraZeneca-2022A366366,ASTRAZENECA,,93.0,YR,,F,Y,,,20221116,,MD,ZA,,2022,Q4,Elderly
215768212,21576821,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,,20221108.0,20221110,20221116,EXP,,ZA-AstraZeneca-2022A366366,ASTRAZENECA,,93.0,YR,,F,Y,,,20221116,,MD,ZA,,2022,Q4,Elderly
215770061,21577006,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221102.0,20221110,20221110,EXP,,FR-SA-2022SA461542,SANOFI AVENTIS,,52.0,YR,A,M,Y,70.0,KG,20221110,,MD,FR,FR,2022,Q4,Adult
215770061,21577006,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,1,I,20220824.0,20221102.0,20221110,20221110,EXP,,FR-SA-2022SA461542,SANOFI AVENTIS,,52.0,YR,A,M,Y,70.0,KG,20221110,,MD,FR,FR,2022,Q4,Adult
215770061,21577006,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220824.0,20221102.0,20221110,20221110,EXP,,FR-SA-2022SA461542,SANOFI AVENTIS,,52.0,YR,A,M,Y,70.0,KG,20221110,,MD,FR,FR,2022,Q4,Adult
215770061,21577006,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220824.0,20221102.0,20221110,20221110,EXP,,FR-SA-2022SA461542,SANOFI AVENTIS,,52.0,YR,A,M,Y,70.0,KG,20221110,,MD,FR,FR,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Pain,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Weight increased,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Haematochezia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Systemic infection,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215785811,21578581,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,matin,,,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thrombocytopenia,,2022,Q4,1,I,20220902.0,20221102.0,20221110,20221110,EXP,,CH-AstraZeneca-2022A363209,ASTRAZENECA,,87.0,YR,,M,Y,,,20221110,,MD,CH,,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Unresponsive to stimuli,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Electrocardiogram ST segment elevation,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pulse absent,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Electrocardiogram T wave inversion,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Shock,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Haemodynamic instability,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Myoclonus,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Anuria,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Coronary artery disease,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Respiratory distress,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215786801,21578680,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,1,I,20221017.0,20221108.0,20221110,20221110,EXP,,NVSC2022GR252455,NOVARTIS,,75.0,YR,,M,Y,,,20221110,,MD,GR,GR,2022,Q4,Elderly
215800691,21580069,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221105.0,20221110,20221110,EXP,,JP-AstraZeneca-2022A368988,ASTRAZENECA,,72.0,YR,,,Y,,,20221110,,HP,JP,,2022,Q4,Elderly
215800691,21580069,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Colon cancer,,2022,Q4,1,I,,20221105.0,20221110,20221110,EXP,,JP-AstraZeneca-2022A368988,ASTRAZENECA,,72.0,YR,,,Y,,,20221110,,HP,JP,,2022,Q4,Elderly
215803551,21580355,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,10.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221101.0,20221110,20221110,EXP,,SI-009507513-2211SVN002388,MERCK,,77.0,YR,,M,Y,,,20221110,,MD,SI,SI,2022,Q4,Elderly
215803551,21580355,15,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,10.0,MG,,,2022,Q4,N-terminal prohormone brain natriuretic peptide,,2022,Q4,1,I,,20221101.0,20221110,20221110,EXP,,SI-009507513-2211SVN002388,MERCK,,77.0,YR,,M,Y,,,20221110,,MD,SI,SI,2022,Q4,Elderly
215820421,21582042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220906.0,20221107.0,20221111,20221111,EXP,,FR-AstraZeneca-2022A367322,ASTRAZENECA,,66.0,YR,,M,Y,103.0,KG,20221111,,MD,FR,,2022,Q4,Elderly
215820421,21582042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220906.0,20221107.0,20221111,20221111,EXP,,FR-AstraZeneca-2022A367322,ASTRAZENECA,,66.0,YR,,M,Y,103.0,KG,20221111,,MD,FR,,2022,Q4,Elderly
215832261,21583226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NC2521,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220813.0,20221103.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A366543,ASTRAZENECA,,18628.0,DY,,M,Y,,,20221111,,MD,CN,,2022,Q4,Elderly
215832261,21583226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NC2521,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,20220813.0,20221103.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A366543,ASTRAZENECA,,18628.0,DY,,M,Y,,,20221111,,MD,CN,,2022,Q4,Elderly
215832261,21583226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NC2521,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Tinea cruris,,2022,Q4,1,I,20220813.0,20221103.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A366543,ASTRAZENECA,,18628.0,DY,,M,Y,,,20221111,,MD,CN,,2022,Q4,Elderly
215832261,21583226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NC2521,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Superinfection,,2022,Q4,1,I,20220813.0,20221103.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A366543,ASTRAZENECA,,18628.0,DY,,M,Y,,,20221111,,MD,CN,,2022,Q4,Elderly
215832261,21583226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,NC2521,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Intertrigo,,2022,Q4,1,I,20220813.0,20221103.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A366543,ASTRAZENECA,,18628.0,DY,,M,Y,,,20221111,,MD,CN,,2022,Q4,Elderly
215835001,21583500,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10660.0,MG,Y,,262110079A,,202293.0,10.0,MG,Tablet,QD,2022,Q4,White blood cells urine positive,,2022,Q4,1,I,20190101.0,20221104.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A368327,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20221111,,MD,CN,,2022,Q4,Adult
215835001,21583500,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10660.0,MG,Y,,262110079A,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pollakiuria,,2022,Q4,1,I,20190101.0,20221104.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A368327,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20221111,,MD,CN,,2022,Q4,Adult
215835001,21583500,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10660.0,MG,Y,,262110079A,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,20190101.0,20221104.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A368327,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20221111,,MD,CN,,2022,Q4,Adult
215835001,21583500,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10660.0,MG,Y,,262110079A,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Micturition urgency,,2022,Q4,1,I,20190101.0,20221104.0,20221111,20221111,EXP,,CN-AstraZeneca-2022A368327,ASTRAZENECA,,57.0,YR,,F,Y,70.0,KG,20221111,,MD,CN,,2022,Q4,Adult
215835062,21583506,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Small intestinal obstruction,,2022,Q4,2,F,,20221122.0,20221111,20221130,EXP,,JP-AstraZeneca-2022A368099,ASTRAZENECA,,60.0,YR,,F,Y,73.0,KG,20221130,,MD,JP,,2022,Q4,Adult
215835062,21583506,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,2,F,,20221122.0,20221111,20221130,EXP,,JP-AstraZeneca-2022A368099,ASTRAZENECA,,60.0,YR,,F,Y,73.0,KG,20221130,,MD,JP,,2022,Q4,Adult
215835872,21583587,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1xdd1 x 10 mg (10 mg, 1 Day)",,,D,,,,,10.0,MG,,,2022,Q4,Diabetes mellitus,,2022,Q4,2,F,20210608.0,20221209.0,20221111,20221215,EXP,,"NL-ARBOR PHARMACEUTICALS, LLC-NL-2022ARB002789",ARBOR,,68.0,YR,,M,Y,,,20221215,,HP,NL,NL,2022,Q4,Elderly
215835872,21583587,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1xdd1 x 10 mg (10 mg, 1 Day)",,,D,,,,,10.0,MG,,,2022,Q4,Off label use,,2022,Q4,2,F,20210608.0,20221209.0,20221111,20221215,EXP,,"NL-ARBOR PHARMACEUTICALS, LLC-NL-2022ARB002789",ARBOR,,68.0,YR,,M,Y,,,20221215,,HP,NL,NL,2022,Q4,Elderly
215835872,21583587,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1xdd1 x 10 mg (10 mg, 1 Day)",,,D,,,,,10.0,MG,,,2022,Q4,Malaise,,2022,Q4,2,F,20210608.0,20221209.0,20221111,20221215,EXP,,"NL-ARBOR PHARMACEUTICALS, LLC-NL-2022ARB002789",ARBOR,,68.0,YR,,M,Y,,,20221215,,HP,NL,NL,2022,Q4,Elderly
215838202,21583820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Off label use,,2022,Q4,2,F,20221001.0,20221206.0,20221111,20221214,EXP,,FR-AstraZeneca-2022A368924,ASTRAZENECA,,1104.0,MON,,M,Y,62.0,KG,20221214,,MD,FR,,2022,Q4,Elderly
215838202,21583820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Leukopenia,,2022,Q4,2,F,20221001.0,20221206.0,20221111,20221214,EXP,,FR-AstraZeneca-2022A368924,ASTRAZENECA,,1104.0,MON,,M,Y,62.0,KG,20221214,,MD,FR,,2022,Q4,Elderly
215838202,21583820,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Agranulocytosis,,2022,Q4,2,F,20221001.0,20221206.0,20221111,20221214,EXP,,FR-AstraZeneca-2022A368924,ASTRAZENECA,,1104.0,MON,,M,Y,62.0,KG,20221214,,MD,FR,,2022,Q4,Elderly
215849141,21584914,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,,2022,Q4,Renal disorder,,2022,Q4,1,I,20220610.0,20221104.0,20221111,20221111,EXP,,SE-AstraZeneca-2022A365815,ASTRAZENECA,,67.0,YR,,M,Y,,,20221111,,MD,SE,,2022,Q4,Elderly
215849181,21584918,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vulvovaginal mycotic infection,,2022,Q4,1,I,20220901.0,20221103.0,20221111,20221111,EXP,,DE-AstraZeneca-2022A363929,ASTRAZENECA,,73.0,YR,,F,Y,104.0,KG,20221111,,MD,DE,,2022,Q4,Elderly
215849181,21584918,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20220901.0,20221103.0,20221111,20221111,EXP,,DE-AstraZeneca-2022A363929,ASTRAZENECA,,73.0,YR,,F,Y,104.0,KG,20221111,,MD,DE,,2022,Q4,Elderly
215849181,21584918,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220901.0,20221103.0,20221111,20221111,EXP,,DE-AstraZeneca-2022A363929,ASTRAZENECA,,73.0,YR,,F,Y,104.0,KG,20221111,,MD,DE,,2022,Q4,Elderly
215849181,21584918,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1830.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220901.0,20221103.0,20221111,20221111,EXP,,DE-AstraZeneca-2022A363929,ASTRAZENECA,,73.0,YR,,F,Y,104.0,KG,20221111,,MD,DE,,2022,Q4,Elderly
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Anxiety,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Thrombosis,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial fibrosis,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Type 1 diabetes mellitus,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215868171,21586817,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hyperlipidaemia,,2022,Q4,1,I,19990101.0,20221031.0,20221113,20221113,EXP,,CA-BEH-2022151718,CSL BEHRING,,48.0,YR,A,F,Y,,,20221113,,CN,CA,CA,2022,Q4,Adult
215887361,21588736,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Sudden cardiac death,,2022,Q4,1,I,,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A371925,ASTRAZENECA,,56.0,YR,,M,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215911111,21591111,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,1,I,20210527.0,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1123724,MYLAN,,70.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215911111,21591111,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Testicular swelling,,2022,Q4,1,I,20210527.0,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1123724,MYLAN,,70.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215911111,21591111,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Testicular pain,,2022,Q4,1,I,20210527.0,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1123724,MYLAN,,70.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215911111,21591111,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Product monitoring error,,2022,Q4,1,I,20210527.0,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1123724,MYLAN,,70.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215919472,21591947,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,2,F,20221024.0,20221222.0,20221114,20221227,EXP,,NVSC2022JP253284,NOVARTIS,,89.0,YR,,F,Y,,,20221227,,MD,JP,JP,2022,Q4,Elderly
215919472,21591947,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Shock,,2022,Q4,2,F,20221024.0,20221222.0,20221114,20221227,EXP,,NVSC2022JP253284,NOVARTIS,,89.0,YR,,F,Y,,,20221227,,MD,JP,JP,2022,Q4,Elderly
215919472,21591947,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,2,F,20221024.0,20221222.0,20221114,20221227,EXP,,NVSC2022JP253284,NOVARTIS,,89.0,YR,,F,Y,,,20221227,,MD,JP,JP,2022,Q4,Elderly
215919571,21591957,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Hepatitis,,2022,Q4,1,I,20221007.0,20221109.0,20221114,20221114,EXP,FR-AFSSAPS-LM20222755,FR-009507513-2211FRA002991,MERCK,,83.0,YR,,M,Y,72.8,KG,20221114,,MD,FR,FR,2022,Q4,Elderly
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Aortic valve incompetence,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diastolic dysfunction,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypertension,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nephrogenic anaemia,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pleural fibrosis,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dermatitis,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic nephropathy,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Depression suicidal,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215919601,21591960,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypertensive nephropathy,,2022,Q4,1,I,20220101.0,20221109.0,20221114,20221114,EXP,,DE-AstraZeneca-2022A373595,ASTRAZENECA,,64.0,YR,,F,Y,,,20221114,,MD,DE,,2022,Q4,Adult
215926652,21592665,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",40.0,MG,,,NJ2398,,,10.0,MG,Tablet,QD,2022,Q4,Rash maculo-papular,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,38,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",40.0,MG,,,NJ2398,,,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Rash maculo-papular,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,39,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Eczema,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Rash maculo-papular,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,40,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Eczema,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Rash maculo-papular,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,41,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Eczema,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Rash maculo-papular,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215926652,21592665,42,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,40.0,MG,,,,,,,,Tablet,,2022,Q4,Eczema,,2022,Q4,2,F,20221106.0,20221111.0,20221114,20221123,EXP,,CN-BAYER-2022A158196,BAYER,,71.0,YR,E,F,Y,55.0,KG,20221123,,HP,CN,CN,2022,Q4,Elderly
215939703,21593970,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,3,F,20221013.0,20221220.0,20221115,20221223,EXP,,US-ABBVIE-4196614,ABBVIE,,68.0,YR,,F,Y,70.307,KG,20221223,,HP,US,US,2022,Q4,Elderly
215939703,21593970,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,20221013.0,20221220.0,20221115,20221223,EXP,,US-ABBVIE-4196614,ABBVIE,,68.0,YR,,F,Y,70.307,KG,20221223,,HP,US,US,2022,Q4,Elderly
215940561,21594056,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,10/2000 mg /per,,,,,,,,,,,,2022,Q4,Angle closure glaucoma,,2022,Q4,1,I,20220505.0,20221103.0,20221115,20221115,EXP,,LV-NOVOPROD-978891,NOVO NORDISK,,68.0,YR,,,Y,50.8,KG,20221115,,HP,LV,LV,2022,Q4,Elderly
215940561,21594056,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,10/2000 mg /per,,,,,,,,,,,,2022,Q4,Presbyopia,,2022,Q4,1,I,20220505.0,20221103.0,20221115,20221115,EXP,,LV-NOVOPROD-978891,NOVO NORDISK,,68.0,YR,,,Y,50.8,KG,20221115,,HP,LV,LV,2022,Q4,Elderly
215940561,21594056,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Oral,10/2000 mg /per,,,,,,,,,,,,2022,Q4,Cataract,,2022,Q4,1,I,20220505.0,20221103.0,20221115,20221115,EXP,,LV-NOVOPROD-978891,NOVO NORDISK,,68.0,YR,,,Y,50.8,KG,20221115,,HP,LV,LV,2022,Q4,Elderly
215949761,21594976,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1/J,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,1,I,20220601.0,20221107.0,20221115,20221115,EXP,,FR-AstraZeneca-2022A367484,ASTRAZENECA,,78.0,YR,,M,Y,65.0,KG,20221115,,MD,FR,,2022,Q4,Elderly
215949761,21594976,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1/J,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Fall,,2022,Q4,1,I,20220601.0,20221107.0,20221115,20221115,EXP,,FR-AstraZeneca-2022A367484,ASTRAZENECA,,78.0,YR,,M,Y,65.0,KG,20221115,,MD,FR,,2022,Q4,Elderly
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Therapeutic product effect increased,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Psychomotor hyperactivity,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Intentional product use issue,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Contusion,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Nervousness,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Insomnia,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215958612,21595861,11,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,UNKNOWN,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,2,F,,20221118.0,20221115,20221124,EXP,,NVSC2022GR250988,NOVARTIS,,64.0,YR,,F,Y,,,20221124,,CN,GR,GR,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Myocardial infarction,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Nervousness,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Contusion,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Insomnia,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Intentional product use issue,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Therapeutic product effect increased,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215961732,21596173,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,202293.0,,,Tablet,,2022,Q4,Psychomotor hyperactivity,,2022,Q4,2,F,,20221118.0,20221115,20221125,EXP,,GR-AstraZeneca-2022A367928,ASTRAZENECA,,64.0,YR,,F,Y,,,20221125,,MD,GR,,2022,Q4,Adult
215968111,21596811,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,,20220827.0,20221115,20221115,EXP,,JP-AstraZeneca-2022A280929,ASTRAZENECA,,80.0,YR,,M,Y,,,20221115,,PH,JP,,2022,Q4,Elderly
215970261,21597026,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,140.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q4,Gastric ulcer,,2022,Q4,1,I,20210929.0,20221108.0,20221115,20221115,EXP,,GB-AstraZeneca-2021A759346,ASTRAZENECA,,23276.0,DY,,M,Y,,,20221115,,MD,GB,,2022,Q4,Elderly
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Sepsis,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Soft tissue swelling,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Confusional state,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Feeling hot,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Erythema,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215973702,21597370,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,2,F,20221003.0,20221114.0,20221115,20221124,EXP,,TH-AstraZeneca-2022A373704,ASTRAZENECA,,64.0,YR,,F,Y,,,20221124,,PH,TH,,2022,Q4,Adult
215983161,21598316,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220920.0,20221112.0,20221115,20221115,EXP,,CN-AstraZeneca-2022A375081,ASTRAZENECA,,17238.0,DY,,M,Y,,,20221115,,MD,CN,,2022,Q4,Elderly
215983161,21598316,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood creatine increased,,2022,Q4,1,I,20220920.0,20221112.0,20221115,20221115,EXP,,CN-AstraZeneca-2022A375081,ASTRAZENECA,,17238.0,DY,,M,Y,,,20221115,,MD,CN,,2022,Q4,Elderly
215985263,21598526,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,730.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thrombotic cerebral infarction,,2022,Q4,3,F,20220131.0,20221215.0,20221115,20221222,EXP,,JP-AstraZeneca-2022A371776,ASTRAZENECA,,80.0,YR,,F,Y,,,20221222,,MD,JP,,2022,Q4,Elderly
215985263,21598526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,730.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thrombotic cerebral infarction,,2022,Q4,3,F,20220131.0,20221215.0,20221115,20221222,EXP,,JP-AstraZeneca-2022A371776,ASTRAZENECA,,80.0,YR,,F,Y,,,20221222,,MD,JP,,2022,Q4,Elderly
215986033,21598603,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221128.0,20221115,20221206,EXP,,DE-AstraZeneca-2022A373613,ASTRAZENECA,,80.0,YR,,M,Y,65.0,KG,20221206,,MD,DE,,2022,Q4,Elderly
215986033,21598603,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,3,F,,20221128.0,20221115,20221206,EXP,,DE-AstraZeneca-2022A373613,ASTRAZENECA,,80.0,YR,,M,Y,65.0,KG,20221206,,MD,DE,,2022,Q4,Elderly
215986033,21598603,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,,,Tablet,,2022,Q4,Iron deficiency anaemia,,2022,Q4,3,F,,20221128.0,20221115,20221206,EXP,,DE-AstraZeneca-2022A373613,ASTRAZENECA,,80.0,YR,,M,Y,65.0,KG,20221206,,MD,DE,,2022,Q4,Elderly
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
215995261,21599526,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221113.0,20221115,20221115,EXP,FR-AFSSAPS-RS20222200,FR-BAUSCH-BL-2022-025393,BAUSCH AND LOMB,,45.0,YR,,M,Y,100.0,KG,20221115,,MD,FR,FR,2022,Q4,Adult
216006591,21600659,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20220205.0,20221111.0,20221116,20221116,EXP,,DE-AstraZeneca-2022A373337,ASTRAZENECA,,77.0,YR,,F,Y,72.0,KG,20221116,,MD,DE,,2022,Q4,Elderly
216013221,21601322,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,Y,,2205019,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hallucination,,2022,Q4,1,I,20221024.0,20221108.0,20221116,20221116,EXP,,CN-AstraZeneca-2022A370224,ASTRAZENECA,,19268.0,DY,,F,Y,,,20221116,,MD,CN,,2022,Q4,Elderly
216027401,21602740,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,Unknown,,,,,,,2022,Q4,Hepatitis,,2022,Q4,1,I,20221007.0,20221108.0,20221116,20221116,EXP,FR-AFSSAPS-LM20222755,FR-PFIZER INC-202201283842,PFIZER,,83.0,YR,,M,Y,72.8,KG,20221116,,MD,FR,FR,2022,Q4,Elderly
216032782,21603278,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,2,F,20220821.0,20221207.0,20221116,20221212,EXP,,JP-AstraZeneca-2022A372399,ASTRAZENECA,,31574.0,DY,,M,Y,54.0,KG,20221212,,MD,JP,,2022,Q4,Elderly
216032782,21603278,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,2,F,20220821.0,20221207.0,20221116,20221212,EXP,,JP-AstraZeneca-2022A372399,ASTRAZENECA,,31574.0,DY,,M,Y,54.0,KG,20221212,,MD,JP,,2022,Q4,Elderly
216044591,21604459,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20221001.0,20221108.0,20221116,20221116,EXP,,JP-AstraZeneca-2022A372818,ASTRAZENECA,,74.0,YR,,F,Y,59.0,KG,20221116,,MD,JP,,2022,Q4,Elderly
216044632,21604463,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknwon,250.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Asthma,,2022,Q4,2,F,20220801.0,20221216.0,20221116,20221223,EXP,,JP-AstraZeneca-2022A348105,ASTRAZENECA,,81.0,YR,,M,Y,,,20221223,,MD,JP,,2022,Q4,Elderly
216044632,21604463,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknwon,250.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Interstitial lung disease,,2022,Q4,2,F,20220801.0,20221216.0,20221116,20221223,EXP,,JP-AstraZeneca-2022A348105,ASTRAZENECA,,81.0,YR,,M,Y,,,20221223,,MD,JP,,2022,Q4,Elderly
216045541,21604554,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20220101.0,20221110.0,20221116,20221116,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-137094,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,79.0,KG,20221116,,CN,CA,CA,2022,Q4,Elderly
216055343,21605534,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Edistride 10,,,,,UNKNOWN,,,,,Film-coated tablet,,2022,Q4,Dizziness,,2022,Q4,3,F,20221014.0,20221206.0,20221116,20221216,EXP,PT-INFARMED-T202210-607,PT-TEVA-2022-PT-2825628,TEVA,,69.0,YR,E,M,Y,92.0,KG,20221216,,PH,PT,PT,2022,Q4,Elderly
216055343,21605534,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Edistride 10,,,,,UNKNOWN,,,,,Film-coated tablet,,2022,Q4,Balance disorder,,2022,Q4,3,F,20221014.0,20221206.0,20221116,20221216,EXP,PT-INFARMED-T202210-607,PT-TEVA-2022-PT-2825628,TEVA,,69.0,YR,E,M,Y,92.0,KG,20221216,,PH,PT,PT,2022,Q4,Elderly
216055343,21605534,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Edistride 10,,,,,UNKNOWN,,,,,Film-coated tablet,,2022,Q4,Blood pressure increased,,2022,Q4,3,F,20221014.0,20221206.0,20221116,20221216,EXP,PT-INFARMED-T202210-607,PT-TEVA-2022-PT-2825628,TEVA,,69.0,YR,E,M,Y,92.0,KG,20221216,,PH,PT,PT,2022,Q4,Elderly
216079451,21607945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20221101.0,20221110.0,20221117,20221117,EXP,,RO-AstraZeneca-2022A373320,ASTRAZENECA,,58.0,YR,,M,Y,,,20221117,,MD,RO,,2022,Q4,Adult
216079451,21607945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vascular stent thrombosis,,2022,Q4,1,I,20221101.0,20221110.0,20221117,20221117,EXP,,RO-AstraZeneca-2022A373320,ASTRAZENECA,,58.0,YR,,M,Y,,,20221117,,MD,RO,,2022,Q4,Adult
216079451,21607945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypotension,,2022,Q4,1,I,20221101.0,20221110.0,20221117,20221117,EXP,,RO-AstraZeneca-2022A373320,ASTRAZENECA,,58.0,YR,,M,Y,,,20221117,,MD,RO,,2022,Q4,Adult
216079451,21607945,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Chest pain,,2022,Q4,1,I,20221101.0,20221110.0,20221117,20221117,EXP,,RO-AstraZeneca-2022A373320,ASTRAZENECA,,58.0,YR,,M,Y,,,20221117,,MD,RO,,2022,Q4,Adult
216096331,21609633,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",1150.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220320.0,20221111.0,20221117,20221117,EXP,FR-AFSSAPS-LY20223182,FR-MYLANLABS-2022M1126987,MYLAN,,69.0,YR,,M,Y,75.0,KG,20221117,,PH,FR,FR,2022,Q4,Elderly
216096331,21609633,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",1150.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Shock,,2022,Q4,1,I,20220320.0,20221111.0,20221117,20221117,EXP,FR-AFSSAPS-LY20223182,FR-MYLANLABS-2022M1126987,MYLAN,,69.0,YR,,M,Y,75.0,KG,20221117,,PH,FR,FR,2022,Q4,Elderly
216099412,21609941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Ketoacidosis,,2022,Q4,2,F,20210707.0,20221219.0,20221117,20221230,EXP,,JP-AstraZeneca-2022A208489,ASTRAZENECA,"Hongo M, et al.. P-67-6 -A case where ketoacidosis was induced in a DAPA user, triggered by vomiting and poor food intake associated with GLP-R agonists.. Diabetes mellitus 2022;65(S1):: S276-. (not from E.",73.0,YR,,F,Y,38.0,KG,20221230,,MD,JP,,2022,Q4,Elderly
216099412,21609941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,2,F,20210707.0,20221219.0,20221117,20221230,EXP,,JP-AstraZeneca-2022A208489,ASTRAZENECA,"Hongo M, et al.. P-67-6 -A case where ketoacidosis was induced in a DAPA user, triggered by vomiting and poor food intake associated with GLP-R agonists.. Diabetes mellitus 2022;65(S1):: S276-. (not from E.",73.0,YR,,F,Y,38.0,KG,20221230,,MD,JP,,2022,Q4,Elderly
216099412,21609941,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,15.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Decreased appetite,,2022,Q4,2,F,20210707.0,20221219.0,20221117,20221230,EXP,,JP-AstraZeneca-2022A208489,ASTRAZENECA,"Hongo M, et al.. P-67-6 -A case where ketoacidosis was induced in a DAPA user, triggered by vomiting and poor food intake associated with GLP-R agonists.. Diabetes mellitus 2022;65(S1):: S276-. (not from E.",73.0,YR,,F,Y,38.0,KG,20221230,,MD,JP,,2022,Q4,Elderly
216106111,21610611,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0, Tablets",,,,,,,,,,Tablet,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221114.0,20221117,20221117,EXP,,DE-PURDUE-USA-2022-0298038,PURDUE,,75.0,YR,,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216106111,21610611,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0, Tablets",,,,,,,,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221114.0,20221117,20221117,EXP,,DE-PURDUE-USA-2022-0298038,PURDUE,,75.0,YR,,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216106111,21610611,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0, Tablets",,,,,,,,,,Tablet,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221114.0,20221117,20221117,EXP,,DE-PURDUE-USA-2022-0298038,PURDUE,,75.0,YR,,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216106111,21610611,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0, Tablets",,,,,,,,,,Tablet,,2022,Q4,Cold sweat,,2022,Q4,1,I,,20221114.0,20221117,20221117,EXP,,DE-PURDUE-USA-2022-0298038,PURDUE,,75.0,YR,,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216126911,21612691,2,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,,,,,U,,,,10.0,MG,,QD,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221117.0,20221118,20221118,EXP,FR-AFSSAPS-DJ20221990,FR-ABBVIE-4205496,ABBVIE,,69.0,YR,,M,Y,67.0,KG,20221118,,MD,FR,FR,2022,Q4,Elderly
216138041,21613804,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,N,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,1,I,20221109.0,20221111.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A377998,ASTRAZENECA,,26298.0,DY,,F,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Elderly
216138041,21613804,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,N,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,1,I,20221109.0,20221111.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A377998,ASTRAZENECA,,26298.0,DY,,F,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Elderly
216138041,21613804,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,N,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,1,I,20221109.0,20221111.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A377998,ASTRAZENECA,,26298.0,DY,,F,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Elderly
216138041,21613804,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,N,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Eczema,,2022,Q4,1,I,20221109.0,20221111.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A377998,ASTRAZENECA,,26298.0,DY,,F,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Elderly
216140571,21614057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Headache,,2022,Q4,1,I,20221026.0,20221110.0,20221118,20221118,EXP,,GB-AstraZeneca-2022A372097,ASTRAZENECA,,49.0,YR,,M,Y,108.0,KG,20221118,,MD,GB,,2022,Q4,Adult
216140571,21614057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Gastrooesophageal reflux disease,,2022,Q4,1,I,20221026.0,20221110.0,20221118,20221118,EXP,,GB-AstraZeneca-2022A372097,ASTRAZENECA,,49.0,YR,,M,Y,108.0,KG,20221118,,MD,GB,,2022,Q4,Adult
216140571,21614057,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,20221026.0,20221110.0,20221118,20221118,EXP,,GB-AstraZeneca-2022A372097,ASTRAZENECA,,49.0,YR,,M,Y,108.0,KG,20221118,,MD,GB,,2022,Q4,Adult
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Head injury,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Fall,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Abdominal pain,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Pancreatic disorder,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216144992,21614499,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd (1-0-0)",,,,,,,,10.0,MG,,QD,2022,Q4,Rectal discharge,,2022,Q4,2,F,20220701.0,20221220.0,20221118,20221230,EXP,,DE-NOVOPROD-965076,NOVO NORDISK,,77.0,YR,,M,Y,87.0,KG,20221230,,CN,DE,DE,2022,Q4,Elderly
216146901,21614690,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg 2 Tage,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Penile haemorrhage,,2022,Q4,1,I,20221015.0,20221109.0,20221118,20221118,EXP,,DE-AstraZeneca-2022A369845,ASTRAZENECA,,80.0,YR,,M,Y,62.0,KG,20221118,,MD,DE,,2022,Q4,Elderly
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Coronary artery disease,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood creatinine abnormal,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic retinopathy,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Carotid arteriosclerosis,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Restenosis,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149651,21614965,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Glomerular filtration rate abnormal,,2022,Q4,1,I,,20221112.0,20221118,20221118,EXP,,RO-AstraZeneca-2022A380620,ASTRAZENECA,,48.0,YR,,M,Y,,,20221118,,MD,RO,,2022,Q4,Adult
216149681,21614968,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Viral infection,,2022,Q4,1,I,20221021.0,20221111.0,20221118,20221118,EXP,,JP-AstraZeneca-2022A375757,ASTRAZENECA,,72.0,YR,,M,Y,59.0,KG,20221118,,MD,JP,,2022,Q4,Elderly
216149681,21614968,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Drug-induced liver injury,,2022,Q4,1,I,20221021.0,20221111.0,20221118,20221118,EXP,,JP-AstraZeneca-2022A375757,ASTRAZENECA,,72.0,YR,,M,Y,59.0,KG,20221118,,MD,JP,,2022,Q4,Elderly
216149681,21614968,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Underdose,,2022,Q4,1,I,20221021.0,20221111.0,20221118,20221118,EXP,,JP-AstraZeneca-2022A375757,ASTRAZENECA,,72.0,YR,,M,Y,59.0,KG,20221118,,MD,JP,,2022,Q4,Elderly
216150801,21615080,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2990.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q4,Tremor,,2022,Q4,1,I,20220726.0,20221110.0,20221118,20221118,EXP,,FI-AstraZeneca-2022A371525,ASTRAZENECA,,81.0,YR,,M,Y,,,20221118,,MD,FI,,2022,Q4,Elderly
216150801,21615080,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2990.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q4,Seizure,,2022,Q4,1,I,20220726.0,20221110.0,20221118,20221118,EXP,,FI-AstraZeneca-2022A371525,ASTRAZENECA,,81.0,YR,,M,Y,,,20221118,,MD,FI,,2022,Q4,Elderly
216150801,21615080,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2990.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,20220726.0,20221110.0,20221118,20221118,EXP,,FI-AstraZeneca-2022A371525,ASTRAZENECA,,81.0,YR,,M,Y,,,20221118,,MD,FI,,2022,Q4,Elderly
216153161,21615316,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (10 mg, 1-0-0-0)",,,,,,,,10.0,MG,,,2022,Q4,Fall,,2022,Q4,1,I,20210630.0,20221115.0,20221118,20221118,EXP,,DE-MYLANLABS-2022M1128906,MYLAN,,79.0,YR,,M,Y,,,20221118,,PH,DE,DE,2022,Q4,Elderly
216153161,21615316,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram (10 mg, 1-0-0-0)",,,,,,,,10.0,MG,,,2022,Q4,Subgaleal haematoma,,2022,Q4,1,I,20210630.0,20221115.0,20221118,20221118,EXP,,DE-MYLANLABS-2022M1128906,MYLAN,,79.0,YR,,M,Y,,,20221118,,PH,DE,DE,2022,Q4,Elderly
216154271,21615427,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",1350.0,MG,U,U,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Abortion spontaneous,,2022,Q4,1,I,20220728.0,20221114.0,20221118,20221118,EXP,FR-AFSSAPS-LY20224135,FR-MYLANLABS-2022M1127521,MYLAN,,42.0,YR,,F,Y,54.0,KG,20221118,,MD,FR,FR,2022,Q4,Adult
216156421,21615642,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.000000 mg?once a day,30.0,MG,U,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Herpes simplex,,2022,Q4,1,I,20221106.0,20221112.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A379844,ASTRAZENECA,,56.0,YR,,M,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Adult
216156421,21615642,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.000000 mg?once a day,30.0,MG,U,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oral herpes,,2022,Q4,1,I,20221106.0,20221112.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A379844,ASTRAZENECA,,56.0,YR,,M,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Adult
216156421,21615642,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.000000 mg?once a day,30.0,MG,U,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Herpes simplex,,2022,Q4,1,I,20221106.0,20221112.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A379844,ASTRAZENECA,,56.0,YR,,M,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Adult
216156421,21615642,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.000000 mg?once a day,30.0,MG,U,,NJ2398,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oral herpes,,2022,Q4,1,I,20221106.0,20221112.0,20221118,20221118,EXP,,CN-AstraZeneca-2022A379844,ASTRAZENECA,,56.0,YR,,M,Y,55.0,KG,20221118,,MD,CN,,2022,Q4,Adult
216158291,21615829,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"form strength : 10 mg ,Unit dose : 10 mg   , frequency time :1 day , Therapy Start date : ASKU",,,Y,N,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220906.0,20221110.0,20221118,20221118,EXP,FR-AFSSAPS-AN20222327,FR-TEVA-2022-FR-2826866,TEVA,,66.0,YR,E,M,Y,103.0,KG,20221118,,MD,FR,FR,2022,Q4,Elderly
216158291,21615829,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"form strength : 10 mg ,Unit dose : 10 mg   , frequency time :1 day , Therapy Start date : ASKU",,,Y,N,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,20220906.0,20221110.0,20221118,20221118,EXP,FR-AFSSAPS-AN20222327,FR-TEVA-2022-FR-2826866,TEVA,,66.0,YR,E,M,Y,103.0,KG,20221118,,MD,FR,FR,2022,Q4,Elderly
216162261,21616226,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,12150.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,20221104.0,20221115.0,20221118,20221118,EXP,,CO-AstraZeneca-2022A382801,ASTRAZENECA,,28053.0,DY,,M,Y,70.0,KG,20221118,,CN,CO,,2022,Q4,Elderly
216162561,21616256,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20221001.0,20221111.0,20221118,20221118,EXP,,FR-AstraZeneca-2022A373175,ASTRAZENECA,,73.0,YR,,F,Y,,,20221118,,MD,FR,,2022,Q4,Elderly
216162561,21616256,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20221001.0,20221111.0,20221118,20221118,EXP,,FR-AstraZeneca-2022A373175,ASTRAZENECA,,73.0,YR,,F,Y,,,20221118,,MD,FR,,2022,Q4,Elderly
216172171,21617217,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221108.0,20221118,20221118,PER,,DE-drreddys-SPO/GER/22/0157088,DR REDDYS,,81.0,YR,E,M,Y,100.0,KG,20221119,,PH,DE,DE,2022,Q4,Elderly
216172171,21617217,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tabletten",,,U,U,UNKNOWN,,,10.0,MG,Tablet,QD,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20221108.0,20221118,20221118,PER,,DE-drreddys-SPO/GER/22/0157088,DR REDDYS,,81.0,YR,E,M,Y,100.0,KG,20221119,,PH,DE,DE,2022,Q4,Elderly
216176981,21617698,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",120.0,MG,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-DJ20221990,NVSC2022FR255629,NOVARTIS,,69.0,YR,,M,Y,67.0,KG,20221119,,MD,FR,FR,2022,Q4,Elderly
216177751,21617775,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day (Every morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Liver function test abnormal,,2022,Q4,1,I,20220416.0,20221106.0,20221119,20221119,EXP,,GB-AUROBINDO-AUR-APL-2022-048099,AUROBINDO,,49.0,YR,,M,Y,,,20221119,,PH,GB,GB,2022,Q4,Adult
216178062,21617806,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",70.0,MG,Y,,,,,10.0,MG,Tablet,QD,2022,Q4,Hepatic cytolysis,,2022,Q4,2,F,20220921.0,20221114.0,20221119,20221121,EXP,,NVSC2022FR256370,NOVARTIS,,65.0,YR,,M,Y,105.0,KG,20221121,,MD,FR,FR,2022,Q4,Elderly
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216178091,21617809,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221001.0,20221114.0,20221119,20221119,EXP,FR-AFSSAPS-RS20222200,NVSC2022FR255815,NOVARTIS,,45.0,YR,,M,Y,100.0,KG,20221119,,MD,FR,FR,2022,Q4,Adult
216179222,21617922,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 milligram,,,,,,,,5.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,2,F,20210901.0,20221124.0,20221119,20221208,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20221208,,MD,JP,JP,2022,Q4,Elderly
216179222,21617922,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 milligram,,,,,,,,5.0,MG,,,2022,Q4,Blood glucose abnormal,,2022,Q4,2,F,20210901.0,20221124.0,20221119,20221208,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20221208,,MD,JP,JP,2022,Q4,Elderly
216179222,21617922,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 milligram,,,,,,,,5.0,MG,,,2022,Q4,Off label use,,2022,Q4,2,F,20210901.0,20221124.0,20221119,20221208,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20221208,,MD,JP,JP,2022,Q4,Elderly
216179222,21617922,3,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,5 milligram,,,,,,,,5.0,MG,,,2022,Q4,Vascular stenosis,,2022,Q4,2,F,20210901.0,20221124.0,20221119,20221208,EXP,,JP-JNJFOC-20221137698,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20221208,,MD,JP,JP,2022,Q4,Elderly
216201331,21620133,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Pericardial haemorrhage,,2022,Q4,1,I,,20221113.0,20221121,20221121,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-137482,BRISTOL MYERS SQUIBB,Chitturi K. Missouri^s Chapter of ACC Annual Meeting.,64.0,YR,A,M,Y,,,20221121,,MD,US,US,2022,Q4,Adult
216214601,21621460,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Vasculitis,,2022,Q4,1,I,20200731.0,20221115.0,20221121,20221121,EXP,,CA-TAKEDA-2022TUS077095,TAKEDA,,70.0,YR,,M,Y,,,20221121,,MD,CA,CA,2022,Q4,Elderly
216214601,21621460,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20200731.0,20221115.0,20221121,20221121,EXP,,CA-TAKEDA-2022TUS077095,TAKEDA,,70.0,YR,,M,Y,,,20221121,,MD,CA,CA,2022,Q4,Elderly
216214601,21621460,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Hyperthermia,,2022,Q4,1,I,20200731.0,20221115.0,20221121,20221121,EXP,,CA-TAKEDA-2022TUS077095,TAKEDA,,70.0,YR,,M,Y,,,20221121,,MD,CA,CA,2022,Q4,Elderly
216214601,21621460,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20200731.0,20221115.0,20221121,20221121,EXP,,CA-TAKEDA-2022TUS077095,TAKEDA,,70.0,YR,,M,Y,,,20221121,,MD,CA,CA,2022,Q4,Elderly
216226561,21622656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,N,,,,202293.0,,,,,2022,Q4,Illness,,2022,Q4,1,I,20211116.0,20221118.0,20221121,20221121,EXP,,GB-AstraZeneca-2022A331314,ASTRAZENECA,,54.0,YR,,M,Y,98.0,KG,20221121,,MD,GB,,2022,Q4,Adult
216226561,21622656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,N,,,,202293.0,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,1,I,20211116.0,20221118.0,20221121,20221121,EXP,,GB-AstraZeneca-2022A331314,ASTRAZENECA,,54.0,YR,,M,Y,98.0,KG,20221121,,MD,GB,,2022,Q4,Adult
216226561,21622656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,N,,,,202293.0,,,,,2022,Q4,Cystitis,,2022,Q4,1,I,20211116.0,20221118.0,20221121,20221121,EXP,,GB-AstraZeneca-2022A331314,ASTRAZENECA,,54.0,YR,,M,Y,98.0,KG,20221121,,MD,GB,,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216234771,21623477,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, 1-0-0-0, Tablet",,,U,U,,,,10.0,MG,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129172,MYLAN,,62.0,YR,,F,Y,75.0,KG,20221121,,PH,DE,DE,2022,Q4,Adult
216244121,21624412,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Paraesthesia,,2022,Q4,1,I,20220428.0,20220810.0,20221121,20221121,5DAY,,US-BRACCO-2022US03180,BRACCO,,61.0,YR,,M,Y,,,20221122,,HP,US,US,2022,Q4,Adult
216244121,21624412,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20220428.0,20220810.0,20221121,20221121,5DAY,,US-BRACCO-2022US03180,BRACCO,,61.0,YR,,M,Y,,,20221122,,HP,US,US,2022,Q4,Adult
216244121,21624412,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20220428.0,20220810.0,20221121,20221121,5DAY,,US-BRACCO-2022US03180,BRACCO,,61.0,YR,,M,Y,,,20221122,,HP,US,US,2022,Q4,Adult
216244121,21624412,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20220428.0,20220810.0,20221121,20221121,5DAY,,US-BRACCO-2022US03180,BRACCO,,61.0,YR,,M,Y,,,20221122,,HP,US,US,2022,Q4,Adult
216244121,21624412,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Erythema,,2022,Q4,1,I,20220428.0,20220810.0,20221121,20221121,5DAY,,US-BRACCO-2022US03180,BRACCO,,61.0,YR,,M,Y,,,20221122,,HP,US,US,2022,Q4,Adult
216248691,21624869,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,120.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221115.0,20221122,20221122,EXP,,FR-AstraZeneca-2022A376347,ASTRAZENECA,,69.0,YR,,M,Y,67.0,KG,20221122,,MD,FR,,2022,Q4,Elderly
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Feeding disorder,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Large intestine perforation,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Ileus,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Physical deconditioning,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Blood potassium decreased,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Staphylococcal infection,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Familial mediterranean fever,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Disease progression,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Impaired healing,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Ileal perforation,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Abdominal wall abscess,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Behcet's syndrome,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Postoperative wound infection,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Enterocolitis,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Blood albumin decreased,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216271293,21627129,35,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Haemoglobin decreased,,2022,Q4,3,F,20200325.0,20221114.0,20221122,20221205,EXP,,NVSJ2022JP101638,NOVARTIS,,35.0,YR,,F,Y,62.5,KG,20221205,,MD,JP,JP,2022,Q4,Adult
216276793,21627679,14,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form,QD",,,D,,Unk,,,,,Film-coated tablet,QD,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,3,F,20221029.0,20221226.0,20221122,20221227,EXP,FR-AFSSAPS-AM20222427,NVSC2022FR261412,NOVARTIS,,76.0,YR,,M,Y,60.0,KG,20221227,,MD,FR,FR,2022,Q4,Elderly
216277731,21627773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11440.0,MG,Y,,Unknown,,202293.0,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221114.0,20221122,20221122,EXP,,ES-AstraZeneca-2022A373929,ASTRAZENECA,,74.0,YR,,F,Y,,,20221122,,MD,ES,,2022,Q4,Elderly
216277731,21627773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11440.0,MG,Y,,Unknown,,202293.0,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221114.0,20221122,20221122,EXP,,ES-AstraZeneca-2022A373929,ASTRAZENECA,,74.0,YR,,F,Y,,,20221122,,MD,ES,,2022,Q4,Elderly
216277731,21627773,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,11440.0,MG,Y,,Unknown,,202293.0,10.0,MG,,QD,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221114.0,20221122,20221122,EXP,,ES-AstraZeneca-2022A373929,ASTRAZENECA,,74.0,YR,,F,Y,,,20221122,,MD,ES,,2022,Q4,Elderly
216279571,21627957,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1540.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Orchitis,,2022,Q4,1,I,20220919.0,20221114.0,20221122,20221122,EXP,,DE-AstraZeneca-2022A374346,ASTRAZENECA,,57.0,YR,,M,Y,85.0,KG,20221122,,MD,DE,,2022,Q4,Adult
216306391,21630639,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,,20221116.0,20221123,20221123,EXP,,JP-AstraZeneca-2022A382307,ASTRAZENECA,,95.0,YR,,F,Y,,,20221123,,MD,JP,,2022,Q4,Elderly
216306391,21630639,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,,20221116.0,20221123,20221123,EXP,,JP-AstraZeneca-2022A382307,ASTRAZENECA,,95.0,YR,,F,Y,,,20221123,,MD,JP,,2022,Q4,Elderly
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Erectile dysfunction,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Blood testosterone increased,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Diverticulitis,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Depression,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Seborrhoeic keratosis,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Arthritis,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Diabetic retinopathy,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Diverticulum,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Insomnia,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Exposure to chemical pollution,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Essential hypertension,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Suspected COVID-19,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Erectile dysfunction,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Epicondylitis,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Rotator cuff syndrome,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Bundle branch block right,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216312861,21631286,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Carpal tunnel syndrome,,2022,Q4,1,I,20050609.0,20221117.0,20221123,20221123,EXP,,GB-ABBVIE-4131022,ABBVIE,,50.0,YR,,M,Y,,,20221123,,HP,GB,GB,2022,Q4,Adult
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216314291,21631429,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,70.0,MG,D,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221121.0,20221123,20221123,EXP,IE-HPRA-2022-099851,NVSC2022IE261694,NOVARTIS,,73.0,YR,,F,Y,60.0,KG,20221123,,PH,IE,IE,2022,Q4,Elderly
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Lactic acidosis,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216316892,21631689,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Cardiac arrest,,2022,Q4,2,F,,20221115.0,20221123,20221205,EXP,,JP-AstraZeneca-2022A382561,ASTRAZENECA,Tazoe S. et al. O27-1 A case of type 2 diabetes mellitus leading to cardiac arrest. The 59th Kinki Regional Meeting of the Japan Diabetes Society 2022 Nov 05 2022;125.,58.0,YR,,M,Y,,,20221205,,MD,JP,,2022,Q4,Adult
216330301,21633030,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,JP-AstraZeneca-2022A382074,ASTRAZENECA,,65.0,YR,,F,Y,,,20221123,,MD,JP,,2022,Q4,Elderly
216330301,21633030,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pneumonia,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,JP-AstraZeneca-2022A382074,ASTRAZENECA,,65.0,YR,,F,Y,,,20221123,,MD,JP,,2022,Q4,Elderly
216345421,21634542,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10, Take one daily",,,U,,,,202293.0,,,,,2022,Q4,Rash,,2022,Q4,1,I,20220927.0,20221116.0,20221123,20221123,EXP,,GB-AstraZeneca-2022A380557,ASTRAZENECA,,67.0,YR,,F,Y,94.0,KG,20221123,,MD,GB,,2022,Q4,Elderly
216345421,21634542,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10, Take one daily",,,U,,,,202293.0,,,,,2022,Q4,Genital rash,,2022,Q4,1,I,20220927.0,20221116.0,20221123,20221123,EXP,,GB-AstraZeneca-2022A380557,ASTRAZENECA,,67.0,YR,,F,Y,94.0,KG,20221123,,MD,GB,,2022,Q4,Elderly
216345591,21634559,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,5.0,MG,Tablets,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20221014.0,20221116.0,20221123,20221123,PER,,JP-Eisai Medical Research-EC-2022-126542,EISAI,,68.0,YR,E,F,Y,,,20221123,,PH,JP,JP,2022,Q4,Elderly
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216347031,21634703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221115.0,20221123,20221123,EXP,,FR-AstraZeneca-2022A375903,ASTRAZENECA,,45.0,YR,,M,Y,100.0,KG,20221123,,MD,FR,,2022,Q4,Adult
216348201,21634820,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q4,Drug ineffective for unapproved indication,,2022,Q4,1,I,,20221116.0,20221123,20221123,EXP,,AU-MYLANLABS-2022M1131451,MYLAN,"Zein R, Wong D, Wilson G. COMIRNATY (BIONTECH-PFIZER) COVID-19 VACCINE ASSOCIATED IGA NEPHROPATHY. Nephrology 2022;27 (Suppl. 1):84 (plus poster).",37.0,YR,,M,Y,,,20221123,,HP,AU,AU,2022,Q4,Adult
216348201,21634820,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,U,,,,10.0,MG,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221116.0,20221123,20221123,EXP,,AU-MYLANLABS-2022M1131451,MYLAN,"Zein R, Wong D, Wilson G. COMIRNATY (BIONTECH-PFIZER) COVID-19 VACCINE ASSOCIATED IGA NEPHROPATHY. Nephrology 2022;27 (Suppl. 1):84 (plus poster).",37.0,YR,,M,Y,,,20221123,,HP,AU,AU,2022,Q4,Adult
216360292,21636029,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once per day,220.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Cerebral haemorrhage,,2022,Q4,2,F,20221110.0,20221124.0,20221123,20221125,EXP,,GB-AstraZeneca-2022A384210,ASTRAZENECA,,66.0,YR,,M,Y,125.0,KG,20221125,,MD,GB,,2022,Q4,Elderly
216360292,21636029,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once per day,220.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,2,F,20221110.0,20221124.0,20221123,20221125,EXP,,GB-AstraZeneca-2022A384210,ASTRAZENECA,,66.0,YR,,M,Y,125.0,KG,20221125,,MD,GB,,2022,Q4,Elderly
216360292,21636029,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once per day,220.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Pulmonary embolism,,2022,Q4,2,F,20221110.0,20221124.0,20221123,20221125,EXP,,GB-AstraZeneca-2022A384210,ASTRAZENECA,,66.0,YR,,M,Y,125.0,KG,20221125,,MD,GB,,2022,Q4,Elderly
216360292,21636029,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once per day,220.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Chest pain,,2022,Q4,2,F,20221110.0,20221124.0,20221123,20221125,EXP,,GB-AstraZeneca-2022A384210,ASTRAZENECA,,66.0,YR,,M,Y,125.0,KG,20221125,,MD,GB,,2022,Q4,Elderly
216360292,21636029,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg once per day,220.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Circulatory collapse,,2022,Q4,2,F,20221110.0,20221124.0,20221123,20221125,EXP,,GB-AstraZeneca-2022A384210,ASTRAZENECA,,66.0,YR,,M,Y,125.0,KG,20221125,,MD,GB,,2022,Q4,Elderly
216361251,21636125,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20220330.0,20221123,20221123,PER,,US-STRIDES ARCOLAB LIMITED-2022SP003509,STRIDES,"Kumar GS, Chaudhary C, Cheng R, Klein L.. A surprising case of melas in a patient presenting with decompensated heart failure.. J-Am-Coll-Cardiol. 2022;79 (Suppl.)(9):3382",31.0,YR,,F,Y,,,20221124,,HP,US,US,2022,Q4,Young Adult
216361271,21636127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20221111.0,20221116.0,20221123,20221123,EXP,,GB-AstraZeneca-2022A382955,ASTRAZENECA,,72.0,YR,,M,Y,,,20221124,,CN,GB,,2022,Q4,Elderly
216361271,21636127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Palpitations,,2022,Q4,1,I,20221111.0,20221116.0,20221123,20221123,EXP,,GB-AstraZeneca-2022A382955,ASTRAZENECA,,72.0,YR,,M,Y,,,20221124,,CN,GB,,2022,Q4,Elderly
216361271,21636127,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac flutter,,2022,Q4,1,I,20221111.0,20221116.0,20221123,20221123,EXP,,GB-AstraZeneca-2022A382955,ASTRAZENECA,,72.0,YR,,M,Y,,,20221124,,CN,GB,,2022,Q4,Elderly
216372201,21637220,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,2205022,,,10.0,MG,Tablet,QD,2022,Q4,Diabetic coma,,2022,Q4,1,I,20221118.0,20221123.0,20221124,20221124,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-204444",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,61.0,KG,20221124,,CN,CN,CN,2022,Q4,Elderly
216372201,21637220,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,2205022,,,10.0,MG,Tablet,QD,2022,Q4,Off label use,,2022,Q4,1,I,20221118.0,20221123.0,20221124,20221124,EXP,,"CN-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-204444",BOEHRINGER INGELHEIM,,71.0,YR,E,M,Y,61.0,KG,20221124,,CN,CN,CN,2022,Q4,Elderly
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Dyslipidaemia,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypokalaemia,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Cardiomyopathy,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Toxicity to various agents,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216375702,21637570,44,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",17750.0,MG,,,,,,10.0,MG,,QD,2022,Q4,Hypomagnesaemia,,2022,Q4,2,F,20221104.0,20221129.0,20221124,20221205,EXP,,US-TAKEDA-2022TUS086604,TAKEDA,,64.0,YR,,F,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216381901,21638190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7610.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20221018.0,20221116.0,20221124,20221124,EXP,,DK-AstraZeneca-2022A378961,ASTRAZENECA,,78.0,YR,,F,Y,,,20221124,,MD,DK,,2022,Q4,Elderly
216381901,21638190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7610.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Gastroenteritis,,2022,Q4,1,I,20221018.0,20221116.0,20221124,20221124,EXP,,DK-AstraZeneca-2022A378961,ASTRAZENECA,,78.0,YR,,F,Y,,,20221124,,MD,DK,,2022,Q4,Elderly
216381901,21638190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7610.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221018.0,20221116.0,20221124,20221124,EXP,,DK-AstraZeneca-2022A378961,ASTRAZENECA,,78.0,YR,,F,Y,,,20221124,,MD,DK,,2022,Q4,Elderly
216381901,21638190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7610.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221018.0,20221116.0,20221124,20221124,EXP,,DK-AstraZeneca-2022A378961,ASTRAZENECA,,78.0,YR,,F,Y,,,20221124,,MD,DK,,2022,Q4,Elderly
216381901,21638190,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7610.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal failure,,2022,Q4,1,I,20221018.0,20221116.0,20221124,20221124,EXP,,DK-AstraZeneca-2022A378961,ASTRAZENECA,,78.0,YR,,F,Y,,,20221124,,MD,DK,,2022,Q4,Elderly
216400291,21640029,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827264,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216400291,21640029,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827264,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216400291,21640029,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827264,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216401311,21640131,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827246,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216401311,21640131,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827246,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216401311,21640131,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,5.0,MG,Tablet,Q12H,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827246,TEVA,,64.0,YR,A,M,Y,89.0,KG,20221124,,HP,CA,CA,2022,Q4,Adult
216406792,21640679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Off label use,,2022,Q4,2,F,20221110.0,20221117.0,20221124,20221214,EXP,,JP-AstraZeneca-2022A374849,ASTRAZENECA,,90.0,YR,,M,Y,,,20221214,,PH,JP,,2022,Q4,Elderly
216406792,21640679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Puncture site infection,,2022,Q4,2,F,20221110.0,20221117.0,20221124,20221214,EXP,,JP-AstraZeneca-2022A374849,ASTRAZENECA,,90.0,YR,,M,Y,,,20221214,,PH,JP,,2022,Q4,Elderly
216406792,21640679,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221110.0,20221117.0,20221124,20221214,EXP,,JP-AstraZeneca-2022A374849,ASTRAZENECA,,90.0,YR,,M,Y,,,20221214,,PH,JP,,2022,Q4,Elderly
216407493,21640749,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,20221030.0,20221130.0,20221125,20221205,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-141753,BRISTOL MYERS SQUIBB,,68.0,YR,E,F,Y,,,20221205,,MD,DE,DE,2022,Q4,Elderly
216413922,21641392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Chills,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Heart rate increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood pressure systolic increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Respiratory rate increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Chills,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Heart rate increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood pressure systolic increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216413922,21641392,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,2110065,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Respiratory rate increased,,2022,Q4,2,F,20221111.0,20221117.0,20221125,20221213,EXP,,CN-AstraZeneca-2022A383791,ASTRAZENECA,,27394.0,DY,,M,Y,62.0,KG,20221213,,MD,CN,,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Nephrolithiasis,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Aspartate aminotransferase increased,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Cholelithiasis,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Alanine aminotransferase increased,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Haemangioma of liver,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Constipation,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Drug-induced liver injury,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216415531,21641553,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, QD",,,U,,,,,5.0,MG,,QD,2022,Q4,Lipoma,,2022,Q4,1,I,20220801.0,20221118.0,20221125,20221125,EXP,,NVSJ2022JP096848,NOVARTIS,,73.0,YR,,M,Y,64.5,KG,20221125,,MD,JP,JP,2022,Q4,Elderly
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421581,21642158,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049557,AUROBINDO,,45.0,YR,,M,Y,100.0,KG,20221125,,MD,FR,FR,2022,Q4,Adult
216421671,21642167,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",111.429,MG,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221111.0,20221125,20221125,EXP,,FR-AUROBINDO-AUR-APL-2022-049561,AUROBINDO,,69.0,YR,,M,Y,67.0,KG,20221125,,MD,FR,FR,2022,Q4,Elderly
216425551,21642555,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 tablet/day,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Orchitis,,2022,Q4,1,I,20221006.0,20221118.0,20221125,20221125,EXP,,FR-AstraZeneca-2022A382015,ASTRAZENECA,,72.0,YR,,M,Y,74.0,KG,20221125,,MD,FR,,2022,Q4,Elderly
216425562,21642556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,2,F,,20221206.0,20221125,20221214,EXP,,JP-AstraZeneca-2022A385156,ASTRAZENECA,,47.0,YR,,M,Y,,,20221214,,MD,JP,,2022,Q4,Adult
216425562,21642556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug-induced liver injury,,2022,Q4,2,F,,20221206.0,20221125,20221214,EXP,,JP-AstraZeneca-2022A385156,ASTRAZENECA,,47.0,YR,,M,Y,,,20221214,,MD,JP,,2022,Q4,Adult
216425562,21642556,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Viral myocarditis,,2022,Q4,2,F,,20221206.0,20221125,20221214,EXP,,JP-AstraZeneca-2022A385156,ASTRAZENECA,,47.0,YR,,M,Y,,,20221214,,MD,JP,,2022,Q4,Adult
216427031,21642703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pleural effusion,,2022,Q4,1,I,,20221118.0,20221125,20221125,EXP,,DE-AstraZeneca-2022A385549,ASTRAZENECA,,69.0,YR,,F,Y,,,20221125,,MD,DE,,2022,Q4,Elderly
216427031,21642703,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,,20221118.0,20221125,20221125,EXP,,DE-AstraZeneca-2022A385549,ASTRAZENECA,,69.0,YR,,F,Y,,,20221125,,MD,DE,,2022,Q4,Elderly
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Pneumonia,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Rhinorrhoea,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cardiotoxicity,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Nasal congestion,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Troponin increased,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Hyperthermia,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Cough,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Dizziness,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Headache,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Myocarditis infectious,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216431452,21643145,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,U,,,,,10.0,MG,,,2022,Q4,Bone pain,,2022,Q4,2,F,20221014.0,20221130.0,20221125,20221205,EXP,,MX-SA-2022SA472974,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20221205,,MD,MX,MX,2022,Q4,Adult
216433261,21643326,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Respiratory tract infection,,2022,Q4,1,I,20200706.0,20221122.0,20221125,20221125,EXP,,ES-ROCHE-2650374,ROCHE,,82.0,YR,,M,Y,83.0,KG,20221125,,MD,ES,,2022,Q4,Elderly
216433261,21643326,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Bronchitis,,2022,Q4,1,I,20200706.0,20221122.0,20221125,20221125,EXP,,ES-ROCHE-2650374,ROCHE,,82.0,YR,,M,Y,83.0,KG,20221125,,MD,ES,,2022,Q4,Elderly
216439261,21643926,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,570.0,MG,Y,,2110127,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20221109.0,20221119.0,20221125,20221125,EXP,,CN-AstraZeneca-2022A387250,ASTRAZENECA,,23072.0,DY,,F,Y,48.0,KG,20221125,,MD,CN,,2022,Q4,Elderly
216439261,21643926,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,570.0,MG,Y,,2110127,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood bilirubin abnormal,,2022,Q4,1,I,20221109.0,20221119.0,20221125,20221125,EXP,,CN-AstraZeneca-2022A387250,ASTRAZENECA,,23072.0,DY,,F,Y,48.0,KG,20221125,,MD,CN,,2022,Q4,Elderly
216440851,21644085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Malnutrition,,2022,Q4,1,I,20220824.0,20221122.0,20221125,20221125,EXP,,FR-AstraZeneca-2022A384508,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221125,,MD,FR,,2022,Q4,Adult
216440851,21644085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220824.0,20221122.0,20221125,20221125,EXP,,FR-AstraZeneca-2022A384508,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221125,,MD,FR,,2022,Q4,Adult
216440851,21644085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221122.0,20221125,20221125,EXP,,FR-AstraZeneca-2022A384508,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221125,,MD,FR,,2022,Q4,Adult
216440851,21644085,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220824.0,20221122.0,20221125,20221125,EXP,,FR-AstraZeneca-2022A384508,ASTRAZENECA,,52.0,YR,,M,Y,70.0,KG,20221125,,MD,FR,,2022,Q4,Adult
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Bundle branch block left,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Cerebral haemorrhage,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Altered state of consciousness,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular extrasystoles,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216447921,21644792,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,In the morning,,,,,,,,10.0,MG,Tablet,QD,2022,Q4,Fall,,2022,Q4,1,I,,20221117.0,20221125,20221125,EXP,,JP-AstraZeneca-2022A384020,ASTRAZENECA,,80.0,YR,,F,Y,,,20221125,,MD,JP,,2022,Q4,Elderly
216480404,21648040,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Drug-induced liver injury,,2022,Q4,4,F,,20221216.0,20221128,20221227,EXP,,SI-JNJFOC-20221156987,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20221227,,HP,SI,SI,2022,Q4,Elderly
216509812,21650981,10,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD",,,,,,,,,,Film-coated tablet,QD,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,2,F,20221029.0,20221124.0,20221128,20221201,EXP,FR-AFSSAPS-AM20222427,FR-SA-2022SA486575,SANOFI AVENTIS,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,FR,FR,2022,Q4,Elderly
216516923,21651692,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,QD,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,3,F,20221029.0,20221215.0,20221128,20221220,EXP,,FR-AstraZeneca-2022A385852,ASTRAZENECA,,76.0,YR,,M,Y,60.0,KG,20221216,,MD,FR,,2022,Q4,Elderly
216531133,21653113,13,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,Daily; Per Day,,,U,,,,,,,,QD,2022,Q4,Infectious pleural effusion,,2022,Q4,3,F,20221119.0,20221209.0,20221128,20221215,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-140965,BRISTOL MYERS SQUIBB,,73.0,YR,E,M,Y,66.0,KG,20221216,,HP,JP,JP,2022,Q4,Elderly
216546001,21654600,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,,BR-NOVOPROD-983432,NOVO NORDISK,,50.0,YR,,F,Y,82.6,KG,20221129,,MD,BR,BR,2022,Q4,Adult
216546001,21654600,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,unknown,,,,,,,2022,Q4,Femur fracture,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,,BR-NOVOPROD-983432,NOVO NORDISK,,50.0,YR,,F,Y,82.6,KG,20221129,,MD,BR,BR,2022,Q4,Adult
216546011,21654601,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,unknown,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20221117.0,20221129,20221129,EXP,,BR-NOVOPROD-982519,NOVO NORDISK,,50.0,YR,,F,Y,82.6,KG,20221129,,MD,BR,BR,2022,Q4,Adult
216546011,21654601,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, qd",,,,,unknown,,,10.0,MG,,QD,2022,Q4,Femur fracture,,2022,Q4,1,I,,20221117.0,20221129,20221129,EXP,,BR-NOVOPROD-982519,NOVO NORDISK,,50.0,YR,,F,Y,82.6,KG,20221129,,MD,BR,BR,2022,Q4,Adult
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Blood creatinine increased,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216549221,21654922,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,Y,,,,,10.0,MG,,,2022,Q4,Blood urea increased,,2022,Q4,1,I,,20221118.0,20221129,20221129,EXP,,PL-TEVA-2022-PL-2829797,TEVA,,91.0,YR,E,F,Y,,,20221128,,MD,PL,PL,2022,Q4,Elderly
216552292,21655229,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, qd",,,,,unknown,,,5.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic encephalopathy,,2022,Q4,2,F,20221111.0,20221130.0,20221129,20221212,EXP,,JP-NOVOPROD-983340,NOVO NORDISK,,6.0,DEC,,F,Y,55.0,KG,20221212,,MD,JP,JP,2022,Q4,Child
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216554751,21655475,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,70.0,MG,,,,,,10.0,MG,"Tablet, film coated",QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221123.0,20221129,20221129,EXP,IE-HPRA-2022-099851,IE-ASTELLAS-2022US041842,ASTELLAS,,73.0,YR,,F,Y,60.0,KG,20221129,,CN,IE,IE,2022,Q4,Elderly
216557631,21655763,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,10.0,MG,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220320.0,20221116.0,20221129,20221129,EXP,FR-AFSSAPS-LY20223182,FR-Accord-288031,ACCORD,,69.0,YR,E,M,Y,75.0,KG,20221129,,PH,FR,FR,2022,Q4,Elderly
216557631,21655763,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,10.0,MG,,,2022,Q4,Shock,,2022,Q4,1,I,20220320.0,20221116.0,20221129,20221129,EXP,FR-AFSSAPS-LY20223182,FR-Accord-288031,ACCORD,,69.0,YR,E,M,Y,75.0,KG,20221129,,PH,FR,FR,2022,Q4,Elderly
216559511,21655951,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220824.0,20221121.0,20221129,20221129,EXP,,FR-PERRIGO-22FR015223,PERRIGO,,52.0,YR,,M,Y,70.0,KG,20221129,,CN,FR,FR,2022,Q4,Adult
216559511,21655951,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Malnutrition,,2022,Q4,1,I,20220824.0,20221121.0,20221129,20221129,EXP,,FR-PERRIGO-22FR015223,PERRIGO,,52.0,YR,,M,Y,70.0,KG,20221129,,CN,FR,FR,2022,Q4,Adult
216559511,21655951,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220824.0,20221121.0,20221129,20221129,EXP,,FR-PERRIGO-22FR015223,PERRIGO,,52.0,YR,,M,Y,70.0,KG,20221129,,CN,FR,FR,2022,Q4,Adult
216559511,21655951,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, qd",,,U,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220824.0,20221121.0,20221129,20221129,EXP,,FR-PERRIGO-22FR015223,PERRIGO,,52.0,YR,,M,Y,70.0,KG,20221129,,CN,FR,FR,2022,Q4,Adult
216561201,21656120,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,,20221116.0,20221129,20221129,PER,,AU-LUPIN PHARMACEUTICALS INC.-2022-13805,LUPIN,"Zein R, Wong D, Wilson G. Comirnaty (Biontech-Pfizer) covid-19 vaccine associated Iga nephropathy. Nephrology. 2022;27 (1):84",37.0,YR,,M,Y,,,20221129,,HP,AU,AU,2022,Q4,Adult
216561811,21656181,26,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,,,,10.0,MG,,QD,2022,Q4,COVID-19,,2022,Q4,1,I,20220907.0,20221124.0,20221129,20221129,EXP,,NVSC2022DE217501,NOVARTIS,,82.0,YR,,M,Y,65.0,KG,20221129,,MD,DE,DE,2022,Q4,Elderly
216566091,21656609,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"qd, 10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221117.0,20221129,20221129,EXP,,DE-MYLANLABS-2022M1130111,MYLAN,,81.0,YR,,M,Y,100.0,KG,20221129,,PH,DE,DE,2022,Q4,Elderly
216566091,21656609,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"qd, 10 mg, 1-0-0-0 tablet",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20221117.0,20221129,20221129,EXP,,DE-MYLANLABS-2022M1130111,MYLAN,,81.0,YR,,M,Y,100.0,KG,20221129,,PH,DE,DE,2022,Q4,Elderly
216583703,21658370,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Fanconi syndrome,,2022,Q4,3,F,20221114.0,20221221.0,20221129,20221228,EXP,AT-BASGAGES-2022-110941,AT-OTSUKA-2022_052969,OTSUKA,,80.0,YR,,F,Y,,,20221228,,PH,AT,AT,2022,Q4,Elderly
216586011,21658601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216586011,21658601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216586011,21658601,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q4,Dysgeusia,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216586011,21658601,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Take one tablet once a day for treating heart f...,,,,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216586011,21658601,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Take one tablet once a day for treating heart f...,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216586011,21658601,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Take one tablet once a day for treating heart f...,,,,,,,,,,,,2022,Q4,Dysgeusia,,2022,Q4,1,I,20221118.0,20221121.0,20221129,20221129,EXP,,GB-AstraZeneca-2022A384199,ASTRAZENECA,,37.0,YR,,M,Y,57.0,KG,20221129,,MD,GB,,2022,Q4,Adult
216597691,21659769,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,7360.0,MG,Y,,JX20140204,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketosis,,2022,Q4,1,I,20221113.0,20221122.0,20221129,20221129,EXP,,CN-AstraZeneca-2022A389574,ASTRAZENECA,,65.0,YR,,M,Y,90.0,KG,20221130,,MD,CN,,2022,Q4,Elderly
216605192,21660519,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Gout,,2022,Q4,2,F,20220716.0,20221202.0,20221130,20221216,PER,,JP-AMGEN-JPNNI2022206778,AMGEN,,71.0,YR,E,M,Y,,,20221216,,MD,JP,JP,2022,Q4,Elderly
216605192,21660519,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,20220716.0,20221202.0,20221130,20221216,PER,,JP-AMGEN-JPNNI2022206778,AMGEN,,71.0,YR,E,M,Y,,,20221216,,MD,JP,JP,2022,Q4,Elderly
216605192,21660519,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,20220716.0,20221202.0,20221130,20221216,PER,,JP-AMGEN-JPNNI2022206778,AMGEN,,71.0,YR,E,M,Y,,,20221216,,MD,JP,JP,2022,Q4,Elderly
216616761,21661676,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Heat illness,,2022,Q4,1,I,,20221122.0,20221130,20221130,EXP,,JP-AstraZeneca-2022A389470,ASTRAZENECA,,82.0,YR,,F,Y,,,20221130,,HP,JP,,2022,Q4,Elderly
216616761,21661676,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,,20221122.0,20221130,20221130,EXP,,JP-AstraZeneca-2022A389470,ASTRAZENECA,,82.0,YR,,F,Y,,,20221130,,HP,JP,,2022,Q4,Elderly
216616761,21661676,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Heat illness,,2022,Q4,1,I,,20221122.0,20221130,20221130,EXP,,JP-AstraZeneca-2022A389470,ASTRAZENECA,,82.0,YR,,F,Y,,,20221130,,HP,JP,,2022,Q4,Elderly
216616761,21661676,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,,20221122.0,20221130,20221130,EXP,,JP-AstraZeneca-2022A389470,ASTRAZENECA,,82.0,YR,,F,Y,,,20221130,,HP,JP,,2022,Q4,Elderly
216623612,21662361,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Pancreatitis acute,,2022,Q4,2,F,20221012.0,20221129.0,20221130,20221205,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-2022-143062,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,61.7,KG,20221205,,HP,CH,CH,2022,Q4,Elderly
216623612,21662361,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20221012.0,20221129.0,20221130,20221205,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-2022-143062,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,61.7,KG,20221205,,HP,CH,CH,2022,Q4,Elderly
216623612,21662361,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Pancreatitis acute,,2022,Q4,2,F,20221012.0,20221129.0,20221130,20221205,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-2022-143062,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,61.7,KG,20221205,,HP,CH,CH,2022,Q4,Elderly
216623612,21662361,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,Unknown,QD,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20221012.0,20221129.0,20221130,20221205,EXP,,CH-BRISTOL-MYERS SQUIBB COMPANY-2022-143062,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,61.7,KG,20221205,,HP,CH,CH,2022,Q4,Elderly
216628371,21662837,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,310.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dermatitis bullous,,2022,Q4,1,I,,20221123.0,20221130,20221130,EXP,,TR-AstraZeneca-2022A389653,ASTRAZENECA,,67.0,YR,,M,Y,,,20221130,,MD,TR,,2022,Q4,Elderly
216630601,21663060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221122.0,20221130,20221130,EXP,,AU-AstraZeneca-2022A389545,ASTRAZENECA,,70.0,YR,,M,Y,,,20221130,,HP,AU,,2022,Q4,Elderly
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hypoosmolar state,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hypovolaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Ulcer,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hypoosmolar state,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hypovolaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Ulcer,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216631171,21663117,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-SA-2022SA488699,SANOFI AVENTIS,,61.0,YR,A,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216637241,21663724,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,nj2315,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Mental fatigue,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216637241,21663724,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,nj2315,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urine ketone body present,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216637241,21663724,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,nj2315,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Blood ketone body present,,2022,Q4,1,I,20221109.0,20221122.0,20221130,20221130,EXP,,CN-AstraZeneca-2022A389333,ASTRAZENECA,,43.0,YR,,F,Y,75.0,KG,20221130,,MD,CN,,2022,Q4,Adult
216643281,21664328,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Anuria,,2022,Q4,1,I,20220613.0,20221123.0,20221130,20221130,EXP,,LV-AstraZeneca-2022A389727,ASTRAZENECA,,21337.0,DY,,F,Y,136.0,KG,20221130,,MD,LV,,2022,Q4,Elderly
216643281,21664328,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Anuria,,2022,Q4,1,I,20220613.0,20221123.0,20221130,20221130,EXP,,LV-AstraZeneca-2022A389727,ASTRAZENECA,,21337.0,DY,,F,Y,136.0,KG,20221130,,MD,LV,,2022,Q4,Elderly
216643281,21664328,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,,,Unknown,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Anuria,,2022,Q4,1,I,20220613.0,20221123.0,20221130,20221130,EXP,,LV-AstraZeneca-2022A389727,ASTRAZENECA,,21337.0,DY,,F,Y,136.0,KG,20221130,,MD,LV,,2022,Q4,Elderly
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hypoosmolar state,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hypovolaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Ulcer,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hypoosmolar state,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hypovolaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Drug hypersensitivity,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Ulcer,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216647291,21664729,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (10 mg orally 0-0-1 since unknown)",,,Y,U,,,,10.0,MG,,QD,2022,Q4,Upper gastrointestinal haemorrhage,,2022,Q4,1,I,20220525.0,20221125.0,20221130,20221130,EXP,CH-SM-2022-17592,CH-MYLANLABS-2022M1133090,MYLAN,,61.0,YR,,M,Y,,,20221130,,MD,CH,CH,2022,Q4,Adult
216663591,21666359,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Fasciitis,,2022,Q4,1,I,,20221123.0,20221201,20221201,EXP,,FR-AstraZeneca-2022A389957,ASTRAZENECA,,92.0,YR,,F,Y,,,20221201,,MD,FR,,2022,Q4,Elderly
216664051,21666405,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"form strength : 10 mg, unit dose : 10 mg, frequency time : 1 days, duration : 13 days",,,Y,,UNKNOWN,,,10.0,MG,Film-coated tablet,,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-DJ20221990,FR-TEVA-2022-FR-2829657,TEVA,,69.0,YR,E,M,Y,67.0,KG,20221201,,MD,FR,FR,2022,Q4,Elderly
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Diarrhoea,Diarrhoea,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216666591,21666659,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,UNKNOWN,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221121.0,20221201,20221201,EXP,FR-AFSSAPS-RS20222200,FR-TEVA-2022-FR-2829982,TEVA,,45.0,YR,A,M,Y,100.0,KG,20221201,,MD,FR,FR,2022,Q4,Adult
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216669611,21666961,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221125.0,20221201,20221201,EXP,IE-HPRA-2022-099851,IE-CHEPLA-2022011441,CHEPLAPHARM,,73.0,YR,,F,Y,60.0,KG,20221201,,PH,COUNTRY NOT SPECIFIED,IE,2022,Q4,Elderly
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Leukocyturia,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Cough,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Infection,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216670041,21667004,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0",,,U,,,,,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007734,DE-Accord-289221,ACCORD,,62.0,YR,A,F,Y,75.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Pulmonary hilar enlargement,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Anaemia,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216672241,21667224,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1x1)",,,U,,,,,10.0,MG,,QD,2022,Q4,Pleural effusion,,2022,Q4,1,I,,20221124.0,20221201,20221201,EXP,,NVSC2022RS275531,NOVARTIS,,77.0,YR,,M,Y,,,20221201,,MD,RS,RS,2022,Q4,Elderly
216673651,21667365,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221123.0,20221201,20221201,EXP,,DE-AstraZeneca-2022A388588,ASTRAZENECA,,60.0,YR,,M,Y,,,20221201,,MD,DE,,2022,Q4,Adult
216674591,21667459,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0,",,,U,,,,,,,Tablet,,2022,Q4,Hyperventilation,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007908,DE-Accord-288445,ACCORD,,81.0,YR,E,M,Y,100.0,KG,20221201,,PH,DE,DE,2022,Q4,Elderly
216674591,21667459,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1-0-0-0,",,,U,,,,,,,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221118.0,20221201,20221201,EXP,DE-BFARM-22007908,DE-Accord-288445,ACCORD,,81.0,YR,E,M,Y,100.0,KG,20221201,,PH,DE,DE,2022,Q4,Elderly
216682501,21668250,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10mg daily,,,Y,,,,202293.0,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221109.0,20221123.0,20221201,20221201,EXP,,GB-AstraZeneca-2022A385772,ASTRAZENECA,,50.0,YR,,F,Y,,,20221201,,MD,GB,,2022,Q4,Adult
216689931,21668993,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain lower,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain lower,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216689931,21668993,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,6370.0,MG,Y,U,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20220711.0,20221123.0,20221201,20221201,EXP,,LV-AstraZeneca-2022A389696,ASTRAZENECA,,27989.0,DY,,,Y,88.0,KG,20221201,,MD,LV,,2022,Q4,Elderly
216691461,21669146,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Iron deficiency anaemia,,2022,Q4,1,I,,20221123.0,20221201,20221201,EXP,,DE-AstraZeneca-2022A388619,ASTRAZENECA,,80.0,YR,,M,Y,,,20221201,,MD,DE,,2022,Q4,Elderly
216691461,21669146,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221123.0,20221201,20221201,EXP,,DE-AstraZeneca-2022A388619,ASTRAZENECA,,80.0,YR,,M,Y,,,20221201,,MD,DE,,2022,Q4,Elderly
216691461,21669146,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Renal failure,,2022,Q4,1,I,,20221123.0,20221201,20221201,EXP,,DE-AstraZeneca-2022A388619,ASTRAZENECA,,80.0,YR,,M,Y,,,20221201,,MD,DE,,2022,Q4,Elderly
216707392,21670739,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1190.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Erysipelas,,2022,Q4,2,F,20221102.0,20221209.0,20221202,20221220,EXP,,DK-AstraZeneca-2022A389018,ASTRAZENECA,,34.0,YR,,M,Y,95.0,KG,20221216,,MD,DK,,2022,Q4,Young Adult
216707392,21670739,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1190.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Skin infection,,2022,Q4,2,F,20221102.0,20221209.0,20221202,20221220,EXP,,DK-AstraZeneca-2022A389018,ASTRAZENECA,,34.0,YR,,M,Y,95.0,KG,20221216,,MD,DK,,2022,Q4,Young Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Lactic acidosis,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216724791,21672479,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,Y,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221001.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365889,RANBAXY,,45.0,YR,,M,Y,100.0,KG,20221202,,MD,FR,FR,2022,Q4,Adult
216728701,21672870,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,,,,,,10.0,MG,,QD,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,20210101.0,20221129.0,20221202,20221202,EXP,,CN-009507513-2212CHN000822,MERCK,"Zhang N, Tian Y.. Refractory type 2 diabetes mellitus with multi?drug combination transferred to semaglutide: a case report. Chin J Diabetes Mellitus. 2022;14:194-7",39.0,YR,,M,Y,82.0,KG,20221202,,HP,CN,CN,2022,Q4,Adult
216729181,21672918,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,24.0,MG,Y,,2107137,,202293.0,3.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20220421.0,20221126.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A393095,ASTRAZENECA,,79.0,YR,,M,Y,60.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216729181,21672918,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,24.0,MG,Y,,2107137,,202293.0,3.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20220421.0,20221126.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A393095,ASTRAZENECA,,79.0,YR,,M,Y,60.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216730311,21673031,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221118.0,20221202,20221202,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-365900,RANBAXY,,69.0,YR,,M,Y,67.0,KG,20221202,,MD,FR,FR,2022,Q4,Elderly
216735951,21673595,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg 10 DIE,,,,,,,,10.0,MG,,,2022,Q4,Gastrointestinal disorder,,2022,Q4,1,I,20220101.0,20221125.0,20221202,20221202,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32664",IPSEN,,50.0,YR,A,F,Y,,,20221202,,CN,CA,CA,2022,Q4,Adult
216735951,21673595,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg 10 DIE,,,,,,,,10.0,MG,,,2022,Q4,Haemorrhoids,,2022,Q4,1,I,20220101.0,20221125.0,20221202,20221202,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32664",IPSEN,,50.0,YR,A,F,Y,,,20221202,,CN,CA,CA,2022,Q4,Adult
216735951,21673595,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg 10 DIE,,,,,,,,10.0,MG,,,2022,Q4,Faeces soft,,2022,Q4,1,I,20220101.0,20221125.0,20221202,20221202,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32664",IPSEN,,50.0,YR,A,F,Y,,,20221202,,CN,CA,CA,2022,Q4,Adult
216735951,21673595,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg 10 DIE,,,,,,,,10.0,MG,,,2022,Q4,Nausea,,2022,Q4,1,I,20220101.0,20221125.0,20221202,20221202,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32664",IPSEN,,50.0,YR,A,F,Y,,,20221202,,CN,CA,CA,2022,Q4,Adult
216735951,21673595,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg 10 DIE,,,,,,,,10.0,MG,,,2022,Q4,Haemorrhage,,2022,Q4,1,I,20220101.0,20221125.0,20221202,20221202,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32664",IPSEN,,50.0,YR,A,F,Y,,,20221202,,CN,CA,CA,2022,Q4,Adult
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216738831,21673883,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,UNKNOWN,,,10.0,MG,film coated tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221125.0,20221202,20221202,EXP,,IE-ROCHE-3230133,ROCHE,,73.0,YR,,F,Y,60.0,KG,20221202,,HP,IE,,2022,Q4,Elderly
216739101,21673910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HF3402,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nephrolithiasis,,2022,Q4,1,I,20221117.0,20221124.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390331,ASTRAZENECA,,28855.0,DY,,M,Y,51.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216739101,21673910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HF3402,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal disorder,,2022,Q4,1,I,20221117.0,20221124.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390331,ASTRAZENECA,,28855.0,DY,,M,Y,51.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216739101,21673910,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HF3402,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hydronephrosis,,2022,Q4,1,I,20221117.0,20221124.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390331,ASTRAZENECA,,28855.0,DY,,M,Y,51.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Electrolyte imbalance,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216739741,21673974,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram,10 mg, 1-0-0-0",,,,,,,,10.0,MG,,QD,2022,Q4,Cough,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,DE-MYLANLABS-2022M1133316,MYLAN,,76.0,YR,,M,Y,77.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
216740281,21674028,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,60.0,MG,Y,,2205042,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20221117.0,20221126.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390937,ASTRAZENECA,,29230.0,DY,,F,Y,60.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216740601,21674060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Oedema,,2022,Q4,1,I,20221127.0,20221201.0,20221202,20221202,EXP,,IL-AstraZeneca-2022A395244,ASTRAZENECA,,56.0,YR,,F,Y,,,20221202,,CN,IL,,2022,Q4,Adult
216740601,21674060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Hypersensitivity,,2022,Q4,1,I,20221127.0,20221201.0,20221202,20221202,EXP,,IL-AstraZeneca-2022A395244,ASTRAZENECA,,56.0,YR,,F,Y,,,20221202,,CN,IL,,2022,Q4,Adult
216740601,21674060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,20221127.0,20221201.0,20221202,20221202,EXP,,IL-AstraZeneca-2022A395244,ASTRAZENECA,,56.0,YR,,F,Y,,,20221202,,CN,IL,,2022,Q4,Adult
216740601,21674060,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221127.0,20221201.0,20221202,20221202,EXP,,IL-AstraZeneca-2022A395244,ASTRAZENECA,,56.0,YR,,F,Y,,,20221202,,CN,IL,,2022,Q4,Adult
216742521,21674252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2205041,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pruritus,,2022,Q4,1,I,20221110.0,20221125.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390840,ASTRAZENECA,,27175.0,DY,,F,Y,70.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216742521,21674252,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,2205041,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,20221110.0,20221125.0,20221202,20221202,EXP,,CN-AstraZeneca-2022A390840,ASTRAZENECA,,27175.0,DY,,F,Y,70.0,KG,20221202,,MD,CN,,2022,Q4,Elderly
216749921,21674992,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q4,Herpes zoster,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,FR-AstraZeneca-2022A392397,ASTRAZENECA,,53.0,YR,,M,Y,,,20221202,,MD,FR,,2022,Q4,Adult
216752171,21675217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,GB-AstraZeneca-2022A389744,ASTRAZENECA,,78.0,YR,,F,Y,83.0,KG,20221202,,MD,GB,,2022,Q4,Elderly
216752171,21675217,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,U,,,,202293.0,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,GB-AstraZeneca-2022A389744,ASTRAZENECA,,78.0,YR,,F,Y,83.0,KG,20221202,,MD,GB,,2022,Q4,Elderly
216752832,21675283,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20221112.0,20221207.0,20221202,20221212,EXP,IT-MINISAL02-896316,IT-DSJP-DSE-2022-143182,DAIICHI,,77.0,YR,,M,Y,80.0,KG,20221212,,MD,IT,IT,2022,Q4,Elderly
216752832,21675283,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Drug interaction,,2022,Q4,2,F,20221112.0,20221207.0,20221202,20221212,EXP,IT-MINISAL02-896316,IT-DSJP-DSE-2022-143182,DAIICHI,,77.0,YR,,M,Y,80.0,KG,20221212,,MD,IT,IT,2022,Q4,Elderly
216757761,21675776,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221116.0,20221129.0,20221202,20221202,EXP,,DE-AstraZeneca-2022A391972,ASTRAZENECA,,59.0,YR,,F,Y,85.0,KG,20221202,,MD,DE,,2022,Q4,Adult
216757761,21675776,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q4,Swollen tongue,,2022,Q4,1,I,20221116.0,20221129.0,20221202,20221202,EXP,,DE-AstraZeneca-2022A391972,ASTRAZENECA,,59.0,YR,,F,Y,85.0,KG,20221202,,MD,DE,,2022,Q4,Adult
216757761,21675776,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q4,Palatal swelling,,2022,Q4,1,I,20221116.0,20221129.0,20221202,20221202,EXP,,DE-AstraZeneca-2022A391972,ASTRAZENECA,,59.0,YR,,F,Y,85.0,KG,20221202,,MD,DE,,2022,Q4,Adult
216757761,21675776,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q4,Dysphagia,,2022,Q4,1,I,20221116.0,20221129.0,20221202,20221202,EXP,,DE-AstraZeneca-2022A391972,ASTRAZENECA,,59.0,YR,,F,Y,85.0,KG,20221202,,MD,DE,,2022,Q4,Adult
216757761,21675776,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,,,2022,Q4,Pharyngeal swelling,,2022,Q4,1,I,20221116.0,20221129.0,20221202,20221202,EXP,,DE-AstraZeneca-2022A391972,ASTRAZENECA,,59.0,YR,,F,Y,85.0,KG,20221202,,MD,DE,,2022,Q4,Adult
216757851,21675785,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thrombosis,,2022,Q4,1,I,,20221124.0,20221202,20221202,EXP,,RO-AstraZeneca-2022A389855,ASTRAZENECA,,84.0,YR,,M,Y,,,20221202,,MD,RO,,2022,Q4,Elderly
216759551,21675955,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,D,,,,202293.0,,,Tablet,,2022,Q4,Cerebral infarction,,2022,Q4,1,I,,20221129.0,20221202,20221202,EXP,,JP-AstraZeneca-2022A394367,ASTRAZENECA,,70.0,YR,,M,Y,,,20221202,,MD,JP,,2022,Q4,Elderly
216759551,21675955,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,D,,,,202293.0,,,Tablet,,2022,Q4,Septic shock,,2022,Q4,1,I,,20221129.0,20221202,20221202,EXP,,JP-AstraZeneca-2022A394367,ASTRAZENECA,,70.0,YR,,M,Y,,,20221202,,MD,JP,,2022,Q4,Elderly
216759551,21675955,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,D,,,,202293.0,,,Tablet,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,,20221129.0,20221202,20221202,EXP,,JP-AstraZeneca-2022A394367,ASTRAZENECA,,70.0,YR,,M,Y,,,20221202,,MD,JP,,2022,Q4,Elderly
216759551,21675955,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,D,,,,202293.0,,,Tablet,,2022,Q4,Dermatitis infected,,2022,Q4,1,I,,20221129.0,20221202,20221202,EXP,,JP-AstraZeneca-2022A394367,ASTRAZENECA,,70.0,YR,,M,Y,,,20221202,,MD,JP,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Nasal congestion,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Appetite disorder,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Tremor,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Swelling,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Heart rate increased,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Confusional state,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Decreased appetite,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Nausea,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Rhinorrhoea,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216760441,21676044,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,PH0053,,202293.0,,,Tablet,,2022,Q4,Constipation,,2022,Q4,1,I,,20221125.0,20221202,20221202,EXP,,CA-AstraZeneca-2022A392421,ASTRAZENECA,,85.0,YR,,M,Y,,,20221202,,CN,CA,,2022,Q4,Elderly
216765091,21676509,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; Dapagliflozin 10mg, 1 tablet/day",,,,,,,,,,Tablet,,2022,Q4,Oedema genital,,2022,Q4,1,I,20210629.0,20221121.0,20221202,20221202,EXP,PT-INFARMED-G202211-313,PT-TEVA-2022-PT-2829939,TEVA,,84.0,YR,E,M,Y,,,20221128,,MD,PT,PT,2022,Q4,Elderly
216765091,21676509,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; Dapagliflozin 10mg, 1 tablet/day",,,,,,,,,,Tablet,,2022,Q4,Pruritus genital,,2022,Q4,1,I,20210629.0,20221121.0,20221202,20221202,EXP,PT-INFARMED-G202211-313,PT-TEVA-2022-PT-2829939,TEVA,,84.0,YR,E,M,Y,,,20221128,,MD,PT,PT,2022,Q4,Elderly
216765091,21676509,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; Dapagliflozin 10mg, 1 tablet/day",,,,,,,,,,Tablet,,2022,Q4,Tongue oedema,,2022,Q4,1,I,20210629.0,20221121.0,20221202,20221202,EXP,PT-INFARMED-G202211-313,PT-TEVA-2022-PT-2829939,TEVA,,84.0,YR,E,M,Y,,,20221128,,MD,PT,PT,2022,Q4,Elderly
216765091,21676509,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; Dapagliflozin 10mg, 1 tablet/day",,,,,,,,,,Tablet,,2022,Q4,Lip oedema,,2022,Q4,1,I,20210629.0,20221121.0,20221202,20221202,EXP,PT-INFARMED-G202211-313,PT-TEVA-2022-PT-2829939,TEVA,,84.0,YR,E,M,Y,,,20221128,,MD,PT,PT,2022,Q4,Elderly
216765091,21676509,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 Milligram Daily; Dapagliflozin 10mg, 1 tablet/day",,,,,,,,,,Tablet,,2022,Q4,Genital erythema,,2022,Q4,1,I,20210629.0,20221121.0,20221202,20221202,EXP,PT-INFARMED-G202211-313,PT-TEVA-2022-PT-2829939,TEVA,,84.0,YR,E,M,Y,,,20221128,,MD,PT,PT,2022,Q4,Elderly
216777162,21677716,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,Unk,,,,,,,2022,Q4,Coronary artery disease,,2022,Q4,2,F,20221030.0,20221222.0,20221203,20221229,EXP,,NVSC2022DE275960,NOVARTIS,,68.0,YR,,F,Y,,,20221229,,MD,DE,DE,2022,Q4,Elderly
216777162,21677716,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,Unk,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20221030.0,20221222.0,20221203,20221229,EXP,,NVSC2022DE275960,NOVARTIS,,68.0,YR,,F,Y,,,20221229,,MD,DE,DE,2022,Q4,Elderly
216777162,21677716,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,Unk,,,U,,Unk,,,,,,,2022,Q4,Aortic stenosis,,2022,Q4,2,F,20221030.0,20221222.0,20221203,20221229,EXP,,NVSC2022DE275960,NOVARTIS,,68.0,YR,,F,Y,,,20221229,,MD,DE,DE,2022,Q4,Elderly
216790931,21679093,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, unknown",,,,,,,,10.0,MG,,,2022,Q4,Eye infarction,,2022,Q4,1,I,,20221122.0,20221204,20221204,EXP,,NL-ELI_LILLY_AND_COMPANY-NL202211012682,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20221204,,CN,NL,NL,2022,Q4,Elderly
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,COVID-19,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216809171,21680917,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Glucose tolerance impaired,,2022,Q4,1,I,20220101.0,20221201.0,20221205,20221205,EXP,,DE-AstraZeneca-2022A396502,ASTRAZENECA,,63.0,YR,,M,Y,,,20221205,,MD,DE,,2022,Q4,Adult
216812531,21681253,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,U,,,,10.0,MG,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20221121.0,20221205,20221205,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367164,RANBAXY,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hyperkalemia and renal dysfunction after simultaneous use of sacubitril, valsartan and dapagliflozin - case report and literature review. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221205,,HP,PL,PL,2022,Q4,Elderly
216812531,21681253,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,U,,,,10.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221121.0,20221205,20221205,EXP,,PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-367164,RANBAXY,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hyperkalemia and renal dysfunction after simultaneous use of sacubitril, valsartan and dapagliflozin - case report and literature review. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221205,,HP,PL,PL,2022,Q4,Elderly
216827301,21682730,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, qd",,,,,,,,,,Film-coated tablet,QD,2022,Q4,Anaphylactic shock,,2022,Q4,1,I,20220816.0,20221130.0,20221205,20221205,EXP,FR-AFSSAPS-NY20222704,FR-MYLANLABS-2022M1135336,MYLAN,,58.0,YR,,F,Y,78.0,KG,20221205,,MD,FR,FR,2022,Q4,Adult
216830711,21683071,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Polydipsia,,2022,Q4,1,I,,20221130.0,20221205,20221205,EXP,,PT-MYLANLABS-2022M1135149,MYLAN,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022;14(8):e27908",67.0,YR,,M,Y,,,20221205,,HP,PT,PT,2022,Q4,Elderly
216830711,21683071,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Dysgeusia,,2022,Q4,1,I,,20221130.0,20221205,20221205,EXP,,PT-MYLANLABS-2022M1135149,MYLAN,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022;14(8):e27908",67.0,YR,,M,Y,,,20221205,,HP,PT,PT,2022,Q4,Elderly
216830711,21683071,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Respiratory failure,,2022,Q4,1,I,,20221130.0,20221205,20221205,EXP,,PT-MYLANLABS-2022M1135149,MYLAN,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022;14(8):e27908",67.0,YR,,M,Y,,,20221205,,HP,PT,PT,2022,Q4,Elderly
216830711,21683071,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,,20221130.0,20221205,20221205,EXP,,PT-MYLANLABS-2022M1135149,MYLAN,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022;14(8):e27908",67.0,YR,,M,Y,,,20221205,,HP,PT,PT,2022,Q4,Elderly
216830711,21683071,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Hyperglycaemic hyperosmolar nonketotic syndrome,,2022,Q4,1,I,,20221130.0,20221205,20221205,EXP,,PT-MYLANLABS-2022M1135149,MYLAN,"Pombo F, Seabra C, Sa AJ, Ferreira I. Chemotherapy-Induced Dysgeusia and Its Perverse Consequences: A Case Report. Cureus. 2022;14(8):e27908",67.0,YR,,M,Y,,,20221205,,HP,PT,PT,2022,Q4,Elderly
216836191,21683619,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,,20221123.0,20221205,20221205,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202211013838,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20221205,,CN,GB,GB,2022,Q4,Adult
216836191,21683619,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,"Sleep disorder due to general medical condition, insomnia type",,2022,Q4,1,I,,20221123.0,20221205,20221205,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202211013838,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20221205,,CN,GB,GB,2022,Q4,Adult
216836191,21683619,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Nervous system disorder,,2022,Q4,1,I,,20221123.0,20221205,20221205,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202211013838,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20221205,,CN,GB,GB,2022,Q4,Adult
216836191,21683619,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Blood glucose decreased,,2022,Q4,1,I,,20221123.0,20221205,20221205,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202211013838,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20221205,,CN,GB,GB,2022,Q4,Adult
216868031,21686803,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",,,,,,,,5.0,MG,Oral Drug Unspecified Form,QD,2022,Q4,Arrhythmia,,2022,Q4,1,I,20221130.0,20221130.0,20221206,20221206,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-148111,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20221206,,HP,JP,JP,2022,Q4,Elderly
216868031,21686803,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"5 mg, Everyday",,,,,,,,5.0,MG,Oral Drug Unspecified Form,QD,2022,Q4,Interstitial lung disease,,2022,Q4,1,I,20221130.0,20221130.0,20221206,20221206,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-148111,BRISTOL MYERS SQUIBB,,68.0,YR,E,M,Y,,,20221206,,HP,JP,JP,2022,Q4,Elderly
216877522,21687752,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Creatinine renal clearance decreased,,2022,Q4,2,F,20221128.0,20221205.0,20221206,20221213,EXP,,JP-AstraZeneca-2022A395084,ASTRAZENECA,,90.0,YR,,F,Y,,,20221213,,MD,JP,,2022,Q4,Elderly
216878211,21687821,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg/day,,,Y,,,,,10.0,MG,,,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221121.0,20221206,20221206,EXP,FR-AFSSAPS-GR20222273,FR-Accord-288749,ACCORD,,76.0,YR,E,F,Y,75.0,KG,20221206,,PH,FR,FR,2022,Q4,Elderly
216878211,21687821,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10mg/day,,,Y,,,,,10.0,MG,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221121.0,20221206,20221206,EXP,FR-AFSSAPS-GR20222273,FR-Accord-288749,ACCORD,,76.0,YR,E,F,Y,75.0,KG,20221206,,PH,FR,FR,2022,Q4,Elderly
216890381,21689038,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, 1x/day",,,,,,,,,,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,,20221201.0,20221206,20221206,EXP,GB-MHRA-TPP2067026C9133293YC1669391004229,GB-PFIZER INC-202201345830,PFIZER,,62.0,YR,,F,Y,57.0,KG,20221206,,MD,GB,GB,2022,Q4,Adult
216890381,21689038,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"1 DF, 1x/day",,,,,,,,,,Tablet,QD,2022,Q4,Swelling face,,2022,Q4,1,I,,20221201.0,20221206,20221206,EXP,GB-MHRA-TPP2067026C9133293YC1669391004229,GB-PFIZER INC-202201345830,PFIZER,,62.0,YR,,F,Y,57.0,KG,20221206,,MD,GB,GB,2022,Q4,Adult
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Blood triglycerides increased,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Back pain,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Arrhythmia supraventricular,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Amnesia,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Liver disorder,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Blood urea increased,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Urine ketone body present,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Off label use,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Neck pain,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Vitamin D deficiency,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Blood creatinine increased,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Medication error,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Bradycardia,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Blood pressure decreased,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Pyrexia,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Balance disorder,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216899521,21689952,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,MK0080,,202293.0,,,Tablet,QD,2022,Q4,Glucose urine present,,2022,Q4,1,I,20220801.0,20221128.0,20221206,20221206,EXP,,MX-AstraZeneca-2022A394575,ASTRAZENECA,,26085.0,DY,,M,Y,64.0,KG,20221206,,CN,MX,,2022,Q4,Elderly
216900341,21690034,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216900341,21690034,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216900341,21690034,16,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216900341,21690034,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216900341,21690034,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216900341,21690034,17,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (10),,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20180101.0,20221124.0,20221206,20221206,EXP,,NVSC2022SG283220,NOVARTIS,,68.0,YR,,M,Y,,,20221206,,MD,SG,SG,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood urea increased,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperkalaemia,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood creatinine increased,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Renal impairment,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug ineffective,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Glomerular filtration rate increased,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Creatinine urine increased,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Oedema,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pulmonary oedema,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216941824,21694182,6,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood uric acid increased,,2022,Q4,4,F,20211201.0,20221212.0,20221207,20221219,EXP,,NVSC2022PL281788,NOVARTIS,"Korzeniowska K, Malesza K, Miciak-Lawicka E, Jablecka A. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - ppis przypadku i przegladglad pismiennictwa [Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and literature review]. GERIATRIA. 2022;16(3):171-8",91.0,YR,,F,Y,,,20221219,,HP,PL,PL,2022,Q4,Elderly
216995311,21699531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20221109.0,20221130.0,20221208,20221208,EXP,,DK-AstraZeneca-2022A392594,ASTRAZENECA,,87.0,YR,,F,Y,,,20221208,,MD,DK,,2022,Q4,Elderly
216995311,21699531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20221109.0,20221130.0,20221208,20221208,EXP,,DK-AstraZeneca-2022A392594,ASTRAZENECA,,87.0,YR,,F,Y,,,20221208,,MD,DK,,2022,Q4,Elderly
216995311,21699531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Feeling cold,,2022,Q4,1,I,20221109.0,20221130.0,20221208,20221208,EXP,,DK-AstraZeneca-2022A392594,ASTRAZENECA,,87.0,YR,,F,Y,,,20221208,,MD,DK,,2022,Q4,Elderly
216995311,21699531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221109.0,20221130.0,20221208,20221208,EXP,,DK-AstraZeneca-2022A392594,ASTRAZENECA,,87.0,YR,,F,Y,,,20221208,,MD,DK,,2022,Q4,Elderly
216995311,21699531,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20221109.0,20221130.0,20221208,20221208,EXP,,DK-AstraZeneca-2022A392594,ASTRAZENECA,,87.0,YR,,F,Y,,,20221208,,MD,DK,,2022,Q4,Elderly
216999771,21699977,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,,,,D,U,,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,1,I,,20221130.0,20221208,20221208,EXP,GB-MHRA-ADR 23357992,GB-EMD Serono-E2B_90089859,EMD SERONO INC,,20.0,WK,I,,Y,,,20221208,,MD,GB,,2022,Q4,Youth
217002811,21700281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,160.0,MG,Y,,unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dermatitis allergic,,2022,Q4,1,I,20220924.0,20221206.0,20221208,20221208,EXP,,CN-AstraZeneca-2022A400024,ASTRAZENECA,,24690.0,DY,,M,Y,67.0,KG,20221208,,MD,CN,,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217007661,21700766,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 10 mg daily,,,,,"UNKNOWN,Unknown",,,10.0,MG,,QD,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221128.0,20221208,20221208,EXP,IE-HPRA-2022-099851,IE-TEVA-2022-IE-2832439,TEVA,,73.0,YR,E,F,Y,60.0,KG,20221208,,PH,IE,IE,2022,Q4,Elderly
217008741,21700874,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Hepatitis,,2022,Q4,1,I,20221007.0,20221126.0,20221208,20221208,EXP,FR-AFSSAPS-2022092904,FR-Accord-289989,ACCORD,,83.0,YR,E,M,Y,72.8,KG,20221208,,MD,FR,FR,2022,Q4,Elderly
217012741,21701274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Renal failure,,2022,Q4,1,I,20220401.0,20221201.0,20221208,20221208,EXP,,PL-AstraZeneca-2022A393746,ASTRAZENECA,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and litareture review... GERIATRICS 2022;(3):171-178.",91.0,YR,,F,Y,,,20221208,,MD,PL,,2022,Q4,Elderly
217012741,21701274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Drug interaction,,2022,Q4,1,I,20220401.0,20221201.0,20221208,20221208,EXP,,PL-AstraZeneca-2022A393746,ASTRAZENECA,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and litareture review... GERIATRICS 2022;(3):171-178.",91.0,YR,,F,Y,,,20221208,,MD,PL,,2022,Q4,Elderly
217012741,21701274,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 milligram,,,Y,,,,202293.0,,,Tablet,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220401.0,20221201.0,20221208,20221208,EXP,,PL-AstraZeneca-2022A393746,ASTRAZENECA,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin - case report and litareture review... GERIATRICS 2022;(3):171-178.",91.0,YR,,F,Y,,,20221208,,MD,PL,,2022,Q4,Elderly
217038581,21703858,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10MG ONCE A DAY,,,,,,,202293.0,10.0,MG,,QD,2022,Q4,Genital abscess,,2022,Q4,1,I,,20221207.0,20221209,20221209,EXP,,GB-AstraZeneca-2022A400698,ASTRAZENECA,,65.0,YR,,M,Y,,,20221209,,MD,GB,,2022,Q4,Elderly
217042161,21704216,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1x1,320.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Angioedema,,2022,Q4,1,I,20221114.0,20221207.0,20221209,20221209,EXP,,SE-AstraZeneca-2022A399596,ASTRAZENECA,,78.0,YR,,F,Y,,,20221209,,MD,SE,,2022,Q4,Elderly
217042161,21704216,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg 1x1,320.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urticaria,,2022,Q4,1,I,20221114.0,20221207.0,20221209,20221209,EXP,,SE-AstraZeneca-2022A399596,ASTRAZENECA,,78.0,YR,,F,Y,,,20221209,,MD,SE,,2022,Q4,Elderly
217044981,21704498,3,I,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Drug-disease interaction,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832811,TEVA,,93.0,YR,E,F,Y,66.0,KG,20221209,,HP,CA,CA,2022,Q4,Elderly
217044981,21704498,3,I,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Altered state of consciousness,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832811,TEVA,,93.0,YR,E,F,Y,66.0,KG,20221209,,HP,CA,CA,2022,Q4,Elderly
217044981,21704498,3,I,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,10 Milligram Daily;,,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221130.0,20221209,20221209,EXP,,CA-TEVA-2022-CA-2832811,TEVA,,93.0,YR,E,F,Y,66.0,KG,20221209,,HP,CA,CA,2022,Q4,Elderly
217046021,21704602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2022,Q4,Genital infection female,,2022,Q4,1,I,,20221201.0,20221209,20221209,EXP,,DE-AstraZeneca-2022A396579,ASTRAZENECA,,76.0,YR,,F,Y,,,20221209,,MD,DE,,2022,Q4,Elderly
217046021,21704602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,unknown,,202293.0,,,Tablet,,2022,Q4,Lichen sclerosus,,2022,Q4,1,I,,20221201.0,20221209,20221209,EXP,,DE-AstraZeneca-2022A396579,ASTRAZENECA,,76.0,YR,,F,Y,,,20221209,,MD,DE,,2022,Q4,Elderly
217050421,21705042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,20221001.0,20221201.0,20221209,20221209,EXP,,FR-AstraZeneca-2022A393819,ASTRAZENECA,,78.0,YR,,M,Y,54.7,KG,20221209,,MD,FR,,2022,Q4,Elderly
217050421,21705042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Extremity necrosis,,2022,Q4,1,I,20221001.0,20221201.0,20221209,20221209,EXP,,FR-AstraZeneca-2022A393819,ASTRAZENECA,,78.0,YR,,M,Y,54.7,KG,20221209,,MD,FR,,2022,Q4,Elderly
217050421,21705042,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Extremity necrosis,,2022,Q4,1,I,20221001.0,20221201.0,20221209,20221209,EXP,,FR-AstraZeneca-2022A393819,ASTRAZENECA,,78.0,YR,,M,Y,54.7,KG,20221209,,MD,FR,,2022,Q4,Elderly
217055631,21705563,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,,,Tablet,QD,2022,Q4,Diabetes insipidus,,2022,Q4,1,I,20220101.0,20221202.0,20221209,20221209,EXP,,FR-AstraZeneca-2022A395485,ASTRAZENECA,,65.0,YR,,F,Y,49.4,KG,20221209,,MD,FR,,2022,Q4,Elderly
217056051,21705605,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,not provided,,,N,U,Unknown,,,,,,,2022,Q4,Acute generalised exanthematous pustulosis,,2022,Q4,1,I,20221112.0,20221205.0,20221209,20221209,EXP,FR-AFSSAPS-NC20223078,FR-PFIZER INC-202201350044,PFIZER,,51.0,YR,,M,Y,107.0,KG,20221209,,MD,FR,FR,2022,Q4,Adult
217060691,21706069,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (was taken until the evening before surgery),,,U,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20201126.0,20221209,20221209,EXP,,NVSC2020DE358590,NOVARTIS,Malicek D. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin. ANASTHESIOL-INTENSIVMED. 2020;61(10):472-8,76.0,YR,,M,Y,,,20221209,,HP,DE,DE,2022,Q4,Elderly
217060691,21706069,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (was taken until the evening before surgery),,,U,,,,,,,,,2022,Q4,Haemodynamic instability,,2022,Q4,1,I,,20201126.0,20221209,20221209,EXP,,NVSC2020DE358590,NOVARTIS,Malicek D. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin. ANASTHESIOL-INTENSIVMED. 2020;61(10):472-8,76.0,YR,,M,Y,,,20221209,,HP,DE,DE,2022,Q4,Elderly
217060691,21706069,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK (was taken until the evening before surgery),,,U,,,,,,,,,2022,Q4,Product use issue,,2022,Q4,1,I,,20201126.0,20221209,20221209,EXP,,NVSC2020DE358590,NOVARTIS,Malicek D. Severe condition of shock with combined lactic and ketoacidosis in a patient after left-sided pancreas resection under permanent therapy with metformin and dapagliflozin. ANASTHESIOL-INTENSIVMED. 2020;61(10):472-8,76.0,YR,,M,Y,,,20221209,,HP,DE,DE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217064191,21706419,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg daily,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221125.0,20221209,20221209,EXP,,IE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-368158,RANBAXY,,73.0,YR,,F,Y,60.0,KG,20221209,,PH,IE,IE,2022,Q4,Elderly
217065471,21706547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,ASKU,,202293.0,10.0,MG,,QD,2022,Q4,Scrotal pain,,2022,Q4,1,I,20221103.0,20221207.0,20221209,20221209,EXP,,DK-AstraZeneca-2022A399516,ASTRAZENECA,,79.0,YR,,M,Y,64.0,KG,20221209,,MD,DK,,2022,Q4,Elderly
217065471,21706547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,ASKU,,202293.0,10.0,MG,,QD,2022,Q4,Fournier's gangrene,,2022,Q4,1,I,20221103.0,20221207.0,20221209,20221209,EXP,,DK-AstraZeneca-2022A399516,ASTRAZENECA,,79.0,YR,,M,Y,64.0,KG,20221209,,MD,DK,,2022,Q4,Elderly
217066232,21706623,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10960.0,MG,N,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Bladder cancer,,2022,Q4,2,F,20221201.0,20221208.0,20221209,20221220,EXP,,DE-AstraZeneca-2022A399296,ASTRAZENECA,,60.0,YR,,F,Y,73.0,KG,20221216,,MD,DE,,2022,Q4,Adult
217073601,21707360,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1-0-0,,,U,,,,202293.0,,,,,2022,Q4,Somnolence,,2022,Q4,1,I,,20221208.0,20221209,20221209,EXP,,CZ-AstraZeneca-2022A400904,ASTRAZENECA,,39.0,YR,,F,Y,,,20221209,,MD,CZ,,2022,Q4,Adult
217073601,21707360,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1-0-0,,,U,,,,202293.0,,,,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,,20221208.0,20221209,20221209,EXP,,CZ-AstraZeneca-2022A400904,ASTRAZENECA,,39.0,YR,,F,Y,,,20221209,,MD,CZ,,2022,Q4,Adult
217073601,21707360,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1-0-0,,,U,,,,202293.0,,,,,2022,Q4,Acidosis,,2022,Q4,1,I,,20221208.0,20221209,20221209,EXP,,CZ-AstraZeneca-2022A400904,ASTRAZENECA,,39.0,YR,,F,Y,,,20221209,,MD,CZ,,2022,Q4,Adult
217073601,21707360,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,1-0-0,,,U,,,,202293.0,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221208.0,20221209,20221209,EXP,,CZ-AstraZeneca-2022A400904,ASTRAZENECA,,39.0,YR,,F,Y,,,20221209,,MD,CZ,,2022,Q4,Adult
217074221,21707422,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20221202.0,20221209,20221209,EXP,,JP-AstraZeneca-2022A398867,ASTRAZENECA,,72.0,YR,,F,Y,,,20221209,,PH,JP,,2022,Q4,Elderly
217079721,21707972,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221208.0,20221209,20221209,EXP,DE-BFARM-22009744,DE-BAUSCH-BL-2022-026953,BAUSCH AND LOMB,,63.0,YR,,M,Y,75.0,KG,20221209,,MD,DE,DE,2022,Q4,Adult
217081011,21708101,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,,,,,,2022,Q4,Weight decreased,,2022,Q4,1,I,20200101.0,20221129.0,20221209,20221209,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211006386,ELI LILLY AND CO,,64.0,YR,,M,Y,59.0,KG,20221209,,CN,CN,CN,2022,Q4,Adult
217081011,21708101,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,,,,,,2022,Q4,Weight decreased,,2022,Q4,1,I,20200101.0,20221129.0,20221209,20221209,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211006386,ELI LILLY AND CO,,64.0,YR,,M,Y,59.0,KG,20221209,,CN,CN,CN,2022,Q4,Adult
217081011,21708101,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,,,,,,2022,Q4,Glucose urine present,,2022,Q4,1,I,20200101.0,20221129.0,20221209,20221209,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211006386,ELI LILLY AND CO,,64.0,YR,,M,Y,59.0,KG,20221209,,CN,CN,CN,2022,Q4,Adult
217081011,21708101,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK UNK, unknown",,,U,,ASKU,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,20200101.0,20221129.0,20221209,20221209,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211006386,ELI LILLY AND CO,,64.0,YR,,M,Y,59.0,KG,20221209,,CN,CN,CN,2022,Q4,Adult
217084752,21708475,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,,20221129.0,20221210,20221214,EXP,,PL-AUROBINDO-AUR-APL-2022-051640,AUROBINDO,"Katarzyna Korzeniowska, Katarzyna Malesza, Ewa Miciak-?awicka, Anna Jab?ecka. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozinn - case report and litareture review. GERIATRIA. 2022;16:171-178",91.0,YR,,F,Y,,,20221214,,MD,PL,PL,2022,Q4,Elderly
217084752,21708475,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221129.0,20221210,20221214,EXP,,PL-AUROBINDO-AUR-APL-2022-051640,AUROBINDO,"Katarzyna Korzeniowska, Katarzyna Malesza, Ewa Miciak-?awicka, Anna Jab?ecka. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozinn - case report and litareture review. GERIATRIA. 2022;16:171-178",91.0,YR,,F,Y,,,20221214,,MD,PL,PL,2022,Q4,Elderly
217084752,21708475,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q4,Cardiac failure,,2022,Q4,2,F,,20221129.0,20221210,20221214,EXP,,PL-AUROBINDO-AUR-APL-2022-051640,AUROBINDO,"Katarzyna Korzeniowska, Katarzyna Malesza, Ewa Miciak-?awicka, Anna Jab?ecka. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozinn - case report and litareture review. GERIATRIA. 2022;16:171-178",91.0,YR,,F,Y,,,20221214,,MD,PL,PL,2022,Q4,Elderly
217084752,21708475,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Daily",,,U,,,,,10.0,MG,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221129.0,20221210,20221214,EXP,,PL-AUROBINDO-AUR-APL-2022-051640,AUROBINDO,"Katarzyna Korzeniowska, Katarzyna Malesza, Ewa Miciak-?awicka, Anna Jab?ecka. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozinn - case report and litareture review. GERIATRIA. 2022;16:171-178",91.0,YR,,F,Y,,,20221214,,MD,PL,PL,2022,Q4,Elderly
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,Glucose tolerance impaired,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,COVID-19,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217084911,21708491,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",,,U,,Unk,,,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220101.0,20221209.0,20221210,20221210,EXP,,NVSC2022DE285914,NOVARTIS,,63.0,YR,,M,Y,,,20221210,,MD,DE,DE,2022,Q4,Adult
217101591,21710159,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q4,Irregular sleep phase,,2022,Q4,1,I,20221101.0,20221205.0,20221211,20221211,PER,,US-JNJFOC-20221213180,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,149.82,KG,20221211,,CN,US,US,2022,Q4,Adult
217101591,21710159,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q4,Hyperventilation,,2022,Q4,1,I,20221101.0,20221205.0,20221211,20221211,PER,,US-JNJFOC-20221213180,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,149.82,KG,20221211,,CN,US,US,2022,Q4,Adult
217101591,21710159,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q4,Product label issue,,2022,Q4,1,I,20221101.0,20221205.0,20221211,20221211,PER,,US-JNJFOC-20221213180,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,149.82,KG,20221211,,CN,US,US,2022,Q4,Adult
217101591,21710159,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20221101.0,20221205.0,20221211,20221211,PER,,US-JNJFOC-20221213180,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,149.82,KG,20221211,,CN,US,US,2022,Q4,Adult
217101591,21710159,6,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,Unknown,,,,,,,,,,,Unknown,,2022,Q4,Oxygen saturation decreased,,2022,Q4,1,I,20221101.0,20221205.0,20221211,20221211,PER,,US-JNJFOC-20221213180,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,149.82,KG,20221211,,CN,US,US,2022,Q4,Adult
217119171,21711917,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,strength- 10 mg,,,Y,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Agranulocytosis,,2022,Q4,1,I,20221010.0,20221130.0,20221212,20221212,EXP,FR-AFSSAPS-DJ20221990,FR-Accord-291390,ACCORD,,69.0,YR,E,M,Y,67.0,KG,20221212,,MD,FR,FR,2022,Q4,Elderly
217128492,21712849,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,not decided,,,N,,unknown,,202293.0,,,Tablet,,2022,Q4,Acute generalised exanthematous pustulosis,,2022,Q4,2,F,20221112.0,20221206.0,20221212,20221214,EXP,,FR-AstraZeneca-2022A398263,ASTRAZENECA,,51.0,YR,,M,Y,107.0,KG,20221214,,MD,FR,,2022,Q4,Adult
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Wrong patient received product,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Seizure,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Magnetic resonance imaging head abnormal,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Hypoxic-ischaemic encephalopathy,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217135191,21713519,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg daily,,,D,,,,,10.0,MG,,,2022,Q4,Rhabdomyolysis,,2022,Q4,1,I,20221009.0,20221130.0,20221212,20221212,EXP,IE-HPRA-2022099851,IE-Accord-290814,ACCORD,,73.0,YR,E,F,Y,60.0,KG,20221212,,PH,IE,IE,2022,Q4,Elderly
217136241,21713624,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Dermatitis exfoliative,,2022,Q4,1,I,20221013.0,20221208.0,20221212,20221212,EXP,,"DK-Hill Dermaceuticals, Inc.-2135766",HILL DERM,,64.0,YR,,F,Y,102.0,KG,20221212,,MD,COUNTRY NOT SPECIFIED,DK,2022,Q4,Adult
217145113,21714511,9,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 DF, QD (medicinal product : FORXIGA 10 mg,film-coated tablet)",,,,,,,,,,Film-coated tablet,QD,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,3,F,20221029.0,20221228.0,20221212,20221230,EXP,FR-AFSSAPS-AM20222427,FR-ORGANON-O2212FRA000514,ORGANON,,76.0,YR,,M,Y,60.0,KG,20221230,,MD,FR,FR,2022,Q4,Elderly
217148181,21714818,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,STRENGTH: 10 mg,8370.0,MG,,,ASKU,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,1,I,20221117.0,20221207.0,20221212,20221212,EXP,,DK-AstraZeneca-2022A399726,ASTRAZENECA,,62.0,YR,,F,Y,,,20221212,,MD,DK,,2022,Q4,Adult
217154541,21715454,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,610.0,MG,D,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Intestinal obstruction,,2022,Q4,1,I,20221001.0,20221207.0,20221212,20221212,EXP,,JP-AstraZeneca-2022A402813,ASTRAZENECA,,1025.0,MON,,F,Y,,,20221212,,MD,JP,,2022,Q4,Elderly
217154832,21715483,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Formulation unknown,,2022,Q4,Anaemia,,2022,Q4,2,F,20221108.0,20221219.0,20221212,20221223,EXP,,ES-ASTELLAS-2022US040339,ASTELLAS,,77.0,YR,,M,Y,59.0,KG,20221223,,MD,ES,ES,2022,Q4,Elderly
217173481,21717348,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Film-coated tablet,,2022,Q4,Hypertension,,2022,Q4,1,I,20221203.0,20221204.0,20221212,20221212,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-2022-148134,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,46.0,KG,20221212,,HP,CN,CN,2022,Q4,Elderly
217184531,21718453,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221020.0,20221207.0,20221212,20221212,EXP,,FR-BAUSCHBL-2022BNL002665,BAUSCH AND LOMB,,63.0,YR,,M,Y,69.6,KG,20221213,,HP,FR,FR,2022,Q4,Adult
217184531,21718453,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221020.0,20221207.0,20221212,20221212,EXP,,FR-BAUSCHBL-2022BNL002665,BAUSCH AND LOMB,,63.0,YR,,M,Y,69.6,KG,20221213,,HP,FR,FR,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Cough,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Ejection fraction decreased,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Heart rate irregular,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Asthenia,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Fatigue,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Oedema,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Hyperhidrosis,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Movement disorder,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Renal impairment,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (5mg),,,,,,,,,,Tablet,,2022,Q4,Off label use,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Cough,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Cardiac disorder,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Hypotension,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Ejection fraction decreased,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Heart rate irregular,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Asthenia,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Fatigue,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Oedema,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Hyperhidrosis,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Movement disorder,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Wrong technique in product usage process,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Renal impairment,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217187172,21718717,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 dosage form (10mg),,,,,,,,,,Tablet,,2022,Q4,Off label use,,2022,Q4,2,F,20210406.0,20221211.0,20221213,20221219,EXP,,NVSC2022EG285614,NOVARTIS,,56.0,YR,,M,Y,,,20221219,,CN,EG,EG,2022,Q4,Adult
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Drug interaction,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Blood creatine increased,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Blood uric acid increased,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217205571,21720557,5,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Asthenia,,2022,Q4,1,I,20211201.0,20221129.0,20221213,20221213,EXP,,PL-AUROBINDO-AUR-APL-2022-052630,AUROBINDO,"Korzeniowska K., Malesza K., Miciak-Lawicka E., Jablecka A et. al. Hyperkalemia and renal dysfunction aftersimultaneous the use of sacubitril, valsartan and dapagliflozin- case report and litareture review. GERIATRICS.. 2022;3:171-178",91.0,YR,,F,Y,,,20221213,,MD,PL,PL,2022,Q4,Elderly
217206792,21720679,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,2,F,20220101.0,20221213.0,20221213,20221215,EXP,,NL-Merz Pharmaceuticals GmbH-22-03759,MERZ,,61.0,YR,A,M,Y,,,20221215,,MD,NL,NL,2022,Q4,Adult
217206792,21720679,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Epilepsy,,2022,Q4,2,F,20220101.0,20221213.0,20221213,20221215,EXP,,NL-Merz Pharmaceuticals GmbH-22-03759,MERZ,,61.0,YR,A,M,Y,,,20221215,,MD,NL,NL,2022,Q4,Adult
217206792,21720679,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,2,F,20220101.0,20221213.0,20221213,20221215,EXP,,NL-Merz Pharmaceuticals GmbH-22-03759,MERZ,,61.0,YR,A,M,Y,,,20221215,,MD,NL,NL,2022,Q4,Adult
217208111,21720811,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Hyponatraemia,,2022,Q4,1,I,,20221205.0,20221213,20221213,EXP,,RO-AstraZeneca-2022A400369,ASTRAZENECA,"Stoia MA, Pop AE. The long journey of a patient with advanced heart failure between the favorable and secondary effects of pharmacological treatment. Medicine and Pharmacy Reports 2022;(supll 2):s25.",62.0,YR,,,Y,,,20221213,,HP,RO,,2022,Q4,Adult
217209151,21720915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 OD,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Vomiting,,2022,Q4,1,I,20221001.0,20221020.0,20221213,20221213,EXP,,GB-AstraZeneca-2022A404461,ASTRAZENECA,,75.0,YR,,F,Y,,,20221213,,MD,GB,,2022,Q4,Elderly
217209151,21720915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 OD,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Gastrointestinal pain,,2022,Q4,1,I,20221001.0,20221020.0,20221213,20221213,EXP,,GB-AstraZeneca-2022A404461,ASTRAZENECA,,75.0,YR,,F,Y,,,20221213,,MD,GB,,2022,Q4,Elderly
217209151,21720915,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1 OD,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20221001.0,20221020.0,20221213,20221213,EXP,,GB-AstraZeneca-2022A404461,ASTRAZENECA,,75.0,YR,,F,Y,,,20221213,,MD,GB,,2022,Q4,Elderly
217218211,21721821,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,520.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20221118.0,20221209.0,20221213,20221213,EXP,,DK-AstraZeneca-2022A401945,ASTRAZENECA,,86.0,YR,,F,Y,,,20221213,,MD,DK,,2022,Q4,Elderly
217218211,21721821,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,520.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20221118.0,20221209.0,20221213,20221213,EXP,,DK-AstraZeneca-2022A401945,ASTRAZENECA,,86.0,YR,,F,Y,,,20221213,,MD,DK,,2022,Q4,Elderly
217218211,21721821,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,520.0,MG,Y,,ASKED BUT UNKNOWN,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,20221118.0,20221209.0,20221213,20221213,EXP,,DK-AstraZeneca-2022A401945,ASTRAZENECA,,86.0,YR,,F,Y,,,20221213,,MD,DK,,2022,Q4,Elderly
217221311,21722131,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221202.0,20221213,20221213,EXP,GB-MHRA-ADR 27517905,GB-Accord-290700,ACCORD,,81.0,YR,,,Y,,,20221213,,PH,GB,GB,2022,Q4,Elderly
217230531,21723053,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,1,I,20221104.0,20221108.0,20221213,20221213,EXP,,FR-AstraZeneca-2022A404050,ASTRAZENECA,,53.0,YR,,M,Y,,,20221213,,MD,FR,,2022,Q4,Adult
217232791,21723279,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20221016.0,20221207.0,20221213,20221213,EXP,,JP-AstraZeneca-2022A404964,ASTRAZENECA,,31574.0,DY,,M,Y,54.0,KG,20221213,,MD,JP,,2022,Q4,Elderly
217232791,21723279,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20221016.0,20221207.0,20221213,20221213,EXP,,JP-AstraZeneca-2022A404964,ASTRAZENECA,,31574.0,DY,,M,Y,54.0,KG,20221213,,MD,JP,,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Scratch,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Liver function test abnormal,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Skin haemorrhage,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Cholangitis,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Ascites,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217233081,21723308,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Prothrombin time abnormal,,2022,Q4,1,I,20220101.0,20221207.0,20221213,20221213,EXP,,DE-DSJP-DSE-2022-144581,DAIICHI,,71.0,YR,,M,Y,79.0,KG,20221213,,CN,DE,DE,2022,Q4,Elderly
217239611,21723961,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Drug reaction with eosinophilia and systemic symptoms,,2022,Q4,1,I,20220923.0,20221207.0,20221213,20221213,EXP,FR-AFSSAPS-GR20222273,FR-MYLANLABS-2022M1137906,MYLAN,,76.0,YR,,F,Y,75.0,KG,20221213,,PH,FR,FR,2022,Q4,Elderly
217239611,21723961,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg/day,,,Y,,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220923.0,20221207.0,20221213,20221213,EXP,FR-AFSSAPS-GR20222273,FR-MYLANLABS-2022M1137906,MYLAN,,76.0,YR,,F,Y,75.0,KG,20221213,,PH,FR,FR,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Rash erythematous,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Cystitis,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Purpura,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pyelitis,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Septic shock,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Drug eruption,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,51,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Rash maculo-papular,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Rash erythematous,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Cystitis,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Purpura,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Pyelitis,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Septic shock,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Drug eruption,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217240611,21724061,52,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Rash maculo-papular,,2022,Q4,1,I,20211122.0,20221207.0,20221213,20221213,EXP,CH-SM-2021-29387,CH-PFIZER INC-202101881376,PFIZER,,81.0,YR,,M,Y,,,20221213,,MD,CH,CH,2022,Q4,Elderly
217241821,21724182,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20221020.0,20221207.0,20221213,20221213,EXP,,FR-BAUSCH-BL-2022-026920,BAUSCH AND LOMB,,63.0,YR,,M,Y,69.6,KG,20221213,,HP,FR,FR,2022,Q4,Adult
217241821,21724182,13,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221020.0,20221207.0,20221213,20221213,EXP,,FR-BAUSCH-BL-2022-026920,BAUSCH AND LOMB,,63.0,YR,,M,Y,69.6,KG,20221213,,HP,FR,FR,2022,Q4,Adult
217288171,21728817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,Y,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Dizziness,,2022,Q4,1,I,,20221206.0,20221214,20221214,EXP,,IT-AstraZeneca-2022A403150,ASTRAZENECA,,74.0,YR,,F,Y,,,20221214,,MD,IT,,2022,Q4,Elderly
217288171,21728817,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,Y,Unknown,,202293.0,10.0,MG,Tablet,,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,,20221206.0,20221214,20221214,EXP,,IT-AstraZeneca-2022A403150,ASTRAZENECA,,74.0,YR,,F,Y,,,20221214,,MD,IT,,2022,Q4,Elderly
217290071,21729007,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Arterial stenosis,,2022,Q4,1,I,20210101.0,20221206.0,20221214,20221214,EXP,,FR-AstraZeneca-2022A403205,ASTRAZENECA,,72.0,YR,,M,Y,,,20221214,,MD,FR,,2022,Q4,Elderly
217290071,21729007,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Muscle spasms,,2022,Q4,1,I,20210101.0,20221206.0,20221214,20221214,EXP,,FR-AstraZeneca-2022A403205,ASTRAZENECA,,72.0,YR,,M,Y,,,20221214,,MD,FR,,2022,Q4,Elderly
217290071,21729007,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3660.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pain,,2022,Q4,1,I,20210101.0,20221206.0,20221214,20221214,EXP,,FR-AstraZeneca-2022A403205,ASTRAZENECA,,72.0,YR,,M,Y,,,20221214,,MD,FR,,2022,Q4,Elderly
217291971,21729197,8,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,qd (Take one tablet daily in addition to other medi...),,,,,,,,,,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20221129.0,20221209.0,20221214,20221214,EXP,GB-MHRA-TPP33190997C6976595YC1669721364968,GB-DSJP-DSE-2022-144861,DAIICHI,,84.0,YR,,M,Y,87.0,KG,20221214,,HP,GB,GB,2022,Q4,Elderly
217292221,21729222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Cardiac failure congestive,,2022,Q4,1,I,20220120.0,20221206.0,20221214,20221214,EXP,,JP-AstraZeneca-2022A341319,ASTRAZENECA,"Ohara E, et al. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists; 2022;268-.",88.0,YR,,M,Y,68.0,KG,20221214,,PH,JP,,2022,Q4,Elderly
217292221,21729222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Cardiorenal syndrome,,2022,Q4,1,I,20220120.0,20221206.0,20221214,20221214,EXP,,JP-AstraZeneca-2022A341319,ASTRAZENECA,"Ohara E, et al. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists; 2022;268-.",88.0,YR,,M,Y,68.0,KG,20221214,,PH,JP,,2022,Q4,Elderly
217292221,21729222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Dehydration,,2022,Q4,1,I,20220120.0,20221206.0,20221214,20221214,EXP,,JP-AstraZeneca-2022A341319,ASTRAZENECA,"Ohara E, et al. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists; 2022;268-.",88.0,YR,,M,Y,68.0,KG,20221214,,PH,JP,,2022,Q4,Elderly
217292221,21729222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pleural effusion,,2022,Q4,1,I,20220120.0,20221206.0,20221214,20221214,EXP,,JP-AstraZeneca-2022A341319,ASTRAZENECA,"Ohara E, et al. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists; 2022;268-.",88.0,YR,,M,Y,68.0,KG,20221214,,PH,JP,,2022,Q4,Elderly
217292221,21729222,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Nephrotic syndrome,,2022,Q4,1,I,20220120.0,20221206.0,20221214,20221214,EXP,,JP-AstraZeneca-2022A341319,ASTRAZENECA,"Ohara E, et al. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists; 2022;268-.",88.0,YR,,M,Y,68.0,KG,20221214,,PH,JP,,2022,Q4,Elderly
217316852,21731685,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,QD,2022,Q4,Diabetes mellitus,,2022,Q4,2,F,,20221212.0,20221215,20221216,EXP,,IE-JNJFOC-20221217004,JOHNSON AND JOHNSON,,8.0,DEC,E,M,Y,,,20221216,,HP,IE,IE,2022,Q4,Child
217316852,21731685,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,,,,,,,,10.0,MG,Unknown,QD,2022,Q4,Skin abrasion,,2022,Q4,2,F,,20221212.0,20221215,20221216,EXP,,IE-JNJFOC-20221217004,JOHNSON AND JOHNSON,,8.0,DEC,E,M,Y,,,20221216,,HP,IE,IE,2022,Q4,Child
217338921,21733892,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",110.0,MG,,,2111093/NJ,,,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,1,I,20221112.0,20221214.0,20221215,20221215,EXP,,CN-BAYER-2022A171275,BAYER,,75.0,YR,E,F,Y,55.0,KG,20221215,,HP,CN,CN,2022,Q4,Elderly
217338921,21733892,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",110.0,MG,,,2111093/NJ,,,10.0,MG,Tablet,QD,2022,Q4,Altered state of consciousness,,2022,Q4,1,I,20221112.0,20221214.0,20221215,20221215,EXP,,CN-BAYER-2022A171275,BAYER,,75.0,YR,E,F,Y,55.0,KG,20221215,,HP,CN,CN,2022,Q4,Elderly
217338921,21733892,4,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",110.0,MG,,,2111093/NJ,,,10.0,MG,Tablet,QD,2022,Q4,Fall,,2022,Q4,1,I,20221112.0,20221214.0,20221215,20221215,EXP,,CN-BAYER-2022A171275,BAYER,,75.0,YR,E,F,Y,55.0,KG,20221215,,HP,CN,CN,2022,Q4,Elderly
217351371,21735137,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 mg, QD",40.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221208.0,20221215,20221215,EXP,DE-BFARM-22009744,NVSC2022DE285533,NOVARTIS,,63.0,YR,,M,Y,75.0,KG,20221214,,MD,DE,DE,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Infusion related reaction,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Heart rate increased,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Blood pressure diastolic abnormal,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Oxygen saturation decreased,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Blood pressure diastolic increased,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Throat tightness,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Paraesthesia,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Paraesthesia ear,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217358491,21735849,8,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,UNK,,,,,,,,,,,,2022,Q4,Stress,,2022,Q4,1,I,,20221208.0,20221215,20221215,EXP,,CA-PFIZER INC-202201364194,PFIZER,,46.0,YR,,M,Y,,,20221215,,HP,CA,CA,2022,Q4,Adult
217374481,21737448,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,D,,Unknown,,,,,,,2022,Q4,Foetal exposure during pregnancy,,2022,Q4,1,I,,20221202.0,20221216,20221216,EXP,GB-MHRA-ADR 23357992,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-13947,ALKEM,,20.0,WK,,,Y,,,20221216,,MD,GB,GB,2022,Q4,Youth
217374481,21737448,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Transplacental,UNK,,,D,,Unknown,,,,,,,2022,Q4,Congenital hydrocephalus,,2022,Q4,1,I,,20221202.0,20221216,20221216,EXP,GB-MHRA-ADR 23357992,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-13947,ALKEM,,20.0,WK,,,Y,,,20221216,,MD,GB,GB,2022,Q4,Youth
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Blood urea increased,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Glomerular filtration rate increased,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Blood creatinine increased,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377151,21737715,3,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,Y,,,,,10.0,MG,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221130.0,20221216,20221216,EXP,,PL-AUROBINDO-AUR-APL-2022-052580,AUROBINDO,"Korzeniowska K. Hiperkaliemia i zaburzenia czynnosci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny - opis przypadku i przeglad pismiennictwa.. GERIATRIA. 2022;(3):171-178.",91.0,YR,,F,Y,,,20221216,,MD,PL,PL,2022,Q4,Elderly
217377251,21737725,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221202.0,20221216,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-052021,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221216,,HP,CA,CA,2022,Q4,Adult
217377251,21737725,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221202.0,20221216,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-052021,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221216,,HP,CA,CA,2022,Q4,Adult
217377251,21737725,4,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Oral,"5 milligram, Two Times a Day",,,U,,,,,5.0,MG,Tablet,BID,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221202.0,20221216,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-052021,AUROBINDO,,64.0,YR,,M,Y,89.0,KG,20221216,,HP,CA,CA,2022,Q4,Adult
217379261,21737926,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hyponatraemia,,2022,Q4,1,I,20221006.0,20221201.0,20221216,20221216,EXP,,GB-AUROBINDO-AUR-APL-2022-052320,AUROBINDO,,81.0,YR,,M,Y,,,20221216,,MD,GB,GB,2022,Q4,Elderly
217389661,21738966,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,Tablet,QD,2022,Q4,Swelling face,,2022,Q4,1,I,,20221201.0,20221216,20221216,EXP,,GB-AUROBINDO-AUR-APL-2022-052285,AUROBINDO,,62.0,YR,,F,Y,57.0,KG,20221216,,MD,GB,GB,2022,Q4,Adult
217389661,21738966,7,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 dosage form, Once a Day",,,U,,,,,,,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,,20221201.0,20221216,20221216,EXP,,GB-AUROBINDO-AUR-APL-2022-052285,AUROBINDO,,62.0,YR,,F,Y,57.0,KG,20221216,,MD,GB,GB,2022,Q4,Adult
217390021,21739002,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,,10.0,MG,,,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221212.0,20221216,20221216,EXP,DE-BFARM-22009744,DE-MICRO LABS LIMITED-ML2022-06195,MICRO LABS,,63.0,YR,A,M,Y,75.0,KG,20221216,,MD,DE,DE,2022,Q4,Adult
217409451,21740945,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",40.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221209.0,20221216,20221216,EXP,DE-BFARM-22009744,DE-ORGANON-O2212DEU000759,ORGANON,,63.0,YR,,M,Y,75.0,KG,20221216,,MD,DE,DE,2022,Q4,Adult
217436741,21743674,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,Y,,,,,10.0,MG,,,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221207.0,20221217,20221217,EXP,DE-BFARM-22009744,DE-Accord-291947,ACCORD,,63.0,YR,A,M,Y,75.0,KG,20221217,,MD,DE,DE,2022,Q4,Adult
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217441531,21744153,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,,20221203.0,20221218,20221218,EXP,,PL-AUROBINDO-AUR-APL-2022-052966,AUROBINDO,"Korzeniowska K, MaleszaK, Miciak-Lawicka E, Jablecka A.. Hyperkalemia and renal dysfunction after simultaneous the use of sacubitril, valsartan and dapagliflozin ? case report and literature review.. Geriatria. 202;16:171-8",91.0,YR,,F,Y,,,20221218,,MD,PL,PL,2022,Q4,Elderly
217444521,21744452,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Dehydration,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Hypovolaemia,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217444521,21744452,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Hypotension,,2022,Q4,1,I,,20221207.0,20221218,20221218,EXP,,US-PRINSTON PHARMACEUTICAL INC.-2022PRN00455,PRINSTON PHARMACEUTICAL,Schumacher C.. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report.. J Pharm Pract. 2022,64.0,YR,,F,Y,80.0,KG,20221216,,PH,US,US,2022,Q4,Adult
217449771,21744977,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5mg/1000mg,,,,,unknown,,,,,,,2022,Q4,Streptococcal infection,,2022,Q4,1,I,,20221206.0,20221219,20221219,EXP,,PT-NOVOPROD-990344,NOVO NORDISK,Santos A.I.P et. al.. Skin abscess and type 2 diabetes mellitus. Internal Medicine - National Congresses. 2022;953,56.0,YR,,M,Y,,,20221219,,MD,PT,PT,2022,Q4,Adult
217449771,21744977,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5mg/1000mg,,,,,unknown,,,,,,,2022,Q4,Injection site infection,,2022,Q4,1,I,,20221206.0,20221219,20221219,EXP,,PT-NOVOPROD-990344,NOVO NORDISK,Santos A.I.P et. al.. Skin abscess and type 2 diabetes mellitus. Internal Medicine - National Congresses. 2022;953,56.0,YR,,M,Y,,,20221219,,MD,PT,PT,2022,Q4,Adult
217449771,21744977,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5mg/1000mg,,,,,unknown,,,,,,,2022,Q4,Lack of injection site rotation,,2022,Q4,1,I,,20221206.0,20221219,20221219,EXP,,PT-NOVOPROD-990344,NOVO NORDISK,Santos A.I.P et. al.. Skin abscess and type 2 diabetes mellitus. Internal Medicine - National Congresses. 2022;953,56.0,YR,,M,Y,,,20221219,,MD,PT,PT,2022,Q4,Adult
217449771,21744977,3,C,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,DAPAGLIFLOZIN PROPANEDIOL\METFORMIN HYDROCHLORIDE,1,,5mg/1000mg,,,,,unknown,,,,,,,2022,Q4,Treatment noncompliance,,2022,Q4,1,I,,20221206.0,20221219,20221219,EXP,,PT-NOVOPROD-990344,NOVO NORDISK,Santos A.I.P et. al.. Skin abscess and type 2 diabetes mellitus. Internal Medicine - National Congresses. 2022;953,56.0,YR,,M,Y,,,20221219,,MD,PT,PT,2022,Q4,Adult
217456292,21745629,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,10.0,MG,Capsule,QD,2022,Q4,Ischaemic stroke,,2022,Q4,2,F,20221204.0,20221219.0,20221219,20221221,EXP,,PT-ROCHE-3242463,ROCHE,,57.0,YR,,M,Y,87.0,KG,20221221,,MD,PT,,2022,Q4,Adult
217469491,21746949,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",40.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221216.0,20221219,20221219,EXP,DE-BFARM-22009744,DE-009507513-2212DEU006595,MERCK,,63.0,YR,,M,Y,75.0,KG,20221219,,MD,DE,DE,2022,Q4,Adult
217479061,21747906,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,1,I,20221101.0,20221214.0,20221219,20221219,EXP,,CN-009507513-2212CHN006706,MERCK,,75.0,YR,,F,Y,55.0,KG,20221219,,HP,CN,CN,2022,Q4,Elderly
217479061,21747906,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,1,I,20221101.0,20221214.0,20221219,20221219,EXP,,CN-009507513-2212CHN006706,MERCK,,75.0,YR,,F,Y,55.0,KG,20221219,,HP,CN,CN,2022,Q4,Elderly
217479061,21747906,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,,,,,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221101.0,20221214.0,20221219,20221219,EXP,,CN-009507513-2212CHN006706,MERCK,,75.0,YR,,F,Y,55.0,KG,20221219,,HP,CN,CN,2022,Q4,Elderly
217481281,21748128,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 mg, daily",,,,,Unknown,,,20.0,MG,,,2022,Q4,Subdural haematoma,,2022,Q4,1,I,20220520.0,20221212.0,20221219,20221219,EXP,ES-AEMPS-1302483,ES-PFIZER INC-202201366380,PFIZER,,79.0,YR,,F,Y,,,20221219,,PH,ES,ES,2022,Q4,Elderly
217498351,21749835,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,5 milligram,,,U,U,,,,5.0,MG,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20221208.0,20221214.0,20221219,20221219,EXP,,GB-MYLANLABS-2022M1140309,MYLAN,,66.0,YR,,F,Y,,,20221219,,HP,GB,GB,2022,Q4,Elderly
217527441,21752744,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",40.0,MG,Y,,,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221206.0,20221220,20221220,EXP,,DE-AUROBINDO-AUR-APL-2022-053821,AUROBINDO,,63.0,YR,,M,Y,75.0,KG,20221220,,MD,DE,DE,2022,Q4,Adult
217559762,21755976,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,20220101.0,20221219.0,20221220,20221227,EXP,,FR-009507513-2212FRA005950,MERCK,,86.0,YR,,F,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
217559762,21755976,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,2,F,20220101.0,20221219.0,20221220,20221227,EXP,,FR-009507513-2212FRA005950,MERCK,,86.0,YR,,F,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
217559762,21755976,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q4,Pancreatitis necrotising,,2022,Q4,2,F,20220101.0,20221219.0,20221220,20221227,EXP,,FR-009507513-2212FRA005950,MERCK,,86.0,YR,,F,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
217559762,21755976,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q4,Gastrointestinal obstruction,,2022,Q4,2,F,20220101.0,20221219.0,20221220,20221227,EXP,,FR-009507513-2212FRA005950,MERCK,,86.0,YR,,F,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
217559762,21755976,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,U,,,,,,,,,2022,Q4,Polyuria,,2022,Q4,2,F,20220101.0,20221219.0,20221220,20221227,EXP,,FR-009507513-2212FRA005950,MERCK,,86.0,YR,,F,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
217564301,21756430,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1160.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac arrest,,2022,Q4,1,I,20221108.0,20221212.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A403417,ASTRAZENECA,,76.0,YR,,M,Y,,,20221215,,MD,FR,,2022,Q4,Elderly
217564311,21756431,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Haemoglobin increased,,2022,Q4,1,I,,20221207.0,20221220,20221220,EXP,,GB-AstraZeneca-2022A400831,ASTRAZENECA,,49.0,YR,,M,Y,,,20221215,,HP,GB,,2022,Q4,Adult
217564671,21756467,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,20220101.0,20221212.0,20221220,20221220,EXP,,RO-AstraZeneca-2022A407041,ASTRAZENECA,,83.0,YR,,M,Y,,,20221215,,MD,RO,,2022,Q4,Elderly
217564671,21756467,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Death,,2022,Q4,1,I,20220101.0,20221212.0,20221220,20221220,EXP,,RO-AstraZeneca-2022A407041,ASTRAZENECA,,83.0,YR,,M,Y,,,20221215,,MD,RO,,2022,Q4,Elderly
217564951,21756495,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Haemoglobin increased,,2022,Q4,1,I,,20221207.0,20221220,20221220,EXP,,GB-AstraZeneca-2022A400829,ASTRAZENECA,,76.0,YR,,M,Y,,,20221215,,HP,GB,,2022,Q4,Elderly
217565461,21756546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20220214.0,20221206.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A341317,ASTRAZENECA,Ohara E. et al.. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function.. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists 2022;268-.,72.0,YR,,M,Y,54.0,KG,20221215,,MD,JP,,2022,Q4,Elderly
217565461,21756546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,1,I,20220214.0,20221206.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A341317,ASTRAZENECA,Ohara E. et al.. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function.. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists 2022;268-.,72.0,YR,,M,Y,54.0,KG,20221215,,MD,JP,,2022,Q4,Elderly
217565461,21756546,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,1,I,20220214.0,20221206.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A341317,ASTRAZENECA,Ohara E. et al.. P-041 Investigation of adverse events of dapagliflozin in cardiac failure patients with decreased renal function.. The 52th Kanto Block Academic Congress of Japan Society of Hospital Phramacists 2022;268-.,72.0,YR,,M,Y,54.0,KG,20221215,,MD,JP,,2022,Q4,Elderly
217565471,21756547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,330.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220221.0,20221212.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A403427,ASTRAZENECA,,83.0,YR,,M,Y,,,20221215,,MD,FR,,2022,Q4,Elderly
217565471,21756547,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,330.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,1,I,20220221.0,20221212.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A403427,ASTRAZENECA,,83.0,YR,,M,Y,,,20221215,,MD,FR,,2022,Q4,Elderly
217565531,21756553,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,3200.0,MG,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac arrest,,2022,Q4,1,I,20220717.0,20221212.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A403463,ASTRAZENECA,,71.0,YR,,M,Y,,,20221215,,MD,FR,,2022,Q4,Elderly
217566021,21756602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,TAKY exp 01.2025,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asphyxia,,2022,Q4,1,I,20220719.0,20221209.0,20221220,20221220,EXP,,MD-AstraZeneca-2022A406478,ASTRAZENECA,,18509.0,DY,,F,Y,100.0,KG,20221216,,MD,MD,,2022,Q4,Elderly
217566021,21756602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,TAKY exp 01.2025,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pruritus,,2022,Q4,1,I,20220719.0,20221209.0,20221220,20221220,EXP,,MD-AstraZeneca-2022A406478,ASTRAZENECA,,18509.0,DY,,F,Y,100.0,KG,20221216,,MD,MD,,2022,Q4,Elderly
217566021,21756602,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,Y,,TAKY exp 01.2025,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Flushing,,2022,Q4,1,I,20220719.0,20221209.0,20221220,20221220,EXP,,MD-AstraZeneca-2022A406478,ASTRAZENECA,,18509.0,DY,,F,Y,100.0,KG,20221216,,MD,MD,,2022,Q4,Elderly
217566241,21756624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hemiplegia,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A405791,ASTRAZENECA,,69.0,YR,,F,Y,,,20221216,,PH,FR,,2022,Q4,Elderly
217566241,21756624,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A405791,ASTRAZENECA,,69.0,YR,,F,Y,,,20221216,,PH,FR,,2022,Q4,Elderly
217566431,21756643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Urinary retention,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A405015,ASTRAZENECA,,80.0,YR,,M,Y,,,20221216,,MD,JP,,2022,Q4,Elderly
217566431,21756643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Cerebral thrombosis,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A405015,ASTRAZENECA,,80.0,YR,,M,Y,,,20221216,,MD,JP,,2022,Q4,Elderly
217566431,21756643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Urinary tract infection,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A405015,ASTRAZENECA,,80.0,YR,,M,Y,,,20221216,,MD,JP,,2022,Q4,Elderly
217566431,21756643,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,,,,,202293.0,,,Tablet,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221209.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A405015,ASTRAZENECA,,80.0,YR,,M,Y,,,20221216,,MD,JP,,2022,Q4,Elderly
217566461,21756646,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,40.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221208.0,20221220,20221220,EXP,,DE-AstraZeneca-2022A400886,ASTRAZENECA,,63.0,YR,,M,Y,75.0,KG,20221216,,MD,DE,,2022,Q4,Adult
217566562,21756656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20220502.0,20221221.0,20221220,20221229,EXP,,JP-AstraZeneca-2022A405023,ASTRAZENECA,,64.0,YR,,F,Y,53.0,KG,20221229,,MD,JP,,2022,Q4,Adult
217566562,21756656,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,2,F,20220502.0,20221221.0,20221220,20221229,EXP,,JP-AstraZeneca-2022A405023,ASTRAZENECA,,64.0,YR,,F,Y,53.0,KG,20221229,,MD,JP,,2022,Q4,Adult
217566562,21756656,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Weight decreased,,2022,Q4,2,F,20220502.0,20221221.0,20221220,20221229,EXP,,JP-AstraZeneca-2022A405023,ASTRAZENECA,,64.0,YR,,F,Y,53.0,KG,20221229,,MD,JP,,2022,Q4,Adult
217566562,21756656,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,2,F,20220502.0,20221221.0,20221220,20221229,EXP,,JP-AstraZeneca-2022A405023,ASTRAZENECA,,64.0,YR,,F,Y,53.0,KG,20221229,,MD,JP,,2022,Q4,Adult
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Drug interaction,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Venoocclusive disease,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Thirst,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Constipation,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fatigue,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Polyuria,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic ketoacidosis,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217567543,21756754,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pancreatitis necrotising,,2022,Q4,3,F,20221101.0,20221219.0,20221220,20221228,EXP,,FR-AstraZeneca-2022A408429,ASTRAZENECA,,31655.0,DY,,F,Y,,,20221228,,MD,FR,,2022,Q4,Elderly
217569491,21756949,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,350.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Infection,,2022,Q4,1,I,20220101.0,20221216.0,20221220,20221220,EXP,,DK-AstraZeneca-2022A408678,ASTRAZENECA,,81.0,YR,,F,Y,100.0,KG,20221219,,MD,DK,,2022,Q4,Elderly
217569491,21756949,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,350.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fournier's gangrene,,2022,Q4,1,I,20220101.0,20221216.0,20221220,20221220,EXP,,DK-AstraZeneca-2022A408678,ASTRAZENECA,,81.0,YR,,F,Y,100.0,KG,20221219,,MD,DK,,2022,Q4,Elderly
217569861,21756986,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,740.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20221026.0,20221212.0,20221220,20221220,EXP,,JP-AstraZeneca-2022A399450,ASTRAZENECA,,71.0,YR,,M,Y,,,20221220,,MD,JP,,2022,Q4,Elderly
217570051,21757005,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20161201.0,20221212.0,20221220,20221220,EXP,,AU-AstraZeneca-2022A404164,ASTRAZENECA,Dicks J. DAPAGLIFLOZIN AND RECURRENT FOURNIER^S GANGRENE: THE ROLE OF THE PHARMACIST. 46TH NATIONAL CONFERENCE OF THE SOCIETY OF HOSPITAL PHARMACISTSOF AUSTRALIA (SHPA): MEDICINES MANAGEMENT 2022;,54.0,YR,,F,Y,,,20221220,,HP,AU,,2022,Q4,Adult
217570051,21757005,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q4,Necrotising fasciitis,,2022,Q4,1,I,20161201.0,20221212.0,20221220,20221220,EXP,,AU-AstraZeneca-2022A404164,ASTRAZENECA,Dicks J. DAPAGLIFLOZIN AND RECURRENT FOURNIER^S GANGRENE: THE ROLE OF THE PHARMACIST. 46TH NATIONAL CONFERENCE OF THE SOCIETY OF HOSPITAL PHARMACISTSOF AUSTRALIA (SHPA): MEDICINES MANAGEMENT 2022;,54.0,YR,,F,Y,,,20221220,,HP,AU,,2022,Q4,Adult
217570051,21757005,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,Tablet,,2022,Q4,Fournier's gangrene,,2022,Q4,1,I,20161201.0,20221212.0,20221220,20221220,EXP,,AU-AstraZeneca-2022A404164,ASTRAZENECA,Dicks J. DAPAGLIFLOZIN AND RECURRENT FOURNIER^S GANGRENE: THE ROLE OF THE PHARMACIST. 46TH NATIONAL CONFERENCE OF THE SOCIETY OF HOSPITAL PHARMACISTSOF AUSTRALIA (SHPA): MEDICINES MANAGEMENT 2022;,54.0,YR,,F,Y,,,20221220,,HP,AU,,2022,Q4,Adult
217570121,21757012,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,20220101.0,20221212.0,20221220,20221220,EXP,,FR-AstraZeneca-2022A410402,ASTRAZENECA,,45.0,YR,,M,Y,,,20221220,,MD,FR,,2022,Q4,Adult
217570181,21757018,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,GB-AstraZeneca-2022A405554,ASTRAZENECA,,78.0,YR,,M,Y,,,20221220,,PH,GB,,2022,Q4,Elderly
217570181,21757018,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Diabetic foot,,2022,Q4,1,I,,20221212.0,20221220,20221220,EXP,,GB-AstraZeneca-2022A405554,ASTRAZENECA,,78.0,YR,,M,Y,,,20221220,,PH,GB,,2022,Q4,Elderly
217574191,21757419,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,Unknown,,2022,Q4,Immune-mediated hepatitis,,2022,Q4,1,I,,20221207.0,20221220,20221220,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200300168,BRISTOL MYERS SQUIBB,,65.0,YR,E,M,Y,,,20221221,,MD,CA,CA,2022,Q4,Elderly
217574311,21757431,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Underdose,,2022,Q4,1,I,20210203.0,20221121.0,20221220,20221220,PER,,JP-AMGEN-JPNNI2022217361,AMGEN,,21.0,YR,A,M,Y,,,20221220,,MD,JP,JP,2022,Q4,Youth
217583111,21758311,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd (every 1 day)",30.0,MG,Y,U,Unknown,,,10.0,MG,,QD,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221206.0,20221221,20221221,EXP,DE-BFARM-22009744,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-14096,ALKEM,,63.0,YR,,M,Y,75.0,KG,20221221,,MD,DE,DE,2022,Q4,Adult
217597771,21759777,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 OM,,,U,,,,,10.0,MG,Tablet,,2022,Q4,Liver injury,,2022,Q4,1,I,,20221209.0,20221221,20221221,EXP,GB-MHRA-ADR 27537092,GB-Accord-292181,ACCORD,,41.0,YR,A,M,Y,,,20221221,,PH,GB,GB,2022,Q4,Adult
217599491,21759949,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,U,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221213.0,20221221,20221221,EXP,,ZA-AstraZeneca-2022A406353,ASTRAZENECA,,80.0,YR,,F,Y,,,20221221,,CN,ZA,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Glycosuria,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urosepsis,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Tremor,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection bacterial,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Glycosuria,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urosepsis,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Vomiting,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Tremor,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Urinary tract infection bacterial,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217600311,21760031,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10650.0,MG,Y,,NL4324,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221110.0,20221213.0,20221221,20221221,EXP,,CN-AstraZeneca-2022A408396,ASTRAZENECA,,21915.0,DY,,F,Y,60.0,KG,20221221,,MD,CN,,2022,Q4,Elderly
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,General physical health deterioration,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Glucose tolerance impaired,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217602181,21760218,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,COVID-19,,2022,Q4,1,I,20220101.0,20221207.0,20221221,20221221,EXP,,DE-AUROBINDO-AUR-APL-2022-053799,AUROBINDO,,63.0,YR,,M,Y,,,20221221,,MD,DE,DE,2022,Q4,Adult
217606931,21760693,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,Dapagliflozin 5mg / Metformin 1g tablets ? BD;,,,U,U,,,,,,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20221208.0,20221214.0,20221221,20221221,EXP,,GB-EMD Serono-E2B_90090027,EMD SERONO INC,,66.0,YR,E,F,Y,,,20221221,,HP,GB,,2022,Q4,Elderly
217612101,21761210,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,145.0,MG,Y,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hepatic function abnormal,,2022,Q4,1,I,20221028.0,20221213.0,20221221,20221221,EXP,,JP-AstraZeneca-2022A409858,ASTRAZENECA,,76.0,YR,,F,Y,,,20221221,,PH,JP,,2022,Q4,Elderly
217623611,21762361,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,,,,,,,,2022,Q4,Liver injury,,2022,Q4,1,I,,20221209.0,20221221,20221221,EXP,GB-MHRA-MIDB-0b73ab51-29df-474a-a97f-58956012bf89,GB-LABORATORIOS LICONSA S.A.-2212GB05271,INSUD PHARMA,,41.0,YR,,M,Y,,,20221221,,PH,GB,GB,2022,Q4,Adult
217623772,21762377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Cerebral infarction,,2022,Q4,2,F,,20221223.0,20221221,20221230,EXP,,JP-AstraZeneca-2022A409690,ASTRAZENECA,Kanamori T. et al.. E-19 A case of ANCA-associated nephritis during SGLT2 inhibitor use that led to end-stage renal failure in a very short period of time.. The 96th Chubu District Meeting of the Japan Diabetes Society 2022;116.,60.0,YR,,F,Y,,,20221230,,MD,JP,,2022,Q4,Adult
217623772,21762377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Nephritis,,2022,Q4,2,F,,20221223.0,20221221,20221230,EXP,,JP-AstraZeneca-2022A409690,ASTRAZENECA,Kanamori T. et al.. E-19 A case of ANCA-associated nephritis during SGLT2 inhibitor use that led to end-stage renal failure in a very short period of time.. The 96th Chubu District Meeting of the Japan Diabetes Society 2022;116.,60.0,YR,,F,Y,,,20221230,,MD,JP,,2022,Q4,Adult
217623772,21762377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,,20221223.0,20221221,20221230,EXP,,JP-AstraZeneca-2022A409690,ASTRAZENECA,Kanamori T. et al.. E-19 A case of ANCA-associated nephritis during SGLT2 inhibitor use that led to end-stage renal failure in a very short period of time.. The 96th Chubu District Meeting of the Japan Diabetes Society 2022;116.,60.0,YR,,F,Y,,,20221230,,MD,JP,,2022,Q4,Adult
217623772,21762377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221223.0,20221221,20221230,EXP,,JP-AstraZeneca-2022A409690,ASTRAZENECA,Kanamori T. et al.. E-19 A case of ANCA-associated nephritis during SGLT2 inhibitor use that led to end-stage renal failure in a very short period of time.. The 96th Chubu District Meeting of the Japan Diabetes Society 2022;116.,60.0,YR,,F,Y,,,20221230,,MD,JP,,2022,Q4,Adult
217623772,21762377,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,U,,,,202293.0,,,Tablet,,2022,Q4,Malaise,,2022,Q4,2,F,,20221223.0,20221221,20221230,EXP,,JP-AstraZeneca-2022A409690,ASTRAZENECA,Kanamori T. et al.. E-19 A case of ANCA-associated nephritis during SGLT2 inhibitor use that led to end-stage renal failure in a very short period of time.. The 96th Chubu District Meeting of the Japan Diabetes Society 2022;116.,60.0,YR,,F,Y,,,20221230,,MD,JP,,2022,Q4,Adult
217628971,21762897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,Y,,na,,202293.0,,,Tablet,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,20221210.0,20221216.0,20221221,20221221,EXP,,GB-AstraZeneca-2022A410099,ASTRAZENECA,,74.0,YR,,F,Y,,,20221221,,MD,GB,,2022,Q4,Elderly
217628971,21762897,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,Y,,na,,202293.0,,,Tablet,,2022,Q4,Medication error,,2022,Q4,1,I,20221210.0,20221216.0,20221221,20221221,EXP,,GB-AstraZeneca-2022A410099,ASTRAZENECA,,74.0,YR,,F,Y,,,20221221,,MD,GB,,2022,Q4,Elderly
217630901,21763090,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221216.0,20221221,20221221,EXP,,JP-OTSUKA-2022_049674,OTSUKA,,89.0,YR,,F,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
217630901,21763090,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Underdose,,2022,Q4,1,I,,20221216.0,20221221,20221221,EXP,,JP-OTSUKA-2022_049674,OTSUKA,,89.0,YR,,F,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
217630901,21763090,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,,20221216.0,20221221,20221221,EXP,,JP-OTSUKA-2022_049674,OTSUKA,,89.0,YR,,F,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
217630901,21763090,5,SS,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221216.0,20221221,20221221,EXP,,JP-OTSUKA-2022_049674,OTSUKA,,89.0,YR,,F,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
217671111,21767111,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,2111093/NJ,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,1,I,20221112.0,20221214.0,20221222,20221222,EXP,,CN-AstraZeneca-2022A408890,ASTRAZENECA,,27676.0,DY,,F,Y,55.0,KG,20221222,,MD,CN,,2022,Q4,Elderly
217671111,21767111,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,2111093/NJ,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Intentional product misuse,,2022,Q4,1,I,20221112.0,20221214.0,20221222,20221222,EXP,,CN-AstraZeneca-2022A408890,ASTRAZENECA,,27676.0,DY,,F,Y,55.0,KG,20221222,,MD,CN,,2022,Q4,Elderly
217671111,21767111,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,2111093/NJ,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemic coma,,2022,Q4,1,I,20221112.0,20221214.0,20221222,20221222,EXP,,CN-AstraZeneca-2022A408890,ASTRAZENECA,,27676.0,DY,,F,Y,55.0,KG,20221222,,MD,CN,,2022,Q4,Elderly
217671111,21767111,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,110.0,MG,U,,2111093/NJ,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Intentional product misuse,,2022,Q4,1,I,20221112.0,20221214.0,20221222,20221222,EXP,,CN-AstraZeneca-2022A408890,ASTRAZENECA,,27676.0,DY,,F,Y,55.0,KG,20221222,,MD,CN,,2022,Q4,Elderly
217678281,21767828,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK UNK, qd",,,,,UNKNOWN,,,,,,QD,2022,Q4,Off label use,,2022,Q4,1,I,20221026.0,20221220.0,20221222,20221222,EXP,,FR-TAKEDA-2022TUS094919,TAKEDA,,71.0,YR,,F,Y,,,20221222,,HP,FR,FR,2022,Q4,Elderly
217678281,21767828,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"UNK UNK, qd",,,,,UNKNOWN,,,,,,QD,2022,Q4,Clostridium difficile colitis,,2022,Q4,1,I,20221026.0,20221220.0,20221222,20221222,EXP,,FR-TAKEDA-2022TUS094919,TAKEDA,,71.0,YR,,F,Y,,,20221222,,HP,FR,FR,2022,Q4,Elderly
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Genital infection,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Hepatitis,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Back pain,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Fatigue,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Nausea,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217691702,21769170,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1-0-0-0, 10 mg",,,Y,,,,,10.0,MG,UNK,,2022,Q4,Pancreatitis,,2022,Q4,2,F,20170101.0,20221221.0,20221222,20221229,EXP,DE-AMK-262137,DE-TORRENT-00023905,TORRENT,,63.0,YR,A,F,Y,63.0,KG,20221229,,PH,DE,DE,2022,Q4,Adult
217704102,21770410,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q4,Injection site pain,,2022,Q4,2,F,20221101.0,20221226.0,20221223,20221230,EXP,,NVSC2022EG292593,NOVARTIS,,58.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Adult
217704102,21770410,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,2,F,20221101.0,20221226.0,20221223,20221230,EXP,,NVSC2022EG292593,NOVARTIS,,58.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Adult
217704102,21770410,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q4,Arthralgia,,2022,Q4,2,F,20221101.0,20221226.0,20221223,20221230,EXP,,NVSC2022EG292593,NOVARTIS,,58.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Adult
217704102,21770410,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q4,Bone pain,,2022,Q4,2,F,20221101.0,20221226.0,20221223,20221230,EXP,,NVSC2022EG292593,NOVARTIS,,58.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Adult
217704102,21770410,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"1 dosage form, QD",,,,,,,,,,Tablet,QD,2022,Q4,Pain in extremity,,2022,Q4,2,F,20221101.0,20221226.0,20221223,20221230,EXP,,NVSC2022EG292593,NOVARTIS,,58.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Adult
217706991,21770699,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HJ2422,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Regurgitation,,2022,Q4,1,I,20221206.0,20221217.0,20221223,20221223,EXP,,CN-AstraZeneca-2022A412354,ASTRAZENECA,,19857.0,DY,,M,Y,57.0,KG,20221223,,MD,CN,,2022,Q4,Elderly
217706991,21770699,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HJ2422,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal distension,,2022,Q4,1,I,20221206.0,20221217.0,20221223,20221223,EXP,,CN-AstraZeneca-2022A412354,ASTRAZENECA,,19857.0,DY,,M,Y,57.0,KG,20221223,,MD,CN,,2022,Q4,Elderly
217706991,21770699,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HJ2422,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,20221206.0,20221217.0,20221223,20221223,EXP,,CN-AstraZeneca-2022A412354,ASTRAZENECA,,19857.0,DY,,M,Y,57.0,KG,20221223,,MD,CN,,2022,Q4,Elderly
217706991,21770699,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,20.0,MG,Y,,HJ2422,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221206.0,20221217.0,20221223,20221223,EXP,,CN-AstraZeneca-2022A412354,ASTRAZENECA,,19857.0,DY,,M,Y,57.0,KG,20221223,,MD,CN,,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Confusional state,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Personality change,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Balance disorder,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Dysstasia,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Influenza,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Urinary incontinence,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Skin exfoliation,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Head injury,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Fracture,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Spermatic cord inflammation,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Micturition urgency,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Limb injury,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Rhinorrhoea,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217710751,21771075,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,UNK,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20220101.0,20221220.0,20221223,20221223,EXP,,DE-009507513-2212DEU008589,MERCK,,76.0,YR,,M,Y,,,20221223,,CN,DE,DE,2022,Q4,Elderly
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Hepatomegaly,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Mitral valve disease,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Oedema,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Central obesity,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Cardiomegaly,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Lung diffusion test abnormal,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,N-terminal prohormone brain natriuretic peptide increased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Inferior vena cava syndrome,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Arrhythmic storm,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Left ventricular false tendon,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Ventricular arrhythmia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Ventricular internal diameter abnormal,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Left atrial enlargement,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Ventricular hypokinesia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Tricuspid valve incompetence,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Kidney transplant rejection,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,7,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK UNK,,,U,,,,,,,Tablet,,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Hepatomegaly,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Mitral valve disease,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Oedema,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Central obesity,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular tachycardia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Cardiomegaly,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ejection fraction decreased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Lung diffusion test abnormal,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,N-terminal prohormone brain natriuretic peptide increased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Inferior vena cava syndrome,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Arrhythmic storm,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Left ventricular false tendon,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular arrhythmia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular internal diameter abnormal,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain upper,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Left atrial enlargement,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ventricular hypokinesia,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Glomerular filtration rate decreased,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Tricuspid valve incompetence,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Drug ineffective,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Kidney transplant rejection,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711041,21771104,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD (1 tablet in the morning)",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20200701.0,20221215.0,20221223,20221223,EXP,,NVSC2022PL294596,NOVARTIS,,50.0,YR,,M,Y,,,20221223,,MD,PL,PL,2022,Q4,Adult
217711311,21771131,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Paraesthesia,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A408307,ASTRAZENECA,,62.0,YR,,M,Y,79.0,KG,20221223,,MD,GB,,2022,Q4,Adult
217711311,21771131,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Allodynia,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A408307,ASTRAZENECA,,62.0,YR,,M,Y,79.0,KG,20221223,,MD,GB,,2022,Q4,Adult
217716801,21771680,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,770.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Fall,,2022,Q4,1,I,20221117.0,20221220.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A412223,ASTRAZENECA,,25770.0,DY,,M,Y,65.0,KG,20221223,,HP,GB,,2022,Q4,Elderly
217716801,21771680,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,770.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20221117.0,20221220.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A412223,ASTRAZENECA,,25770.0,DY,,M,Y,65.0,KG,20221223,,HP,GB,,2022,Q4,Elderly
217716801,21771680,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,770.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Pneumonia,,2022,Q4,1,I,20221117.0,20221220.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A412223,ASTRAZENECA,,25770.0,DY,,M,Y,65.0,KG,20221223,,HP,GB,,2022,Q4,Elderly
217716801,21771680,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,770.0,MG,,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Cardiac failure,,2022,Q4,1,I,20221117.0,20221220.0,20221223,20221223,EXP,,GB-AstraZeneca-2022A412223,ASTRAZENECA,,25770.0,DY,,M,Y,65.0,KG,20221223,,HP,GB,,2022,Q4,Elderly
217717841,21771784,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"unit dose : 10 mg, frequency time : 1 days, duration  3 days",,,Y,,UNKNOWN,,,10.0,MG,,,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221213.0,20221223,20221223,EXP,DE-BFARM-22009744,DE-TEVA-2022-DE-2836939,TEVA,,63.0,YR,A,M,Y,75.0,KG,20221223,,MD,DE,DE,2022,Q4,Adult
217719061,21771906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dehydration,,2022,Q4,1,I,,20221219.0,20221223,20221223,EXP,,NO-AstraZeneca-2022A410814,ASTRAZENECA,,83.0,YR,,M,Y,,,20221223,,MD,NO,,2022,Q4,Elderly
217719061,21771906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Confusional state,,2022,Q4,1,I,,20221219.0,20221223,20221223,EXP,,NO-AstraZeneca-2022A410814,ASTRAZENECA,,83.0,YR,,M,Y,,,20221223,,MD,NO,,2022,Q4,Elderly
217719061,21771906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketoacidosis,,2022,Q4,1,I,,20221219.0,20221223,20221223,EXP,,NO-AstraZeneca-2022A410814,ASTRAZENECA,,83.0,YR,,M,Y,,,20221223,,MD,NO,,2022,Q4,Elderly
217719061,21771906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypernatraemia,,2022,Q4,1,I,,20221219.0,20221223,20221223,EXP,,NO-AstraZeneca-2022A410814,ASTRAZENECA,,83.0,YR,,M,Y,,,20221223,,MD,NO,,2022,Q4,Elderly
217719061,21771906,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Compression fracture,,2022,Q4,1,I,,20221219.0,20221223,20221223,EXP,,NO-AstraZeneca-2022A410814,ASTRAZENECA,,83.0,YR,,M,Y,,,20221223,,MD,NO,,2022,Q4,Elderly
217724911,21772491,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Noninfective sialoadenitis,,2022,Q4,1,I,20221020.0,20221212.0,20221223,20221223,EXP,,FR-AstraZeneca-2022A397469,ASTRAZENECA,,72.0,YR,,F,Y,87.0,KG,20221223,,MD,FR,,2022,Q4,Elderly
217724911,21772491,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,30.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Dry mouth,,2022,Q4,1,I,20221020.0,20221212.0,20221223,20221223,EXP,,FR-AstraZeneca-2022A397469,ASTRAZENECA,,72.0,YR,,F,Y,87.0,KG,20221223,,MD,FR,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Asthmatic crisis,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Blood glucose increased,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Hypotension,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Syncope,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Asthma,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217727481,21772748,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,5.0,MG,Tablet,QD,2022,Q4,Dizziness,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A411638,ASTRAZENECA,,72.0,YR,,F,Y,,,20221223,,MD,CA,,2022,Q4,Elderly
217728471,21772847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Metabolic disorder,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A410262,ASTRAZENECA,,22.0,YR,,M,Y,60.0,KG,20221223,,MD,CA,,2022,Q4,Youth
217728471,21772847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Glycogen storage disorder,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A410262,ASTRAZENECA,,22.0,YR,,M,Y,60.0,KG,20221223,,MD,CA,,2022,Q4,Youth
217728471,21772847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Lactic acidosis,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A410262,ASTRAZENECA,,22.0,YR,,M,Y,60.0,KG,20221223,,MD,CA,,2022,Q4,Youth
217728471,21772847,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ketoacidosis,,2022,Q4,1,I,,20221215.0,20221223,20221223,EXP,,CA-AstraZeneca-2022A410262,ASTRAZENECA,,22.0,YR,,M,Y,60.0,KG,20221223,,MD,CA,,2022,Q4,Youth
217733301,21773330,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,,1460.0,MG,D,,,,202293.0,10.0,MG,,QD,2022,Q4,Dermo-hypodermitis,,2022,Q4,1,I,20221116.0,20221221.0,20221223,20221223,EXP,,FR-AstraZeneca-2022A413094,ASTRAZENECA,,71.0,YR,,F,Y,91.0,KG,20221223,,MD,FR,,2022,Q4,Elderly
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiogenic shock,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vascular stent thrombosis,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vascular stent thrombosis,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiogenic shock,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiogenic shock,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vascular stent thrombosis,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Vascular stent thrombosis,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Cardiogenic shock,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217736391,21773639,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20221130.0,20221222.0,20221223,20221223,EXP,,DE-BRACCO-2022DE05358,BRACCO,,40.0,YR,,M,Y,,,20221223,,MD,DE,DE,2022,Q4,Adult
217772902,21777290,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,D,,,,,10.0,MG,,,2022,Q4,Off label use,,2022,Q4,2,F,,20221226.0,20221226,20221229,EXP,PL-KRKA-PL2022K16111LIT,PL-STRIDES ARCOLAB LIMITED-2022SP017281,STRIDES,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98,54.0,YR,,F,Y,,,20221229,,MD,PL,PL,2022,Q4,Adult
217772902,21777290,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,D,,,,,10.0,MG,,,2022,Q4,Chronic kidney disease,,2022,Q4,2,F,,20221226.0,20221226,20221229,EXP,PL-KRKA-PL2022K16111LIT,PL-STRIDES ARCOLAB LIMITED-2022SP017281,STRIDES,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98,54.0,YR,,F,Y,,,20221229,,MD,PL,PL,2022,Q4,Adult
217772902,21777290,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,D,,,,,10.0,MG,,,2022,Q4,Muscle spasms,,2022,Q4,2,F,,20221226.0,20221226,20221229,EXP,PL-KRKA-PL2022K16111LIT,PL-STRIDES ARCOLAB LIMITED-2022SP017281,STRIDES,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98,54.0,YR,,F,Y,,,20221229,,MD,PL,PL,2022,Q4,Adult
217772902,21777290,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd",,,D,,,,,10.0,MG,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221226.0,20221226,20221229,EXP,PL-KRKA-PL2022K16111LIT,PL-STRIDES ARCOLAB LIMITED-2022SP017281,STRIDES,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98,54.0,YR,,F,Y,,,20221229,,MD,PL,PL,2022,Q4,Adult
217773291,21777329,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",30.0,MG,Y,,UNK,,,10.0,MG,,,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221212.0,20221226,20221226,EXP,,DE-LAURUS LABS LIMITED-2022LAU000029,LAURUS LABS LIMITED,,63.0,YR,,M,Y,75.0,KG,20221226,,MD,DE,DE,2022,Q4,Adult
217784521,21778452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2205110,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Altered state of consciousness,,2022,Q4,1,I,20221211.0,20221221.0,20221226,20221226,EXP,,CN-AstraZeneca-2022A415780,ASTRAZENECA,,70.0,YR,,M,Y,,,20221226,,MD,CN,,2022,Q4,Elderly
217784521,21778452,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,50.0,MG,U,,2205110,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Coma,,2022,Q4,1,I,20221211.0,20221221.0,20221226,20221226,EXP,,CN-AstraZeneca-2022A415780,ASTRAZENECA,,70.0,YR,,M,Y,,,20221226,,MD,CN,,2022,Q4,Elderly
217791481,21779148,4,C,Dapagliflozin/Metformin tabx 5/1000 mg,,2,,Every 12 hours,,,,,UNK,,,,,,,2022,Q4,Deep vein thrombosis,,2022,Q4,1,I,20221116.0,20221118.0,20221226,20221226,EXP,,CO-ORG100014127-2022001471,HRA PHARMA,,33.0,YR,,F,Y,80.0,KG,20221226,,CN,CO,CO,2022,Q4,Young Adult
217792331,21779233,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10mg 1x/d,2680.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Tubulointerstitial nephritis,,2022,Q4,1,I,20220609.0,20221221.0,20221226,20221226,EXP,,FR-AstraZeneca-2022A413202,ASTRAZENECA,,62.0,YR,,M,Y,105.0,KG,20221226,,MD,FR,,2022,Q4,Adult
217802781,21780278,1,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,U,Unknown,,,,,,,2022,Q4,Liver injury,,2022,Q4,1,I,,20221212.0,20221227,20221227,EXP,GB-MHRA-ADR 27537092,GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2022-14303,ALKEM,,41.0,YR,,M,Y,,,20221227,,PH,GB,GB,2022,Q4,Adult
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Dyspnoea,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood uric acid increased,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Glomerular filtration rate increased,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Oedema peripheral,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood creatinine increased,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Drug ineffective,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Blood urea increased,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217804401,21780440,9,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, Once a Day",,,Y,,,,,10.0,MG,,QD,2022,Q4,Oedema,,2022,Q4,1,I,20211201.0,20221212.0,20221227,20221227,EXP,,PL-AUROBINDO-AUR-APL-2022-054592,AUROBINDO,"Korzeniowska K, Malesza K, Miciak-?awicka E, Jab?ecka A. Hiperkaliemia i zaburzenia czynno?ci nerek po jednoczesnym zastosowaniu sakubitrylu, walsartanu i dapagliflozyny ? opis przypadku i przegl?d pi?miennictwa. Geriatria. 2022;16:171-178",91.0,YR,,F,Y,,,20221227,,MD,PL,PL,2022,Q4,Elderly
217818531,21781853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1180.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash pruritic,,2022,Q4,1,I,20221018.0,20221219.0,20221227,20221227,EXP,,LT-AstraZeneca-2022A414621,ASTRAZENECA,,27781.0,DY,,M,Y,94.0,KG,20221227,,MD,LT,,2022,Q4,Elderly
217818531,21781853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1180.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Renal colic,,2022,Q4,1,I,20221018.0,20221219.0,20221227,20221227,EXP,,LT-AstraZeneca-2022A414621,ASTRAZENECA,,27781.0,DY,,M,Y,94.0,KG,20221227,,MD,LT,,2022,Q4,Elderly
217818531,21781853,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,1180.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Rash,,2022,Q4,1,I,20221018.0,20221219.0,20221227,20221227,EXP,,LT-AstraZeneca-2022A414621,ASTRAZENECA,,27781.0,DY,,M,Y,94.0,KG,20221227,,MD,LT,,2022,Q4,Elderly
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Pancreatitis,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Genital infection,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Hepatitis,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823341,21782334,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,1-0-0-0,18270.0,MG,Y,,,,202293.0,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,1,I,20170101.0,20221219.0,20221227,20221227,EXP,,DE-AstraZeneca-2022A410812,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20221227,,MD,DE,,2022,Q4,Adult
217823611,21782361,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg one per day,,,U,U,,,,10.0,MG,,QD,2022,Q4,Medication error,,2022,Q4,1,I,20221221.0,20221222.0,20221227,20221227,EXP,,GB-EMD Serono-E2B_90090108,EMD SERONO INC,,64.0,YR,A,F,Y,84.0,KG,20221227,,CN,GB,,2022,Q4,Adult
217823611,21782361,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg one per day,,,U,U,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221221.0,20221222.0,20221227,20221227,EXP,,GB-EMD Serono-E2B_90090108,EMD SERONO INC,,64.0,YR,A,F,Y,84.0,KG,20221227,,CN,GB,,2022,Q4,Adult
217823611,21782361,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg one per day,,,U,U,,,,10.0,MG,,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221221.0,20221222.0,20221227,20221227,EXP,,GB-EMD Serono-E2B_90090108,EMD SERONO INC,,64.0,YR,A,F,Y,84.0,KG,20221227,,CN,GB,,2022,Q4,Adult
217823611,21782361,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg one per day,,,U,U,,,,10.0,MG,,QD,2022,Q4,Ageusia,,2022,Q4,1,I,20221221.0,20221222.0,20221227,20221227,EXP,,GB-EMD Serono-E2B_90090108,EMD SERONO INC,,64.0,YR,A,F,Y,84.0,KG,20221227,,CN,GB,,2022,Q4,Adult
217824751,21782475,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,UNK,,,D,,,,,,,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220922.0,20221226.0,20221227,20221227,EXP,FR-AFSSAPS-ST20222481,NVSC2022FR298247,NOVARTIS,,72.0,YR,,M,Y,95.0,KG,20221227,,CN,FR,FR,2022,Q4,Elderly
217832951,21783295,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,unk,,,,,,,2022,Q4,Nervousness,,2022,Q4,1,I,,20221226.0,20221227,20221227,PER,,US-BAYER-2022A175061,BAYER,,76.0,YR,E,M,Y,,,20221227,,CN,US,US,2022,Q4,Elderly
217832951,21783295,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,unk,,,,,,,2022,Q4,Abdominal discomfort,,2022,Q4,1,I,,20221226.0,20221227,20221227,PER,,US-BAYER-2022A175061,BAYER,,76.0,YR,E,M,Y,,,20221227,,CN,US,US,2022,Q4,Elderly
217832951,21783295,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,unk,,,,,,,2022,Q4,Pruritus,,2022,Q4,1,I,,20221226.0,20221227,20221227,PER,,US-BAYER-2022A175061,BAYER,,76.0,YR,E,M,Y,,,20221227,,CN,US,US,2022,Q4,Elderly
217843181,21784318,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Fall,,2022,Q4,1,I,20220101.0,20221222.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A408238,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,PH,JP,,2022,Q4,Elderly
217843181,21784318,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Rib fracture,,2022,Q4,1,I,20220101.0,20221222.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A408238,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,PH,JP,,2022,Q4,Elderly
217843181,21784318,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10.0mg UNKNOWN,,,Y,,,,202293.0,10.0,MG,Tablet,,2022,Q4,Pruritus genital,,2022,Q4,1,I,20220101.0,20221222.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A408238,ASTRAZENECA,,81.0,YR,,M,Y,,,20221227,,PH,JP,,2022,Q4,Elderly
217844211,21784421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,previously had taken the drug half a tablet,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217844211,21784421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,previously had taken the drug half a tablet,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Marasmus,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217844211,21784421,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,previously had taken the drug half a tablet,,,U,,Unknown,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217844211,21784421,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217844211,21784421,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Marasmus,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217844211,21784421,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,,20221219.0,20221227,20221227,EXP,,CN-AstraZeneca-2022A416195,ASTRAZENECA,,57.0,YR,,M,Y,,,20221227,,CN,CN,,2022,Q4,Adult
217845501,21784550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Prinzmetal angina,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,2440.0,MG,Y,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Prinzmetal angina,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217845501,21784550,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,Tablet,,2022,Q4,Prinzmetal angina,,2022,Q4,1,I,20220401.0,20221223.0,20221227,20221227,EXP,,JP-AstraZeneca-2022A209902,ASTRAZENECA,,63.0,YR,,M,Y,59.0,KG,20221227,,MD,JP,,2022,Q4,Adult
217847831,21784783,5,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,,20221222.0,20221227,20221227,EXP,GB-MHRA-MIDB-24654aae-7e94-4296-a530-402c41be1257,GB-DSJP-DSE-2022-146775,DAIICHI,,66.0,YR,,F,Y,,,20221227,,PH,GB,GB,2022,Q4,Elderly
217851751,21785175,6,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 mg,,,U,,Unk,,,10.0,MG,,,2022,Q4,Syncope,,2022,Q4,1,I,20221129.0,20221222.0,20221227,20221227,EXP,PT-INFARMED-F202212-370,NVSC2022PT297676,NOVARTIS,,61.0,YR,,M,Y,75.0,KG,20221227,,MD,PT,PT,2022,Q4,Adult
217854781,21785478,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221221.0,20221227,20221227,EXP,,CA-BAUSCH-BL-2022-027917,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20221227,,HP,CA,CA,2022,Q4,Adult
217854781,21785478,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,,20221221.0,20221227,20221227,EXP,,CA-BAUSCH-BL-2022-027917,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20221227,,HP,CA,CA,2022,Q4,Adult
217854781,21785478,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,1,I,,20221221.0,20221227,20221227,EXP,,CA-BAUSCH-BL-2022-027917,BAUSCH AND LOMB,,64.0,YR,,M,Y,90.0,KG,20221227,,HP,CA,CA,2022,Q4,Adult
217860621,21786062,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Daily",,,Y,,,,,10.0,MG,,,2022,Q4,Haemolytic anaemia,,2022,Q4,1,I,20221125.0,20221214.0,20221228,20221228,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-370213,RANBAXY,,63.0,YR,,M,Y,75.0,KG,20221228,,MD,DE,DE,2022,Q4,Adult
217865361,21786536,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK,(Dapagliflozin 5mg / Metformin 1g tablets ? BD)",,,U,U,,,,,,Tablet,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,20221208.0,20221214.0,20221228,20221228,EXP,,GB-AUROBINDO-AUR-APL-2022-055400,AUROBINDO,,66.0,YR,,F,Y,,,20221228,,HP,GB,GB,2022,Q4,Elderly
217869581,21786958,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,U,Unknown,,,,,,QD,2022,Q4,Thrombocytopenia,,2022,Q4,1,I,20221206.0,20221226.0,20221228,20221228,EXP,FR-AFSSAPS-BR20222810,FR-BRISTOL-MYERS SQUIBB COMPANY-2022-159316,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,73.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Hepatitis,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Genital infection,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Pancreatitis,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217873781,21787378,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, Once a Day (1-0-0-0)",,,Y,,,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20170101.0,20221215.0,20221228,20221228,EXP,,DE-AUROBINDO-AUR-APL-2022-055054,AUROBINDO,,63.0,YR,,F,Y,63.5,KG,20221228,,PH,DE,DE,2022,Q4,Adult
217875771,21787577,8,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,D,,,,,,,Film-coated tablet,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,1,I,20221029.0,20221216.0,20221228,20221228,EXP,FR-EMA-20221212-AUTODUP-1670883827948,FR-Accord-293394,ACCORD,,76.0,YR,A,M,Y,60.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217885851,21788585,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"20 mg, QD",,,Y,U,,,,20.0,MG,Film-coated tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20220802.0,20221222.0,20221228,20221228,EXP,FR-AFSSAPS-AN20222599,NVSC2022FR296125,NOVARTIS,,65.0,YR,,M,Y,108.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Wound,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Abscess,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Cellulitis,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Fournier's gangrene,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Post procedural complication,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217892811,21789281,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Frequency : Daily;?,,,D,D,,,,10.0,MG,,QD,2022,Q4,Postoperative respiratory failure,,2022,Q4,1,I,20221103.0,,20221227,20221227,DIR,642731,,FDA-CTU,,76.0,YR,,F,N,111.4,KG,20221227,N,PH,US,,2022,Q4,Elderly
217900231,21790023,6,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,,,,,QD,2022,Q4,Thrombocytopenia,,2022,Q4,1,I,20221206.0,20221227.0,20221228,20221228,EXP,FR-AFSSAPS-BR20222810,FR-GILEAD-2022-0611054,GILEAD,,74.0,YR,E,M,Y,73.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217905701,21790570,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,N,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,20220906.0,20221221.0,20221228,20221228,EXP,FR-AFSSAPS-AN20222327,FR-MYLANLABS-2022M1146151,MYLAN,,66.0,YR,,M,Y,103.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217905701,21790570,2,I,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"10 milligram, qd",,,Y,N,,,,10.0,MG,Film-coated tablet,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220906.0,20221221.0,20221228,20221228,EXP,FR-AFSSAPS-AN20222327,FR-MYLANLABS-2022M1146151,MYLAN,,66.0,YR,,M,Y,103.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217911511,21791151,5,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,"FORXIGA 10 mg, comprim? pellicul?",,,,,,,,,,Film-coated tablet,QD,2022,Q4,Thrombocytopenia,,2022,Q4,1,I,20221206.0,20221226.0,20221228,20221228,EXP,FR-AFSSAPS-BR20222810,FR-BAUSCH-BL-2022-028127,BAUSCH AND LOMB,,74.0,YR,,M,Y,73.0,KG,20221228,,MD,FR,FR,2022,Q4,Elderly
217913291,21791329,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"1 DF, qd",,,,,,,,,,,QD,2022,Q4,Swollen tongue,,2022,Q4,1,I,20221216.0,20221220.0,20221228,20221228,EXP,GB-MHRA-TPP10425772C3202020YC1671196557272,GB-ESPERIONTHERAPEUTICS-2022GBR02139,ESPERION THERAPEUTICS,,82.0,YR,,F,Y,87.0,KG,20221229,,PH,GB,GB,2022,Q4,Elderly
217922241,21792224,10,C,DAPAGLIFLOZIN PROPANEDIOL,DAPAGLIFLOZIN PROPANEDIOL,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,,20221228.0,20221229,20221229,EXP,,CA-ROCHE-3253304,ROCHE,,64.0,YR,,F,Y,,,20221229,,HP,CA,,2022,Q4,Adult
217925921,21792592,12,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,,,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220922.0,20221227.0,20221229,20221229,EXP,FR-AFSSAPS-ST20222481,FR-SA-2022SA523121,SANOFI AVENTIS,,72.0,YR,E,M,Y,95.0,KG,20221229,,CN,FR,FR,2022,Q4,Elderly
217933201,21793320,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Ageusia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414981,ASTRAZENECA,,64.0,YR,,F,Y,84.0,KG,20221229,,MD,GB,,2022,Q4,Adult
217933201,21793320,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414981,ASTRAZENECA,,64.0,YR,,F,Y,84.0,KG,20221229,,MD,GB,,2022,Q4,Adult
217933201,21793320,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Medication error,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414981,ASTRAZENECA,,64.0,YR,,F,Y,84.0,KG,20221229,,MD,GB,,2022,Q4,Adult
217933201,21793320,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414981,ASTRAZENECA,,64.0,YR,,F,Y,84.0,KG,20221229,,MD,GB,,2022,Q4,Adult
217940211,21794021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Dehydration,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Acidosis,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Brain oedema,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Dehydration,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Acidosis,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Weight decreased,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217940211,21794021,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,Dose unknown,,,N,,,,202293.0,,,Tablet,,2022,Q4,Brain oedema,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,JP-AstraZeneca-2022A415995,ASTRAZENECA,,80.0,YR,,,Y,,,20221229,,MD,JP,,2022,Q4,Elderly
217949271,21794927,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,,,2022,Q4,Guttate psoriasis,,2022,Q4,1,I,20220503.0,20221221.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414948,ASTRAZENECA,,65.0,YR,,F,Y,99.0,KG,20221229,,MD,GB,,2022,Q4,Elderly
217949271,21794927,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,,,2022,Q4,Guttate psoriasis,,2022,Q4,1,I,20220503.0,20221221.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414948,ASTRAZENECA,,65.0,YR,,F,Y,99.0,KG,20221229,,MD,GB,,2022,Q4,Elderly
217949271,21794927,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,,,2022,Q4,Guttate psoriasis,,2022,Q4,1,I,20220503.0,20221221.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414948,ASTRAZENECA,,65.0,YR,,F,Y,99.0,KG,20221229,,MD,GB,,2022,Q4,Elderly
217949271,21794927,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,,,,,202293.0,,,,,2022,Q4,Guttate psoriasis,,2022,Q4,1,I,20220503.0,20221221.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414948,ASTRAZENECA,,65.0,YR,,F,Y,99.0,KG,20221229,,MD,GB,,2022,Q4,Elderly
217949271,21794927,9,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,take one daily,,,,,,,,,,Tablet,,2022,Q4,Guttate psoriasis,,2022,Q4,1,I,20220503.0,20221221.0,20221229,20221229,EXP,,GB-AstraZeneca-2022A414948,ASTRAZENECA,,65.0,YR,,F,Y,99.0,KG,20221229,,MD,GB,,2022,Q4,Elderly
217950691,21795069,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd (10mg one per day; ;)",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-MYLANLABS-2022M1146984,MYLAN,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217950691,21795069,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd (10mg one per day; ;)",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-MYLANLABS-2022M1146984,MYLAN,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217950691,21795069,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd (10mg one per day; ;)",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Ageusia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-MYLANLABS-2022M1146984,MYLAN,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217950691,21795069,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 milligram, qd (10mg one per day; ;)",,,U,U,,,,10.0,MG,Tablet,QD,2022,Q4,Medication error,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,GB-MYLANLABS-2022M1146984,MYLAN,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217951531,21795153,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,NVSC2022GB296924,NOVARTIS,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217951531,21795153,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Nausea,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,NVSC2022GB296924,NOVARTIS,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217951531,21795153,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Medication error,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,NVSC2022GB296924,NOVARTIS,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217951531,21795153,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"10 mg, QD",,,U,,,,,10.0,MG,Tablet,QD,2022,Q4,Ageusia,,2022,Q4,1,I,20221221.0,20221222.0,20221229,20221229,EXP,,NVSC2022GB296924,NOVARTIS,,64.0,YR,,F,Y,84.0,KG,20221229,,CN,GB,GB,2022,Q4,Adult
217952351,21795235,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Muscle spasms,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,PL-AstraZeneca-2022A413077,ASTRAZENECA,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98.,54.0,YR,,F,Y,,,20221229,,MD,PL,,2022,Q4,Adult
217952351,21795235,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,PL-AstraZeneca-2022A413077,ASTRAZENECA,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98.,54.0,YR,,F,Y,,,20221229,,MD,PL,,2022,Q4,Adult
217952351,21795235,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10.0mg UNKNOWN,,,,,,,,10.0,MG,,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,,20221221.0,20221229,20221229,EXP,,PL-AstraZeneca-2022A413077,ASTRAZENECA,Rosentryt P.. A 54-year-old woman with hypertension and chronic kidney disease.. Med. Prakt. 2022;10:93-98.,54.0,YR,,F,Y,,,20221229,,MD,PL,,2022,Q4,Adult
217955301,21795530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Drug interaction,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217955301,21795530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Hypotension,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217955301,21795530,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,"10 mg, 1x/day",,,U,,,,,10.0,MG,,QD,2022,Q4,Dehydration,,2022,Q4,1,I,,20221216.0,20221229,20221229,EXP,,US-JUBILANT CADISTA PHARMACEUTICALS-2022JUB00503,JUBILANT,Schumacher C. Severe Hypotension With Concomitant Sodium-Glucose Co-Transporter-2 Inhibitor and Angiotensin Receptor-Neprilysin Inhibitor Therapy in a Patient With Heart Failure Reduced Ejection Fraction: A Case Report. Journal of Pharmacy Practice. 2022;0:1-5,64.0,YR,,F,Y,80.0,KG,20221229,,HP,US,US,2022,Q4,Adult
217959211,21795921,4,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,,10.0,MG,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20220115.0,20221226.0,20221229,20221229,EXP,FR-AFSSAPS-LL20223590,FR-BAUSCH-BL-2022-028121,BAUSCH AND LOMB,,57.0,YR,,M,Y,,,20221229,,MD,FR,FR,2022,Q4,Adult
217965141,21796514,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,UNKNOWN,,,10.0,MG,,,2022,Q4,Hepatic function abnormal,,2022,Q4,1,I,20220816.0,20221228.0,20221229,20221229,EXP,,JP-ROCHE-3253734,ROCHE,,50.0,YR,,F,Y,72.2,KG,20221230,,MD,JP,JP,2022,Q4,Adult
217965141,21796514,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,UNKNOWN,,,10.0,MG,,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20220816.0,20221228.0,20221229,20221229,EXP,,JP-ROCHE-3253734,ROCHE,,50.0,YR,,F,Y,72.2,KG,20221230,,MD,JP,JP,2022,Q4,Adult
217965141,21796514,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,UNKNOWN,,,10.0,MG,,,2022,Q4,Nausea,,2022,Q4,1,I,20220816.0,20221228.0,20221229,20221229,EXP,,JP-ROCHE-3253734,ROCHE,,50.0,YR,,F,Y,72.2,KG,20221230,,MD,JP,JP,2022,Q4,Adult
217965141,21796514,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,,,UNKNOWN,,,10.0,MG,,,2022,Q4,Dizziness,,2022,Q4,1,I,20220816.0,20221228.0,20221229,20221229,EXP,,JP-ROCHE-3253734,ROCHE,,50.0,YR,,F,Y,72.2,KG,20221230,,MD,JP,JP,2022,Q4,Adult
217967231,21796723,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,20220101.0,20221220.0,20221230,20221230,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32414",IPSEN,,79.0,YR,E,M,Y,,,20221230,,CN,CA,CA,2022,Q4,Elderly
217967231,21796723,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,20220101.0,20221220.0,20221230,20221230,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32414",IPSEN,,79.0,YR,E,M,Y,,,20221230,,CN,CA,CA,2022,Q4,Elderly
217967231,21796723,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q4,Oxygen saturation decreased,,2022,Q4,1,I,20220101.0,20221220.0,20221230,20221230,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32414",IPSEN,,79.0,YR,E,M,Y,,,20221230,,CN,CA,CA,2022,Q4,Elderly
217967231,21796723,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 mg,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20220101.0,20221220.0,20221230,20221230,EXP,,"CA-Ipsen Biopharmaceuticals, Inc.-2022-32414",IPSEN,,79.0,YR,E,M,Y,,,20221230,,CN,CA,CA,2022,Q4,Elderly
217969701,21796970,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tab qd,,,,,unknown,,,,,,,2022,Q4,Rash,,2022,Q4,1,I,20220929.0,20221222.0,20221230,20221230,EXP,GB-MHRA-TPP41525543C4757292YC1664450072842,GB-NOVOPROD-1006149,NOVO NORDISK,,55.0,YR,,M,Y,74.0,KG,20221230,,HP,GB,GB,2022,Q4,Adult
217969701,21796970,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tab qd,,,,,unknown,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20220929.0,20221222.0,20221230,20221230,EXP,GB-MHRA-TPP41525543C4757292YC1664450072842,GB-NOVOPROD-1006149,NOVO NORDISK,,55.0,YR,,M,Y,74.0,KG,20221230,,HP,GB,GB,2022,Q4,Adult
217969701,21796970,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tab qd,,,,,unknown,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20220929.0,20221222.0,20221230,20221230,EXP,GB-MHRA-TPP41525543C4757292YC1664450072842,GB-NOVOPROD-1006149,NOVO NORDISK,,55.0,YR,,M,Y,74.0,KG,20221230,,HP,GB,GB,2022,Q4,Adult
217969701,21796970,3,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,1 Tab qd,,,,,unknown,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,1,I,20220929.0,20221222.0,20221230,20221230,EXP,GB-MHRA-TPP41525543C4757292YC1664450072842,GB-NOVOPROD-1006149,NOVO NORDISK,,55.0,YR,,M,Y,74.0,KG,20221230,,HP,GB,GB,2022,Q4,Adult
217992571,21799257,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20221126.0,20221224.0,20221230,20221230,EXP,,NVSC2022EG279108,NOVARTIS,,65.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Elderly
217992571,21799257,2,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Product dispensing error,,2022,Q4,1,I,20221126.0,20221224.0,20221230,20221230,EXP,,NVSC2022EG279108,NOVARTIS,,65.0,YR,,F,Y,,,20221230,,CN,EG,EG,2022,Q4,Elderly
217994301,21799430,11,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,,,,,,,,,QD,2022,Q4,Cough,,2022,Q4,1,I,,20221229.0,20221230,20221230,EXP,GB-MHRA-TPP16373293C8701962YC1671466834982,"GB-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-210440",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,75.0,KG,20221230,,PH,GB,GB,2022,Q4,Elderly
217995901,21799590,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,QD,2022,Q4,Seroma,,2022,Q4,1,I,20220703.0,20221222.0,20221230,20221230,EXP,,RU-drreddys-LIT/RUS/22/0159197,DR REDDYS,"Pavlenko T, Lebedeva A, Protsenko D. Bridging therapy according to new clinical guidelines: A review. Cons med. 2022;24(10):703-12. doi:10.26442/20751753.2022.10.201912",66.0,YR,E,,Y,,,20221230,,HP,RU,RU,2022,Q4,Elderly
217995901,21799590,12,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,,,,U,U,UNKNOWN,,,,,,QD,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20220703.0,20221222.0,20221230,20221230,EXP,,RU-drreddys-LIT/RUS/22/0159197,DR REDDYS,"Pavlenko T, Lebedeva A, Protsenko D. Bridging therapy according to new clinical guidelines: A review. Cons med. 2022;24(10):703-12. doi:10.26442/20751753.2022.10.201912",66.0,YR,E,,Y,,,20221230,,HP,RU,RU,2022,Q4,Elderly
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Back pain,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Genital infection,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Hepatitis,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Fatigue,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Pancreatitis,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218003891,21800389,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,,10 Milligram Daily; 1-0-0-0,,,Y,,UNKNOWN,,,10.0,MG,,QD,2022,Q4,Nausea,,2022,Q4,1,I,20170101.0,20221222.0,20221230,20221230,EXP,DE-AMK-262137,DE-TEVA-2022-DE-2840470,TEVA,,63.0,YR,A,F,Y,63.5,KG,20221230,,PH,DE,DE,2022,Q4,Adult
218007831,21800783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Generalised oedema,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Generalised oedema,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Condition aggravated,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218007831,21800783,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,10.0,MG,U,,,,202293.0,10.0,MG,Tablet,QD,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20221213.0,20221222.0,20221230,20221230,EXP,,CZ-AstraZeneca-2022A414215,ASTRAZENECA,,84.0,YR,,F,Y,,,20221230,,MD,CZ,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Hypertension,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Gangrene,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Localised infection,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Foot amputation,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218009251,21800925,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Extremity necrosis,,2022,Q4,1,I,20221014.0,20221223.0,20221230,20221230,EXP,,BR-AstraZeneca-2022A417844,ASTRAZENECA,,20120.0,DY,,F,Y,,,20221230,,CN,BR,,2022,Q4,Elderly
218010031,21801003,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,Unknown,,,10.0,MG,Tablet,QD,2022,Q4,Asthenia,,2022,Q4,1,I,20221227.0,20221227.0,20221230,20221230,EXP,,UA-AstraZeneca-2022A418333,ASTRAZENECA,,22989.0,DY,,M,Y,,,20221230,,MD,UA,,2022,Q4,Elderly
218010031,21801003,2,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,D,,Unknown,,,10.0,MG,Tablet,QD,2022,Q4,Aneurysm ruptured,,2022,Q4,1,I,20221227.0,20221227.0,20221230,20221230,EXP,,UA-AstraZeneca-2022A418333,ASTRAZENECA,,22989.0,DY,,M,Y,,,20221230,,MD,UA,,2022,Q4,Elderly
218010081,21801008,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Medication error,,2022,Q4,1,I,,20221222.0,20221230,20221230,EXP,,GB-AstraZeneca-2022A416249,ASTRAZENECA,,58.0,YR,,F,Y,,,20221230,,MD,GB,,2022,Q4,Adult
218010081,21801008,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,,,U,,,,202293.0,,,Tablet,,2022,Q4,Diabetic ketosis,,2022,Q4,1,I,,20221222.0,20221230,20221230,EXP,,GB-AstraZeneca-2022A416249,ASTRAZENECA,,58.0,YR,,F,Y,,,20221230,,MD,GB,,2022,Q4,Adult
218010101,21801010,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,200.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20220129.0,20221223.0,20221230,20221230,EXP,,DE-AstraZeneca-2022A415539,ASTRAZENECA,,66.0,YR,,M,Y,95.0,KG,20221230,,MD,DE,,2022,Q4,Elderly
218010101,21801010,1,PS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,,200.0,MG,U,,,,202293.0,10.0,MG,,QD,2022,Q4,Syncope,,2022,Q4,1,I,20220129.0,20221223.0,20221230,20221230,EXP,,DE-AstraZeneca-2022A415539,ASTRAZENECA,,66.0,YR,,M,Y,95.0,KG,20221230,,MD,DE,,2022,Q4,Elderly
218025541,21802554,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221217.0,20221231,20221231,EXP,,PL-AUROBINDO-AUR-APL-2022-055840,AUROBINDO,Rosentryt P. A 54-year-old woman with hypertension and chronic kidney disease. Med. Prakt.. Med. Prakt.. 2022;10:93-98,54.0,YR,,F,Y,,,20221231,,MD,PL,PL,2022,Q4,Adult
218025541,21802554,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,,20221217.0,20221231,20221231,EXP,,PL-AUROBINDO-AUR-APL-2022-055840,AUROBINDO,Rosentryt P. A 54-year-old woman with hypertension and chronic kidney disease. Med. Prakt.. Med. Prakt.. 2022;10:93-98,54.0,YR,,F,Y,,,20221231,,MD,PL,PL,2022,Q4,Adult
218025541,21802554,10,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,10 milligram,,,U,,,,,10.0,MG,,,2022,Q4,Muscle spasms,,2022,Q4,1,I,,20221217.0,20221231,20221231,EXP,,PL-AUROBINDO-AUR-APL-2022-055840,AUROBINDO,Rosentryt P. A 54-year-old woman with hypertension and chronic kidney disease. Med. Prakt.. Med. Prakt.. 2022;10:93-98,54.0,YR,,F,Y,,,20221231,,MD,PL,PL,2022,Q4,Adult
218026861,21802686,3,SS,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Oral,10 mg,,,U,,Unk,,,10.0,MG,,,2022,Q4,Metabolic acidosis,,2022,Q4,1,I,20220115.0,20221226.0,20221231,20221231,EXP,FR-AFSSAPS-LL20223590,NVSC2022FR298627,NOVARTIS,,57.0,YR,,M,Y,,,20221231,,MD,FR,FR,2022,Q4,Adult
218027021,21802702,4,C,DAPAGLIFLOZIN,DAPAGLIFLOZIN,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fall,,2022,Q4,1,I,,20221218.0,20221231,20221231,EXP,,GB-AUROBINDO-AUR-APL-2022-056116,AUROBINDO,,91.0,YR,,,Y,,,20221231,,PH,GB,GB,2022,Q4,Elderly
